data_1q38_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q38 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.622 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -72.8 150.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.622 ' N ' HG13 ' A' ' 12' ' ' ILE . 3.6 m -52.08 -44.89 64.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.006 0.431 . . . . 0.0 110.156 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -171.62 143.84 1.78 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.858 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.58 146.77 28.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.824 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -114.68 125.04 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.668 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.93 114.5 27.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.355 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.3 mtp180 -115.07 129.61 56.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.424 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.69 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.3 p90 -142.22 148.94 38.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 111.76 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -155.69 142.93 13.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.637 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 53.0 Cg_exo -57.6 109.94 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 50' ' ' VAL . 1.2 tptp -77.22 -23.66 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -95.26 -20.38 19.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -110.67 2.0 18.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.984 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 24' ' ' SER . 6.0 p 33.77 85.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.129 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.45 -147.21 6.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.532 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -96.32 157.87 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 67.5 m95 -87.99 173.92 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.686 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttp -145.59 155.05 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -123.96 140.33 53.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.339 0.59 . . . . 0.0 112.407 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.73 112.06 7.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.592 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -91.06 127.94 36.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.766 HG22 HD22 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -137.56 107.46 8.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.727 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 23.4 Cg_exo -64.77 91.9 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.583 2.189 . . . . 0.0 113.025 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.84 -152.26 50.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.677 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -107.45 71.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.766 HD22 HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.3 -31.69 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.634 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.58 179.88 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -77.0 106.81 8.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -123.29 113.31 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -128.55 127.85 43.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.26 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.6 123.57 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.652 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HB3' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -123.16 -156.49 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' A' ' 43' ' ' LYS . . . 94.93 14.98 47.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.989 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD21 ' CE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -101.63 -166.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.62 162.29 37.06 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.745 0.307 . . . . 0.0 111.4 -179.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 45.5 Cg_endo -68.38 146.36 68.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.264 1.976 . . . . 0.0 112.628 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.0 0.14 83.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.202 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 46' ' ' LYS . 5.5 p -120.29 137.97 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.961 0.381 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.483 HG21 HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -114.56 129.57 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.184 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.64 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 34.4 m-85 -104.98 -178.16 3.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 mm-40 -123.25 130.12 52.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.52 129.25 7.64 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.314 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.67 114.33 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.405 0.145 . . . . 0.0 110.776 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 3.5 mt -101.99 107.01 18.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 0.0 110.827 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.0 mp -109.47 117.74 55.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.675 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -81.5 140.33 34.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.488 0.661 . . . . 0.0 111.098 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG22 ' HA2' ' A' ' 62' ' ' GLY . 29.7 mt -119.09 132.45 68.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.452 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.657 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -106.88 -173.43 2.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -24.8 64.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.38 -5.51 22.87 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.572 0.225 . . . . 0.0 111.598 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.509 ' HA2' HG22 ' A' ' 58' ' ' ILE . . . 82.5 154.52 14.99 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.146 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 62.77 96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.71 0.404 . . . . 0.0 111.633 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.657 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 10.3 mm100 -124.05 -89.93 0.58 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 112.315 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.49 145.35 26.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.98 114.5 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 134.47 47.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.758 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 127.7 55.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -136.1 160.56 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.136 0.493 . . . . 0.0 111.656 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.0 150.76 20.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.883 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.9 140.43 49.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.483 HG22 HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.888 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 p80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.92 0.391 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.545 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -73.02 149.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.712 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.545 ' N ' HG13 ' A' ' 12' ' ' ILE . 7.8 t -44.62 -51.01 9.47 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 110.456 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 16' ' ' ILE . 4.1 pttt -171.48 143.95 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -105.78 136.77 44.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD13 ' HD2' ' A' ' 14' ' ' LYS . 3.0 mp -114.64 124.72 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.857 0.36 . . . . 0.0 110.679 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 25.8 tp -104.99 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -115.91 129.58 56.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.027 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.594 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 19.7 p90 -153.2 157.58 40.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.038 0.447 . . . . 0.0 111.541 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -159.39 156.9 26.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.79 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.93 117.71 4.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.137 1.891 . . . . 0.0 112.386 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -34.73 64.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -90.56 -34.57 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -169.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.596 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.09 168.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.65 -166.13 28.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.95 160.24 14.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -74.83 -179.94 4.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -146.24 127.57 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.103 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.29 134.46 55.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 111.915 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.86 133.22 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.194 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.1 m -85.76 132.07 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.175 0.512 . . . . 0.0 111.693 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.94 118.38 20.89 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.983 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 36' ' ' HIS . 53.9 Cg_exo -56.53 78.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.905 2.403 . . . . 0.0 113.462 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.74 10.35 0.97 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.259 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.452 ' H ' ' C ' ' A' ' 34' ' ' PRO . 1.8 t-160 74.68 104.19 0.07 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.877 0.37 . . . . 0.0 110.358 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 37' ' ' LEU . 7.5 mp -65.82 -35.22 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.0 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.22 -63.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.85 116.38 20.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -128.02 109.56 11.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.389 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -116.68 146.26 42.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.568 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 45' ' ' LEU . 2.2 mt -96.09 134.73 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.575 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -108.7 171.16 7.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 47.66 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.268 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -141.51 -169.34 2.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.49 146.44 12.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.47 122.97 10.78 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.612 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.27 9.53 2.97 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.246 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.35 130.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.901 0.35 . . . . 0.0 111.407 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 23' ' ' ASN . 11.3 t -83.02 145.37 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.22 166.07 26.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.59 0.709 . . . . 0.0 112.131 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.2 tp10 -133.24 128.67 36.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.67 139.87 11.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.517 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -133.52 131.63 40.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.773 0.321 . . . . 0.0 110.749 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.407 HD21 HD12 ' A' ' 17' ' ' LEU . 6.0 mt -99.92 109.91 22.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.456 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.3 mp -108.14 115.42 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.15 121.66 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.432 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 1.4 mt -113.4 113.4 43.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.519 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.29 -176.41 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.2 -18.31 57.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.168 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 64' ' ' GLN . 2.6 p90 -103.25 -4.78 23.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.94 -178.35 16.38 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.866 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.9 p80 -53.18 161.38 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.687 0.28 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 1.9 pt20 -170.24 0.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.663 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -145.45 116.8 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.468 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.431 HG21 HG13 ' A' ' 56' ' ' ILE . 42.0 t -134.23 123.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.535 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.23 121.73 18.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.04 138.76 34.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.027 0.442 . . . . 0.0 111.767 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -156.38 126.85 6.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.767 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -95.41 137.93 33.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -139.65 149.11 43.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.009 0.433 . . . . 0.0 111.548 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.543 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.808 0.337 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.655 HG13 ' N ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -72.26 150.09 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.655 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.34 -50.95 37.51 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -171.55 144.58 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.366 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -104.52 139.56 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.256 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 16' ' ' ILE . 17.5 mm -117.07 124.04 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.091 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 55' ' ' LEU . 26.8 tp -105.63 113.99 27.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.858 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.94 128.92 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.631 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.585 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -156.69 148.4 22.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.141 0.496 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 161.21 33.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.619 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' SER . 48.9 Cg_exo -57.72 117.56 4.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.281 1.988 . . . . 0.0 112.357 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -66.94 -36.84 83.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.503 -179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.472 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 1.7 t-20 -96.44 -43.43 7.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.267 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.51 165.87 16.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.13 152.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.74 -127.68 1.53 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -139.93 168.76 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.45 173.39 12.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.94 137.59 36.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.69 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.3 mt-10 -120.22 133.31 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.038 0.447 . . . . 0.0 111.832 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -139.62 117.74 11.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.202 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.4 m -86.3 131.06 34.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.09 0.472 . . . . 0.0 112.147 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 37' ' ' LEU . 1.6 mp -133.77 106.42 11.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.757 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.63 90.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.438 2.092 . . . . 0.0 112.378 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.69 -93.29 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.15 93.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -68.26 -33.96 75.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.855 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.671 ' N ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 169.02 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.72 117.22 21.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.035 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -115.82 113.69 23.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.842 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -122.99 130.18 52.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 45' ' ' LEU . 4.6 mm -85.5 127.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -173.36 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 39.01 53.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.591 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' CD1' HG21 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -141.89 -174.18 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.8 151.27 12.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.244 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.17 168.62 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.8 -7.03 60.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.674 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.86 121.56 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 1.6 p -82.44 103.24 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.67 160.03 14.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.135 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.585 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 1.6 tp10 -117.79 129.11 55.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.64 145.15 16.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.149 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -133.77 131.91 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.057 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.661 HD12 HD11 ' A' ' 17' ' ' LEU . 4.9 tp -119.01 107.31 13.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.899 0.381 . . . . 0.0 111.051 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.6 mp -116.67 116.44 52.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.907 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -89.8 126.38 35.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.72 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 2.7 mp -113.15 125.26 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.235 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -101.15 -177.31 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.506 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -64.3 -26.78 68.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.54 -0.39 43.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.12 169.11 13.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.73 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 8.8 p80 -56.98 151.97 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 6.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 tt0 -143.66 116.74 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.18 121.21 31.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 m -134.96 121.52 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -100.94 129.7 46.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.69 132.6 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.305 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 151.24 19.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.63 153.9 35.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.052 0.453 . . . . 0.0 111.811 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.709 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.2 m80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.764 0.316 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -98.38 149.56 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.606 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -48.11 -47.56 34.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.891 0.377 . . . . 0.0 110.299 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -175.45 143.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.829 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.78 139.01 39.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.1 mm -116.07 129.31 72.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.607 HD11 HD21 ' A' ' 55' ' ' LEU . 28.5 tp -105.03 113.01 26.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.01 129.01 52.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -152.12 150.08 29.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.335 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.538 HH11 ' HA ' ' A' ' 25' ' ' VAL . 7.1 ptt85 -148.51 160.84 35.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.33 114.59 2.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.172 1.915 . . . . 0.0 111.622 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -61.8 -30.89 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.702 HD21 HG12 ' A' ' 50' ' ' VAL . 2.0 p30 -99.48 -38.79 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -3.27 57.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.538 ' HA ' HH11 ' A' ' 20' ' ' ARG . 32.9 m 35.44 41.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.092 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.37 -160.4 12.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -73.66 169.11 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.447 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 37.3 m95 -99.51 173.11 6.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.493 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.22 139.51 41.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.345 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -120.37 134.7 55.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 116.96 10.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.947 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 60.1 m -85.33 138.95 31.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.274 0.559 . . . . 0.0 112.475 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.79 HG21 ' HA ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -135.45 107.07 10.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.476 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.26 87.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.83 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.16 25.91 48.36 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.941 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.79 ' HA ' HG21 ' A' ' 33' ' ' ILE . 0.3 OUTLIER 58.62 99.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.832 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -72.86 -22.46 60.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.578 ' N ' HD23 ' A' ' 37' ' ' LEU . 17.8 t-20 -176.82 -105.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.2 p -127.19 121.73 32.11 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.64 103.38 10.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -115.85 142.97 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.233 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.624 HG23 HD11 ' A' ' 45' ' ' LEU . 2.5 mt -86.5 125.38 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -101.1 168.9 9.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -140.43 23.41 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.404 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 57.32 -167.97 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.563 0.22 . . . . 0.0 111.197 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.44 147.23 24.79 Favored Pre-proline 0 CA--C 1.527 0.082 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.49 45.04 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.995 2.463 . . . . 0.0 113.219 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.98 -19.01 7.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.516 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -120.56 136.86 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.935 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.702 HG12 HD21 ' A' ' 23' ' ' ASN . 9.5 p -77.63 147.0 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.15 148.21 51.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 112.307 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -111.93 129.82 56.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.806 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 136.97 13.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.597 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' NE2' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.86 123.66 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.449 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD21 HD11 ' A' ' 17' ' ' LEU . 3.8 mt -108.18 108.97 20.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 111.021 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.672 HD13 ' HB ' ' A' ' 66' ' ' VAL . 1.3 mm -112.35 118.7 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.672 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.96 133.86 41.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.289 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.827 HG12 ' HB3' ' A' ' 63' ' ' HIS . 6.4 mt -113.65 127.48 70.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 111.644 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' A' ' 12' ' ' ILE . 2.8 mm100 -95.18 -176.46 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -32.25 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.66 15.48 28.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.73 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.05 161.04 12.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.237 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.827 ' HB3' HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.55 163.78 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.722 0.296 . . . . 0.0 110.986 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.44 6.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.66 115.89 12.57 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.958 0.408 . . . . 0.0 111.607 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.672 ' HB ' HD13 ' A' ' 56' ' ' ILE . 1.2 p -136.03 139.07 46.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -137.06 136.05 38.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.34 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HG2' ' NE2' ' A' ' 54' ' ' GLN . 1.6 mtm180 -111.32 129.46 55.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -156.02 127.98 7.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.805 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.68 132.78 39.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.074 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -136.61 150.76 48.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.831 -179.238 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.723 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 32.7 m-70 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.744 0.307 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.633 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -67.28 150.14 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.1 t -49.76 -48.98 49.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.707 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HZ1' HD13 ' A' ' 16' ' ' ILE . 4.3 ptmt -169.72 144.25 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.993 0.425 . . . . 0.0 111.445 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -105.19 139.12 40.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.952 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD13 ' HZ1' ' A' ' 14' ' ' LYS . 28.5 mm -114.45 117.97 57.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.525 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.727 HD13 HD11 ' A' ' 55' ' ' LEU . 42.6 tp -104.9 113.74 27.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.831 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -119.34 128.72 54.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.913 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 8.6 p90 -151.63 162.16 41.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.904 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.16 161.69 27.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.684 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.53 118.94 5.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 121.906 1.737 . . . . 0.0 111.832 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -29.67 70.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.528 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -99.39 -41.17 7.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.471 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 160.06 17.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.281 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.77 147.44 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.31 -164.72 37.38 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.63 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -89.14 155.6 19.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.96 -172.59 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.78 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -141.16 144.33 34.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.8 mt-10 -120.05 132.95 55.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.202 0.525 . . . . 0.0 111.792 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 118.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.937 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 87.7 m -85.42 132.5 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 112.091 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 14.4 mt -123.88 107.56 30.95 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.759 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.7 104.26 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.603 2.202 . . . . 0.0 112.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.723 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . 58.8 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.159 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -146.06 111.82 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.243 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 -3.52 56.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.77 -63.91 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.872 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.76 105.22 8.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 110.818 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -126.47 115.21 19.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -120.57 144.47 48.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.257 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.3 mt -94.33 132.68 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.506 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.39 154.38 25.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.227 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 38.13 4.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.642 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 171.02 11.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.328 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 135.96 10.47 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.29 157.95 10.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.659 2.24 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.37 -62.08 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.611 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.13 133.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 111.173 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 51' ' ' TYR . 5.3 p -82.85 144.76 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.027 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -125.4 138.92 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.945 0.402 . . . . 0.0 111.923 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 10.7 tp10 -105.22 129.29 53.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.5 144.67 15.72 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 119.822 -1.18 . . . . 0.0 114.309 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -133.66 129.47 36.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.377 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 17' ' ' LEU . 4.7 tp -124.9 106.67 10.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.88 116.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.941 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.407 ' OG ' HG23 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.42 127.43 33.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 63' ' ' HIS . 15.1 mm -112.84 124.39 69.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.309 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 -177.1 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.24 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.42 -2.54 28.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.54 -166.4 12.15 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.438 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.582 ' HA ' HD11 ' A' ' 58' ' ' ILE . 21.1 p-80 -64.65 140.81 58.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.319 . . . . 0.0 110.707 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 -51.59 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.2 126.18 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.484 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 123.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -137.41 130.85 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -111.46 139.55 46.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -155.94 127.83 7.44 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.028 0.442 . . . . 0.0 111.501 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.82 124.1 39.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.7 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -125.18 162.73 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.85 0.357 . . . . 0.0 111.741 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.388 -179.708 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.8 m80 . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.505 0.193 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.553 HG13 ' HG2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -67.4 156.39 6.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.914 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.468 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.19 -41.51 65.33 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -162.39 143.15 10.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.831 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.756 ' HH ' HD21 ' A' ' 55' ' ' LEU . 8.2 t80 -122.83 153.12 39.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.655 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 58' ' ' ILE . 3.7 mp -120.11 121.88 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.682 0.277 . . . . 0.0 110.751 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.696 HD12 ' HH ' ' A' ' 15' ' ' TYR . 10.5 tp -104.84 114.22 28.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.639 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.64 129.84 56.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -140.9 155.08 46.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.83 146.2 12.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.685 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' N ' ' HG2' ' A' ' 20' ' ' ARG . 39.7 Cg_exo -58.18 114.63 2.05 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.214 1.943 . . . . 0.0 111.974 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -65.63 -35.82 81.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.495 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.452 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -91.28 -43.85 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.328 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.533 ' C ' HG22 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -79.41 0.53 28.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG22 ' C ' ' A' ' 24' ' ' SER . 4.4 m 29.62 63.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.258 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.68 -153.39 29.58 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.541 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -88.32 164.91 15.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.3 172.7 8.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.029 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -152.24 123.95 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.571 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.42 130.11 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.123 0.487 . . . . 0.0 112.178 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.03 137.09 51.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.779 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 97.8 m -85.27 115.66 23.16 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.532 0.682 . . . . 0.0 111.858 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.731 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.82 110.46 17.22 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.597 178.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.15 79.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.092 1.861 . . . . 0.0 111.945 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 45.46 37.81 6.67 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.414 ' HE2' ' H ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER 59.74 97.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.923 0.392 . . . . 0.0 110.882 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 -32.84 68.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -163.63 -89.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.82 123.87 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.837 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.414 ' H ' ' HE2' ' A' ' 36' ' ' HIS . 44.9 t80 -127.92 119.39 25.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.045 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -98.67 146.91 25.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.986 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 43' ' ' LYS . 12.1 mt -108.04 115.01 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.117 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 42' ' ' ILE . 7.8 mmpt? 25.73 -126.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.205 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.92 80.27 0.19 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.452 ' CD2' ' H ' ' A' ' 45' ' ' LEU . 1.3 mm? -68.54 -155.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HD3' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -155.65 140.65 12.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.63 107.11 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.653 2.236 . . . . 0.0 112.484 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.61 -3.93 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.861 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.575 HG21 ' HD3' ' A' ' 46' ' ' LYS . 78.6 t -104.31 115.91 47.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 2.8 p -83.23 116.39 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.363 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -107.98 169.48 8.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.25 0.547 . . . . 0.0 111.454 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -124.16 129.92 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.118 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.57 139.61 10.61 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.18 138.58 49.49 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.756 HD21 ' HH ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -99.28 105.39 17.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.644 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' N ' ' HE1' ' A' ' 15' ' ' TYR . 4.2 mp -116.0 113.44 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -106.42 133.41 51.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.234 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.739 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 9.6 mt -114.05 127.21 71.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.553 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -98.7 -179.02 4.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.914 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -66.45 -16.87 64.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.031 0.443 . . . . 0.0 110.085 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -103.06 -4.95 23.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.941 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 124.56 171.24 13.34 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.39 139.03 58.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.7 0.286 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.77 9.97 1.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.832 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -142.73 114.98 8.39 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 112.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -137.2 126.58 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.381 179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -137.2 131.02 31.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.007 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -107.51 125.49 51.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -155.73 133.89 11.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 111.359 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.92 140.79 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.278 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -143.48 142.81 31.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 111.806 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.574 179.353 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.612 HD13 ' HG2' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -80.46 155.07 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.555 ' H ' HG13 ' A' ' 12' ' ' ILE . 16.5 t -53.71 -47.11 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.075 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -172.96 144.0 1.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.116 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -106.23 143.9 33.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.421 HG22 ' HD3' ' A' ' 18' ' ' ARG . 19.5 mm -116.19 118.58 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 111.04 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 49.2 tp -105.37 114.95 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.651 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.48 128.99 55.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.439 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.619 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 44.5 p90 -140.4 147.73 40.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.313 0.578 . . . . 0.0 110.838 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -161.99 153.07 15.11 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.256 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.62 110.5 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.332 2.022 . . . . 0.0 112.247 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -32.22 73.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.288 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.83 -37.28 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.51 -162.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 26' ' ' GLY . 3.9 p -60.96 166.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.29 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.675 ' H ' HG23 ' A' ' 25' ' ' VAL . . . -74.87 -108.78 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.649 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 59.97 65.98 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.071 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.438 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 -57.48 168.39 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.72 134.37 35.26 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 7.5 mt-10 -119.06 136.79 53.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.449 0.642 . . . . 0.0 112.65 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.05 119.74 15.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 62.2 m -85.28 131.59 34.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG21 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -132.63 107.3 13.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.65 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.84 84.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.615 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.68 60.62 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.782 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.5 m170 60.89 106.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 0.0 111.162 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.682 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -76.85 -30.69 56.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 37' ' ' LEU . 10.4 p-10 -177.98 -148.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.81 105.6 7.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.28 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -103.23 114.75 29.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.128 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 41' ' ' THR . 2.4 t -101.57 147.56 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 mt -107.61 114.74 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.754 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HE2' ' H ' ' A' ' 43' ' ' LYS . 9.0 mmpt? 34.92 -129.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.624 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 45' ' ' LEU . . . -129.45 -43.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.714 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HG ' ' C ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 55.21 -176.68 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.49 0.186 . . . . 0.0 110.769 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -160.74 142.87 9.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.33 143.02 94.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.546 2.164 . . . . 0.0 112.14 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.8 -29.9 4.79 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.97 135.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.632 0.254 . . . . 0.0 111.187 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.15 118.57 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 164.98 11.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.697 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.8 tp10 -123.16 129.31 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.494 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.51 132.1 10.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.127 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 19.8 mm-40 -134.32 112.71 11.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 14.5 mt -106.14 105.55 15.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.962 0.41 . . . . 0.0 110.293 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.77 114.78 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.174 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 1.8 t -89.59 116.25 27.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.32 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 6.2 mt -102.44 121.17 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.045 0.45 . . . . 0.0 111.573 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.612 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -78.87 -176.36 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.179 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -30.69 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -103.03 1.23 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.02 13.39 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.009 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 2.1 p-80 -75.87 156.24 34.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.244 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -26.68 0.14 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.293 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.27 119.02 38.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 111.191 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 132.64 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.232 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.7 132.69 33.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.281 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.95 129.44 56.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.406 ' CE1' HD13 ' A' ' 55' ' ' LEU . 34.0 p90 -156.39 128.66 7.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.99 136.4 36.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.916 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.34 159.18 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.952 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.929 -179.127 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -101.26 147.9 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.436 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.4 m -45.16 -49.79 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.268 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HB2' HG22 ' A' ' 32' ' ' THR . 6.7 pttt -175.61 144.16 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.733 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -111.15 135.43 51.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.488 HG21 ' HD2' ' A' ' 18' ' ' ARG . 10.2 mt -114.16 121.46 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 111.237 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 66.4 tp -105.3 114.66 28.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -121.0 128.33 52.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.529 ' CE3' ' HG ' ' A' ' 17' ' ' LEU . 16.4 p90 -148.15 158.67 44.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.979 0.419 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -160.5 162.44 23.4 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.614 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.5 111.32 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.374 2.049 . . . . 0.0 111.985 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -54.6 -24.81 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.773 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.544 ' HB2' HG13 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -99.68 -43.92 6.3 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.18 175.49 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.375 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.54 HG23 HH12 ' A' ' 20' ' ' ARG . 11.3 p -136.0 145.65 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.55 -111.28 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.561 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -127.81 148.17 50.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -82.57 -174.96 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.736 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.13 124.31 20.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.3 mt-10 -119.73 136.61 54.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 112.136 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.19 138.73 40.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.302 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.1 m -94.34 132.57 38.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.168 0.509 . . . . 0.0 112.156 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -135.68 107.71 9.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.862 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.18 83.96 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.485 2.124 . . . . 0.0 112.179 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -90.68 0.64 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.298 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -168.48 93.33 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.695 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.75 HD23 ' H ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -66.34 -33.46 75.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.75 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.0 OUTLIER 179.66 -92.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.782 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.06 117.45 21.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.669 0.271 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.98 101.66 9.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.8 130.64 54.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -81.55 119.57 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -175.22 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.31 47.7 21.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.204 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.13 166.68 23.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.798 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.88 116.54 4.5 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.14 105.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.857 2.371 . . . . 0.0 112.567 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 -33.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.45 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 135.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 23' ' ' ASN . 11.4 p -76.49 140.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -126.11 142.73 51.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.904 -178.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 19.1 pt-20 -116.32 129.19 56.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.45 141.21 16.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.617 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -133.62 114.43 13.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 17' ' ' LEU . 3.9 mt -106.55 107.57 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 0.0 110.701 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.1 mp -113.54 122.23 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.211 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.59 ' HB3' ' CB ' ' A' ' 65' ' ' GLU . 0.3 OUTLIER -89.61 131.96 35.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.119 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -113.17 122.74 67.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.636 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 7.6 tt0 -119.56 -175.77 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.472 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.83 -22.1 63.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HD2' HE22 ' A' ' 64' ' ' GLN . 0.3 OUTLIER -103.15 15.83 28.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.193 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.14 -169.38 27.93 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.409 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.594 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -56.01 152.43 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.678 0.275 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.594 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.96 -50.65 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.895 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.59 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -99.08 118.85 36.76 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.825 -178.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -134.12 119.86 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.949 0.404 . . . . 0.0 111.168 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 m -137.21 135.4 37.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.23 125.81 9.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.609 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.65 124.55 43.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.411 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.45 156.3 48.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.39 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -179.568 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 78.2 m80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.825 0.345 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -89.61 144.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.57 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.69 -52.38 60.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.99 0.424 . . . . 0.0 110.154 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HD2' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -168.76 143.85 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.79 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -113.11 129.12 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.307 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 17' ' ' LEU . 22.9 mm -114.11 137.61 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -115.22 114.48 25.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.247 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 5.1 mtt-85 -113.97 128.31 56.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.196 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -154.75 157.34 37.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 112.228 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 8.3 ptt85 -159.13 160.19 28.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -58.14 125.11 17.54 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 112.418 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 3.0 tttm -76.91 -37.07 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.462 HD22 HG12 ' A' ' 49' ' ' VAL . 5.6 p30 -90.35 -31.97 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.68 168.61 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.13 130.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.81 -120.16 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.581 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -136.52 166.29 23.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 40.6 m95 -84.32 -174.97 5.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tttm -148.94 145.19 27.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -119.8 129.75 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.113 0.482 . . . . 0.0 111.727 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.12 111.77 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.192 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -88.98 140.2 29.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.811 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.633 HG21 HD13 ' A' ' 37' ' ' LEU . 4.0 mt -130.57 116.32 17.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.423 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.23 87.72 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.832 2.354 . . . . 0.0 112.08 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 -89.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -169.7 92.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.633 HD13 HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.66 -33.79 25.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.423 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER 178.08 -157.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.599 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -86.18 106.61 17.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.729 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -84.57 119.48 25.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.019 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 m -122.78 124.47 43.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.422 HD11 HD21 ' A' ' 17' ' ' LEU . 3.3 mt -90.18 122.62 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.02 105.1 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.7 8.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -95.09 -144.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.503 0.192 . . . . 0.0 110.499 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -165.85 140.46 3.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.5 95.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.407 2.071 . . . . 0.0 112.008 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.99 -27.71 3.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG12 HD22 ' A' ' 23' ' ' ASN . 1.9 t -92.52 124.0 44.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 110.659 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HA ' HG22 ' A' ' 72' ' ' THR . 63.1 t -100.93 123.14 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 0.0 111.384 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 18.0 m-85 -106.09 118.08 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.438 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 pt-20 -82.04 149.15 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.37 160.9 34.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.375 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -132.83 151.9 51.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 45.2 tp -111.19 107.7 17.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.92 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.1 mp -92.55 138.31 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.007 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.55 123.52 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 110.951 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 HD13 ' HD2' ' A' ' 14' ' ' LYS . 5.4 mt -113.27 117.79 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.824 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.97 171.66 10.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.892 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.98 -23.36 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.85 4.11 37.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.51 -134.09 11.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.619 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 64.77 168.8 0.18 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.856 0.36 . . . . 0.0 111.333 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -158.52 109.14 2.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.108 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tm-20 -100.11 116.28 31.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.328 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 21.1 t -123.51 138.03 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 54.3 m -137.79 125.58 22.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.392 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.22 144.54 28.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.29 157.09 35.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.57 119.05 28.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.47 ' C ' HG21 ' A' ' 72' ' ' THR . 17.7 p90 -142.55 153.09 43.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.358 0.599 . . . . 0.0 112.45 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.47 HG21 ' C ' ' A' ' 71' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.829 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m170 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -90.71 142.81 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.354 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 2.2 m -66.23 -49.17 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.103 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.81 11.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.126 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.92 128.21 54.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.098 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 17' ' ' LEU . 32.9 mm -113.84 134.28 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.196 0.522 . . . . 0.0 110.987 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -111.55 114.55 27.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.311 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -112.28 128.24 56.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.935 179.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -147.94 155.77 41.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.328 0.585 . . . . 0.0 112.306 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.06 152.51 18.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -57.97 114.67 2.07 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.414 2.076 . . . . 0.0 112.55 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 1.8 ttmm -70.39 -36.39 74.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.154 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -84.3 -36.85 22.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.69 -169.57 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.781 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.03 103.25 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.909 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.19 -138.13 3.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 150.7 45.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -67.21 174.86 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.755 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.31 150.45 37.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.9 136.75 54.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 111.78 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 112.05 7.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.8 m -85.62 138.39 32.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.606 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.06 114.87 17.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 90.33 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.457 2.105 . . . . 0.0 112.304 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 66.57 -91.8 0.18 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.309 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -160.78 74.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.631 HD22 ' H ' ' A' ' 38' ' ' ASN . 2.0 pt? -65.6 -33.62 76.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.631 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.6 OUTLIER 173.95 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.335 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -76.94 105.41 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.391 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -89.99 116.76 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -116.01 131.41 56.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -102.08 130.45 51.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.989 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -135.03 -168.32 2.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.94 61.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.616 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.599 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -74.07 -170.19 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.785 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 49' ' ' VAL . 18.8 mttt -137.98 150.79 68.56 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.54 122.38 8.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.38 -16.86 31.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.551 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 46' ' ' LYS . 7.7 p -119.96 125.66 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 82.6 t -96.5 142.82 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.728 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 26.9 m-85 -109.93 124.8 52.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.811 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -89.74 156.22 18.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.0 152.24 21.3 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.446 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.35 132.27 41.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.1 tp -99.9 107.01 18.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.879 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.19 138.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.663 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -117.02 121.49 41.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 111.906 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.87 125.7 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.432 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.739 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -118.64 178.96 4.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -22.16 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.03 -4.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.56 23.89 59.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.739 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 7.4 m80 -67.28 173.03 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 89.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -101.01 116.16 32.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.269 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 p -130.77 139.23 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.241 0.543 . . . . 0.0 112.418 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.4 m -137.6 125.64 22.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.753 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 146.85 27.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.22 146.25 21.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 111.807 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -108.59 121.3 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.489 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -129.58 149.13 51.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.442 179.517 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -100.34 141.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.523 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -54.79 -49.08 71.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.297 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 144.25 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.016 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -116.56 135.69 53.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.123 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 17' ' ' LEU . 17.2 mm -114.68 135.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.178 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -115.54 114.96 25.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.962 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.745 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.6 mtp180 -114.55 129.18 56.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.775 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -145.0 154.92 43.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 111.749 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.45 152.46 18.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.794 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.0 Cg_exo -58.59 119.11 6.15 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.348 2.032 . . . . 0.0 112.291 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -23.61 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.405 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -98.62 -36.4 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 2.8 m -104.31 113.52 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.997 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 m -95.51 128.59 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.74 -57.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.566 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -167.84 151.55 6.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.767 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 30.9 m95 -87.89 -169.51 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttt -143.11 151.19 40.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -119.94 137.04 54.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.319 0.581 . . . . 0.0 112.455 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 111.34 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.856 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -90.3 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.079 0.466 . . . . 0.0 112.099 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.41 117.65 8.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.57 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.37 86.64 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.223 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.25 -98.91 1.66 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -165.24 94.25 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -33.57 26.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -179.82 -161.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.638 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -86.46 106.22 17.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -89.11 113.44 24.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -108.94 138.03 45.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 17' ' ' LEU . 15.3 mt -105.97 117.23 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -115.74 129.36 56.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.33 8.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.715 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.704 ' H ' HD21 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -79.95 -165.91 0.92 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.543 0.211 . . . . 0.0 110.614 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HZ1' HG21 ' A' ' 49' ' ' VAL . 4.2 mttp -130.99 142.1 44.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.678 0.275 . . . . 0.0 111.424 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.02 94.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.727 2.285 . . . . 0.0 111.908 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.29 -25.84 6.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.503 HG21 ' HZ1' ' A' ' 46' ' ' LYS . 6.4 t -92.98 128.25 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.671 0.272 . . . . 0.0 110.793 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.621 ' HA ' HG23 ' A' ' 72' ' ' THR . 1.1 t -94.36 146.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 12.9 m-85 -117.54 122.76 44.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.769 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.31 148.33 26.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.23 148.47 18.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.533 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HG2' HD12 ' A' ' 56' ' ' ILE . 2.3 tt0 -132.91 142.44 48.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -107.72 107.06 17.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 54' ' ' GLN . 5.2 mp -96.88 137.64 24.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -110.49 132.27 54.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.306 0.574 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.39 121.67 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.898 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.737 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -114.41 176.58 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.99 -32.3 73.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -102.19 1.17 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.64 88.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.833 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.737 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 1.3 m-70 -98.32 -41.05 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 110.51 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' SER . 31.4 mt-30 66.5 80.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.751 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 10.4 tt0 -96.75 126.6 42.03 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -125.95 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -137.87 121.74 17.68 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.08 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.6 141.0 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.606 -179.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -155.88 154.32 31.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.376 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.29 127.59 50.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.543 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -146.65 152.99 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.435 0.636 . . . . 0.0 112.499 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.621 HG23 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.77 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.017 0.437 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.595 HG13 ' H ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -104.28 157.42 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.617 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -51.08 -37.58 46.56 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HD2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -167.73 143.35 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.905 178.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -118.12 133.2 56.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.814 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 58' ' ' ILE . 4.1 mp -114.45 138.39 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.078 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.589 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -113.1 114.62 27.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.214 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.774 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -118.21 128.17 54.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.491 ' CE3' HD23 ' A' ' 17' ' ' LEU . 10.2 p90 -153.31 155.09 35.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 112.537 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.35 161.75 26.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.354 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.457 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.5 Cg_exo -57.72 113.92 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.283 1.988 . . . . 0.0 112.353 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HZ2' HG12 ' A' ' 50' ' ' VAL . 6.1 ttpm? -60.1 -27.82 67.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.959 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.12 -37.01 64.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 t -94.68 -159.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.59 136.59 43.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.25 -163.37 54.49 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.881 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 61.45 58.02 2.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.348 . . . . 0.0 111.416 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.634 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 55.3 m95 -79.43 179.21 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.504 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mttt -142.7 145.19 33.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.21 129.16 53.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 112.232 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.02 111.27 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.931 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.3 m -97.52 123.07 41.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 112.297 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.433 HG22 ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -123.08 110.76 30.94 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 101.52 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.257 1.971 . . . . 0.0 111.621 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.3 -91.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.829 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.21 101.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.938 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -81.05 -33.31 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.937 0.399 . . . . 0.0 110.405 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.0 -168.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -77.09 105.85 8.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.551 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 109.92 21.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.38 127.85 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.72 122.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -131.77 122.47 25.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.12 25.41 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.4 mm? -76.32 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.533 0.206 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HD3' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.4 152.23 59.96 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 120.732 0.301 . . . . 0.0 110.745 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 137.43 19.9 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.561 2.174 . . . . 0.0 112.517 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.02 -15.37 63.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.699 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG11 ' HD3' ' A' ' 46' ' ' LYS . 6.3 p -119.55 134.89 61.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 72' ' ' THR . 96.2 t -104.32 140.72 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.441 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.457 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.3 m-85 -105.93 119.36 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.191 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HG2' HH21 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -85.44 138.37 32.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.87 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.57 146.31 16.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.873 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.461 HE21 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.4 136.8 45.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.5 mt -101.71 106.67 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.6 mp -94.82 119.53 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -103.63 130.31 51.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.197 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 16' ' ' ILE . 49.7 mt -113.35 128.78 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.569 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.617 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.5 OUTLIER -116.04 -178.02 3.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.02 -8.62 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.02 -4.67 46.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.59 31.44 54.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.423 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.6 m-70 -89.42 -178.58 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 110.744 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 63' ' ' HIS . 1.4 mt-30 -149.32 104.83 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.523 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.6 tm-20 -96.99 125.66 41.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -131.45 134.08 61.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -137.2 122.51 19.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.13 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 HH21 HE21 ' A' ' 54' ' ' GLN . 6.8 mtp180 -84.54 147.28 27.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.348 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.37 141.49 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.99 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -114.08 123.33 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.294 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -141.65 151.7 43.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.988 0.423 . . . . 0.0 111.657 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 50' ' ' VAL . 20.7 p . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.684 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.417 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.811 0.338 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.601 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -103.41 149.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.237 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -52.69 -47.28 67.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.013 179.215 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.669 ' HZ3' HD12 ' A' ' 58' ' ' ILE . 7.6 ptmt -159.3 143.84 15.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.201 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -119.62 132.08 55.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.922 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 17' ' ' LEU . 19.7 mm -114.07 132.97 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 111.01 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' HG21 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -109.55 114.37 27.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.979 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 18.5 mtt180 -115.94 128.76 56.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.586 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.405 ' CE3' HD23 ' A' ' 17' ' ' LEU . 14.2 p90 -152.71 160.02 43.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.463 0.649 . . . . 0.0 112.016 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HG2' ' CE2' ' A' ' 28' ' ' TRP . 3.6 ppt_? -159.42 160.01 28.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.999 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.4 Cg_exo -57.88 117.38 4.08 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.227 1.951 . . . . 0.0 112.42 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -60.28 -38.81 84.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.49 -27.15 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.441 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -96.96 -164.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.76 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 24' ' ' SER . 1.2 m -148.03 114.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.18 -179.65 24.93 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.826 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 60.58 88.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.911 0.386 . . . . 0.0 111.159 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CE2' ' HG2' ' A' ' 20' ' ' ARG . 43.0 m95 -101.05 -176.53 3.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.728 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.2 tttt -151.21 147.53 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.963 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.42 138.87 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.774 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.75 111.76 8.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.274 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -89.29 137.89 31.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 111.859 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG23 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 109.74 8.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.324 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 57.9 Cg_endo -70.87 87.39 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 112.8 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 52.78 39.16 54.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.605 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.89 84.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.026 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.699 HD11 ' H ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -69.32 -33.56 73.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.443 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.699 ' H ' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER 177.66 -154.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.702 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.4 t -77.15 105.11 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -97.02 127.51 43.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -99.33 147.43 25.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.697 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 43' ' ' LYS . 24.5 mm -108.49 137.67 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.233 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' N ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -42.4 138.54 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.47 130.35 38.12 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.149 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.7 mm? -85.3 -136.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HE2' ' HB ' ' A' ' 49' ' ' VAL . 16.4 tttt -136.79 117.65 11.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.504 0.193 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.09 112.33 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.567 2.178 . . . . 0.0 112.072 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.18 -24.66 6.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.352 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.574 ' HB ' ' HE2' ' A' ' 46' ' ' LYS . 7.1 p -118.06 137.42 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.716 ' HA ' HG23 ' A' ' 72' ' ' THR . 46.7 t -97.09 139.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.517 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 24.8 m-85 -105.26 128.92 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.624 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.38 137.81 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.036 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.03 157.04 27.19 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.823 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.4 143.23 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -107.46 106.14 16.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.134 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.26 138.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.132 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -121.0 119.36 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.733 -178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.669 HD12 ' HZ3' ' A' ' 14' ' ' LYS . 1.1 mt -114.34 127.84 71.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.067 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 61' ' ' TYR . 10.3 pt20 -118.41 -177.39 3.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.985 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.37 -4.62 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.525 ' HB2' ' NE2' ' A' ' 59' ' ' GLN . 7.6 m-85 -101.27 -5.04 26.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.09 16.02 68.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.198 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.465 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -67.31 174.84 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.809 0.305 . . . . 0.0 110.601 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 63' ' ' HIS . 3.0 mm-40 -152.16 95.02 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -97.52 117.99 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.063 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.1 p -127.82 134.04 66.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.8 m -137.53 121.53 17.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 138.95 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.958 0.408 . . . . 0.0 111.476 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.12 157.41 43.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -119.95 121.35 38.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -147.14 159.82 43.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.228 0.537 . . . . 0.0 111.986 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.973 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p80 . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG13 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -67.54 155.61 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.733 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.6 ' N ' HG13 ' A' ' 12' ' ' ILE . 74.9 m -54.09 -39.05 66.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.612 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HZ1' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -157.14 144.81 18.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.088 0.47 . . . . 0.0 111.37 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.33 126.33 44.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.011 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.532 HG21 ' N ' ' A' ' 17' ' ' LEU . 1.6 mt -112.54 135.48 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' N ' HG21 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -105.56 115.27 29.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.775 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.7 mmm180 -110.06 134.56 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -161.44 150.45 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.143 0.496 . . . . 0.0 111.609 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.606 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -159.43 152.8 18.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.904 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 51.2 Cg_exo -58.66 117.2 3.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.51 2.14 . . . . 0.0 112.621 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -33.38 74.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.036 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB3' HG11 ' A' ' 49' ' ' VAL . 8.1 t-20 -92.43 -43.68 9.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.74 -164.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.101 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.51 163.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.7 26.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.38 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 59.56 -179.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.199 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 29.5 m95 -92.77 -178.81 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.85 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.6 OUTLIER -120.14 133.66 55.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.167 0.508 . . . . 0.0 112.181 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.98 110.83 9.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.83 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 39.8 m -90.95 139.55 30.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.608 HG21 HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.23 106.98 6.7 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.886 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_endo -60.28 90.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.73 60.57 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 57.94 85.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD23 HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -80.91 -31.97 34.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.488 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 4.7 p-10 -166.76 -170.98 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.57 118.97 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.86 125.52 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.676 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 t -107.76 147.7 30.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.375 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.06 137.46 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.802 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 1.5 tpmp? -48.7 155.73 0.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 129.04 49.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.71 -136.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.5 ttmm -153.38 134.6 8.43 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 21.0 Cg_exo -65.09 117.01 4.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 112.25 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.26 54.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' A' ' 23' ' ' ASN . 2.2 t -118.86 131.36 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -99.92 136.45 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.641 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 22.1 m-85 -105.96 118.91 37.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 18.8 pt-20 -80.07 137.89 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 147.49 19.0 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.854 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 66' ' ' VAL . 1.4 tt0 -132.97 150.54 52.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 30.1 tp -123.93 110.19 14.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 111.588 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 6.0 mt -97.52 138.35 22.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.594 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -114.2 121.73 44.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.499 HD12 ' HZ1' ' A' ' 14' ' ' LYS . 2.4 mt -111.79 124.58 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.11 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.512 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -115.45 178.36 4.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.47 -14.57 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -101.35 -4.53 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.39 64.22 4.44 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.652 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 61.42 87.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.443 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.257 179.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 54' ' ' GLN . 16.3 t -134.07 136.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m -138.09 121.13 16.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.605 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 68' ' ' ARG . 5.0 mtt180 -91.86 146.16 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 111.87 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -156.17 146.49 21.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.212 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -114.41 133.08 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -144.5 148.36 34.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 112.253 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.974 179.378 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.265 0.078 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -98.37 143.16 13.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.844 0.355 . . . . 0.0 111.186 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.497 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -60.19 -46.83 88.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.155 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 143.97 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.064 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -111.82 135.29 52.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.24 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 58' ' ' ILE . 3.3 mp -114.15 133.09 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 110.467 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.541 ' N ' HG21 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -115.24 114.29 25.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.269 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.781 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -115.63 127.96 55.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' TRP . 20.7 p90 -144.86 161.37 39.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.953 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -156.54 150.85 19.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.7 Cg_exo -57.54 125.52 19.04 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.363 2.042 . . . . 0.0 112.719 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.497 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 37.9 tttp -76.66 -38.61 54.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.129 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -84.12 -39.58 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -98.3 142.95 29.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.785 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . 7.2 p -87.54 132.33 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.973 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.39 -142.41 3.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -114.89 175.96 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.854 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 30.7 m95 -89.46 -167.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.781 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.5 mttp -152.38 155.9 38.5 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -122.17 130.39 53.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.512 . . . . 0.0 112.061 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.3 111.12 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.102 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 99.7 m -90.04 141.07 29.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 112.0 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.505 HG13 ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -138.24 107.65 8.01 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.221 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.25 92.72 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.456 2.104 . . . . 0.0 112.093 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -98.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -165.75 70.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.702 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HG ' HD21 ' A' ' 38' ' ' ASN . 1.5 pt? -72.27 -33.03 67.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.597 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -164.33 -179.73 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t -79.74 108.48 13.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.09 110.3 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.666 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -115.58 144.88 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.77 125.38 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.986 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -119.36 153.41 35.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.65 13.31 3.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.85 HD13 ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -104.14 -166.11 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.51 0.195 . . . . 0.0 110.614 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -161.24 156.14 20.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.566 0.222 . . . . 0.0 111.167 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.34 104.76 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.478 2.119 . . . . 0.0 112.002 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.86 -14.66 4.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.043 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 46' ' ' LYS . 14.4 t -116.26 124.99 73.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.89 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.6 t -110.23 133.36 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HA ' ' H ' ' A' ' 22' ' ' LYS . 57.6 m-85 -109.3 126.55 53.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.93 131.4 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.79 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -139.68 161.87 26.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.614 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.443 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -134.58 152.78 52.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.886 0.474 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.0 mt -124.18 106.87 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.543 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 57' ' ' SER . 87.3 mt -94.46 138.53 20.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.275 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.73 119.14 32.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.288 0.566 . . . . 0.0 111.345 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 16' ' ' ILE . 28.9 mt -114.15 125.19 71.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.764 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.34 173.37 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.83 -18.45 65.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.226 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -102.25 9.64 39.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.78 -114.28 4.95 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.801 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.54 -174.91 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.962 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.66 99.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.34 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 5.0 tt0 -96.81 116.33 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.8 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -131.17 131.18 63.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.3 m -137.72 125.09 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.326 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.58 147.1 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.28 . . . . 0.0 110.746 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 155.61 33.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.006 0.432 . . . . 0.0 111.64 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -116.75 133.44 56.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -147.86 150.72 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.85 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.293 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -67.48 149.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.974 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -55.33 -50.58 69.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.248 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.6 pttt -171.12 144.8 2.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.03 154.23 19.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.738 179.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.566 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -115.73 147.77 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 111.376 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -134.0 109.32 8.91 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.339 176.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.743 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 6.0 mtp180 -122.84 127.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.644 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 5.6 p90 -161.08 159.68 29.49 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.354 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.494 HH11 ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.95 165.92 17.47 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.343 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -54.29 115.88 2.68 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 121.283 1.322 . . . . 0.0 112.619 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 6.3 tptm -34.05 -53.6 0.47 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.79 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -101.67 -44.41 5.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.866 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 21' ' ' PRO . 47.0 t -76.61 -177.24 4.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.94 132.18 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.15 34.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.522 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.58 139.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.421 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 62.0 m95 -60.3 167.08 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.723 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -132.29 158.91 40.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 30' ' ' GLU . 10.5 pm0 -138.11 127.92 25.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.356 0.598 . . . . 0.0 112.431 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -143.14 122.47 13.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -107.47 120.97 43.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.702 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -122.63 107.26 34.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.559 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.7 Cg_endo -72.67 110.75 3.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.316 2.011 . . . . 0.0 112.42 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.47 -120.78 23.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.508 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -143.73 68.52 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' H ' HD21 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -65.64 -33.03 74.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.928 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.42 -172.42 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.9 m -85.2 105.74 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -93.5 107.56 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.484 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.92 140.38 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.421 HD13 ' HZ ' ' A' ' 71' ' ' PHE . 2.3 mp -100.18 130.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.71 75.77 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.113 0.483 . . . . 0.0 111.287 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.4 11.0 0.86 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.285 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -124.82 -152.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.755 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.586 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 160.52 162.0 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 123.728 0.643 . . . . 0.0 110.492 178.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 11.3 Cg_endo -54.31 -6.9 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.544 2.163 . . . . 0.0 112.123 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 46' ' ' LYS . . . -89.63 -46.57 4.25 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.955 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -113.78 136.87 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 111.544 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 72' ' ' THR . 3.0 p -103.02 117.57 48.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' HB2' HD21 ' A' ' 45' ' ' LEU . 30.4 m-85 -102.05 125.88 48.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 2.1 tt0 -78.7 126.73 31.13 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.633 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -115.29 159.6 13.69 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.062 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.2 tt0 -133.48 114.46 13.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.0 111.762 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -101.36 106.2 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.976 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 51.2 mt -116.49 120.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.716 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.52 138.18 35.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG22 ' HA2' ' A' ' 62' ' ' GLY . 1.8 mp -117.71 130.6 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.46 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.99 -176.58 6.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.04 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 4.5 pt20 -61.05 -30.59 70.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.913 0.387 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.481 ' N ' ' HG3' ' A' ' 60' ' ' GLN . 2.1 p90 -103.24 -4.64 24.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 58' ' ' ILE . . . 105.83 156.99 22.17 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.669 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 22.2 m80 65.97 135.97 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.362 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 57' ' ' SER . 1.9 mm-40 -166.49 -57.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.769 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tp10 -145.51 144.6 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.511 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.7 t -134.77 121.69 35.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.72 0.295 . . . . 0.0 111.779 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 121.69 17.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.23 121.81 45.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.735 0.303 . . . . 0.0 111.132 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -151.97 131.56 13.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.627 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.9 p30 -92.95 138.73 31.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.421 ' HZ ' HD13 ' A' ' 42' ' ' ILE . 28.8 p90 -141.31 161.89 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.366 . . . . 0.0 111.872 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.643 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.902 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 121.133 0.492 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -84.51 153.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.1 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.673 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -56.52 -45.32 81.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.835 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.48 144.04 8.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.778 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.2 156.61 17.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.505 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.631 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -120.78 148.42 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.355 0.598 . . . . 0.0 111.347 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -133.06 109.85 9.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.745 176.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.771 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt180 -118.37 127.84 54.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.666 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.2 p90 -161.35 153.65 20.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 117.901 -1.52 . . . . 0.0 114.904 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.83 164.07 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.025 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -56.73 110.63 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 121.584 1.523 . . . . 0.0 112.588 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HD3' ' HB3' ' A' ' 70' ' ' ASP . 9.0 tptt -30.79 -47.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.379 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 -44.06 7.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.807 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.51 82.71 5.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 110.842 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.92 145.32 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.76 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -134.28 125.01 26.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.953 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.468 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 68.1 m95 -64.12 171.48 2.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.771 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.1 mttt -120.96 162.92 19.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -134.48 123.92 24.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.098 0.475 . . . . 0.0 112.031 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.92 111.78 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.97 118.16 35.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 111.405 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -132.75 111.51 13.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.463 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.835 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.8 Cg_exo -46.61 160.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.64 2.227 . . . . 0.0 113.024 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.24 105.05 0.28 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.664 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 44.17 39.08 2.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.738 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -72.7 -16.61 61.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.839 0.352 . . . . 0.0 110.546 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.536 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -172.57 169.62 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -83.57 106.3 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -117.79 120.04 36.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 m -116.38 146.45 42.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.95 117.66 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.44 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.51 61.77 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.187 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.44 -17.23 4.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.888 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -92.43 137.78 32.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.408 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -104.01 161.5 22.74 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.333 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -55.83 96.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.252 1.968 . . . . 0.0 112.832 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.37 -9.49 3.5 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.847 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.484 ' HB ' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -120.55 138.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 22' ' ' LYS . 2.4 p -112.62 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.211 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.611 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 34.1 m-85 -105.39 124.9 50.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.25 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.987 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 10.3 tt0 -79.53 126.6 31.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.604 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -112.98 156.63 15.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 60.3 tt0 -132.7 114.58 14.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.226 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.54 106.18 17.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.631 ' HB ' HG23 ' A' ' 16' ' ' ILE . 77.0 mt -116.9 121.26 67.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.595 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 2.4 m -82.22 135.98 35.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.501 . . . . 0.0 110.071 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -117.03 132.38 66.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.021 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.719 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -95.2 -175.68 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.321 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG3' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.41 -27.43 67.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -103.31 -5.49 22.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.747 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.87 151.87 27.76 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.921 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 66.2 129.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 111.447 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.719 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 7.7 mm-40 -156.53 -51.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.26 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.6 tt0 -144.11 145.15 31.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 56' ' ' ILE . 58.0 t -134.62 123.25 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.277 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -137.34 120.5 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.939 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -112.9 118.42 34.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.68 137.49 13.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.661 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.987 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 16.1 p-10 -92.3 135.28 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.152 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 71' ' ' PHE . 9.1 p90 -140.82 162.97 34.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.063 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.439 -0.982 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.02 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.401 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 4.5 p-80 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.675 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -96.79 151.36 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.675 ' N ' HG13 ' A' ' 12' ' ' ILE . 20.3 m -49.74 -49.25 48.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -168.47 144.16 3.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.103 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -106.7 156.97 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.715 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.656 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.66 147.61 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -133.34 109.61 9.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.606 177.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.17 127.15 44.07 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.687 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -162.54 164.6 26.79 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.449 -1.3 . . . . 0.0 114.117 -176.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 138.01 10.2 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 113.681 -1.6 . . . . 0.0 108.219 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 13.9 Cg_endo -55.57 109.34 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.172 1.915 . . . . 0.0 111.37 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.579 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -49.79 -59.22 4.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.808 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' HG13 ' A' ' 49' ' ' VAL . 55.6 t30 -62.77 -43.94 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.303 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.493 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -103.3 67.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.806 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -47.05 137.8 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.345 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.14 -82.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -154.17 148.77 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -67.11 170.68 6.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.3 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.8 tptt -138.0 165.8 25.66 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.3 pt-20 -142.32 126.28 17.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.901 0.381 . . . . 0.0 111.808 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.92 129.69 21.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -105.09 119.5 39.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 111.538 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -116.81 106.67 47.53 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.548 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 9.7 Cg_exo -72.0 97.64 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.683 2.255 . . . . 0.0 113.044 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 45.15 44.83 9.89 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.217 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 56.15 79.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.2 pt? -69.3 -32.9 72.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.776 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 -164.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.638 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.26 105.65 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -122.99 107.85 12.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.35 147.36 45.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.554 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 HD11 ' HZ ' ' A' ' 71' ' ' PHE . 14.8 mt -90.77 137.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 149.59 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.254 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 45' ' ' LEU . . . 113.55 23.46 5.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.624 HD22 ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -125.61 171.95 10.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.526 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 4.8 pttt -178.35 165.7 1.12 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 92.3 Cg_exo -47.61 -22.98 3.3 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.587 2.191 . . . . 0.0 112.218 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.51 -36.2 17.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.405 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -114.2 124.22 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 120.992 0.425 . . . . 0.0 111.782 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.579 HG11 ' HB3' ' A' ' 22' ' ' LYS . 1.8 p -102.04 131.22 50.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' HB2' HD22 ' A' ' 45' ' ' LEU . 4.0 m-85 -112.18 119.21 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.518 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -78.98 127.77 32.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.629 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -127.71 158.1 21.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.898 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HG2' HD11 ' A' ' 56' ' ' ILE . 2.7 tt0 -133.63 121.18 21.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.552 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 6.0 mt -110.22 106.84 16.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.024 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.807 HG23 HG23 ' A' ' 66' ' ' VAL . 32.4 mt -112.55 119.6 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.897 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.589 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.63 135.04 35.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.357 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.519 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.5 mp -117.33 132.16 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.897 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.82 -176.78 5.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.487 179.024 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -63.61 -30.28 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.578 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -102.6 1.07 34.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 101.46 150.23 23.52 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.028 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 65.83 144.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 111.578 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -169.2 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.072 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -144.56 144.08 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.612 -178.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.807 HG23 HG23 ' A' ' 56' ' ' ILE . 84.7 t -133.91 114.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -137.1 120.3 16.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -112.22 133.98 54.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.94 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -156.56 154.83 30.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.932 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -100.88 122.0 42.69 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.426 ' HZ ' HD11 ' A' ' 42' ' ' ILE . 2.4 p90 -138.62 163.8 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.387 0.613 . . . . 0.0 111.826 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.693 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.749 HD11 ' HG2' ' A' ' 59' ' ' GLN . 0.6 OUTLIER -75.33 145.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.616 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.9 t -53.02 -44.96 67.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.88 0.372 . . . . 0.0 110.106 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.7 pttt -175.8 146.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.964 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -101.38 154.37 18.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.481 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -114.89 147.96 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.408 0.623 . . . . 0.0 112.037 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -132.14 109.53 10.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.536 176.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -117.93 127.47 53.88 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.651 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.66 159.98 35.96 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.435 -1.306 . . . . 0.0 113.405 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD2' ' CZ3' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -157.46 155.84 28.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.194 178.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 17.1 Cg_endo -54.08 109.79 0.43 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 122.347 2.032 . . . . 0.0 111.202 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.586 ' HB3' HG11 ' A' ' 50' ' ' VAL . 1.1 tmtp? -45.83 -55.27 6.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.205 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.55 -43.87 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.799 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 8.5 t -71.07 150.89 45.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.988 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.97 135.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.031 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.39 -159.85 22.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.55 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 14.6 ptp180 -116.75 164.25 14.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.491 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 60.7 m95 -66.46 167.79 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.52 160.08 37.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.03 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 123.79 24.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 111.969 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' LEU . . . -141.44 112.4 7.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.107 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 130.42 44.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 112.193 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.845 HG23 HD11 ' A' ' 37' ' ' LEU . 1.1 pt -137.2 106.44 8.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.672 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 85.5 Cg_endo -81.92 122.0 3.75 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 35.46 7.48 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.375 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 50.48 78.25 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.986 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.845 HD11 HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.21 -30.62 71.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' H ' HD13 ' A' ' 37' ' ' LEU . 11.7 t30 -168.26 174.88 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -77.09 105.12 7.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.219 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -115.57 117.05 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.613 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 141.86 47.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.409 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.76 134.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.47 53.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.51 2.63 24.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.281 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.799 HD22 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -108.41 129.35 55.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.388 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -111.52 163.34 17.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.542 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -49.82 95.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.639 2.226 . . . . 0.0 112.671 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.21 -6.73 5.37 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.778 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -120.77 138.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.727 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.8 p -115.13 133.96 59.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.502 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.799 ' HB2' HD22 ' A' ' 45' ' ' LEU . 17.3 m-85 -116.43 130.03 56.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.583 0.23 . . . . 0.0 111.331 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 37.8 tt0 -88.27 127.8 35.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.628 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -117.09 155.24 16.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.704 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 6.1 tt0 -132.27 114.45 14.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 4.9 mt -103.12 106.77 17.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.111 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 HG21 ' O ' ' A' ' 65' ' ' GLU . 96.7 mt -117.09 122.67 70.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.0 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.25 134.73 35.65 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.7 mp -120.26 130.7 74.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.749 ' HG2' HD11 ' A' ' 12' ' ' ILE . 4.7 mm100 -126.12 -174.02 3.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -6.6 27.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.828 0.347 . . . . 0.0 111.011 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -103.05 -4.76 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.707 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.39 161.93 5.87 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.805 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.1 t60 66.69 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.677 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 59.65 -95.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.571 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.551 ' HB3' ' HG ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -128.65 144.27 51.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.869 -178.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.65 126.3 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.15 124.46 21.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 125.6 54.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.241 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.31 127.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 111.928 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.56 133.32 39.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.978 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -140.95 163.69 32.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.617 0.722 . . . . 0.0 112.515 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.727 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.554 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.034 0.445 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.712 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -95.07 154.02 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.414 179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.712 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.2 m -46.26 -41.07 12.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.768 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 17.1 pttt -174.2 143.5 0.89 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.562 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.642 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -101.41 147.36 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.04 148.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 121.183 0.516 . . . . 0.0 111.219 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -126.03 109.35 12.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.005 176.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.2 mtt-85 -118.2 125.87 51.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.677 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -156.2 157.01 35.14 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 117.878 -1.529 . . . . 0.0 114.133 -176.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.463 ' CZ ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -159.76 151.76 17.05 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.835 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 54.2 Cg_exo -53.61 108.64 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 120.888 1.058 . . . . 0.0 111.242 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' H ' ' H ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -21.9 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.896 -179.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -44.15 6.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.226 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.31 67.52 9.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.289 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 4.3 p -53.82 124.17 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.882 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.09 76.23 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.697 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 27' ' ' ARG . 6.5 mtt-85 65.08 125.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 0.0 111.544 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -62.28 166.96 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.779 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mmpp? -127.33 152.83 46.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.17 124.26 34.18 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 17' ' ' LEU . . . -142.94 111.66 6.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.981 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 111.88 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.642 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -138.58 106.92 7.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.184 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 61.3 Cg_endo -72.29 111.87 3.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.234 1.956 . . . . 0.0 113.1 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.75 11.45 36.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.173 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.18 84.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.636 HD23 HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -66.0 -18.35 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.765 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -160.48 -178.71 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.726 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.97 105.82 9.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -99.69 105.68 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -122.07 146.03 47.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.225 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.676 HD12 ' HZ ' ' A' ' 71' ' ' PHE . 2.6 mp -97.02 134.33 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -108.63 -4.89 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.909 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.48 -63.08 5.4 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.394 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.76 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.748 0.419 . . . . 0.0 111.333 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -102.78 157.39 33.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.557 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 1.1 Cg_endo -42.37 104.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.383 2.722 . . . . 0.0 113.351 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.47 -12.02 8.43 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.447 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 49' ' ' VAL . 8.1 p -120.85 139.35 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.815 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.5 p -111.26 128.42 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.818 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.835 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 21.3 m-85 -107.55 120.36 41.98 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.003 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.914 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 14.8 tt0 -80.13 127.08 31.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.677 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -116.04 152.63 17.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mt-30 -130.9 117.06 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 111.602 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.2 mt -100.22 106.27 17.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.17 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.9 mp -109.44 113.92 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.742 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.676 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 2.1 m -87.58 121.23 29.76 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.192 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 64' ' ' GLN . 1.9 mt -114.6 133.32 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.408 0.623 . . . . 0.0 112.577 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.616 ' HB2' ' NE2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -96.6 -174.89 3.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.741 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.64 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.24 4.14 36.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.716 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 92.53 -133.41 11.72 Favored Glycine 0 N--CA 1.454 -0.128 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.869 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -43.83 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.887 0.375 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.676 ' HB3' ' O ' ' A' ' 57' ' ' SER . 5.5 tp-100 -110.45 -52.56 2.77 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.8 mm-40 -146.52 144.95 29.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 111.243 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.501 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -135.96 131.78 49.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.67 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 67' ' ' THR . 0.6 OUTLIER -137.91 126.39 23.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.057 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -112.69 123.66 50.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.559 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CD2' HG22 ' A' ' 67' ' ' THR . 51.2 m-85 -155.62 126.89 7.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.463 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.914 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -93.33 139.0 31.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.091 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.676 ' HZ ' HD12 ' A' ' 42' ' ' ILE . 25.7 p90 -145.27 159.51 42.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.428 0.632 . . . . 0.0 111.979 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.815 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.724 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.299 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.927 0.394 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.622 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -79.52 148.45 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.622 ' N ' HG13 ' A' ' 12' ' ' ILE . 66.2 m -49.51 -45.73 47.57 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 1.1 pttt -170.77 143.46 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.093 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -107.85 147.18 31.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.594 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.484 HG23 ' HG2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -115.72 145.08 21.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 179.118 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -122.93 111.83 17.1 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.765 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -117.86 128.6 54.99 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.706 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -159.46 162.97 35.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.996 0.903 . . . . 0.0 113.301 -178.233 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.564 HH12 ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -159.6 144.24 11.19 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.761 178.36 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.8 Cg_endo -54.61 112.43 1.01 Allowed 'Trans proline' 0 C--N 1.335 -0.142 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.564 ' HA ' HH12 ' A' ' 20' ' ' ARG . 6.0 tptt -51.6 -34.28 36.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.223 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -98.29 -44.06 6.71 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.275 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -79.6 127.4 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.398 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.52 115.06 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.932 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.24 -169.32 20.93 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.35 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -64.6 176.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -136.79 159.99 40.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.582 179.297 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -141.79 128.52 20.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.44 . . . . 0.0 111.295 -179.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -141.02 114.44 8.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -93.77 115.58 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 111.823 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -122.67 107.55 33.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.027 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 28.1 Cg_exo -61.07 90.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.312 2.008 . . . . 0.0 112.925 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.8 52.9 6.48 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.225 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 t60 52.63 60.8 3.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -65.86 -22.27 66.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.538 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.488 ' N ' HD11 ' A' ' 37' ' ' LEU . 3.4 p-10 -170.53 -171.84 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.2 105.46 9.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -97.97 130.19 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -101.37 148.01 25.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.184 0.516 . . . . 0.0 112.259 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.512 HG23 ' H ' ' A' ' 44' ' ' GLY . 18.7 mt -94.28 138.58 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.653 179.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -32.97 -41.67 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.015 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' H ' HG23 ' A' ' 42' ' ' ILE . . . 120.74 114.36 2.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.189 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.63 122.84 43.97 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.704 0.288 . . . . 0.0 110.499 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.599 ' O ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -83.76 135.13 43.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.95 -178.816 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.15 144.4 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.982 3.121 . . . . 0.0 114.537 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.27 -5.85 68.23 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.055 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.4 138.13 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.1 p -97.38 122.44 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.474 ' HA ' ' H ' ' A' ' 22' ' ' LYS . 38.2 m-85 -110.75 133.48 53.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.65 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -97.49 129.12 44.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.018 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.706 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -124.12 150.88 17.06 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.778 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 44.4 tt0 -132.62 144.42 50.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 111.482 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.06 107.66 12.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.409 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 82.0 mt -114.0 117.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 1.4 m -82.21 138.5 34.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.389 0.614 . . . . 0.0 111.025 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mt -118.16 132.24 68.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.951 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.694 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.69 -176.41 3.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 178.657 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.41 -29.92 70.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -103.08 -1.55 28.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 63' ' ' HIS . . . 95.22 155.47 31.39 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 75.3 t60 65.94 126.55 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 2.9 mm-40 -155.6 -56.96 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.6 tt0 -145.4 143.82 30.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.436 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.88 115.79 19.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.299 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m -136.15 121.58 19.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.291 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.17 139.62 43.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.38 135.97 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 4.1 p-10 -95.94 137.47 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 51' ' ' TYR . 29.4 p90 -141.43 165.57 27.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 18.1 p . . . . . 0 C--N 1.32 -0.705 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.72 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 6.5 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.726 HG13 ' N ' ' A' ' 13' ' ' SER . 0.6 OUTLIER -88.44 152.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.051 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.726 ' N ' HG13 ' A' ' 12' ' ' ILE . 39.0 t -52.32 -45.21 65.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.065 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 21.4 pttt -174.6 144.53 0.86 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.685 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.16 157.22 17.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.876 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.681 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.64 147.7 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 121.181 0.515 . . . . 0.0 111.181 179.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -128.2 110.42 12.4 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.626 176.525 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.5 mtp-105 -122.37 125.63 46.32 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.0 p90 -162.89 153.3 16.45 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.356 -177.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -159.95 162.72 24.0 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.766 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 15.2 Cg_endo -56.75 124.03 15.27 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 C-N-CA 122.656 2.238 . . . . 0.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 54.3 tttt -67.32 -44.03 80.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.883 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -89.75 -36.55 15.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.962 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.534 ' O ' HG12 ' A' ' 25' ' ' VAL . 3.1 m -85.08 -18.17 35.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.501 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 24' ' ' SER . 5.7 p 33.62 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.296 0.57 . . . . 0.0 112.102 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . -108.33 -106.8 3.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.901 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 152.87 36.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -74.8 150.94 39.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.252 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.762 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -121.84 140.43 52.39 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -122.23 128.84 51.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -141.64 115.39 9.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.674 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.37 118.19 33.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 111.331 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.74 HG21 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -129.84 112.27 17.44 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.2 Cg_exo -52.11 175.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.672 2.248 . . . . 0.0 112.481 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.72 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . -43.17 94.86 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.18 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 35' ' ' GLY . 1.1 p-80 22.75 72.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.358 0.663 . . . . 0.0 112.613 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.74 HD11 HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -69.23 -30.29 68.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.328 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.534 ' OD1' HD12 ' A' ' 37' ' ' LEU . 3.4 p-10 -174.25 -163.41 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -90.81 105.82 18.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.019 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -116.73 113.1 22.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -128.69 146.57 50.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.8 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -165.1 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 0.0 111.563 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.14 25.5 75.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.683 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -178.68 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.189 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 142.04 35.71 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.95 104.37 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.566 2.177 . . . . 0.0 111.977 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.66 -13.95 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.378 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.52 139.62 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 117.195 0.497 . . . . 0.0 111.441 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -76.59 146.29 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.111 0.481 . . . . 0.0 109.964 178.488 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -143.98 101.05 3.67 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.093 -179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.4 pt-20 -77.58 126.81 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.962 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -126.35 152.03 18.17 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.632 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -134.8 141.62 46.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 111.583 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 1.5 mt -121.38 106.21 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.663 178.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.681 ' HB ' HG22 ' A' ' 16' ' ' ILE . 2.6 mp -116.01 118.34 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.781 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -82.03 133.63 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.573 0.701 . . . . 0.0 111.144 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.28 133.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -117.12 -175.45 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.29 178.465 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -63.92 -13.63 47.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.473 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -103.15 -4.97 23.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 143.87 0.88 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.511 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 60.48 107.38 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.645 0.26 . . . . 0.0 110.981 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 57' ' ' SER . 78.8 mm-40 -129.85 -67.19 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.655 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.96 146.67 50.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.99 -178.537 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.414 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.77 126.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.293 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.15 132.38 41.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 117.43 33.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -144.47 126.92 15.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.747 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.8 122.14 42.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' TYR . 38.2 p90 -122.71 162.86 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.309 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 50' ' ' VAL . 7.0 p . . . . . 0 C--N 1.329 -0.291 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.9 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.597 0.236 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.692 HD12 ' HG2' ' A' ' 59' ' ' GLN . 1.2 tt -67.26 148.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.7 t -51.24 -48.02 62.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.4 149.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.763 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.5 m-85 -102.19 136.64 41.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.37 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.457 HG22 ' HD2' ' A' ' 18' ' ' ARG . 16.8 mm -114.87 122.88 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 111.633 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 HD11 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -108.25 114.73 28.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 179.034 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.709 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.7 mtt180 -116.93 128.77 55.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.815 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -150.35 153.39 35.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.683 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.57 159.03 29.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.364 -179.937 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.7 114.05 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.095 1.864 . . . . 0.0 111.745 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -32.13 73.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -38.3 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.39 170.43 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.5 p -117.88 136.45 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.846 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.98 33.41 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.979 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.66 173.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 111.519 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.683 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 67.6 m95 -90.15 -171.47 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -142.35 145.43 33.91 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.474 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -120.4 133.31 55.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.269 0.556 . . . . 0.0 112.139 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.08 112.19 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.98 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 38.8 m -89.35 137.72 32.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 112.474 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -132.81 106.25 12.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.381 178.056 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.95 100.32 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.408 2.072 . . . . 0.0 112.383 -179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.88 -90.17 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -177.18 79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.744 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.548 ' HG ' HD21 ' A' ' 38' ' ' ASN . 0.5 OUTLIER -72.7 -33.22 66.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.548 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -173.4 -165.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.05 118.32 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -103.55 113.26 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 t -121.7 134.0 54.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 mt -98.02 116.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -121.46 134.09 55.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 25.92 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -101.35 175.02 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -98.23 124.74 46.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.0 4.69 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.777 2.318 . . . . 0.0 112.365 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 -30.45 6.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.652 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.62 134.23 63.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' HA ' HG22 ' A' ' 72' ' ' THR . 60.8 t -78.22 146.97 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.415 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.51 107.74 14.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.76 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 18.3 pt-20 -79.7 130.39 35.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.379 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -133.01 153.94 20.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.191 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.478 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.64 134.01 42.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.639 0.257 . . . . 0.0 110.393 179.675 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -100.19 106.97 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 110.365 179.644 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 HH11 ' A' ' 18' ' ' ARG . 5.2 mp -105.46 115.31 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.815 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.8 OUTLIER -86.0 119.75 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 12' ' ' ILE . 8.4 mt -109.67 112.29 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.253 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.692 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -89.45 -177.24 5.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.572 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -68.07 -14.86 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.603 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -101.46 0.9 37.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.766 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 112.4 177.34 19.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.92 144.34 39.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.578 0.228 . . . . 0.0 110.596 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.4 2.77 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.574 -179.59 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.522 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 2.5 tt0 -145.63 129.77 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -134.88 131.28 53.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.012 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -136.15 123.74 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' HE21 ' A' ' 54' ' ' GLN . 36.8 mtm180 -102.54 135.7 43.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 111.371 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.58 155.06 32.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.23 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -106.73 134.02 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.411 ' CE2' HD11 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -152.05 153.54 34.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.141 0.496 . . . . 0.0 112.287 -178.779 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.446 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.694 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -70.83 154.08 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 179.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.694 ' N ' HG13 ' A' ' 12' ' ' ILE . 58.0 m -52.37 -41.3 62.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.2 pttt -172.23 149.04 2.22 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.041 0.448 . . . . 0.0 111.713 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -106.82 134.08 50.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.78 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.661 HG13 HD13 ' A' ' 58' ' ' ILE . 2.8 mm -114.28 120.23 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.24 114.69 29.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.537 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -116.25 129.55 56.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.542 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -154.37 158.69 40.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 111.493 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -159.54 163.42 23.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.666 -179.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -57.52 114.45 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.982 1.788 . . . . 0.0 111.616 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -50.71 -31.23 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.357 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -70.17 -37.36 75.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -176.48 4.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.97 13.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.82 -160.24 8.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.647 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 57.81 70.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -84.45 162.57 19.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 25.7 mttp -141.26 133.87 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.876 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 2.2 pt-20 -120.52 132.69 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.11 0.481 . . . . 0.0 111.977 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.67 111.99 12.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.808 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 84.8 m -91.79 132.09 36.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.456 HG13 ' C ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -136.92 104.8 8.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.115 177.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.5 Cg_exo -60.22 105.64 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.447 2.098 . . . . 0.0 112.15 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 64.36 -94.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.122 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.03 109.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.575 HD11 ' N ' ' A' ' 37' ' ' LEU . 6.6 mp -82.74 -34.13 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.659 HD21 ' H ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -178.01 -112.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.053 -179.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.659 ' H ' HD21 ' A' ' 38' ' ' ASN . 55.0 m -121.43 105.09 10.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.39 109.01 21.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -120.88 132.11 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.5 mt -98.61 127.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 -166.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.83 29.76 28.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.357 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -93.94 172.04 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -122.93 136.8 27.22 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.81 165.42 18.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.645 2.23 . . . . 0.0 112.466 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.4 -33.03 3.49 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.735 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.55 116.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.438 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 61.9 t -77.77 144.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 71' ' ' PHE . 3.2 m-85 -102.36 126.55 49.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 130.62 52.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.61 158.03 27.97 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.679 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -132.46 145.11 50.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.294 179.669 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -100.45 107.25 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.738 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -106.64 114.83 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.51 125.04 34.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.263 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.745 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 45.9 mt -102.43 123.35 55.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.495 ' HG3' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -100.23 -175.05 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.943 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.83 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.301 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.03 6.9 38.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.76 175.49 18.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.64 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 3.0 p80 -55.99 157.41 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.716 0.293 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.495 HE21 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -161.35 -17.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.409 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -114.2 127.75 56.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.09 130.68 55.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.415 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.23 121.2 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.679 ' HG2' HE21 ' A' ' 54' ' ' GLN . 2.5 mtt180 -96.87 132.65 42.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.318 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -155.62 156.65 35.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.263 0.554 . . . . 0.0 111.965 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.62 137.81 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -150.0 141.69 23.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.514 -178.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.612 ' HA ' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.336 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.965 0.412 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 57' ' ' SER . 4.7 tt -97.31 157.35 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.404 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -48.87 -52.72 22.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.796 179.455 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.603 ' HD2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -166.17 144.79 5.75 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.198 0.523 . . . . 0.0 111.754 179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.8 m-85 -102.37 136.87 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.873 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.486 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.34 129.86 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.853 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -118.11 114.84 23.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.986 179.438 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.58 129.21 50.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -149.73 162.02 41.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 2.8 ptt180 -158.56 153.43 21.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 18.0 Cg_endo -58.49 109.61 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.967 1.778 . . . . 0.0 111.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 4.1 ttpp -57.36 -35.21 69.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -70.3 -29.25 65.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -78.22 -161.02 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.999 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.35 -7.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.501 ' HA2' HH11 ' A' ' 20' ' ' ARG . . . 179.67 -128.58 1.24 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.952 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HB3' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER 64.6 75.24 0.38 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.918 0.389 . . . . 0.0 111.06 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 93.5 m95 -83.04 175.8 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.145 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 13.7 mttm -154.25 136.88 15.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.767 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -120.16 135.77 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.052 0.453 . . . . 0.0 112.131 -178.762 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 114.86 8.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.13 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 m -96.62 137.78 35.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.149 0.5 . . . . 0.0 112.222 -179.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -135.39 110.75 10.6 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.456 179.311 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HB2' HD13 ' A' ' 37' ' ' LEU . 73.7 Cg_exo -50.15 93.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.766 2.31 . . . . 0.0 113.169 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 28.09 3.42 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.24 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.5 69.79 0.67 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' H ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -71.89 -7.21 47.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.164 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -164.02 -174.6 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.593 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -80.47 105.53 11.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.82 107.42 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.778 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -114.59 146.58 40.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -91.62 124.38 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -138.56 161.77 36.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.74 21.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.6 mt -74.59 -161.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.505 0.193 . . . . 0.0 110.55 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.15 133.81 12.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.643 0.258 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.1 155.45 28.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.448 2.099 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.18 -21.48 10.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.921 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.38 117.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.772 0.32 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.695 ' HA ' HG23 ' A' ' 72' ' ' THR . 62.5 t -81.26 144.54 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.428 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' N ' HG11 ' A' ' 50' ' ' VAL . 53.4 m-85 -124.62 103.9 8.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 12.9 pt-20 -79.67 130.18 35.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.383 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.53 161.34 24.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.972 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.632 ' HB2' HD13 ' A' ' 56' ' ' ILE . 1.4 mt-30 -132.62 139.17 47.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 110.432 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -99.91 107.11 19.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -111.03 115.17 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.486 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -92.2 117.7 30.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.164 179.337 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.603 ' HB ' ' HD2' ' A' ' 14' ' ' LYS . 43.2 mt -101.73 116.13 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.812 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -90.0 -175.07 4.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.32 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.44 -23.05 64.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.06 14.15 32.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.645 0.259 . . . . 0.0 111.48 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.01 -174.56 23.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.803 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -52.34 161.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.724 0.297 . . . . 0.0 111.238 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -169.27 -20.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.587 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -123.72 128.42 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.53 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.89 133.24 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.814 0.34 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 3.1 m -137.8 123.86 20.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.71 134.45 40.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 111.636 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.93 159.08 38.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.507 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -109.51 133.7 52.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.9 p90 -151.82 145.98 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.695 HG23 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 178.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.865 0.364 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD12 ' HG2' ' A' ' 59' ' ' GLN . 1.6 tt -79.72 155.25 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.494 ' H ' HG13 ' A' ' 12' ' ' ILE . 3.2 m -49.91 -53.36 26.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.764 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.797 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -158.89 144.91 16.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.1 m-85 -104.7 137.72 42.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.202 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.527 HG21 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -114.25 142.69 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 110.81 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.48 115.83 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.12 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.4 mtp180 -118.99 129.77 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.646 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.409 ' CZ2' HG21 ' A' ' 42' ' ' ILE . 13.2 p90 -152.6 158.82 43.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 111.991 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.36 157.07 26.78 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.291 179.792 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.78 113.41 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.318 2.012 . . . . 0.0 112.083 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.444 -179.476 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -95.02 -41.2 9.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -87.15 161.82 17.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.22 148.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 27' ' ' ARG . . . 170.39 -140.6 6.09 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.517 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -139.88 166.77 23.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.459 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 74.0 m95 -75.65 174.61 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 18.2 mttt -145.31 141.16 28.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.679 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -119.98 134.92 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 128.3 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.825 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.1 m -112.39 135.67 52.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -137.21 106.76 8.67 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.153 178.418 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.8 Cg_exo -58.84 111.6 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 112.477 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 57.83 -104.95 0.51 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.368 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.85 93.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.72 -25.75 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.979 179.9 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.655 ' N ' HD23 ' A' ' 37' ' ' LEU . 1.2 p-10 178.74 -168.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.456 179.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -76.49 105.82 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -108.8 112.84 25.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.725 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -121.57 132.62 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.409 HG21 ' CZ2' ' A' ' 19' ' ' TRP . 9.8 mt -90.21 126.08 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.57 165.92 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.44 -16.36 4.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.243 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -69.63 160.16 32.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.716 0.293 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' HG2' ' HD2' ' A' ' 47' ' ' PRO . 3.3 ttmt -104.77 133.44 20.16 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.047 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.57 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 55.2 Cg_exo -52.0 133.03 45.06 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.524 2.149 . . . . 0.0 112.18 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.12 -22.1 40.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.12 120.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.311 . . . . 0.0 110.953 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.474 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 14.0 t -85.78 140.63 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -123.08 161.51 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -129.82 132.2 46.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.926 179.408 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.73 155.42 26.49 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.413 -179.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.91 131.64 41.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 5.9 tp -99.7 106.48 18.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.891 0.376 . . . . 0.0 111.011 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' HB ' HG21 ' A' ' 16' ' ' ILE . 3.8 mp -92.07 138.44 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.955 179.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 65' ' ' GLU . 1.4 m -110.4 114.98 28.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.313 0.578 . . . . 0.0 111.011 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 5.6 mt -95.5 114.13 31.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.591 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.725 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -97.03 -176.26 3.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.327 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.543 ' HG2' ' NE2' ' A' ' 59' ' ' GLN . 11.4 pt20 -62.12 -21.94 65.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -102.83 12.08 36.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.725 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 100.8 173.36 29.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.434 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 7.0 p80 -53.55 147.93 10.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.483 0.183 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 2.0 pt20 -165.33 -6.64 0.03 OUTLIER 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.4 tt0 -132.65 112.99 12.49 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.891 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.2 p -136.98 140.99 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.3 m -132.24 122.12 24.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.715 179.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' H ' ' HE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.29 141.49 30.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.304 -179.373 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.14 158.31 37.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.49 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 129.46 56.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -152.06 163.76 38.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.474 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 11.4 p . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.751 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 m80 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.6 0.238 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.6 tt -77.81 150.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -49.21 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.611 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -166.13 146.07 6.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -102.04 141.99 34.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.38 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -115.16 142.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.487 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 115.46 19.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.416 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -120.85 137.95 54.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.674 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -156.73 159.51 38.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.43 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.45 157.45 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.521 -179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.72 110.86 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.269 1.979 . . . . 0.0 112.014 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.42 67.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.66 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -100.3 -36.05 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.404 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.16 -167.78 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.25 154.39 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.022 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.43 23.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 60.87 175.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 68.0 m95 -85.61 -172.33 4.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.4 mttt -148.3 154.76 40.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.242 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.17 138.27 49.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 112.092 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 111.82 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 92.5 m -98.4 131.19 44.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -134.69 106.05 10.77 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.268 178.124 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 52.0 Cg_exo -56.23 98.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.688 2.258 . . . . 0.0 112.895 -179.019 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 22.88 8.43 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.163 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 57.13 98.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 179.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.66 -18.37 41.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.562 ' N ' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -169.09 -163.19 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.762 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.17 105.48 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.608 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.21 106.75 16.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.35 144.05 45.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.86 129.33 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.213 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 141.77 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.09 56.08 0.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.654 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 3.0 mt -137.18 78.02 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.4 ttpt -34.75 130.41 0.47 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.466 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 45.2 Cg_exo -56.89 175.79 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.661 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.05 -35.53 3.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.04 127.15 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.67 142.08 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.452 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 7.8 m-85 -108.8 136.79 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -112.26 130.1 56.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.119 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.67 156.49 26.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.975 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.6 146.0 51.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 18.8 tp -100.23 107.0 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.391 . . . . 0.0 110.859 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.568 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.7 mp -95.12 122.06 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.491 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -94.83 114.91 26.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.424 0.631 . . . . 0.0 109.926 179.723 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 27.6 mt -106.7 111.16 34.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.953 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -90.2 -176.17 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.887 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.75 -15.94 45.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -103.12 0.62 32.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.32 176.39 19.4 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.26 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 15.9 p80 -55.36 156.31 4.49 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.548 0.174 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.9 1.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 3.7 tt0 -145.53 113.73 6.59 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -136.75 139.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.419 ' N ' HG23 ' A' ' 66' ' ' VAL . 31.8 m -137.1 124.73 22.3 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.448 179.543 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -85.01 141.01 30.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.779 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -155.86 156.63 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.731 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -114.96 131.64 56.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.873 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -152.04 162.55 40.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.486 -178.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.202 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.7 p80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.943 0.401 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.844 HD13 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -72.98 147.48 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.042 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.697 ' N ' HG13 ' A' ' 12' ' ' ILE . 14.8 m -52.13 -45.99 65.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.759 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -158.78 144.65 16.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.042 0.448 . . . . 0.0 111.416 179.512 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -112.89 142.97 44.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 179.682 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -113.89 138.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.221 -179.587 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.532 HD21 ' CE3' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -122.03 114.86 21.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.283 179.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.35 129.98 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.149 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.532 ' CE3' HD21 ' A' ' 17' ' ' LEU . 10.1 p90 -158.52 158.44 34.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.402 0.62 . . . . 0.0 112.526 -179.299 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HD3' ' CE2' ' A' ' 28' ' ' TRP . 1.9 ptt180 -159.73 162.27 25.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.665 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 31.3 Cg_exo -58.82 109.62 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.929 1.753 . . . . 0.0 111.621 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -65.78 -22.62 66.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.968 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.0 -17.98 31.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -158.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -166.66 139.03 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.75 -60.06 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.574 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -165.5 157.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.076 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 59.0 m95 -92.36 172.73 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 14.2 mttp -132.51 128.2 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.83 130.41 54.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 112.303 -178.241 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.08 111.79 8.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.872 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.9 m -93.91 130.87 39.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 36' ' ' HIS . 4.4 mp -136.68 107.65 9.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.66 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.0 Cg_exo -45.89 91.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.167 2.578 . . . . 0.0 113.249 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.39 42.46 1.84 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.506 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.507 ' HA ' HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER 54.34 47.84 22.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.668 HD21 ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -70.95 -24.27 62.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.731 -179.544 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.668 ' HB3' HD21 ' A' ' 37' ' ' LEU . 1.7 p-10 -133.77 168.93 17.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -78.94 105.88 10.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -121.34 130.7 53.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 145.02 29.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.241 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 43' ' ' LYS . 4.4 mt -90.57 137.37 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.437 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -57.55 123.88 17.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.825 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.29 146.65 28.85 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.63 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 72' ' ' THR . 11.3 mt -103.75 173.02 6.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -94.98 125.28 51.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.57 111.77 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.638 2.225 . . . . 0.0 112.236 -179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.84 -5.58 8.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.657 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.87 135.22 58.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 72' ' ' THR . 10.8 t -81.24 137.05 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.75 179.581 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.86 97.04 4.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.2 pt-20 -87.38 132.08 34.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.091 0.472 . . . . 0.0 110.519 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.67 154.0 24.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.69 134.81 50.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.843 0.354 . . . . 0.0 110.392 179.811 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 15' ' ' TYR . 13.2 tp -99.56 107.67 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.546 ' CG1' ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -102.42 115.36 44.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 0.0 111.547 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -81.41 113.73 19.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 16' ' ' ILE . 30.4 mt -105.64 126.39 60.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.601 -179.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.844 ' HG3' HD13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -112.5 -174.98 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.419 179.8 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.27 -7.48 2.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.332 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.611 ' HB2' HE22 ' A' ' 64' ' ' GLN . 55.4 m-85 -97.97 -5.25 34.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.81 106.54 0.04 OUTLIER Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.374 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.8 m80 61.6 120.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.419 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.611 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -157.5 -20.33 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.874 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.94 119.49 9.11 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.865 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -137.32 132.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 0.0 112.06 179.157 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.6 m -137.5 128.69 27.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 2.0 mtm180 -96.3 148.03 23.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.181 0.515 . . . . 0.0 111.136 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -156.43 158.84 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.237 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -113.58 127.27 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.023 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.453 ' C ' HG23 ' A' ' 72' ' ' THR . 1.4 p90 -148.29 161.3 41.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.089 0.471 . . . . 0.0 112.121 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.462 ' HA ' HD11 ' A' ' 45' ' ' LEU . 1.1 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.009 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.943 0.401 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -67.62 144.02 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.3 179.484 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -57.72 6.71 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 144.33 18.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.897 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.7 m-85 -108.93 136.6 48.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 179.326 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.583 HG12 HG22 ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.245 0.545 . . . . 0.0 111.081 -179.729 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 114.88 28.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.053 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.757 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.03 129.47 50.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.761 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -151.01 160.61 43.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.468 . . . . 0.0 111.666 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 6.2 ptt180 -159.41 161.38 27.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 14.0 Cg_endo -57.95 110.39 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.186 1.924 . . . . 0.0 111.796 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -62.77 -48.06 80.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.724 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.75 -38.91 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.8 -179.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.511 ' HB2' ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.03 -179.52 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.498 . . . . 0.0 111.85 -179.281 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.72 143.4 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.772 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -154.83 18.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.146 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 27' ' ' ARG . 9.8 mtt180 -135.74 162.88 31.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 111.074 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.86 157.19 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.757 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.8 mmtt -132.14 136.11 46.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.555 ' HG2' HH21 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -119.87 127.21 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.092 0.473 . . . . 0.0 111.935 -178.754 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.44 111.68 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.142 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.583 HG22 HG12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -91.5 135.21 34.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.927 -179.263 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 36' ' ' HIS . 1.5 mt -122.97 107.79 32.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.307 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.4 Cg_exo -54.69 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.793 2.329 . . . . 0.0 113.061 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.74 30.66 4.91 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.118 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.438 ' HA ' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 53.54 72.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -68.94 -31.89 71.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.906 179.865 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -146.18 -165.34 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 p -77.69 106.14 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.51 102.29 7.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -127.95 143.12 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.3 mm -81.68 116.92 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 134.76 37.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.81 17.39 1.88 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.312 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.9 mt -76.05 -143.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.521 0.2 . . . . 0.0 110.75 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HB3' HG23 ' A' ' 49' ' ' VAL . 1.5 tppt? -146.94 122.81 5.48 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 120.647 0.26 . . . . 0.0 110.973 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.79 91.16 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.423 2.082 . . . . 0.0 111.851 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -117.72 113.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.103 179.414 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.27 130.42 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.348 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -105.57 107.14 17.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 130.33 34.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.88 159.65 28.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.131 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 146.59 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -102.05 106.43 17.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.201 -179.869 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 66' ' ' VAL . 2.3 mp -92.48 126.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -90.17 135.53 33.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.225 0.536 . . . . 0.0 110.194 179.648 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.2 mt -115.02 109.11 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.563 -179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 7.1 mm100 -101.12 -175.1 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.293 178.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.11 -14.5 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.742 0.305 . . . . 0.0 110.794 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.614 ' HB2' HE22 ' A' ' 64' ' ' GLN . 42.7 m-85 -103.21 -5.25 23.34 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.975 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.21 -153.71 17.39 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.854 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.472 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 2.6 m-70 -62.28 141.23 58.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.862 -0.199 . . . . 0.0 110.778 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.614 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -145.22 -59.51 0.35 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 2.5 tt0 -100.49 114.2 27.61 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.8 p -136.12 132.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 112.081 178.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -137.29 125.18 22.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 142.32 30.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -156.1 159.31 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.436 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.42 135.46 50.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.41 ' CE2' HD11 ' A' ' 45' ' ' LEU . 4.8 p90 -151.61 141.25 21.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.326 -178.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.834 0.349 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -101.04 157.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.56 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -59.47 -44.33 93.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.984 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.05 144.62 0.76 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.801 179.471 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 12.5 m-85 -105.62 136.82 44.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.835 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.75 127.71 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 178.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -116.44 116.52 27.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.731 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.82 128.78 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.741 -179.732 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.676 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 2.7 p90 -152.2 142.7 22.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.482 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -147.9 153.62 42.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.673 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 67.6 Cg_exo -57.13 126.71 23.0 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 113.05 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 -33.43 19.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.784 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.17 -43.92 6.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.584 ' HB2' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -83.92 -15.72 46.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.686 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 55.18 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.763 179.866 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 -138.54 7.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.646 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.0 ttm105 -110.9 155.12 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.439 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 79.0 m95 -77.78 175.27 10.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.051 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.731 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -139.26 135.65 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.401 179.31 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.2 pt-20 -120.1 131.62 55.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.987 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.05 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.844 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -102.1 132.1 48.18 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -139.42 106.7 7.15 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.752 178.965 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 77.7 Cg_endo -82.31 102.45 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.322 2.015 . . . . 0.0 113.549 -178.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 8.85 87.61 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.51 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.75 88.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.706 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -66.32 -22.06 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.41 -172.91 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 106.55 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.724 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -108.32 109.41 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.093 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.548 HG23 ' HZ2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -121.27 126.26 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.748 179.677 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.448 HG23 ' CZ2' ' A' ' 19' ' ' TRP . 3.3 mt -81.87 118.52 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.178 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.548 ' HZ2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -132.12 76.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 179.885 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.01 22.31 3.45 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.628 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.643 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -98.03 -157.5 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 155.87 14.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.796 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.99 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.56 6.66 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.357 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG12 ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.559 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.48 148.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.747 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.4 m-85 -114.49 143.56 44.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.0 tt0 -79.51 128.63 33.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.45 133.65 9.33 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.517 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' HD11 ' A' ' 56' ' ' ILE . 12.0 tt0 -134.15 116.86 15.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.634 0.254 . . . . 0.0 110.811 179.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -99.64 107.75 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 179.282 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.714 HG21 HG23 ' A' ' 66' ' ' VAL . 4.3 mp -111.44 114.59 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.602 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -84.02 138.36 33.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.134 179.144 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.562 ' HB ' ' HG2' ' A' ' 14' ' ' LYS . 2.6 mt -115.19 108.49 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.867 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.795 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 4.7 tp60 -86.49 -175.86 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.39 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.535 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 6.6 mm100 -61.27 -20.51 62.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.58 -179.548 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' HH ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -102.72 16.01 27.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.515 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.84 -108.56 3.08 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -51.77 111.48 0.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.795 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 4.1 tp-100 -120.97 -67.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.2 tt0 -139.51 145.43 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.714 HG23 HG21 ' A' ' 56' ' ' ILE . 96.8 t -135.04 133.96 53.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 m -136.76 134.46 37.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.223 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.0 122.62 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.92 133.95 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.217 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.47 137.65 38.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.06 158.71 43.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.649 177.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.8 0.333 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -66.86 155.5 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.343 179.524 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 12' ' ' ILE . 2.2 m -56.57 -52.81 63.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.1 OUTLIER -176.66 145.76 0.55 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.569 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.748 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 3.3 m-30 -101.66 141.09 35.05 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.102 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mm -114.75 132.74 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -121.24 114.22 21.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.237 178.564 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.6 mtp180 -109.99 129.17 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 -179.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.637 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 3.1 p90 -142.4 140.18 31.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.25 0.548 . . . . 0.0 111.699 179.673 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.92 144.84 17.13 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.915 -179.803 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 51.2 Cg_exo -56.94 117.73 4.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.252 1.968 . . . . 0.0 112.327 -179.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.497 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 mmmt -58.58 -17.86 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.74 -18.57 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.141 -179.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.31 -166.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.949 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.18 -26.29 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.057 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.92 -128.57 1.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.423 -179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.0 63.05 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 74.6 m95 -63.71 -177.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.2 mmtp -131.94 152.3 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.425 179.197 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.23 133.77 55.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.15 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.446 178.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.563 ' CG2' ' HB2' ' A' ' 14' ' ' LYS . 51.6 m -106.51 126.45 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.309 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -140.16 105.24 6.66 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.811 178.087 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 107.45 2.01 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.167 1.911 . . . . 0.0 112.658 -179.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.09 116.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.401 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.26 102.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.23 -33.12 33.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.68 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.1 OUTLIER -179.32 -159.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.308 179.9 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 m -77.3 105.37 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.6 114.41 26.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -98.71 147.65 24.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.036 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 43' ' ' LYS . 3.6 mt -99.57 115.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 42' ' ' ILE . 3.8 mmpt? 18.4 -93.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.089 0.868 . . . . 0.0 112.584 179.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.84 105.5 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.387 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.627 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -73.49 -175.55 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.638 0.256 . . . . 0.0 110.886 -179.808 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 160.96 33.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.086 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.07 149.92 50.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.684 2.256 . . . . 0.0 112.881 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.62 -2.18 59.48 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.052 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.08 112.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.701 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.3 t -91.56 148.05 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 179.026 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 53.3 m-85 -139.68 107.47 5.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.926 178.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 tp10 -87.92 128.85 35.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -117.22 147.59 18.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.545 -178.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.52 115.75 15.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 17' ' ' LEU . 32.7 tp -99.19 107.36 19.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.76 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.3 mp -112.18 115.25 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.582 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 7.9 m -82.14 133.4 35.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.447 HG21 ' N ' ' A' ' 59' ' ' GLN . 2.8 mp -121.67 133.14 69.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.334 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 3.8 tt0 -110.79 -175.14 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.527 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -61.08 -17.7 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.1 -5.71 23.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.68 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.47 153.16 5.68 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.999 178.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 t60 58.37 97.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.619 0.247 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.71 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 -122.77 -60.72 1.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 tt0 -135.54 145.32 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.913 -178.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.35 114.48 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 178.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.9 m -133.37 127.18 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -104.06 132.09 50.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -155.58 130.81 9.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.618 -179.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.45 149.81 20.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.82 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -150.8 148.18 28.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.513 0.673 . . . . 0.0 112.671 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.7 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.492 0.187 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.608 HG21 ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -101.59 157.44 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 111.306 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 t -82.16 -31.68 30.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 4.0 pttt -175.86 143.92 0.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.973 179.317 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.601 ' HB2' HG13 ' A' ' 33' ' ' ILE . 34.1 m-85 -108.04 143.14 37.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.597 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.68 122.81 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.129 0.49 . . . . 0.0 110.736 179.66 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.799 HD13 ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -109.96 114.61 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.631 179.372 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.758 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.02 129.61 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.252 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.624 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.7 p90 -150.38 149.36 29.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.568 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.54 HH12 ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -153.79 145.41 16.69 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 -179.514 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 49.0 Cg_exo -59.15 110.55 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.706 2.271 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.63 -19.64 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.1 -18.24 62.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -117.57 -162.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.608 179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.09 125.59 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.57 -142.49 47.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.669 179.651 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 63.14 59.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.091 0.472 . . . . 0.0 111.138 -179.975 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -76.53 174.81 9.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.749 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.8 mttt -142.43 132.31 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.857 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.68 135.62 54.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.298 0.571 . . . . 0.0 112.396 -178.489 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.14 111.77 6.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 179.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 m -88.31 132.61 34.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.146 0.498 . . . . 0.0 112.294 -178.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 HG13 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -140.4 105.54 6.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.217 179.29 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.868 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 17.6 Cg_endo -58.2 -179.75 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.504 2.136 . . . . 0.0 113.516 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.608 ' N ' HG21 ' A' ' 12' ' ' ILE . . . -65.79 88.9 0.11 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.237 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.548 ' HB3' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -179.81 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 109.898 -179.508 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.638 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.74 -3.48 47.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.762 179.39 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.626 HD21 ' H ' ' A' ' 39' ' ' SER . 6.1 p-10 42.47 -125.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.626 ' H ' HD21 ' A' ' 38' ' ' ASN . 2.1 m -88.28 117.04 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.735 0.303 . . . . 0.0 110.974 179.878 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -83.52 126.73 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.286 179.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -97.98 147.44 24.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.421 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.32 131.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -111.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.1 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.413 ' C ' HD23 ' A' ' 45' ' ' LEU . . . -81.39 140.13 20.95 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.14 -178.021 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 45' ' ' LEU . 2.9 mm? -126.67 3.59 6.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.61 179.223 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt 62.54 154.65 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.157 179.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' O ' HG21 ' A' ' 49' ' ' VAL . 88.4 Cg_endo -78.41 155.56 28.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.797 2.332 . . . . 0.0 112.513 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.76 3.35 59.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.192 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -117.92 112.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.089 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.0 t -89.44 148.37 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.05 0.452 . . . . 0.0 110.494 178.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 39.5 m-85 -138.78 104.42 5.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.623 179.428 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 8.4 tt0 -90.26 128.63 36.46 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -142.2 147.94 19.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.331 -179.084 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' CB ' ' HA ' ' A' ' 68' ' ' ARG . 6.0 pm0 -133.83 138.83 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.162 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.799 ' HG ' HD13 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -100.03 107.89 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.071 0.462 . . . . 0.0 111.647 -178.66 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.3 mp -101.69 114.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.137 179.157 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 1.3 m -87.31 136.34 32.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 -179.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' CG2' ' HA2' ' A' ' 62' ' ' GLY . 3.6 mp -118.87 132.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.046 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.781 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 30.1 tt0 -92.73 -175.77 4.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.427 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.555 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 5.4 mt-30 -60.33 -29.53 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.092 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.37 7.98 42.47 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.323 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' HA2' ' CG2' ' A' ' 58' ' ' ILE . . . 94.0 147.95 23.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.082 179.343 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 64.37 157.25 0.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.5 0.19 . . . . 0.0 111.285 179.746 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.781 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -179.01 -57.47 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 179.281 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.5 tt0 -145.09 144.19 30.81 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.114 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.28 114.07 16.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 178.433 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.9 m -137.2 120.74 17.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.814 179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.553 ' HA ' ' CB ' ' A' ' 54' ' ' GLN . 6.5 mtp85 -97.94 132.62 43.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' GLY . 19.8 p90 -149.4 131.31 15.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.191 0.52 . . . . 0.0 112.295 -179.717 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD2' ' HG3' ' A' ' 52' ' ' GLU . 1.7 m-20 -95.2 141.64 28.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.016 179.256 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -152.66 160.75 43.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.475 0.655 . . . . 0.0 112.491 -178.853 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.835 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.653 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 10.2 p-80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.871 0.367 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.654 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -97.14 152.09 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.87 179.885 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.654 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.51 -46.63 48.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.283 179.485 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 16.5 pttm -162.05 144.26 11.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.134 179.366 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -113.07 140.6 47.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.707 179.211 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.22 125.35 71.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 179.745 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.41 114.28 27.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.323 179.789 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -112.21 129.15 56.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.771 179.487 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.667 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -146.21 147.15 31.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.273 0.559 . . . . 0.0 112.234 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -151.29 145.67 18.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.024 179.911 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 47.3 Cg_exo -57.53 109.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.334 2.023 . . . . 0.0 112.549 -179.594 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 1.7 mttm -68.45 -32.68 72.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.52 179.471 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.58 -18.85 47.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 1.7 m -149.48 72.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.576 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.518 HG13 ' NH2' ' A' ' 20' ' ' ARG . 22.7 m -47.02 146.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.947 -179.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.86 79.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.7 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 28' ' ' TRP . 14.5 ttp180 65.15 147.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 111.54 179.728 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.507 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 37.2 m95 -101.72 -176.63 3.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -139.08 153.26 48.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.353 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 138.32 54.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.2 111.97 7.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.823 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m -93.77 126.23 38.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.721 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 37' ' ' LEU . 1.8 mt -138.2 107.04 7.97 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 178.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 24.1 Cg_exo -64.13 109.91 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.515 2.143 . . . . 0.0 113.325 -178.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 49.54 24.73 5.8 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.818 178.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 60.71 115.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.086 0.47 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' ' 37' ' ' LEU . 5.9 mp -82.44 -33.21 28.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.1 OUTLIER -177.51 -153.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.117 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -76.8 104.83 7.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -118.19 122.75 43.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 -179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 141.57 49.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.287 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG21 ' CZ2' ' A' ' 19' ' ' TRP . 20.7 mm -89.96 130.19 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -112.89 156.96 22.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.856 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.35 20.56 1.96 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.26 -179.785 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -121.61 177.98 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.952 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.642 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -139.45 163.47 45.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.702 0.286 . . . . 0.0 111.652 -179.173 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.1 109.51 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.629 2.219 . . . . 0.0 112.605 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.0 -0.21 11.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.104 179.399 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 46' ' ' LYS . 14.7 p -120.23 137.12 55.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.572 HG23 HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.7 137.88 43.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.01 179.7 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 7.9 m-85 -111.21 174.14 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.279 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -116.21 129.49 56.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.736 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.71 132.17 9.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.857 -1.163 . . . . 0.0 113.797 -178.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' THR . 1.4 mt-30 -133.56 113.83 12.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.112 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mt -100.66 107.56 19.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.4 mp -101.77 115.68 44.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.6 119.17 23.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.739 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 20.5 mt -110.62 119.17 58.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.51 -179.472 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -92.27 -175.68 4.11 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.082 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -61.58 -17.44 55.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -103.14 -5.17 23.51 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.28 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.92 179.61 16.01 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -49.4 157.67 0.48 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -165.46 -2.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.33 133.69 21.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.606 0.241 . . . . 0.0 111.383 -179.689 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.94 133.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.975 179.231 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 6.2 m -137.51 137.22 38.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.48 139.65 44.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.52 161.59 40.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.306 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.8 141.25 29.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.245 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.645 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 1.1 t80 -120.24 139.1 53.18 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.157 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.572 HG22 HG23 ' A' ' 50' ' ' VAL . 22.1 p . . . . . 0 C--N 1.333 -0.123 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -105.2 148.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 179.954 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -43.29 52.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.154 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.61 144.94 0.69 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.274 178.863 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.4 m-85 -100.79 150.2 23.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.612 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.556 HD12 ' OG1' ' A' ' 32' ' ' THR . 2.2 mm -125.02 123.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.552 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.11 114.09 27.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.517 178.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.55 129.68 56.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.4 -179.646 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.648 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 4.8 p90 -141.28 149.27 41.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.21 147.98 14.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.405 -179.849 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 48.4 Cg_exo -57.81 114.73 2.09 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.543 2.162 . . . . 0.0 112.665 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.794 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 27.6 mtpt -75.31 -25.07 57.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -86.23 -35.87 19.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.204 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.69 -175.53 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.111 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.03 132.24 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.067 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.5 -165.49 31.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.8 150.04 21.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.82 177.6 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.17 154.57 50.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.881 179.415 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.62 133.44 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.19 0.519 . . . . 0.0 111.891 -179.463 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.85 111.43 8.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.469 179.015 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 58.8 m -90.56 136.74 32.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.318 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.756 HG23 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.07 103.8 6.76 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.474 177.668 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.35 127.4 7.41 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.58 2.186 . . . . 0.0 112.699 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.19 165.82 36.67 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.991 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -81.89 67.13 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.064 0.459 . . . . 0.0 110.759 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.756 HD12 HG23 ' A' ' 33' ' ' ILE . 2.7 mt -78.81 -2.88 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.027 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER 105.96 174.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.503 1.127 . . . . 0.0 110.608 -179.675 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -77.18 111.75 13.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -97.66 117.48 32.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.449 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -127.4 142.17 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.74 116.66 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -119.49 42.36 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.82 10.47 58.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.502 ' HG ' ' CE1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -83.28 166.23 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 110.887 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -94.06 134.85 25.31 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.148 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -38.96 123.38 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.5 2.8 . . . . 0.0 114.07 -179.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.0 7.2 17.67 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.127 178.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 46' ' ' LYS . 2.0 t -121.52 136.67 57.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.551 0.676 . . . . 0.0 112.301 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.49 HG22 ' CG2' ' A' ' 72' ' ' THR . 0.5 OUTLIER -115.34 133.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.993 178.186 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 27.4 m-85 -116.18 -173.12 2.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.966 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.794 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 9.8 tm-20 -126.07 129.45 49.15 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.91 118.47 4.25 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.085 -179.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' HG2' HD12 ' A' ' 56' ' ' ILE . 37.9 tt0 -132.66 113.89 13.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.043 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 tp -103.44 106.74 17.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.507 -179.195 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.517 HD12 ' HG2' ' A' ' 54' ' ' GLN . 4.9 mp -100.52 138.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.591 178.838 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.838 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 4.7 m -94.85 151.11 19.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.356 0.598 . . . . 0.0 110.975 -179.5 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 25.8 mt -116.41 131.84 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.508 -179.417 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.896 ' HG2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -118.74 -176.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.442 178.461 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -20.68 59.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.748 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CD1' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -104.47 -5.68 21.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.445 179.809 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.27 139.21 1.76 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.187 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.28 81.78 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.819 0.343 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.896 ' HB2' ' HG2' ' A' ' 59' ' ' GLN . 1.1 tt0 -101.48 -67.75 0.85 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.608 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.838 ' H ' ' HB2' ' A' ' 57' ' ' SER . 4.0 tp10 -140.54 127.56 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.04 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.27 138.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 111.861 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.87 134.12 34.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.413 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -111.67 143.87 41.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 -179.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.72 161.1 40.78 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.94 148.03 22.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.605 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -120.16 142.38 49.01 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.456 -176.339 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.49 ' CG2' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.694 0.283 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 64' ' ' GLN . 7.9 tp -70.85 144.95 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.391 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.87 95.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.055 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -167.46 145.41 4.68 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.467 179.513 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.707 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 1.4 m-85 -100.45 145.3 28.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.688 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.03 121.06 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 109.938 179.217 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 HD11 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.26 114.07 27.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.476 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.709 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 8.5 mtp85 -114.75 128.75 56.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.747 179.3 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.2 p90 -144.6 145.72 31.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.3 0.572 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 HH11 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -152.06 145.88 18.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.335 -179.812 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 42.3 Cg_exo -58.77 110.24 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.444 2.096 . . . . 0.0 112.335 -179.78 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 8.7 mmtm -72.11 -13.97 61.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.384 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -96.13 -26.92 15.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.549 -179.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.82 -12.93 15.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 t 50.41 70.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.6 -154.26 11.94 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.607 -179.811 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -89.49 141.18 28.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 110.649 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.448 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 42.1 m95 -73.21 178.0 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 mtpp -139.48 147.87 41.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.05 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.81 137.0 54.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.275 0.559 . . . . 0.0 112.304 -178.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.01 122.12 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -97.21 116.76 30.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.221 0.534 . . . . 0.0 112.395 -178.79 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -136.87 106.77 8.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.989 178.945 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.3 Cg_exo -59.94 -157.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.535 2.157 . . . . 0.0 114.157 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 36' ' ' HIS . . . -63.38 110.25 3.26 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.485 -178.339 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 35' ' ' GLY . 12.9 p80 3.7 69.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.218 1.007 . . . . 0.0 113.504 178.911 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.783 ' HG ' ' HB2' ' A' ' 39' ' ' SER . 0.1 OUTLIER -84.16 0.66 47.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.518 179.472 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 81.79 25.02 0.22 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -174.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.783 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . 5.7 t -75.77 176.68 7.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 110.809 -2.905 . . . . 0.0 112.776 -178.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.13 108.48 4.67 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.747 -1.569 . . . . 0.0 112.076 -177.309 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -104.28 141.87 35.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.806 178.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mp -82.3 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.052 0.453 . . . . 0.0 111.691 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -174.29 -170.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.563 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.99 84.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.777 179.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.37 167.57 10.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -96.8 126.4 43.03 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.377 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 13.2 Cg_exo -32.66 137.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.751 3.634 . . . . 0.0 114.963 -179.483 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 -4.16 54.09 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.61 177.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -122.63 126.84 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 117.842 0.821 . . . . 0.0 112.966 -179.238 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.29 146.29 12.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.364 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 71.2 m-85 -137.55 130.94 30.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.672 0.272 . . . . 0.0 110.988 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.734 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . 8.9 tp10 -79.85 129.46 34.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.479 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.68 127.17 7.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.089 -178.265 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -134.23 114.05 12.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.1 mt -101.97 106.4 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 111.495 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.591 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.6 mp -104.13 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.882 178.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.589 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.52 150.14 27.13 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.743 0.782 . . . . 0.0 111.131 -179.039 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -116.65 132.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.585 -179.137 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.919 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.13 -174.21 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.05 -31.71 70.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.248 179.533 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -103.97 -4.95 22.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.146 179.332 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 156.39 30.02 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.858 179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.7 t60 64.0 134.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.919 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 3.6 mm-40 -161.2 -68.86 0.06 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.631 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.589 ' H ' ' HB2' ' A' ' 57' ' ' SER . 1.5 tt0 -137.53 115.34 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.183 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -123.4 129.8 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 111.933 178.795 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -129.42 141.27 51.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.366 179.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -104.88 133.46 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.573 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.99 136.36 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.991 179.534 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.1 142.73 27.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -148.91 161.32 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.171 0.51 . . . . 0.0 111.393 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.738 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.455 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -88.2 -78.2 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.81 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.86 128.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.45 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -92.75 148.71 21.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.699 0.285 . . . . 0.0 110.702 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.41 138.07 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.103 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB1' ' HG3' ' A' ' 9' ' ' PRO . . . -125.53 93.6 44.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.12 109.8 2.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.646 2.231 . . . . 0.0 112.893 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 53.67 63.25 8.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.754 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HG3' ' HB1' ' A' ' 6' ' ' ALA . 92.5 Cg_endo -85.92 -158.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.717 2.278 . . . . 0.0 112.089 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.9 p -64.17 -25.17 67.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.149 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -94.52 -157.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.125 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.622 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -72.8 150.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.622 ' N ' HG13 ' A' ' 12' ' ' ILE . 3.6 m -52.08 -44.89 64.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.006 0.431 . . . . 0.0 110.156 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -171.62 143.84 1.78 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.858 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.58 146.77 28.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.824 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -114.68 125.04 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.668 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.93 114.5 27.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.355 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.3 mtp180 -115.07 129.61 56.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.424 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.69 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.3 p90 -142.22 148.94 38.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 111.76 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -155.69 142.93 13.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.637 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 53.0 Cg_exo -57.6 109.94 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB3' HG13 ' A' ' 50' ' ' VAL . 1.2 tptp -77.22 -23.66 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -95.26 -20.38 19.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -110.67 2.0 18.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.984 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 24' ' ' SER . 6.0 p 33.77 85.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.129 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.45 -147.21 6.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.532 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -96.32 157.87 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 110.929 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 67.5 m95 -87.99 173.92 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.686 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttp -145.59 155.05 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -123.96 140.33 53.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.339 0.59 . . . . 0.0 112.407 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.73 112.06 7.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.592 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -91.06 127.94 36.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.766 HG22 HD22 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -137.56 107.46 8.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.727 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 23.4 Cg_exo -64.77 91.9 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.583 2.189 . . . . 0.0 113.025 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.84 -152.26 50.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.677 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -107.45 71.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.766 HD22 HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.3 -31.69 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.634 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.58 179.88 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -77.0 106.81 8.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -123.29 113.31 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -128.55 127.85 43.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.26 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 mt -83.6 123.57 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.652 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' HB3' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -123.16 -156.49 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' A' ' 43' ' ' LYS . . . 94.93 14.98 47.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.989 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.65 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.63 -166.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.594 ' N ' ' HG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -145.62 162.29 37.06 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.745 0.307 . . . . 0.0 111.4 -179.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.562 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 45.5 Cg_endo -68.38 146.36 68.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.264 1.976 . . . . 0.0 112.628 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.0 0.14 83.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.202 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 46' ' ' LYS . 5.5 p -120.29 137.97 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.961 0.381 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG21 HG22 ' A' ' 72' ' ' THR . 0.8 OUTLIER -114.56 129.57 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.184 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.64 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 34.4 m-85 -104.98 -178.16 3.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 mm-40 -123.25 130.12 52.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.52 129.25 7.64 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.314 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.67 114.33 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.405 0.145 . . . . 0.0 110.776 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 3.5 mt -101.99 107.01 18.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 0.0 110.827 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.0 mp -109.47 117.74 55.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.675 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -81.5 140.33 34.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.488 0.661 . . . . 0.0 111.098 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG22 ' HA2' ' A' ' 62' ' ' GLY . 29.7 mt -119.09 132.45 68.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.452 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.657 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -106.88 -173.43 2.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -24.8 64.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.38 -5.51 22.87 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.572 0.225 . . . . 0.0 111.598 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.509 ' HA2' HG22 ' A' ' 58' ' ' ILE . . . 82.5 154.52 14.99 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.146 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 62.77 96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.71 0.404 . . . . 0.0 111.633 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.657 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 10.3 mm100 -124.05 -89.93 0.58 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 112.315 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.49 145.35 26.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.98 114.5 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 134.47 47.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.758 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 127.7 55.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -136.1 160.56 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.136 0.493 . . . . 0.0 111.656 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.0 150.76 20.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.883 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.64 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.9 140.43 49.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.483 HG22 HG21 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -152.72 168.43 25.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.888 177.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.65 ' OG1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -112.76 -110.39 0.35 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.509 HG22 ' HD3' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -85.42 13.51 6.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.957 0.408 . . . . 0.0 110.965 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 p -105.13 148.71 26.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.716 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 102.95 14.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 78' ' ' THR . 0.7 OUTLIER -148.61 -102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' A' ' 77' ' ' SER . 0.0 OUTLIER 45.58 64.89 7.23 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 111.565 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -77.65 116.42 4.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.432 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.21 31.53 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.433 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 53.59 67.45 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.801 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.04 32.85 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.85 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.79 85.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -166.1 27.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.96 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -121.01 150.78 40.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -86.05 153.84 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 64.91 153.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.22 160.42 30.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ttp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.739 0.304 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.37 -1.77 30.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.953 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.34 -135.15 12.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.566 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 t -152.8 -24.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.56 100.18 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.35 93.4 26.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.39 150.75 41.85 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.648 2.232 . . . . 0.0 112.561 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 53.3 58.41 13.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.373 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.58 148.06 9.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.62 2.214 . . . . 0.0 112.421 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -9.41 42.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.68 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.83 166.6 33.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.545 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -73.02 149.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.712 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.545 ' N ' HG13 ' A' ' 12' ' ' ILE . 7.8 t -44.62 -51.01 9.47 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 110.456 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 16' ' ' ILE . 4.1 pttt -171.48 143.95 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -105.78 136.77 44.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD13 ' HD2' ' A' ' 14' ' ' LYS . 3.0 mp -114.64 124.72 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.857 0.36 . . . . 0.0 110.679 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 25.8 tp -104.99 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -115.91 129.58 56.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.027 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.594 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 19.7 p90 -153.2 157.58 40.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.038 0.447 . . . . 0.0 111.541 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -159.39 156.9 26.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.79 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.93 117.71 4.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.137 1.891 . . . . 0.0 112.386 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -34.73 64.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -90.56 -34.57 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -169.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.596 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.09 168.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.65 -166.13 28.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.95 160.24 14.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -74.83 -179.94 4.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -146.24 127.57 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.103 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.29 134.46 55.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 111.915 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.86 133.22 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.194 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.1 m -85.76 132.07 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.175 0.512 . . . . 0.0 111.693 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.94 118.38 20.89 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.983 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 36' ' ' HIS . 53.9 Cg_exo -56.53 78.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.905 2.403 . . . . 0.0 113.462 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.74 10.35 0.97 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.259 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.452 ' H ' ' C ' ' A' ' 34' ' ' PRO . 1.8 t-160 74.68 104.19 0.07 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.877 0.37 . . . . 0.0 110.358 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 37' ' ' LEU . 7.5 mp -65.82 -35.22 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.0 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.22 -63.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.85 116.38 20.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -128.02 109.56 11.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.389 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -116.68 146.26 42.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.568 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 45' ' ' LEU . 2.2 mt -96.09 134.73 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.575 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -108.7 171.16 7.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 47.66 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.268 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 0.0 OUTLIER -141.51 -169.34 2.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -159.49 146.44 12.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 36.5 Cg_endo -65.47 122.97 10.78 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.612 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 73' ' ' THR . . . 130.27 9.53 2.97 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.246 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 74' ' ' THR . 95.1 t -118.35 130.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.901 0.35 . . . . 0.0 111.407 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 23' ' ' ASN . 11.3 t -83.02 145.37 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.472 ' HD2' ' CB ' ' A' ' 74' ' ' THR . 0.1 OUTLIER -145.22 166.07 26.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.59 0.709 . . . . 0.0 112.131 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.2 tp10 -133.24 128.67 36.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.67 139.87 11.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.517 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HB2' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -133.52 131.63 40.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.773 0.321 . . . . 0.0 110.749 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.407 HD21 HD12 ' A' ' 17' ' ' LEU . 6.0 mt -99.92 109.91 22.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.456 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.3 mp -108.14 115.42 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.15 121.66 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.432 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 1.4 mt -113.4 113.4 43.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.519 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.29 -176.41 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.2 -18.31 57.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.168 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 64' ' ' GLN . 2.6 p90 -103.25 -4.78 23.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.94 -178.35 16.38 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.866 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.9 p80 -53.18 161.38 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.687 0.28 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.453 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 1.9 pt20 -170.24 0.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.663 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -145.45 116.8 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.468 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 HG21 HG13 ' A' ' 56' ' ' ILE . 42.0 t -134.23 123.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.535 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.23 121.73 18.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.04 138.76 34.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.027 0.442 . . . . 0.0 111.767 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -156.38 126.85 6.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.767 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -95.41 137.93 33.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -139.65 149.11 43.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.009 0.433 . . . . 0.0 111.548 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.65 169.44 8.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.543 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 72' ' ' THR . 19.4 m 76.81 91.58 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.7 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.689 HG21 HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -172.07 -153.36 0.08 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.057 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.732 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 69.4 p -120.05 -179.04 3.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.0 p -85.2 -59.3 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.129 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p -147.03 176.19 10.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -136.82 72.61 55.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.74 -33.8 61.69 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.571 2.181 . . . . 0.0 112.36 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.64 102.39 1.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -145.15 154.73 42.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.53 -98.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 m 58.61 13.31 2.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.264 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 51.45 34.84 12.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 58.53 86.66 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.38 39.47 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -149.83 165.87 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -106.16 157.64 17.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.887 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.691 0.281 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.29 63.12 2.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.84 -155.29 9.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.588 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.4 m -99.0 -162.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -107.97 14.23 25.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.214 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.22 77.38 60.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.063 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.88 -44.87 3.59 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.694 2.262 . . . . 0.0 112.295 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.63 152.09 51.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.86 111.59 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 112.18 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 97.39 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -157.21 179.13 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.655 HG13 ' N ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -72.26 150.09 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.655 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.34 -50.95 37.51 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -171.55 144.58 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.366 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.632 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -104.52 139.56 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.256 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 16' ' ' ILE . 17.5 mm -117.07 124.04 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.091 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 55' ' ' LEU . 26.8 tp -105.63 113.99 27.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.858 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.94 128.92 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.631 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.585 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -156.69 148.4 22.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.141 0.496 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 161.21 33.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.619 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' SER . 48.9 Cg_exo -57.72 117.56 4.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.281 1.988 . . . . 0.0 112.357 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -66.94 -36.84 83.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.503 -179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.472 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 1.7 t-20 -96.44 -43.43 7.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.267 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.51 165.87 16.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.13 152.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.74 -127.68 1.53 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -139.93 168.76 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.45 173.39 12.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.94 137.59 36.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.69 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.3 mt-10 -120.22 133.31 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.038 0.447 . . . . 0.0 111.832 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -139.62 117.74 11.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.202 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.4 m -86.3 131.06 34.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.09 0.472 . . . . 0.0 112.147 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 37' ' ' LEU . 1.6 mp -133.77 106.42 11.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.757 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.63 90.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.438 2.092 . . . . 0.0 112.378 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.69 -93.29 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.15 93.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -68.26 -33.96 75.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.855 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.671 ' N ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 169.02 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.72 117.22 21.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.035 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -115.82 113.69 23.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.842 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -122.99 130.18 52.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 45' ' ' LEU . 4.6 mm -85.5 127.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -173.36 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 39.01 53.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.591 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.815 ' HB3' ' H ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -141.89 -174.18 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -162.8 151.27 12.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.244 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.966 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 24.6 Cg_exo -63.17 168.62 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.8 -7.03 60.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.674 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -119.86 121.56 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 1.6 p -82.44 103.24 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' HD2' HG22 ' A' ' 74' ' ' THR . 0.3 OUTLIER -94.67 160.03 14.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.135 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.585 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 1.6 tp10 -117.79 129.11 55.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.64 145.15 16.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.149 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -133.77 131.91 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.057 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD12 HD11 ' A' ' 17' ' ' LEU . 4.9 tp -119.01 107.31 13.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.899 0.381 . . . . 0.0 111.051 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.6 mp -116.67 116.44 52.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.907 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -89.8 126.38 35.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.72 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 2.7 mp -113.15 125.26 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.235 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG2' HD11 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -101.15 -177.31 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.506 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -64.3 -26.78 68.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.54 -0.39 43.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.12 169.11 13.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.73 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 8.8 p80 -56.98 151.97 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 6.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 tt0 -143.66 116.74 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.18 121.21 31.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 m -134.96 121.52 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -100.94 129.7 46.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.69 132.6 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.305 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 151.24 19.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.63 153.9 35.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.052 0.453 . . . . 0.0 111.811 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.482 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -102.39 168.78 9.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.709 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.966 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 39.2 m 76.52 78.94 0.09 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.053 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.634 ' HA ' ' CB ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 170.51 136.68 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.024 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.815 ' H ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 t -124.4 -175.22 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 p -74.81 152.58 38.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.836 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.97 138.29 40.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.81 60.81 8.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.122 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 96.7 Cg_endo -79.91 -136.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.487 2.125 . . . . 0.0 112.171 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 156.7 -66.21 0.3 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.6 p -129.52 -4.12 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.784 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 135.66 33.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 m -105.38 149.93 25.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -134.94 67.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -12.62 13.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.8 178.91 9.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.73 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 56.06 -151.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.36 157.81 33.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.806 0.336 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.59 48.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.63 112.38 0.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.28 82.77 1.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 110.824 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -155.74 98.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -73.26 -49.71 6.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.696 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 57.9 Cg_endo -71.76 132.5 20.27 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.231 1.954 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.07 47.57 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.97 -69.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.368 2.046 . . . . 0.0 112.153 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -165.79 71.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.68 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.2 m80 61.13 -86.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.729 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -98.38 149.56 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.606 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -48.11 -47.56 34.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.891 0.377 . . . . 0.0 110.299 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -175.45 143.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.829 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.78 139.01 39.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.1 mm -116.07 129.31 72.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.607 HD11 HD21 ' A' ' 55' ' ' LEU . 28.5 tp -105.03 113.01 26.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.01 129.01 52.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.531 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -152.12 150.08 29.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.335 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.538 HH11 ' HA ' ' A' ' 25' ' ' VAL . 7.1 ptt85 -148.51 160.84 35.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.33 114.59 2.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.172 1.915 . . . . 0.0 111.622 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -61.8 -30.89 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.748 -179.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.702 HD21 HG12 ' A' ' 50' ' ' VAL . 2.0 p30 -99.48 -38.79 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -3.27 57.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.538 ' HA ' HH11 ' A' ' 20' ' ' ARG . 32.9 m 35.44 41.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.092 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.37 -160.4 12.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -73.66 169.11 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.447 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 37.3 m95 -99.51 173.11 6.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.493 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.22 139.51 41.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.345 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -120.37 134.7 55.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 116.96 10.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.947 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 60.1 m -85.33 138.95 31.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.274 0.559 . . . . 0.0 112.475 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.79 HG21 ' HA ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -135.45 107.07 10.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.476 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.26 87.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.83 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.16 25.91 48.36 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.941 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.79 ' HA ' HG21 ' A' ' 33' ' ' ILE . 0.3 OUTLIER 58.62 99.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.832 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -72.86 -22.46 60.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.578 ' N ' HD23 ' A' ' 37' ' ' LEU . 17.8 t-20 -176.82 -105.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.2 p -127.19 121.73 32.11 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.64 103.38 10.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -115.85 142.97 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.233 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.624 HG23 HD11 ' A' ' 45' ' ' LEU . 2.5 mt -86.5 125.38 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -101.1 168.9 9.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -140.43 23.41 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.404 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.942 ' HB3' ' H ' ' A' ' 75' ' ' SER . 0.2 OUTLIER 57.32 -167.97 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.563 0.22 . . . . 0.0 111.197 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.44 147.23 24.79 Favored Pre-proline 0 CA--C 1.527 0.082 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.868 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 97.3 Cg_endo -85.49 45.04 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.995 2.463 . . . . 0.0 113.219 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.98 -19.01 7.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.516 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.561 HG11 ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER -120.56 136.86 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.935 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG12 HD21 ' A' ' 23' ' ' ASN . 9.5 p -77.63 147.0 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -130.15 148.21 51.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 112.307 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -111.93 129.82 56.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.806 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 136.97 13.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.597 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' NE2' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.86 123.66 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.449 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD21 HD11 ' A' ' 17' ' ' LEU . 3.8 mt -108.18 108.97 20.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 111.021 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.672 HD13 ' HB ' ' A' ' 66' ' ' VAL . 1.3 mm -112.35 118.7 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.672 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.96 133.86 41.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.289 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.827 HG12 ' HB3' ' A' ' 63' ' ' HIS . 6.4 mt -113.65 127.48 70.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 111.644 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' A' ' 12' ' ' ILE . 2.8 mm100 -95.18 -176.46 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -32.25 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.767 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.66 15.48 28.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.73 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.05 161.04 12.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.237 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.827 ' HB3' HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.55 163.78 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.722 0.296 . . . . 0.0 110.986 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.44 6.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.66 115.89 12.57 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.958 0.408 . . . . 0.0 111.607 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.672 ' HB ' HD13 ' A' ' 56' ' ' ILE . 1.2 p -136.03 139.07 46.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -137.06 136.05 38.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.34 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HG2' ' NE2' ' A' ' 54' ' ' GLN . 1.6 mtm180 -111.32 129.46 55.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -156.02 127.98 7.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.805 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.68 132.78 39.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.074 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -136.61 150.76 48.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' A' ' 73' ' ' THR . 21.2 p -109.27 168.4 9.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.831 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.868 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 90.1 m 87.2 65.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.584 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.635 ' HA ' ' CB ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 174.24 146.99 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.588 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.942 ' H ' ' HB3' ' A' ' 45' ' ' LEU . 9.1 t -124.7 179.16 5.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.181 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -76.04 -65.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.341 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.506 ' H ' HG23 ' A' ' 76' ' ' THR . 88.1 p -149.35 133.35 17.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.6 p -139.72 70.19 37.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.869 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 52.4 Cg_exo -54.13 -80.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.42 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 143.77 -152.04 23.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.481 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -67.01 1.03 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 110.868 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -152.16 109.39 3.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -67.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.91 114.75 18.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 -156.38 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -80.75 11.95 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 55.69 76.71 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 56.42 72.06 0.52 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.981 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.889 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.842 0.353 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -108.0 73.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.918 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.87 -93.78 2.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -86.22 -57.01 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.744 0.307 . . . . 0.0 110.98 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 m120 60.61 12.93 3.9 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -171.51 137.41 1.04 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.9 137.52 15.85 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.518 2.145 . . . . 0.0 112.566 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 64.5 139.25 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.12 150.51 42.89 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.486 2.124 . . . . 0.0 112.551 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -128.66 78.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.723 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 32.7 m-70 -61.71 155.66 22.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.633 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -67.28 150.14 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.1 t -49.76 -48.98 49.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.707 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HZ1' HD13 ' A' ' 16' ' ' ILE . 4.3 ptmt -169.72 144.25 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.993 0.425 . . . . 0.0 111.445 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -105.19 139.12 40.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.952 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD13 ' HZ1' ' A' ' 14' ' ' LYS . 28.5 mm -114.45 117.97 57.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.525 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.727 HD13 HD11 ' A' ' 55' ' ' LEU . 42.6 tp -104.9 113.74 27.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.831 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -119.34 128.72 54.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.913 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 8.6 p90 -151.63 162.16 41.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.904 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.16 161.69 27.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.684 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.53 118.94 5.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 121.906 1.737 . . . . 0.0 111.832 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -29.67 70.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.528 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -99.39 -41.17 7.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.471 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 160.06 17.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.281 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.77 147.44 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.31 -164.72 37.38 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.63 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -89.14 155.6 19.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.96 -172.59 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.78 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -141.16 144.33 34.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.8 mt-10 -120.05 132.95 55.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.202 0.525 . . . . 0.0 111.792 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 118.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.937 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 87.7 m -85.42 132.5 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 112.091 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 14.4 mt -123.88 107.56 30.95 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.759 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.7 104.26 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.603 2.202 . . . . 0.0 112.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.723 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . 58.8 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.159 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -146.06 111.82 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.243 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 -3.52 56.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.77 -63.91 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.872 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.76 105.22 8.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 110.818 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -126.47 115.21 19.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -120.57 144.47 48.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.257 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.3 mt -94.33 132.68 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.506 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.39 154.38 25.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.227 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 38.13 4.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.642 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.825 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -126.62 171.02 11.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.328 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -149.7 135.96 10.47 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.29 157.95 10.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.659 2.24 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.37 -62.08 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.611 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 ' OG1' ' A' ' 74' ' ' THR . 0.6 OUTLIER -77.13 133.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 111.173 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 51' ' ' TYR . 5.3 p -82.85 144.76 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.027 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.584 ' CE2' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -125.4 138.92 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.945 0.402 . . . . 0.0 111.923 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 10.7 tp10 -105.22 129.29 53.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.5 144.67 15.72 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 119.822 -1.18 . . . . 0.0 114.309 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -133.66 129.47 36.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.377 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 17' ' ' LEU . 4.7 tp -124.9 106.67 10.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.88 116.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.941 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.407 ' OG ' HG23 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.42 127.43 33.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 63' ' ' HIS . 15.1 mm -112.84 124.39 69.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.309 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 -177.1 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.24 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.42 -2.54 28.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.54 -166.4 12.15 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.438 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.582 ' HA ' HD11 ' A' ' 58' ' ' ILE . 21.1 p-80 -64.65 140.81 58.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.319 . . . . 0.0 110.707 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 -51.59 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -97.2 126.18 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.484 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 123.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -137.41 130.85 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -111.46 139.55 46.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -155.94 127.83 7.44 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.028 0.442 . . . . 0.0 111.501 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.82 124.1 39.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.7 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -125.18 162.73 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.85 0.357 . . . . 0.0 111.741 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -107.36 168.39 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.388 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 m 85.11 101.39 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.243 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.825 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -145.95 153.61 41.0 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -159.89 -6.52 0.06 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -71.25 -103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.121 -0.231 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.445 ' H ' HG23 ' A' ' 76' ' ' THR . 1.1 t 44.92 75.24 0.11 Allowed 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.68 101.62 5.47 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.267 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.25 -64.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.974 2.449 . . . . 0.0 112.138 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.72 -148.95 18.85 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.631 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -79.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.757 0.313 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -109.3 -56.37 2.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.8 t -161.34 -54.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' HB3' ' H ' ' A' ' 85' ' ' HIS . 5.8 m80 -131.07 -147.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.918 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.449 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 32.9 m170 64.05 106.38 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 129.52 31.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 108.82 13.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.112 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -167.92 91.16 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.154 -0.926 . . . . 0.0 110.82 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.74 -161.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.29 -19.84 28.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.352 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.46 ' H ' ' HG ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -67.5 113.65 5.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.689 0.28 . . . . 0.0 110.924 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.79 168.99 0.11 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.39 80.25 0.3 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.291 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.47 120.73 8.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.561 2.174 . . . . 0.0 112.114 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.52 144.16 30.36 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.041 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.68 142.57 12.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.634 2.223 . . . . 0.0 112.303 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.38 -2.6 30.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.8 m80 55.73 -136.8 1.17 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.553 HG13 ' HG2' ' A' ' 59' ' ' GLN . 1.0 OUTLIER -67.4 156.39 6.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.914 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.468 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.19 -41.51 65.33 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -162.39 143.15 10.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.831 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.756 ' HH ' HD21 ' A' ' 55' ' ' LEU . 8.2 t80 -122.83 153.12 39.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.655 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 58' ' ' ILE . 3.7 mp -120.11 121.88 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.682 0.277 . . . . 0.0 110.751 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.696 HD12 ' HH ' ' A' ' 15' ' ' TYR . 10.5 tp -104.84 114.22 28.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.639 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.64 129.84 56.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -140.9 155.08 46.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.83 146.2 12.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.685 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' N ' ' HG2' ' A' ' 20' ' ' ARG . 39.7 Cg_exo -58.18 114.63 2.05 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.214 1.943 . . . . 0.0 111.974 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -65.63 -35.82 81.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.495 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.452 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -91.28 -43.85 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.328 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.533 ' C ' HG22 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -79.41 0.53 28.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG22 ' C ' ' A' ' 24' ' ' SER . 4.4 m 29.62 63.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.258 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.68 -153.39 29.58 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.541 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -88.32 164.91 15.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.3 172.7 8.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.029 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -152.24 123.95 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.571 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.42 130.11 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.123 0.487 . . . . 0.0 112.178 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.03 137.09 51.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.779 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 97.8 m -85.27 115.66 23.16 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.532 0.682 . . . . 0.0 111.858 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.731 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.82 110.46 17.22 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.597 178.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.15 79.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.092 1.861 . . . . 0.0 111.945 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 45.46 37.81 6.67 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.414 ' HE2' ' H ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER 59.74 97.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.923 0.392 . . . . 0.0 110.882 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 -32.84 68.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -163.63 -89.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.82 123.87 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.837 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' H ' ' HE2' ' A' ' 36' ' ' HIS . 44.9 t80 -127.92 119.39 25.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.045 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -98.67 146.91 25.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.986 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 43' ' ' LYS . 12.1 mt -108.04 115.01 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.117 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 42' ' ' ILE . 7.8 mmpt? 25.73 -126.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.205 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.92 80.27 0.19 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.452 ' CD2' ' H ' ' A' ' 45' ' ' LEU . 1.3 mm? -68.54 -155.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HD3' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -155.65 140.65 12.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.63 107.11 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.653 2.236 . . . . 0.0 112.484 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.61 -3.93 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.861 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.575 HG21 ' HD3' ' A' ' 46' ' ' LYS . 78.6 t -104.31 115.91 47.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 2.8 p -83.23 116.39 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.363 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -107.98 169.48 8.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.25 0.547 . . . . 0.0 111.454 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -124.16 129.92 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.118 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.57 139.61 10.61 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.18 138.58 49.49 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.756 HD21 ' HH ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -99.28 105.39 17.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.644 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' N ' ' HE1' ' A' ' 15' ' ' TYR . 4.2 mp -116.0 113.44 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -106.42 133.41 51.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.234 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.739 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 9.6 mt -114.05 127.21 71.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.553 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -98.7 -179.02 4.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.914 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -66.45 -16.87 64.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.031 0.443 . . . . 0.0 110.085 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -103.06 -4.95 23.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.941 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 124.56 171.24 13.34 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.739 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.39 139.03 58.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.7 0.286 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.77 9.97 1.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.832 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -142.73 114.98 8.39 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 112.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -137.2 126.58 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.381 179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -137.2 131.02 31.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.007 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -107.51 125.49 51.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -155.73 133.89 11.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 111.359 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.92 140.79 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.278 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' HE2' HG22 ' A' ' 74' ' ' THR . 52.0 p90 -143.48 142.81 31.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 111.806 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 p -103.28 134.4 46.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.574 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.8 m 62.96 143.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.13 0.491 . . . . 0.0 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.478 HG22 ' HE2' ' A' ' 71' ' ' PHE . 0.6 OUTLIER -154.02 -13.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.113 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -72.84 175.75 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.444 HG21 ' OG1' ' A' ' 78' ' ' THR . 10.5 t -118.85 7.09 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.233 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.44 82.56 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.444 ' OG1' HG21 ' A' ' 76' ' ' THR . 15.8 m -145.97 95.04 4.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.306 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -71.29 163.14 40.13 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.762 2.308 . . . . 0.0 112.122 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.55 -49.07 0.16 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.726 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 p -120.55 158.35 27.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.037 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -121.33 -34.47 3.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.33 142.34 56.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.04 89.05 2.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.229 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 51.61 85.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 -86.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.44 164.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.369 . . . . 0.0 111.092 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -159.07 143.49 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.898 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -139.39 90.0 2.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.54 99.7 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.398 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.05 89.66 2.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.978 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 54.52 73.67 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.59 129.12 13.97 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.035 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.35 117.7 4.81 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.448 2.098 . . . . 0.0 112.265 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -120.67 143.52 36.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.965 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.76 169.42 22.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.516 2.144 . . . . 0.0 112.246 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -62.86 126.15 26.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -74.23 -169.67 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.612 HD13 ' HG2' ' A' ' 59' ' ' GLN . 0.7 OUTLIER -80.46 155.07 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.555 ' H ' HG13 ' A' ' 12' ' ' ILE . 16.5 t -53.71 -47.11 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.075 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -172.96 144.0 1.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.116 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -106.23 143.9 33.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.421 HG22 ' HD3' ' A' ' 18' ' ' ARG . 19.5 mm -116.19 118.58 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 111.04 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 49.2 tp -105.37 114.95 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.651 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.48 128.99 55.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.439 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.619 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 44.5 p90 -140.4 147.73 40.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.313 0.578 . . . . 0.0 110.838 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -161.99 153.07 15.11 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.256 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.62 110.5 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.332 2.022 . . . . 0.0 112.247 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -32.22 73.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.288 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.83 -37.28 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.51 -162.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG23 ' H ' ' A' ' 26' ' ' GLY . 3.9 p -60.96 166.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.29 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.675 ' H ' HG23 ' A' ' 25' ' ' VAL . . . -74.87 -108.78 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.649 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.523 HH22 HG21 ' A' ' 78' ' ' THR . 4.5 mtp180 59.97 65.98 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.071 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.438 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 -57.48 168.39 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.72 134.37 35.26 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 7.5 mt-10 -119.06 136.79 53.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.449 0.642 . . . . 0.0 112.65 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.05 119.74 15.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 62.2 m -85.28 131.59 34.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG21 HD11 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -132.63 107.3 13.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.65 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.84 84.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.615 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.68 60.62 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.782 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.5 m170 60.89 106.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 0.0 111.162 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.682 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -76.85 -30.69 56.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 37' ' ' LEU . 10.4 p-10 -177.98 -148.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.81 105.6 7.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.28 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -103.23 114.75 29.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.128 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.476 ' O ' HG22 ' A' ' 41' ' ' THR . 2.4 t -101.57 147.56 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.4 mt -107.61 114.74 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.754 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.677 ' HE2' ' H ' ' A' ' 43' ' ' LYS . 9.0 mmpt? 34.92 -129.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.624 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 45' ' ' LEU . . . -129.45 -43.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.714 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.102 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.4 OUTLIER 55.21 -176.68 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.49 0.186 . . . . 0.0 110.769 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -160.74 142.87 9.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.33 143.02 94.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.546 2.164 . . . . 0.0 112.14 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.8 -29.9 4.79 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.728 ' HB ' ' CG2' ' A' ' 74' ' ' THR . 2.8 t -96.97 135.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.632 0.254 . . . . 0.0 111.187 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.15 118.57 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CE2' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.94 164.98 11.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.697 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.8 tp10 -123.16 129.31 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.494 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.51 132.1 10.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.127 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 19.8 mm-40 -134.32 112.71 11.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB3' ' OH ' ' A' ' 15' ' ' TYR . 14.5 mt -106.14 105.55 15.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.962 0.41 . . . . 0.0 110.293 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.77 114.78 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.174 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 1.8 t -89.59 116.25 27.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.32 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 6.2 mt -102.44 121.17 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.045 0.45 . . . . 0.0 111.573 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.612 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -78.87 -176.36 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.179 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -30.69 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -103.03 1.23 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.02 13.39 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.009 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 2.1 p-80 -75.87 156.24 34.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.244 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -26.68 0.14 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.293 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.27 119.02 38.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 111.191 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 132.64 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.232 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.7 132.69 33.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.281 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.95 129.44 56.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.406 ' CE1' HD13 ' A' ' 55' ' ' LEU . 34.0 p90 -156.39 128.66 7.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.99 136.4 36.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.916 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.34 159.18 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.952 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 73' ' ' THR . 3.0 p -109.38 169.09 8.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.929 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 72' ' ' THR . 25.9 m 98.29 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.256 0.972 . . . . 0.0 111.125 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 1.102 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -141.95 175.63 9.57 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.303 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.562 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 7.6 t -166.81 -63.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.477 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 p 60.3 107.73 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -56.27 -55.1 37.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.523 HG21 HH22 ' A' ' 27' ' ' ARG . 80.7 p 47.12 76.62 0.53 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.834 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.21 -8.9 15.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.617 2.211 . . . . 0.0 112.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.37 -103.65 1.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.538 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.63 -17.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.748 0.308 . . . . 0.0 111.015 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.2 mtp-105 -125.2 -7.07 7.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 84' ' ' HIS . 0.6 OUTLIER 57.06 -156.39 0.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.448 ' H ' ' HB3' ' A' ' 83' ' ' SER . 16.4 m-70 63.37 109.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -109.49 -8.02 15.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.167 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.448 ' HB3' ' H ' ' A' ' 87' ' ' HIS . 14.1 m-70 -103.93 -149.9 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.051 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' H ' ' HB3' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 61.32 -171.48 0.15 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.906 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -34.68 60.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.969 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.688 0.28 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.45 145.84 25.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.97 133.57 4.71 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.51 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 t -98.59 136.09 39.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.17 -63.41 1.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.18 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 101.04 3.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.245 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.05 119.51 6.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -118.68 145.59 37.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.517 2.145 . . . . 0.0 112.287 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.68 -173.62 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -74.24 -90.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -101.26 147.9 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.436 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.4 m -45.16 -49.79 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.268 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HB2' HG22 ' A' ' 32' ' ' THR . 6.7 pttt -175.61 144.16 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.733 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -111.15 135.43 51.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.488 HG21 ' HD2' ' A' ' 18' ' ' ARG . 10.2 mt -114.16 121.46 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 111.237 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 66.4 tp -105.3 114.66 28.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.736 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -121.0 128.33 52.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.529 ' CE3' ' HG ' ' A' ' 17' ' ' LEU . 16.4 p90 -148.15 158.67 44.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.979 0.419 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -160.5 162.44 23.4 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.614 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.5 111.32 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.374 2.049 . . . . 0.0 111.985 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HZ2' ' HG3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -54.6 -24.81 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.773 -179.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.544 ' HB2' HG13 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -99.68 -43.92 6.3 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.18 175.49 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.375 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.54 HG23 HH12 ' A' ' 20' ' ' ARG . 11.3 p -136.0 145.65 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.55 -111.28 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.561 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -127.81 148.17 50.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -82.57 -174.96 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.736 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.13 124.31 20.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.3 mt-10 -119.73 136.61 54.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 112.136 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.19 138.73 40.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.302 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.1 m -94.34 132.57 38.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.168 0.509 . . . . 0.0 112.156 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -135.68 107.71 9.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.862 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.18 83.96 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.485 2.124 . . . . 0.0 112.179 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.46 -90.68 0.64 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.298 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -168.48 93.33 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.695 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.75 HD23 ' H ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -66.34 -33.46 75.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.75 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.0 OUTLIER 179.66 -92.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.782 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.06 117.45 21.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.669 0.271 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.98 101.66 9.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.8 130.64 54.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -81.55 119.57 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -175.22 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.31 47.7 21.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.204 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HB2' ' HB ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.13 166.68 23.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.798 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG2' ' OG ' ' A' ' 75' ' ' SER . 0.3 OUTLIER -146.88 116.54 4.5 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.14 105.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.857 2.371 . . . . 0.0 112.567 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 -33.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.45 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.742 HG12 HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -110.55 135.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 23' ' ' ASN . 11.4 p -76.49 140.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.688 ' CZ ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -126.11 142.73 51.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.904 -178.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 19.1 pt-20 -116.32 129.19 56.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.45 141.21 16.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.617 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -133.62 114.43 13.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 17' ' ' LEU . 3.9 mt -106.55 107.57 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 0.0 110.701 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.1 mp -113.54 122.23 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.211 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.59 ' HB3' ' CB ' ' A' ' 65' ' ' GLU . 0.3 OUTLIER -89.61 131.96 35.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.119 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -113.17 122.74 67.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.636 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 7.6 tt0 -119.56 -175.77 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.472 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.83 -22.1 63.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HD2' HE22 ' A' ' 64' ' ' GLN . 0.3 OUTLIER -103.15 15.83 28.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.193 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.14 -169.38 27.93 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.409 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.594 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -56.01 152.43 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.678 0.275 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.594 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.96 -50.65 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.895 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.59 ' CB ' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -99.08 118.85 36.76 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.825 -178.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -134.12 119.86 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.949 0.404 . . . . 0.0 111.168 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 m -137.21 135.4 37.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.23 125.81 9.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.609 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.65 124.55 43.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.411 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.45 156.3 48.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.39 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.5 p -108.99 134.19 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 172.45 -100.43 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.104 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.742 HG23 HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER 48.83 140.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' A' ' 46' ' ' LYS . 4.4 t -176.24 -168.74 0.27 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.616 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 p -117.61 145.53 44.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t 62.4 174.88 0.14 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.036 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -144.5 76.44 14.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 32.4 Cg_exo -58.1 -77.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.594 2.196 . . . . 0.0 112.307 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 173.77 -171.95 44.89 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.425 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.7 p -137.37 -165.54 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 82' ' ' ARG . 6.0 mtp-105 -106.35 143.69 34.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m 54.29 43.2 30.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.03 10.4 2.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.447 ' HB2' ' H ' ' A' ' 86' ' ' HIS . 4.3 p-80 -105.76 -159.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.447 ' H ' ' HB2' ' A' ' 85' ' ' HIS . 0.1 OUTLIER -96.06 58.38 1.86 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -166.68 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.167 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 160.69 41.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mtt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -96.36 90.0 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -175.87 84.92 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -144.3 29.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.785 0.326 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m120 57.39 88.14 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.09 97.09 49.39 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.308 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.77 118.14 4.98 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.635 2.223 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -87.9 112.64 50.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.7 152.58 29.3 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.573 2.182 . . . . 0.0 112.362 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.73 -58.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.853 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -142.2 -78.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -89.61 144.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.57 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.69 -52.38 60.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.99 0.424 . . . . 0.0 110.154 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HD2' HD13 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -168.76 143.85 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.79 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -113.11 129.12 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.307 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 17' ' ' LEU . 22.9 mm -114.11 137.61 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -115.22 114.48 25.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.247 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 5.1 mtt-85 -113.97 128.31 56.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.196 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -154.75 157.34 37.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 112.228 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 8.3 ptt85 -159.13 160.19 28.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -58.14 125.11 17.54 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 112.418 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 3.0 tttm -76.91 -37.07 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.462 HD22 HG12 ' A' ' 49' ' ' VAL . 5.6 p30 -90.35 -31.97 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.68 168.61 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.13 130.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.81 -120.16 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.581 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -136.52 166.29 23.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 40.6 m95 -84.32 -174.97 5.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tttm -148.94 145.19 27.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -119.8 129.75 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.113 0.482 . . . . 0.0 111.727 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.12 111.77 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.192 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -88.98 140.2 29.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.811 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.633 HG21 HD13 ' A' ' 37' ' ' LEU . 4.0 mt -130.57 116.32 17.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.423 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.23 87.72 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.832 2.354 . . . . 0.0 112.08 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 -89.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -169.7 92.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.633 HD13 HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -83.66 -33.79 25.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.423 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER 178.08 -157.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.599 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -86.18 106.61 17.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.729 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -84.57 119.48 25.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.019 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 m -122.78 124.47 43.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.422 HD11 HD21 ' A' ' 17' ' ' LEU . 3.3 mt -90.18 122.62 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.02 105.1 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.7 8.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.812 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.2 OUTLIER -95.09 -144.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.503 0.192 . . . . 0.0 110.499 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -165.85 140.46 3.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.5 95.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.407 2.071 . . . . 0.0 112.008 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.99 -27.71 3.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG12 HD22 ' A' ' 23' ' ' ASN . 1.9 t -92.52 124.0 44.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 110.659 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HA ' HG22 ' A' ' 72' ' ' THR . 63.1 t -100.93 123.14 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 0.0 111.384 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 18.0 m-85 -106.09 118.08 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.438 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 pt-20 -82.04 149.15 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.37 160.9 34.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.375 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -132.83 151.9 51.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 45.2 tp -111.19 107.7 17.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.92 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.1 mp -92.55 138.31 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.007 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.55 123.52 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 110.951 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 HD13 ' HD2' ' A' ' 14' ' ' LYS . 5.4 mt -113.27 117.79 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.824 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.97 171.66 10.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.892 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.98 -23.36 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.85 4.11 37.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.51 -134.09 11.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.619 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 64.77 168.8 0.18 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.856 0.36 . . . . 0.0 111.333 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -158.52 109.14 2.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.108 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tm-20 -100.11 116.28 31.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.328 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 21.1 t -123.51 138.03 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 54.3 m -137.79 125.58 22.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.392 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.22 144.54 28.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.29 157.09 35.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.57 119.05 28.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.47 ' C ' HG21 ' A' ' 72' ' ' THR . 17.7 p90 -142.55 153.09 43.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.358 0.599 . . . . 0.0 112.45 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.47 HG21 ' C ' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -147.06 167.73 23.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.829 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.812 HG22 ' HB2' ' A' ' 45' ' ' LEU . 51.0 p -38.56 -61.59 0.69 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 111.527 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.79 -23.48 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.66 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.444 ' O ' HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -81.37 174.57 11.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.52 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 t -69.08 -78.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.761 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m 54.16 83.54 0.22 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.233 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.15 -29.95 88.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.665 2.243 . . . . 0.0 112.468 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.9 83.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 t -164.1 -68.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.35 83.71 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.758 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.9 t -113.13 -82.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -125.33 98.15 5.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -167.46 -75.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -164.56 140.88 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.04 82.46 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.762 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 -173.66 4.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.937 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.678 0.275 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.48 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -68.57 -44.15 75.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.228 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.85 147.75 7.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.338 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.449 ' HB2' ' H ' ' A' ' 5' ' ' ASN . 1.2 m -105.59 -103.38 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.544 0.211 . . . . 0.0 111.124 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.449 ' H ' ' HB2' ' A' ' 4' ' ' SER . 0.6 OUTLIER -166.28 108.57 0.73 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.741 0.305 . . . . 0.0 110.904 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.85 70.63 7.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.321 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.74 141.59 8.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.607 2.205 . . . . 0.0 112.447 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -158.85 123.12 2.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.24 -56.77 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.503 2.135 . . . . 0.0 112.161 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.52 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -84.29 -68.22 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -90.71 142.81 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.354 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 2.2 m -66.23 -49.17 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.103 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.81 11.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.126 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.92 128.21 54.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.098 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 17' ' ' LEU . 32.9 mm -113.84 134.28 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.196 0.522 . . . . 0.0 110.987 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.541 ' N ' HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -111.55 114.55 27.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.311 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -112.28 128.24 56.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.935 179.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -147.94 155.77 41.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.328 0.585 . . . . 0.0 112.306 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.06 152.51 18.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -57.97 114.67 2.07 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.414 2.076 . . . . 0.0 112.55 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 1.8 ttmm -70.39 -36.39 74.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.154 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -84.3 -36.85 22.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.69 -169.57 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.781 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.03 103.25 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.909 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.19 -138.13 3.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 150.7 45.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -67.21 174.86 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.755 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.31 150.45 37.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.9 136.75 54.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 111.78 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 112.05 7.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.8 m -85.62 138.39 32.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.606 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.06 114.87 17.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 90.33 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.457 2.105 . . . . 0.0 112.304 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA2' HG21 ' A' ' 12' ' ' ILE . . . 66.57 -91.8 0.18 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.309 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -160.78 74.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.631 HD22 ' H ' ' A' ' 38' ' ' ASN . 2.0 pt? -65.6 -33.62 76.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.631 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.6 OUTLIER 173.95 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.335 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -76.94 105.41 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.391 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -89.99 116.76 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -116.01 131.41 56.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -102.08 130.45 51.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.989 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -135.03 -168.32 2.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.94 61.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.616 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.599 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -74.07 -170.19 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.785 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 49' ' ' VAL . 18.8 mttt -137.98 150.79 68.56 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.54 122.38 8.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.38 -16.86 31.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.551 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 46' ' ' LYS . 7.7 p -119.96 125.66 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 82.6 t -96.5 142.82 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.728 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 26.9 m-85 -109.93 124.8 52.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.811 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -89.74 156.22 18.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.0 152.24 21.3 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.446 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.35 132.27 41.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 27.1 tp -99.9 107.01 18.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.879 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.19 138.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.663 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -117.02 121.49 41.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 111.906 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.87 125.7 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.432 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.739 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -118.64 178.96 4.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -22.16 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.03 -4.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.56 23.89 59.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.739 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 7.4 m80 -67.28 173.03 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 89.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -101.01 116.16 32.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.269 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 p -130.77 139.23 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.241 0.543 . . . . 0.0 112.418 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.4 m -137.6 125.64 22.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.753 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 146.85 27.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.22 146.25 21.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 111.807 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -108.59 121.3 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.489 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -129.58 149.13 51.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 77' ' ' SER . 71.2 p -142.4 163.67 32.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.655 HG21 HG23 ' A' ' 74' ' ' THR . 8.8 t -101.71 -27.27 13.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.314 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 73' ' ' THR . 3.3 t -161.06 13.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.078 0.465 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.5 t -93.2 -87.31 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -172.46 104.39 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.193 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.409 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -169.39 -90.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.091 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -163.73 119.61 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.171 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.81 54.33 3.99 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.664 2.243 . . . . 0.0 112.576 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.27 -152.92 24.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.686 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.2 m -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -77.13 -176.9 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.7 p -103.85 -8.62 19.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.55 126.48 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -143.45 -78.44 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.698 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.95 -76.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.78 16.08 10.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.42 -174.5 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.75 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -99.61 8.89 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.023 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.45 36.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.408 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.4 125.36 25.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 110.834 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -76.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . . . -63.08 143.42 97.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.247 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 -35.97 4.95 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.656 2.237 . . . . 0.0 112.257 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -160.23 70.9 3.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 51.2 Cg_endo -69.95 -86.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.582 2.188 . . . . 0.0 112.698 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.0 m 62.47 170.38 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.074 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.63 -51.79 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -100.34 141.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.523 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -54.79 -49.08 71.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.297 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 144.25 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.016 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -116.56 135.69 53.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.123 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.519 HG22 ' N ' ' A' ' 17' ' ' LEU . 17.2 mm -114.68 135.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.178 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -115.54 114.96 25.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.962 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.745 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.6 mtp180 -114.55 129.18 56.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.775 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -145.0 154.92 43.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 111.749 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.45 152.46 18.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.794 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.0 Cg_exo -58.59 119.11 6.15 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.348 2.032 . . . . 0.0 112.291 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -23.61 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.405 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -98.62 -36.4 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 2.8 m -104.31 113.52 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.997 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 m -95.51 128.59 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.74 -57.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.566 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -167.84 151.55 6.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.767 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 30.9 m95 -87.89 -169.51 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.745 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttt -143.11 151.19 40.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -119.94 137.04 54.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.319 0.581 . . . . 0.0 112.455 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 111.34 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.856 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -90.3 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.079 0.466 . . . . 0.0 112.099 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.41 117.65 8.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.57 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.37 86.64 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.223 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.25 -98.91 1.66 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -165.24 94.25 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -33.57 26.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.0 OUTLIER -179.82 -161.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.638 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -86.46 106.22 17.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -89.11 113.44 24.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -108.94 138.03 45.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 17' ' ' LEU . 15.3 mt -105.97 117.23 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -115.74 129.36 56.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.33 8.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.715 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.704 ' H ' HD21 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -79.95 -165.91 0.92 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.543 0.211 . . . . 0.0 110.614 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HZ1' HG21 ' A' ' 49' ' ' VAL . 4.2 mttp -130.99 142.1 44.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.678 0.275 . . . . 0.0 111.424 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.02 94.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.727 2.285 . . . . 0.0 111.908 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.29 -25.84 6.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.503 HG21 ' HZ1' ' A' ' 46' ' ' LYS . 6.4 t -92.98 128.25 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.671 0.272 . . . . 0.0 110.793 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.621 ' HA ' HG23 ' A' ' 72' ' ' THR . 1.1 t -94.36 146.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 12.9 m-85 -117.54 122.76 44.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.769 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.31 148.33 26.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.23 148.47 18.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.533 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HG2' HD12 ' A' ' 56' ' ' ILE . 2.3 tt0 -132.91 142.44 48.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -107.72 107.06 17.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 54' ' ' GLN . 5.2 mp -96.88 137.64 24.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -110.49 132.27 54.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.306 0.574 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -113.39 121.67 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.898 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.737 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -114.41 176.58 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.99 -32.3 73.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -102.19 1.17 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.64 88.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.833 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.737 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 1.3 m-70 -98.32 -41.05 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 110.51 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' SER . 31.4 mt-30 66.5 80.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.751 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 10.4 tt0 -96.75 126.6 42.03 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -125.95 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -137.87 121.74 17.68 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.08 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.6 141.0 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.606 -179.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -155.88 154.32 31.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.376 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.29 127.59 50.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.543 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -146.65 152.99 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.435 0.636 . . . . 0.0 112.499 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.655 HG21 ' HG ' ' A' ' 75' ' ' SER . 0.1 OUTLIER -148.41 167.27 25.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.77 178.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.56 ' H ' ' HB2' ' A' ' 45' ' ' LEU . 1.6 t -68.17 -34.86 77.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.654 0.264 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 t -158.78 67.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.0 111.259 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.655 ' HG ' HG21 ' A' ' 72' ' ' THR . 0.3 OUTLIER -161.61 -66.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.653 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.01 116.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.779 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 118.01 31.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -159.43 71.33 3.37 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG2' ' H ' ' A' ' 80' ' ' GLY . 73.3 Cg_endo -77.37 -72.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.595 2.196 . . . . 0.0 112.571 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.523 ' H ' ' HG2' ' A' ' 79' ' ' PRO . . . -151.43 169.64 31.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.542 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.57 -169.78 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.168 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 56.16 32.66 20.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.982 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -125.16 -32.85 2.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.52 -10.3 5.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.42 93.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -171.55 -156.92 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.78 -91.39 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.48 123.98 41.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.064 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -45.9 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.4 -73.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.7 p -131.37 148.72 52.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -120.17 -8.33 9.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.41 113.45 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.263 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.98 89.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.335 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -171.53 70.68 0.48 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.9 156.22 48.09 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.49 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.9 -162.08 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.385 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -93.16 130.31 38.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.437 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.595 HG13 ' H ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -104.28 157.42 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.617 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -51.08 -37.58 46.56 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HD2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -167.73 143.35 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.905 178.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -118.12 133.2 56.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.814 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 58' ' ' ILE . 4.1 mp -114.45 138.39 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.078 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.589 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -113.1 114.62 27.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.214 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.774 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -118.21 128.17 54.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.491 ' CE3' HD23 ' A' ' 17' ' ' LEU . 10.2 p90 -153.31 155.09 35.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 112.537 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.634 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.35 161.75 26.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.354 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.457 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.5 Cg_exo -57.72 113.92 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.283 1.988 . . . . 0.0 112.353 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HZ2' HG12 ' A' ' 50' ' ' VAL . 6.1 ttpm? -60.1 -27.82 67.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.959 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.12 -37.01 64.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 t -94.68 -159.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.59 136.59 43.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.25 -163.37 54.49 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.881 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 61.45 58.02 2.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.348 . . . . 0.0 111.416 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.634 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 55.3 m95 -79.43 179.21 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.504 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mttt -142.7 145.19 33.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.21 129.16 53.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 112.232 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.02 111.27 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.931 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.3 m -97.52 123.07 41.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 112.297 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.433 HG22 ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -123.08 110.76 30.94 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.69 101.52 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.257 1.971 . . . . 0.0 111.621 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.3 -91.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.829 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.21 101.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.938 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -81.05 -33.31 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.937 0.399 . . . . 0.0 110.405 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.0 -168.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -77.09 105.85 8.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.551 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 109.92 21.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.38 127.85 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.72 122.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -131.77 122.47 25.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.12 25.41 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.62 ' HB2' HG22 ' A' ' 73' ' ' THR . 2.4 mm? -76.32 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.533 0.206 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HD3' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.4 152.23 59.96 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 120.732 0.301 . . . . 0.0 110.745 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 137.43 19.9 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.561 2.174 . . . . 0.0 112.517 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.02 -15.37 63.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.699 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG11 ' HD3' ' A' ' 46' ' ' LYS . 6.3 p -119.55 134.89 61.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HA ' HG22 ' A' ' 72' ' ' THR . 96.2 t -104.32 140.72 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.441 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.457 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.3 m-85 -105.93 119.36 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.191 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HG2' HH21 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -85.44 138.37 32.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.87 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.57 146.31 16.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.873 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.461 HE21 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.4 136.8 45.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.5 mt -101.71 106.67 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.6 mp -94.82 119.53 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -103.63 130.31 51.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.197 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 16' ' ' ILE . 49.7 mt -113.35 128.78 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.569 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.617 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.5 OUTLIER -116.04 -178.02 3.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.02 -8.62 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.02 -4.67 46.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.59 31.44 54.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.423 ' O ' ' HG3' ' A' ' 64' ' ' GLN . 3.6 m-70 -89.42 -178.58 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 110.744 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 63' ' ' HIS . 1.4 mt-30 -149.32 104.83 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.523 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.6 tm-20 -96.99 125.66 41.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -131.45 134.08 61.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -137.2 122.51 19.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.13 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 HH21 HE21 ' A' ' 54' ' ' GLN . 6.8 mtp180 -84.54 147.28 27.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.348 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.37 141.49 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.99 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -114.08 123.33 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.294 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -141.65 151.7 43.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.988 0.423 . . . . 0.0 111.657 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 50' ' ' VAL . 20.7 p -144.85 142.28 29.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.676 HG21 HG23 ' A' ' 74' ' ' THR . 11.2 t -70.81 -27.81 64.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.773 0.321 . . . . 0.0 111.012 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.676 HG23 HG21 ' A' ' 73' ' ' THR . 2.8 t -173.74 60.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.029 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -131.64 -90.75 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -165.75 -176.16 3.76 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.172 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 m 58.18 54.75 5.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.83 70.02 24.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.72 -59.83 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.637 2.225 . . . . 0.0 112.488 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.97 -54.78 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.446 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -82.96 88.34 6.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -81.25 -43.14 19.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 t -146.34 -55.09 0.26 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.23 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -129.27 78.93 1.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 54.95 -113.37 0.78 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.438 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -81.52 -20.96 38.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.68 0.276 . . . . 0.0 111.154 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 59.78 37.2 22.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.782 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.84 125.54 27.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.147 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.75 169.17 9.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.94 -163.27 9.45 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.528 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 p -131.81 141.81 49.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -90.96 -41.16 11.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.818 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.12 113.28 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.91 140.85 62.37 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.548 2.165 . . . . 0.0 112.399 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -90.35 128.45 49.09 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.74 -53.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.469 2.113 . . . . 0.0 112.727 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.82 141.26 28.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.417 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -138.62 -175.66 4.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.018 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.601 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -103.41 149.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.237 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.601 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -52.69 -47.28 67.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.013 179.215 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.669 ' HZ3' HD12 ' A' ' 58' ' ' ILE . 7.6 ptmt -159.3 143.84 15.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.201 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -119.62 132.08 55.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.922 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 17' ' ' LEU . 19.7 mm -114.07 132.97 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 111.01 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' HG21 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -109.55 114.37 27.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.979 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 18.5 mtt180 -115.94 128.76 56.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.586 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.405 ' CE3' HD23 ' A' ' 17' ' ' LEU . 14.2 p90 -152.71 160.02 43.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.463 0.649 . . . . 0.0 112.016 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HG2' ' CE2' ' A' ' 28' ' ' TRP . 3.6 ppt_? -159.42 160.01 28.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.999 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.4 Cg_exo -57.88 117.38 4.08 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.227 1.951 . . . . 0.0 112.42 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -60.28 -38.81 84.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.49 -27.15 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.441 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -96.96 -164.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.76 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 24' ' ' SER . 1.2 m -148.03 114.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.18 -179.65 24.93 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.826 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 60.58 88.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.911 0.386 . . . . 0.0 111.159 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CE2' ' HG2' ' A' ' 20' ' ' ARG . 43.0 m95 -101.05 -176.53 3.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.728 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.2 tttt -151.21 147.53 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.963 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.42 138.87 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.774 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.75 111.76 8.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.274 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -89.29 137.89 31.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 111.859 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG23 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 109.74 8.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.324 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 57.9 Cg_endo -70.87 87.39 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 112.8 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 52.78 39.16 54.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.605 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.89 84.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.026 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.699 HD11 ' H ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -69.32 -33.56 73.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.443 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.699 ' H ' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER 177.66 -154.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.702 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.4 t -77.15 105.11 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -97.02 127.51 43.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -99.33 147.43 25.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.697 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 43' ' ' LYS . 24.5 mm -108.49 137.67 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.233 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' N ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -42.4 138.54 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.47 130.35 38.12 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.149 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.709 ' H ' ' HB ' ' A' ' 73' ' ' THR . 2.7 mm? -85.3 -136.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.574 ' HE2' ' HB ' ' A' ' 49' ' ' VAL . 16.4 tttt -136.79 117.65 11.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.504 0.193 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.408 ' HG3' HG21 ' A' ' 74' ' ' THR . 34.7 Cg_exo -60.09 112.33 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.567 2.178 . . . . 0.0 112.072 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.18 -24.66 6.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.352 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.574 ' HB ' ' HE2' ' A' ' 46' ' ' LYS . 7.1 p -118.06 137.42 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.716 ' HA ' HG23 ' A' ' 72' ' ' THR . 46.7 t -97.09 139.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.517 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 24.8 m-85 -105.26 128.92 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.624 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.38 137.81 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.036 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.03 157.04 27.19 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.823 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.4 143.23 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -107.46 106.14 16.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.134 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.26 138.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.132 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -121.0 119.36 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.733 -178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.669 HD12 ' HZ3' ' A' ' 14' ' ' LYS . 1.1 mt -114.34 127.84 71.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.067 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 61' ' ' TYR . 10.3 pt20 -118.41 -177.39 3.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.985 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.37 -4.62 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.525 ' HB2' ' NE2' ' A' ' 59' ' ' GLN . 7.6 m-85 -101.27 -5.04 26.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.09 16.02 68.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.198 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.465 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -67.31 174.84 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.809 0.305 . . . . 0.0 110.601 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 63' ' ' HIS . 3.0 mm-40 -152.16 95.02 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -97.52 117.99 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.063 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.1 p -127.82 134.04 66.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.8 m -137.53 121.53 17.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 138.95 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.958 0.408 . . . . 0.0 111.476 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.12 157.41 43.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -119.95 121.35 38.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -147.14 159.82 43.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.228 0.537 . . . . 0.0 111.986 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -146.92 166.4 26.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.973 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.709 ' HB ' ' H ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -53.61 -50.19 66.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.738 0.304 . . . . 0.0 111.367 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.548 ' H ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -125.74 -46.98 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.981 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.4 t -68.24 -176.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.846 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.01 146.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.846 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.63 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.1 t -84.16 -101.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER 51.06 67.81 3.94 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.335 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.32 -167.01 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.43 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.73 8.5 79.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 56.4 p -126.0 -156.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.504 0.192 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 47.66 22.78 0.35 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.609 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -66.83 -27.03 67.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.716 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.34 62.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.748 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.51 -17.54 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -83.51 177.67 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -74.21 153.47 39.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -95.03 132.17 40.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.3 m80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.779 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.828 0.347 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -151.28 135.55 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.2 -105.58 0.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.519 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.9 t 56.24 85.01 0.08 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.44 164.78 4.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.012 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -64.54 131.46 95.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.7 Cg_exo -65.83 119.31 6.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.671 2.247 . . . . 0.0 112.213 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 141.54 7.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.93 171.42 2.13 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.545 2.163 . . . . 0.0 112.551 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -61.75 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.656 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p80 35.07 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.301 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG13 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -67.54 155.61 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.733 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.6 ' N ' HG13 ' A' ' 12' ' ' ILE . 74.9 m -54.09 -39.05 66.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.612 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HZ1' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -157.14 144.81 18.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.088 0.47 . . . . 0.0 111.37 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.33 126.33 44.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.011 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.532 HG21 ' N ' ' A' ' 17' ' ' LEU . 1.6 mt -112.54 135.48 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' N ' HG21 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -105.56 115.27 29.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.775 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.7 mmm180 -110.06 134.56 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -161.44 150.45 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.143 0.496 . . . . 0.0 111.609 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.606 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -159.43 152.8 18.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.904 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 51.2 Cg_exo -58.66 117.2 3.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.51 2.14 . . . . 0.0 112.621 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -33.38 74.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.036 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB3' HG11 ' A' ' 49' ' ' VAL . 8.1 t-20 -92.43 -43.68 9.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.74 -164.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.101 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.51 163.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.7 26.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.38 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 59.56 -179.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.199 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.606 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 29.5 m95 -92.77 -178.81 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.85 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.6 OUTLIER -120.14 133.66 55.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.167 0.508 . . . . 0.0 112.181 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.98 110.83 9.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.83 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 39.8 m -90.95 139.55 30.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.608 HG21 HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.23 106.98 6.7 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.886 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_endo -60.28 90.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.73 60.57 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 57.94 85.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD23 HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -80.91 -31.97 34.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 4.7 p-10 -166.76 -170.98 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.57 118.97 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.86 125.52 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.676 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 t -107.76 147.7 30.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.375 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.06 137.46 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.802 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 1.5 tpmp? -48.7 155.73 0.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 129.04 49.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' C ' HG21 ' A' ' 73' ' ' THR . 2.9 mm? -74.71 -136.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' N ' HG21 ' A' ' 73' ' ' THR . 20.5 ttmm -153.38 134.6 8.43 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 21.0 Cg_exo -65.09 117.01 4.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 112.25 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.26 54.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG11 ' HB3' ' A' ' 23' ' ' ASN . 2.2 t -118.86 131.36 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -99.92 136.45 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.641 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 22.1 m-85 -105.96 118.91 37.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 18.8 pt-20 -80.07 137.89 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 147.49 19.0 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.854 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 66' ' ' VAL . 1.4 tt0 -132.97 150.54 52.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 30.1 tp -123.93 110.19 14.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 111.588 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 6.0 mt -97.52 138.35 22.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.594 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -114.2 121.73 44.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.499 HD12 ' HZ1' ' A' ' 14' ' ' LYS . 2.4 mt -111.79 124.58 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.11 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.512 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -115.45 178.36 4.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.47 -14.57 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -101.35 -4.53 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.39 64.22 4.44 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.652 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 61.42 87.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.443 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.257 179.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 54' ' ' GLN . 16.3 t -134.07 136.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m -138.09 121.13 16.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.605 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 68' ' ' ARG . 5.0 mtt180 -91.86 146.16 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 111.87 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -156.17 146.49 21.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.212 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -114.41 133.08 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -144.5 148.36 34.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 112.253 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 76' ' ' THR . 16.2 p -144.65 162.51 36.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.974 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.559 HG21 ' N ' ' A' ' 46' ' ' LYS . 4.2 t -83.2 -31.75 26.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.632 0.254 . . . . 0.0 111.334 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 -6.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.449 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 72' ' ' THR . 24.4 t -53.47 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.056 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.449 ' HG1' ' H ' ' A' ' 77' ' ' SER . 7.9 t -169.45 -171.88 1.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.449 ' H ' ' HG1' ' A' ' 76' ' ' THR . 2.6 m 58.77 -133.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.427 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 56.28 58.92 9.04 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 120.627 0.251 . . . . 0.0 111.175 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 78' ' ' THR . 81.1 Cg_endo -89.77 -172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.761 2.307 . . . . 0.0 112.43 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.25 25.12 29.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.31 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -106.24 16.53 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -91.49 44.45 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 m 54.57 59.67 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -56.28 143.56 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.125 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 156.19 48.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.634 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 142.92 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 2.9 m80 56.24 -162.4 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' H ' ' HB3' ' A' ' 87' ' ' HIS . 19.6 m170 -77.6 -38.8 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.747 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.765 0.317 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.67 -174.6 3.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.66 -23.8 34.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.1 p 48.7 38.26 11.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.45 58.64 4.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.56 61.18 7.32 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.37 -59.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.7 2.267 . . . . 0.0 112.548 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -148.26 108.7 3.65 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.58 150.79 67.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.597 2.198 . . . . 0.0 112.633 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -114.92 145.28 42.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 57.85 -114.74 0.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -98.37 143.16 13.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.844 0.355 . . . . 0.0 111.186 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.497 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -60.19 -46.83 88.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.155 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 143.97 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.064 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -111.82 135.29 52.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.24 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 58' ' ' ILE . 3.3 mp -114.15 133.09 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 110.467 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.541 ' N ' HG21 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -115.24 114.29 25.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.269 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.781 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -115.63 127.96 55.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 28' ' ' TRP . 20.7 p90 -144.86 161.37 39.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.953 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -156.54 150.85 19.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.7 Cg_exo -57.54 125.52 19.04 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.363 2.042 . . . . 0.0 112.719 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.497 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 37.9 tttp -76.66 -38.61 54.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.129 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -84.12 -39.58 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -98.3 142.95 29.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.785 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . 7.2 p -87.54 132.33 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.973 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.39 -142.41 3.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -114.89 175.96 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.854 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 30.7 m95 -89.46 -167.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.781 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.5 mttp -152.38 155.9 38.5 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -122.17 130.39 53.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.512 . . . . 0.0 112.061 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.3 111.12 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.102 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 99.7 m -90.04 141.07 29.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 112.0 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.505 HG13 ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -138.24 107.65 8.01 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.221 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.25 92.72 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.456 2.104 . . . . 0.0 112.093 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -98.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -165.75 70.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.702 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HG ' HD21 ' A' ' 38' ' ' ASN . 1.5 pt? -72.27 -33.03 67.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.597 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -164.33 -179.73 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t -79.74 108.48 13.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.09 110.3 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.666 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -115.58 144.88 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.77 125.38 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.986 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -119.36 153.41 35.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.65 13.31 3.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.85 HD13 ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -104.14 -166.11 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.51 0.195 . . . . 0.0 110.614 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -161.24 156.14 20.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.566 0.222 . . . . 0.0 111.167 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 29.8 Cg_endo -63.34 104.76 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.478 2.119 . . . . 0.0 112.002 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.86 -14.66 4.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.043 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG21 ' HG2' ' A' ' 46' ' ' LYS . 14.4 t -116.26 124.99 73.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.89 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.6 t -110.23 133.36 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' HA ' ' H ' ' A' ' 22' ' ' LYS . 57.6 m-85 -109.3 126.55 53.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.558 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.93 131.4 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.79 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -139.68 161.87 26.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.614 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' O ' HD22 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -134.58 152.78 52.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.886 0.474 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.0 mt -124.18 106.87 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.543 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 57' ' ' SER . 87.3 mt -94.46 138.53 20.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.275 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.73 119.14 32.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.288 0.566 . . . . 0.0 111.345 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 16' ' ' ILE . 28.9 mt -114.15 125.19 71.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.764 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.34 173.37 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.83 -18.45 65.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.226 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -102.25 9.64 39.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.78 -114.28 4.95 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.801 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.54 -174.91 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.962 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.66 99.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.34 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 5.0 tt0 -96.81 116.33 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.8 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -131.17 131.18 63.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.3 m -137.72 125.09 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.326 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.58 147.1 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.28 . . . . 0.0 110.746 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 155.61 33.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.006 0.432 . . . . 0.0 111.64 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -116.75 133.44 56.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -147.86 150.72 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.85 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.23 166.68 26.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.293 178.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -65.76 -39.5 91.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -137.23 -41.12 0.58 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 6.9 t -78.61 34.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.318 . . . . 0.0 111.154 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.629 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -62.21 157.24 19.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.406 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -139.48 53.53 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 85.73 2.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.581 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.6 -71.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.875 2.383 . . . . 0.0 112.817 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -40.23 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.946 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.11 86.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.913 0.387 . . . . 0.0 110.982 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.17 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.8 p -123.55 -5.35 8.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.952 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' HB3' ' H ' ' A' ' 85' ' ' HIS . 0.3 OUTLIER -79.72 -88.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.47 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -126.99 167.26 16.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.957 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -97.93 61.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 85' ' ' HIS . 80.1 m-70 -129.7 47.04 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.44 68.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.77 15.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.52 -163.25 44.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 p -145.46 166.59 25.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.707 0.289 . . . . 0.0 110.794 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.4 m120 61.0 15.55 6.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.0 81.0 0.27 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -65.82 154.13 75.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.666 2.244 . . . . 0.0 112.175 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.9 112.39 14.14 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.24 84.64 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.605 2.204 . . . . 0.0 112.127 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.99 -24.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.027 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -105.92 -161.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.628 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -67.48 149.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.974 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -55.33 -50.58 69.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.248 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.6 pttt -171.12 144.8 2.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -102.03 154.23 19.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.738 179.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.566 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -115.73 147.77 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 111.376 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -134.0 109.32 8.91 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.339 176.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.743 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 6.0 mtp180 -122.84 127.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.644 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 5.6 p90 -161.08 159.68 29.49 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.354 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.494 HH11 ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.95 165.92 17.47 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.343 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -54.29 115.88 2.68 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 121.283 1.322 . . . . 0.0 112.619 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 6.3 tptm -34.05 -53.6 0.47 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.79 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -101.67 -44.41 5.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.866 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 21' ' ' PRO . 47.0 t -76.61 -177.24 4.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.94 132.18 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.15 34.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.522 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.58 139.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.421 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 62.0 m95 -60.3 167.08 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.723 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -132.29 158.91 40.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 30' ' ' GLU . 10.5 pm0 -138.11 127.92 25.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.356 0.598 . . . . 0.0 112.431 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -143.14 122.47 13.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -107.47 120.97 43.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.702 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -122.63 107.26 34.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.559 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.7 Cg_endo -72.67 110.75 3.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.316 2.011 . . . . 0.0 112.42 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.47 -120.78 23.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.508 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -143.73 68.52 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' H ' HD21 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -65.64 -33.03 74.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.928 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.42 -172.42 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.9 m -85.2 105.74 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -93.5 107.56 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.484 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.92 140.38 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.421 HD13 ' HZ ' ' A' ' 71' ' ' PHE . 2.3 mp -100.18 130.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.71 75.77 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.113 0.483 . . . . 0.0 111.287 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.4 11.0 0.86 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.285 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.843 HD12 HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -124.82 -152.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.755 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.904 ' HA ' ' H ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 160.52 162.0 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 123.728 0.643 . . . . 0.0 110.492 178.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 11.3 Cg_endo -54.31 -6.9 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.544 2.163 . . . . 0.0 112.123 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 46' ' ' LYS . . . -89.63 -46.57 4.25 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.955 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -113.78 136.87 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 111.544 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' HA ' HG22 ' A' ' 72' ' ' THR . 3.0 p -103.02 117.57 48.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' HB2' HD21 ' A' ' 45' ' ' LEU . 30.4 m-85 -102.05 125.88 48.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 2.1 tt0 -78.7 126.73 31.13 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.633 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -115.29 159.6 13.69 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.062 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.2 tt0 -133.48 114.46 13.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.0 111.762 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -101.36 106.2 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.976 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 51.2 mt -116.49 120.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.716 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.52 138.18 35.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG22 ' HA2' ' A' ' 62' ' ' GLY . 1.8 mp -117.71 130.6 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.46 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.99 -176.58 6.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.04 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 4.5 pt20 -61.05 -30.59 70.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.913 0.387 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.481 ' N ' ' HG3' ' A' ' 60' ' ' GLN . 2.1 p90 -103.24 -4.64 24.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 58' ' ' ILE . . . 105.83 156.99 22.17 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.669 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 22.2 m80 65.97 135.97 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.362 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 57' ' ' SER . 1.9 mm-40 -166.49 -57.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.769 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tp10 -145.51 144.6 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.511 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.7 t -134.77 121.69 35.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.72 0.295 . . . . 0.0 111.779 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 121.69 17.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.23 121.81 45.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.735 0.303 . . . . 0.0 111.132 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -151.97 131.56 13.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.627 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.9 p30 -92.95 138.73 31.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.421 ' HZ ' HD13 ' A' ' 42' ' ' ILE . 28.8 p90 -141.31 161.89 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.366 . . . . 0.0 111.872 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.643 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.19 134.45 20.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.902 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 72' ' ' THR . 1.4 t 162.77 78.86 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.904 ' H ' ' HA ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -160.31 -169.57 2.52 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.746 -0.596 . . . . 0.0 111.132 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER 75.95 76.96 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.5 -153.77 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 78' ' ' THR . 0.3 OUTLIER -151.62 62.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.236 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -168.21 150.54 5.17 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.754 0.311 . . . . 0.0 111.493 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 78' ' ' THR . 0.2 OUTLIER -28.95 143.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.281 3.321 . . . . 0.0 113.973 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.97 102.9 0.23 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.43 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.4 p -162.64 -176.04 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -124.8 -179.39 4.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 132.51 9.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -165.75 27.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.702 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 38.1 m80 64.31 159.09 0.09 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.241 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -92.94 75.98 4.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -133.55 100.58 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.2 2.15 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.067 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.956 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tpp . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.811 0.339 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 ttp-105 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.03 -30.45 4.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.15 94.67 9.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -82.99 -48.89 10.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.55 74.07 40.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.226 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.05 -26.11 6.79 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.974 2.45 . . . . 0.0 112.241 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -58.94 133.59 87.11 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.063 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.73 93.51 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.418 2.079 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.52 -63.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -167.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.743 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -84.51 153.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.1 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.673 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -56.52 -45.32 81.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.835 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.48 144.04 8.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.778 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.2 156.61 17.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.505 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.631 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -120.78 148.42 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.355 0.598 . . . . 0.0 111.347 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -133.06 109.85 9.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.745 176.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.771 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt180 -118.37 127.84 54.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.666 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.2 p90 -161.35 153.65 20.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 117.901 -1.52 . . . . 0.0 114.904 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.83 164.07 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.025 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -56.73 110.63 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 121.584 1.523 . . . . 0.0 112.588 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HD3' ' HB3' ' A' ' 70' ' ' ASP . 9.0 tptt -30.79 -47.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.379 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 -44.06 7.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.807 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.51 82.71 5.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 110.842 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.92 145.32 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.76 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -134.28 125.01 26.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.953 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.468 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 68.1 m95 -64.12 171.48 2.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.771 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.1 mttt -120.96 162.92 19.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -134.48 123.92 24.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.098 0.475 . . . . 0.0 112.031 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.92 111.78 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.97 118.16 35.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 111.405 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -132.75 111.51 13.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.463 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.835 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.8 Cg_exo -46.61 160.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.64 2.227 . . . . 0.0 113.024 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.24 105.05 0.28 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.664 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 44.17 39.08 2.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.738 ' HB3' ' HB2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -72.7 -16.61 61.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.839 0.352 . . . . 0.0 110.546 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.536 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -172.57 169.62 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -83.57 106.3 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -117.79 120.04 36.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 m -116.38 146.45 42.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 mp -94.95 117.66 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.44 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.51 61.77 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.187 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.44 -17.23 4.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.888 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -92.43 137.78 32.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.408 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -104.01 161.5 22.74 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.333 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.704 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 38.5 Cg_exo -55.83 96.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.252 1.968 . . . . 0.0 112.832 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.491 ' H ' ' HG1' ' A' ' 74' ' ' THR . . . 138.37 -9.49 3.5 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.847 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.484 ' HB ' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -120.55 138.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.313 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 22' ' ' LYS . 2.4 p -112.62 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.211 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.611 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 34.1 m-85 -105.39 124.9 50.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.25 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.987 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 10.3 tt0 -79.53 126.6 31.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.604 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -112.98 156.63 15.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 60.3 tt0 -132.7 114.58 14.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.226 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.54 106.18 17.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.631 ' HB ' HG23 ' A' ' 16' ' ' ILE . 77.0 mt -116.9 121.26 67.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.595 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 2.4 m -82.22 135.98 35.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.501 . . . . 0.0 110.071 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -117.03 132.38 66.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.021 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.719 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -95.2 -175.68 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.321 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.401 ' HG3' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.41 -27.43 67.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -103.31 -5.49 22.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.747 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.87 151.87 27.76 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.921 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 66.2 129.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 111.447 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.719 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 7.7 mm-40 -156.53 -51.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.26 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.6 tt0 -144.11 145.15 31.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 56' ' ' ILE . 58.0 t -134.62 123.25 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.277 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -137.34 120.5 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.939 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -112.9 118.42 34.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.68 137.49 13.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.661 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.987 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 16.1 p-10 -92.3 135.28 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.152 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 71' ' ' PHE . 9.1 p90 -140.82 162.97 34.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.063 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -149.85 131.52 14.95 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.02 177.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.457 HG23 HG21 ' A' ' 74' ' ' THR . 5.0 t -84.48 12.21 7.3 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.704 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -118.33 -179.9 3.92 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.157 -175.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.77 -164.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.545 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.02 95.6 1.87 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 m -166.15 -164.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.425 HG23 ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -169.35 162.47 7.42 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.74 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HD2' HG23 ' A' ' 78' ' ' THR . 23.9 Cg_endo -89.47 1.8 5.71 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.012 2.475 . . . . 0.0 113.03 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.41 -61.21 0.28 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.788 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.486 ' HB3' ' H ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER 62.58 -89.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.59 0.233 . . . . 0.0 111.079 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.486 ' H ' ' HB3' ' A' ' 81' ' ' SER . 0.0 OUTLIER -110.49 160.43 16.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -127.8 -72.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -124.36 -87.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -27.13 0.86 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -165.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -100.09 105.84 17.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -156.99 -43.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.893 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.887 0.375 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 2' ' ' ARG . 4.7 ptp85 -104.1 -40.06 6.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.773 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.31 -166.31 12.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -165.94 -171.5 2.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -74.38 -80.15 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.408 ' N ' ' HD3' ' A' ' 7' ' ' PRO . . . -161.74 66.05 2.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -88.2 14.55 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.123 2.549 . . . . 0.0 112.194 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.38 84.78 0.2 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.79 159.62 45.02 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.079 . . . . 0.0 112.386 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -46.9 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.401 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 4.5 p-80 -144.25 168.25 20.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.048 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.675 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -96.79 151.36 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.675 ' N ' HG13 ' A' ' 12' ' ' ILE . 20.3 m -49.74 -49.25 48.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -168.47 144.16 3.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.103 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -106.7 156.97 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.715 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.656 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.66 147.61 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -133.34 109.61 9.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.606 177.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.17 127.15 44.07 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.687 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -162.54 164.6 26.79 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.449 -1.3 . . . . 0.0 114.117 -176.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 138.01 10.2 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 113.681 -1.6 . . . . 0.0 108.219 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 13.9 Cg_endo -55.57 109.34 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.172 1.915 . . . . 0.0 111.37 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.579 ' HB3' HG11 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -49.79 -59.22 4.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.808 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' HG13 ' A' ' 49' ' ' VAL . 55.6 t30 -62.77 -43.94 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.303 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.493 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -103.3 67.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.806 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -47.05 137.8 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.345 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.14 -82.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -154.17 148.77 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -67.11 170.68 6.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.3 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.8 tptt -138.0 165.8 25.66 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.3 pt-20 -142.32 126.28 17.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.901 0.381 . . . . 0.0 111.808 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.92 129.69 21.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -105.09 119.5 39.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 111.538 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -116.81 106.67 47.53 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.548 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 9.7 Cg_exo -72.0 97.64 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.683 2.255 . . . . 0.0 113.044 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 45.15 44.83 9.89 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.217 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 56.15 79.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.448 ' H ' HD22 ' A' ' 37' ' ' LEU . 2.2 pt? -69.3 -32.9 72.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.776 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 -164.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.638 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.26 105.65 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -122.99 107.85 12.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.35 147.36 45.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.554 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 HD11 ' HZ ' ' A' ' 71' ' ' PHE . 14.8 mt -90.77 137.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 149.59 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.254 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 45' ' ' LEU . . . 113.55 23.46 5.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.624 HD22 ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -125.61 171.95 10.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.526 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 4.8 pttt -178.35 165.7 1.12 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.693 ' HD3' ' HA ' ' A' ' 74' ' ' THR . 92.3 Cg_exo -47.61 -22.98 3.3 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.587 2.191 . . . . 0.0 112.218 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.51 -36.2 17.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.405 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -114.2 124.22 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 120.992 0.425 . . . . 0.0 111.782 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.579 HG11 ' HB3' ' A' ' 22' ' ' LYS . 1.8 p -102.04 131.22 50.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' HB2' HD22 ' A' ' 45' ' ' LEU . 4.0 m-85 -112.18 119.21 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.518 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.687 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -78.98 127.77 32.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.629 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -127.71 158.1 21.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.898 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HG2' HD11 ' A' ' 56' ' ' ILE . 2.7 tt0 -133.63 121.18 21.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.552 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 6.0 mt -110.22 106.84 16.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.024 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.807 HG23 HG23 ' A' ' 66' ' ' VAL . 32.4 mt -112.55 119.6 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.897 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.589 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.63 135.04 35.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.357 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.519 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.5 mp -117.33 132.16 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.897 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.82 -176.78 5.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.487 179.024 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.458 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -63.61 -30.28 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.578 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -102.6 1.07 34.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 101.46 150.23 23.52 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.028 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 65.83 144.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 111.578 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -169.2 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.072 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -144.56 144.08 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.612 -178.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.807 HG23 HG23 ' A' ' 56' ' ' ILE . 84.7 t -133.91 114.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -137.1 120.3 16.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -112.22 133.98 54.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.94 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -156.56 154.83 30.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.932 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -100.88 122.0 42.69 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.426 ' HZ ' HD11 ' A' ' 42' ' ' ILE . 2.4 p90 -138.62 163.8 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.387 0.613 . . . . 0.0 111.826 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -139.26 134.44 32.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.693 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 74' ' ' THR . 3.6 t -55.39 -31.4 61.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 110.261 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.932 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 68.6 p 55.75 112.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.345 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 t -77.75 43.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.271 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.01 119.3 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.7 m -147.49 12.64 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.175 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -167.95 69.6 0.86 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.25 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.28 20.21 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.737 2.291 . . . . 0.0 112.545 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.15 37.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m 55.89 88.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.857 0.36 . . . . 0.0 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -68.52 -74.2 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m 55.04 -162.94 0.14 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -132.35 101.59 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -118.65 162.66 18.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -107.55 -8.23 16.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -118.35 -61.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.79 100.82 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.969 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptp . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.766 0.317 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER 57.68 -169.92 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.187 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.4 -155.69 19.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.631 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -111.35 135.55 51.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.326 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -121.64 71.26 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.02 125.43 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.201 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.78 140.68 56.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.32 2.014 . . . . 0.0 112.233 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -116.5 157.9 44.61 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.25 -165.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.761 2.308 . . . . 0.0 112.538 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -67.39 -155.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.561 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 10' ' ' SER . 11.7 m80 62.28 172.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.749 HD11 ' HG2' ' A' ' 59' ' ' GLN . 0.6 OUTLIER -75.33 145.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.616 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.9 t -53.02 -44.96 67.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.88 0.372 . . . . 0.0 110.106 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.7 pttt -175.8 146.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.964 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -101.38 154.37 18.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.481 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -114.89 147.96 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.408 0.623 . . . . 0.0 112.037 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -132.14 109.53 10.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.536 176.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -117.93 127.47 53.88 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.651 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.66 159.98 35.96 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.435 -1.306 . . . . 0.0 113.405 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD2' ' CZ3' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -157.46 155.84 28.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.194 178.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 17.1 Cg_endo -54.08 109.79 0.43 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 122.347 2.032 . . . . 0.0 111.202 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.586 ' HB3' HG11 ' A' ' 50' ' ' VAL . 1.1 tmtp? -45.83 -55.27 6.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.205 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.55 -43.87 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.799 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 8.5 t -71.07 150.89 45.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.988 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.97 135.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.031 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.39 -159.85 22.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.55 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 14.6 ptp180 -116.75 164.25 14.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.491 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 60.7 m95 -66.46 167.79 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.52 160.08 37.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.03 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 123.79 24.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 111.969 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' LEU . . . -141.44 112.4 7.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.107 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 130.42 44.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 112.193 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.845 HG23 HD11 ' A' ' 37' ' ' LEU . 1.1 pt -137.2 106.44 8.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.672 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 85.5 Cg_endo -81.92 122.0 3.75 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 35.46 7.48 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.375 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 50.48 78.25 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.986 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.845 HD11 HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.21 -30.62 71.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' H ' HD13 ' A' ' 37' ' ' LEU . 11.7 t30 -168.26 174.88 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -77.09 105.12 7.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.219 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -115.57 117.05 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.613 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 141.86 47.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.409 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.76 134.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.47 53.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.51 2.63 24.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.281 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.799 HD22 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -108.41 129.35 55.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.388 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -111.52 163.34 17.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.542 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.598 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.3 Cg_endo -49.82 95.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.639 2.226 . . . . 0.0 112.671 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.21 -6.73 5.37 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.778 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -120.77 138.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.727 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.8 p -115.13 133.96 59.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.502 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.799 ' HB2' HD22 ' A' ' 45' ' ' LEU . 17.3 m-85 -116.43 130.03 56.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.583 0.23 . . . . 0.0 111.331 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.758 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 37.8 tt0 -88.27 127.8 35.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.628 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -117.09 155.24 16.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.704 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 6.1 tt0 -132.27 114.45 14.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 4.9 mt -103.12 106.77 17.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.111 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 HG21 ' O ' ' A' ' 65' ' ' GLU . 96.7 mt -117.09 122.67 70.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.0 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.25 134.73 35.65 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 12' ' ' ILE . 1.7 mp -120.26 130.7 74.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.749 ' HG2' HD11 ' A' ' 12' ' ' ILE . 4.7 mm100 -126.12 -174.02 3.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -6.6 27.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.828 0.347 . . . . 0.0 111.011 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -103.05 -4.76 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.707 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.39 161.93 5.87 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.805 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.1 t60 66.69 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.677 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 59.65 -95.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.571 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.551 ' HB3' ' HG ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -128.65 144.27 51.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.869 -178.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.65 126.3 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.15 124.46 21.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 125.6 54.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.241 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -156.31 127.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 111.928 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.56 133.32 39.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.978 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -140.95 163.69 32.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.617 0.722 . . . . 0.0 112.515 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.727 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -148.18 133.18 18.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.554 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -83.22 28.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.598 ' OG1' ' HA ' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -140.95 -71.18 0.36 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -177.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.548 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.2 OUTLIER -57.02 -68.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.5 ' H ' HG23 ' A' ' 72' ' ' THR . 23.3 p 50.13 37.35 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 110.912 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.592 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.6 OUTLIER 60.03 -160.48 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.062 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.659 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 7.5 t 42.66 41.43 0.58 Allowed Pre-proline 0 N--CA 1.469 0.496 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.659 ' HD3' ' N ' ' A' ' 78' ' ' THR . 34.4 Cg_endo -100.26 47.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.37 2.047 . . . . 0.0 112.429 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.84 142.99 16.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.835 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.59 89.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.736 0.303 . . . . 0.0 110.781 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -106.77 70.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 t -165.74 113.33 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -70.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.044 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -121.14 -68.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.183 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.11 139.65 46.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.81 -26.32 7.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 88.02 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.801 0.334 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -148.39 -12.62 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.77 -3.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.482 -0.865 . . . . 0.0 112.851 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -76.34 79.23 3.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -147.85 155.36 41.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.97 75.45 0.57 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.94 118.66 5.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.532 2.155 . . . . 0.0 112.255 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -89.4 159.27 44.69 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.686 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -42.79 -73.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.729 2.286 . . . . 0.0 112.391 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -168.84 7.94 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.696 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -135.09 132.41 38.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.945 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.712 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -95.07 154.02 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.414 179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.712 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.2 m -46.26 -41.07 12.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.768 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 17.1 pttt -174.2 143.5 0.89 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.562 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.642 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -101.41 147.36 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.04 148.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 121.183 0.516 . . . . 0.0 111.219 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -126.03 109.35 12.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.005 176.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.2 mtt-85 -118.2 125.87 51.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.677 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -156.2 157.01 35.14 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 117.878 -1.529 . . . . 0.0 114.133 -176.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.463 ' CZ ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -159.76 151.76 17.05 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.835 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 54.2 Cg_exo -53.61 108.64 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 120.888 1.058 . . . . 0.0 111.242 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' H ' ' H ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -21.9 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.896 -179.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -44.15 6.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.226 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.31 67.52 9.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.289 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.463 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 4.3 p -53.82 124.17 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.882 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.09 76.23 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.697 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 27' ' ' ARG . 6.5 mtt-85 65.08 125.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 0.0 111.544 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -62.28 166.96 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.779 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mmpp? -127.33 152.83 46.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.17 124.26 34.18 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 17' ' ' LEU . . . -142.94 111.66 6.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.981 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 111.88 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.642 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -138.58 106.92 7.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.184 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 61.3 Cg_endo -72.29 111.87 3.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.234 1.956 . . . . 0.0 113.1 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.75 11.45 36.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.173 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.18 84.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.636 HD23 HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -66.0 -18.35 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.765 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -160.48 -178.71 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.726 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.97 105.82 9.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -99.69 105.68 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -122.07 146.03 47.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.225 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.676 HD12 ' HZ ' ' A' ' 71' ' ' PHE . 2.6 mp -97.02 134.33 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -108.63 -4.89 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.909 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.48 -63.08 5.4 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.394 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.76 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.748 0.419 . . . . 0.0 111.333 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' C ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -102.78 157.39 33.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.557 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 1.1 Cg_endo -42.37 104.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.383 2.722 . . . . 0.0 113.351 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.47 -12.02 8.43 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.447 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 49' ' ' VAL . 8.1 p -120.85 139.35 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.815 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.5 p -111.26 128.42 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.818 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.835 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 21.3 m-85 -107.55 120.36 41.98 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.003 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.914 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 14.8 tt0 -80.13 127.08 31.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.677 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -116.04 152.63 17.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mt-30 -130.9 117.06 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 111.602 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.2 mt -100.22 106.27 17.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.17 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.9 mp -109.44 113.92 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.742 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.676 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 2.1 m -87.58 121.23 29.76 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.192 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 64' ' ' GLN . 1.9 mt -114.6 133.32 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.408 0.623 . . . . 0.0 112.577 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.616 ' HB2' ' NE2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -96.6 -174.89 3.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.741 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.64 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.24 4.14 36.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.716 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 58' ' ' ILE . . . 92.53 -133.41 11.72 Favored Glycine 0 N--CA 1.454 -0.128 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.869 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -43.83 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.887 0.375 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.676 ' HB3' ' O ' ' A' ' 57' ' ' SER . 5.5 tp-100 -110.45 -52.56 2.77 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.8 mm-40 -146.52 144.95 29.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 111.243 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.501 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -135.96 131.78 49.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.67 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 67' ' ' THR . 0.6 OUTLIER -137.91 126.39 23.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.057 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -112.69 123.66 50.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.559 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CD2' HG22 ' A' ' 67' ' ' THR . 51.2 m-85 -155.62 126.89 7.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.463 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.914 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -93.33 139.0 31.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.091 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.676 ' HZ ' HD12 ' A' ' 42' ' ' ILE . 25.7 p90 -145.27 159.51 42.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.428 0.632 . . . . 0.0 111.979 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.815 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -149.6 132.4 16.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.299 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.633 ' H ' HD11 ' A' ' 45' ' ' LEU . 2.4 t -93.38 11.58 27.83 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -107.13 -24.38 11.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 112.426 -2.17 . . . . 0.0 111.317 -177.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.411 ' HB2' ' HG1' ' A' ' 72' ' ' THR . 2.2 t -98.33 42.02 1.11 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.678 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.473 ' HG1' ' H ' ' A' ' 77' ' ' SER . 35.2 p -130.67 -51.15 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.473 ' H ' ' HG1' ' A' ' 76' ' ' THR . 2.4 p -98.55 -154.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.651 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 15.3 t -147.09 39.54 0.23 Allowed Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 78' ' ' THR . 48.7 Cg_endo -93.3 177.97 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.137 1.891 . . . . 0.0 112.585 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.21 -111.94 1.15 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.447 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.71 -163.03 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 58.31 16.12 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.7 t -164.71 -96.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.04 22.55 4.52 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.0 178.2 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.53 86.55 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -136.47 136.45 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t60 55.8 70.67 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.888 -179.938 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.745 0.307 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 54.74 57.16 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.795 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.55 -153.4 24.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.4 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m 58.99 89.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.93 40.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 62.9 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.308 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.31 122.67 11.12 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.575 2.183 . . . . 0.0 112.296 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -68.3 111.86 9.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.728 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.45 169.58 9.47 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.455 2.104 . . . . 0.0 112.075 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 t -78.16 1.62 20.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -147.78 176.58 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.622 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -79.52 148.45 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.622 ' N ' HG13 ' A' ' 12' ' ' ILE . 66.2 m -49.51 -45.73 47.57 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 1.1 pttt -170.77 143.46 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.093 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -107.85 147.18 31.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.594 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.484 HG23 ' HG2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -115.72 145.08 21.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 179.118 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -122.93 111.83 17.1 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.765 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -117.86 128.6 54.99 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.706 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -159.46 162.97 35.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.996 0.903 . . . . 0.0 113.301 -178.233 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.564 HH12 ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -159.6 144.24 11.19 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.761 178.36 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.8 Cg_endo -54.61 112.43 1.01 Allowed 'Trans proline' 0 C--N 1.335 -0.142 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.564 ' HA ' HH12 ' A' ' 20' ' ' ARG . 6.0 tptt -51.6 -34.28 36.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.223 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -98.29 -44.06 6.71 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.275 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -79.6 127.4 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.398 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -72.52 115.06 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.932 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.24 -169.32 20.93 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.35 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -64.6 176.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.765 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -136.79 159.99 40.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.582 179.297 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -141.79 128.52 20.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.44 . . . . 0.0 111.295 -179.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -141.02 114.44 8.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -93.77 115.58 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 111.823 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -122.67 107.55 33.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.027 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 28.1 Cg_exo -61.07 90.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.312 2.008 . . . . 0.0 112.925 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.8 52.9 6.48 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.225 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 t60 52.63 60.8 3.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.554 ' H ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -65.86 -22.27 66.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.538 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' N ' HD11 ' A' ' 37' ' ' LEU . 3.4 p-10 -170.53 -171.84 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.2 105.46 9.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -97.97 130.19 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -101.37 148.01 25.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.184 0.516 . . . . 0.0 112.259 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.512 HG23 ' H ' ' A' ' 44' ' ' GLY . 18.7 mt -94.28 138.58 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.653 179.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -32.97 -41.67 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.015 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' H ' HG23 ' A' ' 42' ' ' ILE . . . 120.74 114.36 2.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.189 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.637 ' HB3' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -100.63 122.84 43.97 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.704 0.288 . . . . 0.0 110.499 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.599 ' O ' HG21 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -83.76 135.13 43.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.95 -178.816 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 3.4 Cg_exo -39.15 144.4 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.982 3.121 . . . . 0.0 114.537 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.27 -5.85 68.23 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.055 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.4 138.13 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.1 p -97.38 122.44 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.474 ' HA ' ' H ' ' A' ' 22' ' ' LYS . 38.2 m-85 -110.75 133.48 53.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.65 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -97.49 129.12 44.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.018 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.706 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -124.12 150.88 17.06 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.778 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 44.4 tt0 -132.62 144.42 50.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 111.482 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.06 107.66 12.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.409 179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 82.0 mt -114.0 117.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 1.4 m -82.21 138.5 34.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.389 0.614 . . . . 0.0 111.025 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mt -118.16 132.24 68.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.951 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.694 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.69 -176.41 3.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 178.657 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.41 -29.92 70.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -103.08 -1.55 28.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 63' ' ' HIS . . . 95.22 155.47 31.39 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 75.3 t60 65.94 126.55 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 2.9 mm-40 -155.6 -56.96 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.6 tt0 -145.4 143.82 30.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.436 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.88 115.79 19.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.299 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m -136.15 121.58 19.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.291 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.17 139.62 43.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.38 135.97 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 4.1 p-10 -95.94 137.47 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 51' ' ' TYR . 29.4 p90 -141.43 165.57 27.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 18.1 p -99.12 166.4 11.26 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -51.54 175.58 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.298 -178.402 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.68 -55.99 2.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.058 -178.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.504 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 5.9 p 54.04 22.37 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.348 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 t -157.87 68.23 0.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.097 0.475 . . . . 0.0 110.831 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.557 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 m -62.26 -178.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.166 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.622 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 12.4 t -91.07 -27.91 0.31 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 78' ' ' THR . 75.4 Cg_endo -80.34 -163.97 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.293 1.995 . . . . 0.0 112.508 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.85 -9.17 7.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.344 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 178.91 6.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.96 114.93 29.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 24.45 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.826 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 65.28 154.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 167.1 16.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -63.36 157.48 22.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.728 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.3 148.82 20.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.071 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.91 139.22 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.034 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -98.17 87.58 3.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.15 177.73 16.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.487 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -105.14 -81.33 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.632 0.254 . . . . 0.0 110.82 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 56.02 -159.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.74 113.9 8.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.08 -18.75 30.16 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.632 2.221 . . . . 0.0 112.411 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -112.09 99.25 45.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.93 162.78 34.29 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.528 2.152 . . . . 0.0 112.497 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.99 81.69 7.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.855 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.72 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 6.5 p80 -74.41 165.87 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.229 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.726 HG13 ' N ' ' A' ' 13' ' ' SER . 0.6 OUTLIER -88.44 152.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.051 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.726 ' N ' HG13 ' A' ' 12' ' ' ILE . 39.0 t -52.32 -45.21 65.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.065 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 21.4 pttt -174.6 144.53 0.86 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.685 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.16 157.22 17.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.876 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.681 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.64 147.7 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 121.181 0.515 . . . . 0.0 111.181 179.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -128.2 110.42 12.4 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.626 176.525 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.5 mtp-105 -122.37 125.63 46.32 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.547 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.0 p90 -162.89 153.3 16.45 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.356 -177.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -159.95 162.72 24.0 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.766 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 15.2 Cg_endo -56.75 124.03 15.27 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 C-N-CA 122.656 2.238 . . . . 0.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 54.3 tttt -67.32 -44.03 80.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.883 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -89.75 -36.55 15.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.962 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.534 ' O ' HG12 ' A' ' 25' ' ' VAL . 3.1 m -85.08 -18.17 35.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.501 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 24' ' ' SER . 5.7 p 33.62 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.296 0.57 . . . . 0.0 112.102 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . -108.33 -106.8 3.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.901 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 152.87 36.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -74.8 150.94 39.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.252 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.762 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -121.84 140.43 52.39 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -122.23 128.84 51.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -141.64 115.39 9.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.674 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.37 118.19 33.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 111.331 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.74 HG21 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -129.84 112.27 17.44 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.2 Cg_exo -52.11 175.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.672 2.248 . . . . 0.0 112.481 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.72 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . -43.17 94.86 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.18 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 35' ' ' GLY . 1.1 p-80 22.75 72.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.358 0.663 . . . . 0.0 112.613 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.74 HD11 HG21 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -69.23 -30.29 68.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.328 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.534 ' OD1' HD12 ' A' ' 37' ' ' LEU . 3.4 p-10 -174.25 -163.41 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -90.81 105.82 18.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.019 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -116.73 113.1 22.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -128.69 146.57 50.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.8 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -165.1 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 0.0 111.563 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.14 25.5 75.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.683 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.937 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -125.2 -178.68 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.189 -179.538 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.51 142.04 35.71 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.95 104.37 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.566 2.177 . . . . 0.0 111.977 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.66 -13.95 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.378 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.928 ' HB ' HG23 ' A' ' 74' ' ' THR . 2.2 t -116.52 139.62 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 117.195 0.497 . . . . 0.0 111.441 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -76.59 146.29 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.111 0.481 . . . . 0.0 109.964 178.488 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -143.98 101.05 3.67 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.093 -179.949 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.4 pt-20 -77.58 126.81 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.962 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -126.35 152.03 18.17 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.632 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -134.8 141.62 46.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 111.583 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 1.5 mt -121.38 106.21 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.663 178.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.681 ' HB ' HG22 ' A' ' 16' ' ' ILE . 2.6 mp -116.01 118.34 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.781 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -82.03 133.63 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.573 0.701 . . . . 0.0 111.144 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.28 133.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -117.12 -175.45 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.29 178.465 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -63.92 -13.63 47.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.473 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -103.15 -4.97 23.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 143.87 0.88 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.511 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 60.48 107.38 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.645 0.26 . . . . 0.0 110.981 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 57' ' ' SER . 78.8 mm-40 -129.85 -67.19 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.655 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.96 146.67 50.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.99 -178.537 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.414 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.77 126.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.293 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.15 132.38 41.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 117.43 33.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -144.47 126.92 15.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.747 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.8 122.14 42.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' TYR . 38.2 p90 -122.71 162.86 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.309 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 50' ' ' VAL . 7.0 p -128.37 133.45 48.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.9 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.837 ' HB ' HD12 ' A' ' 45' ' ' LEU . 0.2 OUTLIER 161.11 97.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.593 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.937 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -158.84 -163.22 1.2 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.855 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 0.9 OUTLIER 87.84 93.31 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.774 0.671 . . . . 0.0 111.198 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -171.89 14.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.787 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.48 ' O ' HG21 ' A' ' 78' ' ' THR . 1.5 m -138.47 -114.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.712 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.604 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 8.8 t 35.89 49.59 1.1 Allowed Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 78' ' ' THR . 29.1 Cg_endo -101.57 32.96 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.707 2.271 . . . . 0.0 112.939 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.02 178.48 16.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.438 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -158.58 -69.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.688 0.28 . . . . 0.0 111.243 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -101.9 134.98 44.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.173 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t 55.67 91.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -60.34 158.95 10.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 170.18 9.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.43 71.37 0.58 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -86.84 24.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.07 -12.1 6.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.721 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -87.01 168.18 13.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.97 39.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.549 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.39 77.83 0.21 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.357 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -69.97 -169.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.22 128.36 7.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.22 -89.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.436 2.091 . . . . 0.0 112.244 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 53.22 74.54 0.75 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.159 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.4 90.48 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.464 2.109 . . . . 0.0 112.377 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.18 123.22 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.281 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 -151.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.692 HD12 ' HG2' ' A' ' 59' ' ' GLN . 1.2 tt -67.26 148.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.7 t -51.24 -48.02 62.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.4 149.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.763 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.5 m-85 -102.19 136.64 41.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.37 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.457 HG22 ' HD2' ' A' ' 18' ' ' ARG . 16.8 mm -114.87 122.88 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 111.633 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD11 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -108.25 114.73 28.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 179.034 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.709 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.7 mtt180 -116.93 128.77 55.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.815 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -150.35 153.39 35.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.683 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.57 159.03 29.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.364 -179.937 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.7 114.05 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.095 1.864 . . . . 0.0 111.745 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -32.13 73.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -38.3 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.39 170.43 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 25' ' ' VAL . 14.5 p -117.88 136.45 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.846 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.98 33.41 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.979 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.66 173.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 111.519 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.683 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 67.6 m95 -90.15 -171.47 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -142.35 145.43 33.91 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.474 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -120.4 133.31 55.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.269 0.556 . . . . 0.0 112.139 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.08 112.19 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.98 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 38.8 m -89.35 137.72 32.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 112.474 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -132.81 106.25 12.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.381 178.056 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.95 100.32 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.408 2.072 . . . . 0.0 112.383 -179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.88 -90.17 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -177.18 79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.744 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.548 ' HG ' HD21 ' A' ' 38' ' ' ASN . 0.5 OUTLIER -72.7 -33.22 66.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.548 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -173.4 -165.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.05 118.32 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -103.55 113.26 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 t -121.7 134.0 54.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 mt -98.02 116.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -121.46 134.09 55.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 25.92 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 73' ' ' THR . 0.9 OUTLIER -101.35 175.02 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -98.23 124.74 46.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.0 4.69 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.777 2.318 . . . . 0.0 112.365 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 -30.45 6.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.652 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.62 134.23 63.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' HA ' HG22 ' A' ' 72' ' ' THR . 60.8 t -78.22 146.97 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.415 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.51 107.74 14.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.76 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 18.3 pt-20 -79.7 130.39 35.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.379 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -133.01 153.94 20.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.191 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.64 134.01 42.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.639 0.257 . . . . 0.0 110.393 179.675 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -100.19 106.97 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 110.365 179.644 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.507 HD12 HH11 ' A' ' 18' ' ' ARG . 5.2 mp -105.46 115.31 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.815 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.8 OUTLIER -86.0 119.75 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 12' ' ' ILE . 8.4 mt -109.67 112.29 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.253 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.692 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -89.45 -177.24 5.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.572 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -68.07 -14.86 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.603 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -101.46 0.9 37.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.766 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 112.4 177.34 19.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.92 144.34 39.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.578 0.228 . . . . 0.0 110.596 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.4 2.77 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.574 -179.59 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.522 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 2.5 tt0 -145.63 129.77 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -134.88 131.28 53.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.012 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -136.15 123.74 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' HE21 ' A' ' 54' ' ' GLN . 36.8 mtm180 -102.54 135.7 43.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 111.371 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.58 155.06 32.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.23 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -106.73 134.02 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.411 ' CE2' HD11 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -152.05 153.54 34.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.141 0.496 . . . . 0.0 112.287 -178.779 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -147.97 166.75 26.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.446 178.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.504 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -47.67 -47.21 29.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.451 -179.815 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -168.37 48.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.6 t -142.58 -25.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 52.93 -97.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.52 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -159.15 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.672 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -162.4 -51.91 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.672 ' HD2' ' H ' ' A' ' 78' ' ' THR . 29.8 Cg_endo -63.55 131.97 33.74 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.159 1.906 . . . . 0.0 112.246 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.96 -28.29 31.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.684 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.69 142.74 19.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.989 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.79 54.79 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.686 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.77 65.92 1.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.693 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 45.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.041 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 m170 62.56 112.96 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -19.41 62.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -114.33 141.36 47.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.95 108.63 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.3 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.883 179.969 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' H3 ' ' HG2' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.728 0.299 . . . . 0.0 111.162 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -137.48 128.36 27.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.31 105.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 t -152.2 135.0 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.732 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.92 169.71 8.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.04 124.64 6.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.42 135.4 69.71 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.571 2.18 . . . . 0.0 112.532 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -132.49 101.13 14.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.707 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.71 -47.99 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.558 2.172 . . . . 0.0 112.499 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 m -133.55 175.48 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -153.4 148.05 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.205 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.694 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -70.83 154.08 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 179.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.694 ' N ' HG13 ' A' ' 12' ' ' ILE . 58.0 m -52.37 -41.3 62.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.2 pttt -172.23 149.04 2.22 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.041 0.448 . . . . 0.0 111.713 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -106.82 134.08 50.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.78 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.661 HG13 HD13 ' A' ' 58' ' ' ILE . 2.8 mm -114.28 120.23 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD11 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -104.24 114.69 29.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.537 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -116.25 129.55 56.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.542 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -154.37 158.69 40.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 111.493 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -159.54 163.42 23.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.666 -179.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -57.52 114.45 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.982 1.788 . . . . 0.0 111.616 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -50.71 -31.23 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.357 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -70.17 -37.36 75.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -176.48 4.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.97 13.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.82 -160.24 8.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.647 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 57.81 70.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -84.45 162.57 19.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 25.7 mttp -141.26 133.87 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.876 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 2.2 pt-20 -120.52 132.69 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.11 0.481 . . . . 0.0 111.977 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.67 111.99 12.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.808 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 84.8 m -91.79 132.09 36.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 HG13 ' C ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -136.92 104.8 8.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.115 177.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.5 Cg_exo -60.22 105.64 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.447 2.098 . . . . 0.0 112.15 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA2' HG23 ' A' ' 12' ' ' ILE . . . 64.36 -94.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.122 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.03 109.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.575 HD11 ' N ' ' A' ' 37' ' ' LEU . 6.6 mp -82.74 -34.13 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.659 HD21 ' H ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -178.01 -112.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.053 -179.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.659 ' H ' HD21 ' A' ' 38' ' ' ASN . 55.0 m -121.43 105.09 10.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.39 109.01 21.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -120.88 132.11 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.5 mt -98.61 127.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 -166.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.83 29.76 28.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.357 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -93.94 172.04 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -122.93 136.8 27.22 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.81 165.42 18.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.645 2.23 . . . . 0.0 112.466 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.4 -33.03 3.49 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.735 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.55 116.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.438 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 61.9 t -77.77 144.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 71' ' ' PHE . 3.2 m-85 -102.36 126.55 49.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 130.62 52.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.61 158.03 27.97 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.679 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -132.46 145.11 50.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.294 179.669 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD21 HD11 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -100.45 107.25 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.738 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -106.64 114.83 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.51 125.04 34.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.263 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.745 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 45.9 mt -102.43 123.35 55.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.495 ' HG3' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -100.23 -175.05 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.943 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.83 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.301 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.03 6.9 38.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.76 175.49 18.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.64 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 3.0 p80 -55.99 157.41 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.716 0.293 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.495 HE21 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -161.35 -17.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.409 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.598 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -114.2 127.75 56.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.09 130.68 55.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.415 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.23 121.2 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.679 ' HG2' HE21 ' A' ' 54' ' ' GLN . 2.5 mtt180 -96.87 132.65 42.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.318 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -155.62 156.65 35.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.263 0.554 . . . . 0.0 111.965 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.62 137.81 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -150.0 141.69 23.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.514 -178.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.612 ' HA ' HD11 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -149.68 166.77 28.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.336 178.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 45' ' ' LEU . 4.1 t -91.31 127.96 36.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.716 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.521 HG21 ' O ' ' A' ' 73' ' ' THR . 3.9 t 45.41 24.71 0.18 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.951 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t -134.31 -68.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.517 ' HA ' ' HG1' ' A' ' 72' ' ' THR . 0.2 OUTLIER 60.14 178.27 0.09 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.301 -179.904 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.31 126.89 8.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.3 p 48.88 88.13 0.12 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.479 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.91 83.24 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.64 2.227 . . . . 0.0 112.221 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.24 -9.26 39.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.421 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t 57.39 57.04 4.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.746 0.308 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 55.07 85.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 t -143.82 140.07 29.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -116.5 -26.9 6.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -90.94 59.91 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -105.13 91.54 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -89.1 174.8 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.46 162.36 15.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.939 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 2.4 tpt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.574 ' H ' ' HG3' ' A' ' 1' ' ' MET . 17.3 mtp85 -72.93 -156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.51 109.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.456 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.1 p -103.97 -9.63 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.799 0.333 . . . . 0.0 111.094 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -93.59 137.47 32.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.19 87.77 32.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.1 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.25 -47.41 6.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.531 2.154 . . . . 0.0 112.402 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 57.13 85.58 0.19 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.77 101.64 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.541 2.161 . . . . 0.0 112.208 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.33 132.77 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.096 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.7 152.61 43.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.426 HD11 ' HB3' ' A' ' 57' ' ' SER . 4.7 tt -97.31 157.35 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.404 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -48.87 -52.72 22.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.796 179.455 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.603 ' HD2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -166.17 144.79 5.75 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.198 0.523 . . . . 0.0 111.754 179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.8 m-85 -102.37 136.87 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.873 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.34 129.86 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.853 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -118.11 114.84 23.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.986 179.438 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.58 129.21 50.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -149.73 162.02 41.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 2.8 ptt180 -158.56 153.43 21.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 18.0 Cg_endo -58.49 109.61 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.967 1.778 . . . . 0.0 111.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 4.1 ttpp -57.36 -35.21 69.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -70.3 -29.25 65.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -78.22 -161.02 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.999 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.35 -7.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' HA2' HH11 ' A' ' 20' ' ' ARG . . . 179.67 -128.58 1.24 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.952 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HB3' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER 64.6 75.24 0.38 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.918 0.389 . . . . 0.0 111.06 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 93.5 m95 -83.04 175.8 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.145 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 13.7 mttm -154.25 136.88 15.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.767 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -120.16 135.77 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.052 0.453 . . . . 0.0 112.131 -178.762 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 114.86 8.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.13 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 m -96.62 137.78 35.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.149 0.5 . . . . 0.0 112.222 -179.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -135.39 110.75 10.6 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.456 179.311 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HB2' HD13 ' A' ' 37' ' ' LEU . 73.7 Cg_exo -50.15 93.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.766 2.31 . . . . 0.0 113.169 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 28.09 3.42 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.24 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.5 69.79 0.67 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' H ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -71.89 -7.21 47.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.164 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -164.02 -174.6 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.593 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -80.47 105.53 11.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.82 107.42 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.778 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -114.59 146.58 40.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -91.62 124.38 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -138.56 161.77 36.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.74 21.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.6 mt -74.59 -161.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.505 0.193 . . . . 0.0 110.55 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.15 133.81 12.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.643 0.258 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HB3' ' HB2' ' A' ' 75' ' ' SER . 35.8 Cg_exo -57.1 155.45 28.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.448 2.099 . . . . 0.0 111.796 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.18 -21.48 10.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.921 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.38 117.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.772 0.32 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.695 ' HA ' HG23 ' A' ' 72' ' ' THR . 62.5 t -81.26 144.54 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.428 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' N ' HG11 ' A' ' 50' ' ' VAL . 53.4 m-85 -124.62 103.9 8.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 12.9 pt-20 -79.67 130.18 35.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.383 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.53 161.34 24.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.972 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.632 ' HB2' HD13 ' A' ' 56' ' ' ILE . 1.4 mt-30 -132.62 139.17 47.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 110.432 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -99.91 107.11 19.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -111.03 115.17 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.486 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -92.2 117.7 30.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.164 179.337 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.603 ' HB ' ' HD2' ' A' ' 14' ' ' LYS . 43.2 mt -101.73 116.13 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.812 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -90.0 -175.07 4.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.32 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.44 -23.05 64.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.06 14.15 32.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.645 0.259 . . . . 0.0 111.48 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.01 -174.56 23.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.803 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -52.34 161.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.724 0.297 . . . . 0.0 111.238 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -169.27 -20.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.587 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -123.72 128.42 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.53 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.89 133.24 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.814 0.34 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 3.1 m -137.8 123.86 20.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.71 134.45 40.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 111.636 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.93 159.08 38.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.507 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -109.51 133.7 52.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.9 p90 -151.82 145.98 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.695 HG23 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -148.51 148.12 29.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 178.524 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -70.16 144.64 51.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.425 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 m 64.51 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.093 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 47' ' ' PRO . 8.5 t -72.71 -174.16 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.047 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.77 176.53 12.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.85 -28.3 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.7 135.56 9.89 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.212 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.4 102.42 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.591 2.194 . . . . 0.0 112.275 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.19 -154.0 6.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.569 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -107.05 10.78 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -93.38 23.39 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.802 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.3 m -105.51 -172.65 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -84.68 65.05 8.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -66.6 166.36 12.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.08 79.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -102.41 61.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.29 154.07 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.818 0.342 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -114.04 98.21 6.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.23 -174.09 14.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.439 ' HG ' ' HB2' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -150.06 -79.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.673 0.273 . . . . 0.0 110.857 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 52.78 74.45 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.67 130.81 23.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.54 -178.06 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.847 2.365 . . . . 0.0 112.402 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -81.04 128.2 71.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.22 -38.11 57.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.495 2.13 . . . . 0.0 112.175 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 -176.16 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.807 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -118.93 142.18 48.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD12 ' HG2' ' A' ' 59' ' ' GLN . 1.6 tt -79.72 155.25 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.494 ' H ' HG13 ' A' ' 12' ' ' ILE . 3.2 m -49.91 -53.36 26.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.764 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.797 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -158.89 144.91 16.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.1 m-85 -104.7 137.72 42.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.202 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.527 HG21 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -114.25 142.69 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 110.81 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.48 115.83 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.12 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.4 mtp180 -118.99 129.77 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.646 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.409 ' CZ2' HG21 ' A' ' 42' ' ' ILE . 13.2 p90 -152.6 158.82 43.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 111.991 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.36 157.07 26.78 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.291 179.792 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.78 113.41 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.318 2.012 . . . . 0.0 112.083 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.444 -179.476 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -95.02 -41.2 9.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -87.15 161.82 17.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.22 148.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 27' ' ' ARG . . . 170.39 -140.6 6.09 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.517 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -139.88 166.77 23.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.459 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 74.0 m95 -75.65 174.61 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 18.2 mttt -145.31 141.16 28.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.679 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -119.98 134.92 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 128.3 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.825 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.1 m -112.39 135.67 52.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -137.21 106.76 8.67 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.153 178.418 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.8 Cg_exo -58.84 111.6 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 112.477 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 57.83 -104.95 0.51 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.368 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.85 93.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.72 -25.75 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.979 179.9 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.655 ' N ' HD23 ' A' ' 37' ' ' LEU . 1.2 p-10 178.74 -168.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.456 179.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -76.49 105.82 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -108.8 112.84 25.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.725 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -121.57 132.62 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.409 HG21 ' CZ2' ' A' ' 19' ' ' TRP . 9.8 mt -90.21 126.08 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.57 165.92 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.44 -16.36 4.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.243 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -69.63 160.16 32.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.716 0.293 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' HG2' ' HD2' ' A' ' 47' ' ' PRO . 3.3 ttmt -104.77 133.44 20.16 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.047 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.57 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 55.2 Cg_exo -52.0 133.03 45.06 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.524 2.149 . . . . 0.0 112.18 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.12 -22.1 40.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.12 120.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.311 . . . . 0.0 110.953 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.474 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 14.0 t -85.78 140.63 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -123.08 161.51 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -129.82 132.2 46.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.926 179.408 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.73 155.42 26.49 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.413 -179.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.91 131.64 41.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 5.9 tp -99.7 106.48 18.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.891 0.376 . . . . 0.0 111.011 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' HB ' HG21 ' A' ' 16' ' ' ILE . 3.8 mp -92.07 138.44 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.955 179.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 65' ' ' GLU . 1.4 m -110.4 114.98 28.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.313 0.578 . . . . 0.0 111.011 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 5.6 mt -95.5 114.13 31.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.591 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.725 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -97.03 -176.26 3.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.327 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.543 ' HG2' ' NE2' ' A' ' 59' ' ' GLN . 11.4 pt20 -62.12 -21.94 65.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -102.83 12.08 36.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.725 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 100.8 173.36 29.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.434 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 7.0 p80 -53.55 147.93 10.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.483 0.183 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 2.0 pt20 -165.33 -6.64 0.03 OUTLIER 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.4 tt0 -132.65 112.99 12.49 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.891 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.2 p -136.98 140.99 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.3 m -132.24 122.12 24.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.715 179.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' H ' ' HE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.29 141.49 30.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.304 -179.373 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.14 158.31 37.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.49 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 129.46 56.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -152.06 163.76 38.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.474 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 11.4 p -141.22 167.09 23.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.751 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -42.87 -60.07 1.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.717 0.294 . . . . 0.0 111.292 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.575 ' H ' HG22 ' A' ' 73' ' ' THR . 1.0 OUTLIER -177.06 85.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -160.95 -50.23 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 t -126.64 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.394 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.24 153.91 0.08 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.257 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.09 144.37 3.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.3 86.94 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.561 2.174 . . . . 0.0 112.439 -179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.43 -125.85 5.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -130.48 112.68 13.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.783 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.39 -74.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -8.0 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.36 156.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.43 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 103.6 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.439 ' HB2' ' HG ' ' A' ' 4' ' ' SER . 34.0 p80 -147.37 154.53 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.18 153.48 37.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -126.86 108.31 10.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.928 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -122.26 146.77 46.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.81 140.53 4.35 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.641 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -135.22 26.75 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.897 0.379 . . . . 0.0 110.763 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -75.89 -169.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -157.68 102.87 1.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 4.31 3.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.678 2.252 . . . . 0.0 112.598 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -104.46 113.65 64.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 -179.934 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 8' ' ' GLN . 3.8 Cg_exo -80.05 -24.94 5.36 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.899 2.399 . . . . 0.0 112.139 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.655 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -148.67 88.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 m80 59.97 -86.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.201 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.6 tt -77.81 150.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.984 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -49.21 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.611 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -166.13 146.07 6.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -102.04 141.99 34.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.38 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.568 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -115.16 142.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.487 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 115.46 19.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.416 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -120.85 137.95 54.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.674 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -156.73 159.51 38.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.43 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.45 157.45 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.521 -179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.72 110.86 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.269 1.979 . . . . 0.0 112.014 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.42 67.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.66 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -100.3 -36.05 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.404 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.16 -167.78 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.25 154.39 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.022 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.43 23.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 60.87 175.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 68.0 m95 -85.61 -172.33 4.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.4 mttt -148.3 154.76 40.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.242 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.17 138.27 49.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 112.092 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 111.82 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 92.5 m -98.4 131.19 44.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 HG22 ' HA ' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -134.69 106.05 10.77 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.268 178.124 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 52.0 Cg_exo -56.23 98.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.688 2.258 . . . . 0.0 112.895 -179.019 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 10' ' ' SER . . . 51.5 22.88 8.43 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.163 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 57.13 98.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 179.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.66 -18.37 41.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.562 ' N ' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -169.09 -163.19 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.762 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.17 105.48 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.608 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.21 106.75 16.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.35 144.05 45.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.86 129.33 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.213 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 141.77 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.09 56.08 0.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.654 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 73' ' ' THR . 3.0 mt -137.18 78.02 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.4 ttpt -34.75 130.41 0.47 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.466 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 45.2 Cg_exo -56.89 175.79 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.661 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.05 -35.53 3.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.04 127.15 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.745 HG23 HG21 ' A' ' 76' ' ' THR . 38.3 t -83.67 142.08 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.452 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 7.8 m-85 -108.8 136.79 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -112.26 130.1 56.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.119 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.67 156.49 26.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.975 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.6 146.0 51.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 18.8 tp -100.23 107.0 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.391 . . . . 0.0 110.859 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.568 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.7 mp -95.12 122.06 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.491 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -94.83 114.91 26.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.424 0.631 . . . . 0.0 109.926 179.723 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 27.6 mt -106.7 111.16 34.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.953 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -90.2 -176.17 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.887 178.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.75 -15.94 45.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -103.12 0.62 32.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.32 176.39 19.4 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.26 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 15.9 p80 -55.36 156.31 4.49 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.548 0.174 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.9 1.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 3.7 tt0 -145.53 113.73 6.59 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -136.75 139.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.419 ' N ' HG23 ' A' ' 66' ' ' VAL . 31.8 m -137.1 124.73 22.3 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.448 179.543 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -85.01 141.01 30.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.779 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -155.86 156.63 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.731 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -114.96 131.64 56.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.873 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -152.04 162.55 40.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.486 -178.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.24 154.8 41.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.202 179.222 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 45' ' ' LEU . 14.1 t -75.21 -24.77 57.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.715 0.293 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 73' ' ' THR . 0.1 OUTLIER -161.51 63.6 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 t -160.95 -132.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.745 HG21 HG23 ' A' ' 50' ' ' VAL . 5.6 t -64.58 -170.68 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 111.645 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.492 ' H ' ' HG1' ' A' ' 76' ' ' THR . 0.9 OUTLIER 67.02 156.98 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.341 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.8 138.75 12.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.93 66.1 8.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.457 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -128.92 12.07 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.98 -172.86 4.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.699 0.285 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 55.04 78.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.22 173.95 6.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.805 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -69.53 -34.29 74.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.022 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -162.55 127.15 3.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -160.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.101 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -95.99 -7.18 37.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.79 -5.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.339 -0.838 . . . . 0.0 111.059 179.871 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttm105 -118.44 26.55 9.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.4 -54.85 0.4 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.0 t -61.26 138.26 58.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -79.77 130.97 35.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.29 68.53 3.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.1 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.11 6.69 4.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.542 2.161 . . . . 0.0 112.336 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 64.86 138.66 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.01 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.25 7.47 2.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.553 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 m -140.24 -79.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -163.01 165.6 24.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.844 HD13 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -72.98 147.48 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.042 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.697 ' N ' HG13 ' A' ' 12' ' ' ILE . 14.8 m -52.13 -45.99 65.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.759 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -158.78 144.65 16.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.042 0.448 . . . . 0.0 111.416 179.512 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -112.89 142.97 44.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 179.682 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -113.89 138.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.221 -179.587 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.532 HD21 ' CE3' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -122.03 114.86 21.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.283 179.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.35 129.98 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.149 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.532 ' CE3' HD21 ' A' ' 17' ' ' LEU . 10.1 p90 -158.52 158.44 34.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.402 0.62 . . . . 0.0 112.526 -179.299 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HD3' ' CE2' ' A' ' 28' ' ' TRP . 1.9 ptt180 -159.73 162.27 25.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.665 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 31.3 Cg_exo -58.82 109.62 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.929 1.753 . . . . 0.0 111.621 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -65.78 -22.62 66.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.968 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.0 -17.98 31.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -158.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -166.66 139.03 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.75 -60.06 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.574 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -165.5 157.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.076 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 59.0 m95 -92.36 172.73 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 14.2 mttp -132.51 128.2 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.83 130.41 54.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 112.303 -178.241 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.08 111.79 8.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.872 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.9 m -93.91 130.87 39.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 36' ' ' HIS . 4.4 mp -136.68 107.65 9.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.66 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.0 Cg_exo -45.89 91.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.167 2.578 . . . . 0.0 113.249 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.39 42.46 1.84 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.506 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.507 ' HA ' HG21 ' A' ' 33' ' ' ILE . 0.6 OUTLIER 54.34 47.84 22.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.668 HD21 ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -70.95 -24.27 62.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.731 -179.544 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.668 ' HB3' HD21 ' A' ' 37' ' ' LEU . 1.7 p-10 -133.77 168.93 17.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -78.94 105.88 10.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -121.34 130.7 53.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 145.02 29.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.241 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 43' ' ' LYS . 4.4 mt -90.57 137.37 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.437 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -57.55 123.88 17.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.825 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.29 146.65 28.85 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.63 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 72' ' ' THR . 11.3 mt -103.75 173.02 6.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -94.98 125.28 51.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.57 111.77 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.638 2.225 . . . . 0.0 112.236 -179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.84 -5.58 8.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.657 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.87 135.22 58.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 72' ' ' THR . 10.8 t -81.24 137.05 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.75 179.581 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.86 97.04 4.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.2 pt-20 -87.38 132.08 34.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.091 0.472 . . . . 0.0 110.519 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.67 154.0 24.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.69 134.81 50.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.843 0.354 . . . . 0.0 110.392 179.811 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 15' ' ' TYR . 13.2 tp -99.56 107.67 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.546 ' CG1' ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -102.42 115.36 44.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 0.0 111.547 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -81.41 113.73 19.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 16' ' ' ILE . 30.4 mt -105.64 126.39 60.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.601 -179.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.844 ' HG3' HD13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -112.5 -174.98 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.419 179.8 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.27 -7.48 2.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.332 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.611 ' HB2' HE22 ' A' ' 64' ' ' GLN . 55.4 m-85 -97.97 -5.25 34.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.81 106.54 0.04 OUTLIER Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.374 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.8 m80 61.6 120.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.419 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.611 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -157.5 -20.33 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.874 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.94 119.49 9.11 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.865 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.546 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -137.32 132.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 0.0 112.06 179.157 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.6 m -137.5 128.69 27.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 2.0 mtm180 -96.3 148.03 23.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.181 0.515 . . . . 0.0 111.136 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -156.43 158.84 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.237 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -113.58 127.27 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.023 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.453 ' C ' HG23 ' A' ' 72' ' ' THR . 1.4 p90 -148.29 161.3 41.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.089 0.471 . . . . 0.0 112.121 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.462 ' HA ' HD11 ' A' ' 45' ' ' LEU . 1.1 p -147.21 166.84 25.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.009 178.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.641 HG21 ' H ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -50.96 -54.14 26.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.209 179.926 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.641 ' H ' HG21 ' A' ' 73' ' ' THR . 1.1 t -167.29 75.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.0 -26.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.8 -169.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.29 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 156.73 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.044 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.409 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -111.07 -53.66 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.572 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.409 ' HD2' ' H ' ' A' ' 78' ' ' THR . 94.6 Cg_endo -85.49 163.26 10.99 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.361 2.041 . . . . 0.0 112.582 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.6 -164.08 33.38 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.614 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.8 p -70.31 -4.74 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -60.46 103.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -79.36 -168.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.798 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.24 77.39 7.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -76.11 145.5 39.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.46 173.19 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.39 3.46 35.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -67.85 175.64 2.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.125 -0.941 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpp . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.767 0.318 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 2' ' ' ARG . 7.0 mmt180 -123.7 -2.23 8.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.27 178.09 47.71 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.4 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -135.77 85.89 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.769 0.319 . . . . 0.0 110.822 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.9 -43.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.04 137.49 87.88 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.178 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.11 178.98 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.554 2.169 . . . . 0.0 112.313 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -112.84 93.09 22.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.71 -20.85 70.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.034 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.7 p -147.36 137.72 23.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -84.15 147.33 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -67.62 144.02 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.3 179.484 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.71 -57.72 6.71 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.025 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 144.33 18.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.897 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.7 m-85 -108.93 136.6 48.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 179.326 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.583 HG12 HG22 ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.245 0.545 . . . . 0.0 111.081 -179.729 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 114.88 28.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.053 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.757 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.03 129.47 50.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.761 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -151.01 160.61 43.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.468 . . . . 0.0 111.666 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 6.2 ptt180 -159.41 161.38 27.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 14.0 Cg_endo -57.95 110.39 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.186 1.924 . . . . 0.0 111.796 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -62.77 -48.06 80.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.724 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.75 -38.91 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.8 -179.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.511 ' HB2' ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.03 -179.52 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.498 . . . . 0.0 111.85 -179.281 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.72 143.4 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.772 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -154.83 18.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.146 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 27' ' ' ARG . 9.8 mtt180 -135.74 162.88 31.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 111.074 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.86 157.19 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.757 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.8 mmtt -132.14 136.11 46.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.555 ' HG2' HH21 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -119.87 127.21 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.092 0.473 . . . . 0.0 111.935 -178.754 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.44 111.68 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.142 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.583 HG22 HG12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -91.5 135.21 34.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.927 -179.263 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 36' ' ' HIS . 1.5 mt -122.97 107.79 32.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.307 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.4 Cg_exo -54.69 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.793 2.329 . . . . 0.0 113.061 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.74 30.66 4.91 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.118 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.438 ' HA ' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 53.54 72.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -68.94 -31.89 71.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.906 179.865 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -146.18 -165.34 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 p -77.69 106.14 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.51 102.29 7.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -127.95 143.12 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.3 mm -81.68 116.92 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 134.76 37.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.81 17.39 1.88 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.312 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.614 ' HB2' HG23 ' A' ' 73' ' ' THR . 11.9 mt -76.05 -143.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.521 0.2 . . . . 0.0 110.75 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HB3' HG23 ' A' ' 49' ' ' VAL . 1.5 tppt? -146.94 122.81 5.48 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 120.647 0.26 . . . . 0.0 110.973 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.79 91.16 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.423 2.082 . . . . 0.0 111.851 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -117.72 113.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.103 179.414 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG22 ' HG1' ' A' ' 76' ' ' THR . 29.4 t -76.27 130.42 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.348 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -105.57 107.14 17.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 130.33 34.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.88 159.65 28.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.131 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 146.59 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -102.05 106.43 17.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.201 -179.869 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 66' ' ' VAL . 2.3 mp -92.48 126.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -90.17 135.53 33.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.225 0.536 . . . . 0.0 110.194 179.648 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.2 mt -115.02 109.11 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.563 -179.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 7.1 mm100 -101.12 -175.1 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.293 178.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.11 -14.5 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.742 0.305 . . . . 0.0 110.794 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.614 ' HB2' HE22 ' A' ' 64' ' ' GLN . 42.7 m-85 -103.21 -5.25 23.34 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.975 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.21 -153.71 17.39 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.854 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.472 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 2.6 m-70 -62.28 141.23 58.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.862 -0.199 . . . . 0.0 110.778 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.614 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -145.22 -59.51 0.35 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 2.5 tt0 -100.49 114.2 27.61 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.8 p -136.12 132.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 112.081 178.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -137.29 125.18 22.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 142.32 30.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -156.1 159.31 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.436 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.42 135.46 50.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.41 ' CE2' HD11 ' A' ' 45' ' ' LEU . 4.8 p90 -151.61 141.25 21.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.326 -178.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.59 167.12 29.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.072 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.614 HG23 ' HB2' ' A' ' 45' ' ' LEU . 1.5 t -86.33 77.82 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.178 178.815 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 69.02 157.98 0.15 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.892 -179.237 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.58 67.12 0.65 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 77' ' ' SER . 1.2 m -170.69 149.71 3.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.964 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 76' ' ' THR . 8.4 t 59.28 -170.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.464 ' H ' ' HG ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -130.24 164.06 43.5 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.382 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -28.55 114.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.595 2.863 . . . . 0.0 113.607 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 81.14 0.27 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.646 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -88.78 133.49 34.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 110.755 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -2.12 25.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.27 -175.53 3.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 110.22 16.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.69 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -149.77 29.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -97.73 -17.82 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.902 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.96 23.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -167.57 1.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.023 -179.924 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.905 0.383 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -139.86 49.48 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.822 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.99 178.71 36.11 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.515 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 t -111.51 98.46 7.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.825 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -126.05 -82.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.73 92.64 44.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.05 -165.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.784 2.323 . . . . 0.0 112.459 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 11' ' ' HIS . 14.4 pt20 -114.25 147.0 36.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' HIS . 90.6 Cg_endo -80.62 62.03 8.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.723 2.282 . . . . 0.0 112.58 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m 65.21 -2.73 0.72 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.306 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.568 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 94.7 m-70 -147.03 172.54 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.578 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.56 HG13 ' H ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -101.04 157.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.56 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -59.47 -44.33 93.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.984 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.05 144.62 0.76 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.801 179.471 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 12.5 m-85 -105.62 136.82 44.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.835 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.75 127.71 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 178.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -116.44 116.52 27.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.731 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.82 128.78 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.741 -179.732 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.676 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 2.7 p90 -152.2 142.7 22.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.482 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -147.9 153.62 42.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.673 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 67.6 Cg_exo -57.13 126.71 23.0 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 113.05 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 -33.43 19.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.784 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.17 -43.92 6.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.584 ' HB2' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -83.92 -15.72 46.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.686 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 55.18 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.763 179.866 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 -138.54 7.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.646 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.0 ttm105 -110.9 155.12 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.439 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 79.0 m95 -77.78 175.27 10.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.051 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.731 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -139.26 135.65 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.401 179.31 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.2 pt-20 -120.1 131.62 55.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.987 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.05 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.844 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -102.1 132.1 48.18 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -139.42 106.7 7.15 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.752 178.965 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 77.7 Cg_endo -82.31 102.45 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.322 2.015 . . . . 0.0 113.549 -178.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 8.85 87.61 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.51 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.75 88.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.706 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -66.32 -22.06 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.41 -172.91 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 106.55 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.724 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -108.32 109.41 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.093 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.548 HG23 ' HZ2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -121.27 126.26 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.748 179.677 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG23 ' CZ2' ' A' ' 19' ' ' TRP . 3.3 mt -81.87 118.52 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.178 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.548 ' HZ2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -132.12 76.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 179.885 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.01 22.31 3.45 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.628 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.643 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -98.03 -157.5 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 155.87 14.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.796 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.541 ' HA ' ' HG1' ' A' ' 74' ' ' THR . 12.3 Cg_endo -55.99 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.56 6.66 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.357 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG12 ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.559 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -114.48 148.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.747 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.673 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.4 m-85 -114.49 143.56 44.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.0 tt0 -79.51 128.63 33.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.45 133.65 9.33 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.517 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' HD11 ' A' ' 56' ' ' ILE . 12.0 tt0 -134.15 116.86 15.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.634 0.254 . . . . 0.0 110.811 179.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.435 HD13 ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -99.64 107.75 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 179.282 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.714 HG21 HG23 ' A' ' 66' ' ' VAL . 4.3 mp -111.44 114.59 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.602 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -84.02 138.36 33.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.134 179.144 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.562 ' HB ' ' HG2' ' A' ' 14' ' ' LYS . 2.6 mt -115.19 108.49 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.867 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.795 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 4.7 tp60 -86.49 -175.86 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.39 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.535 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 6.6 mm100 -61.27 -20.51 62.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.58 -179.548 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' HH ' ' HG2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -102.72 16.01 27.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.515 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.84 -108.56 3.08 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -51.77 111.48 0.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.795 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 4.1 tp-100 -120.97 -67.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.2 tt0 -139.51 145.43 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.714 HG23 HG21 ' A' ' 56' ' ' ILE . 96.8 t -135.04 133.96 53.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 m -136.76 134.46 37.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.223 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.0 122.62 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.92 133.95 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.217 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.47 137.65 38.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.06 158.71 43.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.59 166.82 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.649 177.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.589 HG22 ' C ' ' A' ' 45' ' ' LEU . 2.7 t -69.22 -42.52 75.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.741 0.305 . . . . 0.0 111.216 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.541 ' HG1' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -134.44 -172.06 2.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.9 170.33 0.25 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.3 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.34 134.62 48.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -151.01 -28.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.77 103.68 5.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.16 -170.01 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.41 65.97 2.72 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 m -114.42 -10.7 12.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.15 -166.22 1.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.983 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -114.46 144.41 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.036 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -162.17 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.771 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.51 160.37 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.745 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 79.42 8.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 -173.44 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -98.7 -172.1 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.909 179.942 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.654 0.264 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -121.12 -67.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.44 65.76 0.18 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.59 101.28 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -99.21 -71.57 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.5 91.17 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.959 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.74 148.61 35.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 57.21 67.41 2.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.95 -166.16 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.0 112.257 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -87.59 -45.65 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 179.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.57 -153.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -66.86 155.5 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.343 179.524 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 12' ' ' ILE . 2.2 m -56.57 -52.81 63.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.1 OUTLIER -176.66 145.76 0.55 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.569 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.748 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 3.3 m-30 -101.66 141.09 35.05 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.102 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mm -114.75 132.74 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -121.24 114.22 21.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.237 178.564 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.6 mtp180 -109.99 129.17 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 -179.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.637 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 3.1 p90 -142.4 140.18 31.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.25 0.548 . . . . 0.0 111.699 179.673 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.92 144.84 17.13 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.915 -179.803 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 51.2 Cg_exo -56.94 117.73 4.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.252 1.968 . . . . 0.0 112.327 -179.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.497 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 mmmt -58.58 -17.86 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.74 -18.57 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.141 -179.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.31 -166.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.949 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.18 -26.29 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.057 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.92 -128.57 1.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.423 -179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.0 63.05 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 74.6 m95 -63.71 -177.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.2 mmtp -131.94 152.3 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.425 179.197 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.23 133.77 55.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.808 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.15 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.446 178.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.563 ' CG2' ' HB2' ' A' ' 14' ' ' LYS . 51.6 m -106.51 126.45 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.309 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.748 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -140.16 105.24 6.66 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.811 178.087 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 107.45 2.01 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.167 1.911 . . . . 0.0 112.658 -179.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.09 116.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.401 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.26 102.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.23 -33.12 33.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.68 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.1 OUTLIER -179.32 -159.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.308 179.9 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 m -77.3 105.37 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.6 114.41 26.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -98.71 147.65 24.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.036 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 43' ' ' LYS . 3.6 mt -99.57 115.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 42' ' ' ILE . 3.8 mmpt? 18.4 -93.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.089 0.868 . . . . 0.0 112.584 179.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.84 105.5 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.387 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.627 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -73.49 -175.55 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.638 0.256 . . . . 0.0 110.886 -179.808 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 160.96 33.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.086 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.07 149.92 50.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.684 2.256 . . . . 0.0 112.881 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' H ' ' HG ' ' A' ' 75' ' ' SER . . . 76.62 -2.18 59.48 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.052 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.08 112.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.701 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.3 t -91.56 148.05 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 179.026 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 53.3 m-85 -139.68 107.47 5.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.926 178.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 tp10 -87.92 128.85 35.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -117.22 147.59 18.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.545 -178.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -133.52 115.75 15.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 17' ' ' LEU . 32.7 tp -99.19 107.36 19.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.76 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.3 mp -112.18 115.25 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.582 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 7.9 m -82.14 133.4 35.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.447 HG21 ' N ' ' A' ' 59' ' ' GLN . 2.8 mp -121.67 133.14 69.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.334 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 3.8 tt0 -110.79 -175.14 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.527 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -61.08 -17.7 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.1 -5.71 23.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.68 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.47 153.16 5.68 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.999 178.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 t60 58.37 97.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.619 0.247 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.71 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 -122.77 -60.72 1.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 tt0 -135.54 145.32 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.913 -178.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.35 114.48 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 178.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.9 m -133.37 127.18 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -104.06 132.09 50.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -155.58 130.81 9.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.618 -179.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.45 149.81 20.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.82 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -150.8 148.18 28.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.513 0.673 . . . . 0.0 112.671 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.445 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.7 p -149.04 146.17 27.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.516 179.314 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 74' ' ' THR . 5.9 t -75.55 -40.66 56.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.446 -179.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.546 ' N ' HG22 ' A' ' 73' ' ' THR . 0.1 OUTLIER -131.88 -24.85 2.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.255 -179.886 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.442 ' HG ' ' H ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -75.33 -171.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.051 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.98 130.5 18.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 -179.811 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.6 t -157.37 26.26 0.3 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 86.29 18.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.3 5.78 4.39 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.741 2.294 . . . . 0.0 112.648 -179.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.82 -172.96 45.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -65.17 -39.3 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.726 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 82' ' ' ARG . 10.4 mtt85 -146.38 165.16 30.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.97 138.09 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.652 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.33 115.3 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -115.1 -52.14 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.644 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -153.63 -17.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 60.34 -87.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.25 179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 63.67 169.01 0.16 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.924 0.392 . . . . 0.0 111.04 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.963 -179.763 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.721 0.295 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 2' ' ' ARG . 2.8 ttp180 58.46 -164.57 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.032 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 159.36 74.86 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 p -76.09 -179.26 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.1 48.11 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.84 97.33 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.213 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 135.21 28.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.492 2.128 . . . . 0.0 112.305 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.47 131.78 23.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.99 80.74 2.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.474 2.116 . . . . 0.0 112.246 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.505 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -64.47 -25.4 67.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 179.881 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.34 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.608 HG21 ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -101.59 157.44 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 111.306 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 t -82.16 -31.68 30.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 4.0 pttt -175.86 143.92 0.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.973 179.317 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.601 ' HB2' HG13 ' A' ' 33' ' ' ILE . 34.1 m-85 -108.04 143.14 37.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.597 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.68 122.81 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.129 0.49 . . . . 0.0 110.736 179.66 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.799 HD13 ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -109.96 114.61 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.631 179.372 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.758 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.02 129.61 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.252 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.624 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.7 p90 -150.38 149.36 29.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.568 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.54 HH12 ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -153.79 145.41 16.69 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 -179.514 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 49.0 Cg_exo -59.15 110.55 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.706 2.271 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -64.63 -19.64 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.1 -18.24 62.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -117.57 -162.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.608 179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.09 125.59 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.57 -142.49 47.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.669 179.651 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 63.14 59.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.091 0.472 . . . . 0.0 111.138 -179.975 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -76.53 174.81 9.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.749 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.8 mttt -142.43 132.31 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.857 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.68 135.62 54.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.298 0.571 . . . . 0.0 112.396 -178.489 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.14 111.77 6.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 179.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 m -88.31 132.61 34.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.146 0.498 . . . . 0.0 112.294 -178.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 HG13 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -140.4 105.54 6.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.217 179.29 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.868 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 17.6 Cg_endo -58.2 -179.75 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.504 2.136 . . . . 0.0 113.516 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.608 ' N ' HG21 ' A' ' 12' ' ' ILE . . . -65.79 88.9 0.11 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.237 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.548 ' HB3' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -179.81 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 109.898 -179.508 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.638 HD13 ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.74 -3.48 47.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.762 179.39 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.626 HD21 ' H ' ' A' ' 39' ' ' SER . 6.1 p-10 42.47 -125.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.626 ' H ' HD21 ' A' ' 38' ' ' ASN . 2.1 m -88.28 117.04 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.735 0.303 . . . . 0.0 110.974 179.878 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -83.52 126.73 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.286 179.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -97.98 147.44 24.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.421 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.32 131.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -111.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.1 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.413 ' C ' HD23 ' A' ' 45' ' ' LEU . . . -81.39 140.13 20.95 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.14 -178.021 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HB2' HG21 ' A' ' 73' ' ' THR . 2.9 mm? -126.67 3.59 6.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.61 179.223 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt 62.54 154.65 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.157 179.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.545 ' HB3' ' HG1' ' A' ' 74' ' ' THR . 88.4 Cg_endo -78.41 155.56 28.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.797 2.332 . . . . 0.0 112.513 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.76 3.35 59.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.192 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -117.92 112.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.089 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.0 t -89.44 148.37 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.05 0.452 . . . . 0.0 110.494 178.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 39.5 m-85 -138.78 104.42 5.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.623 179.428 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 8.4 tt0 -90.26 128.63 36.46 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -142.2 147.94 19.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.331 -179.084 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' CB ' ' HA ' ' A' ' 68' ' ' ARG . 6.0 pm0 -133.83 138.83 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.162 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.799 ' HG ' HD13 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -100.03 107.89 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.071 0.462 . . . . 0.0 111.647 -178.66 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.3 mp -101.69 114.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.137 179.157 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 1.3 m -87.31 136.34 32.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 -179.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' CG2' ' HA2' ' A' ' 62' ' ' GLY . 3.6 mp -118.87 132.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.046 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.781 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 30.1 tt0 -92.73 -175.77 4.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.427 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.555 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 5.4 mt-30 -60.33 -29.53 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.092 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.37 7.98 42.47 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.323 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' HA2' ' CG2' ' A' ' 58' ' ' ILE . . . 94.0 147.95 23.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.082 179.343 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 64.37 157.25 0.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.5 0.19 . . . . 0.0 111.285 179.746 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.781 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -179.01 -57.47 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 179.281 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.5 tt0 -145.09 144.19 30.81 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.114 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.28 114.07 16.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 178.433 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.9 m -137.2 120.74 17.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.814 179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' HA ' ' CB ' ' A' ' 54' ' ' GLN . 6.5 mtp85 -97.94 132.62 43.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' GLY . 19.8 p90 -149.4 131.31 15.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.191 0.52 . . . . 0.0 112.295 -179.717 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD2' ' HG3' ' A' ' 52' ' ' GLU . 1.7 m-20 -95.2 141.64 28.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.016 179.256 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -152.66 160.75 43.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.475 0.655 . . . . 0.0 112.491 -178.853 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 75' ' ' SER . 1.0 OUTLIER -148.11 167.13 25.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.835 178.952 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.699 HG23 ' H ' ' A' ' 74' ' ' THR . 8.8 t -96.69 -47.07 6.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.683 0.278 . . . . 0.0 111.68 -179.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.699 ' H ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -135.97 -2.93 2.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 -179.736 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.513 ' HB2' HG21 ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.75 166.11 14.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.811 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.15 100.34 13.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.74 105.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.994 179.835 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 118.04 0.68 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.083 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.9 149.35 89.66 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.477 2.118 . . . . 0.0 112.344 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.95 3.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.582 -179.956 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 59.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 0.0 110.803 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.18 156.52 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 161.96 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -66.64 108.74 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -77.43 90.7 3.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -65.77 -76.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.51 -29.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -117.43 99.53 7.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.9 0.381 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -130.01 -20.54 3.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.47 -6.92 65.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' A' ' 5' ' ' ASN . 0.1 OUTLIER 61.56 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.69 0.281 . . . . 0.0 111.206 179.959 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' H ' ' HB3' ' A' ' 4' ' ' SER . 0.5 OUTLIER -58.98 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.961 -179.88 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 119.94 29.23 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.95 -93.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.426 2.084 . . . . 0.0 112.083 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 15.9 pt20 -84.0 148.1 52.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.707 179.77 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 Cg_exo -72.95 -157.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.75 2.3 . . . . 0.0 112.362 -179.722 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.94 69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.755 179.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.653 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 10.2 p-80 -64.11 162.75 13.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.689 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.654 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -97.14 152.09 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.87 179.885 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.654 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.51 -46.63 48.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.283 179.485 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 16.5 pttm -162.05 144.26 11.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.134 179.366 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -113.07 140.6 47.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.707 179.211 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.22 125.35 71.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 179.745 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.41 114.28 27.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.323 179.789 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -112.21 129.15 56.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.771 179.487 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.667 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -146.21 147.15 31.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.273 0.559 . . . . 0.0 112.234 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' NH2' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -151.29 145.67 18.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.024 179.911 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 47.3 Cg_exo -57.53 109.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.334 2.023 . . . . 0.0 112.549 -179.594 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 1.7 mttm -68.45 -32.68 72.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.52 179.471 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.58 -18.85 47.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 1.7 m -149.48 72.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.576 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.518 HG13 ' NH2' ' A' ' 20' ' ' ARG . 22.7 m -47.02 146.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.947 -179.474 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.86 79.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.7 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' A' ' 28' ' ' TRP . 14.5 ttp180 65.15 147.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 111.54 179.728 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.507 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 37.2 m95 -101.72 -176.63 3.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -139.08 153.26 48.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.353 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 138.32 54.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.2 111.97 7.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.823 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m -93.77 126.23 38.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.721 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 37' ' ' LEU . 1.8 mt -138.2 107.04 7.97 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 178.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 24.1 Cg_exo -64.13 109.91 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.515 2.143 . . . . 0.0 113.325 -178.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 49.54 24.73 5.8 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.818 178.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 60.71 115.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.086 0.47 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' ' 37' ' ' LEU . 5.9 mp -82.44 -33.21 28.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.1 OUTLIER -177.51 -153.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.117 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -76.8 104.83 7.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -118.19 122.75 43.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 -179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 141.57 49.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.287 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG21 ' CZ2' ' A' ' 19' ' ' TRP . 20.7 mm -89.96 130.19 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -112.89 156.96 22.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.856 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.35 20.56 1.96 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.26 -179.785 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -121.61 177.98 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.952 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.642 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -139.45 163.47 45.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.702 0.286 . . . . 0.0 111.652 -179.173 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.1 109.51 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.629 2.219 . . . . 0.0 112.605 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.0 -0.21 11.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.104 179.399 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 46' ' ' LYS . 14.7 p -120.23 137.12 55.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.572 HG23 HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.7 137.88 43.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.01 179.7 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 7.9 m-85 -111.21 174.14 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.279 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -116.21 129.49 56.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.736 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.71 132.17 9.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.857 -1.163 . . . . 0.0 113.797 -178.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' THR . 1.4 mt-30 -133.56 113.83 12.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.112 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mt -100.66 107.56 19.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.4 mp -101.77 115.68 44.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.6 119.17 23.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.739 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 20.5 mt -110.62 119.17 58.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.51 -179.472 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HG2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -92.27 -175.68 4.11 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.082 179.447 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -61.58 -17.44 55.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -103.14 -5.17 23.51 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.28 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.92 179.61 16.01 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -49.4 157.67 0.48 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -165.46 -2.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.33 133.69 21.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.606 0.241 . . . . 0.0 111.383 -179.689 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.3 t -134.94 133.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.975 179.231 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 6.2 m -137.51 137.22 38.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.48 139.65 44.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.52 161.59 40.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.306 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.8 141.25 29.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.245 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.645 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 1.1 t80 -120.24 139.1 53.18 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.157 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.572 HG22 HG23 ' A' ' 50' ' ' VAL . 22.1 p -152.09 168.52 25.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.583 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.863 HG22 ' H ' ' A' ' 74' ' ' THR . 1.2 t -115.44 -64.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.876 179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.863 ' H ' HG22 ' A' ' 73' ' ' THR . 0.1 OUTLIER -107.34 -31.96 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 t -78.07 89.85 4.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.43 105.37 0.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.232 -179.758 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 101.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.31 69.76 21.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -166.28 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.993 2.462 . . . . 0.0 112.241 -179.777 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.49 99.28 0.01 OUTLIER Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.478 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m 55.78 -149.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.463 0.173 . . . . 0.0 110.671 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 83' ' ' SER . 0.1 OUTLIER 59.05 -147.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.794 179.906 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 82' ' ' ARG . 3.0 m -60.0 173.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.837 0.351 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -104.37 146.42 28.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -157.82 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 13.74 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -100.46 -168.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.011 -179.926 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.23 129.2 21.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 116.86 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.12 -124.91 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -132.91 105.1 6.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -21.91 63.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.78 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.47 131.4 44.37 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.578 2.185 . . . . 0.0 112.465 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.39 67.44 5.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.609 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.82 -72.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.742 2.295 . . . . 0.0 112.05 -179.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -131.98 1.21 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -68.18 -103.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -105.2 148.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 179.954 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -43.29 52.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.154 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.61 144.94 0.69 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.274 178.863 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.4 m-85 -100.79 150.2 23.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.612 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.556 HD12 ' OG1' ' A' ' 32' ' ' THR . 2.2 mm -125.02 123.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.552 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.11 114.09 27.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.517 178.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.55 129.68 56.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.4 -179.646 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.648 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 4.8 p90 -141.28 149.27 41.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.21 147.98 14.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.405 -179.849 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 48.4 Cg_exo -57.81 114.73 2.09 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.543 2.162 . . . . 0.0 112.665 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.794 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 27.6 mtpt -75.31 -25.07 57.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -86.23 -35.87 19.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.204 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.69 -175.53 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.111 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.03 132.24 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.067 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.5 -165.49 31.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.8 150.04 21.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.82 177.6 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.17 154.57 50.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.881 179.415 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.62 133.44 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.19 0.519 . . . . 0.0 111.891 -179.463 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.85 111.43 8.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.469 179.015 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 58.8 m -90.56 136.74 32.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.318 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.756 HG23 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.07 103.8 6.76 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.474 177.668 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.35 127.4 7.41 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.58 2.186 . . . . 0.0 112.699 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.19 165.82 36.67 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.991 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -81.89 67.13 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.064 0.459 . . . . 0.0 110.759 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.756 HD12 HG23 ' A' ' 33' ' ' ILE . 2.7 mt -78.81 -2.88 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.027 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER 105.96 174.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.503 1.127 . . . . 0.0 110.608 -179.675 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -77.18 111.75 13.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -97.66 117.48 32.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.449 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -127.4 142.17 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.74 116.66 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -119.49 42.36 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.82 10.47 58.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.502 ' HG ' ' CE1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -83.28 166.23 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 110.887 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -94.06 134.85 25.31 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.148 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 66.9 Cg_exo -38.96 123.38 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.5 2.8 . . . . 0.0 114.07 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.0 7.2 17.67 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.127 178.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 t -121.52 136.67 57.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.551 0.676 . . . . 0.0 112.301 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.49 HG22 ' CG2' ' A' ' 72' ' ' THR . 0.5 OUTLIER -115.34 133.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.993 178.186 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 27.4 m-85 -116.18 -173.12 2.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.966 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.794 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 9.8 tm-20 -126.07 129.45 49.15 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.91 118.47 4.25 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.085 -179.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' HG2' HD12 ' A' ' 56' ' ' ILE . 37.9 tt0 -132.66 113.89 13.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.043 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 tp -103.44 106.74 17.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.507 -179.195 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.517 HD12 ' HG2' ' A' ' 54' ' ' GLN . 4.9 mp -100.52 138.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.591 178.838 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.838 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 4.7 m -94.85 151.11 19.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.356 0.598 . . . . 0.0 110.975 -179.5 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 25.8 mt -116.41 131.84 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.508 -179.417 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.896 ' HG2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -118.74 -176.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.442 178.461 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -20.68 59.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.748 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CD1' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -104.47 -5.68 21.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.445 179.809 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.27 139.21 1.76 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.187 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.28 81.78 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.819 0.343 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.896 ' HB2' ' HG2' ' A' ' 59' ' ' GLN . 1.1 tt0 -101.48 -67.75 0.85 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.608 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.838 ' H ' ' HB2' ' A' ' 57' ' ' SER . 4.0 tp10 -140.54 127.56 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.04 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.27 138.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 111.861 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.87 134.12 34.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.413 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -111.67 143.87 41.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 -179.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.72 161.1 40.78 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.94 148.03 22.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.605 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -120.16 142.38 49.01 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.456 -176.339 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.49 ' CG2' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -149.92 168.08 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.592 179.272 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 46' ' ' LYS . 6.0 p -80.13 -147.35 0.05 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.916 179.558 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.528 ' OG1' ' HG3' ' A' ' 47' ' ' PRO . 1.8 p -65.31 -10.47 32.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.621 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.19 163.67 6.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.91 98.86 11.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.26 34.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.46 86.48 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.44 -158.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.452 2.101 . . . . 0.0 112.296 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 -67.26 1.41 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.421 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.19 -91.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.661 0.267 . . . . 0.0 110.852 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.66 -14.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -150.52 -1.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.56 59.38 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.89 -116.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.83 -165.7 0.14 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.791 0.329 . . . . 0.0 110.986 -179.878 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 55.61 74.69 0.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.025 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.09 -16.0 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.942 179.897 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.817 0.341 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.39 34.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.59 -79.9 0.19 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m 55.45 33.43 20.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 59.3 179.39 0.08 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.101 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.31 67.44 6.23 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.28 167.37 25.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.449 2.099 . . . . 0.0 112.247 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.05 106.1 39.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.71 -178.74 4.82 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.519 2.146 . . . . 0.0 112.572 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -82.97 -2.03 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -139.68 -155.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 64' ' ' GLN . 7.9 tp -70.85 144.95 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.391 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.87 95.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.055 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -167.46 145.41 4.68 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.467 179.513 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.707 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 1.4 m-85 -100.45 145.3 28.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.688 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.03 121.06 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 109.938 179.217 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 HD11 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.26 114.07 27.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.476 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.709 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 8.5 mtp85 -114.75 128.75 56.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.747 179.3 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.659 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.2 p90 -144.6 145.72 31.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.3 0.572 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 HH11 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -152.06 145.88 18.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.335 -179.812 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 42.3 Cg_exo -58.77 110.24 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.444 2.096 . . . . 0.0 112.335 -179.78 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 8.7 mmtm -72.11 -13.97 61.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.384 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -96.13 -26.92 15.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.549 -179.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.82 -12.93 15.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 t 50.41 70.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.6 -154.26 11.94 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.607 -179.811 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -89.49 141.18 28.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 110.649 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.448 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 42.1 m95 -73.21 178.0 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 mtpp -139.48 147.87 41.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.05 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.81 137.0 54.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.275 0.559 . . . . 0.0 112.304 -178.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.01 122.12 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -97.21 116.76 30.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.221 0.534 . . . . 0.0 112.395 -178.79 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -136.87 106.77 8.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.989 178.945 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.3 Cg_exo -59.94 -157.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.535 2.157 . . . . 0.0 114.157 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 36' ' ' HIS . . . -63.38 110.25 3.26 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.485 -178.339 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 35' ' ' GLY . 12.9 p80 3.7 69.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.218 1.007 . . . . 0.0 113.504 178.911 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.783 ' HG ' ' HB2' ' A' ' 39' ' ' SER . 0.1 OUTLIER -84.16 0.66 47.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.518 179.472 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 81.79 25.02 0.22 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -174.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.783 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . 5.7 t -75.77 176.68 7.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 110.809 -2.905 . . . . 0.0 112.776 -178.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.13 108.48 4.67 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.747 -1.569 . . . . 0.0 112.076 -177.309 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -104.28 141.87 35.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.806 178.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mp -82.3 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.052 0.453 . . . . 0.0 111.691 -179.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -174.29 -170.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.563 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.99 84.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.777 179.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.6 mm? -115.37 167.57 10.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' O ' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -96.8 126.4 43.03 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.377 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 13.2 Cg_exo -32.66 137.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.751 3.634 . . . . 0.0 114.963 -179.483 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 -4.16 54.09 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.61 177.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -122.63 126.84 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 117.842 0.821 . . . . 0.0 112.966 -179.238 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.577 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.29 146.29 12.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.364 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 71.2 m-85 -137.55 130.94 30.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.672 0.272 . . . . 0.0 110.988 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.734 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . 8.9 tp10 -79.85 129.46 34.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.479 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.68 127.17 7.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.089 -178.265 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -134.23 114.05 12.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.1 mt -101.97 106.4 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 111.495 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.591 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.6 mp -104.13 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.882 178.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.589 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.52 150.14 27.13 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.743 0.782 . . . . 0.0 111.131 -179.039 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -116.65 132.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.585 -179.137 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.919 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.13 -174.21 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.05 -31.71 70.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.248 179.533 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -103.97 -4.95 22.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.146 179.332 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 156.39 30.02 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.858 179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.7 t60 64.0 134.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.919 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 3.6 mm-40 -161.2 -68.86 0.06 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.631 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.589 ' H ' ' HB2' ' A' ' 57' ' ' SER . 1.5 tt0 -137.53 115.34 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.183 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -123.4 129.8 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 111.933 178.795 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -129.42 141.27 51.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.366 179.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -104.88 133.46 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.573 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.99 136.36 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.991 179.534 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.1 142.73 27.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -148.91 161.32 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.171 0.51 . . . . 0.0 111.393 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -137.67 170.32 16.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.738 -179.341 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.815 ' HA ' ' HB2' ' A' ' 45' ' ' LEU . 9.4 p -58.39 -139.39 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.042 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.558 HG21 ' HD3' ' A' ' 47' ' ' PRO . 6.7 p -72.51 11.86 0.56 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 73' ' ' THR . 8.8 t -94.17 -35.08 12.67 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m 68.04 141.86 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.807 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p -149.67 19.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.749 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.3 p -108.97 112.58 59.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.11 -7.54 14.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.096 . . . . 0.0 112.532 -179.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.87 92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.655 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB3' ' H ' ' A' ' 82' ' ' ARG . 9.7 t 55.67 -98.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.45 ' HB3' ' H ' ' A' ' 83' ' ' SER . 10.5 ttp-105 -170.37 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -143.35 -156.81 0.72 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.973 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -65.95 -174.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 111.301 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -139.36 14.66 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.862 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 t60 56.16 81.35 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -66.55 121.18 14.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -108.95 -49.91 3.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.787 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.623 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -72.8 150.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 3.6 m -52.08 -44.89 64.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.006 0.431 . . . . 0.0 110.156 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -171.62 143.84 1.78 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.858 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.58 146.77 28.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.824 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -114.68 125.04 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.668 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -112.93 114.5 27.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.3 mtp180 -115.07 129.61 56.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.424 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.702 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.3 p90 -142.22 148.94 38.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 111.76 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -155.69 142.93 13.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 53.0 Cg_exo -57.6 109.94 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB3' HG12 ' A' ' 50' ' ' VAL . 1.2 tptp -77.22 -23.66 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -95.26 -20.38 19.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.67 2.0 18.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.984 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 25' ' ' VAL . 6.0 p 33.77 85.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.129 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.45 -147.21 6.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.532 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 27' ' ' ARG . 31.5 mtt180 -96.32 157.87 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 110.929 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 67.5 m95 -87.99 173.92 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttp -145.59 155.05 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -123.96 140.33 53.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.339 0.59 . . . . 0.0 112.407 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.73 112.06 7.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.592 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -91.06 127.94 36.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.761 HG22 HD21 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -137.56 107.46 8.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.727 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 23.4 Cg_exo -64.77 91.9 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.583 2.189 . . . . 0.0 113.025 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.84 -152.26 50.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.677 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -107.45 71.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.3 -31.69 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.634 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.58 179.88 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -77.0 106.81 8.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -123.29 113.31 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -128.55 127.85 43.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.26 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 HD22 ' A' ' 17' ' ' LEU . 8.8 mt -83.6 123.57 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.652 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -156.49 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.93 14.98 47.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.989 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.445 ' H ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -101.63 -166.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.755 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.62 162.29 37.06 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.745 0.307 . . . . 0.0 111.4 -179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 45.5 Cg_endo -68.38 146.36 68.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.264 1.976 . . . . 0.0 112.628 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.0 0.14 83.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.202 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 46' ' ' LYS . 5.5 p -120.29 137.97 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.961 0.381 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -114.56 129.57 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.184 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 34.4 m-85 -104.98 -178.16 3.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 mm-40 -123.25 130.12 52.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.52 129.25 7.64 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.314 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.67 114.33 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.405 0.145 . . . . 0.0 110.776 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 16' ' ' ILE . 3.5 mt -101.99 107.01 18.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 0.0 110.827 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.0 mp -109.47 117.74 55.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.675 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -81.5 140.33 34.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.488 0.661 . . . . 0.0 111.098 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.606 HG23 ' HA2' ' A' ' 62' ' ' GLY . 29.7 mt -119.09 132.45 68.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.452 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 4.0 mm100 -106.88 -173.43 2.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -24.8 64.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HE22 ' A' ' 64' ' ' GLN . 4.7 p90 -103.38 -5.51 22.87 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.572 0.225 . . . . 0.0 111.598 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 82.5 154.52 14.99 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.146 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 62.77 96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.71 0.404 . . . . 0.0 111.633 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.658 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 10.3 mm100 -124.05 -89.93 0.58 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 112.315 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.49 145.35 26.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.98 114.5 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 134.47 47.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.758 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 127.7 55.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -136.1 160.56 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.136 0.493 . . . . 0.0 111.656 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.0 150.76 20.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.883 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.9 140.43 49.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.888 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 p80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.92 0.391 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -73.02 149.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.712 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 12' ' ' ILE . 7.8 t -44.62 -51.01 9.47 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 110.456 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HD2' HD11 ' A' ' 16' ' ' ILE . 4.1 pttt -171.48 143.95 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -105.78 136.77 44.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.695 HD13 HG13 ' A' ' 58' ' ' ILE . 3.0 mp -114.64 124.72 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.857 0.36 . . . . 0.0 110.679 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 25.8 tp -104.99 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -115.91 129.58 56.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.027 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 19.7 p90 -153.2 157.58 40.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.038 0.447 . . . . 0.0 111.541 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -159.39 156.9 26.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.79 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 31.3 Cg_exo -58.93 117.71 4.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.137 1.891 . . . . 0.0 112.386 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -34.73 64.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.636 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -90.56 -34.57 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -98.98 -169.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.596 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.09 168.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.65 -166.13 28.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.95 160.24 14.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -74.83 -179.94 4.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -146.24 127.57 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.103 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.29 134.46 55.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 111.915 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.86 133.22 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.194 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.1 m -85.76 132.07 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.175 0.512 . . . . 0.0 111.693 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.94 118.38 20.89 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.983 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 36' ' ' HIS . 53.9 Cg_exo -56.53 78.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.905 2.403 . . . . 0.0 113.462 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.74 10.35 0.97 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.259 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 34' ' ' PRO . 1.8 t-160 74.68 104.19 0.07 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.877 0.37 . . . . 0.0 110.358 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.5 mp -65.82 -35.22 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.0 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.22 -63.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.85 116.38 20.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -128.02 109.56 11.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.389 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -116.68 146.26 42.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.568 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.09 134.73 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.575 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -108.7 171.16 7.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 47.66 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.268 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 -169.34 2.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.803 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.49 146.44 12.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.47 122.97 10.78 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.612 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.27 9.53 2.97 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.246 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.35 130.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.901 0.35 . . . . 0.0 111.407 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 23' ' ' ASN . 11.3 t -83.02 145.37 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.22 166.07 26.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.59 0.709 . . . . 0.0 112.131 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.2 tp10 -133.24 128.67 36.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.67 139.87 11.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.517 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -133.52 131.63 40.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.773 0.321 . . . . 0.0 110.749 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.92 109.91 22.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.3 mp -108.14 115.42 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.15 121.66 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.432 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 16' ' ' ILE . 1.4 mt -113.4 113.4 43.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.519 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.29 -176.41 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.2 -18.31 57.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.168 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 64' ' ' GLN . 2.6 p90 -103.25 -4.78 23.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.94 -178.35 16.38 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.866 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.9 p80 -53.18 161.38 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.687 0.28 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.472 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -170.24 0.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -145.45 116.8 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.468 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 56' ' ' ILE . 42.0 t -134.23 123.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.535 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.23 121.73 18.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -98.04 138.76 34.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.027 0.442 . . . . 0.0 111.767 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -156.38 126.85 6.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.767 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -95.41 137.93 33.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -139.65 149.11 43.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.009 0.433 . . . . 0.0 111.548 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.543 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.808 0.337 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -72.26 150.09 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.674 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.34 -50.95 37.51 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -171.55 144.58 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.366 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -104.52 139.56 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.256 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 mm -117.07 124.04 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.091 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 55' ' ' LEU . 26.8 tp -105.63 113.99 27.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.858 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.94 128.92 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.631 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -156.69 148.4 22.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.141 0.496 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HD3' ' CE2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -148.94 161.21 33.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.619 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' SER . 48.9 Cg_exo -57.72 117.56 4.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.281 1.988 . . . . 0.0 112.357 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -66.94 -36.84 83.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.503 -179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 50' ' ' VAL . 1.7 t-20 -96.44 -43.43 7.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.267 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.51 165.87 16.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.13 152.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.74 -127.68 1.53 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -139.93 168.76 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.404 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 65.5 m95 -82.45 173.39 12.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.94 137.59 36.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.69 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.3 mt-10 -120.22 133.31 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.038 0.447 . . . . 0.0 111.832 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.62 117.74 11.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.202 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.4 m -86.3 131.06 34.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.09 0.472 . . . . 0.0 112.147 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.6 mp -133.77 106.42 11.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.757 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.63 90.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.438 2.092 . . . . 0.0 112.378 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.69 -93.29 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.15 93.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -68.26 -33.96 75.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.855 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 169.02 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.72 117.22 21.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.035 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -115.82 113.69 23.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.842 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -122.99 130.18 52.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.875 HG22 HD11 ' A' ' 45' ' ' LEU . 4.6 mm -85.5 127.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -173.36 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 39.01 53.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.591 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -141.89 -174.18 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.8 151.27 12.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.244 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.17 168.62 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.8 -7.03 60.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.674 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.86 121.56 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' ASN . 1.6 p -82.44 103.24 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.67 160.03 14.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.135 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 1.6 tp10 -117.79 129.11 55.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.64 145.15 16.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.149 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -133.77 131.91 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.057 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 17' ' ' LEU . 4.9 tp -119.01 107.31 13.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.899 0.381 . . . . 0.0 111.051 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.6 mp -116.67 116.44 52.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.907 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -89.8 126.38 35.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.72 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 2.7 mp -113.15 125.26 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.235 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -101.15 -177.31 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.506 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -64.3 -26.78 68.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.54 -0.39 43.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.12 169.11 13.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 8.8 p80 -56.98 151.97 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.81 6.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 tt0 -143.66 116.74 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.18 121.21 31.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 m -134.96 121.52 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -100.94 129.7 46.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.69 132.6 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.305 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 151.24 19.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.63 153.9 35.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.052 0.453 . . . . 0.0 111.811 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.709 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.2 m80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.764 0.316 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -98.38 149.56 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -48.11 -47.56 34.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.891 0.377 . . . . 0.0 110.299 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -175.45 143.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.829 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.78 139.01 39.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.1 mm -116.07 129.31 72.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 28.5 tp -105.03 113.01 26.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.01 129.01 52.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -152.12 150.08 29.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.335 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.555 HH11 ' HA ' ' A' ' 25' ' ' VAL . 7.1 ptt85 -148.51 160.84 35.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.33 114.59 2.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.172 1.915 . . . . 0.0 111.622 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -30.89 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.748 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.48 -38.79 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -3.27 57.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HA ' HH11 ' A' ' 20' ' ' ARG . 32.9 m 35.44 41.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.092 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.37 -160.4 12.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -73.66 169.11 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.461 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 37.3 m95 -99.51 173.11 6.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.493 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.22 139.51 41.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.345 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -120.37 134.7 55.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 116.96 10.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.947 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 60.1 m -85.33 138.95 31.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.274 0.559 . . . . 0.0 112.475 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -135.45 107.07 10.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.476 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.26 87.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.83 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.16 25.91 48.36 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.941 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER 58.62 99.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.832 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.787 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -72.86 -22.46 60.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' H ' HD22 ' A' ' 37' ' ' LEU . 17.8 t-20 -176.82 -105.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.2 p -127.19 121.73 32.11 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.64 103.38 10.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -115.85 142.97 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.233 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.5 125.38 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 6.6 pttt -101.1 168.9 9.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -140.43 23.41 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.404 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.32 -167.97 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.563 0.22 . . . . 0.0 111.197 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.44 147.23 24.79 Favored Pre-proline 0 CA--C 1.527 0.082 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.49 45.04 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.995 2.463 . . . . 0.0 113.219 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.98 -19.01 7.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.516 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.56 136.86 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.935 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.63 147.0 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.15 148.21 51.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 112.307 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -111.93 129.82 56.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.806 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 136.97 13.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.597 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -133.86 123.66 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.449 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 3.8 mt -108.18 108.97 20.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 111.021 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 66' ' ' VAL . 1.3 mm -112.35 118.7 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.672 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.96 133.86 41.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.289 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.844 HG12 ' HB3' ' A' ' 63' ' ' HIS . 6.4 mt -113.65 127.48 70.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 111.644 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.652 ' HG2' HD12 ' A' ' 12' ' ' ILE . 2.8 mm100 -95.18 -176.46 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -68.76 -32.25 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.767 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.66 15.48 28.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.73 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.05 161.04 12.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.237 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.55 163.78 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.722 0.296 . . . . 0.0 110.986 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.44 6.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.66 115.89 12.57 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.958 0.408 . . . . 0.0 111.607 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.729 ' HB ' HD13 ' A' ' 56' ' ' ILE . 1.2 p -136.03 139.07 46.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -137.06 136.05 38.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.34 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -111.32 129.46 55.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -156.02 127.98 7.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.805 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.68 132.78 39.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.074 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -136.61 150.76 48.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.831 -179.238 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.743 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 32.7 m-70 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.744 0.307 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.648 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -67.28 150.14 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.1 t -49.76 -48.98 49.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.707 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -169.72 144.25 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.993 0.425 . . . . 0.0 111.445 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.626 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -105.19 139.12 40.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.952 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 18' ' ' ARG . 28.5 mm -114.45 117.97 57.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.525 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 42.6 tp -104.9 113.74 27.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.831 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -119.34 128.72 54.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.913 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 8.6 p90 -151.63 162.16 41.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.904 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.16 161.69 27.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.684 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.53 118.94 5.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 121.906 1.737 . . . . 0.0 111.832 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -62.92 -29.67 70.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.528 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -99.39 -41.17 7.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.471 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 160.06 17.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.281 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.77 147.44 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.31 -164.72 37.38 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.63 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -89.14 155.6 19.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.96 -172.59 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -141.16 144.33 34.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.8 mt-10 -120.05 132.95 55.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.202 0.525 . . . . 0.0 111.792 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 118.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.937 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 87.7 m -85.42 132.5 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 112.091 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 14.4 mt -123.88 107.56 30.95 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.759 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.7 104.26 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.603 2.202 . . . . 0.0 112.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.743 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . 58.8 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.159 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.06 111.82 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.243 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -82.76 -3.52 56.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 75.77 -63.91 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.872 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.76 105.22 8.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 110.818 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -126.47 115.21 19.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -120.57 144.47 48.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.257 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 45' ' ' LEU . 18.3 mt -94.33 132.68 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.506 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.39 154.38 25.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.227 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 38.13 4.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.642 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD21 HG22 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -126.62 171.02 11.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.328 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 135.96 10.47 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.29 157.95 10.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.659 2.24 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.37 -62.08 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.611 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -77.13 133.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 111.173 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 22' ' ' LYS . 5.3 p -82.85 144.76 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.027 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 138.92 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.945 0.402 . . . . 0.0 111.923 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 10.7 tp10 -105.22 129.29 53.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.5 144.67 15.72 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 119.822 -1.18 . . . . 0.0 114.309 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.8 mt-30 -133.66 129.47 36.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.377 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.626 ' HG ' ' CE1' ' A' ' 15' ' ' TYR . 4.7 tp -124.9 106.67 10.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.417 HD11 ' OE1' ' A' ' 54' ' ' GLN . 3.8 mp -116.88 116.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.941 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.474 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.42 127.43 33.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 63' ' ' HIS . 15.1 mm -112.84 124.39 69.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.309 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 -177.1 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.24 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.42 -2.54 28.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.54 -166.4 12.15 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.438 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.568 ' HA ' HD13 ' A' ' 58' ' ' ILE . 21.1 p-80 -64.65 140.81 58.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.319 . . . . 0.0 110.707 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 -51.59 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.7 tt0 -97.2 126.18 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.484 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 123.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -137.41 130.85 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -111.46 139.55 46.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -155.94 127.83 7.44 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.028 0.442 . . . . 0.0 111.501 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.82 124.1 39.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.7 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -125.18 162.73 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.85 0.357 . . . . 0.0 111.741 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.388 -179.708 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.8 m80 . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.505 0.193 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.774 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.0 OUTLIER -67.4 156.39 6.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.914 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.19 -41.51 65.33 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -162.39 143.15 10.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.831 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 8.2 t80 -122.83 153.12 39.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.655 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 58' ' ' ILE . 3.7 mp -120.11 121.88 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.682 0.277 . . . . 0.0 110.751 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.651 ' HB2' ' HE2' ' A' ' 15' ' ' TYR . 10.5 tp -104.84 114.22 28.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.639 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.64 129.84 56.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -140.9 155.08 46.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.83 146.2 12.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.685 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 20' ' ' ARG . 39.7 Cg_exo -58.18 114.63 2.05 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.214 1.943 . . . . 0.0 111.974 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -65.63 -35.82 81.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.495 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -91.28 -43.85 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.328 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.41 0.53 28.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 29.62 63.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.258 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.68 -153.39 29.58 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.541 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -88.32 164.91 15.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.3 172.7 8.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.029 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -152.24 123.95 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.571 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.42 130.11 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.123 0.487 . . . . 0.0 112.178 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.03 137.09 51.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.779 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 97.8 m -85.27 115.66 23.16 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.532 0.682 . . . . 0.0 111.858 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.82 110.46 17.22 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.597 178.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.15 79.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.092 1.861 . . . . 0.0 111.945 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 45.46 37.81 6.67 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.74 97.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.923 0.392 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -71.49 -32.84 68.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -163.63 -89.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.82 123.87 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.837 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -127.92 119.39 25.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -98.67 146.91 25.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.986 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 43' ' ' LYS . 12.1 mt -108.04 115.01 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.117 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 42' ' ' ILE . 7.8 mmpt? 25.73 -126.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.205 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.92 80.27 0.19 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 45' ' ' LEU . 1.3 mm? -68.54 -155.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.739 ' HD3' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -155.65 140.65 12.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.63 107.11 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.653 2.236 . . . . 0.0 112.484 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.61 -3.93 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.861 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.739 HG23 ' HD3' ' A' ' 46' ' ' LYS . 78.6 t -104.31 115.91 47.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 72' ' ' THR . 2.8 p -83.23 116.39 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.363 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -107.98 169.48 8.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.25 0.547 . . . . 0.0 111.454 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -124.16 129.92 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.118 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.57 139.61 10.61 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -131.18 138.58 49.49 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -99.28 105.39 17.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.644 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.618 ' N ' ' HE1' ' A' ' 15' ' ' TYR . 4.2 mp -116.0 113.44 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.774 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -106.42 133.41 51.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.234 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 9.6 mt -114.05 127.21 71.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -98.7 -179.02 4.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.914 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -66.45 -16.87 64.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.031 0.443 . . . . 0.0 110.085 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -103.06 -4.95 23.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.941 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 124.56 171.24 13.34 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.39 139.03 58.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.7 0.286 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -145.77 9.97 1.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.832 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -142.73 114.98 8.39 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 112.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -137.2 126.58 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.381 179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -137.2 131.02 31.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.007 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -107.51 125.49 51.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -155.73 133.89 11.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 111.359 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.92 140.79 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.278 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -143.48 142.81 31.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 111.806 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.462 HG22 ' HB ' ' A' ' 50' ' ' VAL . 31.6 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.574 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -80.46 155.07 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.544 ' N ' HG13 ' A' ' 12' ' ' ILE . 16.5 t -53.71 -47.11 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.075 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -172.96 144.0 1.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.116 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -106.23 143.9 33.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.441 HG22 ' HD3' ' A' ' 18' ' ' ARG . 19.5 mm -116.19 118.58 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 111.04 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.552 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 49.2 tp -105.37 114.95 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.651 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.48 128.99 55.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.439 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 44.5 p90 -140.4 147.73 40.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.313 0.578 . . . . 0.0 110.838 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -161.99 153.07 15.11 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.256 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.62 110.5 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.332 2.022 . . . . 0.0 112.247 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -32.22 73.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.288 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.83 -37.28 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.51 -162.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 26' ' ' GLY . 3.9 p -60.96 166.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.29 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' ' HG3' ' A' ' 20' ' ' ARG . . . -74.87 -108.78 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.649 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 59.97 65.98 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.071 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 -57.48 168.39 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.72 134.37 35.26 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 7.5 mt-10 -119.06 136.79 53.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.449 0.642 . . . . 0.0 112.65 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.05 119.74 15.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 62.2 m -85.28 131.59 34.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.63 107.3 13.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.65 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.84 84.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.615 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.68 60.62 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.782 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.5 m170 60.89 106.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 0.0 111.162 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.671 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -76.85 -30.69 56.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.605 ' OD1' HD23 ' A' ' 37' ' ' LEU . 10.4 p-10 -177.98 -148.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.81 105.6 7.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.28 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -103.23 114.75 29.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.128 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -101.57 147.56 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 17' ' ' LEU . 42.4 mt -107.61 114.74 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.754 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.784 ' HE2' ' H ' ' A' ' 43' ' ' LYS . 9.0 mmpt? 34.92 -129.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.624 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 45' ' ' LEU . . . -129.45 -43.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.714 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.416 ' HG ' ' C ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 55.21 -176.68 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.49 0.186 . . . . 0.0 110.769 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -160.74 142.87 9.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.33 143.02 94.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.546 2.164 . . . . 0.0 112.14 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.8 -29.9 4.79 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.97 135.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.632 0.254 . . . . 0.0 111.187 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.15 118.57 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -106.94 164.98 11.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.697 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.8 tp10 -123.16 129.31 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.494 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.51 132.1 10.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.127 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 19.8 mm-40 -134.32 112.71 11.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' CD2' HD13 ' A' ' 17' ' ' LEU . 14.5 mt -106.14 105.55 15.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.962 0.41 . . . . 0.0 110.293 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 18' ' ' ARG . 5.1 mp -117.77 114.78 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.174 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.533 ' OG ' HD13 ' A' ' 12' ' ' ILE . 1.8 t -89.59 116.25 27.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.32 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 6.2 mt -102.44 121.17 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.045 0.45 . . . . 0.0 111.573 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -78.87 -176.36 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.179 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -30.69 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -103.03 1.23 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.02 13.39 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.009 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 2.1 p-80 -75.87 156.24 34.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.244 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -26.68 0.14 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.293 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.27 119.02 38.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 111.191 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 132.64 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.232 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.7 132.69 33.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.281 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.95 129.44 56.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -156.39 128.66 7.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.99 136.4 36.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.916 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.34 159.18 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.952 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.929 -179.127 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -101.26 147.9 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.436 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.579 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.4 m -45.16 -49.79 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.268 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HB2' HG23 ' A' ' 32' ' ' THR . 6.7 pttt -175.61 144.16 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.733 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -111.15 135.43 51.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.556 HG22 ' HD2' ' A' ' 18' ' ' ARG . 10.2 mt -114.16 121.46 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 111.237 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 42' ' ' ILE . 66.4 tp -105.3 114.66 28.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.8 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -121.0 128.33 52.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.537 ' CE3' ' HG ' ' A' ' 17' ' ' LEU . 16.4 p90 -148.15 158.67 44.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.979 0.419 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.656 HH12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -160.5 162.44 23.4 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.614 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.5 111.32 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.374 2.049 . . . . 0.0 111.985 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -24.81 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.773 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.518 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 20.2 t30 -99.68 -43.92 6.3 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.18 175.49 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.375 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.656 HG23 HH12 ' A' ' 20' ' ' ARG . 11.3 p -136.0 145.65 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.55 -111.28 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.561 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -127.81 148.17 50.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -82.57 -174.96 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.13 124.31 20.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.3 mt-10 -119.73 136.61 54.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 112.136 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.19 138.73 40.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.302 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.1 m -94.34 132.57 38.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.168 0.509 . . . . 0.0 112.156 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -135.68 107.71 9.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.862 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.18 83.96 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.485 2.124 . . . . 0.0 112.179 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.46 -90.68 0.64 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.298 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -168.48 93.33 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.695 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.735 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.34 -33.46 75.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.434 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.0 OUTLIER 179.66 -92.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.782 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.06 117.45 21.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.669 0.271 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.98 101.66 9.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.8 130.64 54.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 17' ' ' LEU . 3.0 mt -81.55 119.57 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -175.22 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.31 47.7 21.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.204 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -137.13 166.68 23.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.798 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.88 116.54 4.5 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.14 105.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.857 2.371 . . . . 0.0 112.567 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 -33.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.45 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 135.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 11.4 p -76.49 140.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -126.11 142.73 51.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.904 -178.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 19.1 pt-20 -116.32 129.19 56.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.45 141.21 16.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.617 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -133.62 114.43 13.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CE1' ' A' ' 15' ' ' TYR . 3.9 mt -106.55 107.57 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 0.0 110.701 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.8 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.1 mp -113.54 122.23 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.211 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.3 OUTLIER -89.61 131.96 35.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.119 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -113.17 122.74 67.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.636 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 7.6 tt0 -119.56 -175.77 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.472 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.83 -22.1 63.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HD2' HE22 ' A' ' 64' ' ' GLN . 0.3 OUTLIER -103.15 15.83 28.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.193 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.14 -169.38 27.93 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.409 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.585 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -56.01 152.43 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.678 0.275 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.585 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.96 -50.65 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.895 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -99.08 118.85 36.76 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.825 -178.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -134.12 119.86 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.949 0.404 . . . . 0.0 111.168 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 m -137.21 135.4 37.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.23 125.81 9.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.609 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.65 124.55 43.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.411 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.45 156.3 48.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.39 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -179.568 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 78.2 m80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.825 0.345 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -89.61 144.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.585 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.69 -52.38 60.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.99 0.424 . . . . 0.0 110.154 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HD2' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -168.76 143.85 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.79 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -113.11 129.12 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.307 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -114.11 137.61 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.861 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.22 114.48 25.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.247 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 5.1 mtt-85 -113.97 128.31 56.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.196 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -154.75 157.34 37.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 112.228 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 8.3 ptt85 -159.13 160.19 28.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -58.14 125.11 17.54 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 112.418 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 3.0 tttm -76.91 -37.07 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.35 -31.97 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.68 168.61 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.13 130.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.81 -120.16 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.581 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -136.52 166.29 23.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.557 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 40.6 m95 -84.32 -174.97 5.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tttm -148.94 145.19 27.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -119.8 129.75 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.113 0.482 . . . . 0.0 111.727 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.12 111.77 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.192 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -88.98 140.2 29.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.811 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.57 116.32 17.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.423 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' HD21 ' A' ' 37' ' ' LEU . 3.0 Cg_exo -75.23 87.72 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.832 2.354 . . . . 0.0 112.08 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 -89.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -169.7 92.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.66 -33.79 25.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 12.0 p-10 178.08 -157.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.599 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -86.18 106.61 17.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.729 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -84.57 119.48 25.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.019 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 m -122.78 124.47 43.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.18 122.62 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.02 105.1 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.7 8.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -95.09 -144.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.503 0.192 . . . . 0.0 110.499 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -165.85 140.46 3.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.5 95.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.407 2.071 . . . . 0.0 112.008 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.99 -27.71 3.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' THR . 1.9 t -92.52 124.0 44.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 110.659 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 72' ' ' THR . 63.1 t -100.93 123.14 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 0.0 111.384 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 18.0 m-85 -106.09 118.08 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.438 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 pt-20 -82.04 149.15 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.37 160.9 34.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.375 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -132.83 151.9 51.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.861 HD13 HD12 ' A' ' 17' ' ' LEU . 45.2 tp -111.19 107.7 17.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.92 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 66' ' ' VAL . 5.1 mp -92.55 138.31 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.007 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.523 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.55 123.52 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 110.951 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HD2' ' A' ' 14' ' ' LYS . 5.4 mt -113.27 117.79 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.824 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -86.97 171.66 10.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.892 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.98 -23.36 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.85 4.11 37.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.51 -134.09 11.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.619 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 64.77 168.8 0.18 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.856 0.36 . . . . 0.0 111.333 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -158.52 109.14 2.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.108 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tm-20 -100.11 116.28 31.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.328 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 56' ' ' ILE . 21.1 t -123.51 138.03 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 54.3 m -137.79 125.58 22.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.392 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.22 144.54 28.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.29 157.09 35.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.57 119.05 28.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -142.55 153.09 43.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.358 0.599 . . . . 0.0 112.45 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.829 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m170 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.577 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -90.71 142.81 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.354 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 2.2 m -66.23 -49.17 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.103 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.81 11.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.126 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.92 128.21 54.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.098 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 55' ' ' LEU . 32.9 mm -113.84 134.28 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.196 0.522 . . . . 0.0 110.987 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.862 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.55 114.55 27.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.311 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -112.28 128.24 56.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.935 179.386 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -147.94 155.77 41.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.328 0.585 . . . . 0.0 112.306 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.06 152.51 18.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -57.97 114.67 2.07 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.414 2.076 . . . . 0.0 112.55 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 1.8 ttmm -70.39 -36.39 74.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.154 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -84.3 -36.85 22.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.69 -169.57 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.781 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.03 103.25 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.909 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.19 -138.13 3.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 150.7 45.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -67.21 174.86 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.31 150.45 37.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.9 136.75 54.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 111.78 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 112.05 7.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.8 m -85.62 138.39 32.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.606 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -130.06 114.87 17.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.485 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 90.33 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.457 2.105 . . . . 0.0 112.304 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 66.57 -91.8 0.18 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.309 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -160.78 74.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.69 ' HG ' ' ND2' ' A' ' 38' ' ' ASN . 2.0 pt? -65.6 -33.62 76.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.69 ' ND2' ' HG ' ' A' ' 37' ' ' LEU . 17.6 p30 173.95 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.335 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -76.94 105.41 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.391 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -89.99 116.76 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -116.01 131.41 56.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -102.08 130.45 51.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.989 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -135.03 -168.32 2.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.94 61.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.616 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.623 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -74.07 -170.19 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.785 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HE3' ' OH ' ' A' ' 51' ' ' TYR . 18.8 mttt -137.98 150.79 68.56 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.54 122.38 8.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.38 -16.86 31.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.551 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.96 125.66 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 72' ' ' THR . 82.6 t -96.5 142.82 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.728 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 26.9 m-85 -109.93 124.8 52.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.811 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -89.74 156.22 18.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.0 152.24 21.3 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.446 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.35 132.27 41.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.862 HD13 HD12 ' A' ' 17' ' ' LEU . 27.1 tp -99.9 107.01 18.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.879 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.19 138.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.663 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -117.02 121.49 41.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 111.906 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.87 125.7 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.432 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.753 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -118.64 178.96 4.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -22.16 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.03 -4.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.56 23.89 59.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.753 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 7.4 m80 -67.28 173.03 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -148.1 89.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -101.01 116.16 32.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.269 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 p -130.77 139.23 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.241 0.543 . . . . 0.0 112.418 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.4 m -137.6 125.64 22.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.753 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 146.85 27.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.22 146.25 21.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 111.807 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -108.59 121.3 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.489 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -129.58 149.13 51.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 50' ' ' VAL . 71.2 p . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.442 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG21 ' HD2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -100.34 141.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.534 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -54.79 -49.08 71.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.297 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -167.86 144.25 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.016 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -116.56 135.69 53.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.123 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.639 ' O ' HD23 ' A' ' 55' ' ' LEU . 17.2 mm -114.68 135.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.178 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.54 114.96 25.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.962 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.758 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.6 mtp180 -114.55 129.18 56.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.775 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -145.0 154.92 43.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 111.749 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.45 152.46 18.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.794 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.0 Cg_exo -58.59 119.11 6.15 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.348 2.032 . . . . 0.0 112.291 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -23.61 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.405 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -98.62 -36.4 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 2.8 m -104.31 113.52 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.997 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 m -95.51 128.59 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.74 -57.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.566 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -167.84 151.55 6.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.767 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 30.9 m95 -87.89 -169.51 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttt -143.11 151.19 40.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -119.94 137.04 54.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.319 0.581 . . . . 0.0 112.455 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.23 111.34 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.856 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -90.3 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.079 0.466 . . . . 0.0 112.099 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.41 117.65 8.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.57 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.37 86.64 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.223 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.25 -98.91 1.66 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -165.24 94.25 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -82.95 -33.57 26.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -179.82 -161.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -86.46 106.22 17.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -89.11 113.44 24.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -108.94 138.03 45.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 17' ' ' LEU . 15.3 mt -105.97 117.23 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -115.74 129.36 56.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.33 8.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.715 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.753 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -79.95 -165.91 0.92 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.543 0.211 . . . . 0.0 110.614 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 49' ' ' VAL . 4.2 mttp -130.99 142.1 44.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.678 0.275 . . . . 0.0 111.424 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.4 Cg_exo -60.02 94.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.727 2.285 . . . . 0.0 111.908 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.29 -25.84 6.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 46' ' ' LYS . 6.4 t -92.98 128.25 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.671 0.272 . . . . 0.0 110.793 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 t -94.36 146.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CG ' HD12 ' A' ' 45' ' ' LEU . 12.9 m-85 -117.54 122.76 44.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.769 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.31 148.33 26.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.23 148.47 18.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.533 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 66' ' ' VAL . 2.3 tt0 -132.91 142.44 48.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -107.72 107.06 17.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.585 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.2 mp -96.88 137.64 24.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -110.49 132.27 54.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.306 0.574 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 14' ' ' LYS . 9.6 mt -113.39 121.67 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.898 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.742 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -114.41 176.58 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.99 -32.3 73.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -102.19 1.17 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.64 88.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.833 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.742 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 1.3 m-70 -98.32 -41.05 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 110.51 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' SER . 31.4 mt-30 66.5 80.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.751 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 10.4 tt0 -96.75 126.6 42.03 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -125.95 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -137.87 121.74 17.68 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.08 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.6 141.0 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.606 -179.346 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.443 ' HE2' HD12 ' A' ' 55' ' ' LEU . 2.0 p90 -155.88 154.32 31.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.376 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.29 127.59 50.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.543 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -146.65 152.99 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.435 0.636 . . . . 0.0 112.499 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.627 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.77 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.017 0.437 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.65 HG21 ' OG ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -104.28 157.42 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.65 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -51.08 -37.58 46.56 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.69 ' HD2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -167.73 143.35 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.905 178.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.751 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.12 133.2 56.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.814 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.782 HG21 HH11 ' A' ' 18' ' ' ARG . 4.1 mp -114.45 138.39 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.078 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -113.1 114.62 27.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.214 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -118.21 128.17 54.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.467 ' CE3' HD23 ' A' ' 17' ' ' LEU . 10.2 p90 -153.31 155.09 35.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 112.537 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.35 161.75 26.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.354 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.5 Cg_exo -57.72 113.92 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.283 1.988 . . . . 0.0 112.353 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -60.1 -27.82 67.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.12 -37.01 64.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 t -94.68 -159.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.59 136.59 43.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.25 -163.37 54.49 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.881 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 61.45 58.02 2.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.348 . . . . 0.0 111.416 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 55.3 m95 -79.43 179.21 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.504 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mttt -142.7 145.19 33.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.21 129.16 53.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 112.232 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.02 111.27 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.931 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.3 m -97.52 123.07 41.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 112.297 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -123.08 110.76 30.94 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' HD21 ' A' ' 37' ' ' LEU . 23.8 Cg_exo -63.69 101.52 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.257 1.971 . . . . 0.0 111.621 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.3 -91.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.829 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.21 101.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.938 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.668 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -81.05 -33.31 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.937 0.399 . . . . 0.0 110.405 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -174.0 -168.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.438 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -77.09 105.85 8.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.551 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 109.92 21.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.38 127.85 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.72 122.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -131.77 122.47 25.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.12 25.41 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 51' ' ' TYR . 2.4 mm? -76.32 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.533 0.206 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.713 ' HD3' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.4 152.23 59.96 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 120.732 0.301 . . . . 0.0 110.745 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 137.43 19.9 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.561 2.174 . . . . 0.0 112.517 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.02 -15.37 63.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.699 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 ' HD3' ' A' ' 46' ' ' LYS . 6.3 p -119.55 134.89 61.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 72' ' ' THR . 96.2 t -104.32 140.72 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.441 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.3 m-85 -105.93 119.36 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.191 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG2' HH21 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -85.44 138.37 32.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.87 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.57 146.31 16.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.873 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.4 136.8 45.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 17' ' ' LEU . 1.5 mt -101.71 106.67 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.6 mp -94.82 119.53 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.65 ' OG ' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -103.63 130.31 51.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.197 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -113.35 128.78 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.569 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.5 OUTLIER -116.04 -178.02 3.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.02 -8.62 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.02 -4.67 46.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.59 31.44 54.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 8.6 m80 -89.42 -178.58 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 110.744 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' SER . 1.4 mt-30 -149.32 104.83 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.523 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.6 tm-20 -96.99 125.66 41.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -131.45 134.08 61.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -137.2 122.51 19.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.13 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -84.54 147.28 27.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.348 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.37 141.49 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.99 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -114.08 123.33 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.294 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -141.65 151.7 43.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.988 0.423 . . . . 0.0 111.657 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.686 HG21 HG22 ' A' ' 50' ' ' VAL . 20.7 p . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.684 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.448 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.811 0.338 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -103.41 149.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.237 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -52.69 -47.28 67.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.013 179.215 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' NZ ' HD12 ' A' ' 58' ' ' ILE . 7.6 ptmt -159.3 143.84 15.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.201 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -119.62 132.08 55.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.922 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HD23 ' A' ' 55' ' ' LEU . 19.7 mm -114.07 132.97 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 111.01 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.55 114.37 27.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.979 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 18.5 mtt180 -115.94 128.76 56.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.586 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' A' ' 17' ' ' LEU . 14.2 p90 -152.71 160.02 43.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.463 0.649 . . . . 0.0 112.016 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG2' ' CE2' ' A' ' 28' ' ' TRP . 3.6 ppt_? -159.42 160.01 28.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.999 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.4 Cg_exo -57.88 117.38 4.08 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.227 1.951 . . . . 0.0 112.42 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -60.28 -38.81 84.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.49 -27.15 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -96.96 -164.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.76 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.03 114.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.18 -179.65 24.93 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.826 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 60.58 88.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.911 0.386 . . . . 0.0 111.159 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.429 ' CE2' ' HG2' ' A' ' 20' ' ' ARG . 43.0 m95 -101.05 -176.53 3.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.2 tttt -151.21 147.53 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.963 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.42 138.87 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.774 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -137.75 111.76 8.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.274 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -89.29 137.89 31.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 111.859 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.21 109.74 8.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.324 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 57.9 Cg_endo -70.87 87.39 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 112.8 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 52.78 39.16 54.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.605 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.89 84.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.026 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' HG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -69.32 -33.56 73.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.443 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.466 ' H ' HD12 ' A' ' 37' ' ' LEU . 9.3 p-10 177.66 -154.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.702 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.4 t -77.15 105.11 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -97.02 127.51 43.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -99.33 147.43 25.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.697 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.49 137.67 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.233 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.4 138.54 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.47 130.35 38.12 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.149 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.7 mm? -85.3 -136.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HE2' ' HB ' ' A' ' 49' ' ' VAL . 16.4 tttt -136.79 117.65 11.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.504 0.193 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.09 112.33 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.567 2.178 . . . . 0.0 112.072 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.18 -24.66 6.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.352 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HB ' ' HE2' ' A' ' 46' ' ' LYS . 7.1 p -118.06 137.42 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 72' ' ' THR . 46.7 t -97.09 139.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.517 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 24.8 m-85 -105.26 128.92 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.624 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.38 137.81 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.036 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.03 157.04 27.19 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.823 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.4 143.23 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -107.46 106.14 16.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.134 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD13 ' HD2' ' A' ' 18' ' ' ARG . 4.6 mp -92.26 138.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.132 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -121.0 119.36 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.733 -178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' NZ ' ' A' ' 14' ' ' LYS . 1.1 mt -114.34 127.84 71.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.067 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 61' ' ' TYR . 10.3 pt20 -118.41 -177.39 3.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.985 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.37 -4.62 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 7.6 m-85 -101.27 -5.04 26.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.09 16.02 68.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.198 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -67.31 174.84 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.809 0.305 . . . . 0.0 110.601 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 63' ' ' HIS . 3.0 mm-40 -152.16 95.02 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -97.52 117.99 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.063 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.1 p -127.82 134.04 66.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.8 m -137.53 121.53 17.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 138.95 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.958 0.408 . . . . 0.0 111.476 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.12 157.41 43.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -119.95 121.35 38.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -147.14 159.82 43.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.228 0.537 . . . . 0.0 111.986 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.973 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p80 . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -67.54 155.61 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.733 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 74.9 m -54.09 -39.05 66.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.612 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' H ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -157.14 144.81 18.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.088 0.47 . . . . 0.0 111.37 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.33 126.33 44.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.011 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.6 mt -112.54 135.48 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -105.56 115.27 29.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.775 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.744 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.7 mmm180 -110.06 134.56 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 29' ' ' LYS . 4.3 p90 -161.44 150.45 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.143 0.496 . . . . 0.0 111.609 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.626 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -159.43 152.8 18.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.904 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 51.2 Cg_exo -58.66 117.2 3.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.51 2.14 . . . . 0.0 112.621 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -33.38 74.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.036 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' HG13 ' A' ' 49' ' ' VAL . 8.1 t-20 -92.43 -43.68 9.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.74 -164.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.101 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.51 163.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.7 26.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.38 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 59.56 -179.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.199 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 29.5 m95 -92.77 -178.81 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.85 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.703 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.6 OUTLIER -120.14 133.66 55.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.167 0.508 . . . . 0.0 112.181 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.98 110.83 9.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.83 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 39.8 m -90.95 139.55 30.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.81 HG22 HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.23 106.98 6.7 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.886 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_endo -60.28 90.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.73 60.57 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 57.94 85.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -80.91 -31.97 34.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.505 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 4.7 p-10 -166.76 -170.98 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.57 118.97 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.86 125.52 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.676 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 t -107.76 147.7 30.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.375 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.06 137.46 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.802 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -48.7 155.73 0.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 129.04 49.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.491 HD12 ' CD1' ' A' ' 51' ' ' TYR . 2.9 mm? -74.71 -136.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.5 ttmm -153.38 134.6 8.43 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 21.0 Cg_exo -65.09 117.01 4.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 112.25 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.26 54.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 23' ' ' ASN . 2.2 t -118.86 131.36 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.653 ' HA ' HG22 ' A' ' 72' ' ' THR . 41.3 t -99.92 136.45 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.641 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD1' HD12 ' A' ' 45' ' ' LEU . 22.1 m-85 -105.96 118.91 37.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 18.8 pt-20 -80.07 137.89 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 147.49 19.0 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.854 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' OE1' HD11 ' A' ' 56' ' ' ILE . 1.4 tt0 -132.97 150.54 52.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' ILE . 30.1 tp -123.93 110.19 14.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 111.588 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 6.0 mt -97.52 138.35 22.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.609 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -114.2 121.73 44.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' C ' HD11 ' A' ' 12' ' ' ILE . 2.4 mt -111.79 124.58 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.11 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.45 178.36 4.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.47 -14.57 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -101.35 -4.53 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.39 64.22 4.44 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.652 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 61.42 87.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.443 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.609 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.257 179.145 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG13 ' HG3' ' A' ' 54' ' ' GLN . 16.3 t -134.07 136.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m -138.09 121.13 16.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.605 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 68' ' ' ARG . 5.0 mtt180 -91.86 146.16 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 111.87 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -156.17 146.49 21.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.212 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -114.41 133.08 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 45' ' ' LEU . 34.6 p90 -144.5 148.36 34.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 112.253 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 50' ' ' VAL . 16.2 p . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.974 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.265 0.078 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -98.37 143.16 13.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.844 0.355 . . . . 0.0 111.186 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -60.19 -46.83 88.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.155 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 143.97 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.064 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -111.82 135.29 52.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.24 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 58' ' ' ILE . 3.3 mp -114.15 133.09 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 110.467 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' HG ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.24 114.29 25.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.269 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.801 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -115.63 127.96 55.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 28' ' ' TRP . 20.7 p90 -144.86 161.37 39.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.953 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -156.54 150.85 19.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.7 Cg_exo -57.54 125.52 19.04 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.363 2.042 . . . . 0.0 112.719 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.503 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 37.9 tttp -76.66 -38.61 54.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.129 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -84.12 -39.58 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -98.3 142.95 29.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.785 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.54 132.33 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.973 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.39 -142.41 3.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -114.89 175.96 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.854 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 30.7 m95 -89.46 -167.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.5 mttp -152.38 155.9 38.5 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -122.17 130.39 53.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.512 . . . . 0.0 112.061 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.3 111.12 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.102 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 99.7 m -90.04 141.07 29.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 112.0 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.507 HG13 ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -138.24 107.65 8.01 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.221 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HG2' HD22 ' A' ' 37' ' ' LEU . 36.4 Cg_endo -65.25 92.72 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.456 2.104 . . . . 0.0 112.093 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -98.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -165.75 70.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.702 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 37' ' ' LEU . 1.5 pt? -72.27 -33.03 67.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 2.4 p-10 -164.33 -179.73 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t -79.74 108.48 13.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.09 110.3 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.666 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -115.58 144.88 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.77 125.38 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.986 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -119.36 153.41 35.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 45' ' ' LEU . . . 126.65 13.31 3.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -104.14 -166.11 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.51 0.195 . . . . 0.0 110.614 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.24 156.14 20.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.566 0.222 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.34 104.76 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.478 2.119 . . . . 0.0 112.002 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.86 -14.66 4.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.043 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.4 t -116.26 124.99 73.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 72' ' ' THR . 89.6 t -110.23 133.36 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' CE1' HD22 ' A' ' 45' ' ' LEU . 57.6 m-85 -109.3 126.55 53.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.93 131.4 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.79 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 19' ' ' TRP . . . -139.68 161.87 26.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.614 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.754 ' HG3' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -134.58 152.78 52.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.886 0.474 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.0 mt -124.18 106.87 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.543 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CD ' ' A' ' 18' ' ' ARG . 87.3 mt -94.46 138.53 20.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.275 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.597 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.73 119.14 32.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.288 0.566 . . . . 0.0 111.345 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.692 HD12 HD13 ' A' ' 16' ' ' ILE . 28.9 mt -114.15 125.19 71.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.764 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.34 173.37 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 5.1 pt20 -65.83 -18.45 65.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.226 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -102.25 9.64 39.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.78 -114.28 4.95 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.801 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.54 -174.91 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.962 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.66 99.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.34 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 5.0 tt0 -96.81 116.33 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.8 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' GLN . 1.2 p -131.17 131.18 63.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.3 m -137.72 125.09 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.326 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.58 147.1 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.28 . . . . 0.0 110.746 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' HZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -155.96 155.61 33.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.006 0.432 . . . . 0.0 111.64 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -116.75 133.44 56.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -147.86 150.72 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.293 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -67.48 149.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.974 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -55.33 -50.58 69.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.248 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.6 pttt -171.12 144.8 2.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.629 ' CD1' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -102.03 154.23 19.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.738 179.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.73 147.77 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 111.376 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -134.0 109.32 8.91 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.339 176.336 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.761 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 6.0 mtp180 -122.84 127.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 5.6 p90 -161.08 159.68 29.49 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.354 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.95 165.92 17.47 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.343 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -54.29 115.88 2.68 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 121.283 1.322 . . . . 0.0 112.619 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB3' HG13 ' A' ' 50' ' ' VAL . 6.3 tptm -34.05 -53.6 0.47 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.79 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -101.67 -44.41 5.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.866 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.42 ' C ' ' HB2' ' A' ' 21' ' ' PRO . 47.0 t -76.61 -177.24 4.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.94 132.18 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.15 34.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.522 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.58 139.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.421 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 62.0 m95 -60.3 167.08 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.723 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -132.29 158.91 40.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 30' ' ' GLU . 10.5 pm0 -138.11 127.92 25.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.356 0.598 . . . . 0.0 112.431 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 17' ' ' LEU . . . -143.14 122.47 13.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -107.47 120.97 43.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.702 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.63 107.26 34.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.559 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.7 Cg_endo -72.67 110.75 3.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.316 2.011 . . . . 0.0 112.42 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.47 -120.78 23.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.508 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -143.73 68.52 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -65.64 -33.03 74.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.928 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -174.42 -172.42 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.9 m -85.2 105.74 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -93.5 107.56 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.484 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.92 140.38 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.423 HD13 ' HZ ' ' A' ' 71' ' ' PHE . 2.3 mp -100.18 130.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.71 75.77 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.113 0.483 . . . . 0.0 111.287 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.725 ' H ' HD12 ' A' ' 45' ' ' LEU . . . -150.4 11.0 0.86 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.285 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.78 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -124.82 -152.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.755 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 160.52 162.0 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 123.728 0.643 . . . . 0.0 110.492 178.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 11.3 Cg_endo -54.31 -6.9 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.544 2.163 . . . . 0.0 112.123 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.63 -46.57 4.25 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.955 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.656 ' O ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -113.78 136.87 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 111.544 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 22' ' ' LYS . 3.0 p -103.02 117.57 48.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' HD23 ' A' ' 45' ' ' LEU . 30.4 m-85 -102.05 125.88 48.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.788 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 2.1 tt0 -78.7 126.73 31.13 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.654 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -115.29 159.6 13.69 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.062 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.2 tt0 -133.48 114.46 13.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.0 111.762 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -101.36 106.2 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.976 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 51.2 mt -116.49 120.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.716 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.52 138.18 35.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.902 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.8 mp -117.71 130.6 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.46 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.99 -176.58 6.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.04 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 4.5 pt20 -61.05 -30.59 70.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.913 0.387 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.488 ' N ' ' HG3' ' A' ' 60' ' ' GLN . 2.1 p90 -103.24 -4.64 24.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 105.83 156.99 22.17 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.669 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 22.2 m80 65.97 135.97 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.362 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.643 ' HB2' ' O ' ' A' ' 57' ' ' SER . 1.9 mm-40 -166.49 -57.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.769 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tp10 -145.51 144.6 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.511 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.7 t -134.77 121.69 35.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.72 0.295 . . . . 0.0 111.779 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 121.69 17.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.23 121.81 45.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.735 0.303 . . . . 0.0 111.132 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -151.97 131.56 13.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.627 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.788 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.9 p30 -92.95 138.73 31.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.423 ' HZ ' HD13 ' A' ' 42' ' ' ILE . 28.8 p90 -141.31 161.89 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.366 . . . . 0.0 111.872 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.902 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 121.133 0.492 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.688 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.3 tp -84.51 153.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.1 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.678 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -56.52 -45.32 81.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.48 144.04 8.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.778 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.2 156.61 17.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.505 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -120.78 148.42 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.355 0.598 . . . . 0.0 111.347 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.468 ' H ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -133.06 109.85 9.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.745 176.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.798 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt180 -118.37 127.84 54.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.2 p90 -161.35 153.65 20.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 117.901 -1.52 . . . . 0.0 114.904 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.83 164.07 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.025 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -56.73 110.63 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 121.584 1.523 . . . . 0.0 112.588 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 50' ' ' VAL . 9.0 tptt -30.79 -47.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.379 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 -44.06 7.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.807 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -79.51 82.71 5.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 110.842 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.92 145.32 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.76 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -134.28 125.01 26.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.953 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.484 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 68.1 m95 -64.12 171.48 2.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.1 mttt -120.96 162.92 19.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -134.48 123.92 24.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.098 0.475 . . . . 0.0 112.031 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.92 111.78 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.97 118.16 35.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 111.405 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.033 HG22 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -132.75 111.51 13.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.463 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.8 Cg_exo -46.61 160.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.64 2.227 . . . . 0.0 113.024 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.24 105.05 0.28 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.664 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 44.17 39.08 2.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.7 -16.61 61.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.839 0.352 . . . . 0.0 110.546 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.709 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -172.57 169.62 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -83.57 106.3 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -117.79 120.04 36.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 m -116.38 146.45 42.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG21 ' HZ ' ' A' ' 71' ' ' PHE . 2.5 mp -94.95 117.66 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.44 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.51 61.77 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.187 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.44 -17.23 4.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.888 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -92.43 137.78 32.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.408 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 49' ' ' VAL . 15.7 pttt -104.01 161.5 22.74 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.333 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -55.83 96.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.252 1.968 . . . . 0.0 112.832 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.37 -9.49 3.5 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.847 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' HB ' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -120.55 138.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.313 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 22' ' ' LYS . 2.4 p -112.62 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.211 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 34.1 m-85 -105.39 124.9 50.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.25 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 1.017 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 10.3 tt0 -79.53 126.6 31.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -112.98 156.63 15.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.583 ' NE2' HD11 ' A' ' 56' ' ' ILE . 60.3 tt0 -132.7 114.58 14.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.226 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -100.54 106.18 17.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 77.0 mt -116.9 121.26 67.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.4 m -82.22 135.98 35.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.501 . . . . 0.0 110.071 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.688 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.7 mt -117.03 132.38 66.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.021 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.723 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -95.2 -175.68 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.321 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.4 ' OE1' ' HB3' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -60.41 -27.43 67.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 12.2 p90 -103.31 -5.49 22.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.747 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.688 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 97.87 151.87 27.76 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.921 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 66.2 129.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 111.447 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 5.7 mm100 -156.53 -51.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.26 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.6 tt0 -144.11 145.15 31.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 56' ' ' ILE . 58.0 t -134.62 123.25 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.277 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -137.34 120.5 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.939 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -112.9 118.42 34.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.68 137.49 13.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.661 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 1.017 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 16.1 p-10 -92.3 135.28 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.152 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.494 ' HZ ' HG21 ' A' ' 42' ' ' ILE . 9.1 p90 -140.82 162.97 34.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.063 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.439 -0.982 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.02 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.437 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 4.5 p-80 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.689 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -96.79 151.36 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.689 ' N ' HG13 ' A' ' 12' ' ' ILE . 20.3 m -49.74 -49.25 48.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -168.47 144.16 3.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.103 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -106.7 156.97 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.715 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.66 147.61 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -133.34 109.61 9.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.606 177.016 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.17 127.15 44.07 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.696 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -162.54 164.6 26.79 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.449 -1.3 . . . . 0.0 114.117 -176.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 138.01 10.2 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 113.681 -1.6 . . . . 0.0 108.219 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 13.9 Cg_endo -55.57 109.34 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.172 1.915 . . . . 0.0 111.37 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.721 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -49.79 -59.22 4.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.808 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -62.77 -43.94 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.303 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -103.3 67.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.806 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -47.05 137.8 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.345 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.14 -82.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -154.17 148.77 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -67.11 170.68 6.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.3 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.8 tptt -138.0 165.8 25.66 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.3 pt-20 -142.32 126.28 17.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.901 0.381 . . . . 0.0 111.808 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.92 129.69 21.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -105.09 119.5 39.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 111.538 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -116.81 106.67 47.53 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.548 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 9.7 Cg_exo -72.0 97.64 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.683 2.255 . . . . 0.0 113.044 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 45.15 44.83 9.89 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.217 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 56.15 79.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.3 -32.9 72.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.776 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -165.3 -164.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.638 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.26 105.65 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -122.99 107.85 12.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.35 147.36 45.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.554 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.628 HD12 ' HZ ' ' A' ' 71' ' ' PHE . 14.8 mt -90.77 137.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 149.59 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.254 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 113.55 23.46 5.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -125.61 171.95 10.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.526 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HG2' HG23 ' A' ' 49' ' ' VAL . 4.8 pttt -178.35 165.7 1.12 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 92.3 Cg_exo -47.61 -22.98 3.3 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.587 2.191 . . . . 0.0 112.218 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.51 -36.2 17.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.405 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -114.2 124.22 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 120.992 0.425 . . . . 0.0 111.782 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' A' ' 22' ' ' LYS . 1.8 p -102.04 131.22 50.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m-85 -112.18 119.21 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.518 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -78.98 127.77 32.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -127.71 158.1 21.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.898 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.7 tt0 -133.63 121.18 21.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.552 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 6.0 mt -110.22 106.84 16.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.024 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.728 ' H ' HG22 ' A' ' 16' ' ' ILE . 32.4 mt -112.55 119.6 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.897 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.663 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.63 135.04 35.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.357 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.5 mp -117.33 132.16 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.897 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.82 -176.78 5.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.487 179.024 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -63.61 -30.28 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.578 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -102.6 1.07 34.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 101.46 150.23 23.52 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.028 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 65.83 144.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 111.578 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -169.2 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.072 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -144.56 144.08 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.612 -178.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 56' ' ' ILE . 84.7 t -133.91 114.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -137.1 120.3 16.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -112.22 133.98 54.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.94 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 4.4 p90 -156.56 154.83 30.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.932 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -100.88 122.0 42.69 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.628 ' HZ ' HD12 ' A' ' 42' ' ' ILE . 2.4 p90 -138.62 163.8 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.387 0.613 . . . . 0.0 111.826 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.432 ' HA ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.693 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.6 OUTLIER -75.33 145.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.9 t -53.02 -44.96 67.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.88 0.372 . . . . 0.0 110.106 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.7 pttt -175.8 146.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.964 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -101.38 154.37 18.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.605 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -114.89 147.96 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.408 0.623 . . . . 0.0 112.037 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -132.14 109.53 10.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.536 176.045 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -117.93 127.47 53.88 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.668 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -158.66 159.98 35.96 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.435 -1.306 . . . . 0.0 113.405 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HG3' ' CE3' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -157.46 155.84 28.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.194 178.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 17.1 Cg_endo -54.08 109.79 0.43 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 122.347 2.032 . . . . 0.0 111.202 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB3' HG13 ' A' ' 50' ' ' VAL . 1.1 tmtp? -45.83 -55.27 6.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.205 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.55 -43.87 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.799 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 8.5 t -71.07 150.89 45.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.988 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.97 135.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.031 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.39 -159.85 22.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.55 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 14.6 ptp180 -116.75 164.25 14.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.49 ' CE3' ' HG3' ' A' ' 20' ' ' ARG . 60.7 m95 -66.46 167.79 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.52 160.08 37.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.03 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 123.79 24.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 111.969 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.44 112.4 7.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.107 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 130.42 44.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 112.193 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.86 HG22 HD11 ' A' ' 37' ' ' LEU . 1.1 pt -137.2 106.44 8.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.672 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 85.5 Cg_endo -81.92 122.0 3.75 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 35.46 7.48 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.375 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 50.48 78.25 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.986 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.21 -30.62 71.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.495 ' H ' HD12 ' A' ' 37' ' ' LEU . 12.1 t-20 -168.26 174.88 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -77.09 105.12 7.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.219 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -115.57 117.05 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.613 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 141.86 47.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.409 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 17' ' ' LEU . 2.8 mp -86.76 134.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.882 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.47 53.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.51 2.63 24.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.281 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -108.41 129.35 55.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.388 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -111.52 163.34 17.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.542 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -49.82 95.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.639 2.226 . . . . 0.0 112.671 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.21 -6.73 5.37 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.778 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -120.77 138.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.737 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.8 p -115.13 133.96 59.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.502 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 45' ' ' LEU . 17.3 m-85 -116.43 130.03 56.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.583 0.23 . . . . 0.0 111.331 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 37.8 tt0 -88.27 127.8 35.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -117.09 155.24 16.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.704 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 30.5 tt0 -132.27 114.45 14.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 4.9 mt -103.12 106.77 17.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.111 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLU . 96.7 mt -117.09 122.67 70.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.0 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.25 134.73 35.65 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 16' ' ' ILE . 1.7 mp -120.26 130.7 74.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.693 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 4.7 mm100 -126.12 -174.02 3.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -6.6 27.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.828 0.347 . . . . 0.0 111.011 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -103.05 -4.76 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.707 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.39 161.93 5.87 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.805 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.1 t60 66.69 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.693 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 59.65 -95.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.571 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.65 144.27 51.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.869 -178.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.65 126.3 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.15 124.46 21.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 125.6 54.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.241 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.445 ' CE1' HD12 ' A' ' 55' ' ' LEU . 16.3 p90 -156.31 127.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 111.928 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.777 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.56 133.32 39.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.978 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -140.95 163.69 32.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.617 0.722 . . . . 0.0 112.515 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.968 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.554 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.034 0.445 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.928 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -95.07 154.02 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.414 179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.718 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.2 m -46.26 -41.07 12.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 17.1 pttt -174.2 143.5 0.89 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.562 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -101.41 147.36 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -115.04 148.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 121.183 0.516 . . . . 0.0 111.219 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -126.03 109.35 12.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.005 176.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.2 mtt-85 -118.2 125.87 51.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.712 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -156.2 157.01 35.14 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 117.878 -1.529 . . . . 0.0 114.133 -176.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.76 151.76 17.05 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.871 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 54.2 Cg_exo -53.61 108.64 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 120.888 1.058 . . . . 0.0 111.242 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' H ' ' H ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -21.9 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.896 -179.15 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -44.15 6.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.226 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.31 67.52 9.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.289 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -53.82 124.17 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.882 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.09 76.23 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.697 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 27' ' ' ARG . 6.5 mtt-85 65.08 125.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 0.0 111.544 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -62.28 166.96 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.779 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mmpp? -127.33 152.83 46.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.17 124.26 34.18 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -142.94 111.66 6.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.981 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 111.88 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -138.58 106.92 7.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.184 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 61.3 Cg_endo -72.29 111.87 3.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.234 1.956 . . . . 0.0 113.1 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.75 11.45 36.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.173 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.18 84.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.7 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.0 -18.35 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.765 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' OD1' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -160.48 -178.71 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.726 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.97 105.82 9.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -99.69 105.68 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -122.07 146.03 47.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.225 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.02 134.33 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -108.63 -4.89 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.909 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.48 -63.08 5.4 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.394 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.763 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.748 0.419 . . . . 0.0 111.333 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -102.78 157.39 33.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.557 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 1.1 Cg_endo -42.37 104.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.383 2.722 . . . . 0.0 113.351 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.47 -12.02 8.43 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.447 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 46' ' ' LYS . 8.1 p -120.85 139.35 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.827 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.5 p -111.26 128.42 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.818 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.871 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 21.3 m-85 -107.55 120.36 41.98 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.003 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.931 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 14.8 tt0 -80.13 127.08 31.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -116.04 152.63 17.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mt-30 -130.9 117.06 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 111.602 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.2 mt -100.22 106.27 17.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.17 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.9 mp -109.44 113.92 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.742 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.928 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.1 m -87.58 121.23 29.76 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.192 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 64' ' ' GLN . 1.9 mt -114.6 133.32 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.408 0.623 . . . . 0.0 112.577 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.639 ' H ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -96.6 -174.89 3.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.741 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.64 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.24 4.14 36.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.716 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 58' ' ' ILE . . . 92.53 -133.41 11.72 Favored Glycine 0 N--CA 1.454 -0.128 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.869 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -43.83 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.887 0.375 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.712 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . 46.3 tp60 -110.45 -52.56 2.77 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 56' ' ' ILE . 1.8 mm-40 -146.52 144.95 29.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 111.243 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -135.96 131.78 49.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.67 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.91 126.39 23.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.057 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -112.69 123.66 50.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.559 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -155.62 126.89 7.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.463 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.931 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -93.33 139.0 31.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.091 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -145.27 159.51 42.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.428 0.632 . . . . 0.0 111.979 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.827 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.724 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.299 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.927 0.394 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -79.52 148.45 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' HG13 ' A' ' 12' ' ' ILE . 66.2 m -49.51 -45.73 47.57 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 1.1 pttt -170.77 143.46 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.093 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -107.85 147.18 31.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.594 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.571 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -115.72 145.08 21.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 179.118 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -122.93 111.83 17.1 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -117.86 128.6 54.99 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.739 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -159.46 162.97 35.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.996 0.903 . . . . 0.0 113.301 -178.233 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.578 HH12 ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -159.6 144.24 11.19 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.761 178.36 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 10.8 Cg_endo -54.61 112.43 1.01 Allowed 'Trans proline' 0 C--N 1.335 -0.142 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' HH12 ' A' ' 20' ' ' ARG . 6.0 tptt -51.6 -34.28 36.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.223 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -98.29 -44.06 6.71 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.275 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -79.6 127.4 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.398 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.4 p -72.52 115.06 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.932 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.24 -169.32 20.93 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.35 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -64.6 176.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -136.79 159.99 40.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.582 179.297 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -141.79 128.52 20.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.44 . . . . 0.0 111.295 -179.751 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.02 114.44 8.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -93.77 115.58 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 111.823 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.67 107.55 33.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.027 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 28.1 Cg_exo -61.07 90.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.312 2.008 . . . . 0.0 112.925 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.8 52.9 6.48 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.225 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 t60 52.63 60.8 3.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -65.86 -22.27 66.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.538 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.617 ' HB3' HD22 ' A' ' 37' ' ' LEU . 3.4 p-10 -170.53 -171.84 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.2 105.46 9.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -97.97 130.19 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -101.37 148.01 25.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.184 0.516 . . . . 0.0 112.259 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 44' ' ' GLY . 18.7 mt -94.28 138.58 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.653 179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HD2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -32.97 -41.67 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.015 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 120.74 114.36 2.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.189 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.523 HD12 ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -100.63 122.84 43.97 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.704 0.288 . . . . 0.0 110.499 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.748 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -83.76 135.13 43.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.95 -178.816 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 3.4 Cg_exo -39.15 144.4 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.982 3.121 . . . . 0.0 114.537 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.27 -5.85 68.23 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.055 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.4 138.13 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.831 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.1 p -97.38 122.44 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 45' ' ' LEU . 38.2 m-85 -110.75 133.48 53.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -97.49 129.12 44.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.018 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -124.12 150.88 17.06 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.778 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 44.4 tt0 -132.62 144.42 50.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 111.482 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD12 ' HG ' ' A' ' 17' ' ' LEU . 1.3 mp -123.06 107.66 12.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.409 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.571 ' HB ' HG22 ' A' ' 16' ' ' ILE . 82.0 mt -114.0 117.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.744 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -82.21 138.5 34.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.389 0.614 . . . . 0.0 111.025 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG23 ' HA2' ' A' ' 62' ' ' GLY . 4.2 mt -118.16 132.24 68.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.951 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.69 -176.41 3.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 178.657 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.41 -29.92 70.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -103.08 -1.55 28.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 95.22 155.47 31.39 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 75.3 t60 65.94 126.55 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.699 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 2.9 mm-40 -155.6 -56.96 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.6 tt0 -145.4 143.82 30.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.436 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.88 115.79 19.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.299 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m -136.15 121.58 19.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.291 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.17 139.62 43.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.38 135.97 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 4.1 p-10 -95.94 137.47 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 50' ' ' VAL . 29.4 p90 -141.43 165.57 27.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 18.1 p . . . . . 0 C--N 1.32 -0.705 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.748 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 6.5 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.736 HG13 ' N ' ' A' ' 13' ' ' SER . 0.6 OUTLIER -88.44 152.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.051 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.736 ' N ' HG13 ' A' ' 12' ' ' ILE . 39.0 t -52.32 -45.21 65.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.065 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.798 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 21.4 pttt -174.6 144.53 0.86 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.685 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.16 157.22 17.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.876 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.64 147.7 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 121.181 0.515 . . . . 0.0 111.181 179.473 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -128.2 110.42 12.4 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.626 176.525 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.776 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.5 mtp-105 -122.37 125.63 46.32 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.561 ' CB ' ' HA2' ' A' ' 53' ' ' GLY . 2.0 p90 -162.89 153.3 16.45 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.356 -177.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -159.95 162.72 24.0 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.766 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 15.2 Cg_endo -56.75 124.03 15.27 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 C-N-CA 122.656 2.238 . . . . 0.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 54.3 tttt -67.32 -44.03 80.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.883 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -89.75 -36.55 15.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.962 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 3.1 m -85.08 -18.17 35.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.501 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 25' ' ' VAL . 5.7 p 33.62 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.296 0.57 . . . . 0.0 112.102 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . -108.33 -106.8 3.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.901 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 152.87 36.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -74.8 150.94 39.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.252 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.776 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -121.84 140.43 52.39 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.967 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -122.23 128.84 51.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.64 115.39 9.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.674 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.37 118.19 33.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 111.331 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -129.84 112.27 17.44 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.2 Cg_exo -52.11 175.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.672 2.248 . . . . 0.0 112.481 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . -43.17 94.86 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.18 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 35' ' ' GLY . 1.1 p-80 22.75 72.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.358 0.663 . . . . 0.0 112.613 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -69.23 -30.29 68.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.328 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 37' ' ' LEU . 3.4 p-10 -174.25 -163.41 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -90.81 105.82 18.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.019 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -116.73 113.1 22.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -128.69 146.57 50.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.8 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -165.1 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 0.0 111.563 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.14 25.5 75.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.683 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.535 HD22 ' HE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -125.2 -178.68 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.189 -179.538 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 142.04 35.71 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.95 104.37 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.566 2.177 . . . . 0.0 111.977 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.66 -13.95 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.378 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.52 139.62 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 117.195 0.497 . . . . 0.0 111.441 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.494 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -76.59 146.29 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.111 0.481 . . . . 0.0 109.964 178.488 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HE2' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -143.98 101.05 3.67 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.093 -179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.4 pt-20 -77.58 126.81 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.962 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -126.35 152.03 18.17 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.632 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -134.8 141.62 46.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 111.583 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 1.5 mt -121.38 106.21 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.663 178.584 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.667 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.6 mp -116.01 118.34 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.781 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -82.03 133.63 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.573 0.701 . . . . 0.0 111.144 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.28 133.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.594 ' HB2' ' CG ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -117.12 -175.45 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.29 178.465 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -63.92 -13.63 47.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.473 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -103.15 -4.97 23.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 143.87 0.88 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.511 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 60.48 107.38 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.645 0.26 . . . . 0.0 110.981 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.671 ' HB2' ' O ' ' A' ' 57' ' ' SER . 23.6 mm100 -129.85 -67.19 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.96 146.67 50.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.99 -178.537 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.77 126.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.293 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.15 132.38 41.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 117.43 33.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -144.47 126.92 15.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.747 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.8 122.14 42.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 51' ' ' TYR . 38.2 p90 -122.71 162.86 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.309 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 50' ' ' VAL . 7.0 p . . . . . 0 C--N 1.329 -0.291 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.9 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.597 0.236 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.2 tt -67.26 148.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.462 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.7 t -51.24 -48.02 62.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -175.4 149.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.763 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.5 m-85 -102.19 136.64 41.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.37 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.87 122.88 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 111.633 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -108.25 114.73 28.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 179.034 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.723 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.7 mtt180 -116.93 128.77 55.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.815 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -150.35 153.39 35.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.706 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.57 159.03 29.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.364 -179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.7 114.05 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.095 1.864 . . . . 0.0 111.745 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -32.13 73.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -38.3 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.39 170.43 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.88 136.45 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.846 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.98 33.41 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.979 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.66 173.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 111.519 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 67.6 m95 -90.15 -171.47 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -142.35 145.43 33.91 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.474 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -120.4 133.31 55.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.269 0.556 . . . . 0.0 112.139 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.08 112.19 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.98 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 38.8 m -89.35 137.72 32.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 112.474 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -132.81 106.25 12.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.381 178.056 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.95 100.32 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.408 2.072 . . . . 0.0 112.383 -179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.88 -90.17 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -177.18 79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.744 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.7 -33.22 66.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -173.4 -165.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.05 118.32 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -103.55 113.26 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 t -121.7 134.0 54.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HD22 ' A' ' 17' ' ' LEU . 6.9 mt -98.02 116.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -121.46 134.09 55.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 25.92 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -101.35 175.02 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 21.8 mtmt -98.23 124.74 46.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 14.5 Cg_exo -69.0 4.69 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.777 2.318 . . . . 0.0 112.365 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 -30.45 6.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.652 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.62 134.23 63.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.22 146.97 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.415 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 74.2 m-85 -118.51 107.74 14.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.76 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 18.3 pt-20 -79.7 130.39 35.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.379 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -133.01 153.94 20.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.191 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.3 mt-30 -133.64 134.01 42.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.639 0.257 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.19 106.97 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 110.365 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' HD2' ' A' ' 18' ' ' ARG . 5.2 mp -105.46 115.31 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.815 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.602 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -86.0 119.75 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 8.4 mt -109.67 112.29 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.253 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -89.45 -177.24 5.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.572 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -68.07 -14.86 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.603 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -101.46 0.9 37.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.766 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 112.4 177.34 19.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.92 144.34 39.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.578 0.228 . . . . 0.0 110.596 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.4 2.77 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.574 -179.59 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 2.5 tt0 -145.63 129.77 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -134.88 131.28 53.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.012 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -136.15 123.74 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -102.54 135.7 43.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 111.371 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.58 155.06 32.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.23 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -106.73 134.02 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.05 153.54 34.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.141 0.496 . . . . 0.0 112.287 -178.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.446 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.715 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -70.83 154.08 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 179.816 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.715 ' N ' HG13 ' A' ' 12' ' ' ILE . 58.0 m -52.37 -41.3 62.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.2 pttt -172.23 149.04 2.22 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.041 0.448 . . . . 0.0 111.713 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -106.82 134.08 50.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.78 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.633 HG13 HD12 ' A' ' 58' ' ' ILE . 2.8 mm -114.28 120.23 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -104.24 114.69 29.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.537 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -116.25 129.55 56.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.542 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -154.37 158.69 40.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 111.493 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -159.54 163.42 23.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.666 -179.949 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -57.52 114.45 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.982 1.788 . . . . 0.0 111.616 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -50.71 -31.23 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.357 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -70.17 -37.36 75.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -176.48 4.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.97 13.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.82 -160.24 8.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.647 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 57.81 70.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -84.45 162.57 19.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 25.7 mttp -141.26 133.87 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.876 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 2.2 pt-20 -120.52 132.69 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.11 0.481 . . . . 0.0 111.977 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.67 111.99 12.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.808 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 84.8 m -91.79 132.09 36.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.471 HG13 ' C ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -136.92 104.8 8.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.115 177.962 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.5 Cg_exo -60.22 105.64 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.447 2.098 . . . . 0.0 112.15 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.36 -94.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.122 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.03 109.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.6 mp -82.74 -34.13 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.01 -112.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.053 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.0 m -121.43 105.09 10.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.39 109.01 21.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -120.88 132.11 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.5 mt -98.61 127.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 -166.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.83 29.76 28.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.357 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -93.94 172.04 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -122.93 136.8 27.22 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.81 165.42 18.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.645 2.23 . . . . 0.0 112.466 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.4 -33.03 3.49 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.735 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.55 116.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 61.9 t -77.77 144.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' PHE . 3.2 m-85 -102.36 126.55 49.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 130.62 52.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.61 158.03 27.97 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -132.46 145.11 50.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.294 179.669 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 107.25 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -106.64 114.83 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -88.51 125.04 34.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.263 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 45.9 mt -102.43 123.35 55.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HG3' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -100.23 -175.05 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.943 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.83 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.301 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.03 6.9 38.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.76 175.49 18.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.64 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 3.0 p80 -55.99 157.41 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.716 0.293 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.528 HE21 ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -161.35 -17.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.409 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -114.2 127.75 56.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.09 130.68 55.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.415 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.23 121.2 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 2.5 mtt180 -96.87 132.65 42.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.318 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -155.62 156.65 35.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.263 0.554 . . . . 0.0 111.965 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.62 137.81 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -150.0 141.69 23.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.514 -178.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.336 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.965 0.412 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.667 HD13 ' HB3' ' A' ' 57' ' ' SER . 4.7 tt -97.31 157.35 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.87 -52.72 22.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.796 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.611 ' HD2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -166.17 144.79 5.75 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.198 0.523 . . . . 0.0 111.754 179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.8 m-85 -102.37 136.87 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.873 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.34 129.86 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.853 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -118.11 114.84 23.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.986 179.438 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.58 129.21 50.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -149.73 162.02 41.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 2.8 ptt180 -158.56 153.43 21.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 18.0 Cg_endo -58.49 109.61 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.967 1.778 . . . . 0.0 111.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.518 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 4.1 ttpp -57.36 -35.21 69.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -70.3 -29.25 65.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -78.22 -161.02 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.999 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.35 -7.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' HH11 ' A' ' 20' ' ' ARG . . . 179.67 -128.58 1.24 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.952 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.435 ' HB3' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER 64.6 75.24 0.38 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.918 0.389 . . . . 0.0 111.06 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 93.5 m95 -83.04 175.8 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.145 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 13.7 mttm -154.25 136.88 15.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.767 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -120.16 135.77 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.052 0.453 . . . . 0.0 112.131 -178.762 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 114.86 8.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.13 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 m -96.62 137.78 35.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.149 0.5 . . . . 0.0 112.222 -179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -135.39 110.75 10.6 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.456 179.311 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.652 ' HB2' HD12 ' A' ' 37' ' ' LEU . 73.7 Cg_exo -50.15 93.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.766 2.31 . . . . 0.0 113.169 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 28.09 3.42 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.24 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.5 69.79 0.67 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.988 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -71.89 -7.21 47.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.164 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.3 p-10 -164.02 -174.6 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -80.47 105.53 11.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.82 107.42 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.778 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -114.59 146.58 40.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -91.62 124.38 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -138.56 161.77 36.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.74 21.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.6 mt -74.59 -161.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.505 0.193 . . . . 0.0 110.55 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.15 133.81 12.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.643 0.258 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.1 155.45 28.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.448 2.099 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.18 -21.48 10.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.921 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.38 117.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.772 0.32 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 62.5 t -81.26 144.54 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.428 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 53.4 m-85 -124.62 103.9 8.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 12.9 pt-20 -79.67 130.18 35.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.383 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.53 161.34 24.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.972 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.4 mt-30 -132.62 139.17 47.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 110.432 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -99.91 107.11 19.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -111.03 115.17 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.486 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.667 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -92.2 117.7 30.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.164 179.337 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.611 ' HB ' ' HD2' ' A' ' 14' ' ' LYS . 43.2 mt -101.73 116.13 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.812 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -90.0 -175.07 4.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.32 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.44 -23.05 64.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.06 14.15 32.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.645 0.259 . . . . 0.0 111.48 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.01 -174.56 23.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.803 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -52.34 161.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.724 0.297 . . . . 0.0 111.238 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -169.27 -20.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.587 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -123.72 128.42 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.53 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.89 133.24 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.814 0.34 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 3.1 m -137.8 123.86 20.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.71 134.45 40.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 111.636 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.93 159.08 38.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.507 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -109.51 133.7 52.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.9 p90 -151.82 145.98 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 178.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.865 0.364 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.6 tt -79.72 155.25 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.48 ' H ' HG13 ' A' ' 12' ' ' ILE . 3.2 m -49.91 -53.36 26.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.764 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.821 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -158.89 144.91 16.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.1 m-85 -104.7 137.72 42.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.202 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -114.25 142.69 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 110.81 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.48 115.83 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.12 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.4 mtp180 -118.99 129.77 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.646 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -152.6 158.82 43.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 111.991 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.36 157.07 26.78 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.291 179.792 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 19.1 Cg_endo -58.78 113.41 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.318 2.012 . . . . 0.0 112.083 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.444 -179.476 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -95.02 -41.2 9.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -87.15 161.82 17.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.22 148.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 27' ' ' ARG . . . 170.39 -140.6 6.09 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.517 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -139.88 166.77 23.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 74.0 m95 -75.65 174.61 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 18.2 mttt -145.31 141.16 28.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.679 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -119.98 134.92 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 128.3 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.825 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.1 m -112.39 135.67 52.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -137.21 106.76 8.67 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.153 178.418 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.821 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.8 Cg_exo -58.84 111.6 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 112.477 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.83 -104.95 0.51 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.368 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.85 93.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.655 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.72 -25.75 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.979 179.9 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.2 p-10 178.74 -168.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.456 179.661 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -76.49 105.82 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -108.8 112.84 25.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.725 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -121.57 132.62 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.8 mt -90.21 126.08 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.57 165.92 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.44 -16.36 4.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.243 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -69.63 160.16 32.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.716 0.293 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HG2' ' HD2' ' A' ' 47' ' ' PRO . 3.3 ttmt -104.77 133.44 20.16 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.047 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.593 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 55.2 Cg_exo -52.0 133.03 45.06 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.524 2.149 . . . . 0.0 112.18 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.12 -22.1 40.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.12 120.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.311 . . . . 0.0 110.953 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.64 ' HA ' HG22 ' A' ' 72' ' ' THR . 14.0 t -85.78 140.63 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -123.08 161.51 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -129.82 132.2 46.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.926 179.408 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.73 155.42 26.49 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.413 -179.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.91 131.64 41.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 5.9 tp -99.7 106.48 18.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.891 0.376 . . . . 0.0 111.011 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 16' ' ' ILE . 3.8 mp -92.07 138.44 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.955 179.408 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -110.4 114.98 28.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.313 0.578 . . . . 0.0 111.011 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 5.6 mt -95.5 114.13 31.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.591 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' NE2' ' HG2' ' A' ' 60' ' ' GLN . 0.9 OUTLIER -97.03 -176.26 3.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.327 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HG2' ' NE2' ' A' ' 59' ' ' GLN . 11.4 pt20 -62.12 -21.94 65.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -102.83 12.08 36.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.725 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 100.8 173.36 29.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.434 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.7 p-80 -53.55 147.93 10.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.483 0.183 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 2.0 pt20 -165.33 -6.64 0.03 OUTLIER 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 3.4 tt0 -132.65 112.99 12.49 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.891 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.2 p -136.98 140.99 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.3 m -132.24 122.12 24.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.715 179.528 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' H ' ' HE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.29 141.49 30.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.304 -179.373 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.14 158.31 37.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.49 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 129.46 56.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -152.06 163.76 38.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 50' ' ' VAL . 11.4 p . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.751 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 m80 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.6 0.238 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 59' ' ' GLN . 1.6 tt -77.81 150.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.984 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -49.21 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.611 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -166.13 146.07 6.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -102.04 141.99 34.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.38 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.632 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -115.16 142.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.487 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 115.46 19.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.416 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -120.85 137.95 54.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.674 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -156.73 159.51 38.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.43 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.45 157.45 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.521 -179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.72 110.86 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.269 1.979 . . . . 0.0 112.014 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.42 67.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.66 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.8 ' HB2' HG23 ' A' ' 49' ' ' VAL . 19.4 m-20 -100.3 -36.05 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.404 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.16 -167.78 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.25 154.39 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.022 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.43 23.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 60.87 175.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.597 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 68.0 m95 -85.61 -172.33 4.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.4 mttt -148.3 154.76 40.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.242 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.17 138.27 49.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 112.092 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 111.82 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 92.5 m -98.4 131.19 44.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.48 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -134.69 106.05 10.77 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.268 178.124 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 52.0 Cg_exo -56.23 98.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.688 2.258 . . . . 0.0 112.895 -179.019 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 22.88 8.43 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.163 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.481 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 57.13 98.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 179.922 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.705 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.66 -18.37 41.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -169.09 -163.19 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.17 105.48 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.608 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.21 106.75 16.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.35 144.05 45.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.86 129.33 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.213 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 141.77 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.09 56.08 0.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.654 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 3.0 mt -137.18 78.02 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.4 ttpt -34.75 130.41 0.47 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.466 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 45.2 Cg_exo -56.89 175.79 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.661 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.05 -35.53 3.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 23' ' ' ASN . 2.8 p -115.04 127.15 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.67 142.08 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 7.8 m-85 -108.8 136.79 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -112.26 130.1 56.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.119 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.67 156.49 26.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.975 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.6 146.0 51.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 18.8 tp -100.23 107.0 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.391 . . . . 0.0 110.859 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 16' ' ' ILE . 1.7 mp -95.12 122.06 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.491 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -94.83 114.91 26.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.424 0.631 . . . . 0.0 109.926 179.723 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 27.6 mt -106.7 111.16 34.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.953 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.483 ' HG3' HD12 ' A' ' 12' ' ' ILE . 3.3 mt-30 -90.2 -176.17 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.887 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.75 -15.94 45.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -103.12 0.62 32.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.32 176.39 19.4 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.26 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 15.9 p80 -55.36 156.31 4.49 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.548 0.174 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.9 1.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 3.7 tt0 -145.53 113.73 6.59 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -136.75 139.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 m -137.1 124.73 22.3 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.448 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -85.01 141.01 30.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.779 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -155.86 156.63 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.731 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -114.96 131.64 56.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.873 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -152.04 162.55 40.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.486 -178.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.202 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.7 p80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.943 0.401 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.727 HD12 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -72.98 147.48 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.042 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.71 ' N ' HG13 ' A' ' 12' ' ' ILE . 14.8 m -52.13 -45.99 65.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -158.78 144.65 16.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.042 0.448 . . . . 0.0 111.416 179.512 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -112.89 142.97 44.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 179.682 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -113.89 138.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.221 -179.587 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -122.03 114.86 21.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.283 179.633 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.35 129.98 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.149 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -158.52 158.44 34.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.402 0.62 . . . . 0.0 112.526 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.586 ' NH1' HG23 ' A' ' 25' ' ' VAL . 1.9 ptt180 -159.73 162.27 25.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.665 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 31.3 Cg_exo -58.82 109.62 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.929 1.753 . . . . 0.0 111.621 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -65.78 -22.62 66.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.968 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.0 -17.98 31.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -158.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG23 ' NH1' ' A' ' 20' ' ' ARG . 14.4 p -166.66 139.03 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.75 -60.06 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.574 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -165.5 157.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.076 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.53 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 59.0 m95 -92.36 172.73 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 14.2 mttp -132.51 128.2 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.83 130.41 54.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 112.303 -178.241 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.08 111.79 8.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.872 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.9 m -93.91 130.87 39.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 40' ' ' TYR . 4.4 mp -136.68 107.65 9.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.66 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.0 Cg_exo -45.89 91.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.167 2.578 . . . . 0.0 113.249 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.39 42.46 1.84 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.506 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 54.34 47.84 22.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.588 HD13 ' H ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -70.95 -24.27 62.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.731 -179.544 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.588 ' H ' HD13 ' A' ' 37' ' ' LEU . 1.7 p-10 -133.77 168.93 17.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -78.94 105.88 10.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 33' ' ' ILE . 8.8 p90 -121.34 130.7 53.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 145.02 29.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.241 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.57 137.37 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.437 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 123.88 17.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.29 146.65 28.85 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.63 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.3 mt -103.75 173.02 6.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 12.6 ttpp -94.98 125.28 51.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 34.2 Cg_exo -59.57 111.77 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.638 2.225 . . . . 0.0 112.236 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.84 -5.58 8.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.657 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.87 135.22 58.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.8 t -81.24 137.05 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.75 179.581 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.86 97.04 4.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.2 pt-20 -87.38 132.08 34.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.091 0.472 . . . . 0.0 110.519 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.67 154.0 24.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.69 134.81 50.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.843 0.354 . . . . 0.0 110.392 179.811 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' CD1' HD12 ' A' ' 17' ' ' LEU . 13.2 tp -99.56 107.67 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.578 ' CG1' ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -102.42 115.36 44.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 0.0 111.547 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -81.41 113.73 19.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.714 HG23 ' H ' ' A' ' 63' ' ' HIS . 30.4 mt -105.64 126.39 60.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.601 -179.386 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.727 ' HG3' HD12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -112.5 -174.98 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.419 179.8 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.27 -7.48 2.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.332 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' HB2' HE22 ' A' ' 64' ' ' GLN . 55.4 m-85 -97.97 -5.25 34.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.81 106.54 0.04 OUTLIER Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.374 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.714 ' H ' HG23 ' A' ' 58' ' ' ILE . 44.8 m80 61.6 120.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.419 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.603 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -157.5 -20.33 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.874 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -145.94 119.49 9.11 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.865 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -137.32 132.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 0.0 112.06 179.157 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.6 m -137.5 128.69 27.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 2.0 mtm180 -96.3 148.03 23.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.181 0.515 . . . . 0.0 111.136 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -156.43 158.84 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.237 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -113.58 127.27 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.023 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 45' ' ' LEU . 1.4 p90 -148.29 161.3 41.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.089 0.471 . . . . 0.0 112.121 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.009 178.861 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.943 0.401 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' HG2' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -67.62 144.02 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.3 179.484 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.53 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -49.71 -57.72 6.71 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.025 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 144.33 18.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.897 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.7 m-85 -108.93 136.6 48.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.245 0.545 . . . . 0.0 111.081 -179.729 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 114.88 28.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.053 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.03 129.47 50.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.761 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -151.01 160.61 43.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.468 . . . . 0.0 111.666 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 6.2 ptt180 -159.41 161.38 27.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 14.0 Cg_endo -57.95 110.39 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.186 1.924 . . . . 0.0 111.796 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -62.77 -48.06 80.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.724 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.75 -38.91 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.8 -179.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.03 -179.52 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.498 . . . . 0.0 111.85 -179.281 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.72 143.4 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.772 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -154.83 18.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.146 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 27' ' ' ARG . 9.8 mtt180 -135.74 162.88 31.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 111.074 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.86 157.19 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.8 mmtt -132.14 136.11 46.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.238 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HH21 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -119.87 127.21 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.092 0.473 . . . . 0.0 111.935 -178.754 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.44 111.68 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.142 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -91.5 135.21 34.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.927 -179.263 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.97 107.79 32.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.69 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.793 2.329 . . . . 0.0 113.061 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.74 30.66 4.91 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.118 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 72.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -31.89 71.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -146.18 -165.34 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 p -77.69 106.14 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.51 102.29 7.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -127.95 143.12 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.3 mm -81.68 116.92 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 134.76 37.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.81 17.39 1.88 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.312 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.548 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.9 mt -76.05 -143.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.521 0.2 . . . . 0.0 110.75 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -146.94 122.81 5.48 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 120.647 0.26 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.79 91.16 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.423 2.082 . . . . 0.0 111.851 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -117.72 113.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.103 179.414 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.27 130.42 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.348 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 45' ' ' LEU . 48.8 m-85 -105.57 107.14 17.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.428 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 130.33 34.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.88 159.65 28.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.131 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 146.59 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -102.05 106.43 17.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.201 -179.869 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.3 mp -92.48 126.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -90.17 135.53 33.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.225 0.536 . . . . 0.0 110.194 179.648 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.2 mt -115.02 109.11 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.563 -179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.747 ' HG2' HD11 ' A' ' 12' ' ' ILE . 7.1 mm100 -101.12 -175.1 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.293 178.231 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.11 -14.5 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.742 0.305 . . . . 0.0 110.794 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -103.21 -5.25 23.34 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.975 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 113.21 -153.71 17.39 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.854 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.47 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 2.6 m-70 -62.28 141.23 58.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.862 -0.199 . . . . 0.0 110.778 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.534 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -145.22 -59.51 0.35 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 2.5 tt0 -100.49 114.2 27.61 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.8 p -136.12 132.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 112.081 178.534 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -137.29 125.18 22.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 142.32 30.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -156.1 159.31 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.436 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.42 135.46 50.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 45' ' ' LEU . 4.8 p90 -151.61 141.25 21.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.326 -178.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.072 179.255 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.834 0.349 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -101.04 157.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -59.47 -44.33 93.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.984 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.05 144.62 0.76 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.801 179.471 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' THR . 12.5 m-85 -105.62 136.82 44.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.835 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.75 127.71 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 178.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.667 ' HG ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -116.44 116.52 27.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.82 128.78 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.741 -179.732 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.692 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 2.7 p90 -152.2 142.7 22.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.482 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.9 153.62 42.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 67.6 Cg_exo -57.13 126.71 23.0 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 113.05 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 -33.43 19.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.784 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 49' ' ' VAL . 51.7 t30 -99.17 -43.92 6.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -83.92 -15.72 46.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.686 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 55.18 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.763 179.866 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 -138.54 7.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.646 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.0 ttm105 -110.9 155.12 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.453 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 79.0 m95 -77.78 175.27 10.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.051 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -139.26 135.65 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.401 179.31 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.2 pt-20 -120.1 131.62 55.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.987 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.05 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.844 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -102.1 132.1 48.18 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -139.42 106.7 7.15 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.752 178.965 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' HD21 ' A' ' 37' ' ' LEU . 77.7 Cg_endo -82.31 102.45 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.322 2.015 . . . . 0.0 113.549 -178.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 8.85 87.61 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.51 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.75 88.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.706 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -66.32 -22.06 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.41 -172.91 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 106.55 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.724 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -108.32 109.41 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.093 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.27 126.26 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.748 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -81.87 118.52 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.178 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.12 76.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' C ' HD13 ' A' ' 45' ' ' LEU . . . -136.01 22.31 3.45 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.628 179.419 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.763 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -98.03 -157.5 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 155.87 14.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.796 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.99 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.56 6.66 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.357 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.559 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.071 HG23 HG22 ' A' ' 72' ' ' THR . 1.5 p -114.48 148.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.747 177.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.4 m-85 -114.49 143.56 44.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.0 tt0 -79.51 128.63 33.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.45 133.65 9.33 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.517 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 56' ' ' ILE . 34.7 tt0 -134.15 116.86 15.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.634 0.254 . . . . 0.0 110.811 179.343 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.667 HD22 ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -99.64 107.75 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 179.282 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 66' ' ' VAL . 4.3 mp -111.44 114.59 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.602 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -84.02 138.36 33.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.134 179.144 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.595 ' HB ' ' HG2' ' A' ' 14' ' ' LYS . 2.6 mt -115.19 108.49 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.867 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 4.7 tp60 -86.49 -175.86 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.39 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.52 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 6.6 mm100 -61.27 -20.51 62.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.58 -179.548 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.72 16.01 27.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.515 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.84 -108.56 3.08 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -51.77 111.48 0.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 23.6 tp60 -120.97 -67.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.27 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 4.2 tt0 -139.51 145.43 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HG23 ' A' ' 56' ' ' ILE . 96.8 t -135.04 133.96 53.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 m -136.76 134.46 37.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.223 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.0 122.62 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.92 133.95 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.217 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.47 137.65 38.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.06 158.71 43.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.071 HG22 HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.649 177.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.8 0.333 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.662 HG21 ' CE1' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -66.86 155.5 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.343 179.524 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.455 ' H ' HG13 ' A' ' 12' ' ' ILE . 2.2 m -56.57 -52.81 63.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.607 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -176.66 145.76 0.55 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.569 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 3.3 m-30 -101.66 141.09 35.05 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.102 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 55' ' ' LEU . 21.2 mm -114.75 132.74 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -121.24 114.22 21.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.237 178.564 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.6 mtp180 -109.99 129.17 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 -179.411 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.65 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 3.1 p90 -142.4 140.18 31.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.25 0.548 . . . . 0.0 111.699 179.673 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.92 144.84 17.13 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.915 -179.803 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 51.2 Cg_exo -56.94 117.73 4.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.252 1.968 . . . . 0.0 112.327 -179.451 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 mmmt -58.58 -17.86 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.74 -18.57 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.141 -179.676 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.31 -166.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.949 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.18 -26.29 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.057 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 175.92 -128.57 1.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.423 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.0 63.05 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 74.6 m95 -63.71 -177.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.2 mmtp -131.94 152.3 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.425 179.197 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.23 133.77 55.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.808 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.15 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.446 178.847 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 14' ' ' LYS . 51.6 m -106.51 126.45 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.309 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -140.16 105.24 6.66 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.811 178.087 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 107.45 2.01 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.167 1.911 . . . . 0.0 112.658 -179.664 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.09 116.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.401 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.26 102.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.23 -33.12 33.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.68 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -179.32 -159.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.308 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 m -77.3 105.37 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.6 114.41 26.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -98.71 147.65 24.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.036 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 43' ' ' LYS . 3.6 mt -99.57 115.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 44' ' ' GLY . 3.8 mmpt? 18.4 -93.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.089 0.868 . . . . 0.0 112.584 179.702 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 43' ' ' LYS . . . 178.84 105.5 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.387 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -73.49 -175.55 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.638 0.256 . . . . 0.0 110.886 -179.808 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 160.96 33.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.086 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.07 149.92 50.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.684 2.256 . . . . 0.0 112.881 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.62 -2.18 59.48 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.052 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.08 112.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.701 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.3 t -91.56 148.05 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 179.026 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.445 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 53.3 m-85 -139.68 107.47 5.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.926 178.946 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 tp10 -87.92 128.85 35.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -117.22 147.59 18.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.545 -178.921 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.447 ' HB3' HD11 ' A' ' 56' ' ' ILE . 1.1 mt-30 -133.52 115.75 15.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.202 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 17' ' ' LEU . 32.7 tp -99.19 107.36 19.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.76 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.3 mp -112.18 115.25 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.582 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 7.9 m -82.14 133.4 35.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.626 HG23 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mp -121.67 133.14 69.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.334 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 3.8 tt0 -110.79 -175.14 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.742 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -61.08 -17.7 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.1 -5.71 23.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.68 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 77.47 153.16 5.68 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.999 178.86 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 t60 58.37 97.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.619 0.247 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 -122.77 -60.72 1.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 tt0 -135.54 145.32 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.913 -178.378 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.35 114.48 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 178.812 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.9 m -133.37 127.18 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -104.06 132.09 50.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -155.58 130.81 9.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.618 -179.666 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.45 149.81 20.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.82 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -150.8 148.18 28.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.513 0.673 . . . . 0.0 112.671 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.7 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.492 0.187 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -101.59 157.44 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 111.306 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 t -82.16 -31.68 30.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.222 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.837 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 4.0 pttt -175.86 143.92 0.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.973 179.317 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HB2' HG13 ' A' ' 33' ' ' ILE . 34.1 m-85 -108.04 143.14 37.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.597 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.68 122.81 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.129 0.49 . . . . 0.0 110.736 179.66 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.779 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -109.96 114.61 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.631 179.372 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.02 129.61 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.252 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.642 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.7 p90 -150.38 149.36 29.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.568 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.568 HH12 ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -153.79 145.41 16.69 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 -179.514 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 49.0 Cg_exo -59.15 110.55 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.706 2.271 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HE2' HH12 ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.63 -19.64 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.1 -18.24 62.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -117.57 -162.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.608 179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.09 125.59 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.57 -142.49 47.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.669 179.651 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 63.14 59.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.091 0.472 . . . . 0.0 111.138 -179.975 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -76.53 174.81 9.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.749 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.773 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.8 mttt -142.43 132.31 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.857 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.68 135.62 54.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.298 0.571 . . . . 0.0 112.396 -178.489 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.14 111.77 6.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 179.134 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 m -88.31 132.61 34.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.146 0.498 . . . . 0.0 112.294 -178.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -140.4 105.54 6.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.217 179.29 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.837 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 17.6 Cg_endo -58.2 -179.75 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.504 2.136 . . . . 0.0 113.516 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -65.79 88.9 0.11 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.237 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.596 ' HB3' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -179.81 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 109.898 -179.508 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.875 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.74 -3.48 47.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.762 179.39 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.659 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.8 p30 42.47 -125.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -88.28 117.04 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.735 0.303 . . . . 0.0 110.974 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.43 ' CB ' HD13 ' A' ' 33' ' ' ILE . 32.5 t80 -83.52 126.73 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.286 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -97.98 147.44 24.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.421 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.32 131.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.51 -111.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.1 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' C ' HD22 ' A' ' 45' ' ' LEU . . . -81.39 140.13 20.95 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.14 -178.021 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.437 HD22 ' C ' ' A' ' 44' ' ' GLY . 2.9 mm? -126.67 3.59 6.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.61 179.223 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt 62.54 154.65 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.157 179.544 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.41 155.56 28.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.797 2.332 . . . . 0.0 112.513 -179.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.76 3.35 59.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.192 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 112.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.089 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.0 t -89.44 148.37 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.05 0.452 . . . . 0.0 110.494 178.974 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 39.5 m-85 -138.78 104.42 5.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.623 179.428 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 8.4 tt0 -90.26 128.63 36.46 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -142.2 147.94 19.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.331 -179.084 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' CB ' ' HA ' ' A' ' 68' ' ' ARG . 6.0 pm0 -133.83 138.83 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.162 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.779 ' HG ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -100.03 107.89 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.071 0.462 . . . . 0.0 111.647 -178.66 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.3 mp -101.69 114.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.137 179.157 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 1.3 m -87.31 136.34 32.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 -179.705 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.804 HD13 ' HE3' ' A' ' 14' ' ' LYS . 3.6 mp -118.87 132.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.046 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 30.1 tt0 -92.73 -175.77 4.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.427 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.58 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 5.4 mt-30 -60.33 -29.53 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.092 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.37 7.98 42.47 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.323 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.474 ' HA2' ' CG2' ' A' ' 58' ' ' ILE . . . 94.0 147.95 23.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.082 179.343 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.575 ' H ' HG23 ' A' ' 58' ' ' ILE . 5.3 m-70 64.37 157.25 0.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.5 0.19 . . . . 0.0 111.285 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.764 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -179.01 -57.47 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 179.281 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.5 tt0 -145.09 144.19 30.81 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.114 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.28 114.07 16.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 178.433 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.9 m -137.2 120.74 17.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.814 179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 54' ' ' GLN . 6.5 mtp85 -97.94 132.62 43.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' GLY . 19.8 p90 -149.4 131.31 15.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.191 0.52 . . . . 0.0 112.295 -179.717 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 52' ' ' GLU . 1.7 m-20 -95.2 141.64 28.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.016 179.256 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -152.66 160.75 43.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.475 0.655 . . . . 0.0 112.491 -178.853 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.474 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.835 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.674 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 10.2 p-80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.871 0.367 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.664 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -97.14 152.09 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.87 179.885 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.664 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.51 -46.63 48.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.283 179.485 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 16.5 pttm -162.05 144.26 11.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.134 179.366 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -113.07 140.6 47.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.707 179.211 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.421 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -114.22 125.35 71.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 179.745 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.41 114.28 27.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.323 179.789 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -112.21 129.15 56.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.771 179.487 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -146.21 147.15 31.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.273 0.559 . . . . 0.0 112.234 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.29 145.67 18.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.024 179.911 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 47.3 Cg_exo -57.53 109.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.334 2.023 . . . . 0.0 112.549 -179.594 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 1.7 mttm -68.45 -32.68 72.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.52 179.471 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.58 -18.85 47.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 1.7 m -149.48 72.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.576 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 20' ' ' ARG . 22.7 m -47.02 146.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.947 -179.474 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.86 79.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.7 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' A' ' 28' ' ' TRP . 14.5 ttp180 65.15 147.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 111.54 179.728 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.509 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 37.2 m95 -101.72 -176.63 3.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -139.08 153.26 48.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.353 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 138.32 54.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.2 111.97 7.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.823 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m -93.77 126.23 38.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.721 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 mt -138.2 107.04 7.97 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 178.747 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 24.1 Cg_exo -64.13 109.91 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.515 2.143 . . . . 0.0 113.325 -178.949 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 49.54 24.73 5.8 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.818 178.962 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 60.71 115.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.086 0.47 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HD2' ' A' ' 34' ' ' PRO . 5.9 mp -82.44 -33.21 28.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -177.51 -153.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.117 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -76.8 104.83 7.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -118.19 122.75 43.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 -179.411 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 141.57 49.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.287 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.96 130.19 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.714 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -112.89 156.96 22.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.856 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.35 20.56 1.96 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.26 -179.785 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.689 HD23 ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -121.61 177.98 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.952 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.659 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -139.45 163.47 45.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.702 0.286 . . . . 0.0 111.652 -179.173 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.1 109.51 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.629 2.219 . . . . 0.0 112.605 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.0 -0.21 11.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.104 179.399 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 46' ' ' LYS . 14.7 p -120.23 137.12 55.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -112.7 137.88 43.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.01 179.7 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CD1' HD23 ' A' ' 45' ' ' LEU . 7.9 m-85 -111.21 174.14 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.279 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -116.21 129.49 56.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.736 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.71 132.17 9.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.857 -1.163 . . . . 0.0 113.797 -178.521 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' THR . 5.8 mt-30 -133.56 113.83 12.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.112 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 15' ' ' TYR . 3.9 mt -100.66 107.56 19.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.4 mp -101.77 115.68 44.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -82.6 119.17 23.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.739 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 20.5 mt -110.62 119.17 58.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.51 -179.472 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -175.68 4.11 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.082 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -61.58 -17.44 55.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -103.14 -5.17 23.51 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.28 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.92 179.61 16.01 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -49.4 157.67 0.48 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 65' ' ' GLU . 2.7 pt20 -165.46 -2.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.852 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.649 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.33 133.69 21.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.606 0.241 . . . . 0.0 111.383 -179.689 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' ILE . 67.3 t -134.94 133.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.975 179.231 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 6.2 m -137.51 137.22 38.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.48 139.65 44.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.52 161.59 40.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.306 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.8 141.25 29.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.245 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 1.1 t80 -120.24 139.1 53.18 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.157 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.333 -0.123 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.583 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -105.2 148.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 179.954 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -43.29 52.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.154 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.61 144.94 0.69 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.274 178.863 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.745 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.4 m-85 -100.79 150.2 23.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.612 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.2 mm -125.02 123.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.552 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.695 HD12 HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -110.11 114.09 27.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.517 178.818 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.55 129.68 56.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.4 -179.646 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 4.8 p90 -141.28 149.27 41.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.21 147.98 14.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.405 -179.849 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 48.4 Cg_exo -57.81 114.73 2.09 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.543 2.162 . . . . 0.0 112.665 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.814 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 27.6 mtpt -75.31 -25.07 57.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -86.23 -35.87 19.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.204 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.69 -175.53 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.111 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.03 132.24 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.067 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.5 -165.49 31.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.8 150.04 21.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.82 177.6 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.17 154.57 50.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.881 179.415 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.62 133.44 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.19 0.519 . . . . 0.0 111.891 -179.463 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.85 111.43 8.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.469 179.015 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 58.8 m -90.56 136.74 32.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.318 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.799 HG22 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.07 103.8 6.76 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.474 177.668 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.35 127.4 7.41 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.58 2.186 . . . . 0.0 112.699 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.19 165.82 36.67 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.991 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -81.89 67.13 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.064 0.459 . . . . 0.0 110.759 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.799 HD12 HG22 ' A' ' 33' ' ' ILE . 2.7 mt -78.81 -2.88 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.027 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER 105.96 174.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.503 1.127 . . . . 0.0 110.608 -179.675 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -77.18 111.75 13.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -97.66 117.48 32.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.449 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -127.4 142.17 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.74 116.66 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -119.49 42.36 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.82 10.47 58.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -83.28 166.23 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 110.887 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.587 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -94.06 134.85 25.31 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.148 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -38.96 123.38 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.5 2.8 . . . . 0.0 114.07 -179.803 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.0 7.2 17.67 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.127 178.45 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' LYS . 2.0 t -121.52 136.67 57.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.551 0.676 . . . . 0.0 112.301 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -115.34 133.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.993 178.186 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 27.4 m-85 -116.18 -173.12 2.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.966 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.814 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 9.8 tm-20 -126.07 129.45 49.15 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.91 118.47 4.25 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.085 -179.104 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -132.66 113.89 13.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.695 HD13 HD12 ' A' ' 17' ' ' LEU . 22.7 tp -103.44 106.74 17.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.507 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.628 HG13 HG13 ' A' ' 66' ' ' VAL . 4.9 mp -100.52 138.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.591 178.838 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 4.7 m -94.85 151.11 19.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.356 0.598 . . . . 0.0 110.975 -179.5 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 25.8 mt -116.41 131.84 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.508 -179.417 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.882 ' HG2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -118.74 -176.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.442 178.461 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -75.22 -20.68 59.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.748 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -104.47 -5.68 21.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.445 179.809 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.27 139.21 1.76 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.187 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.28 81.78 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.819 0.343 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.882 ' HB2' ' HG2' ' A' ' 59' ' ' GLN . 1.3 tt0 -101.48 -67.75 0.85 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.608 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.822 ' H ' ' HB2' ' A' ' 57' ' ' SER . 4.0 tp10 -140.54 127.56 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.04 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.628 HG13 HG13 ' A' ' 56' ' ' ILE . 5.4 t -116.27 138.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 111.861 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.87 134.12 34.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.413 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -111.67 143.87 41.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 -179.449 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.72 161.1 40.78 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.94 148.03 22.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.624 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -120.16 142.38 49.01 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.456 -176.339 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.816 HG23 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.694 0.283 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 ' CD1' ' HG3' ' A' ' 64' ' ' GLN . 7.9 tp -70.85 144.95 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.391 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.87 95.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.055 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -167.46 145.41 4.68 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.467 179.513 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 1.4 m-85 -100.45 145.3 28.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.688 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.03 121.06 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 109.938 179.217 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.26 114.07 27.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.476 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 8.5 mtp85 -114.75 128.75 56.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.747 179.3 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.669 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.2 p90 -144.6 145.72 31.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.3 0.572 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -152.06 145.88 18.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.335 -179.812 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG3' ' HE1' ' A' ' 51' ' ' TYR . 42.3 Cg_exo -58.77 110.24 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.444 2.096 . . . . 0.0 112.335 -179.78 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.77 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 8.7 mmtm -72.11 -13.97 61.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.384 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.13 -26.92 15.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.549 -179.421 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.82 -12.93 15.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 t 50.41 70.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.6 -154.26 11.94 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.607 -179.811 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -89.49 141.18 28.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 110.649 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.465 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 42.1 m95 -73.21 178.0 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 mtpp -139.48 147.87 41.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.05 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.81 137.0 54.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.275 0.559 . . . . 0.0 112.304 -178.678 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.01 122.12 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -97.21 116.76 30.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.221 0.534 . . . . 0.0 112.395 -178.79 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -136.87 106.77 8.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.989 178.945 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.3 Cg_exo -59.94 -157.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.535 2.157 . . . . 0.0 114.157 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.696 ' O ' HD23 ' A' ' 37' ' ' LEU . . . -63.38 110.25 3.26 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.485 -178.339 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 35' ' ' GLY . 12.9 p80 3.7 69.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.218 1.007 . . . . 0.0 113.504 178.911 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.809 ' HG ' ' HB2' ' A' ' 39' ' ' SER . 0.1 OUTLIER -84.16 0.66 47.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.518 179.472 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 81.79 25.02 0.22 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -174.592 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.809 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . 5.7 t -75.77 176.68 7.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 110.809 -2.905 . . . . 0.0 112.776 -178.39 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.13 108.48 4.67 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.747 -1.569 . . . . 0.0 112.076 -177.309 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -104.28 141.87 35.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.806 178.849 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.734 HD13 HD22 ' A' ' 17' ' ' LEU . 1.3 mp -82.3 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.052 0.453 . . . . 0.0 111.691 -179.314 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -174.29 -170.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.563 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.99 84.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.777 179.645 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 45' ' ' LEU . 1.6 mm? -115.37 167.57 10.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -96.8 126.4 43.03 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.377 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 13.2 Cg_exo -32.66 137.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.751 3.634 . . . . 0.0 114.963 -179.483 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 -4.16 54.09 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.61 177.932 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -122.63 126.84 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 117.842 0.821 . . . . 0.0 112.966 -179.238 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.926 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.29 146.29 12.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.364 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HE1' ' HG3' ' A' ' 21' ' ' PRO . 71.2 m-85 -137.55 130.94 30.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.672 0.272 . . . . 0.0 110.988 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.77 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . 8.9 tp10 -79.85 129.46 34.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.479 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.68 127.17 7.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.089 -178.265 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.23 114.05 12.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 17' ' ' LEU . 2.1 mt -101.97 106.4 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 111.495 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.61 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.6 mp -104.13 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.882 178.866 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.616 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.52 150.14 27.13 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.743 0.782 . . . . 0.0 111.131 -179.039 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -116.65 132.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.585 -179.137 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.945 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.13 -174.21 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -31.71 70.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.248 179.533 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -103.97 -4.95 22.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.146 179.332 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 156.39 30.02 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.858 179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.7 t60 64.0 134.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.945 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 3.8 mm100 -161.2 -68.86 0.06 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.631 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.616 ' H ' ' HB2' ' A' ' 57' ' ' SER . 1.5 tt0 -137.53 115.34 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.183 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -123.4 129.8 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 111.933 178.795 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -129.42 141.27 51.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.366 179.716 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -104.88 133.46 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.573 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.99 136.36 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.991 179.534 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.1 142.73 27.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.318 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -148.91 161.32 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.171 0.51 . . . . 0.0 111.393 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.738 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -88.2 -78.2 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.81 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.86 128.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.45 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -92.75 148.71 21.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.699 0.285 . . . . 0.0 110.702 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.41 138.07 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.103 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' PRO . . . -125.53 93.6 44.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.12 109.8 2.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.646 2.231 . . . . 0.0 112.893 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 53.67 63.25 8.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.754 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 92.5 Cg_endo -85.92 -158.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.717 2.278 . . . . 0.0 112.089 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.9 p -64.17 -25.17 67.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.149 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.52 -157.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.125 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.623 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -72.8 150.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 3.6 m -52.08 -44.89 64.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.006 0.431 . . . . 0.0 110.156 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -171.62 143.84 1.78 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.858 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.58 146.77 28.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.824 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -114.68 125.04 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.668 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -112.93 114.5 27.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.3 mtp180 -115.07 129.61 56.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.424 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.702 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.3 p90 -142.22 148.94 38.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 111.76 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -155.69 142.93 13.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 53.0 Cg_exo -57.6 109.94 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB3' HG12 ' A' ' 50' ' ' VAL . 1.2 tptp -77.22 -23.66 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -95.26 -20.38 19.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.67 2.0 18.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.984 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 25' ' ' VAL . 6.0 p 33.77 85.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.129 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.45 -147.21 6.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.532 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 27' ' ' ARG . 31.5 mtt180 -96.32 157.87 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 110.929 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 67.5 m95 -87.99 173.92 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttp -145.59 155.05 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -123.96 140.33 53.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.339 0.59 . . . . 0.0 112.407 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.73 112.06 7.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.592 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -91.06 127.94 36.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.761 HG22 HD21 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -137.56 107.46 8.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.727 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 23.4 Cg_exo -64.77 91.9 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.583 2.189 . . . . 0.0 113.025 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.84 -152.26 50.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.677 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -107.45 71.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.3 -31.69 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.634 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.58 179.88 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -77.0 106.81 8.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -123.29 113.31 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -128.55 127.85 43.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.26 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 HD22 ' A' ' 17' ' ' LEU . 8.8 mt -83.6 123.57 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.652 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -156.49 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.93 14.98 47.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.989 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.66 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.63 -166.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.755 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.62 162.29 37.06 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.745 0.307 . . . . 0.0 111.4 -179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 45.5 Cg_endo -68.38 146.36 68.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.264 1.976 . . . . 0.0 112.628 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.0 0.14 83.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.202 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 46' ' ' LYS . 5.5 p -120.29 137.97 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.961 0.381 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -114.56 129.57 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.184 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 34.4 m-85 -104.98 -178.16 3.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 mm-40 -123.25 130.12 52.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.52 129.25 7.64 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.314 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.67 114.33 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.405 0.145 . . . . 0.0 110.776 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 16' ' ' ILE . 3.5 mt -101.99 107.01 18.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 0.0 110.827 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.0 mp -109.47 117.74 55.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.675 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -81.5 140.33 34.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.488 0.661 . . . . 0.0 111.098 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.606 HG23 ' HA2' ' A' ' 62' ' ' GLY . 29.7 mt -119.09 132.45 68.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.452 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 4.0 mm100 -106.88 -173.43 2.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -24.8 64.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HE22 ' A' ' 64' ' ' GLN . 4.7 p90 -103.38 -5.51 22.87 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.572 0.225 . . . . 0.0 111.598 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 82.5 154.52 14.99 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.146 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 62.77 96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.71 0.404 . . . . 0.0 111.633 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.658 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 10.3 mm100 -124.05 -89.93 0.58 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 112.315 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.49 145.35 26.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.98 114.5 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 134.47 47.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.758 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 127.7 55.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -136.1 160.56 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.136 0.493 . . . . 0.0 111.656 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.0 150.76 20.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.883 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.9 140.43 49.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.72 168.43 25.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.888 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.66 ' OG1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -112.76 -110.39 0.35 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.531 ' H ' ' HB ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -85.42 13.51 6.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.957 0.408 . . . . 0.0 110.965 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 p -105.13 148.71 26.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.716 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 102.95 14.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 78' ' ' THR . 0.7 OUTLIER -148.61 -102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.447 ' H ' ' HB2' ' A' ' 77' ' ' SER . 0.0 OUTLIER 45.58 64.89 7.23 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 111.565 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -77.65 116.42 4.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.432 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.21 31.53 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.433 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 53.59 67.45 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.801 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.04 32.85 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.85 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.79 85.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -166.1 27.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.96 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -121.01 150.78 40.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -86.05 153.84 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 64.91 153.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.22 160.42 30.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ttp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.739 0.304 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.37 -1.77 30.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.953 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.34 -135.15 12.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.566 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 t -152.8 -24.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.56 100.18 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.35 93.4 26.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.39 150.75 41.85 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.648 2.232 . . . . 0.0 112.561 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 53.3 58.41 13.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.373 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.58 148.06 9.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.62 2.214 . . . . 0.0 112.421 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -9.41 42.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.68 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.83 166.6 33.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -73.02 149.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.712 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 12' ' ' ILE . 7.8 t -44.62 -51.01 9.47 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 110.456 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HD2' HD11 ' A' ' 16' ' ' ILE . 4.1 pttt -171.48 143.95 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -105.78 136.77 44.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.695 HD13 HG13 ' A' ' 58' ' ' ILE . 3.0 mp -114.64 124.72 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.857 0.36 . . . . 0.0 110.679 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 25.8 tp -104.99 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -115.91 129.58 56.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.027 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 19.7 p90 -153.2 157.58 40.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.038 0.447 . . . . 0.0 111.541 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -159.39 156.9 26.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.79 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 31.3 Cg_exo -58.93 117.71 4.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.137 1.891 . . . . 0.0 112.386 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -34.73 64.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.636 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -90.56 -34.57 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -98.98 -169.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.596 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.09 168.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.65 -166.13 28.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.95 160.24 14.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -74.83 -179.94 4.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -146.24 127.57 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.103 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.29 134.46 55.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 111.915 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.86 133.22 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.194 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.1 m -85.76 132.07 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.175 0.512 . . . . 0.0 111.693 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.94 118.38 20.89 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.983 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 36' ' ' HIS . 53.9 Cg_exo -56.53 78.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.905 2.403 . . . . 0.0 113.462 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.74 10.35 0.97 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.259 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 34' ' ' PRO . 1.8 t-160 74.68 104.19 0.07 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.877 0.37 . . . . 0.0 110.358 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 37' ' ' LEU . 7.5 mp -65.82 -35.22 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.0 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.22 -63.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.85 116.38 20.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -128.02 109.56 11.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.389 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -116.68 146.26 42.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.568 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.09 134.73 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.575 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -108.7 171.16 7.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 47.66 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.268 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.774 HD13 HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -141.51 -169.34 2.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -159.49 146.44 12.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 36.5 Cg_endo -65.47 122.97 10.78 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.612 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' A' ' 73' ' ' THR . . . 130.27 9.53 2.97 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.246 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.586 HG11 ' O ' ' A' ' 75' ' ' SER . 95.1 t -118.35 130.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.901 0.35 . . . . 0.0 111.407 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 23' ' ' ASN . 11.3 t -83.02 145.37 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' HD2' ' HG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER -145.22 166.07 26.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.59 0.709 . . . . 0.0 112.131 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.2 tp10 -133.24 128.67 36.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.67 139.87 11.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.517 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -133.52 131.63 40.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.773 0.321 . . . . 0.0 110.749 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.92 109.91 22.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.3 mp -108.14 115.42 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.15 121.66 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.432 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 16' ' ' ILE . 1.4 mt -113.4 113.4 43.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.519 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.29 -176.41 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.2 -18.31 57.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.168 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 64' ' ' GLN . 2.6 p90 -103.25 -4.78 23.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.94 -178.35 16.38 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.866 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.9 p80 -53.18 161.38 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.687 0.28 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.472 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -170.24 0.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -145.45 116.8 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.468 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 56' ' ' ILE . 42.0 t -134.23 123.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.535 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.23 121.73 18.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -98.04 138.76 34.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.027 0.442 . . . . 0.0 111.767 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -156.38 126.85 6.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.767 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -95.41 137.93 33.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -139.65 149.11 43.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.009 0.433 . . . . 0.0 111.548 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.65 169.44 8.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.543 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.4 m 76.81 91.58 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.7 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.774 HG22 HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -172.07 -153.36 0.08 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.057 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.751 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 69.4 p -120.05 -179.04 3.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.0 p -85.2 -59.3 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.129 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p -147.03 176.19 10.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -136.82 72.61 55.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.74 -33.8 61.69 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.571 2.181 . . . . 0.0 112.36 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.64 102.39 1.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -145.15 154.73 42.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.53 -98.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 m 58.61 13.31 2.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.264 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 51.45 34.84 12.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 58.53 86.66 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.38 39.47 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -149.83 165.87 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -106.16 157.64 17.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.887 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.691 0.281 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.29 63.12 2.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.84 -155.29 9.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.588 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.4 m -99.0 -162.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -107.97 14.23 25.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.214 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.22 77.38 60.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.063 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.88 -44.87 3.59 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.694 2.262 . . . . 0.0 112.295 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.63 152.09 51.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.86 111.59 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 112.18 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 97.39 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -157.21 179.13 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -72.26 150.09 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.674 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.34 -50.95 37.51 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -171.55 144.58 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.366 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -104.52 139.56 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.256 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 mm -117.07 124.04 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.091 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 55' ' ' LEU . 26.8 tp -105.63 113.99 27.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.858 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.94 128.92 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.631 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -156.69 148.4 22.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.141 0.496 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HD3' ' CE2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -148.94 161.21 33.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.619 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' SER . 48.9 Cg_exo -57.72 117.56 4.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.281 1.988 . . . . 0.0 112.357 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -66.94 -36.84 83.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.503 -179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 50' ' ' VAL . 1.7 t-20 -96.44 -43.43 7.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.267 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.51 165.87 16.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.13 152.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.74 -127.68 1.53 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -139.93 168.76 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.404 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 65.5 m95 -82.45 173.39 12.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.94 137.59 36.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.69 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.3 mt-10 -120.22 133.31 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.038 0.447 . . . . 0.0 111.832 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.62 117.74 11.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.202 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.4 m -86.3 131.06 34.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.09 0.472 . . . . 0.0 112.147 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.6 mp -133.77 106.42 11.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.757 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.63 90.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.438 2.092 . . . . 0.0 112.378 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.69 -93.29 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.15 93.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -68.26 -33.96 75.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.855 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 169.02 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.72 117.22 21.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.035 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -115.82 113.69 23.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.842 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -122.99 130.18 52.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.875 HG22 HD11 ' A' ' 45' ' ' LEU . 4.6 mm -85.5 127.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -173.36 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 39.01 53.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.591 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -141.89 -174.18 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -162.8 151.27 12.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.244 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.967 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 24.6 Cg_exo -63.17 168.62 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.8 -7.03 60.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.674 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -119.86 121.56 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' ASN . 1.6 p -82.44 103.24 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.61 ' HD2' HG23 ' A' ' 74' ' ' THR . 0.3 OUTLIER -94.67 160.03 14.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.135 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 1.6 tp10 -117.79 129.11 55.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.64 145.15 16.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.149 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -133.77 131.91 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.057 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 17' ' ' LEU . 4.9 tp -119.01 107.31 13.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.899 0.381 . . . . 0.0 111.051 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.6 mp -116.67 116.44 52.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.907 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -89.8 126.38 35.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.72 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 2.7 mp -113.15 125.26 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.235 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -101.15 -177.31 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.506 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -64.3 -26.78 68.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.54 -0.39 43.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.12 169.11 13.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 8.8 p80 -56.98 151.97 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.81 6.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 tt0 -143.66 116.74 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.18 121.21 31.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 m -134.96 121.52 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -100.94 129.7 46.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.69 132.6 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.305 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 151.24 19.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.464 ' CE2' HG21 ' A' ' 74' ' ' THR . 5.4 p90 -151.63 153.9 35.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.052 0.453 . . . . 0.0 111.811 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -102.39 168.78 9.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.709 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.967 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 39.2 m 76.52 78.94 0.09 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.053 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.698 ' OG1' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER 170.51 136.68 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.024 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.819 ' H ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 t -124.4 -175.22 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 p -74.81 152.58 38.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.836 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.97 138.29 40.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.81 60.81 8.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.122 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 96.7 Cg_endo -79.91 -136.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.487 2.125 . . . . 0.0 112.171 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 156.7 -66.21 0.3 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.6 p -129.52 -4.12 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.784 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 135.66 33.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 m -105.38 149.93 25.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -134.94 67.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -12.62 13.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.8 178.91 9.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.73 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 56.06 -151.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.36 157.81 33.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.806 0.336 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.59 48.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.63 112.38 0.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.28 82.77 1.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 110.824 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -155.74 98.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -73.26 -49.71 6.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.696 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 57.9 Cg_endo -71.76 132.5 20.27 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.231 1.954 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.07 47.57 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.97 -69.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.368 2.046 . . . . 0.0 112.153 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -165.79 71.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.68 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.2 m80 61.13 -86.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.729 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -98.38 149.56 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -48.11 -47.56 34.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.891 0.377 . . . . 0.0 110.299 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -175.45 143.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.829 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.78 139.01 39.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.1 mm -116.07 129.31 72.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 28.5 tp -105.03 113.01 26.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.01 129.01 52.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -152.12 150.08 29.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.335 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.555 HH11 ' HA ' ' A' ' 25' ' ' VAL . 7.1 ptt85 -148.51 160.84 35.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.33 114.59 2.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.172 1.915 . . . . 0.0 111.622 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -30.89 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.748 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.48 -38.79 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -3.27 57.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HA ' HH11 ' A' ' 20' ' ' ARG . 32.9 m 35.44 41.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.092 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.37 -160.4 12.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -73.66 169.11 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.461 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 37.3 m95 -99.51 173.11 6.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.493 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.22 139.51 41.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.345 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -120.37 134.7 55.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 116.96 10.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.947 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 60.1 m -85.33 138.95 31.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.274 0.559 . . . . 0.0 112.475 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -135.45 107.07 10.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.476 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.26 87.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.83 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.16 25.91 48.36 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.941 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER 58.62 99.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.832 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.787 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -72.86 -22.46 60.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' H ' HD22 ' A' ' 37' ' ' LEU . 17.8 t-20 -176.82 -105.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.2 p -127.19 121.73 32.11 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.64 103.38 10.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -115.85 142.97 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.233 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.5 125.38 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 6.6 pttt -101.1 168.9 9.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -140.43 23.41 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.404 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.907 ' HB3' ' H ' ' A' ' 75' ' ' SER . 0.2 OUTLIER 57.32 -167.97 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.563 0.22 . . . . 0.0 111.197 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.44 147.23 24.79 Favored Pre-proline 0 CA--C 1.527 0.082 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.789 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 97.3 Cg_endo -85.49 45.04 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.995 2.463 . . . . 0.0 113.219 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.98 -19.01 7.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.516 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER -120.56 136.86 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.935 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.63 147.0 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.724 ' HD2' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -130.15 148.21 51.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 112.307 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -111.93 129.82 56.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.806 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 136.97 13.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.597 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -133.86 123.66 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.449 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 3.8 mt -108.18 108.97 20.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 111.021 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 66' ' ' VAL . 1.3 mm -112.35 118.7 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.672 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.96 133.86 41.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.289 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.844 HG12 ' HB3' ' A' ' 63' ' ' HIS . 6.4 mt -113.65 127.48 70.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 111.644 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.652 ' HG2' HD12 ' A' ' 12' ' ' ILE . 2.8 mm100 -95.18 -176.46 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 0.3 OUTLIER -68.76 -32.25 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.767 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.66 15.48 28.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.73 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.05 161.04 12.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.237 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.55 163.78 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.722 0.296 . . . . 0.0 110.986 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.44 6.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.66 115.89 12.57 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.958 0.408 . . . . 0.0 111.607 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.729 ' HB ' HD13 ' A' ' 56' ' ' ILE . 1.2 p -136.03 139.07 46.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -137.06 136.05 38.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.34 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -111.32 129.46 55.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -156.02 127.98 7.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.805 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.68 132.78 39.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.074 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 74' ' ' THR . 21.2 p90 -136.61 150.76 48.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' THR . 21.2 p -109.27 168.4 9.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.831 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.789 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 90.1 m 87.2 65.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.584 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.816 ' HB ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER 174.24 146.99 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.588 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.907 ' H ' ' HB3' ' A' ' 45' ' ' LEU . 9.1 t -124.7 179.16 5.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.181 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.503 ' HA ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -76.04 -65.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.341 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.48 ' H ' HG23 ' A' ' 76' ' ' THR . 88.1 p -149.35 133.35 17.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.6 p -139.72 70.19 37.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.869 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 52.4 Cg_exo -54.13 -80.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 143.77 -152.04 23.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.481 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -67.01 1.03 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 110.868 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -152.16 109.39 3.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -67.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.91 114.75 18.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 -156.38 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -80.75 11.95 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 55.69 76.71 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 56.42 72.06 0.52 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.981 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.889 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.842 0.353 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -108.0 73.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.918 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.87 -93.78 2.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -86.22 -57.01 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.744 0.307 . . . . 0.0 110.98 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 m120 60.61 12.93 3.9 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -171.51 137.41 1.04 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.9 137.52 15.85 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.518 2.145 . . . . 0.0 112.566 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 64.5 139.25 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.12 150.51 42.89 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.486 2.124 . . . . 0.0 112.551 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -128.66 78.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.743 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 32.7 m-70 -61.71 155.66 22.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.648 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -67.28 150.14 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.1 t -49.76 -48.98 49.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.707 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -169.72 144.25 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.993 0.425 . . . . 0.0 111.445 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.626 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -105.19 139.12 40.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.952 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 18' ' ' ARG . 28.5 mm -114.45 117.97 57.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.525 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 42.6 tp -104.9 113.74 27.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.831 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -119.34 128.72 54.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.913 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 8.6 p90 -151.63 162.16 41.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.904 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.16 161.69 27.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.684 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.53 118.94 5.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 121.906 1.737 . . . . 0.0 111.832 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -62.92 -29.67 70.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.528 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -99.39 -41.17 7.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.471 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 160.06 17.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.281 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.77 147.44 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.31 -164.72 37.38 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.63 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -89.14 155.6 19.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.96 -172.59 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -141.16 144.33 34.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.8 mt-10 -120.05 132.95 55.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.202 0.525 . . . . 0.0 111.792 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 118.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.937 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 87.7 m -85.42 132.5 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 112.091 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 14.4 mt -123.88 107.56 30.95 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.759 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.7 104.26 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.603 2.202 . . . . 0.0 112.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.743 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . 58.8 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.159 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.06 111.82 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.243 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -82.76 -3.52 56.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 75.77 -63.91 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.872 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.76 105.22 8.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 110.818 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -126.47 115.21 19.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -120.57 144.47 48.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.257 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 45' ' ' LEU . 18.3 mt -94.33 132.68 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.506 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.39 154.38 25.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.227 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 38.13 4.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.642 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -126.62 171.02 11.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.328 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -149.7 135.96 10.47 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.29 157.95 10.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.659 2.24 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.37 -62.08 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.611 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.719 HG13 HG23 ' A' ' 74' ' ' THR . 0.6 OUTLIER -77.13 133.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 111.173 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 22' ' ' LYS . 5.3 p -82.85 144.76 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.027 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -125.4 138.92 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.945 0.402 . . . . 0.0 111.923 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 10.7 tp10 -105.22 129.29 53.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.5 144.67 15.72 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 119.822 -1.18 . . . . 0.0 114.309 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.8 mt-30 -133.66 129.47 36.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.377 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.626 ' HG ' ' CE1' ' A' ' 15' ' ' TYR . 4.7 tp -124.9 106.67 10.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.417 HD11 ' OE1' ' A' ' 54' ' ' GLN . 3.8 mp -116.88 116.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.941 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.474 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.42 127.43 33.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 63' ' ' HIS . 15.1 mm -112.84 124.39 69.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.309 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 -177.1 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.24 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.42 -2.54 28.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.54 -166.4 12.15 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.438 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.568 ' HA ' HD13 ' A' ' 58' ' ' ILE . 21.1 p-80 -64.65 140.81 58.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.319 . . . . 0.0 110.707 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 -51.59 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.7 tt0 -97.2 126.18 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.484 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 123.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -137.41 130.85 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -111.46 139.55 46.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -155.94 127.83 7.44 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.028 0.442 . . . . 0.0 111.501 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.82 124.1 39.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.7 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -125.18 162.73 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.85 0.357 . . . . 0.0 111.741 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -107.36 168.39 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.388 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 45' ' ' LEU . 4.5 m 85.11 101.39 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.243 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.842 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -145.95 153.61 41.0 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -159.89 -6.52 0.06 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -71.25 -103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.121 -0.231 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.482 ' H ' HG23 ' A' ' 76' ' ' THR . 1.1 t 44.92 75.24 0.11 Allowed 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.68 101.62 5.47 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.267 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.25 -64.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.974 2.449 . . . . 0.0 112.138 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.72 -148.95 18.85 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.631 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -79.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.757 0.313 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -109.3 -56.37 2.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.8 t -161.34 -54.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.502 ' HB3' ' H ' ' A' ' 85' ' ' HIS . 5.8 m80 -131.07 -147.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.918 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 32.9 m170 64.05 106.38 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 129.52 31.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 108.82 13.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.112 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -167.92 91.16 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.154 -0.926 . . . . 0.0 110.82 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 3.9 mtt180 -85.74 -161.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 2' ' ' ARG . . . 109.29 -19.84 28.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.352 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.5 113.65 5.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.689 0.28 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.79 168.99 0.11 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.39 80.25 0.3 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.291 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.47 120.73 8.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.561 2.174 . . . . 0.0 112.114 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.52 144.16 30.36 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.041 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.68 142.57 12.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.634 2.223 . . . . 0.0 112.303 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.38 -2.6 30.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.8 m80 55.73 -136.8 1.17 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.774 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.0 OUTLIER -67.4 156.39 6.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.914 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.19 -41.51 65.33 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -162.39 143.15 10.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.831 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 8.2 t80 -122.83 153.12 39.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.655 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 58' ' ' ILE . 3.7 mp -120.11 121.88 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.682 0.277 . . . . 0.0 110.751 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.651 ' HB2' ' HE2' ' A' ' 15' ' ' TYR . 10.5 tp -104.84 114.22 28.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.639 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.64 129.84 56.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -140.9 155.08 46.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.83 146.2 12.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.685 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 20' ' ' ARG . 39.7 Cg_exo -58.18 114.63 2.05 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.214 1.943 . . . . 0.0 111.974 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -65.63 -35.82 81.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.495 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -91.28 -43.85 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.328 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.41 0.53 28.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 29.62 63.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.258 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.68 -153.39 29.58 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.541 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -88.32 164.91 15.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.3 172.7 8.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.029 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -152.24 123.95 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.571 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.42 130.11 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.123 0.487 . . . . 0.0 112.178 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.03 137.09 51.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.779 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 97.8 m -85.27 115.66 23.16 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.532 0.682 . . . . 0.0 111.858 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.82 110.46 17.22 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.597 178.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.15 79.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.092 1.861 . . . . 0.0 111.945 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 45.46 37.81 6.67 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.74 97.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.923 0.392 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -71.49 -32.84 68.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -163.63 -89.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.82 123.87 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.837 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -127.92 119.39 25.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -98.67 146.91 25.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.986 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 43' ' ' LYS . 12.1 mt -108.04 115.01 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.117 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 42' ' ' ILE . 7.8 mmpt? 25.73 -126.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.205 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.92 80.27 0.19 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 45' ' ' LEU . 1.3 mm? -68.54 -155.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.739 ' HD3' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -155.65 140.65 12.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 40.0 Cg_exo -57.63 107.11 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.653 2.236 . . . . 0.0 112.484 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.61 -3.93 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.861 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.739 HG23 ' HD3' ' A' ' 46' ' ' LYS . 78.6 t -104.31 115.91 47.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 72' ' ' THR . 2.8 p -83.23 116.39 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.363 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -107.98 169.48 8.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.25 0.547 . . . . 0.0 111.454 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -124.16 129.92 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.118 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.57 139.61 10.61 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -131.18 138.58 49.49 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -99.28 105.39 17.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.644 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.618 ' N ' ' HE1' ' A' ' 15' ' ' TYR . 4.2 mp -116.0 113.44 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.774 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -106.42 133.41 51.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.234 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 9.6 mt -114.05 127.21 71.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -98.7 -179.02 4.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.914 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -66.45 -16.87 64.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.031 0.443 . . . . 0.0 110.085 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -103.06 -4.95 23.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.941 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 124.56 171.24 13.34 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.39 139.03 58.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.7 0.286 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -145.77 9.97 1.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.832 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -142.73 114.98 8.39 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 112.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -137.2 126.58 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.381 179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -137.2 131.02 31.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.007 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -107.51 125.49 51.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -155.73 133.89 11.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 111.359 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.92 140.79 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.278 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -143.48 142.81 31.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 111.806 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.462 HG22 ' HB ' ' A' ' 50' ' ' VAL . 31.6 p -103.28 134.4 46.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 47' ' ' PRO . 58.8 m 62.96 143.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.13 0.491 . . . . 0.0 111.157 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.557 HG23 ' HG ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -154.02 -13.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.113 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -72.84 175.75 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.5 t -118.85 7.09 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.233 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.44 82.56 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.8 m -145.97 95.04 4.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.306 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -71.29 163.14 40.13 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.762 2.308 . . . . 0.0 112.122 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.55 -49.07 0.16 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.726 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 p -120.55 158.35 27.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.037 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -121.33 -34.47 3.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.33 142.34 56.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.04 89.05 2.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.229 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 51.61 85.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 -86.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -164.44 164.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.369 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -159.07 143.49 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.898 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -139.39 90.0 2.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.54 99.7 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.398 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.05 89.66 2.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.978 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 54.52 73.67 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.59 129.12 13.97 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.035 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.35 117.7 4.81 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.448 2.098 . . . . 0.0 112.265 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -120.67 143.52 36.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.965 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.76 169.42 22.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.516 2.144 . . . . 0.0 112.246 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -62.86 126.15 26.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -74.23 -169.67 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -80.46 155.07 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.544 ' N ' HG13 ' A' ' 12' ' ' ILE . 16.5 t -53.71 -47.11 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.075 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -172.96 144.0 1.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.116 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -106.23 143.9 33.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.441 HG22 ' HD3' ' A' ' 18' ' ' ARG . 19.5 mm -116.19 118.58 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 111.04 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.552 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 49.2 tp -105.37 114.95 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.651 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.48 128.99 55.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.439 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 44.5 p90 -140.4 147.73 40.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.313 0.578 . . . . 0.0 110.838 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -161.99 153.07 15.11 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.256 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.62 110.5 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.332 2.022 . . . . 0.0 112.247 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -32.22 73.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.288 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.83 -37.28 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.51 -162.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 26' ' ' GLY . 3.9 p -60.96 166.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.29 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' ' HG3' ' A' ' 20' ' ' ARG . . . -74.87 -108.78 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.649 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 59.97 65.98 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.071 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 -57.48 168.39 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.72 134.37 35.26 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 7.5 mt-10 -119.06 136.79 53.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.449 0.642 . . . . 0.0 112.65 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.05 119.74 15.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 62.2 m -85.28 131.59 34.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.63 107.3 13.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.65 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.84 84.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.615 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.68 60.62 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.782 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.5 m170 60.89 106.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 0.0 111.162 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.671 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -76.85 -30.69 56.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.605 ' OD1' HD23 ' A' ' 37' ' ' LEU . 10.4 p-10 -177.98 -148.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.81 105.6 7.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.28 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -103.23 114.75 29.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.128 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -101.57 147.56 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 17' ' ' LEU . 42.4 mt -107.61 114.74 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.754 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.784 ' HE2' ' H ' ' A' ' 43' ' ' LYS . 9.0 mmpt? 34.92 -129.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.624 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 45' ' ' LEU . . . -129.45 -43.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.714 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.117 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.4 OUTLIER 55.21 -176.68 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.49 0.186 . . . . 0.0 110.769 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -160.74 142.87 9.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 32.5 Cg_exo -57.33 143.02 94.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.546 2.164 . . . . 0.0 112.14 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.8 -29.9 4.79 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.045 ' HB ' HG23 ' A' ' 74' ' ' THR . 2.8 t -96.97 135.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.632 0.254 . . . . 0.0 111.187 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.15 118.57 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.551 ' CE2' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.94 164.98 11.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.697 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.8 tp10 -123.16 129.31 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.494 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.51 132.1 10.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.127 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 19.8 mm-40 -134.32 112.71 11.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' CD2' HD13 ' A' ' 17' ' ' LEU . 14.5 mt -106.14 105.55 15.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.962 0.41 . . . . 0.0 110.293 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 18' ' ' ARG . 5.1 mp -117.77 114.78 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.174 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.533 ' OG ' HD13 ' A' ' 12' ' ' ILE . 1.8 t -89.59 116.25 27.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.32 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 6.2 mt -102.44 121.17 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.045 0.45 . . . . 0.0 111.573 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -78.87 -176.36 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.179 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -30.69 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -103.03 1.23 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.02 13.39 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.009 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 2.1 p-80 -75.87 156.24 34.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.244 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -26.68 0.14 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.293 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.27 119.02 38.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 111.191 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 132.64 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.232 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.7 132.69 33.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.281 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.95 129.44 56.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -156.39 128.66 7.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.99 136.4 36.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.916 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.34 159.18 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.952 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 73' ' ' THR . 3.0 p -109.38 169.09 8.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.929 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 72' ' ' THR . 25.9 m 98.29 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.256 0.972 . . . . 0.0 111.125 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 1.117 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -141.95 175.63 9.57 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.303 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.59 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 7.6 t -166.81 -63.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.477 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 p 60.3 107.73 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -56.27 -55.1 37.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.7 p 47.12 76.62 0.53 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.834 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.21 -8.9 15.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.617 2.211 . . . . 0.0 112.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.37 -103.65 1.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.538 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.405 ' H ' ' H ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -161.63 -17.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.748 0.308 . . . . 0.0 111.015 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' SER . 9.2 mtp-105 -125.2 -7.07 7.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.06 -156.39 0.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 63.37 109.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -109.49 -8.02 15.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.167 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.508 ' HB3' ' H ' ' A' ' 87' ' ' HIS . 14.1 m-70 -103.93 -149.9 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.051 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.508 ' H ' ' HB3' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 61.32 -171.48 0.15 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.906 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -34.68 60.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.969 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.688 0.28 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.45 145.84 25.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.97 133.57 4.71 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.51 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 t -98.59 136.09 39.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.17 -63.41 1.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.18 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 101.04 3.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.245 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.05 119.51 6.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -118.68 145.59 37.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.517 2.145 . . . . 0.0 112.287 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.68 -173.62 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -74.24 -90.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -101.26 147.9 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.436 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.579 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.4 m -45.16 -49.79 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.268 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HB2' HG23 ' A' ' 32' ' ' THR . 6.7 pttt -175.61 144.16 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.733 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -111.15 135.43 51.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.556 HG22 ' HD2' ' A' ' 18' ' ' ARG . 10.2 mt -114.16 121.46 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 111.237 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 42' ' ' ILE . 66.4 tp -105.3 114.66 28.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.8 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -121.0 128.33 52.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.537 ' CE3' ' HG ' ' A' ' 17' ' ' LEU . 16.4 p90 -148.15 158.67 44.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.979 0.419 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.656 HH12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -160.5 162.44 23.4 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.614 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.5 111.32 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.374 2.049 . . . . 0.0 111.985 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -24.81 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.773 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.518 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 20.2 t30 -99.68 -43.92 6.3 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.18 175.49 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.375 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.656 HG23 HH12 ' A' ' 20' ' ' ARG . 11.3 p -136.0 145.65 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.55 -111.28 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.561 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -127.81 148.17 50.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -82.57 -174.96 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.13 124.31 20.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.3 mt-10 -119.73 136.61 54.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 112.136 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.19 138.73 40.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.302 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.1 m -94.34 132.57 38.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.168 0.509 . . . . 0.0 112.156 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -135.68 107.71 9.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.862 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.18 83.96 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.485 2.124 . . . . 0.0 112.179 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.46 -90.68 0.64 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.298 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -168.48 93.33 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.695 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.735 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.34 -33.46 75.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.434 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.0 OUTLIER 179.66 -92.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.782 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.06 117.45 21.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.669 0.271 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.98 101.66 9.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.8 130.64 54.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 17' ' ' LEU . 3.0 mt -81.55 119.57 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -175.22 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.31 47.7 21.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.204 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.737 ' HB2' ' HB ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.13 166.68 23.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.798 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG2' ' OG ' ' A' ' 75' ' ' SER . 0.3 OUTLIER -146.88 116.54 4.5 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.14 105.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.857 2.371 . . . . 0.0 112.567 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 -33.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.45 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG22 HG21 ' A' ' 74' ' ' THR . 0.1 OUTLIER -110.55 135.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 11.4 p -76.49 140.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.702 ' CZ ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -126.11 142.73 51.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.904 -178.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 19.1 pt-20 -116.32 129.19 56.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.45 141.21 16.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.617 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -133.62 114.43 13.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CE1' ' A' ' 15' ' ' TYR . 3.9 mt -106.55 107.57 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 0.0 110.701 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.8 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.1 mp -113.54 122.23 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.211 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.3 OUTLIER -89.61 131.96 35.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.119 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -113.17 122.74 67.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.636 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 7.6 tt0 -119.56 -175.77 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.472 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.83 -22.1 63.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HD2' HE22 ' A' ' 64' ' ' GLN . 0.3 OUTLIER -103.15 15.83 28.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.193 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.14 -169.38 27.93 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.409 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.585 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -56.01 152.43 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.678 0.275 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.585 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.96 -50.65 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.895 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -99.08 118.85 36.76 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.825 -178.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -134.12 119.86 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.949 0.404 . . . . 0.0 111.168 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 m -137.21 135.4 37.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.23 125.81 9.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.609 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.65 124.55 43.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.411 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.45 156.3 48.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.39 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 73' ' ' THR . 20.5 p -108.99 134.19 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.737 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 172.45 -100.43 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.104 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.8 HG21 HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER 48.83 140.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 46' ' ' LYS . 4.4 t -176.24 -168.74 0.27 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.616 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 p -117.61 145.53 44.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t 62.4 174.88 0.14 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.036 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -144.5 76.44 14.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.1 -77.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.594 2.196 . . . . 0.0 112.307 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.77 -171.95 44.89 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.7 p -137.37 -165.54 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 82' ' ' ARG . 6.0 mtp-105 -106.35 143.69 34.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m 54.29 43.2 30.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.03 10.4 2.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -105.76 -159.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.06 58.38 1.86 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -166.68 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.167 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 160.69 41.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mtt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -96.36 90.0 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -175.87 84.92 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -144.3 29.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.785 0.326 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m120 57.39 88.14 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.09 97.09 49.39 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.308 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.77 118.14 4.98 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.635 2.223 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -87.9 112.64 50.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.7 152.58 29.3 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.573 2.182 . . . . 0.0 112.362 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.73 -58.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.853 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -142.2 -78.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -89.61 144.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.585 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.69 -52.38 60.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.99 0.424 . . . . 0.0 110.154 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HD2' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -168.76 143.85 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.79 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -113.11 129.12 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.307 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -114.11 137.61 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.861 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.22 114.48 25.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.247 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 5.1 mtt-85 -113.97 128.31 56.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.196 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -154.75 157.34 37.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 112.228 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 8.3 ptt85 -159.13 160.19 28.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -58.14 125.11 17.54 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 112.418 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 3.0 tttm -76.91 -37.07 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.35 -31.97 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.68 168.61 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.13 130.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.81 -120.16 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.581 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -136.52 166.29 23.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.557 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 40.6 m95 -84.32 -174.97 5.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tttm -148.94 145.19 27.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -119.8 129.75 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.113 0.482 . . . . 0.0 111.727 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.12 111.77 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.192 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -88.98 140.2 29.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.811 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.57 116.32 17.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.423 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' HD21 ' A' ' 37' ' ' LEU . 3.0 Cg_exo -75.23 87.72 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.832 2.354 . . . . 0.0 112.08 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 -89.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -169.7 92.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.66 -33.79 25.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 12.0 p-10 178.08 -157.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.599 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -86.18 106.61 17.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.729 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -84.57 119.48 25.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.019 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 m -122.78 124.47 43.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.18 122.62 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.02 105.1 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.7 8.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.827 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -95.09 -144.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.503 0.192 . . . . 0.0 110.499 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -165.85 140.46 3.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.5 95.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.407 2.071 . . . . 0.0 112.008 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.99 -27.71 3.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' THR . 1.9 t -92.52 124.0 44.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 110.659 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 72' ' ' THR . 63.1 t -100.93 123.14 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 0.0 111.384 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 18.0 m-85 -106.09 118.08 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.438 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 pt-20 -82.04 149.15 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.37 160.9 34.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.375 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -132.83 151.9 51.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.861 HD13 HD12 ' A' ' 17' ' ' LEU . 45.2 tp -111.19 107.7 17.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.92 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 66' ' ' VAL . 5.1 mp -92.55 138.31 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.007 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.523 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.55 123.52 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 110.951 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HD2' ' A' ' 14' ' ' LYS . 5.4 mt -113.27 117.79 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.824 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -86.97 171.66 10.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.892 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.98 -23.36 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.85 4.11 37.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.51 -134.09 11.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.619 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 64.77 168.8 0.18 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.856 0.36 . . . . 0.0 111.333 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -158.52 109.14 2.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.108 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tm-20 -100.11 116.28 31.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.328 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 56' ' ' ILE . 21.1 t -123.51 138.03 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 54.3 m -137.79 125.58 22.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.392 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.22 144.54 28.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.29 157.09 35.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.57 119.05 28.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -142.55 153.09 43.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.358 0.599 . . . . 0.0 112.45 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -147.06 167.73 23.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.829 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.827 HG23 ' HB2' ' A' ' 45' ' ' LEU . 51.0 p -38.56 -61.59 0.69 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 111.527 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.79 -23.48 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.66 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.37 174.57 11.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 t -69.08 -78.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.761 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m 54.16 83.54 0.22 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.233 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.15 -29.95 88.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.665 2.243 . . . . 0.0 112.468 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.9 83.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 t -164.1 -68.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.35 83.71 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.758 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.9 t -113.13 -82.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -125.33 98.15 5.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -167.46 -75.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -164.56 140.88 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.04 82.46 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.762 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 -173.66 4.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.937 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.678 0.275 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -68.57 -44.15 75.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.228 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.85 147.75 7.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.338 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 5' ' ' ASN . 1.2 m -105.59 -103.38 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.544 0.211 . . . . 0.0 111.124 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.425 ' H ' ' HB2' ' A' ' 4' ' ' SER . 0.6 OUTLIER -166.28 108.57 0.73 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.741 0.305 . . . . 0.0 110.904 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.85 70.63 7.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.321 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.74 141.59 8.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.607 2.205 . . . . 0.0 112.447 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -158.85 123.12 2.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.24 -56.77 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.503 2.135 . . . . 0.0 112.161 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.52 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -84.29 -68.22 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.577 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -90.71 142.81 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.354 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 2.2 m -66.23 -49.17 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.103 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.81 11.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.126 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.92 128.21 54.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.098 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 55' ' ' LEU . 32.9 mm -113.84 134.28 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.196 0.522 . . . . 0.0 110.987 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.862 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.55 114.55 27.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.311 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -112.28 128.24 56.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.935 179.386 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -147.94 155.77 41.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.328 0.585 . . . . 0.0 112.306 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.06 152.51 18.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -57.97 114.67 2.07 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.414 2.076 . . . . 0.0 112.55 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 1.8 ttmm -70.39 -36.39 74.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.154 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -84.3 -36.85 22.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.69 -169.57 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.781 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.03 103.25 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.909 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.19 -138.13 3.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 150.7 45.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -67.21 174.86 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.31 150.45 37.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.9 136.75 54.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 111.78 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 112.05 7.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.8 m -85.62 138.39 32.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.606 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -130.06 114.87 17.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.485 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 90.33 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.457 2.105 . . . . 0.0 112.304 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 66.57 -91.8 0.18 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.309 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -160.78 74.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.69 ' HG ' ' ND2' ' A' ' 38' ' ' ASN . 2.0 pt? -65.6 -33.62 76.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.69 ' ND2' ' HG ' ' A' ' 37' ' ' LEU . 17.6 p30 173.95 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.335 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -76.94 105.41 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.391 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -89.99 116.76 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -116.01 131.41 56.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -102.08 130.45 51.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.989 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -135.03 -168.32 2.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.94 61.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.616 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.623 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -74.07 -170.19 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.785 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HE3' ' OH ' ' A' ' 51' ' ' TYR . 18.8 mttt -137.98 150.79 68.56 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.54 122.38 8.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.38 -16.86 31.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.551 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.96 125.66 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 72' ' ' THR . 82.6 t -96.5 142.82 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.728 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 26.9 m-85 -109.93 124.8 52.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.811 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -89.74 156.22 18.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.0 152.24 21.3 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.446 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.35 132.27 41.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.862 HD13 HD12 ' A' ' 17' ' ' LEU . 27.1 tp -99.9 107.01 18.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.879 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.19 138.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.663 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -117.02 121.49 41.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 111.906 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.87 125.7 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.432 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.753 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -118.64 178.96 4.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -22.16 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.03 -4.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.56 23.89 59.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.753 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 7.4 m80 -67.28 173.03 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -148.1 89.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -101.01 116.16 32.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.269 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 p -130.77 139.23 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.241 0.543 . . . . 0.0 112.418 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.4 m -137.6 125.64 22.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.753 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 146.85 27.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.22 146.25 21.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 111.807 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -108.59 121.3 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.489 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 77' ' ' SER . 38.9 p90 -129.58 149.13 51.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 111.995 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 50' ' ' VAL . 71.2 p -142.4 163.67 32.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.849 HG23 HG22 ' A' ' 74' ' ' THR . 8.8 t -101.71 -27.27 13.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.314 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.849 HG22 HG23 ' A' ' 73' ' ' THR . 3.3 t -161.06 13.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.078 0.465 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.411 ' HB3' HG21 ' A' ' 72' ' ' THR . 32.5 t -93.2 -87.31 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -172.46 104.39 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.193 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -169.39 -90.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.091 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -163.73 119.61 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.171 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.81 54.33 3.99 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.664 2.243 . . . . 0.0 112.576 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.27 -152.92 24.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.686 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.2 m -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -77.13 -176.9 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.7 p -103.85 -8.62 19.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.55 126.48 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -143.45 -78.44 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.698 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.95 -76.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.78 16.08 10.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.42 -174.5 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.75 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -99.61 8.89 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.023 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.45 36.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.408 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.4 125.36 25.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 110.834 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -76.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.08 143.42 97.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.247 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 -35.97 4.95 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.656 2.237 . . . . 0.0 112.257 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -160.23 70.9 3.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.95 -86.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.582 2.188 . . . . 0.0 112.698 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.0 m 62.47 170.38 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.074 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.63 -51.79 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG21 ' HD2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -100.34 141.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.534 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -54.79 -49.08 71.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.297 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -167.86 144.25 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.016 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -116.56 135.69 53.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.123 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.639 ' O ' HD23 ' A' ' 55' ' ' LEU . 17.2 mm -114.68 135.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.178 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.54 114.96 25.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.962 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.758 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.6 mtp180 -114.55 129.18 56.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.775 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -145.0 154.92 43.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 111.749 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.45 152.46 18.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.794 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.0 Cg_exo -58.59 119.11 6.15 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.348 2.032 . . . . 0.0 112.291 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -23.61 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.405 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -98.62 -36.4 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 2.8 m -104.31 113.52 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.997 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 m -95.51 128.59 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.74 -57.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.566 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -167.84 151.55 6.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.767 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 30.9 m95 -87.89 -169.51 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttt -143.11 151.19 40.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -119.94 137.04 54.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.319 0.581 . . . . 0.0 112.455 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.23 111.34 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.856 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -90.3 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.079 0.466 . . . . 0.0 112.099 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.41 117.65 8.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.57 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.37 86.64 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.223 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.25 -98.91 1.66 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -165.24 94.25 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -82.95 -33.57 26.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -179.82 -161.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.638 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -86.46 106.22 17.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -89.11 113.44 24.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -108.94 138.03 45.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 17' ' ' LEU . 15.3 mt -105.97 117.23 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -115.74 129.36 56.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.33 8.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.715 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.946 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER -79.95 -165.91 0.92 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.543 0.211 . . . . 0.0 110.614 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 49' ' ' VAL . 4.2 mttp -130.99 142.1 44.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.678 0.275 . . . . 0.0 111.424 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.4 Cg_exo -60.02 94.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.727 2.285 . . . . 0.0 111.908 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.29 -25.84 6.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 46' ' ' LYS . 6.4 t -92.98 128.25 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.671 0.272 . . . . 0.0 110.793 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 t -94.36 146.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CG ' HD12 ' A' ' 45' ' ' LEU . 12.9 m-85 -117.54 122.76 44.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.769 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.31 148.33 26.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.23 148.47 18.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.533 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 66' ' ' VAL . 2.3 tt0 -132.91 142.44 48.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -107.72 107.06 17.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.585 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.2 mp -96.88 137.64 24.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -110.49 132.27 54.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.306 0.574 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 14' ' ' LYS . 9.6 mt -113.39 121.67 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.898 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.742 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -114.41 176.58 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.99 -32.3 73.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -102.19 1.17 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.64 88.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.833 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.742 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 1.3 m-70 -98.32 -41.05 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 110.51 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' SER . 31.4 mt-30 66.5 80.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.751 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 10.4 tt0 -96.75 126.6 42.03 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -125.95 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -137.87 121.74 17.68 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.08 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.6 141.0 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.606 -179.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.443 ' HE2' HD12 ' A' ' 55' ' ' LEU . 2.0 p90 -155.88 154.32 31.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.376 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.29 127.59 50.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.543 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -146.65 152.99 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.435 0.636 . . . . 0.0 112.499 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.627 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -148.41 167.27 25.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.77 178.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.946 HG22 ' HB2' ' A' ' 45' ' ' LEU . 1.6 t -68.17 -34.86 77.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.654 0.264 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.567 HG22 HG23 ' A' ' 73' ' ' THR . 2.7 t -158.78 67.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.3 OUTLIER -161.61 -66.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.653 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.531 ' H ' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER 57.01 116.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.779 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 118.01 31.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -159.43 71.33 3.37 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.507 ' HG2' ' H ' ' A' ' 80' ' ' GLY . 73.3 Cg_endo -77.37 -72.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.595 2.196 . . . . 0.0 112.571 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 79' ' ' PRO . . . -151.43 169.64 31.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.542 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.57 -169.78 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.168 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 56.16 32.66 20.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.982 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -125.16 -32.85 2.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.52 -10.3 5.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.42 93.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -171.55 -156.92 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.78 -91.39 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.48 123.98 41.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.064 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -45.9 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.4 -73.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.7 p -131.37 148.72 52.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -120.17 -8.33 9.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.41 113.45 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.263 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.98 89.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.335 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -171.53 70.68 0.48 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.9 156.22 48.09 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.49 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.9 -162.08 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.385 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -93.16 130.31 38.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.437 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.65 HG21 ' OG ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -104.28 157.42 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.65 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -51.08 -37.58 46.56 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.69 ' HD2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -167.73 143.35 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.905 178.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.751 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.12 133.2 56.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.814 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.782 HG21 HH11 ' A' ' 18' ' ' ARG . 4.1 mp -114.45 138.39 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.078 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -113.1 114.62 27.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.214 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -118.21 128.17 54.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.467 ' CE3' HD23 ' A' ' 17' ' ' LEU . 10.2 p90 -153.31 155.09 35.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 112.537 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.35 161.75 26.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.354 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.5 Cg_exo -57.72 113.92 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.283 1.988 . . . . 0.0 112.353 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -60.1 -27.82 67.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.12 -37.01 64.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 t -94.68 -159.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.59 136.59 43.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.25 -163.37 54.49 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.881 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 61.45 58.02 2.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.348 . . . . 0.0 111.416 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 55.3 m95 -79.43 179.21 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.504 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mttt -142.7 145.19 33.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.21 129.16 53.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 112.232 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.02 111.27 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.931 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.3 m -97.52 123.07 41.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 112.297 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -123.08 110.76 30.94 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' HD21 ' A' ' 37' ' ' LEU . 23.8 Cg_exo -63.69 101.52 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.257 1.971 . . . . 0.0 111.621 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.3 -91.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.829 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.21 101.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.938 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.668 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -81.05 -33.31 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.937 0.399 . . . . 0.0 110.405 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -174.0 -168.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.438 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -77.09 105.85 8.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.551 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 109.92 21.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.38 127.85 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.72 122.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -131.77 122.47 25.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.12 25.41 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG22 ' A' ' 73' ' ' THR . 2.4 mm? -76.32 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.533 0.206 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.713 ' HD3' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.4 152.23 59.96 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 120.732 0.301 . . . . 0.0 110.745 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 137.43 19.9 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.561 2.174 . . . . 0.0 112.517 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.02 -15.37 63.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.699 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 ' HD3' ' A' ' 46' ' ' LYS . 6.3 p -119.55 134.89 61.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 72' ' ' THR . 96.2 t -104.32 140.72 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.441 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.3 m-85 -105.93 119.36 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.191 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG2' HH21 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -85.44 138.37 32.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.87 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.57 146.31 16.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.873 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.4 136.8 45.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 17' ' ' LEU . 1.5 mt -101.71 106.67 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.6 mp -94.82 119.53 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.65 ' OG ' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -103.63 130.31 51.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.197 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -113.35 128.78 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.569 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.5 OUTLIER -116.04 -178.02 3.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.02 -8.62 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.02 -4.67 46.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.59 31.44 54.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 8.6 m80 -89.42 -178.58 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 110.744 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' SER . 1.4 mt-30 -149.32 104.83 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.523 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.6 tm-20 -96.99 125.66 41.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -131.45 134.08 61.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -137.2 122.51 19.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.13 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -84.54 147.28 27.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.348 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.37 141.49 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.99 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -114.08 123.33 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.294 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -141.65 151.7 43.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.988 0.423 . . . . 0.0 111.657 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.686 HG21 HG22 ' A' ' 50' ' ' VAL . 20.7 p -144.85 142.28 29.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.976 HG23 HG22 ' A' ' 74' ' ' THR . 11.2 t -70.81 -27.81 64.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.773 0.321 . . . . 0.0 111.012 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.976 HG22 HG23 ' A' ' 73' ' ' THR . 2.8 t -173.74 60.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.029 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.403 ' HB3' HG21 ' A' ' 72' ' ' THR . 23.2 t -131.64 -90.75 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -165.75 -176.16 3.76 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.172 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 m 58.18 54.75 5.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.83 70.02 24.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.72 -59.83 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.637 2.225 . . . . 0.0 112.488 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.97 -54.78 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.446 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -82.96 88.34 6.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -81.25 -43.14 19.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 t -146.34 -55.09 0.26 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.23 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -129.27 78.93 1.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 54.95 -113.37 0.78 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.438 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -81.52 -20.96 38.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.68 0.276 . . . . 0.0 111.154 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.1 t60 59.78 37.2 22.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.782 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.84 125.54 27.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.147 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.75 169.17 9.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.94 -163.27 9.45 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.528 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 p -131.81 141.81 49.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -90.96 -41.16 11.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.818 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . . . -155.12 113.28 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 6' ' ' ALA . 38.9 Cg_endo -65.91 140.85 62.37 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.548 2.165 . . . . 0.0 112.399 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -90.35 128.45 49.09 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.74 -53.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.469 2.113 . . . . 0.0 112.727 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.82 141.26 28.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.448 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -138.62 -175.66 4.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.018 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -103.41 149.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.237 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -52.69 -47.28 67.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.013 179.215 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' NZ ' HD12 ' A' ' 58' ' ' ILE . 7.6 ptmt -159.3 143.84 15.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.201 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -119.62 132.08 55.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.922 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HD23 ' A' ' 55' ' ' LEU . 19.7 mm -114.07 132.97 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 111.01 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.55 114.37 27.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.979 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 18.5 mtt180 -115.94 128.76 56.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.586 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' A' ' 17' ' ' LEU . 14.2 p90 -152.71 160.02 43.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.463 0.649 . . . . 0.0 112.016 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG2' ' CE2' ' A' ' 28' ' ' TRP . 3.6 ppt_? -159.42 160.01 28.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.999 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.4 Cg_exo -57.88 117.38 4.08 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.227 1.951 . . . . 0.0 112.42 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -60.28 -38.81 84.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.49 -27.15 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -96.96 -164.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.76 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.03 114.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.18 -179.65 24.93 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.826 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 60.58 88.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.911 0.386 . . . . 0.0 111.159 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.429 ' CE2' ' HG2' ' A' ' 20' ' ' ARG . 43.0 m95 -101.05 -176.53 3.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.2 tttt -151.21 147.53 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.963 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.42 138.87 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.774 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -137.75 111.76 8.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.274 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -89.29 137.89 31.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 111.859 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.21 109.74 8.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.324 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 57.9 Cg_endo -70.87 87.39 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 112.8 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 52.78 39.16 54.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.605 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.89 84.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.026 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' HG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -69.32 -33.56 73.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.443 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.466 ' H ' HD12 ' A' ' 37' ' ' LEU . 9.3 p-10 177.66 -154.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.702 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.4 t -77.15 105.11 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -97.02 127.51 43.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -99.33 147.43 25.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.697 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.49 137.67 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.233 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.4 138.54 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.47 130.35 38.12 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.149 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.762 ' H ' ' HB ' ' A' ' 73' ' ' THR . 2.7 mm? -85.3 -136.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HE2' ' HB ' ' A' ' 49' ' ' VAL . 16.4 tttt -136.79 117.65 11.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.504 0.193 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.09 112.33 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.567 2.178 . . . . 0.0 112.072 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . 122.18 -24.66 6.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.352 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HB ' ' HE2' ' A' ' 46' ' ' LYS . 7.1 p -118.06 137.42 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 77' ' ' SER . 46.7 t -97.09 139.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.517 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 24.8 m-85 -105.26 128.92 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.624 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.38 137.81 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.036 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.03 157.04 27.19 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.823 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.4 143.23 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -107.46 106.14 16.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.134 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD13 ' HD2' ' A' ' 18' ' ' ARG . 4.6 mp -92.26 138.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.132 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -121.0 119.36 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.733 -178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' NZ ' ' A' ' 14' ' ' LYS . 1.1 mt -114.34 127.84 71.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.067 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 61' ' ' TYR . 10.3 pt20 -118.41 -177.39 3.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.985 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.37 -4.62 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 7.6 m-85 -101.27 -5.04 26.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.09 16.02 68.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.198 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -67.31 174.84 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.809 0.305 . . . . 0.0 110.601 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 63' ' ' HIS . 3.0 mm-40 -152.16 95.02 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -97.52 117.99 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.063 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.1 p -127.82 134.04 66.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.8 m -137.53 121.53 17.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 138.95 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.958 0.408 . . . . 0.0 111.476 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.12 157.41 43.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -119.95 121.35 38.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -147.14 159.82 43.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.228 0.537 . . . . 0.0 111.986 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -146.92 166.4 26.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.973 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.762 ' HB ' ' H ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -53.61 -50.19 66.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.738 0.304 . . . . 0.0 111.367 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.555 HG23 HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -125.74 -46.98 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.981 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 48' ' ' GLY . 8.4 t -68.24 -176.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.846 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.01 146.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.846 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.77 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.1 t -84.16 -101.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.434 ' H ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER 51.06 67.81 3.94 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.335 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.32 -167.01 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.43 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.73 8.5 79.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 56.4 p -126.0 -156.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.504 0.192 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 47.66 22.78 0.35 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.609 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -66.83 -27.03 67.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.716 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.34 62.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.748 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.51 -17.54 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -83.51 177.67 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -74.21 153.47 39.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -95.03 132.17 40.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.3 m80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.779 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.828 0.347 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -151.28 135.55 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.2 -105.58 0.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.519 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.9 t 56.24 85.01 0.08 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.44 164.78 4.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.012 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -64.54 131.46 95.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.7 Cg_exo -65.83 119.31 6.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.671 2.247 . . . . 0.0 112.213 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 141.54 7.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.93 171.42 2.13 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.545 2.163 . . . . 0.0 112.551 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -61.75 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.656 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p80 35.07 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.301 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -67.54 155.61 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.733 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 74.9 m -54.09 -39.05 66.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.612 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' H ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -157.14 144.81 18.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.088 0.47 . . . . 0.0 111.37 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.33 126.33 44.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.011 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.6 mt -112.54 135.48 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -105.56 115.27 29.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.775 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.744 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.7 mmm180 -110.06 134.56 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 29' ' ' LYS . 4.3 p90 -161.44 150.45 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.143 0.496 . . . . 0.0 111.609 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.626 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -159.43 152.8 18.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.904 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 51.2 Cg_exo -58.66 117.2 3.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.51 2.14 . . . . 0.0 112.621 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -33.38 74.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.036 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' HG13 ' A' ' 49' ' ' VAL . 8.1 t-20 -92.43 -43.68 9.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.74 -164.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.101 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.51 163.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.7 26.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.38 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 59.56 -179.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.199 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 29.5 m95 -92.77 -178.81 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.85 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.703 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.6 OUTLIER -120.14 133.66 55.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.167 0.508 . . . . 0.0 112.181 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.98 110.83 9.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.83 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 39.8 m -90.95 139.55 30.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.81 HG22 HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.23 106.98 6.7 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.886 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_endo -60.28 90.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.73 60.57 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 57.94 85.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -80.91 -31.97 34.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.505 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 4.7 p-10 -166.76 -170.98 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.57 118.97 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.86 125.52 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.676 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 t -107.76 147.7 30.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.375 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.06 137.46 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.802 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -48.7 155.73 0.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 129.04 49.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 73' ' ' THR . 2.9 mm? -74.71 -136.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.5 ttmm -153.38 134.6 8.43 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 21.0 Cg_exo -65.09 117.01 4.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 112.25 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.26 54.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 23' ' ' ASN . 2.2 t -118.86 131.36 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.653 ' HA ' HG22 ' A' ' 72' ' ' THR . 41.3 t -99.92 136.45 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.641 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD1' HD12 ' A' ' 45' ' ' LEU . 22.1 m-85 -105.96 118.91 37.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 18.8 pt-20 -80.07 137.89 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 147.49 19.0 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.854 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' OE1' HD11 ' A' ' 56' ' ' ILE . 1.4 tt0 -132.97 150.54 52.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' ILE . 30.1 tp -123.93 110.19 14.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 111.588 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 6.0 mt -97.52 138.35 22.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.609 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -114.2 121.73 44.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' C ' HD11 ' A' ' 12' ' ' ILE . 2.4 mt -111.79 124.58 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.11 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.45 178.36 4.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.47 -14.57 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -101.35 -4.53 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.39 64.22 4.44 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.652 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 61.42 87.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.443 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.609 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.257 179.145 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG13 ' HG3' ' A' ' 54' ' ' GLN . 16.3 t -134.07 136.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m -138.09 121.13 16.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.605 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 68' ' ' ARG . 5.0 mtt180 -91.86 146.16 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 111.87 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -156.17 146.49 21.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.212 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -114.41 133.08 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 45' ' ' LEU . 34.6 p90 -144.5 148.36 34.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 112.253 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 50' ' ' VAL . 16.2 p -144.65 162.51 36.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.974 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.835 HG23 HG22 ' A' ' 74' ' ' THR . 4.2 t -83.2 -31.75 26.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.632 0.254 . . . . 0.0 111.334 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.835 HG22 HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -163.84 -6.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.449 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 72' ' ' THR . 24.4 t -53.47 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.056 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -169.45 -171.88 1.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 78' ' ' THR . 2.6 m 58.77 -133.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.437 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 56.28 58.92 9.04 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 120.627 0.251 . . . . 0.0 111.175 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 78' ' ' THR . 81.1 Cg_endo -89.77 -172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.761 2.307 . . . . 0.0 112.43 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.25 25.12 29.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.31 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -106.24 16.53 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -91.49 44.45 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 m 54.57 59.67 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -56.28 143.56 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.125 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 156.19 48.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.634 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 142.92 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.9 m80 56.24 -162.4 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -77.6 -38.8 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.747 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.765 0.317 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.67 -174.6 3.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.66 -23.8 34.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.1 p 48.7 38.26 11.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.45 58.64 4.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.56 61.18 7.32 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.37 -59.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.7 2.267 . . . . 0.0 112.548 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -148.26 108.7 3.65 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.58 150.79 67.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.597 2.198 . . . . 0.0 112.633 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -114.92 145.28 42.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 57.85 -114.74 0.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -98.37 143.16 13.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.844 0.355 . . . . 0.0 111.186 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -60.19 -46.83 88.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.155 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 143.97 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.064 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -111.82 135.29 52.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.24 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 58' ' ' ILE . 3.3 mp -114.15 133.09 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 110.467 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' HG ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.24 114.29 25.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.269 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.801 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -115.63 127.96 55.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 28' ' ' TRP . 20.7 p90 -144.86 161.37 39.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.953 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -156.54 150.85 19.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.7 Cg_exo -57.54 125.52 19.04 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.363 2.042 . . . . 0.0 112.719 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.503 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 37.9 tttp -76.66 -38.61 54.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.129 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -84.12 -39.58 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -98.3 142.95 29.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.785 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.54 132.33 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.973 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.39 -142.41 3.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -114.89 175.96 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.854 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 30.7 m95 -89.46 -167.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.5 mttp -152.38 155.9 38.5 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -122.17 130.39 53.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.512 . . . . 0.0 112.061 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.3 111.12 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.102 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 99.7 m -90.04 141.07 29.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 112.0 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.507 HG13 ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -138.24 107.65 8.01 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.221 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HG2' HD22 ' A' ' 37' ' ' LEU . 36.4 Cg_endo -65.25 92.72 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.456 2.104 . . . . 0.0 112.093 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -98.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -165.75 70.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.702 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 37' ' ' LEU . 1.5 pt? -72.27 -33.03 67.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 2.4 p-10 -164.33 -179.73 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t -79.74 108.48 13.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.09 110.3 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.666 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -115.58 144.88 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.77 125.38 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.986 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -119.36 153.41 35.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 45' ' ' LEU . . . 126.65 13.31 3.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.734 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.4 OUTLIER -104.14 -166.11 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.51 0.195 . . . . 0.0 110.614 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.24 156.14 20.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.566 0.222 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 29.8 Cg_endo -63.34 104.76 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.478 2.119 . . . . 0.0 112.002 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.86 -14.66 4.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.043 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.4 t -116.26 124.99 73.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 72' ' ' THR . 89.6 t -110.23 133.36 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' CE1' HD22 ' A' ' 45' ' ' LEU . 57.6 m-85 -109.3 126.55 53.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.93 131.4 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.79 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 19' ' ' TRP . . . -139.68 161.87 26.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.614 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.754 ' HG3' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -134.58 152.78 52.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.886 0.474 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.0 mt -124.18 106.87 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.543 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CD ' ' A' ' 18' ' ' ARG . 87.3 mt -94.46 138.53 20.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.275 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.597 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.73 119.14 32.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.288 0.566 . . . . 0.0 111.345 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.692 HD12 HD13 ' A' ' 16' ' ' ILE . 28.9 mt -114.15 125.19 71.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.764 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.34 173.37 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 5.1 pt20 -65.83 -18.45 65.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.226 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -102.25 9.64 39.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.78 -114.28 4.95 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.801 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.54 -174.91 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.962 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.66 99.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.34 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 5.0 tt0 -96.81 116.33 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.8 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' GLN . 1.2 p -131.17 131.18 63.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.3 m -137.72 125.09 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.326 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.58 147.1 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.28 . . . . 0.0 110.746 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' HZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -155.96 155.61 33.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.006 0.432 . . . . 0.0 111.64 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -116.75 133.44 56.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -147.86 150.72 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.23 166.68 26.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.293 178.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.734 HG22 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -65.76 -39.5 91.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.23 -41.12 0.58 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 6.9 t -78.61 34.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.318 . . . . 0.0 111.154 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.567 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -62.21 157.24 19.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.406 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -139.48 53.53 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 85.73 2.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.581 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.6 -71.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.875 2.383 . . . . 0.0 112.817 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -40.23 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.946 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.11 86.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.913 0.387 . . . . 0.0 110.982 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -172.17 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.724 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.8 p -123.55 -5.35 8.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.952 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.454 ' HB3' ' H ' ' A' ' 85' ' ' HIS . 0.3 OUTLIER -79.72 -88.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -126.99 167.26 16.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.957 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -97.93 61.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -129.7 47.04 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.44 68.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.77 15.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.52 -163.25 44.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 p -145.46 166.59 25.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.707 0.289 . . . . 0.0 110.794 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.4 m120 61.0 15.55 6.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.0 81.0 0.27 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -65.82 154.13 75.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.666 2.244 . . . . 0.0 112.175 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -71.9 112.39 14.14 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.24 84.64 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.605 2.204 . . . . 0.0 112.127 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.99 -24.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.027 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -105.92 -161.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -67.48 149.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.974 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -55.33 -50.58 69.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.248 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.6 pttt -171.12 144.8 2.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.629 ' CD1' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -102.03 154.23 19.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.738 179.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.73 147.77 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 111.376 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -134.0 109.32 8.91 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.339 176.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.761 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 6.0 mtp180 -122.84 127.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 5.6 p90 -161.08 159.68 29.49 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.354 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.95 165.92 17.47 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.343 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -54.29 115.88 2.68 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 121.283 1.322 . . . . 0.0 112.619 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB3' HG13 ' A' ' 50' ' ' VAL . 6.3 tptm -34.05 -53.6 0.47 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.79 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -101.67 -44.41 5.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.866 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.42 ' C ' ' HB2' ' A' ' 21' ' ' PRO . 47.0 t -76.61 -177.24 4.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.94 132.18 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.15 34.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.522 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.58 139.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.421 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 62.0 m95 -60.3 167.08 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.723 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -132.29 158.91 40.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 30' ' ' GLU . 10.5 pm0 -138.11 127.92 25.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.356 0.598 . . . . 0.0 112.431 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 17' ' ' LEU . . . -143.14 122.47 13.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -107.47 120.97 43.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.702 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.63 107.26 34.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.559 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.7 Cg_endo -72.67 110.75 3.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.316 2.011 . . . . 0.0 112.42 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.47 -120.78 23.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.508 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -143.73 68.52 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -65.64 -33.03 74.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.928 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -174.42 -172.42 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.9 m -85.2 105.74 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -93.5 107.56 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.484 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.92 140.38 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.423 HD13 ' HZ ' ' A' ' 71' ' ' PHE . 2.3 mp -100.18 130.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.71 75.77 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.113 0.483 . . . . 0.0 111.287 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.725 ' H ' HD12 ' A' ' 45' ' ' LEU . . . -150.4 11.0 0.86 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.285 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.78 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -124.82 -152.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.755 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.968 ' HA ' ' H ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 160.52 162.0 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 123.728 0.643 . . . . 0.0 110.492 178.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 11.3 Cg_endo -54.31 -6.9 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.544 2.163 . . . . 0.0 112.123 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.63 -46.57 4.25 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.955 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.656 ' O ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -113.78 136.87 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 111.544 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 22' ' ' LYS . 3.0 p -103.02 117.57 48.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' HD23 ' A' ' 45' ' ' LEU . 30.4 m-85 -102.05 125.88 48.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.788 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 2.1 tt0 -78.7 126.73 31.13 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.654 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -115.29 159.6 13.69 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.062 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.2 tt0 -133.48 114.46 13.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.0 111.762 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -101.36 106.2 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.976 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 51.2 mt -116.49 120.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.716 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.52 138.18 35.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.902 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.8 mp -117.71 130.6 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.46 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.99 -176.58 6.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.04 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 4.5 pt20 -61.05 -30.59 70.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.913 0.387 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.488 ' N ' ' HG3' ' A' ' 60' ' ' GLN . 2.1 p90 -103.24 -4.64 24.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 105.83 156.99 22.17 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.669 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 22.2 m80 65.97 135.97 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.362 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.643 ' HB2' ' O ' ' A' ' 57' ' ' SER . 1.9 mm-40 -166.49 -57.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.769 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tp10 -145.51 144.6 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.511 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.7 t -134.77 121.69 35.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.72 0.295 . . . . 0.0 111.779 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 121.69 17.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.23 121.81 45.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.735 0.303 . . . . 0.0 111.132 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -151.97 131.56 13.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.627 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.788 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.9 p30 -92.95 138.73 31.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.423 ' HZ ' HD13 ' A' ' 42' ' ' ILE . 28.8 p90 -141.31 161.89 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.366 . . . . 0.0 111.872 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.19 134.45 20.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.902 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' C ' ' A' ' 72' ' ' THR . 1.4 t 162.77 78.86 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.968 ' H ' ' HA ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -160.31 -169.57 2.52 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.746 -0.596 . . . . 0.0 111.132 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER 75.95 76.96 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.5 -153.77 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.62 62.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.535 HG22 ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -168.21 150.54 5.17 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.754 0.311 . . . . 0.0 111.493 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HD2' HG22 ' A' ' 78' ' ' THR . 0.2 OUTLIER -28.95 143.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.281 3.321 . . . . 0.0 113.973 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.97 102.9 0.23 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.43 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.4 p -162.64 -176.04 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -124.8 -179.39 4.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 132.51 9.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -165.75 27.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.702 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 38.1 m80 64.31 159.09 0.09 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.241 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -92.94 75.98 4.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -133.55 100.58 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.2 2.15 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.067 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.956 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tpp . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.811 0.339 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 ttp-105 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.03 -30.45 4.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.15 94.67 9.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -82.99 -48.89 10.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.55 74.07 40.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.226 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.05 -26.11 6.79 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.974 2.45 . . . . 0.0 112.241 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -58.94 133.59 87.11 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.063 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.73 93.51 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.418 2.079 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.52 -63.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -167.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.743 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.688 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.3 tp -84.51 153.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.1 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.678 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -56.52 -45.32 81.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.48 144.04 8.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.778 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.2 156.61 17.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.505 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -120.78 148.42 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.355 0.598 . . . . 0.0 111.347 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.468 ' H ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -133.06 109.85 9.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.745 176.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.798 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt180 -118.37 127.84 54.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.2 p90 -161.35 153.65 20.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 117.901 -1.52 . . . . 0.0 114.904 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.83 164.07 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.025 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -56.73 110.63 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 121.584 1.523 . . . . 0.0 112.588 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 50' ' ' VAL . 9.0 tptt -30.79 -47.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.379 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 -44.06 7.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.807 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -79.51 82.71 5.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 110.842 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.92 145.32 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.76 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -134.28 125.01 26.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.953 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.484 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 68.1 m95 -64.12 171.48 2.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.1 mttt -120.96 162.92 19.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -134.48 123.92 24.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.098 0.475 . . . . 0.0 112.031 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.92 111.78 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.97 118.16 35.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 111.405 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.033 HG22 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -132.75 111.51 13.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.463 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.8 Cg_exo -46.61 160.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.64 2.227 . . . . 0.0 113.024 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.24 105.05 0.28 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.664 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 44.17 39.08 2.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.7 -16.61 61.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.839 0.352 . . . . 0.0 110.546 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.709 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -172.57 169.62 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -83.57 106.3 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -117.79 120.04 36.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 m -116.38 146.45 42.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG21 ' HZ ' ' A' ' 71' ' ' PHE . 2.5 mp -94.95 117.66 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.44 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.51 61.77 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.187 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.44 -17.23 4.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.888 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -92.43 137.78 32.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.408 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 49' ' ' VAL . 15.7 pttt -104.01 161.5 22.74 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.333 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.667 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 38.5 Cg_exo -55.83 96.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.252 1.968 . . . . 0.0 112.832 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.37 -9.49 3.5 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.847 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' HB ' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -120.55 138.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.313 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 22' ' ' LYS . 2.4 p -112.62 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.211 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 34.1 m-85 -105.39 124.9 50.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.25 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 1.017 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 10.3 tt0 -79.53 126.6 31.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -112.98 156.63 15.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.583 ' NE2' HD11 ' A' ' 56' ' ' ILE . 60.3 tt0 -132.7 114.58 14.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.226 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -100.54 106.18 17.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 77.0 mt -116.9 121.26 67.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.4 m -82.22 135.98 35.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.501 . . . . 0.0 110.071 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.688 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.7 mt -117.03 132.38 66.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.021 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.723 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -95.2 -175.68 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.321 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.4 ' OE1' ' HB3' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -60.41 -27.43 67.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 12.2 p90 -103.31 -5.49 22.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.747 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.688 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 97.87 151.87 27.76 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.921 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 66.2 129.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 111.447 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 5.7 mm100 -156.53 -51.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.26 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.6 tt0 -144.11 145.15 31.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 56' ' ' ILE . 58.0 t -134.62 123.25 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.277 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -137.34 120.5 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.939 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -112.9 118.42 34.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.68 137.49 13.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.661 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 1.017 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 16.1 p-10 -92.3 135.28 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.152 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.494 ' HZ ' HG21 ' A' ' 42' ' ' ILE . 9.1 p90 -140.82 162.97 34.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.063 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -149.85 131.52 14.95 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.02 177.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.638 ' H ' HD23 ' A' ' 45' ' ' LEU . 5.0 t -84.48 12.21 7.3 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.667 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -118.33 -179.9 3.92 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.157 -175.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.77 -164.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.545 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.02 95.6 1.87 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 m -166.15 -164.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.591 HG22 ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -169.35 162.47 7.42 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.74 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 78' ' ' THR . 23.9 Cg_endo -89.47 1.8 5.71 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.012 2.475 . . . . 0.0 113.03 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.41 -61.21 0.28 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.788 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.423 ' HB3' ' H ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER 62.58 -89.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.59 0.233 . . . . 0.0 111.079 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' H ' ' HB3' ' A' ' 81' ' ' SER . 0.0 OUTLIER -110.49 160.43 16.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -127.8 -72.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -124.36 -87.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -27.13 0.86 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -165.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -100.09 105.84 17.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -156.99 -43.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.893 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.887 0.375 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 2' ' ' ARG . 4.7 ptp85 -104.1 -40.06 6.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.773 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.31 -166.31 12.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -165.94 -171.5 2.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -74.38 -80.15 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.74 66.05 2.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -88.2 14.55 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.123 2.549 . . . . 0.0 112.194 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.38 84.78 0.2 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.79 159.62 45.02 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.079 . . . . 0.0 112.386 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -46.9 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.437 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 4.5 p-80 -144.25 168.25 20.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.048 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.689 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -96.79 151.36 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.689 ' N ' HG13 ' A' ' 12' ' ' ILE . 20.3 m -49.74 -49.25 48.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -168.47 144.16 3.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.103 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -106.7 156.97 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.715 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.66 147.61 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -133.34 109.61 9.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.606 177.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.17 127.15 44.07 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.696 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -162.54 164.6 26.79 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.449 -1.3 . . . . 0.0 114.117 -176.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 138.01 10.2 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 113.681 -1.6 . . . . 0.0 108.219 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 13.9 Cg_endo -55.57 109.34 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.172 1.915 . . . . 0.0 111.37 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.721 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -49.79 -59.22 4.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.808 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -62.77 -43.94 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.303 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -103.3 67.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.806 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -47.05 137.8 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.345 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.14 -82.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -154.17 148.77 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -67.11 170.68 6.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.3 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.8 tptt -138.0 165.8 25.66 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.3 pt-20 -142.32 126.28 17.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.901 0.381 . . . . 0.0 111.808 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.92 129.69 21.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -105.09 119.5 39.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 111.538 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -116.81 106.67 47.53 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.548 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 9.7 Cg_exo -72.0 97.64 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.683 2.255 . . . . 0.0 113.044 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 45.15 44.83 9.89 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.217 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 56.15 79.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.3 -32.9 72.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.776 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -165.3 -164.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.638 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.26 105.65 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -122.99 107.85 12.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.35 147.36 45.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.554 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.628 HD12 ' HZ ' ' A' ' 71' ' ' PHE . 14.8 mt -90.77 137.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 149.59 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.254 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 113.55 23.46 5.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.855 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.6 OUTLIER -125.61 171.95 10.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.526 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.959 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 4.8 pttt -178.35 165.7 1.12 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.697 ' HD3' ' HA ' ' A' ' 74' ' ' THR . 92.3 Cg_exo -47.61 -22.98 3.3 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.587 2.191 . . . . 0.0 112.218 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.51 -36.2 17.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.405 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -114.2 124.22 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 120.992 0.425 . . . . 0.0 111.782 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' A' ' 22' ' ' LYS . 1.8 p -102.04 131.22 50.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m-85 -112.18 119.21 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.518 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -78.98 127.77 32.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -127.71 158.1 21.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.898 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.7 tt0 -133.63 121.18 21.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.552 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 6.0 mt -110.22 106.84 16.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.024 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.728 ' H ' HG22 ' A' ' 16' ' ' ILE . 32.4 mt -112.55 119.6 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.897 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.663 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.63 135.04 35.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.357 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.5 mp -117.33 132.16 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.897 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.82 -176.78 5.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.487 179.024 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 0.6 OUTLIER -63.61 -30.28 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.578 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -102.6 1.07 34.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 101.46 150.23 23.52 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.028 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 65.83 144.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 111.578 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -169.2 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.072 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -144.56 144.08 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.612 -178.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 56' ' ' ILE . 84.7 t -133.91 114.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -137.1 120.3 16.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -112.22 133.98 54.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.94 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 4.4 p90 -156.56 154.83 30.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.932 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -100.88 122.0 42.69 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.628 ' HZ ' HD12 ' A' ' 42' ' ' ILE . 2.4 p90 -138.62 163.8 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.387 0.613 . . . . 0.0 111.826 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.606 ' O ' HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -139.26 134.44 32.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.693 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.855 HG22 ' HB2' ' A' ' 45' ' ' LEU . 3.6 t -55.39 -31.4 61.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 110.261 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.959 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 68.6 p 55.75 112.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.345 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 t -77.75 43.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.271 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.01 119.3 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.7 m -147.49 12.64 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.175 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -167.95 69.6 0.86 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.25 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.28 20.21 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.737 2.291 . . . . 0.0 112.545 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.15 37.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m 55.89 88.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.857 0.36 . . . . 0.0 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -68.52 -74.2 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m 55.04 -162.94 0.14 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -132.35 101.59 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -118.65 162.66 18.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -107.55 -8.23 16.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -118.35 -61.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.79 100.82 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.969 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptp . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.766 0.317 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER 57.68 -169.92 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.187 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.4 -155.69 19.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.631 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -111.35 135.55 51.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.326 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -121.64 71.26 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.02 125.43 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.201 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.78 140.68 56.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.32 2.014 . . . . 0.0 112.233 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -116.5 157.9 44.61 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.25 -165.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.761 2.308 . . . . 0.0 112.538 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.441 ' HB2' ' H ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -67.39 -155.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.561 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.441 ' H ' ' HB2' ' A' ' 10' ' ' SER . 11.7 m80 62.28 172.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.6 OUTLIER -75.33 145.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.9 t -53.02 -44.96 67.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.88 0.372 . . . . 0.0 110.106 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.7 pttt -175.8 146.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.964 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -101.38 154.37 18.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.605 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -114.89 147.96 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.408 0.623 . . . . 0.0 112.037 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -132.14 109.53 10.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.536 176.045 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -117.93 127.47 53.88 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.668 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -158.66 159.98 35.96 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.435 -1.306 . . . . 0.0 113.405 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HG3' ' CE3' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -157.46 155.84 28.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.194 178.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 17.1 Cg_endo -54.08 109.79 0.43 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 122.347 2.032 . . . . 0.0 111.202 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB3' HG13 ' A' ' 50' ' ' VAL . 1.1 tmtp? -45.83 -55.27 6.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.205 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.55 -43.87 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.799 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 8.5 t -71.07 150.89 45.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.988 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.97 135.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.031 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.39 -159.85 22.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.55 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 14.6 ptp180 -116.75 164.25 14.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.49 ' CE3' ' HG3' ' A' ' 20' ' ' ARG . 60.7 m95 -66.46 167.79 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.52 160.08 37.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.03 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 123.79 24.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 111.969 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.44 112.4 7.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.107 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 130.42 44.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 112.193 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.86 HG22 HD11 ' A' ' 37' ' ' LEU . 1.1 pt -137.2 106.44 8.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.672 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 85.5 Cg_endo -81.92 122.0 3.75 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 35.46 7.48 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.375 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 50.48 78.25 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.986 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.21 -30.62 71.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.495 ' H ' HD12 ' A' ' 37' ' ' LEU . 12.1 t-20 -168.26 174.88 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -77.09 105.12 7.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.219 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -115.57 117.05 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.613 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 141.86 47.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.409 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 17' ' ' LEU . 2.8 mp -86.76 134.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.882 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.47 53.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.51 2.63 24.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.281 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -108.41 129.35 55.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.388 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -111.52 163.34 17.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.542 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.64 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.3 Cg_endo -49.82 95.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.639 2.226 . . . . 0.0 112.671 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.21 -6.73 5.37 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.778 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -120.77 138.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.737 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.8 p -115.13 133.96 59.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.502 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 45' ' ' LEU . 17.3 m-85 -116.43 130.03 56.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.583 0.23 . . . . 0.0 111.331 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 37.8 tt0 -88.27 127.8 35.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -117.09 155.24 16.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.704 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 30.5 tt0 -132.27 114.45 14.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 4.9 mt -103.12 106.77 17.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.111 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLU . 96.7 mt -117.09 122.67 70.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.0 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.25 134.73 35.65 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 16' ' ' ILE . 1.7 mp -120.26 130.7 74.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.693 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 4.7 mm100 -126.12 -174.02 3.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -6.6 27.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.828 0.347 . . . . 0.0 111.011 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -103.05 -4.76 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.707 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.39 161.93 5.87 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.805 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.1 t60 66.69 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.693 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 59.65 -95.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.571 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.65 144.27 51.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.869 -178.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.65 126.3 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.15 124.46 21.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 125.6 54.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.241 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' CE1' HD12 ' A' ' 55' ' ' LEU . 16.3 p90 -156.31 127.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 111.928 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.777 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.56 133.32 39.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.978 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -140.95 163.69 32.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.617 0.722 . . . . 0.0 112.515 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.968 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -148.18 133.18 18.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.554 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.556 HG22 HD13 ' A' ' 45' ' ' LEU . 4.7 t -83.22 28.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.781 HG23 ' OG1' ' A' ' 72' ' ' THR . 0.5 OUTLIER -140.95 -71.18 0.36 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -177.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.451 ' N ' ' OG1' ' A' ' 74' ' ' THR . 0.2 OUTLIER -57.02 -68.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 72' ' ' THR . 23.3 p 50.13 37.35 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 110.912 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.585 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.6 OUTLIER 60.03 -160.48 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.062 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 7.5 t 42.66 41.43 0.58 Allowed Pre-proline 0 N--CA 1.469 0.496 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.665 ' HD3' ' N ' ' A' ' 78' ' ' THR . 34.4 Cg_endo -100.26 47.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.37 2.047 . . . . 0.0 112.429 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.84 142.99 16.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.835 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.59 89.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.736 0.303 . . . . 0.0 110.781 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -106.77 70.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 t -165.74 113.33 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -70.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.044 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -121.14 -68.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.183 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.11 139.65 46.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.81 -26.32 7.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 88.02 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.801 0.334 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -148.39 -12.62 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.77 -3.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.482 -0.865 . . . . 0.0 112.851 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -76.34 79.23 3.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -147.85 155.36 41.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.97 75.45 0.57 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.94 118.66 5.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.532 2.155 . . . . 0.0 112.255 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -89.4 159.27 44.69 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.686 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -42.79 -73.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.729 2.286 . . . . 0.0 112.391 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -168.84 7.94 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.696 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -135.09 132.41 38.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.945 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.928 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -95.07 154.02 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.414 179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.718 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.2 m -46.26 -41.07 12.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 17.1 pttt -174.2 143.5 0.89 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.562 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -101.41 147.36 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -115.04 148.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 121.183 0.516 . . . . 0.0 111.219 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -126.03 109.35 12.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.005 176.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.2 mtt-85 -118.2 125.87 51.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.712 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -156.2 157.01 35.14 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 117.878 -1.529 . . . . 0.0 114.133 -176.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.76 151.76 17.05 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.871 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 54.2 Cg_exo -53.61 108.64 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 120.888 1.058 . . . . 0.0 111.242 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' H ' ' H ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -21.9 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.896 -179.15 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -44.15 6.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.226 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.31 67.52 9.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.289 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -53.82 124.17 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.882 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.09 76.23 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.697 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 27' ' ' ARG . 6.5 mtt-85 65.08 125.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 0.0 111.544 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -62.28 166.96 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.779 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mmpp? -127.33 152.83 46.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.17 124.26 34.18 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -142.94 111.66 6.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.981 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 111.88 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -138.58 106.92 7.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.184 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 61.3 Cg_endo -72.29 111.87 3.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.234 1.956 . . . . 0.0 113.1 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.75 11.45 36.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.173 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.18 84.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.7 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.0 -18.35 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.765 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' OD1' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -160.48 -178.71 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.726 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.97 105.82 9.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -99.69 105.68 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -122.07 146.03 47.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.225 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.02 134.33 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -108.63 -4.89 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.909 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.48 -63.08 5.4 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.394 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.796 HD12 HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.748 0.419 . . . . 0.0 111.333 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -102.78 157.39 33.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.557 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.653 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 1.1 Cg_endo -42.37 104.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.383 2.722 . . . . 0.0 113.351 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.47 -12.02 8.43 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.447 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 46' ' ' LYS . 8.1 p -120.85 139.35 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.827 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.5 p -111.26 128.42 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.818 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.871 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 21.3 m-85 -107.55 120.36 41.98 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.003 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.931 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 14.8 tt0 -80.13 127.08 31.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -116.04 152.63 17.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mt-30 -130.9 117.06 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 111.602 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.2 mt -100.22 106.27 17.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.17 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.9 mp -109.44 113.92 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.742 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.928 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.1 m -87.58 121.23 29.76 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.192 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 64' ' ' GLN . 1.9 mt -114.6 133.32 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.408 0.623 . . . . 0.0 112.577 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.639 ' H ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -96.6 -174.89 3.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.741 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.64 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.24 4.14 36.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.716 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 58' ' ' ILE . . . 92.53 -133.41 11.72 Favored Glycine 0 N--CA 1.454 -0.128 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.869 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -43.83 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.887 0.375 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . 46.3 tp60 -110.45 -52.56 2.77 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 56' ' ' ILE . 1.8 mm-40 -146.52 144.95 29.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 111.243 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -135.96 131.78 49.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.67 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.91 126.39 23.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.057 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -112.69 123.66 50.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.559 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -155.62 126.89 7.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.463 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.931 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -93.33 139.0 31.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.091 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -145.27 159.51 42.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.428 0.632 . . . . 0.0 111.979 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.827 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -149.6 132.4 16.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.299 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.796 HG22 HD12 ' A' ' 45' ' ' LEU . 2.4 t -93.38 11.58 27.83 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.653 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -107.13 -24.38 11.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 112.426 -2.17 . . . . 0.0 111.317 -177.331 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -98.33 42.02 1.11 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.678 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.2 p -130.67 -51.15 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 78' ' ' THR . 2.4 p -98.55 -154.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.669 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 15.3 t -147.09 39.54 0.23 Allowed Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 78' ' ' THR . 48.7 Cg_endo -93.3 177.97 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.137 1.891 . . . . 0.0 112.585 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.21 -111.94 1.15 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.447 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.71 -163.03 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 58.31 16.12 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.7 t -164.71 -96.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.04 22.55 4.52 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.0 178.2 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.53 86.55 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -136.47 136.45 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t60 55.8 70.67 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.888 -179.938 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.745 0.307 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 54.74 57.16 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.795 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.55 -153.4 24.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.4 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m 58.99 89.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.93 40.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 62.9 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.308 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.31 122.67 11.12 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.575 2.183 . . . . 0.0 112.296 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.466 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 6.0 mt-30 -68.3 111.86 9.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.728 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.45 169.58 9.47 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.455 2.104 . . . . 0.0 112.075 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 t -78.16 1.62 20.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -147.78 176.58 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -79.52 148.45 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' HG13 ' A' ' 12' ' ' ILE . 66.2 m -49.51 -45.73 47.57 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 1.1 pttt -170.77 143.46 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.093 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -107.85 147.18 31.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.594 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.571 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -115.72 145.08 21.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 179.118 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -122.93 111.83 17.1 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -117.86 128.6 54.99 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.739 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -159.46 162.97 35.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.996 0.903 . . . . 0.0 113.301 -178.233 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.578 HH12 ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -159.6 144.24 11.19 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.761 178.36 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 10.8 Cg_endo -54.61 112.43 1.01 Allowed 'Trans proline' 0 C--N 1.335 -0.142 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' HH12 ' A' ' 20' ' ' ARG . 6.0 tptt -51.6 -34.28 36.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.223 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -98.29 -44.06 6.71 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.275 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -79.6 127.4 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.398 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.4 p -72.52 115.06 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.932 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.24 -169.32 20.93 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.35 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -64.6 176.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -136.79 159.99 40.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.582 179.297 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -141.79 128.52 20.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.44 . . . . 0.0 111.295 -179.751 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.02 114.44 8.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -93.77 115.58 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 111.823 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.67 107.55 33.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.027 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 28.1 Cg_exo -61.07 90.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.312 2.008 . . . . 0.0 112.925 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.8 52.9 6.48 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.225 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 t60 52.63 60.8 3.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -65.86 -22.27 66.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.538 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.617 ' HB3' HD22 ' A' ' 37' ' ' LEU . 3.4 p-10 -170.53 -171.84 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.2 105.46 9.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -97.97 130.19 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -101.37 148.01 25.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.184 0.516 . . . . 0.0 112.259 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 44' ' ' GLY . 18.7 mt -94.28 138.58 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.653 179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.743 ' HD2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -32.97 -41.67 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.015 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 120.74 114.36 2.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.189 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.872 ' HB3' HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -100.63 122.84 43.97 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.704 0.288 . . . . 0.0 110.499 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.995 ' O ' HG21 ' A' ' 73' ' ' THR . 0.0 OUTLIER -83.76 135.13 43.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.95 -178.816 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 3.4 Cg_exo -39.15 144.4 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.982 3.121 . . . . 0.0 114.537 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.27 -5.85 68.23 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.055 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.4 138.13 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.831 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.1 p -97.38 122.44 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 45' ' ' LEU . 38.2 m-85 -110.75 133.48 53.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -97.49 129.12 44.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.018 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -124.12 150.88 17.06 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.778 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 44.4 tt0 -132.62 144.42 50.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 111.482 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD12 ' HG ' ' A' ' 17' ' ' LEU . 1.3 mp -123.06 107.66 12.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.409 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.571 ' HB ' HG22 ' A' ' 16' ' ' ILE . 82.0 mt -114.0 117.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.744 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -82.21 138.5 34.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.389 0.614 . . . . 0.0 111.025 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG23 ' HA2' ' A' ' 62' ' ' GLY . 4.2 mt -118.16 132.24 68.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.951 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.69 -176.41 3.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 178.657 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.41 -29.92 70.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -103.08 -1.55 28.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 95.22 155.47 31.39 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 75.3 t60 65.94 126.55 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.699 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 2.9 mm-40 -155.6 -56.96 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.6 tt0 -145.4 143.82 30.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.436 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.88 115.79 19.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.299 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m -136.15 121.58 19.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.291 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.17 139.62 43.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.38 135.97 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 4.1 p-10 -95.94 137.47 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 50' ' ' VAL . 29.4 p90 -141.43 165.57 27.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 18.1 p -99.12 166.4 11.26 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.995 HG21 ' O ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -51.54 175.58 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.298 -178.402 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.684 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -98.68 -55.99 2.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.058 -178.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.505 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 5.9 p 54.04 22.37 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.348 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 74' ' ' THR . 3.5 t -157.87 68.23 0.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.097 0.475 . . . . 0.0 110.831 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.58 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 m -62.26 -178.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.166 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.622 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 12.4 t -91.07 -27.91 0.31 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 78' ' ' THR . 75.4 Cg_endo -80.34 -163.97 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.293 1.995 . . . . 0.0 112.508 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.85 -9.17 7.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.344 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 178.91 6.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.96 114.93 29.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 24.45 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.826 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 65.28 154.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 167.1 16.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -63.36 157.48 22.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.728 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.3 148.82 20.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.071 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.91 139.22 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.034 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -98.17 87.58 3.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.15 177.73 16.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.487 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -105.14 -81.33 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.632 0.254 . . . . 0.0 110.82 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 56.02 -159.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.74 113.9 8.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.08 -18.75 30.16 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.632 2.221 . . . . 0.0 112.411 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -112.09 99.25 45.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.93 162.78 34.29 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.528 2.152 . . . . 0.0 112.497 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.99 81.69 7.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.855 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.748 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 6.5 p80 -74.41 165.87 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.229 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.736 HG13 ' N ' ' A' ' 13' ' ' SER . 0.6 OUTLIER -88.44 152.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.051 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.736 ' N ' HG13 ' A' ' 12' ' ' ILE . 39.0 t -52.32 -45.21 65.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.065 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.798 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 21.4 pttt -174.6 144.53 0.86 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.685 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.16 157.22 17.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.876 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.64 147.7 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 121.181 0.515 . . . . 0.0 111.181 179.473 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -128.2 110.42 12.4 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.626 176.525 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.776 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.5 mtp-105 -122.37 125.63 46.32 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.561 ' CB ' ' HA2' ' A' ' 53' ' ' GLY . 2.0 p90 -162.89 153.3 16.45 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.356 -177.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -159.95 162.72 24.0 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.766 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 15.2 Cg_endo -56.75 124.03 15.27 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 C-N-CA 122.656 2.238 . . . . 0.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 54.3 tttt -67.32 -44.03 80.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.883 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -89.75 -36.55 15.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.962 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 3.1 m -85.08 -18.17 35.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.501 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 25' ' ' VAL . 5.7 p 33.62 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.296 0.57 . . . . 0.0 112.102 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . -108.33 -106.8 3.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.901 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 152.87 36.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -74.8 150.94 39.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.252 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.776 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -121.84 140.43 52.39 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -122.23 128.84 51.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.64 115.39 9.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.674 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.37 118.19 33.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 111.331 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -129.84 112.27 17.44 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.2 Cg_exo -52.11 175.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.672 2.248 . . . . 0.0 112.481 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . -43.17 94.86 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.18 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 35' ' ' GLY . 1.1 p-80 22.75 72.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.358 0.663 . . . . 0.0 112.613 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -69.23 -30.29 68.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.328 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 37' ' ' LEU . 3.4 p-10 -174.25 -163.41 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -90.81 105.82 18.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.019 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -116.73 113.1 22.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -128.69 146.57 50.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.8 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -165.1 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 0.0 111.563 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.14 25.5 75.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.683 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.953 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -125.2 -178.68 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.189 -179.538 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.51 142.04 35.71 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.95 104.37 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.566 2.177 . . . . 0.0 111.977 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.66 -13.95 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.378 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.983 ' HB ' HG23 ' A' ' 74' ' ' THR . 2.2 t -116.52 139.62 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 117.195 0.497 . . . . 0.0 111.441 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -76.59 146.29 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.111 0.481 . . . . 0.0 109.964 178.488 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HE2' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -143.98 101.05 3.67 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.093 -179.949 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.4 pt-20 -77.58 126.81 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.962 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -126.35 152.03 18.17 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.632 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -134.8 141.62 46.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 111.583 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 1.5 mt -121.38 106.21 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.663 178.584 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.667 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.6 mp -116.01 118.34 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.781 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -82.03 133.63 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.573 0.701 . . . . 0.0 111.144 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.28 133.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.594 ' HB2' ' CG ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -117.12 -175.45 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.29 178.465 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -63.92 -13.63 47.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.473 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -103.15 -4.97 23.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 143.87 0.88 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.511 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 60.48 107.38 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.645 0.26 . . . . 0.0 110.981 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.671 ' HB2' ' O ' ' A' ' 57' ' ' SER . 23.6 mm100 -129.85 -67.19 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.96 146.67 50.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.99 -178.537 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.77 126.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.293 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.15 132.38 41.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 117.43 33.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -144.47 126.92 15.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.747 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.8 122.14 42.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 51' ' ' TYR . 38.2 p90 -122.71 162.86 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.309 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 50' ' ' VAL . 7.0 p -128.37 133.45 48.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.9 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.564 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER 161.11 97.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.593 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.983 HG23 ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -158.84 -163.22 1.2 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.855 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.62 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 0.9 OUTLIER 87.84 93.31 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.774 0.671 . . . . 0.0 111.198 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -171.89 14.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.787 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.433 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.5 m -138.47 -114.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.712 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.608 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 8.8 t 35.89 49.59 1.1 Allowed Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 78' ' ' THR . 29.1 Cg_endo -101.57 32.96 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.707 2.271 . . . . 0.0 112.939 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.02 178.48 16.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.438 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -158.58 -69.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.688 0.28 . . . . 0.0 111.243 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -101.9 134.98 44.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.173 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t 55.67 91.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -60.34 158.95 10.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 170.18 9.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.43 71.37 0.58 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -86.84 24.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.07 -12.1 6.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.721 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -87.01 168.18 13.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.97 39.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.549 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.39 77.83 0.21 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.357 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -69.97 -169.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.22 128.36 7.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.22 -89.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.436 2.091 . . . . 0.0 112.244 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 53.22 74.54 0.75 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.159 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.4 90.48 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.464 2.109 . . . . 0.0 112.377 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.18 123.22 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.281 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 -151.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.2 tt -67.26 148.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.462 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.7 t -51.24 -48.02 62.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -175.4 149.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.763 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.5 m-85 -102.19 136.64 41.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.37 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.87 122.88 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 111.633 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -108.25 114.73 28.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 179.034 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.723 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.7 mtt180 -116.93 128.77 55.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.815 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -150.35 153.39 35.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.706 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.57 159.03 29.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.364 -179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.7 114.05 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.095 1.864 . . . . 0.0 111.745 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -32.13 73.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -38.3 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.39 170.43 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.88 136.45 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.846 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.98 33.41 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.979 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.66 173.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 111.519 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 67.6 m95 -90.15 -171.47 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -142.35 145.43 33.91 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.474 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -120.4 133.31 55.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.269 0.556 . . . . 0.0 112.139 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.08 112.19 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.98 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 38.8 m -89.35 137.72 32.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 112.474 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -132.81 106.25 12.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.381 178.056 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.95 100.32 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.408 2.072 . . . . 0.0 112.383 -179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.88 -90.17 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -177.18 79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.744 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.7 -33.22 66.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -173.4 -165.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.05 118.32 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -103.55 113.26 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 t -121.7 134.0 54.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HD22 ' A' ' 17' ' ' LEU . 6.9 mt -98.02 116.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -121.46 134.09 55.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 25.92 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -101.35 175.02 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 21.8 mtmt -98.23 124.74 46.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 14.5 Cg_exo -69.0 4.69 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.777 2.318 . . . . 0.0 112.365 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 -30.45 6.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.652 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.62 134.23 63.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.22 146.97 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.415 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 74.2 m-85 -118.51 107.74 14.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.76 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 18.3 pt-20 -79.7 130.39 35.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.379 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -133.01 153.94 20.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.191 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 67' ' ' THR . 2.3 mt-30 -133.64 134.01 42.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.639 0.257 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.19 106.97 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 110.365 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' HD2' ' A' ' 18' ' ' ARG . 5.2 mp -105.46 115.31 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.815 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.602 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -86.0 119.75 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 8.4 mt -109.67 112.29 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.253 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -89.45 -177.24 5.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.572 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -68.07 -14.86 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.603 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -101.46 0.9 37.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.766 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 112.4 177.34 19.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.92 144.34 39.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.578 0.228 . . . . 0.0 110.596 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.4 2.77 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.574 -179.59 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 2.5 tt0 -145.63 129.77 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -134.88 131.28 53.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.012 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -136.15 123.74 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -102.54 135.7 43.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 111.371 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.58 155.06 32.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.23 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -106.73 134.02 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.05 153.54 34.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.141 0.496 . . . . 0.0 112.287 -178.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.97 166.75 26.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.446 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -47.21 29.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -168.37 48.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.6 t -142.58 -25.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 52.93 -97.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.52 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.554 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -159.15 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.727 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -162.4 -51.91 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.727 ' HD2' ' H ' ' A' ' 78' ' ' THR . 29.8 Cg_endo -63.55 131.97 33.74 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.159 1.906 . . . . 0.0 112.246 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.96 -28.29 31.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.684 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.69 142.74 19.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.989 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.79 54.79 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.686 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.77 65.92 1.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.693 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 45.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.041 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 m170 62.56 112.96 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -19.41 62.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -114.33 141.36 47.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.95 108.63 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.3 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.883 179.969 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.728 0.299 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -137.48 128.36 27.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.31 105.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 t -152.2 135.0 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.732 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.92 169.71 8.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -146.04 124.64 6.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 42.5 Cg_exo -57.42 135.4 69.71 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.571 2.18 . . . . 0.0 112.532 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -132.49 101.13 14.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.707 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.71 -47.99 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.558 2.172 . . . . 0.0 112.499 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 m -133.55 175.48 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -153.4 148.05 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.205 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.715 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -70.83 154.08 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 179.816 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.715 ' N ' HG13 ' A' ' 12' ' ' ILE . 58.0 m -52.37 -41.3 62.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.2 pttt -172.23 149.04 2.22 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.041 0.448 . . . . 0.0 111.713 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -106.82 134.08 50.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.78 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.633 HG13 HD12 ' A' ' 58' ' ' ILE . 2.8 mm -114.28 120.23 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -104.24 114.69 29.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.537 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -116.25 129.55 56.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.542 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -154.37 158.69 40.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 111.493 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -159.54 163.42 23.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.666 -179.949 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -57.52 114.45 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.982 1.788 . . . . 0.0 111.616 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -50.71 -31.23 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.357 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -70.17 -37.36 75.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -176.48 4.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.97 13.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.82 -160.24 8.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.647 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 57.81 70.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -84.45 162.57 19.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 25.7 mttp -141.26 133.87 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.876 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 2.2 pt-20 -120.52 132.69 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.11 0.481 . . . . 0.0 111.977 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.67 111.99 12.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.808 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 84.8 m -91.79 132.09 36.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.471 HG13 ' C ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -136.92 104.8 8.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.115 177.962 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.5 Cg_exo -60.22 105.64 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.447 2.098 . . . . 0.0 112.15 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.36 -94.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.122 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.03 109.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.6 mp -82.74 -34.13 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.01 -112.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.053 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.0 m -121.43 105.09 10.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.39 109.01 21.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -120.88 132.11 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.5 mt -98.61 127.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 -166.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.83 29.76 28.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.357 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.692 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.7 OUTLIER -93.94 172.04 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -122.93 136.8 27.22 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.81 165.42 18.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.645 2.23 . . . . 0.0 112.466 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.4 -33.03 3.49 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.735 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.55 116.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 61.9 t -77.77 144.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' PHE . 3.2 m-85 -102.36 126.55 49.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 130.62 52.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.61 158.03 27.97 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -132.46 145.11 50.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.294 179.669 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 107.25 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -106.64 114.83 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -88.51 125.04 34.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.263 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 45.9 mt -102.43 123.35 55.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HG3' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -100.23 -175.05 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.943 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.83 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.301 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.03 6.9 38.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.76 175.49 18.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.64 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 3.0 p80 -55.99 157.41 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.716 0.293 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.528 HE21 ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -161.35 -17.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.409 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -114.2 127.75 56.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.09 130.68 55.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.415 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.23 121.2 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 2.5 mtt180 -96.87 132.65 42.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.318 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -155.62 156.65 35.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.263 0.554 . . . . 0.0 111.965 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.62 137.81 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -150.0 141.69 23.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.514 -178.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -149.68 166.77 28.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.336 178.908 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 45' ' ' LEU . 4.1 t -91.31 127.96 36.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.716 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 73' ' ' THR . 3.9 t 45.41 24.71 0.18 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.951 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t -134.31 -68.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 60.14 178.27 0.09 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.301 -179.904 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.527 ' H ' HG22 ' A' ' 76' ' ' THR . 0.3 OUTLIER -153.31 126.89 8.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.3 p 48.88 88.13 0.12 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.479 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.91 83.24 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.64 2.227 . . . . 0.0 112.221 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.24 -9.26 39.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.421 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t 57.39 57.04 4.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.746 0.308 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 55.07 85.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 t -143.82 140.07 29.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -116.5 -26.9 6.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -90.94 59.91 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -105.13 91.54 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -89.1 174.8 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.46 162.36 15.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.939 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 2.4 tpt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.546 ' H ' ' HG3' ' A' ' 1' ' ' MET . 17.3 mtp85 -72.93 -156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.51 109.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.456 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.1 p -103.97 -9.63 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.799 0.333 . . . . 0.0 111.094 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -93.59 137.47 32.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.19 87.77 32.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.1 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.25 -47.41 6.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.531 2.154 . . . . 0.0 112.402 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 57.13 85.58 0.19 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.77 101.64 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.541 2.161 . . . . 0.0 112.208 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.33 132.77 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.096 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.7 152.61 43.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.667 HD13 ' HB3' ' A' ' 57' ' ' SER . 4.7 tt -97.31 157.35 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.87 -52.72 22.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.796 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.611 ' HD2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -166.17 144.79 5.75 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.198 0.523 . . . . 0.0 111.754 179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.8 m-85 -102.37 136.87 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.873 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.34 129.86 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.853 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -118.11 114.84 23.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.986 179.438 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.58 129.21 50.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -149.73 162.02 41.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 2.8 ptt180 -158.56 153.43 21.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 18.0 Cg_endo -58.49 109.61 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.967 1.778 . . . . 0.0 111.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.518 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 4.1 ttpp -57.36 -35.21 69.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -70.3 -29.25 65.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -78.22 -161.02 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.999 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.35 -7.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' HH11 ' A' ' 20' ' ' ARG . . . 179.67 -128.58 1.24 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.952 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.435 ' HB3' HH11 ' A' ' 27' ' ' ARG . 0.0 OUTLIER 64.6 75.24 0.38 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.918 0.389 . . . . 0.0 111.06 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 93.5 m95 -83.04 175.8 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.145 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 13.7 mttm -154.25 136.88 15.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.767 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -120.16 135.77 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.052 0.453 . . . . 0.0 112.131 -178.762 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 114.86 8.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.13 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 m -96.62 137.78 35.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.149 0.5 . . . . 0.0 112.222 -179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -135.39 110.75 10.6 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.456 179.311 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.652 ' HB2' HD12 ' A' ' 37' ' ' LEU . 73.7 Cg_exo -50.15 93.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.766 2.31 . . . . 0.0 113.169 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 28.09 3.42 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.24 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.5 69.79 0.67 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.988 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -71.89 -7.21 47.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.164 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.3 p-10 -164.02 -174.6 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -80.47 105.53 11.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.82 107.42 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.778 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -114.59 146.58 40.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -91.62 124.38 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -138.56 161.77 36.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.74 21.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.6 mt -74.59 -161.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.505 0.193 . . . . 0.0 110.55 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.15 133.81 12.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.643 0.258 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 75' ' ' SER . 35.8 Cg_exo -57.1 155.45 28.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.448 2.099 . . . . 0.0 111.796 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.18 -21.48 10.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.921 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.38 117.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.772 0.32 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 62.5 t -81.26 144.54 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.428 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 53.4 m-85 -124.62 103.9 8.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 12.9 pt-20 -79.67 130.18 35.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.383 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.53 161.34 24.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.972 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.4 mt-30 -132.62 139.17 47.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 110.432 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -99.91 107.11 19.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -111.03 115.17 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.486 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.667 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -92.2 117.7 30.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.164 179.337 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.611 ' HB ' ' HD2' ' A' ' 14' ' ' LYS . 43.2 mt -101.73 116.13 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.812 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -90.0 -175.07 4.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.32 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -60.44 -23.05 64.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.229 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.06 14.15 32.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.645 0.259 . . . . 0.0 111.48 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.01 -174.56 23.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.803 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -52.34 161.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.724 0.297 . . . . 0.0 111.238 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -169.27 -20.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.587 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -123.72 128.42 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.53 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.89 133.24 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.814 0.34 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 3.1 m -137.8 123.86 20.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.71 134.45 40.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 111.636 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.93 159.08 38.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.507 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -109.51 133.7 52.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.9 p90 -151.82 145.98 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -148.51 148.12 29.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 178.524 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -70.16 144.64 51.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.425 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 m 64.51 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.093 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 47' ' ' PRO . 8.5 t -72.71 -174.16 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.047 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.77 176.53 12.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.85 -28.3 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.7 135.56 9.89 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.212 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.4 102.42 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.591 2.194 . . . . 0.0 112.275 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.19 -154.0 6.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.569 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -107.05 10.78 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -93.38 23.39 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.802 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.3 m -105.51 -172.65 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -84.68 65.05 8.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -66.6 166.36 12.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.08 79.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -102.41 61.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.29 154.07 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.818 0.342 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -114.04 98.21 6.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.23 -174.09 14.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 -79.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.673 0.273 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 52.78 74.45 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -101.67 130.81 23.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 72.6 Cg_endo -88.54 -178.06 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.847 2.365 . . . . 0.0 112.402 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -81.04 128.2 71.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.22 -38.11 57.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.495 2.13 . . . . 0.0 112.175 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 -176.16 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.807 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -118.93 142.18 48.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.6 tt -79.72 155.25 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.48 ' H ' HG13 ' A' ' 12' ' ' ILE . 3.2 m -49.91 -53.36 26.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.764 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.821 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -158.89 144.91 16.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.1 m-85 -104.7 137.72 42.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.202 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -114.25 142.69 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 110.81 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.48 115.83 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.12 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.4 mtp180 -118.99 129.77 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.646 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -152.6 158.82 43.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 111.991 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.36 157.07 26.78 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.291 179.792 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 19.1 Cg_endo -58.78 113.41 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.318 2.012 . . . . 0.0 112.083 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.444 -179.476 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -95.02 -41.2 9.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -87.15 161.82 17.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.22 148.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 27' ' ' ARG . . . 170.39 -140.6 6.09 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.517 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -139.88 166.77 23.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 74.0 m95 -75.65 174.61 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 18.2 mttt -145.31 141.16 28.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.679 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -119.98 134.92 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 128.3 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.825 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.1 m -112.39 135.67 52.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -137.21 106.76 8.67 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.153 178.418 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.821 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.8 Cg_exo -58.84 111.6 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 112.477 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.83 -104.95 0.51 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.368 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.85 93.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.655 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.72 -25.75 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.979 179.9 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.2 p-10 178.74 -168.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.456 179.661 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -76.49 105.82 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -108.8 112.84 25.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.725 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -121.57 132.62 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.8 mt -90.21 126.08 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.57 165.92 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.44 -16.36 4.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.243 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -69.63 160.16 32.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.716 0.293 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HG2' ' HD2' ' A' ' 47' ' ' PRO . 3.3 ttmt -104.77 133.44 20.16 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.047 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.593 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 55.2 Cg_exo -52.0 133.03 45.06 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.524 2.149 . . . . 0.0 112.18 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.12 -22.1 40.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.12 120.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.311 . . . . 0.0 110.953 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.64 ' HA ' HG22 ' A' ' 72' ' ' THR . 14.0 t -85.78 140.63 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -123.08 161.51 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -129.82 132.2 46.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.926 179.408 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.73 155.42 26.49 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.413 -179.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.91 131.64 41.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 5.9 tp -99.7 106.48 18.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.891 0.376 . . . . 0.0 111.011 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 16' ' ' ILE . 3.8 mp -92.07 138.44 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.955 179.408 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -110.4 114.98 28.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.313 0.578 . . . . 0.0 111.011 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 5.6 mt -95.5 114.13 31.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.591 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' NE2' ' HG2' ' A' ' 60' ' ' GLN . 0.9 OUTLIER -97.03 -176.26 3.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.327 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HG2' ' NE2' ' A' ' 59' ' ' GLN . 11.4 pt20 -62.12 -21.94 65.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -102.83 12.08 36.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.725 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 100.8 173.36 29.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.434 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.7 p-80 -53.55 147.93 10.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.483 0.183 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 2.0 pt20 -165.33 -6.64 0.03 OUTLIER 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 3.4 tt0 -132.65 112.99 12.49 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.891 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.2 p -136.98 140.99 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.3 m -132.24 122.12 24.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.715 179.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' H ' ' HE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.29 141.49 30.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.304 -179.373 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.14 158.31 37.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.49 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 129.46 56.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -152.06 163.76 38.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 50' ' ' VAL . 11.4 p -141.22 167.09 23.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.751 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -42.87 -60.07 1.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.717 0.294 . . . . 0.0 111.292 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -177.06 85.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -160.95 -50.23 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 t -126.64 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.394 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.24 153.91 0.08 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.257 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.09 144.37 3.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.3 86.94 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.561 2.174 . . . . 0.0 112.439 -179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.43 -125.85 5.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -130.48 112.68 13.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.783 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.39 -74.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -8.0 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.36 156.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.43 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 103.6 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -147.37 154.53 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.18 153.48 37.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -126.86 108.31 10.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.928 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' H3 ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -122.26 146.77 46.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.81 140.53 4.35 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.641 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -135.22 26.75 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.897 0.379 . . . . 0.0 110.763 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -75.89 -169.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -157.68 102.87 1.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 4.31 3.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.678 2.252 . . . . 0.0 112.598 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -104.46 113.65 64.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 -179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' GLN . 3.8 Cg_exo -80.05 -24.94 5.36 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.899 2.399 . . . . 0.0 112.139 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.669 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -148.67 88.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 m80 59.97 -86.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.201 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 59' ' ' GLN . 1.6 tt -77.81 150.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.984 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -49.21 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.611 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -166.13 146.07 6.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -102.04 141.99 34.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.38 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.632 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -115.16 142.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.487 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 115.46 19.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.416 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -120.85 137.95 54.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.674 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -156.73 159.51 38.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.43 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.45 157.45 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.521 -179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.72 110.86 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.269 1.979 . . . . 0.0 112.014 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.42 67.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.66 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.8 ' HB2' HG23 ' A' ' 49' ' ' VAL . 19.4 m-20 -100.3 -36.05 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.404 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.16 -167.78 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.25 154.39 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.022 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.43 23.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 60.87 175.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.597 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 68.0 m95 -85.61 -172.33 4.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.4 mttt -148.3 154.76 40.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.242 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.17 138.27 49.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 112.092 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 111.82 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 92.5 m -98.4 131.19 44.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.48 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -134.69 106.05 10.77 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.268 178.124 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 52.0 Cg_exo -56.23 98.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.688 2.258 . . . . 0.0 112.895 -179.019 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 10' ' ' SER . . . 51.5 22.88 8.43 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.163 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.481 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 57.13 98.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 179.922 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.705 ' H ' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.66 -18.37 41.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -169.09 -163.19 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.762 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.17 105.48 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.608 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.21 106.75 16.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.35 144.05 45.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.86 129.33 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.213 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 141.77 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.09 56.08 0.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.654 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 73' ' ' THR . 3.0 mt -137.18 78.02 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.4 ttpt -34.75 130.41 0.47 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.466 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 45.2 Cg_exo -56.89 175.79 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.661 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.05 -35.53 3.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 23' ' ' ASN . 2.8 p -115.04 127.15 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.67 142.08 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 7.8 m-85 -108.8 136.79 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -112.26 130.1 56.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.119 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.67 156.49 26.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.975 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.6 146.0 51.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 18.8 tp -100.23 107.0 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.391 . . . . 0.0 110.859 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 16' ' ' ILE . 1.7 mp -95.12 122.06 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.491 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -94.83 114.91 26.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.424 0.631 . . . . 0.0 109.926 179.723 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 27.6 mt -106.7 111.16 34.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.953 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.483 ' HG3' HD12 ' A' ' 12' ' ' ILE . 3.3 mt-30 -90.2 -176.17 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.887 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.75 -15.94 45.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -103.12 0.62 32.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.32 176.39 19.4 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.26 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 15.9 p80 -55.36 156.31 4.49 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.548 0.174 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.9 1.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 3.7 tt0 -145.53 113.73 6.59 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -136.75 139.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 m -137.1 124.73 22.3 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.448 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -85.01 141.01 30.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.779 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -155.86 156.63 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.731 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -114.96 131.64 56.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.873 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -152.04 162.55 40.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.486 -178.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.24 154.8 41.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.202 179.222 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 45' ' ' LEU . 14.1 t -75.21 -24.77 57.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.715 0.293 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.517 ' OG1' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -161.51 63.6 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 t -160.95 -132.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 t -64.58 -170.68 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 111.645 -179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.02 156.98 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.341 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.8 138.75 12.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.93 66.1 8.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.457 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -128.92 12.07 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.98 -172.86 4.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.699 0.285 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 55.04 78.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.22 173.95 6.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.805 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -69.53 -34.29 74.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.022 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -162.55 127.15 3.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -160.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.101 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -95.99 -7.18 37.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.79 -5.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.339 -0.838 . . . . 0.0 111.059 179.871 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttm105 -118.44 26.55 9.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.4 -54.85 0.4 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.0 t -61.26 138.26 58.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -79.77 130.97 35.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.29 68.53 3.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.1 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.11 6.69 4.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.542 2.161 . . . . 0.0 112.336 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 64.86 138.66 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.01 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.25 7.47 2.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.553 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 m -140.24 -79.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -163.01 165.6 24.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.727 HD12 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -72.98 147.48 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.042 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.71 ' N ' HG13 ' A' ' 12' ' ' ILE . 14.8 m -52.13 -45.99 65.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -158.78 144.65 16.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.042 0.448 . . . . 0.0 111.416 179.512 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -112.89 142.97 44.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 179.682 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -113.89 138.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.221 -179.587 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -122.03 114.86 21.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.283 179.633 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.35 129.98 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.149 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -158.52 158.44 34.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.402 0.62 . . . . 0.0 112.526 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.586 ' NH1' HG23 ' A' ' 25' ' ' VAL . 1.9 ptt180 -159.73 162.27 25.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.665 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 31.3 Cg_exo -58.82 109.62 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.929 1.753 . . . . 0.0 111.621 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -65.78 -22.62 66.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.968 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.0 -17.98 31.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -158.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG23 ' NH1' ' A' ' 20' ' ' ARG . 14.4 p -166.66 139.03 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.75 -60.06 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.574 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -165.5 157.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.076 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.53 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 59.0 m95 -92.36 172.73 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 14.2 mttp -132.51 128.2 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.83 130.41 54.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 112.303 -178.241 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.08 111.79 8.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.872 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.9 m -93.91 130.87 39.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 40' ' ' TYR . 4.4 mp -136.68 107.65 9.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.66 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.0 Cg_exo -45.89 91.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.167 2.578 . . . . 0.0 113.249 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.39 42.46 1.84 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.506 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 54.34 47.84 22.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.588 HD13 ' H ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -70.95 -24.27 62.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.731 -179.544 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.588 ' H ' HD13 ' A' ' 37' ' ' LEU . 1.7 p-10 -133.77 168.93 17.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -78.94 105.88 10.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 33' ' ' ILE . 8.8 p90 -121.34 130.7 53.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 145.02 29.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.241 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.57 137.37 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.437 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 123.88 17.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.29 146.65 28.85 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.63 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.3 mt -103.75 173.02 6.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 12.6 ttpp -94.98 125.28 51.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 34.2 Cg_exo -59.57 111.77 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.638 2.225 . . . . 0.0 112.236 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.84 -5.58 8.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.657 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.87 135.22 58.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.8 t -81.24 137.05 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.75 179.581 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.86 97.04 4.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.2 pt-20 -87.38 132.08 34.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.091 0.472 . . . . 0.0 110.519 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.67 154.0 24.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.69 134.81 50.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.843 0.354 . . . . 0.0 110.392 179.811 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' CD1' HD12 ' A' ' 17' ' ' LEU . 13.2 tp -99.56 107.67 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.578 ' CG1' ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -102.42 115.36 44.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 0.0 111.547 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -81.41 113.73 19.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.714 HG23 ' H ' ' A' ' 63' ' ' HIS . 30.4 mt -105.64 126.39 60.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.601 -179.386 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.727 ' HG3' HD12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -112.5 -174.98 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.419 179.8 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.27 -7.48 2.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.332 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' HB2' HE22 ' A' ' 64' ' ' GLN . 55.4 m-85 -97.97 -5.25 34.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.81 106.54 0.04 OUTLIER Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.374 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.714 ' H ' HG23 ' A' ' 58' ' ' ILE . 44.8 m80 61.6 120.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.419 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.603 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -157.5 -20.33 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.874 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -145.94 119.49 9.11 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.865 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -137.32 132.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 0.0 112.06 179.157 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.6 m -137.5 128.69 27.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 2.0 mtm180 -96.3 148.03 23.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.181 0.515 . . . . 0.0 111.136 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -156.43 158.84 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.237 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -113.58 127.27 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.023 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 45' ' ' LEU . 1.4 p90 -148.29 161.3 41.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.089 0.471 . . . . 0.0 112.121 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -147.21 166.84 25.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.009 178.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -50.96 -54.14 26.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.209 179.926 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.502 ' H ' HG23 ' A' ' 73' ' ' THR . 1.1 t -167.29 75.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.0 -26.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 55.8 -169.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.29 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -141.98 156.73 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.044 -179.992 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.499 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -111.07 -53.66 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.572 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 78' ' ' THR . 94.6 Cg_endo -85.49 163.26 10.99 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.361 2.041 . . . . 0.0 112.582 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.6 -164.08 33.38 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.614 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.8 p -70.31 -4.74 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -60.46 103.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -79.36 -168.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.798 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.24 77.39 7.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -76.11 145.5 39.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.46 173.19 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.39 3.46 35.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -67.85 175.64 2.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.125 -0.941 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpp . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.767 0.318 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 2' ' ' ARG . 7.0 mmt180 -123.7 -2.23 8.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.27 178.09 47.71 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.4 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -135.77 85.89 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.769 0.319 . . . . 0.0 110.822 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.9 -43.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.04 137.49 87.88 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.178 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.11 178.98 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.554 2.169 . . . . 0.0 112.313 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -112.84 93.09 22.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.71 -20.85 70.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.034 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.7 p -147.36 137.72 23.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -84.15 147.33 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' HG2' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -67.62 144.02 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.3 179.484 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.53 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -49.71 -57.72 6.71 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.025 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 144.33 18.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.897 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.7 m-85 -108.93 136.6 48.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.245 0.545 . . . . 0.0 111.081 -179.729 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 114.88 28.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.053 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.03 129.47 50.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.761 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -151.01 160.61 43.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.468 . . . . 0.0 111.666 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 6.2 ptt180 -159.41 161.38 27.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 14.0 Cg_endo -57.95 110.39 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.186 1.924 . . . . 0.0 111.796 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -62.77 -48.06 80.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.724 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.75 -38.91 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.8 -179.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.03 -179.52 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.498 . . . . 0.0 111.85 -179.281 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.72 143.4 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.772 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -154.83 18.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.146 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 27' ' ' ARG . 9.8 mtt180 -135.74 162.88 31.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 111.074 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.86 157.19 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.8 mmtt -132.14 136.11 46.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.238 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HH21 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -119.87 127.21 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.092 0.473 . . . . 0.0 111.935 -178.754 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.44 111.68 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.142 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -91.5 135.21 34.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.927 -179.263 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.97 107.79 32.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.69 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.793 2.329 . . . . 0.0 113.061 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.74 30.66 4.91 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.118 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 72.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -31.89 71.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -146.18 -165.34 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 p -77.69 106.14 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.51 102.29 7.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -127.95 143.12 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.3 mm -81.68 116.92 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 134.76 37.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.81 17.39 1.88 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.312 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' HG22 ' A' ' 73' ' ' THR . 11.9 mt -76.05 -143.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.521 0.2 . . . . 0.0 110.75 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -146.94 122.81 5.48 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 120.647 0.26 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.523 ' HB3' HG22 ' A' ' 74' ' ' THR . 39.2 Cg_endo -66.79 91.16 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.423 2.082 . . . . 0.0 111.851 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -117.72 113.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.103 179.414 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.27 130.42 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.348 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 45' ' ' LEU . 48.8 m-85 -105.57 107.14 17.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.428 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 130.33 34.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.88 159.65 28.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.131 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 146.59 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -102.05 106.43 17.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.201 -179.869 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.3 mp -92.48 126.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -90.17 135.53 33.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.225 0.536 . . . . 0.0 110.194 179.648 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.2 mt -115.02 109.11 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.563 -179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.747 ' HG2' HD11 ' A' ' 12' ' ' ILE . 7.1 mm100 -101.12 -175.1 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.293 178.231 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.11 -14.5 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.742 0.305 . . . . 0.0 110.794 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -103.21 -5.25 23.34 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.975 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 113.21 -153.71 17.39 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.854 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.47 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 2.6 m-70 -62.28 141.23 58.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.862 -0.199 . . . . 0.0 110.778 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.534 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -145.22 -59.51 0.35 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 2.5 tt0 -100.49 114.2 27.61 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.8 p -136.12 132.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 112.081 178.534 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -137.29 125.18 22.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 142.32 30.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -156.1 159.31 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.436 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.42 135.46 50.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 45' ' ' LEU . 4.8 p90 -151.61 141.25 21.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.326 -178.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 76' ' ' THR . 0.2 OUTLIER -151.59 167.12 29.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.072 179.255 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 45' ' ' LEU . 1.5 t -86.33 77.82 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.178 178.815 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 47' ' ' PRO . 0.4 OUTLIER 69.02 157.98 0.15 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.892 -179.237 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.58 67.12 0.65 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.417 HG21 ' OG1' ' A' ' 72' ' ' THR . 1.2 m -170.69 149.71 3.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.964 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t 59.28 -170.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.24 164.06 43.5 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -28.55 114.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.595 2.863 . . . . 0.0 113.607 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 81.14 0.27 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.646 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -88.78 133.49 34.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 110.755 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -2.12 25.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.27 -175.53 3.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 110.22 16.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.69 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -149.77 29.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -97.73 -17.82 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.902 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.96 23.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -167.57 1.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.023 -179.924 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.905 0.383 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -139.86 49.48 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.822 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.99 178.71 36.11 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.515 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 t -111.51 98.46 7.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.825 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -126.05 -82.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.73 92.64 44.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.05 -165.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.784 2.323 . . . . 0.0 112.459 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 11' ' ' HIS . 14.4 pt20 -114.25 147.0 36.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' HIS . 90.6 Cg_endo -80.62 62.03 8.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.723 2.282 . . . . 0.0 112.58 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m 65.21 -2.73 0.72 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.306 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 94.7 m-70 -147.03 172.54 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.578 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -101.04 157.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -59.47 -44.33 93.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.984 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.05 144.62 0.76 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.801 179.471 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' THR . 12.5 m-85 -105.62 136.82 44.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.835 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.75 127.71 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 178.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.667 ' HG ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -116.44 116.52 27.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.82 128.78 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.741 -179.732 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.692 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 2.7 p90 -152.2 142.7 22.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.482 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.9 153.62 42.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 67.6 Cg_exo -57.13 126.71 23.0 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 113.05 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 -33.43 19.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.784 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 49' ' ' VAL . 51.7 t30 -99.17 -43.92 6.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -83.92 -15.72 46.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.686 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 55.18 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.763 179.866 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 -138.54 7.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.646 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.0 ttm105 -110.9 155.12 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.453 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 79.0 m95 -77.78 175.27 10.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.051 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -139.26 135.65 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.401 179.31 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.2 pt-20 -120.1 131.62 55.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.987 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.05 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.844 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -102.1 132.1 48.18 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -139.42 106.7 7.15 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.752 178.965 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' HD21 ' A' ' 37' ' ' LEU . 77.7 Cg_endo -82.31 102.45 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.322 2.015 . . . . 0.0 113.549 -178.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 8.85 87.61 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.51 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.75 88.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.706 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -66.32 -22.06 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.41 -172.91 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 106.55 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.724 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -108.32 109.41 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.093 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.27 126.26 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.748 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -81.87 118.52 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.178 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.12 76.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' C ' HD13 ' A' ' 45' ' ' LEU . . . -136.01 22.31 3.45 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.628 179.419 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.882 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -98.03 -157.5 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 155.87 14.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.796 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 12.3 Cg_endo -55.99 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.56 6.66 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.357 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.559 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.071 HG23 HG22 ' A' ' 72' ' ' THR . 1.5 p -114.48 148.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.747 177.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.4 m-85 -114.49 143.56 44.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.0 tt0 -79.51 128.63 33.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.45 133.65 9.33 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.517 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 56' ' ' ILE . 34.7 tt0 -134.15 116.86 15.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.634 0.254 . . . . 0.0 110.811 179.343 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD22 ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -99.64 107.75 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 179.282 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 66' ' ' VAL . 4.3 mp -111.44 114.59 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.602 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -84.02 138.36 33.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.134 179.144 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.595 ' HB ' ' HG2' ' A' ' 14' ' ' LYS . 2.6 mt -115.19 108.49 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.867 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 4.7 tp60 -86.49 -175.86 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.39 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.52 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 6.6 mm100 -61.27 -20.51 62.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.58 -179.548 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.72 16.01 27.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.515 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.84 -108.56 3.08 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -51.77 111.48 0.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 23.6 tp60 -120.97 -67.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.27 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 4.2 tt0 -139.51 145.43 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HG23 ' A' ' 56' ' ' ILE . 96.8 t -135.04 133.96 53.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 m -136.76 134.46 37.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.223 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.0 122.62 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.92 133.95 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.217 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.47 137.65 38.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.06 158.71 43.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.071 HG22 HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -143.59 166.82 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.649 177.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.882 HG22 ' HB2' ' A' ' 45' ' ' LEU . 2.7 t -69.22 -42.52 75.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.741 0.305 . . . . 0.0 111.216 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.814 HG23 HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -134.44 -172.06 2.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.9 170.33 0.25 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.3 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.34 134.62 48.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -151.01 -28.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.77 103.68 5.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.16 -170.01 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.41 65.97 2.72 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 m -114.42 -10.7 12.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.15 -166.22 1.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.983 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -114.46 144.41 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.036 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -162.17 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.771 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.51 160.37 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.745 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 79.42 8.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 -173.44 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -98.7 -172.1 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.909 179.942 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.654 0.264 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -121.12 -67.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.44 65.76 0.18 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.59 101.28 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -99.21 -71.57 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.5 91.17 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.959 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.74 148.61 35.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 57.21 67.41 2.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.95 -166.16 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.0 112.257 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -87.59 -45.65 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 179.673 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.57 -153.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.662 HG21 ' CE1' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -66.86 155.5 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.343 179.524 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.455 ' H ' HG13 ' A' ' 12' ' ' ILE . 2.2 m -56.57 -52.81 63.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.607 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -176.66 145.76 0.55 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.569 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 3.3 m-30 -101.66 141.09 35.05 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.102 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 55' ' ' LEU . 21.2 mm -114.75 132.74 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -121.24 114.22 21.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.237 178.564 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.6 mtp180 -109.99 129.17 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 -179.411 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.65 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 3.1 p90 -142.4 140.18 31.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.25 0.548 . . . . 0.0 111.699 179.673 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.92 144.84 17.13 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.915 -179.803 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 51.2 Cg_exo -56.94 117.73 4.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.252 1.968 . . . . 0.0 112.327 -179.451 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 mmmt -58.58 -17.86 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.74 -18.57 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.141 -179.676 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.31 -166.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.949 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.18 -26.29 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.057 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 175.92 -128.57 1.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.423 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.0 63.05 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 74.6 m95 -63.71 -177.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.2 mmtp -131.94 152.3 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.425 179.197 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.23 133.77 55.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.808 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.15 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.446 178.847 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 14' ' ' LYS . 51.6 m -106.51 126.45 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.309 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -140.16 105.24 6.66 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.811 178.087 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 107.45 2.01 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.167 1.911 . . . . 0.0 112.658 -179.664 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.09 116.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.401 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.26 102.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.23 -33.12 33.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.68 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -179.32 -159.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.308 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 m -77.3 105.37 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.6 114.41 26.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -98.71 147.65 24.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.036 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 43' ' ' LYS . 3.6 mt -99.57 115.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 44' ' ' GLY . 3.8 mmpt? 18.4 -93.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.089 0.868 . . . . 0.0 112.584 179.702 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 43' ' ' LYS . . . 178.84 105.5 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.387 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -73.49 -175.55 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.638 0.256 . . . . 0.0 110.886 -179.808 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 160.96 33.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.086 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG3' HG21 ' A' ' 74' ' ' THR . 47.6 Cg_exo -56.07 149.92 50.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.684 2.256 . . . . 0.0 112.881 -179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.62 -2.18 59.48 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.052 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.08 112.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.701 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.3 t -91.56 148.05 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 179.026 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.445 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 53.3 m-85 -139.68 107.47 5.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.926 178.946 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 tp10 -87.92 128.85 35.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -117.22 147.59 18.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.545 -178.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.447 ' HB3' HD11 ' A' ' 56' ' ' ILE . 1.1 mt-30 -133.52 115.75 15.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.202 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 17' ' ' LEU . 32.7 tp -99.19 107.36 19.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.76 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.3 mp -112.18 115.25 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.582 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 7.9 m -82.14 133.4 35.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.626 HG23 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mp -121.67 133.14 69.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.334 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 3.8 tt0 -110.79 -175.14 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.742 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -61.08 -17.7 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.1 -5.71 23.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.68 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 77.47 153.16 5.68 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.999 178.86 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 t60 58.37 97.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.619 0.247 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 -122.77 -60.72 1.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 tt0 -135.54 145.32 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.913 -178.378 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.35 114.48 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 178.812 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.9 m -133.37 127.18 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -104.06 132.09 50.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -155.58 130.81 9.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.618 -179.666 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.45 149.81 20.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.82 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -150.8 148.18 28.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.513 0.673 . . . . 0.0 112.671 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.7 p -149.04 146.17 27.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.516 179.314 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.958 HG23 HG23 ' A' ' 74' ' ' THR . 5.9 t -75.55 -40.66 56.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.446 -179.719 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.958 HG23 HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -131.88 -24.85 2.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.255 -179.886 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -171.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.051 -179.824 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.98 130.5 18.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 -179.811 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.6 t -157.37 26.26 0.3 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 86.29 18.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.3 5.78 4.39 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.741 2.294 . . . . 0.0 112.648 -179.779 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.82 -172.96 45.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -65.17 -39.3 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.726 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 82' ' ' ARG . 10.4 mtt85 -146.38 165.16 30.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.97 138.09 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.652 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.33 115.3 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -115.1 -52.14 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.644 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -153.63 -17.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.445 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 1.8 t-160 60.34 -87.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.25 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.445 ' H ' ' HB3' ' A' ' 87' ' ' HIS . 0.5 OUTLIER 63.67 169.01 0.16 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.924 0.392 . . . . 0.0 111.04 -179.773 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.963 -179.763 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.721 0.295 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 2' ' ' ARG . 2.8 ttp180 58.46 -164.57 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.032 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 159.36 74.86 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 p -76.09 -179.26 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -99.1 48.11 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.84 97.33 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.213 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 135.21 28.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.492 2.128 . . . . 0.0 112.305 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.47 131.78 23.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.99 80.74 2.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.474 2.116 . . . . 0.0 112.246 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.509 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -64.47 -25.4 67.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 179.881 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.34 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -101.59 157.44 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 111.306 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 t -82.16 -31.68 30.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.222 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.837 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 4.0 pttt -175.86 143.92 0.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.973 179.317 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HB2' HG13 ' A' ' 33' ' ' ILE . 34.1 m-85 -108.04 143.14 37.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.597 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.68 122.81 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.129 0.49 . . . . 0.0 110.736 179.66 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.779 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -109.96 114.61 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.631 179.372 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.02 129.61 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.252 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.642 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.7 p90 -150.38 149.36 29.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.568 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.568 HH12 ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -153.79 145.41 16.69 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 -179.514 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 49.0 Cg_exo -59.15 110.55 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.706 2.271 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HE2' HH12 ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.63 -19.64 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.1 -18.24 62.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -117.57 -162.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.608 179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.09 125.59 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.57 -142.49 47.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.669 179.651 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 63.14 59.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.091 0.472 . . . . 0.0 111.138 -179.975 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -76.53 174.81 9.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.749 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.773 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.8 mttt -142.43 132.31 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.857 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.68 135.62 54.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.298 0.571 . . . . 0.0 112.396 -178.489 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.14 111.77 6.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 179.134 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 m -88.31 132.61 34.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.146 0.498 . . . . 0.0 112.294 -178.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -140.4 105.54 6.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.217 179.29 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.837 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 17.6 Cg_endo -58.2 -179.75 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.504 2.136 . . . . 0.0 113.516 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -65.79 88.9 0.11 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.237 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.596 ' HB3' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -179.81 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 109.898 -179.508 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.875 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.74 -3.48 47.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.762 179.39 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.659 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.8 p30 42.47 -125.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -88.28 117.04 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.735 0.303 . . . . 0.0 110.974 179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.43 ' CB ' HD13 ' A' ' 33' ' ' ILE . 32.5 t80 -83.52 126.73 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.286 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -97.98 147.44 24.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.421 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.32 131.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.51 -111.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.1 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' C ' HD22 ' A' ' 45' ' ' LEU . . . -81.39 140.13 20.95 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.14 -178.021 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' H ' HG21 ' A' ' 73' ' ' THR . 2.9 mm? -126.67 3.59 6.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.61 179.223 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' N ' HG21 ' A' ' 73' ' ' THR . 3.2 mtmt 62.54 154.65 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.157 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' CA ' HG23 ' A' ' 74' ' ' THR . 88.4 Cg_endo -78.41 155.56 28.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.797 2.332 . . . . 0.0 112.513 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.76 3.35 59.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.192 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 112.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.089 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.0 t -89.44 148.37 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.05 0.452 . . . . 0.0 110.494 178.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 39.5 m-85 -138.78 104.42 5.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.623 179.428 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 8.4 tt0 -90.26 128.63 36.46 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -142.2 147.94 19.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.331 -179.084 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' CB ' ' HA ' ' A' ' 68' ' ' ARG . 6.0 pm0 -133.83 138.83 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.162 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.779 ' HG ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -100.03 107.89 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.071 0.462 . . . . 0.0 111.647 -178.66 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.3 mp -101.69 114.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.137 179.157 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 1.3 m -87.31 136.34 32.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 -179.705 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.804 HD13 ' HE3' ' A' ' 14' ' ' LYS . 3.6 mp -118.87 132.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.046 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 30.1 tt0 -92.73 -175.77 4.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.427 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.58 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 5.4 mt-30 -60.33 -29.53 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.092 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.37 7.98 42.47 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.323 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.474 ' HA2' ' CG2' ' A' ' 58' ' ' ILE . . . 94.0 147.95 23.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.082 179.343 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.575 ' H ' HG23 ' A' ' 58' ' ' ILE . 5.3 m-70 64.37 157.25 0.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.5 0.19 . . . . 0.0 111.285 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.764 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -179.01 -57.47 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 179.281 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.5 tt0 -145.09 144.19 30.81 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.114 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.28 114.07 16.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 178.433 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.9 m -137.2 120.74 17.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.814 179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 54' ' ' GLN . 6.5 mtp85 -97.94 132.62 43.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' GLY . 19.8 p90 -149.4 131.31 15.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.191 0.52 . . . . 0.0 112.295 -179.717 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 52' ' ' GLU . 1.7 m-20 -95.2 141.64 28.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.016 179.256 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -152.66 160.75 43.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.475 0.655 . . . . 0.0 112.491 -178.853 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 75' ' ' SER . 1.0 OUTLIER -148.11 167.13 25.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.835 178.952 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.991 HG23 HG22 ' A' ' 74' ' ' THR . 8.8 t -96.69 -47.07 6.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.683 0.278 . . . . 0.0 111.68 -179.674 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.991 HG22 HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -135.97 -2.93 2.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 -179.736 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.75 166.11 14.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.811 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.15 100.34 13.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.74 105.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.994 179.835 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 118.04 0.68 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.083 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 70' ' ' ASP . 36.9 Cg_endo -64.9 149.35 89.66 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.477 2.118 . . . . 0.0 112.344 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.95 3.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.582 -179.956 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 59.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 0.0 110.803 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.18 156.52 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 161.96 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -66.64 108.74 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -77.43 90.7 3.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -65.77 -76.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.51 -29.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -117.43 99.53 7.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.9 0.381 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -130.01 -20.54 3.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.47 -6.92 65.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.56 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.69 0.281 . . . . 0.0 111.206 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.961 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 119.94 29.23 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.95 -93.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.426 2.084 . . . . 0.0 112.083 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 15.9 pt20 -84.0 148.1 52.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.707 179.77 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 Cg_exo -72.95 -157.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.75 2.3 . . . . 0.0 112.362 -179.722 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.94 69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.755 179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.674 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 10.2 p-80 -64.11 162.75 13.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.689 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.664 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -97.14 152.09 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.87 179.885 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.664 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.51 -46.63 48.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.283 179.485 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 16.5 pttm -162.05 144.26 11.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.134 179.366 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -113.07 140.6 47.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.707 179.211 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.421 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -114.22 125.35 71.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 179.745 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.41 114.28 27.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.323 179.789 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -112.21 129.15 56.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.771 179.487 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -146.21 147.15 31.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.273 0.559 . . . . 0.0 112.234 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.29 145.67 18.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.024 179.911 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 47.3 Cg_exo -57.53 109.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.334 2.023 . . . . 0.0 112.549 -179.594 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 1.7 mttm -68.45 -32.68 72.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.52 179.471 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.58 -18.85 47.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 1.7 m -149.48 72.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.576 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 20' ' ' ARG . 22.7 m -47.02 146.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.947 -179.474 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.86 79.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.7 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' A' ' 28' ' ' TRP . 14.5 ttp180 65.15 147.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 111.54 179.728 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.509 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 37.2 m95 -101.72 -176.63 3.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -139.08 153.26 48.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.353 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 138.32 54.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.2 111.97 7.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.823 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m -93.77 126.23 38.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.721 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 mt -138.2 107.04 7.97 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 178.747 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 24.1 Cg_exo -64.13 109.91 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.515 2.143 . . . . 0.0 113.325 -178.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 49.54 24.73 5.8 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.818 178.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 60.71 115.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.086 0.47 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HD2' ' A' ' 34' ' ' PRO . 5.9 mp -82.44 -33.21 28.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -177.51 -153.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.117 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -76.8 104.83 7.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -118.19 122.75 43.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 -179.411 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 141.57 49.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.287 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.96 130.19 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.714 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -112.89 156.96 22.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.856 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.35 20.56 1.96 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.26 -179.785 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.766 ' HB2' ' HB ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -121.61 177.98 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.952 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.659 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -139.45 163.47 45.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.702 0.286 . . . . 0.0 111.652 -179.173 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HG3' HG21 ' A' ' 74' ' ' THR . 19.9 Cg_exo -66.1 109.51 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.629 2.219 . . . . 0.0 112.605 -179.692 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.0 -0.21 11.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.104 179.399 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 46' ' ' LYS . 14.7 p -120.23 137.12 55.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -112.7 137.88 43.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.01 179.7 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CD1' HD23 ' A' ' 45' ' ' LEU . 7.9 m-85 -111.21 174.14 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.279 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -116.21 129.49 56.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.736 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.71 132.17 9.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.857 -1.163 . . . . 0.0 113.797 -178.521 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' THR . 5.8 mt-30 -133.56 113.83 12.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.112 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 15' ' ' TYR . 3.9 mt -100.66 107.56 19.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.4 mp -101.77 115.68 44.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -82.6 119.17 23.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.739 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 20.5 mt -110.62 119.17 58.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.51 -179.472 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -175.68 4.11 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.082 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -61.58 -17.44 55.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -103.14 -5.17 23.51 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.28 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.92 179.61 16.01 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -49.4 157.67 0.48 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 65' ' ' GLU . 2.7 pt20 -165.46 -2.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.852 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.649 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.33 133.69 21.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.606 0.241 . . . . 0.0 111.383 -179.689 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' ILE . 67.3 t -134.94 133.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.975 179.231 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 6.2 m -137.51 137.22 38.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.48 139.65 44.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.52 161.59 40.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.306 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.8 141.25 29.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.245 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 1.1 t80 -120.24 139.1 53.18 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.157 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 p -152.09 168.52 25.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 1.2 t -115.44 -64.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.876 179.652 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.755 ' H ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -107.34 -31.96 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 t -78.07 89.85 4.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.43 105.37 0.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.232 -179.758 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 101.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.31 69.76 21.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -166.28 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.993 2.462 . . . . 0.0 112.241 -179.777 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.49 99.28 0.01 OUTLIER Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.478 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m 55.78 -149.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.463 0.173 . . . . 0.0 110.671 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HB3' ' H ' ' A' ' 83' ' ' SER . 0.1 OUTLIER 59.05 -147.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.794 179.906 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.464 ' H ' ' HB3' ' A' ' 82' ' ' ARG . 3.0 m -60.0 173.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.837 0.351 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -104.37 146.42 28.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -157.82 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 13.74 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -100.46 -168.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.011 -179.926 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.23 129.2 21.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 116.86 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.12 -124.91 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -132.91 105.1 6.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -21.91 63.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . . . 58.78 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 6' ' ' ALA . 14.8 Cg_endo -57.47 131.4 44.37 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.578 2.185 . . . . 0.0 112.465 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.39 67.44 5.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.609 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.82 -72.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.742 2.295 . . . . 0.0 112.05 -179.818 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -131.98 1.21 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -68.18 -103.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -105.2 148.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 179.954 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -43.29 52.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.154 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.61 144.94 0.69 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.274 178.863 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.745 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.4 m-85 -100.79 150.2 23.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.612 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.2 mm -125.02 123.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.552 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.695 HD12 HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -110.11 114.09 27.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.517 178.818 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.55 129.68 56.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.4 -179.646 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 4.8 p90 -141.28 149.27 41.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.21 147.98 14.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.405 -179.849 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 48.4 Cg_exo -57.81 114.73 2.09 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.543 2.162 . . . . 0.0 112.665 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.814 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 27.6 mtpt -75.31 -25.07 57.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -86.23 -35.87 19.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.204 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.69 -175.53 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.111 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.03 132.24 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.067 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.5 -165.49 31.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.8 150.04 21.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.82 177.6 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.17 154.57 50.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.881 179.415 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.62 133.44 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.19 0.519 . . . . 0.0 111.891 -179.463 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.85 111.43 8.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.469 179.015 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 58.8 m -90.56 136.74 32.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.318 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.799 HG22 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.07 103.8 6.76 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.474 177.668 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' O ' ' HB1' ' A' ' 6' ' ' ALA . 4.6 Cg_exo -79.35 127.4 7.41 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.58 2.186 . . . . 0.0 112.699 -179.241 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.19 165.82 36.67 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.991 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -81.89 67.13 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.064 0.459 . . . . 0.0 110.759 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.799 HD12 HG22 ' A' ' 33' ' ' ILE . 2.7 mt -78.81 -2.88 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.027 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER 105.96 174.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.503 1.127 . . . . 0.0 110.608 -179.675 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -77.18 111.75 13.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -97.66 117.48 32.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.449 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -127.4 142.17 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.74 116.66 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -119.49 42.36 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.82 10.47 58.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -83.28 166.23 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 110.887 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.691 ' O ' HG21 ' A' ' 73' ' ' THR . 0.0 OUTLIER -94.06 134.85 25.31 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.148 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 66.9 Cg_exo -38.96 123.38 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.5 2.8 . . . . 0.0 114.07 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.0 7.2 17.67 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.127 178.45 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 t -121.52 136.67 57.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.551 0.676 . . . . 0.0 112.301 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -115.34 133.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.993 178.186 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 27.4 m-85 -116.18 -173.12 2.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.966 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.814 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 9.8 tm-20 -126.07 129.45 49.15 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.91 118.47 4.25 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.085 -179.104 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -132.66 113.89 13.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.695 HD13 HD12 ' A' ' 17' ' ' LEU . 22.7 tp -103.44 106.74 17.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.507 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.628 HG13 HG13 ' A' ' 66' ' ' VAL . 4.9 mp -100.52 138.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.591 178.838 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 4.7 m -94.85 151.11 19.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.356 0.598 . . . . 0.0 110.975 -179.5 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 25.8 mt -116.41 131.84 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.508 -179.417 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.882 ' HG2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -118.74 -176.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.442 178.461 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -75.22 -20.68 59.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.748 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -104.47 -5.68 21.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.445 179.809 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.27 139.21 1.76 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.187 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.28 81.78 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.819 0.343 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.882 ' HB2' ' HG2' ' A' ' 59' ' ' GLN . 1.3 tt0 -101.48 -67.75 0.85 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.608 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.822 ' H ' ' HB2' ' A' ' 57' ' ' SER . 4.0 tp10 -140.54 127.56 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.04 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.628 HG13 HG13 ' A' ' 56' ' ' ILE . 5.4 t -116.27 138.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 111.861 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.87 134.12 34.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.413 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -111.67 143.87 41.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 -179.449 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.72 161.1 40.78 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.94 148.03 22.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.624 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -120.16 142.38 49.01 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.456 -176.339 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.816 HG23 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -149.92 168.08 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.592 179.272 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 46' ' ' LYS . 6.0 p -80.13 -147.35 0.05 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.916 179.558 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.539 ' OG1' ' HG3' ' A' ' 47' ' ' PRO . 1.8 p -65.31 -10.47 32.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.621 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.19 163.67 6.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.91 98.86 11.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.26 34.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.46 86.48 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.44 -158.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.452 2.101 . . . . 0.0 112.296 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 -67.26 1.41 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.421 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.19 -91.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.661 0.267 . . . . 0.0 110.852 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.66 -14.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -150.52 -1.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.56 59.38 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.89 -116.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.83 -165.7 0.14 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.791 0.329 . . . . 0.0 110.986 -179.878 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 55.61 74.69 0.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.025 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.09 -16.0 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.942 179.897 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.817 0.341 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.39 34.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.59 -79.9 0.19 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m 55.45 33.43 20.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 59.3 179.39 0.08 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.101 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.31 67.44 6.23 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.28 167.37 25.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.449 2.099 . . . . 0.0 112.247 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.05 106.1 39.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.71 -178.74 4.82 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.519 2.146 . . . . 0.0 112.572 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -82.97 -2.03 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -139.68 -155.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 ' CD1' ' HG3' ' A' ' 64' ' ' GLN . 7.9 tp -70.85 144.95 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.391 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.87 95.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.055 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -167.46 145.41 4.68 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.467 179.513 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 1.4 m-85 -100.45 145.3 28.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.688 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.03 121.06 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 109.938 179.217 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.26 114.07 27.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.476 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 8.5 mtp85 -114.75 128.75 56.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.747 179.3 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.669 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.2 p90 -144.6 145.72 31.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.3 0.572 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -152.06 145.88 18.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.335 -179.812 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG3' ' HE1' ' A' ' 51' ' ' TYR . 42.3 Cg_exo -58.77 110.24 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.444 2.096 . . . . 0.0 112.335 -179.78 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.77 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 8.7 mmtm -72.11 -13.97 61.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.384 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.13 -26.92 15.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.549 -179.421 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.82 -12.93 15.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 t 50.41 70.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.6 -154.26 11.94 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.607 -179.811 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -89.49 141.18 28.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 110.649 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.465 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 42.1 m95 -73.21 178.0 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 mtpp -139.48 147.87 41.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.05 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.81 137.0 54.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.275 0.559 . . . . 0.0 112.304 -178.678 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.01 122.12 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -97.21 116.76 30.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.221 0.534 . . . . 0.0 112.395 -178.79 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -136.87 106.77 8.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.989 178.945 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.3 Cg_exo -59.94 -157.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.535 2.157 . . . . 0.0 114.157 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.696 ' O ' HD23 ' A' ' 37' ' ' LEU . . . -63.38 110.25 3.26 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.485 -178.339 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 35' ' ' GLY . 12.9 p80 3.7 69.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.218 1.007 . . . . 0.0 113.504 178.911 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.809 ' HG ' ' HB2' ' A' ' 39' ' ' SER . 0.1 OUTLIER -84.16 0.66 47.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.518 179.472 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 81.79 25.02 0.22 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -174.592 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.809 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . 5.7 t -75.77 176.68 7.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 110.809 -2.905 . . . . 0.0 112.776 -178.39 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.13 108.48 4.67 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.747 -1.569 . . . . 0.0 112.076 -177.309 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -104.28 141.87 35.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.806 178.849 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.734 HD13 HD22 ' A' ' 17' ' ' LEU . 1.3 mp -82.3 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.052 0.453 . . . . 0.0 111.691 -179.314 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -174.29 -170.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.563 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.99 84.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.777 179.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.796 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.6 mm? -115.37 167.57 10.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.83 ' O ' HG21 ' A' ' 73' ' ' THR . 0.0 OUTLIER -96.8 126.4 43.03 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.377 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.641 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 13.2 Cg_exo -32.66 137.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.751 3.634 . . . . 0.0 114.963 -179.483 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 -4.16 54.09 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.61 177.932 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -122.63 126.84 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 117.842 0.821 . . . . 0.0 112.966 -179.238 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.926 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.29 146.29 12.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.364 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HE1' ' HG3' ' A' ' 21' ' ' PRO . 71.2 m-85 -137.55 130.94 30.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.672 0.272 . . . . 0.0 110.988 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.77 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . 8.9 tp10 -79.85 129.46 34.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.479 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.68 127.17 7.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.089 -178.265 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.23 114.05 12.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 17' ' ' LEU . 2.1 mt -101.97 106.4 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 111.495 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.61 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.6 mp -104.13 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.882 178.866 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.616 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.52 150.14 27.13 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.743 0.782 . . . . 0.0 111.131 -179.039 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -116.65 132.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.585 -179.137 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.945 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.13 -174.21 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -31.71 70.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.248 179.533 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -103.97 -4.95 22.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.146 179.332 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 156.39 30.02 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.858 179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.7 t60 64.0 134.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.945 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 3.8 mm100 -161.2 -68.86 0.06 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.631 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.616 ' H ' ' HB2' ' A' ' 57' ' ' SER . 1.5 tt0 -137.53 115.34 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.183 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -123.4 129.8 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 111.933 178.795 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -129.42 141.27 51.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.366 179.716 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -104.88 133.46 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.573 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.99 136.36 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.991 179.534 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.1 142.73 27.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.318 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -148.91 161.32 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.171 0.51 . . . . 0.0 111.393 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -137.67 170.32 16.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.738 -179.341 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.83 HG21 ' O ' ' A' ' 46' ' ' LYS . 9.4 p -58.39 -139.39 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.042 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.423 HG23 ' HD3' ' A' ' 47' ' ' PRO . 6.7 p -72.51 11.86 0.56 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 73' ' ' THR . 8.8 t -94.17 -35.08 12.67 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.97 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m 68.04 141.86 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.807 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p -149.67 19.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.749 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.3 p -108.97 112.58 59.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.11 -7.54 14.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.096 . . . . 0.0 112.532 -179.587 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.87 92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.655 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.7 t 55.67 -98.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.471 ' HB3' ' H ' ' A' ' 83' ' ' SER . 10.5 ttp-105 -170.37 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -143.35 -156.81 0.72 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.973 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -65.95 -174.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 111.301 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -139.36 14.66 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.862 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 t60 56.16 81.35 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -66.55 121.18 14.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -108.95 -49.91 3.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.787 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.623 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -72.8 150.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 3.6 m -52.08 -44.89 64.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.006 0.431 . . . . 0.0 110.156 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -171.62 143.84 1.78 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.858 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.58 146.77 28.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.824 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -114.68 125.04 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.668 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -112.93 114.5 27.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.3 mtp180 -115.07 129.61 56.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.424 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.702 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.3 p90 -142.22 148.94 38.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 111.76 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -155.69 142.93 13.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 53.0 Cg_exo -57.6 109.94 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB3' HG12 ' A' ' 50' ' ' VAL . 1.2 tptp -77.22 -23.66 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -95.26 -20.38 19.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.67 2.0 18.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.984 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 25' ' ' VAL . 6.0 p 33.77 85.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.129 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.45 -147.21 6.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.532 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 27' ' ' ARG . 31.5 mtt180 -96.32 157.87 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 110.929 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 67.5 m95 -87.99 173.92 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttp -145.59 155.05 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -123.96 140.33 53.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.339 0.59 . . . . 0.0 112.407 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.73 112.06 7.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.592 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -91.06 127.94 36.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.761 HG22 HD21 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -137.56 107.46 8.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.727 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 23.4 Cg_exo -64.77 91.9 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.583 2.189 . . . . 0.0 113.025 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.84 -152.26 50.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.677 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -107.45 71.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.3 -31.69 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.634 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.58 179.88 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -77.0 106.81 8.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -123.29 113.31 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -128.55 127.85 43.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.26 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 HD22 ' A' ' 17' ' ' LEU . 8.8 mt -83.6 123.57 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.652 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -156.49 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.93 14.98 47.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.989 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.445 ' H ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -101.63 -166.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.755 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.62 162.29 37.06 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.745 0.307 . . . . 0.0 111.4 -179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 45.5 Cg_endo -68.38 146.36 68.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.264 1.976 . . . . 0.0 112.628 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.0 0.14 83.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.202 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 46' ' ' LYS . 5.5 p -120.29 137.97 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.961 0.381 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -114.56 129.57 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.184 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 34.4 m-85 -104.98 -178.16 3.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 mm-40 -123.25 130.12 52.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.52 129.25 7.64 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.314 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.67 114.33 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.405 0.145 . . . . 0.0 110.776 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 16' ' ' ILE . 3.5 mt -101.99 107.01 18.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 0.0 110.827 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.0 mp -109.47 117.74 55.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.675 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -81.5 140.33 34.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.488 0.661 . . . . 0.0 111.098 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.606 HG23 ' HA2' ' A' ' 62' ' ' GLY . 29.7 mt -119.09 132.45 68.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.452 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -106.88 -173.43 2.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -24.8 64.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HE22 ' A' ' 64' ' ' GLN . 4.7 p90 -103.38 -5.51 22.87 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.572 0.225 . . . . 0.0 111.598 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 82.5 154.52 14.99 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.146 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 62.77 96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.71 0.404 . . . . 0.0 111.633 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.658 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 10.3 mm100 -124.05 -89.93 0.58 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 112.315 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.49 145.35 26.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.98 114.5 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 134.47 47.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.758 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 127.7 55.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -136.1 160.56 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.136 0.493 . . . . 0.0 111.656 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.0 150.76 20.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.883 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.9 140.43 49.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.888 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 p80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.92 0.391 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -73.02 149.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.712 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 12' ' ' ILE . 7.8 t -44.62 -51.01 9.47 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 110.456 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HD2' HD11 ' A' ' 16' ' ' ILE . 4.1 pttt -171.48 143.95 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -105.78 136.77 44.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.695 HD13 HG13 ' A' ' 58' ' ' ILE . 3.0 mp -114.64 124.72 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.857 0.36 . . . . 0.0 110.679 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 25.8 tp -104.99 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -115.91 129.58 56.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.027 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 19.7 p90 -153.2 157.58 40.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.038 0.447 . . . . 0.0 111.541 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -159.39 156.9 26.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.79 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 31.3 Cg_exo -58.93 117.71 4.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.137 1.891 . . . . 0.0 112.386 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -34.73 64.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.636 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -90.56 -34.57 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -98.98 -169.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.596 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.09 168.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.65 -166.13 28.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.95 160.24 14.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -74.83 -179.94 4.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -146.24 127.57 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.103 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.29 134.46 55.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 111.915 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.86 133.22 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.194 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.1 m -85.76 132.07 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.175 0.512 . . . . 0.0 111.693 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.94 118.38 20.89 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.983 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 36' ' ' HIS . 53.9 Cg_exo -56.53 78.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.905 2.403 . . . . 0.0 113.462 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.74 10.35 0.97 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.259 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 34' ' ' PRO . 1.8 t-160 74.68 104.19 0.07 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.877 0.37 . . . . 0.0 110.358 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.5 mp -65.82 -35.22 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.0 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.22 -63.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.85 116.38 20.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -128.02 109.56 11.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.389 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -116.68 146.26 42.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.568 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.09 134.73 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.575 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -108.7 171.16 7.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 47.66 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.268 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.51 -169.34 2.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.803 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.49 146.44 12.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.47 122.97 10.78 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.612 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.27 9.53 2.97 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.246 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.35 130.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.901 0.35 . . . . 0.0 111.407 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 23' ' ' ASN . 11.3 t -83.02 145.37 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.22 166.07 26.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.59 0.709 . . . . 0.0 112.131 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.2 tp10 -133.24 128.67 36.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.67 139.87 11.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.517 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -133.52 131.63 40.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.773 0.321 . . . . 0.0 110.749 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.92 109.91 22.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.3 mp -108.14 115.42 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.15 121.66 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.432 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 16' ' ' ILE . 1.4 mt -113.4 113.4 43.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.519 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 64' ' ' GLN . 1.9 tt0 -89.29 -176.41 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.2 -18.31 57.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.168 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 64' ' ' GLN . 2.6 p90 -103.25 -4.78 23.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.94 -178.35 16.38 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.866 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.9 p80 -53.18 161.38 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.687 0.28 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.472 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 1.9 pt20 -170.24 0.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -145.45 116.8 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.468 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 56' ' ' ILE . 42.0 t -134.23 123.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.535 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.23 121.73 18.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -98.04 138.76 34.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.027 0.442 . . . . 0.0 111.767 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -156.38 126.85 6.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.767 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -95.41 137.93 33.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -139.65 149.11 43.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.009 0.433 . . . . 0.0 111.548 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.543 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.808 0.337 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -72.26 150.09 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.674 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.34 -50.95 37.51 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -171.55 144.58 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.366 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -104.52 139.56 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.256 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 mm -117.07 124.04 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.091 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 55' ' ' LEU . 26.8 tp -105.63 113.99 27.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.858 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.94 128.92 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.631 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -156.69 148.4 22.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.141 0.496 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HD3' ' CE2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -148.94 161.21 33.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.619 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' SER . 48.9 Cg_exo -57.72 117.56 4.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.281 1.988 . . . . 0.0 112.357 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -66.94 -36.84 83.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.503 -179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 50' ' ' VAL . 1.7 t-20 -96.44 -43.43 7.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.267 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.51 165.87 16.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.13 152.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.74 -127.68 1.53 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -139.93 168.76 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.404 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 65.5 m95 -82.45 173.39 12.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.94 137.59 36.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.69 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.3 mt-10 -120.22 133.31 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.038 0.447 . . . . 0.0 111.832 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.62 117.74 11.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.202 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.4 m -86.3 131.06 34.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.09 0.472 . . . . 0.0 112.147 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.6 mp -133.77 106.42 11.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.757 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.63 90.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.438 2.092 . . . . 0.0 112.378 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.69 -93.29 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.15 93.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -68.26 -33.96 75.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.855 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 169.02 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.72 117.22 21.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.035 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -115.82 113.69 23.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.842 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -122.99 130.18 52.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.875 HG22 HD11 ' A' ' 45' ' ' LEU . 4.6 mm -85.5 127.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -173.36 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 39.01 53.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.591 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -141.89 -174.18 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.8 151.27 12.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.244 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.17 168.62 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.8 -7.03 60.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.674 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.86 121.56 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' ASN . 1.6 p -82.44 103.24 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.67 160.03 14.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.135 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 1.6 tp10 -117.79 129.11 55.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.64 145.15 16.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.149 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -133.77 131.91 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.057 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 17' ' ' LEU . 4.9 tp -119.01 107.31 13.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.899 0.381 . . . . 0.0 111.051 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.6 mp -116.67 116.44 52.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.907 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -89.8 126.38 35.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.72 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 2.7 mp -113.15 125.26 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.235 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -101.15 -177.31 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.506 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -64.3 -26.78 68.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.54 -0.39 43.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.12 169.11 13.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 8.8 p80 -56.98 151.97 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 6.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 tt0 -143.66 116.74 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.18 121.21 31.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 m -134.96 121.52 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -100.94 129.7 46.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.69 132.6 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.305 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 151.24 19.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -151.63 153.9 35.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.052 0.453 . . . . 0.0 111.811 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.709 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.2 m80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.764 0.316 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -98.38 149.56 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -48.11 -47.56 34.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.891 0.377 . . . . 0.0 110.299 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -175.45 143.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.829 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.78 139.01 39.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.1 mm -116.07 129.31 72.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 28.5 tp -105.03 113.01 26.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.01 129.01 52.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -152.12 150.08 29.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.335 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.555 HH11 ' HA ' ' A' ' 25' ' ' VAL . 7.1 ptt85 -148.51 160.84 35.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.33 114.59 2.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.172 1.915 . . . . 0.0 111.622 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -30.89 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.748 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.636 HD22 HG12 ' A' ' 50' ' ' VAL . 2.0 p30 -99.48 -38.79 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -3.27 57.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HA ' HH11 ' A' ' 20' ' ' ARG . 32.9 m 35.44 41.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.092 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.37 -160.4 12.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -73.66 169.11 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.461 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 37.3 m95 -99.51 173.11 6.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.493 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.22 139.51 41.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.345 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -120.37 134.7 55.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 116.96 10.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.947 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 60.1 m -85.33 138.95 31.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.274 0.559 . . . . 0.0 112.475 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -135.45 107.07 10.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.476 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.26 87.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.83 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.16 25.91 48.36 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.941 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.3 OUTLIER 58.62 99.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.832 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.787 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -72.86 -22.46 60.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' H ' HD22 ' A' ' 37' ' ' LEU . 17.8 t-20 -176.82 -105.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.2 p -127.19 121.73 32.11 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.64 103.38 10.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -115.85 142.97 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.233 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.5 125.38 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 6.6 pttt -101.1 168.9 9.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -140.43 23.41 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.404 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.32 -167.97 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.563 0.22 . . . . 0.0 111.197 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.44 147.23 24.79 Favored Pre-proline 0 CA--C 1.527 0.082 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.49 45.04 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.995 2.463 . . . . 0.0 113.219 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.98 -19.01 7.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.516 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.56 136.86 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.935 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.636 HG12 HD22 ' A' ' 23' ' ' ASN . 9.5 p -77.63 147.0 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.15 148.21 51.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 112.307 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -111.93 129.82 56.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.806 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 136.97 13.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.597 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' NE2' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.86 123.66 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.449 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 3.8 mt -108.18 108.97 20.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 111.021 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 66' ' ' VAL . 1.3 mm -112.35 118.7 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.672 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.96 133.86 41.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.289 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.844 HG12 ' HB3' ' A' ' 63' ' ' HIS . 6.4 mt -113.65 127.48 70.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 111.644 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.652 ' HG2' HD12 ' A' ' 12' ' ' ILE . 2.8 mm100 -95.18 -176.46 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -68.76 -32.25 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.767 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.66 15.48 28.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.73 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.05 161.04 12.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.237 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.55 163.78 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.722 0.296 . . . . 0.0 110.986 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.44 6.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.66 115.89 12.57 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.958 0.408 . . . . 0.0 111.607 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.729 ' HB ' HD13 ' A' ' 56' ' ' ILE . 1.2 p -136.03 139.07 46.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -137.06 136.05 38.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.34 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' ' NE2' ' A' ' 54' ' ' GLN . 1.6 mtm180 -111.32 129.46 55.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -156.02 127.98 7.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.805 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.68 132.78 39.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.074 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -136.61 150.76 48.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.831 -179.238 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.743 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 32.7 m-70 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.744 0.307 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.648 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -67.28 150.14 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.1 t -49.76 -48.98 49.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.707 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -169.72 144.25 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.993 0.425 . . . . 0.0 111.445 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.626 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -105.19 139.12 40.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.952 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 18' ' ' ARG . 28.5 mm -114.45 117.97 57.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.525 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 42.6 tp -104.9 113.74 27.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.831 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -119.34 128.72 54.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.913 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 8.6 p90 -151.63 162.16 41.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.904 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.16 161.69 27.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.684 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.53 118.94 5.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 121.906 1.737 . . . . 0.0 111.832 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -62.92 -29.67 70.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.528 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -99.39 -41.17 7.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.471 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 160.06 17.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.281 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.77 147.44 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.31 -164.72 37.38 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.63 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -89.14 155.6 19.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.96 -172.59 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -141.16 144.33 34.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.8 mt-10 -120.05 132.95 55.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.202 0.525 . . . . 0.0 111.792 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 118.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.937 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 87.7 m -85.42 132.5 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 112.091 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 14.4 mt -123.88 107.56 30.95 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.759 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.7 104.26 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.603 2.202 . . . . 0.0 112.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.743 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . 58.8 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.159 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -146.06 111.82 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.243 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -82.76 -3.52 56.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.77 -63.91 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.872 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.76 105.22 8.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 110.818 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -126.47 115.21 19.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -120.57 144.47 48.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.257 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 45' ' ' LEU . 18.3 mt -94.33 132.68 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.506 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.39 154.38 25.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.227 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 38.13 4.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.642 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD21 HG22 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -126.62 171.02 11.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.328 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 135.96 10.47 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.29 157.95 10.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.659 2.24 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.37 -62.08 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.611 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -77.13 133.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 111.173 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 22' ' ' LYS . 5.3 p -82.85 144.76 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.027 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 138.92 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.945 0.402 . . . . 0.0 111.923 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 10.7 tp10 -105.22 129.29 53.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.5 144.67 15.72 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 119.822 -1.18 . . . . 0.0 114.309 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.8 mt-30 -133.66 129.47 36.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.377 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.626 ' HG ' ' CE1' ' A' ' 15' ' ' TYR . 4.7 tp -124.9 106.67 10.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.417 HD11 ' OE1' ' A' ' 54' ' ' GLN . 3.8 mp -116.88 116.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.941 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.474 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.42 127.43 33.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 63' ' ' HIS . 15.1 mm -112.84 124.39 69.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.309 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 -177.1 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.24 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.42 -2.54 28.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.54 -166.4 12.15 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.438 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.568 ' HA ' HD13 ' A' ' 58' ' ' ILE . 21.1 p-80 -64.65 140.81 58.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.319 . . . . 0.0 110.707 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 -51.59 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.7 tt0 -97.2 126.18 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.484 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 123.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -137.41 130.85 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -111.46 139.55 46.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -155.94 127.83 7.44 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.028 0.442 . . . . 0.0 111.501 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.82 124.1 39.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.7 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -125.18 162.73 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.85 0.357 . . . . 0.0 111.741 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.388 -179.708 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.8 m80 . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 120.505 0.193 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.774 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.0 OUTLIER -67.4 156.39 6.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.914 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.19 -41.51 65.33 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -162.39 143.15 10.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.831 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 8.2 t80 -122.83 153.12 39.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.655 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 58' ' ' ILE . 3.7 mp -120.11 121.88 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.682 0.277 . . . . 0.0 110.751 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.651 ' HB2' ' HE2' ' A' ' 15' ' ' TYR . 10.5 tp -104.84 114.22 28.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.639 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.64 129.84 56.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -140.9 155.08 46.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.83 146.2 12.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.685 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 20' ' ' ARG . 39.7 Cg_exo -58.18 114.63 2.05 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.214 1.943 . . . . 0.0 111.974 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -65.63 -35.82 81.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.495 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -91.28 -43.85 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.328 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.41 0.53 28.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 29.62 63.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.258 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.68 -153.39 29.58 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.541 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -88.32 164.91 15.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.3 172.7 8.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.029 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -152.24 123.95 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.571 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.42 130.11 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.123 0.487 . . . . 0.0 112.178 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.03 137.09 51.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.779 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 97.8 m -85.27 115.66 23.16 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.532 0.682 . . . . 0.0 111.858 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.82 110.46 17.22 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.597 178.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.15 79.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.092 1.861 . . . . 0.0 111.945 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 45.46 37.81 6.67 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.74 97.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.923 0.392 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -71.49 -32.84 68.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -163.63 -89.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.82 123.87 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.837 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -127.92 119.39 25.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -98.67 146.91 25.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.986 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 43' ' ' LYS . 12.1 mt -108.04 115.01 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.117 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 42' ' ' ILE . 7.8 mmpt? 25.73 -126.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.205 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.92 80.27 0.19 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 45' ' ' LEU . 1.3 mm? -68.54 -155.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.739 ' HD3' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -155.65 140.65 12.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.63 107.11 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.653 2.236 . . . . 0.0 112.484 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.61 -3.93 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.861 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.739 HG23 ' HD3' ' A' ' 46' ' ' LYS . 78.6 t -104.31 115.91 47.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 72' ' ' THR . 2.8 p -83.23 116.39 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.363 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -107.98 169.48 8.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.25 0.547 . . . . 0.0 111.454 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -124.16 129.92 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.118 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.57 139.61 10.61 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -131.18 138.58 49.49 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -99.28 105.39 17.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.644 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.618 ' N ' ' HE1' ' A' ' 15' ' ' TYR . 4.2 mp -116.0 113.44 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.774 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -106.42 133.41 51.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.234 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 9.6 mt -114.05 127.21 71.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -98.7 -179.02 4.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.914 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -66.45 -16.87 64.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.031 0.443 . . . . 0.0 110.085 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -103.06 -4.95 23.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.941 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 124.56 171.24 13.34 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.39 139.03 58.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.7 0.286 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -145.77 9.97 1.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.832 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -142.73 114.98 8.39 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 112.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -137.2 126.58 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.381 179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -137.2 131.02 31.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.007 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -107.51 125.49 51.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -155.73 133.89 11.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 111.359 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.92 140.79 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.278 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -143.48 142.81 31.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 111.806 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.462 HG22 ' HB ' ' A' ' 50' ' ' VAL . 31.6 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.574 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.861 0.362 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -80.46 155.07 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.636 ' H ' HE21 ' A' ' 59' ' ' GLN . 16.5 t -53.71 -47.11 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.075 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -172.96 144.0 1.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.116 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -106.23 143.9 33.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.441 HG22 ' HD3' ' A' ' 18' ' ' ARG . 19.5 mm -116.19 118.58 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 111.04 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.552 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 49.2 tp -105.37 114.95 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.651 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.48 128.99 55.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.439 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 44.5 p90 -140.4 147.73 40.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.313 0.578 . . . . 0.0 110.838 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -161.99 153.07 15.11 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.256 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.62 110.5 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.332 2.022 . . . . 0.0 112.247 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -32.22 73.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.288 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.83 -37.28 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.51 -162.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 26' ' ' GLY . 3.9 p -60.96 166.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.29 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' ' HG3' ' A' ' 20' ' ' ARG . . . -74.87 -108.78 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.649 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 59.97 65.98 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.071 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 -57.48 168.39 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.72 134.37 35.26 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 7.5 mt-10 -119.06 136.79 53.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.449 0.642 . . . . 0.0 112.65 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.05 119.74 15.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 62.2 m -85.28 131.59 34.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.63 107.3 13.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.65 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.84 84.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.615 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.68 60.62 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.782 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.5 m170 60.89 106.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 0.0 111.162 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -76.85 -30.69 56.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.605 ' OD1' HD23 ' A' ' 37' ' ' LEU . 10.4 p-10 -177.98 -148.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.81 105.6 7.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.28 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -103.23 114.75 29.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.128 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -101.57 147.56 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 17' ' ' LEU . 42.4 mt -107.61 114.74 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.754 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.784 ' HE2' ' H ' ' A' ' 43' ' ' LYS . 9.0 mmpt? 34.92 -129.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.624 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 45' ' ' LEU . . . -129.45 -43.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.714 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.416 ' HG ' ' C ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 55.21 -176.68 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.49 0.186 . . . . 0.0 110.769 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -160.74 142.87 9.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.33 143.02 94.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.546 2.164 . . . . 0.0 112.14 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.8 -29.9 4.79 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.97 135.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.632 0.254 . . . . 0.0 111.187 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.15 118.57 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -106.94 164.98 11.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.697 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.8 tp10 -123.16 129.31 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.494 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.51 132.1 10.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.127 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 19.8 mm-40 -134.32 112.71 11.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' CD2' HD13 ' A' ' 17' ' ' LEU . 14.5 mt -106.14 105.55 15.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.962 0.41 . . . . 0.0 110.293 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 18' ' ' ARG . 5.1 mp -117.77 114.78 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.174 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.533 ' OG ' HD13 ' A' ' 12' ' ' ILE . 1.8 t -89.59 116.25 27.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.32 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 6.2 mt -102.44 121.17 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.045 0.45 . . . . 0.0 111.573 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.636 HE21 ' H ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -78.87 -176.36 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.179 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -30.69 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -103.03 1.23 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.02 13.39 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.009 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 2.1 p-80 -75.87 156.24 34.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.244 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -26.68 0.14 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.293 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.27 119.02 38.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 111.191 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 132.64 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.232 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.7 132.69 33.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.281 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.95 129.44 56.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -156.39 128.66 7.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.99 136.4 36.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.916 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.34 159.18 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.952 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.929 -179.127 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -101.26 147.9 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.436 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.579 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.4 m -45.16 -49.79 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.268 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HB2' HG23 ' A' ' 32' ' ' THR . 6.7 pttt -175.61 144.16 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.733 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -111.15 135.43 51.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.556 HG22 ' HD2' ' A' ' 18' ' ' ARG . 10.2 mt -114.16 121.46 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 111.237 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 42' ' ' ILE . 66.4 tp -105.3 114.66 28.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.8 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -121.0 128.33 52.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.537 ' CE3' ' HG ' ' A' ' 17' ' ' LEU . 16.4 p90 -148.15 158.67 44.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.979 0.419 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.656 HH12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -160.5 162.44 23.4 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.614 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.5 111.32 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.374 2.049 . . . . 0.0 111.985 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -24.81 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.773 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.518 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -99.68 -43.92 6.3 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.18 175.49 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.375 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.656 HG23 HH12 ' A' ' 20' ' ' ARG . 11.3 p -136.0 145.65 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.55 -111.28 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.561 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -127.81 148.17 50.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -82.57 -174.96 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.13 124.31 20.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.3 mt-10 -119.73 136.61 54.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 112.136 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.19 138.73 40.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.302 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.1 m -94.34 132.57 38.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.168 0.509 . . . . 0.0 112.156 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -135.68 107.71 9.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.862 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.18 83.96 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.485 2.124 . . . . 0.0 112.179 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.46 -90.68 0.64 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.298 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -168.48 93.33 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.695 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.735 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.34 -33.46 75.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.434 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.0 OUTLIER 179.66 -92.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.782 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.06 117.45 21.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.669 0.271 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.98 101.66 9.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.8 130.64 54.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 17' ' ' LEU . 3.0 mt -81.55 119.57 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -175.22 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.31 47.7 21.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.204 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -137.13 166.68 23.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.798 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.88 116.54 4.5 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.14 105.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.857 2.371 . . . . 0.0 112.567 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 -33.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.45 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 135.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 11.4 p -76.49 140.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -126.11 142.73 51.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.904 -178.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 19.1 pt-20 -116.32 129.19 56.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.45 141.21 16.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.617 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -133.62 114.43 13.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CE1' ' A' ' 15' ' ' TYR . 3.9 mt -106.55 107.57 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 0.0 110.701 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.8 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.1 mp -113.54 122.23 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.211 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.3 OUTLIER -89.61 131.96 35.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.119 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -113.17 122.74 67.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.636 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 7.6 tt0 -119.56 -175.77 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.472 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.83 -22.1 63.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HD2' HE22 ' A' ' 64' ' ' GLN . 0.3 OUTLIER -103.15 15.83 28.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.193 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.14 -169.38 27.93 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.409 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.585 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -56.01 152.43 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.678 0.275 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.585 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.96 -50.65 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.895 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -99.08 118.85 36.76 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.825 -178.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -134.12 119.86 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.949 0.404 . . . . 0.0 111.168 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 m -137.21 135.4 37.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.23 125.81 9.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.609 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.65 124.55 43.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.411 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.45 156.3 48.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.39 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -179.568 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 78.2 m80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.825 0.345 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -89.61 144.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.585 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.69 -52.38 60.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.99 0.424 . . . . 0.0 110.154 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HD2' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -168.76 143.85 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.79 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -113.11 129.12 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.307 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -114.11 137.61 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.861 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.22 114.48 25.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.247 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 5.1 mtt-85 -113.97 128.31 56.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.196 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -154.75 157.34 37.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 112.228 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 8.3 ptt85 -159.13 160.19 28.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -58.14 125.11 17.54 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 112.418 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 3.0 tttm -76.91 -37.07 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.35 -31.97 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.68 168.61 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.13 130.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.81 -120.16 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.581 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -136.52 166.29 23.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.557 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 40.6 m95 -84.32 -174.97 5.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tttm -148.94 145.19 27.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -119.8 129.75 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.113 0.482 . . . . 0.0 111.727 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.12 111.77 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.192 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -88.98 140.2 29.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.811 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.57 116.32 17.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.423 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' HD21 ' A' ' 37' ' ' LEU . 3.0 Cg_exo -75.23 87.72 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.832 2.354 . . . . 0.0 112.08 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 -89.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -169.7 92.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.66 -33.79 25.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER 178.08 -157.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.599 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -86.18 106.61 17.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.729 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -84.57 119.48 25.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.019 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 m -122.78 124.47 43.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.18 122.62 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.02 105.1 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.7 8.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -95.09 -144.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.503 0.192 . . . . 0.0 110.499 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -165.85 140.46 3.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.5 95.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.407 2.071 . . . . 0.0 112.008 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.99 -27.71 3.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' THR . 1.9 t -92.52 124.0 44.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 110.659 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 72' ' ' THR . 63.1 t -100.93 123.14 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 0.0 111.384 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 18.0 m-85 -106.09 118.08 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.438 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 pt-20 -82.04 149.15 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.37 160.9 34.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.375 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -132.83 151.9 51.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.861 HD13 HD12 ' A' ' 17' ' ' LEU . 45.2 tp -111.19 107.7 17.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.92 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 66' ' ' VAL . 5.1 mp -92.55 138.31 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.007 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.523 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.55 123.52 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 110.951 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HD2' ' A' ' 14' ' ' LYS . 5.4 mt -113.27 117.79 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.824 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.97 171.66 10.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.892 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.98 -23.36 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.85 4.11 37.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.51 -134.09 11.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.619 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 64.77 168.8 0.18 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.856 0.36 . . . . 0.0 111.333 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -158.52 109.14 2.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.108 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tm-20 -100.11 116.28 31.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.328 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 56' ' ' ILE . 21.1 t -123.51 138.03 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 54.3 m -137.79 125.58 22.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.392 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.22 144.54 28.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.29 157.09 35.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.57 119.05 28.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -142.55 153.09 43.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.358 0.599 . . . . 0.0 112.45 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.829 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m170 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.577 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -90.71 142.81 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.354 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 2.2 m -66.23 -49.17 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.103 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.81 11.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.126 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.92 128.21 54.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.098 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 55' ' ' LEU . 32.9 mm -113.84 134.28 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.196 0.522 . . . . 0.0 110.987 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.862 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.55 114.55 27.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.311 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -112.28 128.24 56.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.935 179.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -147.94 155.77 41.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.328 0.585 . . . . 0.0 112.306 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.06 152.51 18.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -57.97 114.67 2.07 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.414 2.076 . . . . 0.0 112.55 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 1.8 ttmm -70.39 -36.39 74.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.154 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -84.3 -36.85 22.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.69 -169.57 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.781 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.03 103.25 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.909 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.19 -138.13 3.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 150.7 45.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -67.21 174.86 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.31 150.45 37.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.9 136.75 54.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 111.78 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 112.05 7.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.8 m -85.62 138.39 32.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.606 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -130.06 114.87 17.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.485 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 90.33 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.457 2.105 . . . . 0.0 112.304 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 66.57 -91.8 0.18 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.309 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -160.78 74.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 38' ' ' ASN . 2.0 pt? -65.6 -33.62 76.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.62 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.6 OUTLIER 173.95 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.335 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -76.94 105.41 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.391 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -89.99 116.76 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -116.01 131.41 56.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -102.08 130.45 51.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.989 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -135.03 -168.32 2.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.94 61.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.616 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.623 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -74.07 -170.19 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.785 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HE3' ' OH ' ' A' ' 51' ' ' TYR . 18.8 mttt -137.98 150.79 68.56 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.54 122.38 8.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.38 -16.86 31.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.551 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.96 125.66 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 72' ' ' THR . 82.6 t -96.5 142.82 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.728 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 26.9 m-85 -109.93 124.8 52.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.811 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -89.74 156.22 18.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.0 152.24 21.3 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.446 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.35 132.27 41.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.862 HD13 HD12 ' A' ' 17' ' ' LEU . 27.1 tp -99.9 107.01 18.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.879 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.19 138.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.663 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -117.02 121.49 41.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 111.906 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.87 125.7 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.432 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.753 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -118.64 178.96 4.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -22.16 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.03 -4.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.56 23.89 59.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.753 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 7.4 m80 -67.28 173.03 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 89.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -101.01 116.16 32.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.269 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 p -130.77 139.23 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.241 0.543 . . . . 0.0 112.418 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.4 m -137.6 125.64 22.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.753 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 146.85 27.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.22 146.25 21.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 111.807 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -108.59 121.3 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.489 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -129.58 149.13 51.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 50' ' ' VAL . 71.2 p . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.442 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG21 ' HD2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -100.34 141.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.534 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -54.79 -49.08 71.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.297 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -167.86 144.25 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.016 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -116.56 135.69 53.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.123 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.639 ' O ' HD23 ' A' ' 55' ' ' LEU . 17.2 mm -114.68 135.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.178 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.54 114.96 25.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.962 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.758 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.6 mtp180 -114.55 129.18 56.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.775 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -145.0 154.92 43.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 111.749 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.45 152.46 18.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.794 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.0 Cg_exo -58.59 119.11 6.15 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.348 2.032 . . . . 0.0 112.291 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -23.61 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.405 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -98.62 -36.4 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 2.8 m -104.31 113.52 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.997 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 m -95.51 128.59 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.74 -57.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.566 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -167.84 151.55 6.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.767 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 30.9 m95 -87.89 -169.51 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttt -143.11 151.19 40.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -119.94 137.04 54.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.319 0.581 . . . . 0.0 112.455 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.23 111.34 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.856 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -90.3 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.079 0.466 . . . . 0.0 112.099 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.41 117.65 8.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.57 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.37 86.64 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.223 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.25 -98.91 1.66 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -165.24 94.25 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -82.95 -33.57 26.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.441 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -179.82 -161.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.638 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -86.46 106.22 17.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -89.11 113.44 24.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -108.94 138.03 45.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 17' ' ' LEU . 15.3 mt -105.97 117.23 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -115.74 129.36 56.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.33 8.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.715 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.753 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -79.95 -165.91 0.92 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.543 0.211 . . . . 0.0 110.614 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 49' ' ' VAL . 4.2 mttp -130.99 142.1 44.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.678 0.275 . . . . 0.0 111.424 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.4 Cg_exo -60.02 94.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.727 2.285 . . . . 0.0 111.908 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.29 -25.84 6.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 46' ' ' LYS . 6.4 t -92.98 128.25 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.671 0.272 . . . . 0.0 110.793 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 t -94.36 146.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CG ' HD12 ' A' ' 45' ' ' LEU . 12.9 m-85 -117.54 122.76 44.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.769 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.31 148.33 26.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.23 148.47 18.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.533 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 66' ' ' VAL . 2.3 tt0 -132.91 142.44 48.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -107.72 107.06 17.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.585 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.2 mp -96.88 137.64 24.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -110.49 132.27 54.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.306 0.574 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 14' ' ' LYS . 9.6 mt -113.39 121.67 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.898 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.742 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -114.41 176.58 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.99 -32.3 73.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -102.19 1.17 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.64 88.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.833 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.742 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 1.3 m-70 -98.32 -41.05 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 110.51 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' SER . 31.4 mt-30 66.5 80.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.751 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 10.4 tt0 -96.75 126.6 42.03 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -125.95 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -137.87 121.74 17.68 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.08 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.6 141.0 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.606 -179.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.443 ' HE2' HD12 ' A' ' 55' ' ' LEU . 2.0 p90 -155.88 154.32 31.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.376 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.29 127.59 50.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.543 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -146.65 152.99 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.435 0.636 . . . . 0.0 112.499 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.627 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.77 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.017 0.437 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.65 HG21 ' OG ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -104.28 157.42 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.65 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -51.08 -37.58 46.56 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.69 ' HD2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -167.73 143.35 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.905 178.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.751 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.12 133.2 56.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.814 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.782 HG21 HH11 ' A' ' 18' ' ' ARG . 4.1 mp -114.45 138.39 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.078 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -113.1 114.62 27.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.214 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -118.21 128.17 54.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.467 ' CE3' HD23 ' A' ' 17' ' ' LEU . 10.2 p90 -153.31 155.09 35.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 112.537 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.35 161.75 26.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.354 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.5 Cg_exo -57.72 113.92 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.283 1.988 . . . . 0.0 112.353 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -60.1 -27.82 67.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.12 -37.01 64.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 t -94.68 -159.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.59 136.59 43.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.25 -163.37 54.49 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.881 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 61.45 58.02 2.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.348 . . . . 0.0 111.416 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 55.3 m95 -79.43 179.21 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.504 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mttt -142.7 145.19 33.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.21 129.16 53.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 112.232 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.02 111.27 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.931 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.3 m -97.52 123.07 41.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 112.297 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -123.08 110.76 30.94 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' HD21 ' A' ' 37' ' ' LEU . 23.8 Cg_exo -63.69 101.52 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.257 1.971 . . . . 0.0 111.621 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.3 -91.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.829 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.21 101.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.938 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.668 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -81.05 -33.31 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.937 0.399 . . . . 0.0 110.405 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.0 -168.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -77.09 105.85 8.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.551 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 109.92 21.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.38 127.85 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.72 122.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -131.77 122.47 25.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.12 25.41 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD12 ' CE2' ' A' ' 51' ' ' TYR . 2.4 mm? -76.32 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.533 0.206 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.713 ' HD3' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.4 152.23 59.96 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 120.732 0.301 . . . . 0.0 110.745 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 137.43 19.9 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.561 2.174 . . . . 0.0 112.517 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.02 -15.37 63.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.699 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 ' HD3' ' A' ' 46' ' ' LYS . 6.3 p -119.55 134.89 61.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 72' ' ' THR . 96.2 t -104.32 140.72 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.441 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.3 m-85 -105.93 119.36 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.191 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG2' HH21 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -85.44 138.37 32.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.87 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.57 146.31 16.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.873 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.521 HE21 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.4 136.8 45.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 17' ' ' LEU . 1.5 mt -101.71 106.67 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.6 mp -94.82 119.53 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.65 ' OG ' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -103.63 130.31 51.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.197 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -113.35 128.78 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.569 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.5 OUTLIER -116.04 -178.02 3.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.02 -8.62 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.02 -4.67 46.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.59 31.44 54.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 3.6 m-70 -89.42 -178.58 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 110.744 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' SER . 1.4 mt-30 -149.32 104.83 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.523 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.6 tm-20 -96.99 125.66 41.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -131.45 134.08 61.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -137.2 122.51 19.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.13 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.521 HH21 HE21 ' A' ' 54' ' ' GLN . 6.8 mtp180 -84.54 147.28 27.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.348 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.37 141.49 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.99 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -114.08 123.33 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.294 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -141.65 151.7 43.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.988 0.423 . . . . 0.0 111.657 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.686 HG21 HG22 ' A' ' 50' ' ' VAL . 20.7 p . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.684 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.448 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.811 0.338 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -103.41 149.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.237 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -52.69 -47.28 67.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.013 179.215 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' NZ ' HD12 ' A' ' 58' ' ' ILE . 7.6 ptmt -159.3 143.84 15.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.201 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -119.62 132.08 55.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.922 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HD23 ' A' ' 55' ' ' LEU . 19.7 mm -114.07 132.97 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 111.01 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.55 114.37 27.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.979 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 18.5 mtt180 -115.94 128.76 56.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.586 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' A' ' 17' ' ' LEU . 14.2 p90 -152.71 160.02 43.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.463 0.649 . . . . 0.0 112.016 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG2' ' CE2' ' A' ' 28' ' ' TRP . 3.6 ppt_? -159.42 160.01 28.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.999 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.4 Cg_exo -57.88 117.38 4.08 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.227 1.951 . . . . 0.0 112.42 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -60.28 -38.81 84.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.49 -27.15 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -96.96 -164.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.76 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.03 114.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.18 -179.65 24.93 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.826 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 60.58 88.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.911 0.386 . . . . 0.0 111.159 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.429 ' CE2' ' HG2' ' A' ' 20' ' ' ARG . 43.0 m95 -101.05 -176.53 3.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.2 tttt -151.21 147.53 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.963 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.42 138.87 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.774 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -137.75 111.76 8.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.274 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -89.29 137.89 31.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 111.859 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.21 109.74 8.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.324 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 57.9 Cg_endo -70.87 87.39 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 112.8 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 52.78 39.16 54.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.605 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.89 84.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.026 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 38' ' ' ASN . 0.1 OUTLIER -69.32 -33.56 73.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.443 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.694 HD22 HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER 177.66 -154.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.702 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.4 t -77.15 105.11 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -97.02 127.51 43.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -99.33 147.43 25.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.697 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.49 137.67 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.233 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.4 138.54 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.47 130.35 38.12 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.149 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 2.7 mm? -85.3 -136.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HE2' ' HB ' ' A' ' 49' ' ' VAL . 16.4 tttt -136.79 117.65 11.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.504 0.193 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.09 112.33 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.567 2.178 . . . . 0.0 112.072 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.18 -24.66 6.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.352 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HB ' ' HE2' ' A' ' 46' ' ' LYS . 7.1 p -118.06 137.42 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HA ' HG22 ' A' ' 72' ' ' THR . 46.7 t -97.09 139.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.517 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 24.8 m-85 -105.26 128.92 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.624 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.38 137.81 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.036 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.03 157.04 27.19 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.823 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.4 143.23 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -107.46 106.14 16.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.134 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD13 ' HD2' ' A' ' 18' ' ' ARG . 4.6 mp -92.26 138.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.132 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -121.0 119.36 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.733 -178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' NZ ' ' A' ' 14' ' ' LYS . 1.1 mt -114.34 127.84 71.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.067 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 61' ' ' TYR . 10.3 pt20 -118.41 -177.39 3.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.985 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.37 -4.62 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 7.6 m-85 -101.27 -5.04 26.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.09 16.02 68.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.198 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -67.31 174.84 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.809 0.305 . . . . 0.0 110.601 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 63' ' ' HIS . 3.0 mm-40 -152.16 95.02 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -97.52 117.99 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.063 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.1 p -127.82 134.04 66.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.8 m -137.53 121.53 17.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 138.95 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.958 0.408 . . . . 0.0 111.476 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.12 157.41 43.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -119.95 121.35 38.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -147.14 159.82 43.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.228 0.537 . . . . 0.0 111.986 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.973 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p80 . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -67.54 155.61 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.733 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 74.9 m -54.09 -39.05 66.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.612 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' H ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -157.14 144.81 18.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.088 0.47 . . . . 0.0 111.37 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.33 126.33 44.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.011 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.6 mt -112.54 135.48 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -105.56 115.27 29.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.775 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.744 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.7 mmm180 -110.06 134.56 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 29' ' ' LYS . 4.3 p90 -161.44 150.45 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.143 0.496 . . . . 0.0 111.609 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.626 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -159.43 152.8 18.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.904 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 51.2 Cg_exo -58.66 117.2 3.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.51 2.14 . . . . 0.0 112.621 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -33.38 74.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.036 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' HG13 ' A' ' 49' ' ' VAL . 8.1 t-20 -92.43 -43.68 9.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.74 -164.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.101 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.51 163.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.7 26.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.38 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 59.56 -179.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.199 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 29.5 m95 -92.77 -178.81 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.85 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.703 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.6 OUTLIER -120.14 133.66 55.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.167 0.508 . . . . 0.0 112.181 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.98 110.83 9.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.83 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 39.8 m -90.95 139.55 30.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.81 HG22 HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.23 106.98 6.7 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.886 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_endo -60.28 90.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.73 60.57 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 57.94 85.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -80.91 -31.97 34.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.505 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 4.7 p-10 -166.76 -170.98 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.57 118.97 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.86 125.52 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.676 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 t -107.76 147.7 30.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.375 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.06 137.46 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.802 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -48.7 155.73 0.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 129.04 49.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.491 HD12 ' CD1' ' A' ' 51' ' ' TYR . 2.9 mm? -74.71 -136.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.5 ttmm -153.38 134.6 8.43 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 21.0 Cg_exo -65.09 117.01 4.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 112.25 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.26 54.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 23' ' ' ASN . 2.2 t -118.86 131.36 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.653 ' HA ' HG22 ' A' ' 72' ' ' THR . 41.3 t -99.92 136.45 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.641 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD1' HD12 ' A' ' 45' ' ' LEU . 22.1 m-85 -105.96 118.91 37.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 18.8 pt-20 -80.07 137.89 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 147.49 19.0 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.854 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' OE1' HD11 ' A' ' 56' ' ' ILE . 1.4 tt0 -132.97 150.54 52.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' ILE . 30.1 tp -123.93 110.19 14.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 111.588 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 6.0 mt -97.52 138.35 22.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.609 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -114.2 121.73 44.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' C ' HD11 ' A' ' 12' ' ' ILE . 2.4 mt -111.79 124.58 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.11 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.45 178.36 4.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.47 -14.57 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -101.35 -4.53 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.39 64.22 4.44 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.652 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 61.42 87.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.443 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.609 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.257 179.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG13 ' HG3' ' A' ' 54' ' ' GLN . 16.3 t -134.07 136.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m -138.09 121.13 16.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.605 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 68' ' ' ARG . 5.0 mtt180 -91.86 146.16 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 111.87 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -156.17 146.49 21.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.212 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -114.41 133.08 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 45' ' ' LEU . 34.6 p90 -144.5 148.36 34.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 112.253 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 50' ' ' VAL . 16.2 p . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.974 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.265 0.078 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -98.37 143.16 13.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.844 0.355 . . . . 0.0 111.186 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -60.19 -46.83 88.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.155 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 143.97 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.064 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -111.82 135.29 52.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.24 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 58' ' ' ILE . 3.3 mp -114.15 133.09 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 110.467 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' HG ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.24 114.29 25.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.269 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.801 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -115.63 127.96 55.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 28' ' ' TRP . 20.7 p90 -144.86 161.37 39.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.953 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -156.54 150.85 19.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.7 Cg_exo -57.54 125.52 19.04 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.363 2.042 . . . . 0.0 112.719 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.503 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 37.9 tttp -76.66 -38.61 54.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.129 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -84.12 -39.58 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -98.3 142.95 29.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.785 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.54 132.33 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.973 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.39 -142.41 3.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -114.89 175.96 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.854 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 30.7 m95 -89.46 -167.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.5 mttp -152.38 155.9 38.5 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -122.17 130.39 53.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.512 . . . . 0.0 112.061 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.3 111.12 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.102 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 99.7 m -90.04 141.07 29.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 112.0 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.507 HG13 ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -138.24 107.65 8.01 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.221 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HG2' HD22 ' A' ' 37' ' ' LEU . 36.4 Cg_endo -65.25 92.72 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.456 2.104 . . . . 0.0 112.093 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -98.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -165.75 70.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.702 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.63 ' HG ' HD22 ' A' ' 38' ' ' ASN . 1.5 pt? -72.27 -33.03 67.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.63 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -164.33 -179.73 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t -79.74 108.48 13.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.09 110.3 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.666 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -115.58 144.88 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.77 125.38 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.986 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -119.36 153.41 35.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 45' ' ' LEU . . . 126.65 13.31 3.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 72' ' ' THR . 0.4 OUTLIER -104.14 -166.11 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.51 0.195 . . . . 0.0 110.614 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.24 156.14 20.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.566 0.222 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.34 104.76 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.478 2.119 . . . . 0.0 112.002 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.86 -14.66 4.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.043 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.4 t -116.26 124.99 73.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 72' ' ' THR . 89.6 t -110.23 133.36 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' CE1' HD22 ' A' ' 45' ' ' LEU . 57.6 m-85 -109.3 126.55 53.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.93 131.4 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.79 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 19' ' ' TRP . . . -139.68 161.87 26.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.614 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.754 ' HG3' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -134.58 152.78 52.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.886 0.474 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.0 mt -124.18 106.87 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.543 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CD ' ' A' ' 18' ' ' ARG . 87.3 mt -94.46 138.53 20.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.275 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.597 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.73 119.14 32.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.288 0.566 . . . . 0.0 111.345 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.692 HD12 HD13 ' A' ' 16' ' ' ILE . 28.9 mt -114.15 125.19 71.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.764 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.34 173.37 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 5.1 pt20 -65.83 -18.45 65.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.226 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -102.25 9.64 39.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.78 -114.28 4.95 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.801 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.54 -174.91 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.962 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.66 99.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.34 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 5.0 tt0 -96.81 116.33 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.8 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' GLN . 1.2 p -131.17 131.18 63.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.3 m -137.72 125.09 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.326 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.58 147.1 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.28 . . . . 0.0 110.746 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' HZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -155.96 155.61 33.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.006 0.432 . . . . 0.0 111.64 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -116.75 133.44 56.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -147.86 150.72 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.293 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -67.48 149.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.974 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -55.33 -50.58 69.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.248 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.6 pttt -171.12 144.8 2.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.629 ' CD1' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -102.03 154.23 19.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.738 179.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.73 147.77 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 111.376 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -134.0 109.32 8.91 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.339 176.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.761 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 6.0 mtp180 -122.84 127.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 5.6 p90 -161.08 159.68 29.49 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.354 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.95 165.92 17.47 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.343 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -54.29 115.88 2.68 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 121.283 1.322 . . . . 0.0 112.619 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB3' HG13 ' A' ' 50' ' ' VAL . 6.3 tptm -34.05 -53.6 0.47 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.79 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -101.67 -44.41 5.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.866 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.42 ' C ' ' HB2' ' A' ' 21' ' ' PRO . 47.0 t -76.61 -177.24 4.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.94 132.18 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.15 34.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.522 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.58 139.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.421 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 62.0 m95 -60.3 167.08 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.723 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -132.29 158.91 40.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 30' ' ' GLU . 10.5 pm0 -138.11 127.92 25.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.356 0.598 . . . . 0.0 112.431 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 17' ' ' LEU . . . -143.14 122.47 13.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -107.47 120.97 43.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.702 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.63 107.26 34.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.559 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.7 Cg_endo -72.67 110.75 3.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.316 2.011 . . . . 0.0 112.42 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.47 -120.78 23.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.508 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -143.73 68.52 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.74 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -65.64 -33.03 74.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.928 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -174.42 -172.42 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.9 m -85.2 105.74 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -93.5 107.56 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.484 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.92 140.38 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.423 HD13 ' HZ ' ' A' ' 71' ' ' PHE . 2.3 mp -100.18 130.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.71 75.77 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.113 0.483 . . . . 0.0 111.287 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.725 ' H ' HD12 ' A' ' 45' ' ' LEU . . . -150.4 11.0 0.86 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.285 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.78 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -124.82 -152.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.755 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.589 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 160.52 162.0 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 123.728 0.643 . . . . 0.0 110.492 178.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 11.3 Cg_endo -54.31 -6.9 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.544 2.163 . . . . 0.0 112.123 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.63 -46.57 4.25 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.955 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.656 ' O ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -113.78 136.87 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 111.544 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 22' ' ' LYS . 3.0 p -103.02 117.57 48.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' HD23 ' A' ' 45' ' ' LEU . 30.4 m-85 -102.05 125.88 48.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.788 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 2.1 tt0 -78.7 126.73 31.13 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.654 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -115.29 159.6 13.69 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.062 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.2 tt0 -133.48 114.46 13.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.0 111.762 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -101.36 106.2 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.976 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 51.2 mt -116.49 120.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.716 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.52 138.18 35.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.902 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.8 mp -117.71 130.6 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.46 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.99 -176.58 6.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.04 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 4.5 pt20 -61.05 -30.59 70.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.913 0.387 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.488 ' N ' ' HG3' ' A' ' 60' ' ' GLN . 2.1 p90 -103.24 -4.64 24.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 105.83 156.99 22.17 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.669 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 22.2 m80 65.97 135.97 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.362 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.643 ' HB2' ' O ' ' A' ' 57' ' ' SER . 1.9 mm-40 -166.49 -57.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.769 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tp10 -145.51 144.6 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.511 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.7 t -134.77 121.69 35.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.72 0.295 . . . . 0.0 111.779 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 121.69 17.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.23 121.81 45.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.735 0.303 . . . . 0.0 111.132 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -151.97 131.56 13.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.627 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.788 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.9 p30 -92.95 138.73 31.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.423 ' HZ ' HD13 ' A' ' 42' ' ' ILE . 28.8 p90 -141.31 161.89 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.366 . . . . 0.0 111.872 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.902 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 121.133 0.492 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.688 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.3 tp -84.51 153.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.1 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.678 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -56.52 -45.32 81.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.48 144.04 8.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.778 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.2 156.61 17.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.505 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -120.78 148.42 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.355 0.598 . . . . 0.0 111.347 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.468 ' H ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -133.06 109.85 9.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.745 176.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.798 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt180 -118.37 127.84 54.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.2 p90 -161.35 153.65 20.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 117.901 -1.52 . . . . 0.0 114.904 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.83 164.07 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.025 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -56.73 110.63 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 121.584 1.523 . . . . 0.0 112.588 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 50' ' ' VAL . 9.0 tptt -30.79 -47.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.379 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 -44.06 7.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.807 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -79.51 82.71 5.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 110.842 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.92 145.32 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.76 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -134.28 125.01 26.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.953 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.484 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 68.1 m95 -64.12 171.48 2.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.1 mttt -120.96 162.92 19.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -134.48 123.92 24.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.098 0.475 . . . . 0.0 112.031 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.92 111.78 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.97 118.16 35.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 111.405 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.033 HG22 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -132.75 111.51 13.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.463 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.8 Cg_exo -46.61 160.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.64 2.227 . . . . 0.0 113.024 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.24 105.05 0.28 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.664 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 44.17 39.08 2.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.7 -16.61 61.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.839 0.352 . . . . 0.0 110.546 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.709 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -172.57 169.62 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -83.57 106.3 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -117.79 120.04 36.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 m -116.38 146.45 42.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG21 ' HZ ' ' A' ' 71' ' ' PHE . 2.5 mp -94.95 117.66 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.44 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.51 61.77 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.187 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.44 -17.23 4.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.888 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -92.43 137.78 32.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.408 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 49' ' ' VAL . 15.7 pttt -104.01 161.5 22.74 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.333 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -55.83 96.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.252 1.968 . . . . 0.0 112.832 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.37 -9.49 3.5 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.847 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' HB ' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -120.55 138.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 22' ' ' LYS . 2.4 p -112.62 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.211 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 34.1 m-85 -105.39 124.9 50.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.25 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 1.017 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 10.3 tt0 -79.53 126.6 31.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -112.98 156.63 15.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.583 ' NE2' HD11 ' A' ' 56' ' ' ILE . 60.3 tt0 -132.7 114.58 14.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.226 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -100.54 106.18 17.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 77.0 mt -116.9 121.26 67.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.4 m -82.22 135.98 35.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.501 . . . . 0.0 110.071 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.688 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.7 mt -117.03 132.38 66.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.021 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.723 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -95.2 -175.68 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.321 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.41 -27.43 67.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 12.2 p90 -103.31 -5.49 22.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.747 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.688 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 97.87 151.87 27.76 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.921 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 66.2 129.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 111.447 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 7.7 mm-40 -156.53 -51.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.26 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.6 tt0 -144.11 145.15 31.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 56' ' ' ILE . 58.0 t -134.62 123.25 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.277 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -137.34 120.5 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.939 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -112.9 118.42 34.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.68 137.49 13.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.661 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 1.017 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 16.1 p-10 -92.3 135.28 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.152 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.494 ' HZ ' HG21 ' A' ' 42' ' ' ILE . 9.1 p90 -140.82 162.97 34.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.063 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.439 -0.982 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.02 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.437 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 4.5 p-80 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.689 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -96.79 151.36 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.689 ' N ' HG13 ' A' ' 12' ' ' ILE . 20.3 m -49.74 -49.25 48.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -168.47 144.16 3.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.103 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -106.7 156.97 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.715 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.66 147.61 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -133.34 109.61 9.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.606 177.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.17 127.15 44.07 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.696 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -162.54 164.6 26.79 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.449 -1.3 . . . . 0.0 114.117 -176.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 138.01 10.2 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 113.681 -1.6 . . . . 0.0 108.219 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 13.9 Cg_endo -55.57 109.34 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.172 1.915 . . . . 0.0 111.37 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.721 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -49.79 -59.22 4.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.808 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -62.77 -43.94 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.303 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -103.3 67.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.806 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -47.05 137.8 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.345 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.14 -82.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -154.17 148.77 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -67.11 170.68 6.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.3 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.8 tptt -138.0 165.8 25.66 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.3 pt-20 -142.32 126.28 17.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.901 0.381 . . . . 0.0 111.808 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.92 129.69 21.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -105.09 119.5 39.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 111.538 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -116.81 106.67 47.53 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.548 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 9.7 Cg_exo -72.0 97.64 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.683 2.255 . . . . 0.0 113.044 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 45.15 44.83 9.89 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.217 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 56.15 79.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.3 -32.9 72.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.776 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 -164.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.638 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.26 105.65 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -122.99 107.85 12.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.35 147.36 45.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.554 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.628 HD12 ' HZ ' ' A' ' 71' ' ' PHE . 14.8 mt -90.77 137.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 149.59 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.254 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 113.55 23.46 5.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -125.61 171.95 10.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.526 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HG2' HG23 ' A' ' 49' ' ' VAL . 4.8 pttt -178.35 165.7 1.12 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 92.3 Cg_exo -47.61 -22.98 3.3 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.587 2.191 . . . . 0.0 112.218 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.51 -36.2 17.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.405 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -114.2 124.22 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 120.992 0.425 . . . . 0.0 111.782 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' A' ' 22' ' ' LYS . 1.8 p -102.04 131.22 50.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m-85 -112.18 119.21 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.518 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -78.98 127.77 32.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -127.71 158.1 21.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.898 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.7 tt0 -133.63 121.18 21.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.552 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 6.0 mt -110.22 106.84 16.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.024 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.728 ' H ' HG22 ' A' ' 16' ' ' ILE . 32.4 mt -112.55 119.6 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.897 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.663 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.63 135.04 35.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.357 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.5 mp -117.33 132.16 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.897 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.82 -176.78 5.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.487 179.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -63.61 -30.28 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.578 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -102.6 1.07 34.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 101.46 150.23 23.52 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.028 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 65.83 144.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 111.578 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -169.2 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.072 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -144.56 144.08 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.612 -178.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 56' ' ' ILE . 84.7 t -133.91 114.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -137.1 120.3 16.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -112.22 133.98 54.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.94 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 4.4 p90 -156.56 154.83 30.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.932 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -100.88 122.0 42.69 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.628 ' HZ ' HD12 ' A' ' 42' ' ' ILE . 2.4 p90 -138.62 163.8 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.387 0.613 . . . . 0.0 111.826 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.432 ' HA ' HD23 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.693 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 m80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.846 0.355 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.6 OUTLIER -75.33 145.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.9 t -53.02 -44.96 67.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.88 0.372 . . . . 0.0 110.106 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.7 pttt -175.8 146.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.964 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -101.38 154.37 18.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.605 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -114.89 147.96 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.408 0.623 . . . . 0.0 112.037 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -132.14 109.53 10.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.536 176.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -117.93 127.47 53.88 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.668 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -158.66 159.98 35.96 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.435 -1.306 . . . . 0.0 113.405 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HG3' ' CE3' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -157.46 155.84 28.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.194 178.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 17.1 Cg_endo -54.08 109.79 0.43 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 122.347 2.032 . . . . 0.0 111.202 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB3' HG13 ' A' ' 50' ' ' VAL . 1.1 tmtp? -45.83 -55.27 6.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.205 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.55 -43.87 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.799 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 8.5 t -71.07 150.89 45.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.988 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.97 135.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.031 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.39 -159.85 22.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.55 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 14.6 ptp180 -116.75 164.25 14.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.49 ' CE3' ' HG3' ' A' ' 20' ' ' ARG . 60.7 m95 -66.46 167.79 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.52 160.08 37.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.03 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 123.79 24.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 111.969 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.44 112.4 7.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.107 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 130.42 44.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 112.193 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.86 HG22 HD11 ' A' ' 37' ' ' LEU . 1.1 pt -137.2 106.44 8.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.672 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 85.5 Cg_endo -81.92 122.0 3.75 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 35.46 7.48 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.375 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 50.48 78.25 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.986 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.21 -30.62 71.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.495 ' H ' HD12 ' A' ' 37' ' ' LEU . 11.7 t30 -168.26 174.88 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -77.09 105.12 7.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.219 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -115.57 117.05 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.613 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 141.86 47.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.409 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 17' ' ' LEU . 2.8 mp -86.76 134.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.882 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.47 53.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.51 2.63 24.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.281 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -108.41 129.35 55.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.388 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -111.52 163.34 17.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.542 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 10.3 Cg_endo -49.82 95.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.639 2.226 . . . . 0.0 112.671 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.21 -6.73 5.37 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.778 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -120.77 138.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.737 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.8 p -115.13 133.96 59.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.502 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 45' ' ' LEU . 17.3 m-85 -116.43 130.03 56.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.583 0.23 . . . . 0.0 111.331 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 37.8 tt0 -88.27 127.8 35.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -117.09 155.24 16.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.704 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 6.1 tt0 -132.27 114.45 14.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 4.9 mt -103.12 106.77 17.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.111 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLU . 96.7 mt -117.09 122.67 70.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.0 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.25 134.73 35.65 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 16' ' ' ILE . 1.7 mp -120.26 130.7 74.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.693 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 4.7 mm100 -126.12 -174.02 3.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -6.6 27.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.828 0.347 . . . . 0.0 111.011 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -103.05 -4.76 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.707 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.39 161.93 5.87 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.805 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.1 t60 66.69 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.693 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 59.65 -95.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.571 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.65 144.27 51.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.869 -178.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.65 126.3 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.15 124.46 21.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 125.6 54.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.241 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.445 ' CE1' HD12 ' A' ' 55' ' ' LEU . 16.3 p90 -156.31 127.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 111.928 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.777 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.56 133.32 39.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.978 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -140.95 163.69 32.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.617 0.722 . . . . 0.0 112.515 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.968 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.554 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.034 0.445 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.928 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -95.07 154.02 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.414 179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.718 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.2 m -46.26 -41.07 12.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 17.1 pttt -174.2 143.5 0.89 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.562 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -101.41 147.36 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -115.04 148.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 121.183 0.516 . . . . 0.0 111.219 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -126.03 109.35 12.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.005 176.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.2 mtt-85 -118.2 125.87 51.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.712 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -156.2 157.01 35.14 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 117.878 -1.529 . . . . 0.0 114.133 -176.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.76 151.76 17.05 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.871 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 54.2 Cg_exo -53.61 108.64 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 120.888 1.058 . . . . 0.0 111.242 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' H ' ' H ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -21.9 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.896 -179.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -44.15 6.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.226 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.31 67.52 9.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.289 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -53.82 124.17 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.882 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.09 76.23 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.697 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 27' ' ' ARG . 6.5 mtt-85 65.08 125.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 0.0 111.544 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -62.28 166.96 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.779 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mmpp? -127.33 152.83 46.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.17 124.26 34.18 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -142.94 111.66 6.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.981 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 111.88 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -138.58 106.92 7.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.184 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 61.3 Cg_endo -72.29 111.87 3.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.234 1.956 . . . . 0.0 113.1 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.75 11.45 36.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.173 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.18 84.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.0 -18.35 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.765 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' OD1' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -160.48 -178.71 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.726 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.97 105.82 9.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -99.69 105.68 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -122.07 146.03 47.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.225 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.02 134.33 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -108.63 -4.89 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.909 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.48 -63.08 5.4 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.394 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.763 ' HB3' ' HD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.748 0.419 . . . . 0.0 111.333 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -102.78 157.39 33.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.557 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 1.1 Cg_endo -42.37 104.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.383 2.722 . . . . 0.0 113.351 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.47 -12.02 8.43 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.447 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 46' ' ' LYS . 8.1 p -120.85 139.35 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.827 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.5 p -111.26 128.42 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.818 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.871 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 21.3 m-85 -107.55 120.36 41.98 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.003 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.931 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 14.8 tt0 -80.13 127.08 31.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -116.04 152.63 17.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mt-30 -130.9 117.06 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 111.602 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.2 mt -100.22 106.27 17.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.17 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.9 mp -109.44 113.92 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.742 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.928 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.1 m -87.58 121.23 29.76 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.192 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 64' ' ' GLN . 1.9 mt -114.6 133.32 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.408 0.623 . . . . 0.0 112.577 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.639 ' H ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -96.6 -174.89 3.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.741 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.64 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.24 4.14 36.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.716 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 58' ' ' ILE . . . 92.53 -133.41 11.72 Favored Glycine 0 N--CA 1.454 -0.128 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.869 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -43.83 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.887 0.375 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.712 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . 5.5 tp-100 -110.45 -52.56 2.77 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 56' ' ' ILE . 1.8 mm-40 -146.52 144.95 29.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 111.243 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -135.96 131.78 49.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.67 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.91 126.39 23.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.057 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -112.69 123.66 50.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.559 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -155.62 126.89 7.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.463 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.931 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -93.33 139.0 31.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.091 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -145.27 159.51 42.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.428 0.632 . . . . 0.0 111.979 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.827 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.724 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.299 177.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.927 0.394 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -79.52 148.45 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' HG13 ' A' ' 12' ' ' ILE . 66.2 m -49.51 -45.73 47.57 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 1.1 pttt -170.77 143.46 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.093 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -107.85 147.18 31.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.594 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.571 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -115.72 145.08 21.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 179.118 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -122.93 111.83 17.1 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -117.86 128.6 54.99 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.739 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -159.46 162.97 35.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.996 0.903 . . . . 0.0 113.301 -178.233 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.578 HH12 ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -159.6 144.24 11.19 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.761 178.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 10.8 Cg_endo -54.61 112.43 1.01 Allowed 'Trans proline' 0 C--N 1.335 -0.142 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' HH12 ' A' ' 20' ' ' ARG . 6.0 tptt -51.6 -34.28 36.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.223 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -98.29 -44.06 6.71 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.275 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -79.6 127.4 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.398 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.4 p -72.52 115.06 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.932 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.24 -169.32 20.93 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.35 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -64.6 176.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -136.79 159.99 40.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.582 179.297 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -141.79 128.52 20.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.44 . . . . 0.0 111.295 -179.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.02 114.44 8.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -93.77 115.58 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 111.823 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.67 107.55 33.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.027 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 28.1 Cg_exo -61.07 90.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.312 2.008 . . . . 0.0 112.925 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.8 52.9 6.48 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.225 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 t60 52.63 60.8 3.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -65.86 -22.27 66.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.538 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.617 ' HB3' HD22 ' A' ' 37' ' ' LEU . 3.4 p-10 -170.53 -171.84 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.2 105.46 9.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -97.97 130.19 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -101.37 148.01 25.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.184 0.516 . . . . 0.0 112.259 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 44' ' ' GLY . 18.7 mt -94.28 138.58 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.653 179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.743 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -32.97 -41.67 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.015 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 120.74 114.36 2.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.189 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.523 HD12 ' CE2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -100.63 122.84 43.97 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.704 0.288 . . . . 0.0 110.499 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.748 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -83.76 135.13 43.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.95 -178.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 3.4 Cg_exo -39.15 144.4 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.982 3.121 . . . . 0.0 114.537 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.27 -5.85 68.23 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.055 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.4 138.13 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.1 p -97.38 122.44 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 45' ' ' LEU . 38.2 m-85 -110.75 133.48 53.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -97.49 129.12 44.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.018 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -124.12 150.88 17.06 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.778 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 44.4 tt0 -132.62 144.42 50.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 111.482 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD12 ' HG ' ' A' ' 17' ' ' LEU . 1.3 mp -123.06 107.66 12.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.409 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.571 ' HB ' HG22 ' A' ' 16' ' ' ILE . 82.0 mt -114.0 117.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.744 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -82.21 138.5 34.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.389 0.614 . . . . 0.0 111.025 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG23 ' HA2' ' A' ' 62' ' ' GLY . 4.2 mt -118.16 132.24 68.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.951 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.69 -176.41 3.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 178.657 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.41 -29.92 70.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -103.08 -1.55 28.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 95.22 155.47 31.39 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 75.3 t60 65.94 126.55 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.699 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 2.9 mm-40 -155.6 -56.96 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.6 tt0 -145.4 143.82 30.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.436 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.88 115.79 19.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.299 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m -136.15 121.58 19.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.291 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.17 139.62 43.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.38 135.97 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 4.1 p-10 -95.94 137.47 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 50' ' ' VAL . 29.4 p90 -141.43 165.57 27.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 18.1 p . . . . . 0 C--N 1.32 -0.705 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.748 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 6.5 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.736 HG13 ' N ' ' A' ' 13' ' ' SER . 0.6 OUTLIER -88.44 152.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.051 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.736 ' N ' HG13 ' A' ' 12' ' ' ILE . 39.0 t -52.32 -45.21 65.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.065 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.798 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 21.4 pttt -174.6 144.53 0.86 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.685 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.16 157.22 17.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.876 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.64 147.7 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 121.181 0.515 . . . . 0.0 111.181 179.473 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -128.2 110.42 12.4 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.626 176.525 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.776 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.5 mtp-105 -122.37 125.63 46.32 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.561 ' CB ' ' HA2' ' A' ' 53' ' ' GLY . 2.0 p90 -162.89 153.3 16.45 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.356 -177.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -159.95 162.72 24.0 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.766 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 15.2 Cg_endo -56.75 124.03 15.27 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 C-N-CA 122.656 2.238 . . . . 0.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 54.3 tttt -67.32 -44.03 80.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.883 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -89.75 -36.55 15.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.962 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 3.1 m -85.08 -18.17 35.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.501 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 25' ' ' VAL . 5.7 p 33.62 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.296 0.57 . . . . 0.0 112.102 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . -108.33 -106.8 3.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.901 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 152.87 36.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -74.8 150.94 39.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.252 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.776 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -121.84 140.43 52.39 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -122.23 128.84 51.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.64 115.39 9.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.674 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.37 118.19 33.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 111.331 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -129.84 112.27 17.44 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.2 Cg_exo -52.11 175.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.672 2.248 . . . . 0.0 112.481 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . -43.17 94.86 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.18 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 35' ' ' GLY . 1.1 p-80 22.75 72.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.358 0.663 . . . . 0.0 112.613 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -69.23 -30.29 68.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.328 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 37' ' ' LEU . 3.4 p-10 -174.25 -163.41 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -90.81 105.82 18.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.019 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -116.73 113.1 22.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -128.69 146.57 50.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.8 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -165.1 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 0.0 111.563 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.14 25.5 75.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.683 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.535 HD22 ' HE2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -125.2 -178.68 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.189 -179.538 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.51 142.04 35.71 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.95 104.37 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.566 2.177 . . . . 0.0 111.977 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.66 -13.95 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.378 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.52 139.62 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 117.195 0.497 . . . . 0.0 111.441 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.494 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -76.59 146.29 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.111 0.481 . . . . 0.0 109.964 178.488 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HE2' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -143.98 101.05 3.67 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.093 -179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.4 pt-20 -77.58 126.81 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.962 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -126.35 152.03 18.17 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.632 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -134.8 141.62 46.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 111.583 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 1.5 mt -121.38 106.21 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.663 178.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.667 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.6 mp -116.01 118.34 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.781 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -82.03 133.63 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.573 0.701 . . . . 0.0 111.144 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.28 133.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.594 ' HB2' ' CG ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -117.12 -175.45 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.29 178.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -63.92 -13.63 47.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.473 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -103.15 -4.97 23.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 143.87 0.88 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.511 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 60.48 107.38 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.645 0.26 . . . . 0.0 110.981 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.671 ' HB2' ' O ' ' A' ' 57' ' ' SER . 78.8 mm-40 -129.85 -67.19 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.96 146.67 50.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.99 -178.537 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.77 126.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.293 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.15 132.38 41.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 117.43 33.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -144.47 126.92 15.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.747 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.8 122.14 42.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 51' ' ' TYR . 38.2 p90 -122.71 162.86 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.309 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 50' ' ' VAL . 7.0 p . . . . . 0 C--N 1.329 -0.291 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.9 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.597 0.236 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.2 tt -67.26 148.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.462 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.7 t -51.24 -48.02 62.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -175.4 149.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.763 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.5 m-85 -102.19 136.64 41.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.37 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.87 122.88 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 111.633 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -108.25 114.73 28.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 179.034 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.723 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.7 mtt180 -116.93 128.77 55.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.815 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -150.35 153.39 35.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.706 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.57 159.03 29.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.364 -179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.7 114.05 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.095 1.864 . . . . 0.0 111.745 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -32.13 73.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -38.3 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.39 170.43 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.88 136.45 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.846 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.98 33.41 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.979 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.66 173.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 111.519 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 67.6 m95 -90.15 -171.47 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -142.35 145.43 33.91 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.474 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -120.4 133.31 55.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.269 0.556 . . . . 0.0 112.139 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.08 112.19 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.98 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 38.8 m -89.35 137.72 32.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 112.474 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -132.81 106.25 12.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.381 178.056 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.95 100.32 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.408 2.072 . . . . 0.0 112.383 -179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.88 -90.17 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -177.18 79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.744 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HG ' HD22 ' A' ' 38' ' ' ASN . 0.5 OUTLIER -72.7 -33.22 66.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.597 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -173.4 -165.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.05 118.32 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -103.55 113.26 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 t -121.7 134.0 54.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HD22 ' A' ' 17' ' ' LEU . 6.9 mt -98.02 116.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -121.46 134.09 55.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 25.92 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -101.35 175.02 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 21.8 mtmt -98.23 124.74 46.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 14.5 Cg_exo -69.0 4.69 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.777 2.318 . . . . 0.0 112.365 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 -30.45 6.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.652 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.62 134.23 63.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.22 146.97 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.415 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 74.2 m-85 -118.51 107.74 14.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.76 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 18.3 pt-20 -79.7 130.39 35.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.379 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -133.01 153.94 20.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.191 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.527 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.64 134.01 42.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.639 0.257 . . . . 0.0 110.393 179.675 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.19 106.97 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 110.365 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' HD2' ' A' ' 18' ' ' ARG . 5.2 mp -105.46 115.31 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.815 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.602 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -86.0 119.75 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 8.4 mt -109.67 112.29 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.253 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -89.45 -177.24 5.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.572 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -68.07 -14.86 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.603 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -101.46 0.9 37.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.766 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 112.4 177.34 19.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.92 144.34 39.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.578 0.228 . . . . 0.0 110.596 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.4 2.77 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.574 -179.59 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.539 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 2.5 tt0 -145.63 129.77 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -134.88 131.28 53.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.012 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -136.15 123.74 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' HE21 ' A' ' 54' ' ' GLN . 36.8 mtm180 -102.54 135.7 43.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 111.371 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.58 155.06 32.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.23 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -106.73 134.02 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.05 153.54 34.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.141 0.496 . . . . 0.0 112.287 -178.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.446 178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.715 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -70.83 154.08 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 179.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.715 ' N ' HG13 ' A' ' 12' ' ' ILE . 58.0 m -52.37 -41.3 62.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.2 pttt -172.23 149.04 2.22 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.041 0.448 . . . . 0.0 111.713 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -106.82 134.08 50.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.78 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.633 HG13 HD12 ' A' ' 58' ' ' ILE . 2.8 mm -114.28 120.23 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -104.24 114.69 29.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.537 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -116.25 129.55 56.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.542 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -154.37 158.69 40.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 111.493 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -159.54 163.42 23.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.666 -179.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -57.52 114.45 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.982 1.788 . . . . 0.0 111.616 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -50.71 -31.23 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.357 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -70.17 -37.36 75.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -176.48 4.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.97 13.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.82 -160.24 8.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.647 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 57.81 70.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -84.45 162.57 19.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 25.7 mttp -141.26 133.87 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.876 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 2.2 pt-20 -120.52 132.69 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.11 0.481 . . . . 0.0 111.977 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.67 111.99 12.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.808 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 84.8 m -91.79 132.09 36.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.471 HG13 ' C ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -136.92 104.8 8.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.115 177.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.5 Cg_exo -60.22 105.64 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.447 2.098 . . . . 0.0 112.15 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.36 -94.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.122 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.03 109.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.6 mp -82.74 -34.13 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.692 HD22 ' H ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -178.01 -112.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.053 -179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.692 ' H ' HD22 ' A' ' 38' ' ' ASN . 55.0 m -121.43 105.09 10.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.39 109.01 21.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -120.88 132.11 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.5 mt -98.61 127.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 -166.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.83 29.76 28.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.357 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 72' ' ' THR . 0.7 OUTLIER -93.94 172.04 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -122.93 136.8 27.22 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.81 165.42 18.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.645 2.23 . . . . 0.0 112.466 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.4 -33.03 3.49 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.735 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.55 116.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 61.9 t -77.77 144.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' PHE . 3.2 m-85 -102.36 126.55 49.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 130.62 52.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.61 158.03 27.97 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.744 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -132.46 145.11 50.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.294 179.669 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 107.25 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -106.64 114.83 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -88.51 125.04 34.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.263 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 45.9 mt -102.43 123.35 55.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.536 ' HG3' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -100.23 -175.05 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.943 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.83 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.301 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.03 6.9 38.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.76 175.49 18.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.64 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 3.0 p80 -55.99 157.41 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.716 0.293 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.536 HE21 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -161.35 -17.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.409 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -114.2 127.75 56.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.09 130.68 55.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.415 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.23 121.2 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.744 ' HG2' HE21 ' A' ' 54' ' ' GLN . 2.5 mtt180 -96.87 132.65 42.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.318 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -155.62 156.65 35.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.263 0.554 . . . . 0.0 111.965 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.62 137.81 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -150.0 141.69 23.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.514 -178.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.336 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.965 0.412 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.667 HD13 ' HB3' ' A' ' 57' ' ' SER . 4.7 tt -97.31 157.35 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.87 -52.72 22.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.796 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.611 ' HD2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -166.17 144.79 5.75 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.198 0.523 . . . . 0.0 111.754 179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.8 m-85 -102.37 136.87 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.873 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.34 129.86 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.853 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -118.11 114.84 23.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.986 179.438 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.58 129.21 50.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -149.73 162.02 41.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 2.8 ptt180 -158.56 153.43 21.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 18.0 Cg_endo -58.49 109.61 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.967 1.778 . . . . 0.0 111.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.518 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 4.1 ttpp -57.36 -35.21 69.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -70.3 -29.25 65.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -78.22 -161.02 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.999 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.35 -7.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' HH11 ' A' ' 20' ' ' ARG . . . 179.67 -128.58 1.24 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.952 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 27' ' ' ARG . 0.0 OUTLIER 64.6 75.24 0.38 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.918 0.389 . . . . 0.0 111.06 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 93.5 m95 -83.04 175.8 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.145 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 13.7 mttm -154.25 136.88 15.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.767 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -120.16 135.77 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.052 0.453 . . . . 0.0 112.131 -178.762 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 114.86 8.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.13 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 m -96.62 137.78 35.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.149 0.5 . . . . 0.0 112.222 -179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -135.39 110.75 10.6 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.456 179.311 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.652 ' HB2' HD12 ' A' ' 37' ' ' LEU . 73.7 Cg_exo -50.15 93.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.766 2.31 . . . . 0.0 113.169 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 28.09 3.42 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.24 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.5 69.79 0.67 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.988 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -71.89 -7.21 47.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.164 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.3 p-10 -164.02 -174.6 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -80.47 105.53 11.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.82 107.42 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.778 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -114.59 146.58 40.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -91.62 124.38 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -138.56 161.77 36.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.74 21.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.6 mt -74.59 -161.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.505 0.193 . . . . 0.0 110.55 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.15 133.81 12.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.643 0.258 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.1 155.45 28.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.448 2.099 . . . . 0.0 111.796 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.18 -21.48 10.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.921 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.38 117.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.772 0.32 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 62.5 t -81.26 144.54 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.428 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 53.4 m-85 -124.62 103.9 8.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 12.9 pt-20 -79.67 130.18 35.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.383 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.53 161.34 24.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.972 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.4 mt-30 -132.62 139.17 47.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 110.432 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -99.91 107.11 19.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -111.03 115.17 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.486 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.667 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -92.2 117.7 30.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.164 179.337 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.611 ' HB ' ' HD2' ' A' ' 14' ' ' LYS . 43.2 mt -101.73 116.13 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.812 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.458 HE22 HE21 ' A' ' 60' ' ' GLN . 1.2 mm100 -90.0 -175.07 4.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.32 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.458 HE21 HE22 ' A' ' 59' ' ' GLN . 9.6 pt20 -60.44 -23.05 64.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.06 14.15 32.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.645 0.259 . . . . 0.0 111.48 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.01 -174.56 23.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.803 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -52.34 161.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.724 0.297 . . . . 0.0 111.238 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -169.27 -20.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.587 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -123.72 128.42 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.53 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.89 133.24 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.814 0.34 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 3.1 m -137.8 123.86 20.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.71 134.45 40.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 111.636 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.93 159.08 38.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.507 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -109.51 133.7 52.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.9 p90 -151.82 145.98 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 178.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.865 0.364 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.6 tt -79.72 155.25 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.48 ' H ' HG13 ' A' ' 12' ' ' ILE . 3.2 m -49.91 -53.36 26.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.764 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.821 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -158.89 144.91 16.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.1 m-85 -104.7 137.72 42.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.202 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -114.25 142.69 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 110.81 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.48 115.83 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.12 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.4 mtp180 -118.99 129.77 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.646 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -152.6 158.82 43.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 111.991 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.36 157.07 26.78 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.291 179.792 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 19.1 Cg_endo -58.78 113.41 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.318 2.012 . . . . 0.0 112.083 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.444 -179.476 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -95.02 -41.2 9.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -87.15 161.82 17.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.22 148.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 27' ' ' ARG . . . 170.39 -140.6 6.09 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.517 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -139.88 166.77 23.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 74.0 m95 -75.65 174.61 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 18.2 mttt -145.31 141.16 28.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.679 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -119.98 134.92 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 128.3 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.825 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.1 m -112.39 135.67 52.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -137.21 106.76 8.67 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.153 178.418 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.821 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.8 Cg_exo -58.84 111.6 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 112.477 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.83 -104.95 0.51 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.368 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.85 93.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.72 -25.75 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.979 179.9 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.2 p-10 178.74 -168.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.456 179.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -76.49 105.82 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -108.8 112.84 25.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.725 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -121.57 132.62 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.8 mt -90.21 126.08 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.57 165.92 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.44 -16.36 4.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.243 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -69.63 160.16 32.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.716 0.293 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HG2' ' HD2' ' A' ' 47' ' ' PRO . 3.3 ttmt -104.77 133.44 20.16 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.047 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.593 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 55.2 Cg_exo -52.0 133.03 45.06 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.524 2.149 . . . . 0.0 112.18 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.12 -22.1 40.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.12 120.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.311 . . . . 0.0 110.953 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.64 ' HA ' HG22 ' A' ' 72' ' ' THR . 14.0 t -85.78 140.63 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -123.08 161.51 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -129.82 132.2 46.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.926 179.408 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.73 155.42 26.49 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.413 -179.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.91 131.64 41.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 5.9 tp -99.7 106.48 18.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.891 0.376 . . . . 0.0 111.011 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 16' ' ' ILE . 3.8 mp -92.07 138.44 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.955 179.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -110.4 114.98 28.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.313 0.578 . . . . 0.0 111.011 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 5.6 mt -95.5 114.13 31.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.591 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' NE2' ' HG2' ' A' ' 60' ' ' GLN . 0.9 OUTLIER -97.03 -176.26 3.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.327 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HG2' ' NE2' ' A' ' 59' ' ' GLN . 11.4 pt20 -62.12 -21.94 65.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -102.83 12.08 36.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.725 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 100.8 173.36 29.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.434 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 7.0 p80 -53.55 147.93 10.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.483 0.183 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 2.0 pt20 -165.33 -6.64 0.03 OUTLIER 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 3.4 tt0 -132.65 112.99 12.49 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.891 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.2 p -136.98 140.99 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.3 m -132.24 122.12 24.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.715 179.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HE ' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.29 141.49 30.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.304 -179.373 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.14 158.31 37.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.49 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 129.46 56.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -152.06 163.76 38.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 50' ' ' VAL . 11.4 p . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.751 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 m80 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.6 0.238 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 59' ' ' GLN . 1.6 tt -77.81 150.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.984 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -49.21 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.611 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -166.13 146.07 6.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -102.04 141.99 34.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.38 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.632 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -115.16 142.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.487 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 115.46 19.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.416 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -120.85 137.95 54.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.674 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -156.73 159.51 38.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.43 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.45 157.45 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.521 -179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.72 110.86 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.269 1.979 . . . . 0.0 112.014 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.42 67.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.66 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.8 ' HB2' HG23 ' A' ' 49' ' ' VAL . 19.4 m-20 -100.3 -36.05 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.404 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.16 -167.78 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.25 154.39 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.022 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.43 23.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 60.87 175.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.597 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 68.0 m95 -85.61 -172.33 4.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.4 mttt -148.3 154.76 40.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.242 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.17 138.27 49.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 112.092 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 111.82 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 92.5 m -98.4 131.19 44.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -134.69 106.05 10.77 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.268 178.124 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 52.0 Cg_exo -56.23 98.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.688 2.258 . . . . 0.0 112.895 -179.019 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.5 22.88 8.43 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.163 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.481 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 57.13 98.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 179.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.705 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.66 -18.37 41.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.09 -163.19 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.762 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.17 105.48 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.608 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.21 106.75 16.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.35 144.05 45.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.86 129.33 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.213 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 141.77 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.09 56.08 0.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.654 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 51' ' ' TYR . 3.0 mt -137.18 78.02 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.4 ttpt -34.75 130.41 0.47 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.466 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 45.2 Cg_exo -56.89 175.79 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.661 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.05 -35.53 3.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 23' ' ' ASN . 2.8 p -115.04 127.15 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.67 142.08 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 7.8 m-85 -108.8 136.79 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -112.26 130.1 56.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.119 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.67 156.49 26.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.975 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.6 146.0 51.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 18.8 tp -100.23 107.0 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.391 . . . . 0.0 110.859 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 16' ' ' ILE . 1.7 mp -95.12 122.06 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.491 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -94.83 114.91 26.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.424 0.631 . . . . 0.0 109.926 179.723 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 27.6 mt -106.7 111.16 34.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.953 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.483 ' HG3' HD12 ' A' ' 12' ' ' ILE . 1.7 mt-30 -90.2 -176.17 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.887 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.75 -15.94 45.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -103.12 0.62 32.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.32 176.39 19.4 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.26 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 15.9 p80 -55.36 156.31 4.49 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.548 0.174 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.9 1.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 3.7 tt0 -145.53 113.73 6.59 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -136.75 139.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 m -137.1 124.73 22.3 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.448 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -85.01 141.01 30.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.779 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -155.86 156.63 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.731 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -114.96 131.64 56.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.873 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -152.04 162.55 40.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.486 -178.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.202 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.7 p80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.943 0.401 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.727 HD12 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -72.98 147.48 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.042 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.71 ' N ' HG13 ' A' ' 12' ' ' ILE . 14.8 m -52.13 -45.99 65.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -158.78 144.65 16.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.042 0.448 . . . . 0.0 111.416 179.512 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -112.89 142.97 44.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 179.682 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -113.89 138.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.221 -179.587 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -122.03 114.86 21.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.283 179.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.35 129.98 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.149 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -158.52 158.44 34.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.402 0.62 . . . . 0.0 112.526 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.586 ' NH1' HG23 ' A' ' 25' ' ' VAL . 1.9 ptt180 -159.73 162.27 25.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.665 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 31.3 Cg_exo -58.82 109.62 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.929 1.753 . . . . 0.0 111.621 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -65.78 -22.62 66.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.968 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.0 -17.98 31.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -158.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG23 ' NH1' ' A' ' 20' ' ' ARG . 14.4 p -166.66 139.03 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.75 -60.06 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.574 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -165.5 157.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.076 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.53 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 59.0 m95 -92.36 172.73 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 14.2 mttp -132.51 128.2 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.83 130.41 54.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 112.303 -178.241 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.08 111.79 8.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.872 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.9 m -93.91 130.87 39.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 40' ' ' TYR . 4.4 mp -136.68 107.65 9.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.66 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.0 Cg_exo -45.89 91.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.167 2.578 . . . . 0.0 113.249 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.39 42.46 1.84 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.506 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 54.34 47.84 22.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.588 HD13 ' H ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -70.95 -24.27 62.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.731 -179.544 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.588 ' H ' HD13 ' A' ' 37' ' ' LEU . 1.7 p-10 -133.77 168.93 17.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -78.94 105.88 10.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 33' ' ' ILE . 8.8 p90 -121.34 130.7 53.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 145.02 29.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.241 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.57 137.37 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.437 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 123.88 17.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.29 146.65 28.85 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.63 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.3 mt -103.75 173.02 6.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 12.6 ttpp -94.98 125.28 51.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 34.2 Cg_exo -59.57 111.77 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.638 2.225 . . . . 0.0 112.236 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.84 -5.58 8.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.657 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.87 135.22 58.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.8 t -81.24 137.05 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.75 179.581 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.86 97.04 4.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.2 pt-20 -87.38 132.08 34.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.091 0.472 . . . . 0.0 110.519 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.67 154.0 24.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.69 134.81 50.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.843 0.354 . . . . 0.0 110.392 179.811 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' CD1' HD12 ' A' ' 17' ' ' LEU . 13.2 tp -99.56 107.67 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.578 ' CG1' ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -102.42 115.36 44.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 0.0 111.547 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -81.41 113.73 19.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.714 HG23 ' H ' ' A' ' 63' ' ' HIS . 30.4 mt -105.64 126.39 60.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.601 -179.386 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.727 ' HG3' HD12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -112.5 -174.98 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.419 179.8 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.27 -7.48 2.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.332 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' HB2' HE22 ' A' ' 64' ' ' GLN . 55.4 m-85 -97.97 -5.25 34.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.81 106.54 0.04 OUTLIER Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.374 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.714 ' H ' HG23 ' A' ' 58' ' ' ILE . 44.8 m80 61.6 120.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.419 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.603 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -157.5 -20.33 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.874 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -145.94 119.49 9.11 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.578 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -137.32 132.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 0.0 112.06 179.157 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.6 m -137.5 128.69 27.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 2.0 mtm180 -96.3 148.03 23.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.181 0.515 . . . . 0.0 111.136 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -156.43 158.84 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.237 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -113.58 127.27 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.023 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 45' ' ' LEU . 1.4 p90 -148.29 161.3 41.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.089 0.471 . . . . 0.0 112.121 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.009 178.861 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.943 0.401 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' HG2' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -67.62 144.02 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.3 179.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.53 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -49.71 -57.72 6.71 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.025 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 144.33 18.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.897 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.7 m-85 -108.93 136.6 48.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.245 0.545 . . . . 0.0 111.081 -179.729 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 114.88 28.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.053 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.03 129.47 50.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.761 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -151.01 160.61 43.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.468 . . . . 0.0 111.666 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 6.2 ptt180 -159.41 161.38 27.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 14.0 Cg_endo -57.95 110.39 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.186 1.924 . . . . 0.0 111.796 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -62.77 -48.06 80.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.724 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.75 -38.91 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.8 -179.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.03 -179.52 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.498 . . . . 0.0 111.85 -179.281 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.72 143.4 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.772 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -154.83 18.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.146 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 27' ' ' ARG . 9.8 mtt180 -135.74 162.88 31.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 111.074 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.86 157.19 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.8 mmtt -132.14 136.11 46.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HH21 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -119.87 127.21 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.092 0.473 . . . . 0.0 111.935 -178.754 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.44 111.68 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.142 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -91.5 135.21 34.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.927 -179.263 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.97 107.79 32.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.69 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.793 2.329 . . . . 0.0 113.061 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.74 30.66 4.91 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.118 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 72.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -31.89 71.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -146.18 -165.34 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 p -77.69 106.14 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.51 102.29 7.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -127.95 143.12 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.3 mm -81.68 116.92 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 134.76 37.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.81 17.39 1.88 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.312 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.548 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.9 mt -76.05 -143.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.521 0.2 . . . . 0.0 110.75 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -146.94 122.81 5.48 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 120.647 0.26 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.79 91.16 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.423 2.082 . . . . 0.0 111.851 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -117.72 113.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.103 179.414 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.27 130.42 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.348 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 45' ' ' LEU . 48.8 m-85 -105.57 107.14 17.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.428 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 130.33 34.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.88 159.65 28.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.131 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 146.59 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -102.05 106.43 17.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.201 -179.869 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.3 mp -92.48 126.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -90.17 135.53 33.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.225 0.536 . . . . 0.0 110.194 179.648 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.2 mt -115.02 109.11 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.563 -179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.747 ' HG2' HD11 ' A' ' 12' ' ' ILE . 7.1 mm100 -101.12 -175.1 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.293 178.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.11 -14.5 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.742 0.305 . . . . 0.0 110.794 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.669 ' HB2' HE22 ' A' ' 64' ' ' GLN . 42.7 m-85 -103.21 -5.25 23.34 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.975 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 113.21 -153.71 17.39 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.854 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.47 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 2.6 m-70 -62.28 141.23 58.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.862 -0.199 . . . . 0.0 110.778 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.669 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -145.22 -59.51 0.35 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 2.5 tt0 -100.49 114.2 27.61 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.8 p -136.12 132.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 112.081 178.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -137.29 125.18 22.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 142.32 30.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -156.1 159.31 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.436 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.42 135.46 50.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 45' ' ' LEU . 4.8 p90 -151.61 141.25 21.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.326 -178.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.072 179.255 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.834 0.349 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -101.04 157.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -59.47 -44.33 93.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.984 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.05 144.62 0.76 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.801 179.471 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' THR . 12.5 m-85 -105.62 136.82 44.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.835 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.75 127.71 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 178.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.667 ' HG ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -116.44 116.52 27.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.82 128.78 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.741 -179.732 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.692 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 2.7 p90 -152.2 142.7 22.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.482 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.9 153.62 42.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 67.6 Cg_exo -57.13 126.71 23.0 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 113.05 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 -33.43 19.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.784 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 49' ' ' VAL . 51.7 t30 -99.17 -43.92 6.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -83.92 -15.72 46.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.686 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 55.18 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.763 179.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 -138.54 7.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.646 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.0 ttm105 -110.9 155.12 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.453 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 79.0 m95 -77.78 175.27 10.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.051 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -139.26 135.65 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.401 179.31 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.2 pt-20 -120.1 131.62 55.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.987 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.05 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.844 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -102.1 132.1 48.18 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -139.42 106.7 7.15 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.752 178.965 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' HD21 ' A' ' 37' ' ' LEU . 77.7 Cg_endo -82.31 102.45 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.322 2.015 . . . . 0.0 113.549 -178.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 8.85 87.61 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.51 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.75 88.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.706 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -66.32 -22.06 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.41 -172.91 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 106.55 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.724 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -108.32 109.41 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.093 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.27 126.26 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.748 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -81.87 118.52 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.178 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.12 76.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' C ' HD13 ' A' ' 45' ' ' LEU . . . -136.01 22.31 3.45 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.628 179.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.763 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -98.03 -157.5 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 155.87 14.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.796 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.99 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.56 6.66 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.357 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.559 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.071 HG23 HG22 ' A' ' 72' ' ' THR . 1.5 p -114.48 148.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.747 177.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.4 m-85 -114.49 143.56 44.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.0 tt0 -79.51 128.63 33.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.45 133.65 9.33 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.517 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 56' ' ' ILE . 12.0 tt0 -134.15 116.86 15.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.634 0.254 . . . . 0.0 110.811 179.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.667 HD22 ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -99.64 107.75 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 179.282 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 66' ' ' VAL . 4.3 mp -111.44 114.59 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.602 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -84.02 138.36 33.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.134 179.144 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.595 ' HB ' ' HG2' ' A' ' 14' ' ' LYS . 2.6 mt -115.19 108.49 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.867 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 4.7 tp60 -86.49 -175.86 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.39 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.52 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 6.6 mm100 -61.27 -20.51 62.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.58 -179.548 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.72 16.01 27.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.515 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.84 -108.56 3.08 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -51.77 111.48 0.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 4.1 tp-100 -120.97 -67.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 4.2 tt0 -139.51 145.43 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HG23 ' A' ' 56' ' ' ILE . 96.8 t -135.04 133.96 53.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 m -136.76 134.46 37.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.223 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.0 122.62 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.92 133.95 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.217 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.47 137.65 38.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.06 158.71 43.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.071 HG22 HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.649 177.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.8 0.333 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.662 HG21 ' CE1' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -66.86 155.5 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.343 179.524 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.455 ' H ' HG13 ' A' ' 12' ' ' ILE . 2.2 m -56.57 -52.81 63.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.607 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -176.66 145.76 0.55 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.569 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 3.3 m-30 -101.66 141.09 35.05 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.102 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 55' ' ' LEU . 21.2 mm -114.75 132.74 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -121.24 114.22 21.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.237 178.564 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.6 mtp180 -109.99 129.17 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 -179.411 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.65 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 3.1 p90 -142.4 140.18 31.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.25 0.548 . . . . 0.0 111.699 179.673 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.92 144.84 17.13 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.915 -179.803 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 51.2 Cg_exo -56.94 117.73 4.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.252 1.968 . . . . 0.0 112.327 -179.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 mmmt -58.58 -17.86 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.74 -18.57 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.141 -179.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.31 -166.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.949 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.18 -26.29 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.057 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 175.92 -128.57 1.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.423 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.0 63.05 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 74.6 m95 -63.71 -177.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.2 mmtp -131.94 152.3 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.425 179.197 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.23 133.77 55.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.15 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.446 178.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 14' ' ' LYS . 51.6 m -106.51 126.45 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -140.16 105.24 6.66 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.811 178.087 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 107.45 2.01 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.167 1.911 . . . . 0.0 112.658 -179.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.09 116.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.401 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.26 102.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.23 -33.12 33.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.68 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -179.32 -159.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.308 179.9 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 m -77.3 105.37 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.6 114.41 26.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -98.71 147.65 24.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.036 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 43' ' ' LYS . 3.6 mt -99.57 115.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 44' ' ' GLY . 3.8 mmpt? 18.4 -93.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.089 0.868 . . . . 0.0 112.584 179.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 43' ' ' LYS . . . 178.84 105.5 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.387 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -73.49 -175.55 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.638 0.256 . . . . 0.0 110.886 -179.808 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 160.96 33.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.086 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.07 149.92 50.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.684 2.256 . . . . 0.0 112.881 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.62 -2.18 59.48 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.052 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.08 112.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.701 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.3 t -91.56 148.05 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 179.026 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.445 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 53.3 m-85 -139.68 107.47 5.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.926 178.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 tp10 -87.92 128.85 35.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -117.22 147.59 18.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.545 -178.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.447 ' HB3' HD11 ' A' ' 56' ' ' ILE . 1.1 mt-30 -133.52 115.75 15.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.202 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 17' ' ' LEU . 32.7 tp -99.19 107.36 19.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.76 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.3 mp -112.18 115.25 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.582 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 7.9 m -82.14 133.4 35.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.626 HG23 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mp -121.67 133.14 69.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.334 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 3.8 tt0 -110.79 -175.14 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.507 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -61.08 -17.7 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.1 -5.71 23.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.68 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 77.47 153.16 5.68 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.999 178.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 t60 58.37 97.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.619 0.247 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 -122.77 -60.72 1.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 tt0 -135.54 145.32 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.913 -178.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.35 114.48 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 178.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.9 m -133.37 127.18 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -104.06 132.09 50.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -155.58 130.81 9.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.618 -179.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.45 149.81 20.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.82 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -150.8 148.18 28.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.513 0.673 . . . . 0.0 112.671 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.7 p . . . . . 0 N--CA 1.454 -0.26 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.516 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.492 0.187 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -101.59 157.44 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 111.306 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 t -82.16 -31.68 30.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.837 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 4.0 pttt -175.86 143.92 0.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.973 179.317 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HB2' HG13 ' A' ' 33' ' ' ILE . 34.1 m-85 -108.04 143.14 37.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.597 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.68 122.81 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.129 0.49 . . . . 0.0 110.736 179.66 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.779 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -109.96 114.61 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.631 179.372 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.02 129.61 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.252 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.642 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.7 p90 -150.38 149.36 29.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.568 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.568 HH12 ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -153.79 145.41 16.69 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 -179.514 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 49.0 Cg_exo -59.15 110.55 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.706 2.271 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HE2' HH12 ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.63 -19.64 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.1 -18.24 62.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -117.57 -162.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.608 179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.09 125.59 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.57 -142.49 47.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.669 179.651 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 63.14 59.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.091 0.472 . . . . 0.0 111.138 -179.975 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -76.53 174.81 9.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.749 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.773 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.8 mttt -142.43 132.31 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.857 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.68 135.62 54.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.298 0.571 . . . . 0.0 112.396 -178.489 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.14 111.77 6.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 179.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 m -88.31 132.61 34.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.146 0.498 . . . . 0.0 112.294 -178.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -140.4 105.54 6.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.217 179.29 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.837 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 17.6 Cg_endo -58.2 -179.75 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.504 2.136 . . . . 0.0 113.516 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -65.79 88.9 0.11 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.237 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.596 ' HB3' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -179.81 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 109.898 -179.508 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.875 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.74 -3.48 47.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.762 179.39 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.681 HD22 ' H ' ' A' ' 39' ' ' SER . 6.1 p-10 42.47 -125.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.681 ' H ' HD22 ' A' ' 38' ' ' ASN . 2.1 m -88.28 117.04 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.735 0.303 . . . . 0.0 110.974 179.878 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.43 ' CB ' HD13 ' A' ' 33' ' ' ILE . 32.5 t80 -83.52 126.73 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.286 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -97.98 147.44 24.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.421 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.32 131.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.51 -111.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.1 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' C ' HD22 ' A' ' 45' ' ' LEU . . . -81.39 140.13 20.95 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.14 -178.021 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.437 HD22 ' C ' ' A' ' 44' ' ' GLY . 2.9 mm? -126.67 3.59 6.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.61 179.223 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt 62.54 154.65 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.157 179.544 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.41 155.56 28.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.797 2.332 . . . . 0.0 112.513 -179.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.76 3.35 59.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.192 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 112.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.089 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.0 t -89.44 148.37 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.05 0.452 . . . . 0.0 110.494 178.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 39.5 m-85 -138.78 104.42 5.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.623 179.428 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 8.4 tt0 -90.26 128.63 36.46 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -142.2 147.94 19.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.331 -179.084 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' CB ' ' HA ' ' A' ' 68' ' ' ARG . 6.0 pm0 -133.83 138.83 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.162 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.779 ' HG ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -100.03 107.89 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.071 0.462 . . . . 0.0 111.647 -178.66 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.3 mp -101.69 114.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.137 179.157 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 1.3 m -87.31 136.34 32.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 -179.705 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.804 HD13 ' HE3' ' A' ' 14' ' ' LYS . 3.6 mp -118.87 132.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.046 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 30.1 tt0 -92.73 -175.77 4.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.427 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.58 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 5.4 mt-30 -60.33 -29.53 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.092 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.37 7.98 42.47 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.323 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.474 ' HA2' ' CG2' ' A' ' 58' ' ' ILE . . . 94.0 147.95 23.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.082 179.343 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.575 ' H ' HG23 ' A' ' 58' ' ' ILE . 5.3 m-70 64.37 157.25 0.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.5 0.19 . . . . 0.0 111.285 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.764 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -179.01 -57.47 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 179.281 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.5 tt0 -145.09 144.19 30.81 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.114 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.28 114.07 16.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 178.433 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.9 m -137.2 120.74 17.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.814 179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 54' ' ' GLN . 6.5 mtp85 -97.94 132.62 43.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' GLY . 19.8 p90 -149.4 131.31 15.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.191 0.52 . . . . 0.0 112.295 -179.717 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 52' ' ' GLU . 1.7 m-20 -95.2 141.64 28.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.016 179.256 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -152.66 160.75 43.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.475 0.655 . . . . 0.0 112.491 -178.853 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.474 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.835 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.674 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 10.2 p-80 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.871 0.367 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.664 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -97.14 152.09 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.87 179.885 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.664 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.51 -46.63 48.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.283 179.485 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 16.5 pttm -162.05 144.26 11.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.134 179.366 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -113.07 140.6 47.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.707 179.211 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.421 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -114.22 125.35 71.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 179.745 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.41 114.28 27.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.323 179.789 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -112.21 129.15 56.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.771 179.487 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -146.21 147.15 31.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.273 0.559 . . . . 0.0 112.234 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.29 145.67 18.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.024 179.911 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 47.3 Cg_exo -57.53 109.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.334 2.023 . . . . 0.0 112.549 -179.594 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 1.7 mttm -68.45 -32.68 72.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.52 179.471 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.58 -18.85 47.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 1.7 m -149.48 72.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.576 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 20' ' ' ARG . 22.7 m -47.02 146.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.947 -179.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.86 79.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.7 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' A' ' 28' ' ' TRP . 14.5 ttp180 65.15 147.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 111.54 179.728 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.509 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 37.2 m95 -101.72 -176.63 3.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -139.08 153.26 48.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.353 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 138.32 54.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.2 111.97 7.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.823 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m -93.77 126.23 38.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.721 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 mt -138.2 107.04 7.97 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 178.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 24.1 Cg_exo -64.13 109.91 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.515 2.143 . . . . 0.0 113.325 -178.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 49.54 24.73 5.8 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.818 178.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 60.71 115.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.086 0.47 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HD2' ' A' ' 34' ' ' PRO . 5.9 mp -82.44 -33.21 28.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -177.51 -153.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.117 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -76.8 104.83 7.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -118.19 122.75 43.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 -179.411 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 141.57 49.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.287 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.96 130.19 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.714 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -112.89 156.96 22.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.856 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.35 20.56 1.96 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.26 -179.785 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.689 HD23 ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -121.61 177.98 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.952 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.659 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -139.45 163.47 45.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.702 0.286 . . . . 0.0 111.652 -179.173 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.1 109.51 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.629 2.219 . . . . 0.0 112.605 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.0 -0.21 11.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.104 179.399 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 46' ' ' LYS . 14.7 p -120.23 137.12 55.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -112.7 137.88 43.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.01 179.7 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CD1' HD23 ' A' ' 45' ' ' LEU . 7.9 m-85 -111.21 174.14 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.279 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -116.21 129.49 56.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.736 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.71 132.17 9.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.857 -1.163 . . . . 0.0 113.797 -178.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' THR . 1.4 mt-30 -133.56 113.83 12.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.112 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 15' ' ' TYR . 3.9 mt -100.66 107.56 19.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.4 mp -101.77 115.68 44.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -82.6 119.17 23.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.739 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 20.5 mt -110.62 119.17 58.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.51 -179.472 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -175.68 4.11 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.082 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -61.58 -17.44 55.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.422 ' HE1' HE21 ' A' ' 64' ' ' GLN . 1.7 p90 -103.14 -5.17 23.51 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.28 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.92 179.61 16.01 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -49.4 157.67 0.48 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.422 HE21 ' HE1' ' A' ' 61' ' ' TYR . 1.4 pt20 -165.46 -2.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.852 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.649 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.33 133.69 21.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.606 0.241 . . . . 0.0 111.383 -179.689 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' ILE . 67.3 t -134.94 133.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.975 179.231 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 6.2 m -137.51 137.22 38.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.48 139.65 44.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.52 161.59 40.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.306 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.8 141.25 29.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.245 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 1.1 t80 -120.24 139.1 53.18 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.157 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.333 -0.123 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.583 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -105.2 148.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 179.954 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -43.29 52.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.154 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.61 144.94 0.69 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.274 178.863 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.745 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.4 m-85 -100.79 150.2 23.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.612 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.2 mm -125.02 123.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.552 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.695 HD12 HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -110.11 114.09 27.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.517 178.818 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.55 129.68 56.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.4 -179.646 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 4.8 p90 -141.28 149.27 41.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.21 147.98 14.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.405 -179.849 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 48.4 Cg_exo -57.81 114.73 2.09 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.543 2.162 . . . . 0.0 112.665 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.814 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 27.6 mtpt -75.31 -25.07 57.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -86.23 -35.87 19.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.204 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.69 -175.53 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.111 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.03 132.24 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.067 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.5 -165.49 31.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.8 150.04 21.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.82 177.6 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.17 154.57 50.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.881 179.415 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.62 133.44 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.19 0.519 . . . . 0.0 111.891 -179.463 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.85 111.43 8.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.469 179.015 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 58.8 m -90.56 136.74 32.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.318 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.799 HG22 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.07 103.8 6.76 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.474 177.668 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.35 127.4 7.41 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.58 2.186 . . . . 0.0 112.699 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.19 165.82 36.67 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.991 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -81.89 67.13 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.064 0.459 . . . . 0.0 110.759 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.799 HD12 HG22 ' A' ' 33' ' ' ILE . 2.7 mt -78.81 -2.88 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.027 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER 105.96 174.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.503 1.127 . . . . 0.0 110.608 -179.675 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -77.18 111.75 13.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -97.66 117.48 32.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.449 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -127.4 142.17 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.74 116.66 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -119.49 42.36 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.82 10.47 58.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -83.28 166.23 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 110.887 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.587 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -94.06 134.85 25.31 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.148 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -38.96 123.38 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.5 2.8 . . . . 0.0 114.07 -179.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.0 7.2 17.67 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.127 178.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' LYS . 2.0 t -121.52 136.67 57.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.551 0.676 . . . . 0.0 112.301 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -115.34 133.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.993 178.186 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 27.4 m-85 -116.18 -173.12 2.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.814 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 9.8 tm-20 -126.07 129.45 49.15 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.91 118.47 4.25 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.085 -179.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.689 HE21 HD11 ' A' ' 56' ' ' ILE . 37.9 tt0 -132.66 113.89 13.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.043 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.695 HD13 HD12 ' A' ' 17' ' ' LEU . 22.7 tp -103.44 106.74 17.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.507 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.689 HD11 HE21 ' A' ' 54' ' ' GLN . 4.9 mp -100.52 138.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.591 178.838 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 4.7 m -94.85 151.11 19.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.356 0.598 . . . . 0.0 110.975 -179.5 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 25.8 mt -116.41 131.84 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.508 -179.417 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.882 ' HG2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -118.74 -176.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.442 178.461 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -75.22 -20.68 59.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.748 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -104.47 -5.68 21.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.445 179.809 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.27 139.21 1.76 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.187 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.28 81.78 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.819 0.343 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.882 ' HB2' ' HG2' ' A' ' 59' ' ' GLN . 1.1 tt0 -101.48 -67.75 0.85 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.608 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.822 ' H ' ' HB2' ' A' ' 57' ' ' SER . 4.0 tp10 -140.54 127.56 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.04 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.628 HG13 HG13 ' A' ' 56' ' ' ILE . 5.4 t -116.27 138.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 111.861 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.87 134.12 34.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.413 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -111.67 143.87 41.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 -179.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.72 161.1 40.78 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.94 148.03 22.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.624 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -120.16 142.38 49.01 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.456 -176.339 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.816 HG23 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.592 179.272 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.694 0.283 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 ' CD1' ' HG3' ' A' ' 64' ' ' GLN . 7.9 tp -70.85 144.95 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.391 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.87 95.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.055 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -167.46 145.41 4.68 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.467 179.513 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 1.4 m-85 -100.45 145.3 28.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.688 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.624 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.03 121.06 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 109.938 179.217 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.26 114.07 27.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.476 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 8.5 mtp85 -114.75 128.75 56.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.747 179.3 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.669 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.2 p90 -144.6 145.72 31.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.3 0.572 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -152.06 145.88 18.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.335 -179.812 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG3' ' HE1' ' A' ' 51' ' ' TYR . 42.3 Cg_exo -58.77 110.24 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.444 2.096 . . . . 0.0 112.335 -179.78 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.77 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 8.7 mmtm -72.11 -13.97 61.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.384 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 50' ' ' VAL . 15.4 p30 -96.13 -26.92 15.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.549 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.82 -12.93 15.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 t 50.41 70.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.6 -154.26 11.94 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.607 -179.811 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -89.49 141.18 28.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 110.649 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.465 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 42.1 m95 -73.21 178.0 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 mtpp -139.48 147.87 41.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.05 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.81 137.0 54.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.275 0.559 . . . . 0.0 112.304 -178.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.01 122.12 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -97.21 116.76 30.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.221 0.534 . . . . 0.0 112.395 -178.79 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -136.87 106.77 8.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.989 178.945 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.3 Cg_exo -59.94 -157.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.535 2.157 . . . . 0.0 114.157 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.696 ' O ' HD23 ' A' ' 37' ' ' LEU . . . -63.38 110.25 3.26 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.485 -178.339 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 35' ' ' GLY . 12.9 p80 3.7 69.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.218 1.007 . . . . 0.0 113.504 178.911 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.809 ' HG ' ' HB2' ' A' ' 39' ' ' SER . 0.1 OUTLIER -84.16 0.66 47.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.518 179.472 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 81.79 25.02 0.22 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -174.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.809 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . 5.7 t -75.77 176.68 7.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 110.809 -2.905 . . . . 0.0 112.776 -178.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.13 108.48 4.67 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.747 -1.569 . . . . 0.0 112.076 -177.309 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -104.28 141.87 35.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.806 178.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.734 HD13 HD22 ' A' ' 17' ' ' LEU . 1.3 mp -82.3 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.052 0.453 . . . . 0.0 111.691 -179.314 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -174.29 -170.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.563 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.99 84.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.777 179.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 45' ' ' LEU . 1.6 mm? -115.37 167.57 10.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -96.8 126.4 43.03 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.377 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 13.2 Cg_exo -32.66 137.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.751 3.634 . . . . 0.0 114.963 -179.483 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 -4.16 54.09 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.61 177.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -122.63 126.84 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 117.842 0.821 . . . . 0.0 112.966 -179.238 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.926 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.29 146.29 12.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.364 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HE1' ' HG3' ' A' ' 21' ' ' PRO . 71.2 m-85 -137.55 130.94 30.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.672 0.272 . . . . 0.0 110.988 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.77 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . 8.9 tp10 -79.85 129.46 34.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.479 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.68 127.17 7.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.089 -178.265 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -134.23 114.05 12.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 17' ' ' LEU . 2.1 mt -101.97 106.4 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 111.495 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.61 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.6 mp -104.13 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.882 178.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.616 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.52 150.14 27.13 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.743 0.782 . . . . 0.0 111.131 -179.039 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -116.65 132.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.585 -179.137 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.945 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.13 -174.21 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.531 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.05 -31.71 70.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.248 179.533 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -103.97 -4.95 22.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.146 179.332 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 156.39 30.02 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.858 179.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.7 t60 64.0 134.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.945 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 3.6 mm-40 -161.2 -68.86 0.06 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.631 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.616 ' H ' ' HB2' ' A' ' 57' ' ' SER . 1.5 tt0 -137.53 115.34 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.183 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -123.4 129.8 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 111.933 178.795 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -129.42 141.27 51.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.366 179.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -104.88 133.46 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.573 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.99 136.36 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.991 179.534 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.1 142.73 27.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -148.91 161.32 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.171 0.51 . . . . 0.0 111.393 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.738 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.895 0.379 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -88.2 -78.2 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.81 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.86 128.0 0.99 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.45 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.5 m -92.75 148.71 21.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.699 0.285 . . . . 0.0 110.702 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.41 138.07 36.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.103 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' PRO . . . -125.53 93.6 44.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.12 109.8 2.91 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.646 2.231 . . . . 0.0 112.893 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 53.67 63.25 8.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.754 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 92.5 Cg_endo -85.92 -158.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.717 2.278 . . . . 0.0 112.089 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.9 p -64.17 -25.17 67.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.036 0.446 . . . . 0.0 110.149 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -94.52 -157.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.125 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.623 HG13 ' N ' ' A' ' 13' ' ' SER . 1.3 tp -72.8 150.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 3.6 m -52.08 -44.89 64.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.006 0.431 . . . . 0.0 110.156 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -171.62 143.84 1.78 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.858 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -103.58 146.77 28.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.824 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -114.68 125.04 71.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.668 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.458 HD22 HD12 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -112.93 114.5 27.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.3 mtp180 -115.07 129.61 56.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.424 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.702 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.3 p90 -142.22 148.94 38.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 111.76 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -155.69 142.93 13.76 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.623 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 53.0 Cg_exo -57.6 109.94 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.477 2.118 . . . . 0.0 112.267 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' HB3' HG12 ' A' ' 50' ' ' VAL . 1.2 tptp -77.22 -23.66 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.706 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -95.26 -20.38 19.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.67 2.0 18.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.984 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 25' ' ' VAL . 6.0 p 33.77 85.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.129 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.45 -147.21 6.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.532 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 27' ' ' ARG . 31.5 mtt180 -96.32 157.87 15.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.77 0.319 . . . . 0.0 110.929 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 67.5 m95 -87.99 173.92 8.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.07 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttp -145.59 155.05 42.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -123.96 140.33 53.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.339 0.59 . . . . 0.0 112.407 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.73 112.06 7.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.592 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -91.06 127.94 36.69 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.761 HG22 HD21 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -137.56 107.46 8.47 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.727 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 23.4 Cg_exo -64.77 91.9 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.583 2.189 . . . . 0.0 113.025 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.84 -152.26 50.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.677 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -107.45 71.18 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -69.3 -31.69 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.634 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.58 179.88 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -77.0 106.81 8.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -123.29 113.31 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -128.55 127.85 43.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.26 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 HD22 ' A' ' 17' ' ' LEU . 8.8 mt -83.6 123.57 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.652 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 -156.49 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.93 14.98 47.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.989 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.66 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.63 -166.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.755 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.62 162.29 37.06 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-O 120.745 0.307 . . . . 0.0 111.4 -179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 46' ' ' LYS . 45.5 Cg_endo -68.38 146.36 68.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.264 1.976 . . . . 0.0 112.628 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.0 0.14 83.57 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.202 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 46' ' ' LYS . 5.5 p -120.29 137.97 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.961 0.381 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -114.56 129.57 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 111.184 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 34.4 m-85 -104.98 -178.16 3.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 mm-40 -123.25 130.12 52.31 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.52 129.25 7.64 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.314 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.67 114.33 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.405 0.145 . . . . 0.0 110.776 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 16' ' ' ILE . 3.5 mt -101.99 107.01 18.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.975 0.417 . . . . 0.0 110.827 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.0 mp -109.47 117.74 55.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.675 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -81.5 140.33 34.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.488 0.661 . . . . 0.0 111.098 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.606 HG23 ' HA2' ' A' ' 62' ' ' GLY . 29.7 mt -119.09 132.45 68.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.452 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.658 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -106.88 -173.43 2.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -24.8 64.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HE2' HE22 ' A' ' 64' ' ' GLN . 4.7 p90 -103.38 -5.51 22.87 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.572 0.225 . . . . 0.0 111.598 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 82.5 154.52 14.99 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.146 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 62.77 96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.71 0.404 . . . . 0.0 111.633 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.658 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 10.3 mm100 -124.05 -89.93 0.58 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 112.315 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.644 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.49 145.35 26.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.98 114.5 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.478 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 134.47 47.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.758 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 127.7 55.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -136.1 160.56 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.136 0.493 . . . . 0.0 111.656 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.0 150.76 20.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.883 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.65 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -118.9 140.43 49.99 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.72 168.43 25.71 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.888 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.66 ' OG1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -112.76 -110.39 0.35 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.531 ' H ' ' HB ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -85.42 13.51 6.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.957 0.408 . . . . 0.0 110.965 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.2 p -105.13 148.71 26.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.716 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 102.95 14.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.173 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 78' ' ' THR . 0.7 OUTLIER -148.61 -102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.447 ' H ' ' HB2' ' A' ' 77' ' ' SER . 0.0 OUTLIER 45.58 64.89 7.23 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 111.565 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -77.65 116.42 4.05 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.538 2.159 . . . . 0.0 112.432 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.21 31.53 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.433 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m 53.59 67.45 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.801 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.04 32.85 5.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.85 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.79 85.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -166.1 27.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.96 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -121.01 150.78 40.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -86.05 153.84 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 64.91 153.99 0.06 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.22 160.42 30.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.021 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ttp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.739 0.304 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.37 -1.77 30.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.953 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.34 -135.15 12.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.566 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 t -152.8 -24.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.56 100.18 5.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.35 93.4 26.52 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.39 150.75 41.85 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.648 2.232 . . . . 0.0 112.561 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 53.3 58.41 13.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.373 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.58 148.06 9.84 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.62 2.214 . . . . 0.0 112.421 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -9.41 42.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.68 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -155.83 166.6 33.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.566 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -73.02 149.61 8.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.712 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 12' ' ' ILE . 7.8 t -44.62 -51.01 9.47 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.953 0.406 . . . . 0.0 110.456 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.461 ' HD2' HD11 ' A' ' 16' ' ' ILE . 4.1 pttt -171.48 143.95 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -105.78 136.77 44.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.573 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.695 HD13 HG13 ' A' ' 58' ' ' ILE . 3.0 mp -114.64 124.72 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.857 0.36 . . . . 0.0 110.679 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 25.8 tp -104.99 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -115.91 129.58 56.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.027 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 19.7 p90 -153.2 157.58 40.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.038 0.447 . . . . 0.0 111.541 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -159.39 156.9 26.42 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.79 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 31.3 Cg_exo -58.93 117.71 4.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.137 1.891 . . . . 0.0 112.386 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -34.73 64.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.636 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -90.56 -34.57 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.532 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -98.98 -169.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.596 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.09 168.67 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.65 -166.13 28.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.95 160.24 14.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -74.83 -179.94 4.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -146.24 127.57 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.103 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.29 134.46 55.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.098 0.475 . . . . 0.0 111.915 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.86 133.22 28.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.194 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 27.1 m -85.76 132.07 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.175 0.512 . . . . 0.0 111.693 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.94 118.38 20.89 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.983 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 36' ' ' HIS . 53.9 Cg_exo -56.53 78.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.905 2.403 . . . . 0.0 113.462 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.74 10.35 0.97 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.259 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 34' ' ' PRO . 1.8 t-160 74.68 104.19 0.07 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.877 0.37 . . . . 0.0 110.358 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 37' ' ' LEU . 7.5 mp -65.82 -35.22 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.0 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.22 -63.36 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.374 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.85 116.38 20.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -128.02 109.56 11.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.389 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -116.68 146.26 42.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.568 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.09 134.73 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.575 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -108.7 171.16 7.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 47.66 5.29 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.268 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.774 HD13 HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -141.51 -169.34 2.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.634 0.254 . . . . 0.0 110.803 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -159.49 146.44 12.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 36.5 Cg_endo -65.47 122.97 10.78 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.222 1.948 . . . . 0.0 112.612 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' A' ' 73' ' ' THR . . . 130.27 9.53 2.97 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.246 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.586 HG11 ' O ' ' A' ' 75' ' ' SER . 95.1 t -118.35 130.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.901 0.35 . . . . 0.0 111.407 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 23' ' ' ASN . 11.3 t -83.02 145.37 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' HD2' ' HG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER -145.22 166.07 26.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.59 0.709 . . . . 0.0 112.131 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 4.2 tp10 -133.24 128.67 36.37 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.67 139.87 11.13 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.517 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -133.52 131.63 40.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.773 0.321 . . . . 0.0 110.749 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.92 109.91 22.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.3 mp -108.14 115.42 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.343 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.15 121.66 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.432 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.695 HG13 HD13 ' A' ' 16' ' ' ILE . 1.4 mt -113.4 113.4 43.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.519 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 64' ' ' GLN . 1.9 tt0 -89.29 -176.41 5.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.567 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.2 -18.31 57.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.168 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 64' ' ' GLN . 2.6 p90 -103.25 -4.78 23.84 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.469 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.94 -178.35 16.38 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.866 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 31.9 p80 -53.18 161.38 0.88 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.687 0.28 . . . . 0.0 111.049 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.472 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 1.9 pt20 -170.24 0.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.667 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -145.45 116.8 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.468 -179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG22 HG13 ' A' ' 56' ' ' ILE . 42.0 t -134.23 123.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.535 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.23 121.73 18.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -98.04 138.76 34.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.027 0.442 . . . . 0.0 111.767 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -156.38 126.85 6.66 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.767 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -95.41 137.93 33.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -139.65 149.11 43.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.009 0.433 . . . . 0.0 111.548 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.65 169.44 8.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.543 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 19.4 m 76.81 91.58 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.7 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.774 HG22 HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -172.07 -153.36 0.08 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.057 -178.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.751 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 69.4 p -120.05 -179.04 3.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.0 p -85.2 -59.3 2.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.129 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.7 p -147.03 176.19 10.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -136.82 72.61 55.16 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.027 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.74 -33.8 61.69 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.571 2.181 . . . . 0.0 112.36 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.64 102.39 1.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -145.15 154.73 42.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.53 -98.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 m 58.61 13.31 2.53 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.264 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 51.45 34.84 12.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.092 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 58.53 86.66 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.38 39.47 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.023 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -149.83 165.87 31.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -106.16 157.64 17.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.887 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.691 0.281 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.29 63.12 2.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.84 -155.29 9.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.588 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.4 m -99.0 -162.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.681 0.277 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -107.97 14.23 25.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.214 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.22 77.38 60.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.063 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.88 -44.87 3.59 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.694 2.262 . . . . 0.0 112.295 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.63 152.09 51.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.86 111.59 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.426 2.084 . . . . 0.0 112.18 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 97.39 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.976 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -157.21 179.13 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.674 HG13 ' N ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -72.26 150.09 8.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.674 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.34 -50.95 37.51 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -171.55 144.58 1.92 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.366 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -104.52 139.56 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.256 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 mm -117.07 124.04 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.091 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 55' ' ' LEU . 26.8 tp -105.63 113.99 27.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.858 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.94 128.92 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.631 179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -156.69 148.4 22.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.141 0.496 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HD3' ' CE2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -148.94 161.21 33.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.619 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' SER . 48.9 Cg_exo -57.72 117.56 4.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.281 1.988 . . . . 0.0 112.357 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.597 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -66.94 -36.84 83.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.503 -179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 50' ' ' VAL . 1.7 t-20 -96.44 -43.43 7.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.267 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -85.51 165.87 16.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.146 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.13 152.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.74 -127.68 1.53 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.0 ptt85 -139.93 168.76 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.404 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 65.5 m95 -82.45 173.39 12.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.684 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -138.94 137.59 36.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.69 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.3 mt-10 -120.22 133.31 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.038 0.447 . . . . 0.0 111.832 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.62 117.74 11.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.202 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.4 m -86.3 131.06 34.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.09 0.472 . . . . 0.0 112.147 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.6 mp -133.77 106.42 11.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.757 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.63 90.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.438 2.092 . . . . 0.0 112.378 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.69 -93.29 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.15 93.72 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.0 110.694 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -68.26 -33.96 75.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.855 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER 169.02 -85.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -127.72 117.22 21.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.035 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -115.82 113.69 23.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.842 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -122.99 130.18 52.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.875 HG22 HD11 ' A' ' 45' ' ' LEU . 4.6 mm -85.5 127.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.016 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -173.36 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 39.01 53.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.591 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -141.89 -174.18 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 111.17 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HD2' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -162.8 151.27 12.08 Favored Pre-proline 0 CA--C 1.528 0.131 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.244 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.967 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 24.6 Cg_exo -63.17 168.62 10.57 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.8 -7.03 60.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.674 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -119.86 121.56 66.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' ASN . 1.6 p -82.44 103.24 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.61 ' HD2' HG23 ' A' ' 74' ' ' THR . 0.3 OUTLIER -94.67 160.03 14.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.135 -178.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 1.6 tp10 -117.79 129.11 55.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.64 145.15 16.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 119.916 -1.135 . . . . 0.0 114.149 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -133.77 131.91 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.057 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 17' ' ' LEU . 4.9 tp -119.01 107.31 13.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.899 0.381 . . . . 0.0 111.051 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.6 mp -116.67 116.44 52.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.907 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -89.8 126.38 35.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.72 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 2.7 mp -113.15 125.26 70.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.235 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -101.15 -177.31 3.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.506 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -64.3 -26.78 68.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.54 -0.39 43.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.12 169.11 13.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.456 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 8.8 p80 -56.98 151.97 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.72 0.295 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 6.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.5 tt0 -143.66 116.74 8.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.18 121.21 31.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.4 m -134.96 121.52 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -100.94 129.7 46.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -155.69 132.6 10.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.305 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 151.24 19.46 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.464 ' CE2' HG21 ' A' ' 74' ' ' THR . 5.4 p90 -151.63 153.9 35.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.052 0.453 . . . . 0.0 111.811 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -102.39 168.78 9.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.709 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.967 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 39.2 m 76.52 78.94 0.09 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.053 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.698 ' OG1' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER 170.51 136.68 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.024 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.819 ' H ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 t -124.4 -175.22 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 p -74.81 152.58 38.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.836 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.97 138.29 40.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.81 60.81 8.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.122 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 96.7 Cg_endo -79.91 -136.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.487 2.125 . . . . 0.0 112.171 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 156.7 -66.21 0.3 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.6 p -129.52 -4.12 4.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.784 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 135.66 33.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.981 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 m -105.38 149.93 25.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -134.94 67.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -12.62 13.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.834 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.8 178.91 9.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.73 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.5 t60 56.06 -151.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.36 157.81 33.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.806 0.336 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.59 48.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.63 112.38 0.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.28 82.77 1.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 110.824 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -155.74 98.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -73.26 -49.71 6.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.696 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 57.9 Cg_endo -71.76 132.5 20.27 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.231 1.954 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.07 47.57 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.97 -69.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.368 2.046 . . . . 0.0 112.153 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 m -165.79 71.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.68 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.2 m80 61.13 -86.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.729 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.652 HD12 ' HG2' ' A' ' 59' ' ' GLN . 0.4 OUTLIER -98.38 149.56 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.486 179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.623 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -48.11 -47.56 34.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.891 0.377 . . . . 0.0 110.299 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -175.45 143.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.829 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -103.78 139.01 39.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 179.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.1 mm -116.07 129.31 72.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 28.5 tp -105.03 113.01 26.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.748 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.01 129.01 52.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.515 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.546 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -152.12 150.08 29.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.335 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.555 HH11 ' HA ' ' A' ' 25' ' ' VAL . 7.1 ptt85 -148.51 160.84 35.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.33 114.59 2.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.172 1.915 . . . . 0.0 111.622 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -30.89 71.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.748 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.636 HD22 HG12 ' A' ' 50' ' ' VAL . 2.0 p30 -99.48 -38.79 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -3.27 57.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HA ' HH11 ' A' ' 20' ' ' ARG . 32.9 m 35.44 41.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.092 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.37 -160.4 12.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.638 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 -73.66 169.11 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.461 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 37.3 m95 -99.51 173.11 6.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.493 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.22 139.51 41.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.345 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -120.37 134.7 55.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 116.96 10.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.947 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 60.1 m -85.33 138.95 31.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.274 0.559 . . . . 0.0 112.475 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -135.45 107.07 10.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.476 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.26 87.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.564 2.176 . . . . 0.0 112.83 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.16 25.91 48.36 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.941 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.3 OUTLIER 58.62 99.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.832 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.787 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -72.86 -22.46 60.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' H ' HD22 ' A' ' 37' ' ' LEU . 17.8 t-20 -176.82 -105.06 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.474 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.2 p -127.19 121.73 32.11 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -115.64 103.38 10.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -115.85 142.97 46.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.233 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.5 125.38 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 6.6 pttt -101.1 168.9 9.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.84 0.352 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.66 -140.43 23.41 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.404 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.907 ' HB3' ' H ' ' A' ' 75' ' ' SER . 0.2 OUTLIER 57.32 -167.97 0.12 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.563 0.22 . . . . 0.0 111.197 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.44 147.23 24.79 Favored Pre-proline 0 CA--C 1.527 0.082 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.789 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 97.3 Cg_endo -85.49 45.04 1.47 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.995 2.463 . . . . 0.0 113.219 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.98 -19.01 7.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.516 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER -120.56 136.86 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.935 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.636 HG12 HD22 ' A' ' 23' ' ' ASN . 9.5 p -77.63 147.0 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.724 ' HD2' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -130.15 148.21 51.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.165 0.507 . . . . 0.0 112.307 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -111.93 129.82 56.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.806 178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 136.97 13.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.597 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' NE2' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.86 123.66 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.449 179.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 3.8 mt -108.18 108.97 20.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 111.021 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 66' ' ' VAL . 1.3 mm -112.35 118.7 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.672 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.96 133.86 41.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.289 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.844 HG12 ' HB3' ' A' ' 63' ' ' HIS . 6.4 mt -113.65 127.48 70.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.178 0.513 . . . . 0.0 111.644 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.652 ' HG2' HD12 ' A' ' 12' ' ' ILE . 2.8 mm100 -95.18 -176.46 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -68.76 -32.25 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.767 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.66 15.48 28.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.73 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.05 161.04 12.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.237 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.844 ' HB3' HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.55 163.78 5.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.722 0.296 . . . . 0.0 110.986 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.44 6.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.654 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.66 115.89 12.57 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 120.958 0.408 . . . . 0.0 111.607 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.729 ' HB ' HD13 ' A' ' 56' ' ' ILE . 1.2 p -136.03 139.07 46.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.995 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 m -137.06 136.05 38.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.34 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HG2' ' NE2' ' A' ' 54' ' ' GLN . 1.6 mtm180 -111.32 129.46 55.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -156.02 127.98 7.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.805 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.68 132.78 39.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.074 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 74' ' ' THR . 21.2 p90 -136.61 150.76 48.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' THR . 21.2 p -109.27 168.4 9.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.831 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.789 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 90.1 m 87.2 65.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.584 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.816 ' HB ' HD13 ' A' ' 45' ' ' LEU . 0.0 OUTLIER 174.24 146.99 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.588 179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.907 ' H ' ' HB3' ' A' ' 45' ' ' LEU . 9.1 t -124.7 179.16 5.09 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.181 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.503 ' HA ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -76.04 -65.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.341 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.48 ' H ' HG23 ' A' ' 76' ' ' THR . 88.1 p -149.35 133.35 17.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.103 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.6 p -139.72 70.19 37.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.869 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 52.4 Cg_exo -54.13 -80.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 79' ' ' PRO . . . 143.77 -152.04 23.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.481 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -67.01 1.03 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 110.868 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -152.16 109.39 3.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -67.71 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.91 114.75 18.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 -156.38 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -80.75 11.95 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 55.69 76.71 0.26 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 56.42 72.06 0.52 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.981 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.889 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.842 0.353 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -108.0 73.86 0.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.918 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.87 -93.78 2.21 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.9 m -86.22 -57.01 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.744 0.307 . . . . 0.0 110.98 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 m120 60.61 12.93 3.9 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -171.51 137.41 1.04 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.9 137.52 15.85 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.518 2.145 . . . . 0.0 112.566 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 64.5 139.25 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.12 150.51 42.89 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.486 2.124 . . . . 0.0 112.551 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -128.66 78.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.743 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 32.7 m-70 -61.71 155.66 22.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.648 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -67.28 150.14 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.1 t -49.76 -48.98 49.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.707 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -169.72 144.25 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.993 0.425 . . . . 0.0 111.445 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.626 ' CE1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -105.19 139.12 40.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.952 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 18' ' ' ARG . 28.5 mm -114.45 117.97 57.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.525 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 42.6 tp -104.9 113.74 27.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.831 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -119.34 128.72 54.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.913 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 8.6 p90 -151.63 162.16 41.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.249 0.547 . . . . 0.0 111.904 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.16 161.69 27.39 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.684 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.53 118.94 5.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 121.906 1.737 . . . . 0.0 111.832 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -62.92 -29.67 70.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.528 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -99.39 -41.17 7.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.471 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 160.06 17.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.281 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.77 147.44 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.31 -164.72 37.38 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.63 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -89.14 155.6 19.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.96 -172.59 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -141.16 144.33 34.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 45.8 mt-10 -120.05 132.95 55.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.202 0.525 . . . . 0.0 111.792 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.31 118.21 11.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.937 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 87.7 m -85.42 132.5 34.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 112.091 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 14.4 mt -123.88 107.56 30.95 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.759 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.7 104.26 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.603 2.202 . . . . 0.0 112.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.743 ' HA3' ' HB3' ' A' ' 11' ' ' HIS . . . 58.8 -92.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.159 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -146.06 111.82 5.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 0.0 111.243 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -82.76 -3.52 56.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.77 -63.91 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.872 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.76 105.22 8.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.882 0.372 . . . . 0.0 110.818 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -126.47 115.21 19.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -120.57 144.47 48.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.257 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 45' ' ' LEU . 18.3 mt -94.33 132.68 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.506 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.39 154.38 25.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.227 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.58 38.13 4.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.642 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.2 OUTLIER -126.62 171.02 11.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.328 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -149.7 135.96 10.47 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.29 157.95 10.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.659 2.24 . . . . 0.0 112.42 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.37 -62.08 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.611 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.719 HG13 HG23 ' A' ' 74' ' ' THR . 0.6 OUTLIER -77.13 133.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 111.173 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 22' ' ' LYS . 5.3 p -82.85 144.76 9.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.027 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -125.4 138.92 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.945 0.402 . . . . 0.0 111.923 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 10.7 tp10 -105.22 129.29 53.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.5 144.67 15.72 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 119.822 -1.18 . . . . 0.0 114.309 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 17' ' ' LEU . 2.8 mt-30 -133.66 129.47 36.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.215 -0.493 . . . . 0.0 110.377 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.626 ' HG ' ' CE1' ' A' ' 15' ' ' TYR . 4.7 tp -124.9 106.67 10.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.417 HD11 ' OE1' ' A' ' 54' ' ' GLN . 3.8 mp -116.88 116.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.941 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.474 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.42 127.43 33.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 63' ' ' HIS . 15.1 mm -112.84 124.39 69.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.309 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.42 -177.1 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.67 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -66.24 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -102.42 -2.54 28.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.54 -166.4 12.15 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.438 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.568 ' HA ' HD13 ' A' ' 58' ' ' ILE . 21.1 p-80 -64.65 140.81 58.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.319 . . . . 0.0 110.707 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 -51.59 0.34 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.286 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 57' ' ' SER . 2.7 tt0 -97.2 126.18 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.484 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.43 123.26 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -137.41 130.85 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mtm105 -111.46 139.55 46.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.943 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -155.94 127.83 7.44 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.028 0.442 . . . . 0.0 111.501 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.82 124.1 39.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.7 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -125.18 162.73 24.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.85 0.357 . . . . 0.0 111.741 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -107.36 168.39 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.388 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 45' ' ' LEU . 4.5 m 85.11 101.39 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.243 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.842 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -145.95 153.61 41.0 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -159.89 -6.52 0.06 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 77' ' ' SER . 0.1 OUTLIER -71.25 -103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.121 -0.231 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.482 ' H ' HG23 ' A' ' 76' ' ' THR . 1.1 t 44.92 75.24 0.11 Allowed 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.68 101.62 5.47 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.267 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.25 -64.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.974 2.449 . . . . 0.0 112.138 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.72 -148.95 18.85 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.631 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -79.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.757 0.313 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -109.3 -56.37 2.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.8 t -161.34 -54.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.502 ' HB3' ' H ' ' A' ' 85' ' ' HIS . 5.8 m80 -131.07 -147.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.918 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 32.9 m170 64.05 106.38 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 129.52 31.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 108.82 13.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.112 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -167.92 91.16 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.154 -0.926 . . . . 0.0 110.82 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 3.9 mtt180 -85.74 -161.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 2' ' ' ARG . . . 109.29 -19.84 28.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.352 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.5 113.65 5.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.689 0.28 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.79 168.99 0.11 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.243 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.39 80.25 0.3 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.291 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.47 120.73 8.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.561 2.174 . . . . 0.0 112.114 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.52 144.16 30.36 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.041 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.68 142.57 12.9 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.634 2.223 . . . . 0.0 112.303 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.38 -2.6 30.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 40.8 m80 55.73 -136.8 1.17 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.774 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.0 OUTLIER -67.4 156.39 6.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.914 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.432 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.19 -41.51 65.33 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -162.39 143.15 10.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.831 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 8.2 t80 -122.83 153.12 39.99 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.655 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.495 HD13 HG13 ' A' ' 58' ' ' ILE . 3.7 mp -120.11 121.88 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.682 0.277 . . . . 0.0 110.751 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.651 ' HB2' ' HE2' ' A' ' 15' ' ' TYR . 10.5 tp -104.84 114.22 28.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.639 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.64 129.84 56.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.721 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -140.9 155.08 46.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.83 146.2 12.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.685 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 20' ' ' ARG . 39.7 Cg_exo -58.18 114.63 2.05 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.214 1.943 . . . . 0.0 111.974 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -65.63 -35.82 81.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.495 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -91.28 -43.85 9.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.328 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.41 0.53 28.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.015 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 29.62 63.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.258 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.68 -153.39 29.58 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.541 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -88.32 164.91 15.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -92.3 172.7 8.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.029 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -152.24 123.95 7.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.571 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.42 130.11 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.123 0.487 . . . . 0.0 112.178 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.03 137.09 51.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.779 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 97.8 m -85.27 115.66 23.16 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.532 0.682 . . . . 0.0 111.858 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.82 110.46 17.22 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.597 178.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.15 79.58 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.092 1.861 . . . . 0.0 111.945 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . 45.46 37.81 6.67 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.74 97.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.923 0.392 . . . . 0.0 110.882 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -71.49 -32.84 68.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.423 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -163.63 -89.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.82 123.87 41.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.837 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -127.92 119.39 25.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.045 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -98.67 146.91 25.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.986 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 43' ' ' LYS . 12.1 mt -108.04 115.01 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.117 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 42' ' ' ILE . 7.8 mmpt? 25.73 -126.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.205 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.92 80.27 0.19 Allowed Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.778 HD22 ' H ' ' A' ' 45' ' ' LEU . 1.3 mm? -68.54 -155.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.739 ' HD3' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -155.65 140.65 12.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 40.0 Cg_exo -57.63 107.11 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.653 2.236 . . . . 0.0 112.484 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.61 -3.93 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.861 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.739 HG23 ' HD3' ' A' ' 46' ' ' LYS . 78.6 t -104.31 115.91 47.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 72' ' ' THR . 2.8 p -83.23 116.39 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.363 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -107.98 169.48 8.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.25 0.547 . . . . 0.0 111.454 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -124.16 129.92 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.118 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -137.57 139.61 10.61 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.662 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -131.18 138.58 49.49 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' CZ ' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -99.28 105.39 17.4 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.644 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.618 ' N ' ' HE1' ' A' ' 15' ' ' TYR . 4.2 mp -116.0 113.44 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.774 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -106.42 133.41 51.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.234 -177.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.757 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 9.6 mt -114.05 127.21 71.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.75 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.568 ' HG2' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -98.7 -179.02 4.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.914 179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -66.45 -16.87 64.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.031 0.443 . . . . 0.0 110.085 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -103.06 -4.95 23.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.941 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 124.56 171.24 13.34 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -62.39 139.03 58.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.7 0.286 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -145.77 9.97 1.19 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.832 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -142.73 114.98 8.39 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.992 0.425 . . . . 0.0 112.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -137.2 126.58 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.381 179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -137.2 131.02 31.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.007 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -107.51 125.49 51.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.308 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -155.73 133.89 11.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.065 0.46 . . . . 0.0 111.359 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.92 140.79 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.278 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -143.48 142.81 31.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 111.806 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.462 HG22 ' HB ' ' A' ' 50' ' ' VAL . 31.6 p -103.28 134.4 46.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.574 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 47' ' ' PRO . 58.8 m 62.96 143.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.13 0.491 . . . . 0.0 111.157 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.557 HG23 ' HG ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -154.02 -13.61 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.113 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 p -72.84 175.75 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.849 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.5 t -118.85 7.09 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.233 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.44 82.56 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.8 m -145.97 95.04 4.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.306 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -71.29 163.14 40.13 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.762 2.308 . . . . 0.0 112.122 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.55 -49.07 0.16 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.726 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 p -120.55 158.35 27.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.037 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.455 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -121.33 -34.47 3.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.752 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.33 142.34 56.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.04 89.05 2.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.229 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 51.61 85.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 -86.87 0.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.045 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.44 164.12 22.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.369 . . . . 0.0 111.092 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -159.07 143.49 15.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.866 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.898 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -139.39 90.0 2.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.54 99.7 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.398 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.05 89.66 2.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.978 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 54.52 73.67 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.105 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.59 129.12 13.97 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.035 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.35 117.7 4.81 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.448 2.098 . . . . 0.0 112.265 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -120.67 143.52 36.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.965 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.76 169.42 22.42 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.516 2.144 . . . . 0.0 112.246 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -62.86 126.15 26.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -74.23 -169.67 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.544 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -80.46 155.07 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.636 ' H ' HE21 ' A' ' 59' ' ' GLN . 16.5 t -53.71 -47.11 70.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.075 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB2' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -172.96 144.0 1.24 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.116 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -106.23 143.9 33.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.379 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.441 HG22 ' HD3' ' A' ' 18' ' ' ARG . 19.5 mm -116.19 118.58 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.964 0.411 . . . . 0.0 111.04 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.552 ' HG ' ' CE3' ' A' ' 19' ' ' TRP . 49.2 tp -105.37 114.95 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.651 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.48 128.99 55.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.439 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 44.5 p90 -140.4 147.73 40.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.313 0.578 . . . . 0.0 110.838 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HG3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -161.99 153.07 15.11 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.256 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.62 110.5 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.332 2.022 . . . . 0.0 112.247 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -32.22 73.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.288 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.83 -37.28 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.51 -162.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.164 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 26' ' ' GLY . 3.9 p -60.96 166.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.29 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' ' HG3' ' A' ' 20' ' ' ARG . . . -74.87 -108.78 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.649 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 59.97 65.98 1.04 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.071 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 -57.48 168.39 0.82 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.794 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.72 134.37 35.26 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 7.5 mt-10 -119.06 136.79 53.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.449 0.642 . . . . 0.0 112.65 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.05 119.74 15.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.476 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 62.2 m -85.28 131.59 34.39 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.63 107.3 13.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.65 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.84 84.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.615 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.68 60.62 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.782 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.5 m170 60.89 106.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 0.0 111.162 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -76.85 -30.69 56.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.605 ' OD1' HD23 ' A' ' 37' ' ' LEU . 10.4 p-10 -177.98 -148.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.036 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.81 105.6 7.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.359 . . . . 0.0 110.28 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -103.23 114.75 29.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.128 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -101.57 147.56 26.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.77 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 17' ' ' LEU . 42.4 mt -107.61 114.74 47.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.754 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.784 ' HE2' ' H ' ' A' ' 43' ' ' LYS . 9.0 mmpt? 34.92 -129.23 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.624 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 45' ' ' LEU . . . -129.45 -43.48 0.21 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.714 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.117 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.4 OUTLIER 55.21 -176.68 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.49 0.186 . . . . 0.0 110.769 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -160.74 142.87 9.33 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 32.5 Cg_exo -57.33 143.02 94.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.546 2.164 . . . . 0.0 112.14 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.8 -29.9 4.79 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.045 ' HB ' HG23 ' A' ' 74' ' ' THR . 2.8 t -96.97 135.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.632 0.254 . . . . 0.0 111.187 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.15 118.57 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.551 ' CE2' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -106.94 164.98 11.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.339 0.59 . . . . 0.0 111.697 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.8 tp10 -123.16 129.31 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.494 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.51 132.1 10.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.127 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 19.8 mm-40 -134.32 112.71 11.23 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' CD2' HD13 ' A' ' 17' ' ' LEU . 14.5 mt -106.14 105.55 15.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.962 0.41 . . . . 0.0 110.293 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' NE ' ' A' ' 18' ' ' ARG . 5.1 mp -117.77 114.78 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.174 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.533 ' OG ' HD13 ' A' ' 12' ' ' ILE . 1.8 t -89.59 116.25 27.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.32 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 6.2 mt -102.44 121.17 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.045 0.45 . . . . 0.0 111.573 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.636 HE21 ' H ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -78.87 -176.36 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.179 179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -30.69 69.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.767 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -103.03 1.23 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.02 13.39 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.009 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 2.1 p-80 -75.87 156.24 34.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.244 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -26.68 0.14 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.293 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.27 119.02 38.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 111.191 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.14 132.64 49.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.232 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.7 132.69 33.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.281 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.95 129.44 56.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.177 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -156.39 128.66 7.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -95.99 136.4 36.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.916 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.34 159.18 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.952 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 73' ' ' THR . 3.0 p -109.38 169.09 8.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.929 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 72' ' ' THR . 25.9 m 98.29 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.256 0.972 . . . . 0.0 111.125 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 1.117 ' HA ' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -141.95 175.63 9.57 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.303 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.59 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 7.6 t -166.81 -63.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.477 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 p 60.3 107.73 0.02 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.2 m -56.27 -55.1 37.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.755 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.7 p 47.12 76.62 0.53 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.834 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.21 -8.9 15.29 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.617 2.211 . . . . 0.0 112.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.37 -103.65 1.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.538 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.405 ' H ' ' H ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -161.63 -17.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.748 0.308 . . . . 0.0 111.015 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' SER . 9.2 mtp-105 -125.2 -7.07 7.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.06 -156.39 0.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.02 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 63.37 109.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -109.49 -8.02 15.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.167 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.508 ' HB3' ' H ' ' A' ' 87' ' ' HIS . 14.1 m-70 -103.93 -149.9 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.051 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.508 ' H ' ' HB3' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 61.32 -171.48 0.15 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.906 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -34.68 60.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.969 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.688 0.28 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.45 145.84 25.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -147.97 133.57 4.71 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.51 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 t -98.59 136.09 39.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.17 -63.41 1.38 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.18 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.73 101.04 3.71 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.245 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.05 119.51 6.49 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.54 2.16 . . . . 0.0 112.333 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -118.68 145.59 37.95 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.61 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.517 2.145 . . . . 0.0 112.287 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.68 -173.62 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.731 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -74.24 -90.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -101.26 147.9 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.436 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.579 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.4 m -45.16 -49.79 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 110.268 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HB2' HG23 ' A' ' 32' ' ' THR . 6.7 pttt -175.61 144.16 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.733 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' CE1' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -111.15 135.43 51.68 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.556 HG22 ' HD2' ' A' ' 18' ' ' ARG . 10.2 mt -114.16 121.46 66.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 111.237 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.762 HD21 HD11 ' A' ' 42' ' ' ILE . 66.4 tp -105.3 114.66 28.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.629 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.8 ' HD3' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -121.0 128.33 52.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.83 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.537 ' CE3' ' HG ' ' A' ' 17' ' ' LEU . 16.4 p90 -148.15 158.67 44.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.979 0.419 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.656 HH12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -160.5 162.44 23.4 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.614 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.5 111.32 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.374 2.049 . . . . 0.0 111.985 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -24.81 22.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.773 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.518 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -99.68 -43.92 6.3 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.18 175.49 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 111.375 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.656 HG23 HH12 ' A' ' 20' ' ' ARG . 11.3 p -136.0 145.65 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.55 -111.28 0.42 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.561 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -127.81 148.17 50.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -82.57 -174.96 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -138.13 124.31 20.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.3 mt-10 -119.73 136.61 54.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 112.136 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.19 138.73 40.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.302 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 91.1 m -94.34 132.57 38.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.168 0.509 . . . . 0.0 112.156 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.424 HG13 ' C ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -135.68 107.71 9.95 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.862 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.18 83.96 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.485 2.124 . . . . 0.0 112.179 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 73.46 -90.68 0.64 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.298 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -168.48 93.33 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 0.0 110.695 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.735 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.34 -33.46 75.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.434 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.0 OUTLIER 179.66 -92.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.782 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.06 117.45 21.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.669 0.271 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.98 101.66 9.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.8 130.64 54.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.853 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 17' ' ' LEU . 3.0 mt -81.55 119.57 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -175.22 2.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.31 47.7 21.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.204 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.737 ' HB2' ' HB ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.13 166.68 23.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.404 0.145 . . . . 0.0 110.798 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG2' ' OG ' ' A' ' 75' ' ' SER . 0.3 OUTLIER -146.88 116.54 4.5 Favored Pre-proline 0 CA--C 1.529 0.172 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.14 105.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.857 2.371 . . . . 0.0 112.567 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 -33.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.45 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG22 HG21 ' A' ' 74' ' ' THR . 0.1 OUTLIER -110.55 135.75 48.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 23' ' ' ASN . 11.4 p -76.49 140.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.702 ' CZ ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -126.11 142.73 51.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.904 -178.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 19.1 pt-20 -116.32 129.19 56.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.45 141.21 16.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.617 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -133.62 114.43 13.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CE1' ' A' ' 15' ' ' TYR . 3.9 mt -106.55 107.57 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.701 0.286 . . . . 0.0 110.701 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.8 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.1 mp -113.54 122.23 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.211 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.3 OUTLIER -89.61 131.96 35.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.119 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.8 mm -113.17 122.74 67.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.636 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.439 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 7.6 tt0 -119.56 -175.77 3.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.472 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.83 -22.1 63.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HD2' HE22 ' A' ' 64' ' ' GLN . 0.3 OUTLIER -103.15 15.83 28.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.193 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.14 -169.38 27.93 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.409 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.585 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -56.01 152.43 10.36 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.678 0.275 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.585 ' HG2' ' C ' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -145.96 -50.65 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.895 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -99.08 118.85 36.76 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.825 -178.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -134.12 119.86 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.949 0.404 . . . . 0.0 111.168 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 m -137.21 135.4 37.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -108.23 141.88 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.23 125.81 9.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.609 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.65 124.55 43.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.407 . . . . 0.0 110.411 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.45 156.3 48.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.39 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 73' ' ' THR . 20.5 p -108.99 134.19 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.737 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER 172.45 -100.43 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.104 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.8 HG21 HG22 ' A' ' 49' ' ' VAL . 0.5 OUTLIER 48.83 140.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 46' ' ' LYS . 4.4 t -176.24 -168.74 0.27 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.616 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.8 p -117.61 145.53 44.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t 62.4 174.88 0.14 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.036 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -144.5 76.44 14.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.1 -77.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.594 2.196 . . . . 0.0 112.307 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.77 -171.95 44.89 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.425 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.7 p -137.37 -165.54 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 82' ' ' ARG . 6.0 mtp-105 -106.35 143.69 34.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m 54.29 43.2 30.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.03 10.4 2.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -105.76 -159.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.06 58.38 1.86 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.87 -166.68 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.167 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 160.69 41.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mtt . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.804 0.335 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -96.36 90.0 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.164 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -175.87 84.92 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -144.3 29.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.785 0.326 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m120 57.39 88.14 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.09 97.09 49.39 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.308 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.77 118.14 4.98 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.635 2.223 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -87.9 112.64 50.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.7 152.58 29.3 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.573 2.182 . . . . 0.0 112.362 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.73 -58.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.853 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -142.2 -78.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -89.61 144.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.585 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -53.69 -52.38 60.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.99 0.424 . . . . 0.0 110.154 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.7 ' HD2' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -168.76 143.85 3.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.79 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -113.11 129.12 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.307 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mm -114.11 137.61 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.861 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.22 114.48 25.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.247 179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 5.1 mtt-85 -113.97 128.31 56.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.196 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -154.75 157.34 37.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 112.228 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 8.3 ptt85 -159.13 160.19 28.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.515 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -58.14 125.11 17.54 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 112.418 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 3.0 tttm -76.91 -37.07 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.061 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.35 -31.97 16.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.68 168.61 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -116.13 130.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.81 -120.16 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.581 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -136.52 166.29 23.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.829 0.347 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.557 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 40.6 m95 -84.32 -174.97 5.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 3.2 tttm -148.94 145.19 27.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -119.8 129.75 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.113 0.482 . . . . 0.0 111.727 -179.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.12 111.77 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.192 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -88.98 140.2 29.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.091 0.472 . . . . 0.0 111.811 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.0 mt -130.57 116.32 17.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.423 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' HD21 ' A' ' 37' ' ' LEU . 3.0 Cg_exo -75.23 87.72 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.832 2.354 . . . . 0.0 112.08 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 -89.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -169.7 92.85 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.718 0.294 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD21 ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.66 -33.79 25.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.562 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER 178.08 -157.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.599 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -86.18 106.61 17.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.729 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -84.57 119.48 25.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.019 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 m -122.78 124.47 43.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.18 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.18 122.62 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.02 105.1 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.7 8.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.363 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.827 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -95.09 -144.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.503 0.192 . . . . 0.0 110.499 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -165.85 140.46 3.85 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.5 95.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.407 2.071 . . . . 0.0 112.008 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.99 -27.71 3.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' THR . 1.9 t -92.52 124.0 44.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 110.659 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 72' ' ' THR . 63.1 t -100.93 123.14 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 0.0 111.384 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.511 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 18.0 m-85 -106.09 118.08 35.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.438 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 pt-20 -82.04 149.15 28.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.37 160.9 34.58 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.926 -1.131 . . . . 0.0 113.375 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -132.83 151.9 51.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.861 HD13 HD12 ' A' ' 17' ' ' LEU . 45.2 tp -111.19 107.7 17.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.92 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 66' ' ' VAL . 5.1 mp -92.55 138.31 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.007 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.523 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.55 123.52 44.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 110.951 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HD2' ' A' ' 14' ' ' LYS . 5.4 mt -113.27 117.79 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.824 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.97 171.66 10.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.892 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.98 -23.36 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -102.85 4.11 37.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.51 -134.09 11.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.619 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 64.77 168.8 0.18 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.856 0.36 . . . . 0.0 111.333 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -158.52 109.14 2.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.108 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tm-20 -100.11 116.28 31.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.328 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.647 HG22 HG13 ' A' ' 56' ' ' ILE . 21.1 t -123.51 138.03 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 54.3 m -137.79 125.58 22.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.392 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.22 144.54 28.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.754 0.311 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.29 157.09 35.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.57 119.05 28.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -142.55 153.09 43.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.358 0.599 . . . . 0.0 112.45 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -147.06 167.73 23.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.829 178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.827 HG23 ' HB2' ' A' ' 45' ' ' LEU . 51.0 p -38.56 -61.59 0.69 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 111.527 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.79 -23.48 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.66 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.37 174.57 11.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.95 135.96 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 t -69.08 -78.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.761 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m 54.16 83.54 0.22 Allowed Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.233 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.15 -29.95 88.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.665 2.243 . . . . 0.0 112.468 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.9 83.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 t -164.1 -68.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.35 83.71 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.758 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.9 t -113.13 -82.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -125.33 98.15 5.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -167.46 -75.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -164.56 140.88 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.04 82.46 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.762 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.68 -173.66 4.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.937 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.678 0.275 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' H ' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -68.57 -44.15 75.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.228 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.85 147.75 7.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.338 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 5' ' ' ASN . 1.2 m -105.59 -103.38 0.33 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.544 0.211 . . . . 0.0 111.124 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.425 ' H ' ' HB2' ' A' ' 4' ' ' SER . 0.6 OUTLIER -166.28 108.57 0.73 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.741 0.305 . . . . 0.0 110.904 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.85 70.63 7.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.321 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.74 141.59 8.68 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.607 2.205 . . . . 0.0 112.447 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -158.85 123.12 2.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.24 -56.77 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.503 2.135 . . . . 0.0 112.161 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.52 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -84.29 -68.22 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.188 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.577 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -90.71 142.81 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.354 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 2.2 m -66.23 -49.17 68.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.103 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.81 11.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.126 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.92 128.21 54.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.098 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.522 ' O ' HD12 ' A' ' 55' ' ' LEU . 32.9 mm -113.84 134.28 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.196 0.522 . . . . 0.0 110.987 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.862 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.55 114.55 27.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.311 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -112.28 128.24 56.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.935 179.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -147.94 155.77 41.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.328 0.585 . . . . 0.0 112.306 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.06 152.51 18.91 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.468 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -57.97 114.67 2.07 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.414 2.076 . . . . 0.0 112.55 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 1.8 ttmm -70.39 -36.39 74.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.154 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -84.3 -36.85 22.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.955 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.69 -169.57 2.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.781 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.03 103.25 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.909 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.19 -138.13 3.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.503 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 150.7 45.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -67.21 174.86 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.31 150.45 37.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.9 136.75 54.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 111.78 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 112.05 7.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.602 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.8 m -85.62 138.39 32.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.606 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -130.06 114.87 17.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.485 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 90.33 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.457 2.105 . . . . 0.0 112.304 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 66.57 -91.8 0.18 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.309 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -160.78 74.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 38' ' ' ASN . 2.0 pt? -65.6 -33.62 76.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.62 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.6 OUTLIER 173.95 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.335 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -76.94 105.41 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.35 . . . . 0.0 110.391 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -89.99 116.76 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.851 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -116.01 131.41 56.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.353 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -102.08 130.45 51.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.989 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -135.03 -168.32 2.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.94 61.15 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.616 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.623 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -74.07 -170.19 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.785 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HE3' ' OH ' ' A' ' 51' ' ' TYR . 18.8 mttt -137.98 150.79 68.56 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.54 122.38 8.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.591 2.194 . . . . 0.0 112.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.38 -16.86 31.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.551 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.96 125.66 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 72' ' ' THR . 82.6 t -96.5 142.82 13.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.728 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 26.9 m-85 -109.93 124.8 52.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.811 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -89.74 156.22 18.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.0 152.24 21.3 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.446 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.35 132.27 41.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.862 HD13 HD12 ' A' ' 17' ' ' LEU . 27.1 tp -99.9 107.01 18.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.879 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.19 138.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.663 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -117.02 121.49 41.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 111.906 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.87 125.7 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.432 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.753 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -118.64 178.96 4.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.868 0.366 . . . . 0.0 111.282 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -22.16 66.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.03 -4.12 59.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.56 23.89 59.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.753 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 7.4 m80 -67.28 173.03 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.1 89.98 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.188 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -101.01 116.16 32.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.269 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 p -130.77 139.23 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.241 0.543 . . . . 0.0 112.418 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.4 m -137.6 125.64 22.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.753 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 146.85 27.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.22 146.25 21.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.05 0.452 . . . . 0.0 111.807 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -108.59 121.3 44.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.489 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 77' ' ' SER . 38.9 p90 -129.58 149.13 51.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 111.995 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 50' ' ' VAL . 71.2 p -142.4 163.67 32.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.849 HG23 HG22 ' A' ' 74' ' ' THR . 8.8 t -101.71 -27.27 13.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.314 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.849 HG22 HG23 ' A' ' 73' ' ' THR . 3.3 t -161.06 13.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.078 0.465 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.411 ' HB3' HG21 ' A' ' 72' ' ' THR . 32.5 t -93.2 -87.31 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -172.46 104.39 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.193 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -169.39 -90.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.091 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -163.73 119.61 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.171 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.81 54.33 3.99 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.664 2.243 . . . . 0.0 112.576 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.27 -152.92 24.22 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.686 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.2 m -87.04 140.67 29.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -77.13 -176.9 4.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.7 p -103.85 -8.62 19.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.55 126.48 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -143.45 -78.44 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.698 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.95 -76.79 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.78 16.08 10.29 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.567 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.42 -174.5 2.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.75 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.875 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -99.61 8.89 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.023 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.45 36.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.408 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.4 125.36 25.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.764 0.316 . . . . 0.0 110.834 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -76.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.08 143.42 97.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.247 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 -35.97 4.95 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.656 2.237 . . . . 0.0 112.257 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -160.23 70.9 3.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.95 -86.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.582 2.188 . . . . 0.0 112.698 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.0 m 62.47 170.38 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.074 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.63 -51.79 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG21 ' HD2' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -100.34 141.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.534 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -54.79 -49.08 71.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.297 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -167.86 144.25 4.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.016 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -116.56 135.69 53.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.123 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.639 ' O ' HD23 ' A' ' 55' ' ' LEU . 17.2 mm -114.68 135.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.178 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -115.54 114.96 25.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.962 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.758 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.6 mtp180 -114.55 129.18 56.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.775 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -145.0 154.92 43.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 111.749 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.45 152.46 18.28 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.794 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 52.0 Cg_exo -58.59 119.11 6.15 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.348 2.032 . . . . 0.0 112.291 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -23.61 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.405 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -98.62 -36.4 9.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 2.8 m -104.31 113.52 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.997 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 m -95.51 128.59 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.74 -57.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.566 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -167.84 151.55 6.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.767 0.318 . . . . 0.0 110.767 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 30.9 m95 -87.89 -169.51 2.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.2 mttt -143.11 151.19 40.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -119.94 137.04 54.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.319 0.581 . . . . 0.0 112.455 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.23 111.34 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.856 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.5 m -90.3 140.54 29.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.079 0.466 . . . . 0.0 112.099 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.41 117.65 8.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.57 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.37 86.64 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.536 2.158 . . . . 0.0 112.223 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 79.25 -98.91 1.66 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.215 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -165.24 94.25 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.86 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -82.95 -33.57 26.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.895 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.441 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -179.82 -161.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.638 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -86.46 106.22 17.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.691 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -89.11 113.44 24.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -108.94 138.03 45.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 17' ' ' LEU . 15.3 mt -105.97 117.23 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.753 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -115.74 129.36 56.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.33 8.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.715 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.946 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER -79.95 -165.91 0.92 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.543 0.211 . . . . 0.0 110.614 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' NZ ' HG11 ' A' ' 49' ' ' VAL . 4.2 mttp -130.99 142.1 44.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.678 0.275 . . . . 0.0 111.424 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.4 Cg_exo -60.02 94.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.727 2.285 . . . . 0.0 111.908 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.29 -25.84 6.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.536 HG11 ' NZ ' ' A' ' 46' ' ' LYS . 6.4 t -92.98 128.25 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.671 0.272 . . . . 0.0 110.793 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.1 t -94.36 146.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CG ' HD12 ' A' ' 45' ' ' LEU . 12.9 m-85 -117.54 122.76 44.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.769 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.31 148.33 26.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.339 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.23 148.47 18.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.533 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.681 ' HG3' HG23 ' A' ' 66' ' ' VAL . 2.3 tt0 -132.91 142.44 48.9 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -107.72 107.06 17.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.585 HD13 ' HD3' ' A' ' 18' ' ' ARG . 5.2 mp -96.88 137.64 24.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -110.49 132.27 54.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.306 0.574 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 14' ' ' LYS . 9.6 mt -113.39 121.67 66.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.898 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.742 ' HG3' ' HB2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -114.41 176.58 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.99 -32.3 73.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -102.19 1.17 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.64 88.19 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.833 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.742 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 1.3 m-70 -98.32 -41.05 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 110.51 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' SER . 31.4 mt-30 66.5 80.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.751 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 10.4 tt0 -96.75 126.6 42.03 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -125.95 136.21 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -137.87 121.74 17.68 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.08 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -86.6 141.0 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 111.606 -179.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.443 ' HE2' HD12 ' A' ' 55' ' ' LEU . 2.0 p90 -155.88 154.32 31.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.376 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -122.29 127.59 50.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.543 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -146.65 152.99 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.435 0.636 . . . . 0.0 112.499 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.627 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -148.41 167.27 25.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.77 178.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.946 HG22 ' HB2' ' A' ' 45' ' ' LEU . 1.6 t -68.17 -34.86 77.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.654 0.264 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.567 HG22 HG23 ' A' ' 73' ' ' THR . 2.7 t -158.78 67.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.133 0.492 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.592 ' HB3' ' OG1' ' A' ' 72' ' ' THR . 0.3 OUTLIER -161.61 -66.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.653 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.531 ' H ' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER 57.01 116.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.779 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 118.01 31.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -159.43 71.33 3.37 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.507 ' HG2' ' H ' ' A' ' 80' ' ' GLY . 73.3 Cg_endo -77.37 -72.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.595 2.196 . . . . 0.0 112.571 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 79' ' ' PRO . . . -151.43 169.64 31.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.542 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.57 -169.78 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.853 0.359 . . . . 0.0 111.168 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 56.16 32.66 20.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.982 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 m -125.16 -32.85 2.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.52 -10.3 5.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.42 93.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -171.55 -156.92 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.78 -91.39 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.48 123.98 41.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.064 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.944 0.402 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -45.9 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.4 -73.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.524 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.7 p -131.37 148.72 52.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -120.17 -8.33 9.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.41 113.45 0.02 OUTLIER Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.263 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.98 89.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.513 2.142 . . . . 0.0 112.335 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -171.53 70.68 0.48 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.9 156.22 48.09 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.49 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.9 -162.08 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.385 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -93.16 130.31 38.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.437 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.65 HG21 ' OG ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -104.28 157.42 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.905 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.65 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -51.08 -37.58 46.56 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.69 ' HD2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -167.73 143.35 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.905 178.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.751 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.12 133.2 56.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.814 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.782 HG21 HH11 ' A' ' 18' ' ' ARG . 4.1 mp -114.45 138.39 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.078 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -113.1 114.62 27.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.214 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -118.21 128.17 54.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.467 ' CE3' HD23 ' A' ' 17' ' ' LEU . 10.2 p90 -153.31 155.09 35.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 112.537 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.35 161.75 26.88 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.354 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.5 Cg_exo -57.72 113.92 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.283 1.988 . . . . 0.0 112.353 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -60.1 -27.82 67.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -74.12 -37.01 64.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 t -94.68 -159.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -138.59 136.59 43.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.25 -163.37 54.49 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.881 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 61.45 58.02 2.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.348 . . . . 0.0 111.416 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 55.3 m95 -79.43 179.21 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.504 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.792 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mttt -142.7 145.19 33.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.21 129.16 53.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 112.232 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.02 111.27 6.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.931 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.3 m -97.52 123.07 41.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 112.297 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -123.08 110.76 30.94 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.967 179.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' HD21 ' A' ' 37' ' ' LEU . 23.8 Cg_exo -63.69 101.52 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.257 1.971 . . . . 0.0 111.621 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.3 -91.57 0.38 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.829 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.21 101.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.938 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.668 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -81.05 -33.31 33.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.937 0.399 . . . . 0.0 110.405 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.0 -168.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.438 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -77.09 105.85 8.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.551 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.26 109.92 21.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.098 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.38 127.85 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.72 122.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -131.77 122.47 25.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.12 25.41 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.621 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG22 ' A' ' 73' ' ' THR . 2.4 mm? -76.32 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.533 0.206 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.713 ' HD3' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -142.4 152.23 59.96 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 120.732 0.301 . . . . 0.0 110.745 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 137.43 19.9 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.561 2.174 . . . . 0.0 112.517 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.02 -15.37 63.02 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.699 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 ' HD3' ' A' ' 46' ' ' LYS . 6.3 p -119.55 134.89 61.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 72' ' ' THR . 96.2 t -104.32 140.72 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.441 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.3 m-85 -105.93 119.36 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.191 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HG2' HH21 ' A' ' 20' ' ' ARG . 0.0 OUTLIER -85.44 138.37 32.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.87 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.57 146.31 16.86 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.873 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.521 HE21 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.4 136.8 45.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 17' ' ' LEU . 1.5 mt -101.71 106.67 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 3.6 mp -94.82 119.53 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.65 ' OG ' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -103.63 130.31 51.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.197 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.7 mt -113.35 128.78 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.569 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 0.5 OUTLIER -116.04 -178.02 3.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -73.02 -8.62 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.066 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.02 -4.67 46.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.924 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.59 31.44 54.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.91 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 3.6 m-70 -89.42 -178.58 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.689 0.281 . . . . 0.0 110.744 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' SER . 1.4 mt-30 -149.32 104.83 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.523 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.6 tm-20 -96.99 125.66 41.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -131.45 134.08 61.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.8 m -137.2 122.51 19.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.13 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.521 HH21 HE21 ' A' ' 54' ' ' GLN . 6.8 mtp180 -84.54 147.28 27.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.348 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.37 141.49 17.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.99 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -114.08 123.33 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.294 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -141.65 151.7 43.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.988 0.423 . . . . 0.0 111.657 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.686 HG21 HG22 ' A' ' 50' ' ' VAL . 20.7 p -144.85 142.28 29.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.684 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.976 HG23 HG22 ' A' ' 74' ' ' THR . 11.2 t -70.81 -27.81 64.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.773 0.321 . . . . 0.0 111.012 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.976 HG22 HG23 ' A' ' 73' ' ' THR . 2.8 t -173.74 60.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.029 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.403 ' HB3' HG21 ' A' ' 72' ' ' THR . 23.2 t -131.64 -90.75 0.42 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -165.75 -176.16 3.76 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.172 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 m 58.18 54.75 5.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.83 70.02 24.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.72 -59.83 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.637 2.225 . . . . 0.0 112.488 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.97 -54.78 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.446 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -82.96 88.34 6.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -81.25 -43.14 19.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 t -146.34 -55.09 0.26 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.23 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -129.27 78.93 1.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 54.95 -113.37 0.78 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.438 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -81.52 -20.96 38.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.68 0.276 . . . . 0.0 111.154 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 59.78 37.2 22.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.782 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.84 125.54 27.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.77 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.147 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.75 169.17 9.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.94 -163.27 9.45 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.528 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 p -131.81 141.81 49.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.797 0.332 . . . . 0.0 111.004 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -90.96 -41.16 11.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.818 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . . . -155.12 113.28 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 6' ' ' ALA . 38.9 Cg_endo -65.91 140.85 62.37 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.548 2.165 . . . . 0.0 112.399 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -90.35 128.45 49.09 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.789 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.74 -53.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.469 2.113 . . . . 0.0 112.727 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.82 141.26 28.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.448 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -138.62 -175.66 4.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.018 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.7 OUTLIER -103.41 149.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.237 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -52.69 -47.28 67.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.013 179.215 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' NZ ' HD12 ' A' ' 58' ' ' ILE . 7.6 ptmt -159.3 143.84 15.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.201 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -119.62 132.08 55.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.922 179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' O ' HD23 ' A' ' 55' ' ' LEU . 19.7 mm -114.07 132.97 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 111.01 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.55 114.37 27.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.979 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 18.5 mtt180 -115.94 128.76 56.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.586 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' A' ' 17' ' ' LEU . 14.2 p90 -152.71 160.02 43.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.463 0.649 . . . . 0.0 112.016 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG2' ' CE2' ' A' ' 28' ' ' TRP . 3.6 ppt_? -159.42 160.01 28.27 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.999 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 50.4 Cg_exo -57.88 117.38 4.08 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.227 1.951 . . . . 0.0 112.42 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -60.28 -38.81 84.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.0 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.49 -27.15 63.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -96.96 -164.91 1.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.76 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.03 114.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.18 -179.65 24.93 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.826 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 60.58 88.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.911 0.386 . . . . 0.0 111.159 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.429 ' CE2' ' HG2' ' A' ' 20' ' ' ARG . 43.0 m95 -101.05 -176.53 3.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.716 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.742 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.2 tttt -151.21 147.53 27.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.963 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -120.42 138.87 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.774 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -137.75 111.76 8.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.274 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -89.29 137.89 31.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.039 0.447 . . . . 0.0 111.859 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.21 109.74 8.28 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.324 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD2' ' HG ' ' A' ' 37' ' ' LEU . 57.9 Cg_endo -70.87 87.39 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 112.8 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 52.78 39.16 54.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.605 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.89 84.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.026 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 38' ' ' ASN . 0.1 OUTLIER -69.32 -33.56 73.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.443 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.694 HD22 HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER 177.66 -154.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.702 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.4 t -77.15 105.11 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -97.02 127.51 43.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.802 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -99.33 147.43 25.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.697 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.49 137.67 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.233 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.4 138.54 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -52.47 130.35 38.12 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.149 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.762 ' H ' ' HB ' ' A' ' 73' ' ' THR . 2.7 mm? -85.3 -136.97 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HE2' ' HB ' ' A' ' 49' ' ' VAL . 16.4 tttt -136.79 117.65 11.04 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.504 0.193 . . . . 0.0 110.726 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.09 112.33 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.567 2.178 . . . . 0.0 112.072 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . 122.18 -24.66 6.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.352 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.585 ' HB ' ' HE2' ' A' ' 46' ' ' LYS . 7.1 p -118.06 137.42 52.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 77' ' ' SER . 46.7 t -97.09 139.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.517 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 24.8 m-85 -105.26 128.92 53.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.624 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.38 137.81 33.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.036 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.03 157.04 27.19 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.823 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.4 143.23 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -107.46 106.14 16.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.134 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD13 ' HD2' ' A' ' 18' ' ' ARG . 4.6 mp -92.26 138.34 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.132 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -121.0 119.36 32.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 111.733 -178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' NZ ' ' A' ' 14' ' ' LYS . 1.1 mt -114.34 127.84 71.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.067 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 61' ' ' TYR . 10.3 pt20 -118.41 -177.39 3.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.985 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.37 -4.62 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.394 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 7.6 m-85 -101.27 -5.04 26.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.77 0.319 . . . . 0.0 111.129 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.09 16.02 68.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.198 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -67.31 174.84 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.809 0.305 . . . . 0.0 110.601 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 63' ' ' HIS . 3.0 mm-40 -152.16 95.02 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.305 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -97.52 117.99 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.063 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.1 p -127.82 134.04 66.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.8 m -137.53 121.53 17.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.34 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 138.95 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.958 0.408 . . . . 0.0 111.476 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.12 157.41 43.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -119.95 121.35 38.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.179 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -147.14 159.82 43.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.228 0.537 . . . . 0.0 111.986 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -146.92 166.4 26.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.973 178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.762 ' HB ' ' H ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -53.61 -50.19 66.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.738 0.304 . . . . 0.0 111.367 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.555 HG23 HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -125.74 -46.98 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.981 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 48' ' ' GLY . 8.4 t -68.24 -176.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.846 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -172.01 146.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.846 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.77 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.1 t -84.16 -101.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.434 ' H ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER 51.06 67.81 3.94 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.335 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.32 -167.01 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.43 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.73 8.5 79.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.477 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 82' ' ' ARG . 56.4 p -126.0 -156.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.504 0.192 . . . . 0.0 110.968 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 47.66 22.78 0.35 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.609 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -66.83 -27.03 67.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.716 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.34 62.34 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.748 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.51 -17.54 64.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -83.51 177.67 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -74.21 153.47 39.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -95.03 132.17 40.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.3 m80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.779 179.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.828 0.347 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -151.28 135.55 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.2 -105.58 0.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.519 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.9 t 56.24 85.01 0.08 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.864 0.364 . . . . 0.0 110.95 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -60.44 164.78 4.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.012 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -64.54 131.46 95.1 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 20.7 Cg_exo -65.83 119.31 6.32 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.671 2.247 . . . . 0.0 112.213 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -161.98 141.54 7.49 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.93 171.42 2.13 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.545 2.163 . . . . 0.0 112.551 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -61.75 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.656 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p80 35.07 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.301 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.621 HG13 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -67.54 155.61 7.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.733 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 74.9 m -54.09 -39.05 66.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.612 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' H ' HG12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -157.14 144.81 18.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.088 0.47 . . . . 0.0 111.37 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.33 126.33 44.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.011 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.6 mt -112.54 135.48 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.769 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -105.56 115.27 29.97 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.775 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.744 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.7 mmm180 -110.06 134.56 52.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.236 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 29' ' ' LYS . 4.3 p90 -161.44 150.45 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.143 0.496 . . . . 0.0 111.609 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.626 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -159.43 152.8 18.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.904 179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 51.2 Cg_exo -58.66 117.2 3.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.51 2.14 . . . . 0.0 112.621 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -33.38 74.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.036 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' HG13 ' A' ' 49' ' ' VAL . 8.1 t-20 -92.43 -43.68 9.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.74 -164.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.101 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.51 163.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.7 26.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.38 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 59.56 -179.72 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.865 0.364 . . . . 0.0 111.199 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 29.5 m95 -92.77 -178.81 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.962 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.744 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.85 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.703 ' HG2' HH11 ' A' ' 18' ' ' ARG . 0.6 OUTLIER -120.14 133.66 55.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.167 0.508 . . . . 0.0 112.181 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.98 110.83 9.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.83 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 39.8 m -90.95 139.55 30.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.81 HG22 HD23 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.23 106.98 6.7 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.886 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 21.1 Cg_endo -60.28 90.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.73 60.57 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.477 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 57.94 85.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.81 HD23 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -80.91 -31.97 34.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.505 ' N ' ' HG ' ' A' ' 37' ' ' LEU . 4.7 p-10 -166.76 -170.98 1.72 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.57 118.97 21.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -107.86 125.52 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.676 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 t -107.76 147.7 30.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.375 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt -105.06 137.46 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.802 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tpmp? -48.7 155.73 0.54 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 129.04 49.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 73' ' ' THR . 2.9 mm? -74.71 -136.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.5 ttmm -153.38 134.6 8.43 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 21.0 Cg_exo -65.09 117.01 4.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 112.25 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.26 54.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 23' ' ' ASN . 2.2 t -118.86 131.36 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.653 ' HA ' HG22 ' A' ' 72' ' ' THR . 41.3 t -99.92 136.45 31.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.641 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD1' HD12 ' A' ' 45' ' ' LEU . 22.1 m-85 -105.96 118.91 37.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 18.8 pt-20 -80.07 137.89 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.06 147.49 19.0 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.854 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' OE1' HD11 ' A' ' 56' ' ' ILE . 1.4 tt0 -132.97 150.54 52.15 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 16' ' ' ILE . 30.1 tp -123.93 110.19 14.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 111.588 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 6.0 mt -97.52 138.35 22.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.609 ' OG ' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -114.2 121.73 44.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.515 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' C ' HD11 ' A' ' 12' ' ' ILE . 2.4 mt -111.79 124.58 68.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.11 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.45 178.36 4.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.47 -14.57 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -101.35 -4.53 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.39 64.22 4.44 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.652 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.37 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 61.42 87.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.443 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.609 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.257 179.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG13 ' HG3' ' A' ' 54' ' ' GLN . 16.3 t -134.07 136.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m -138.09 121.13 16.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.605 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 68' ' ' ARG . 5.0 mtt180 -91.86 146.16 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 111.87 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' CE2' ' HB2' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -156.17 146.49 21.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.212 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -114.41 133.08 55.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 45' ' ' LEU . 34.6 p90 -144.5 148.36 34.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 112.253 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 50' ' ' VAL . 16.2 p -144.65 162.51 36.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.974 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.835 HG23 HG22 ' A' ' 74' ' ' THR . 4.2 t -83.2 -31.75 26.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.632 0.254 . . . . 0.0 111.334 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.835 HG22 HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -163.84 -6.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.449 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 72' ' ' THR . 24.4 t -53.47 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.056 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.9 t -169.45 -171.88 1.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 78' ' ' THR . 2.6 m 58.77 -133.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.797 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.437 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 56.28 58.92 9.04 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 120.627 0.251 . . . . 0.0 111.175 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 78' ' ' THR . 81.1 Cg_endo -89.77 -172.72 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.761 2.307 . . . . 0.0 112.43 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.25 25.12 29.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.31 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -106.24 16.53 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.822 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -91.49 44.45 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 m 54.57 59.67 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.709 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -56.28 143.56 33.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.125 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.47 156.19 48.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.634 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 142.92 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.9 m80 56.24 -162.4 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -77.6 -38.8 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.747 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.765 0.317 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.67 -174.6 3.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.66 -23.8 34.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.1 p 48.7 38.26 11.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.45 58.64 4.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.56 61.18 7.32 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.392 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.37 -59.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.7 2.267 . . . . 0.0 112.548 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -148.26 108.7 3.65 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.703 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.58 150.79 67.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.597 2.198 . . . . 0.0 112.633 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 t -114.92 145.28 42.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 57.85 -114.74 0.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -98.37 143.16 13.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.844 0.355 . . . . 0.0 111.186 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -60.19 -46.83 88.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.155 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.78 143.97 5.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.064 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -111.82 135.29 52.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.24 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 58' ' ' ILE . 3.3 mp -114.15 133.09 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.106 0.479 . . . . 0.0 110.467 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' HG ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.24 114.29 25.02 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.269 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.801 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -115.63 127.96 55.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.081 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.43 ' O ' ' HA ' ' A' ' 28' ' ' TRP . 20.7 p90 -144.86 161.37 39.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.953 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -156.54 150.85 19.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.314 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.7 Cg_exo -57.54 125.52 19.04 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.363 2.042 . . . . 0.0 112.719 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.503 ' H ' ' HA ' ' A' ' 51' ' ' TYR . 37.9 tttp -76.66 -38.61 54.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.129 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -84.12 -39.58 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -98.3 142.95 29.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.785 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.54 132.33 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.973 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.39 -142.41 3.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -114.89 175.96 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.324 . . . . 0.0 110.854 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 19' ' ' TRP . 30.7 m95 -89.46 -167.06 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.801 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.5 mttp -152.38 155.9 38.5 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -122.17 130.39 53.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.176 0.512 . . . . 0.0 112.061 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.3 111.12 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.102 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 99.7 m -90.04 141.07 29.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.104 0.478 . . . . 0.0 112.0 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.507 HG13 ' C ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -138.24 107.65 8.01 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.221 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HG2' HD22 ' A' ' 37' ' ' LEU . 36.4 Cg_endo -65.25 92.72 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.456 2.104 . . . . 0.0 112.093 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -98.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -165.75 70.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.702 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.63 ' HG ' HD22 ' A' ' 38' ' ' ASN . 1.5 pt? -72.27 -33.03 67.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.821 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.63 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -164.33 -179.73 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 t -79.74 108.48 13.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.09 110.3 20.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.666 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -115.58 144.88 43.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.77 125.38 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.986 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -119.36 153.41 35.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.933 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' C ' HD23 ' A' ' 45' ' ' LEU . . . 126.65 13.31 3.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.734 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.4 OUTLIER -104.14 -166.11 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.51 0.195 . . . . 0.0 110.614 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.24 156.14 20.21 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.566 0.222 . . . . 0.0 111.167 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 29.8 Cg_endo -63.34 104.76 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.478 2.119 . . . . 0.0 112.002 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.86 -14.66 4.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.043 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.4 t -116.26 124.99 73.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 72' ' ' THR . 89.6 t -110.23 133.36 55.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' CE1' HD22 ' A' ' 45' ' ' LEU . 57.6 m-85 -109.3 126.55 53.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.93 131.4 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.79 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 19' ' ' TRP . . . -139.68 161.87 26.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.614 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.754 ' HG3' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -134.58 152.78 52.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.886 0.474 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.0 mt -124.18 106.87 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.543 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CD ' ' A' ' 18' ' ' ARG . 87.3 mt -94.46 138.53 20.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.275 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.597 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -119.73 119.14 32.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.288 0.566 . . . . 0.0 111.345 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.692 HD12 HD13 ' A' ' 16' ' ' ILE . 28.9 mt -114.15 125.19 71.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.764 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.34 173.37 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 5.1 pt20 -65.83 -18.45 65.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.226 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -102.25 9.64 39.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.055 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.78 -114.28 4.95 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.801 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.54 -174.91 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.962 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.66 99.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.34 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 5.0 tt0 -96.81 116.33 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.8 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' GLN . 1.2 p -131.17 131.18 63.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.3 m -137.72 125.09 21.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.326 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.58 147.1 27.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.687 0.28 . . . . 0.0 110.746 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' HZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -155.96 155.61 33.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.006 0.432 . . . . 0.0 111.64 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -116.75 133.44 56.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -147.86 150.72 34.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.618 ' HA ' HD12 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.23 166.68 26.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.293 178.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.734 HG22 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -65.76 -39.5 91.11 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.23 -41.12 0.58 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 47' ' ' PRO . 6.9 t -78.61 34.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.318 . . . . 0.0 111.154 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.567 ' HA ' HG23 ' A' ' 72' ' ' THR . 0.2 OUTLIER -62.21 157.24 19.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.406 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -139.48 53.53 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.749 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.69 85.73 2.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.581 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.6 -71.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.875 2.383 . . . . 0.0 112.817 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -40.23 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.946 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.11 86.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.913 0.387 . . . . 0.0 110.982 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -172.17 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.724 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 88.8 p -123.55 -5.35 8.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.952 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.454 ' HB3' ' H ' ' A' ' 85' ' ' HIS . 0.3 OUTLIER -79.72 -88.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -126.99 167.26 16.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.917 0.389 . . . . 0.0 110.957 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -97.93 61.29 1.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.428 ' HD2' ' HB2' ' A' ' 85' ' ' HIS . 80.1 m-70 -129.7 47.04 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.44 68.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.77 15.62 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.52 -163.25 44.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.6 p -145.46 166.59 25.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.707 0.289 . . . . 0.0 110.794 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.4 m120 61.0 15.55 6.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.0 81.0 0.27 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -65.82 154.13 75.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.666 2.244 . . . . 0.0 112.175 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.9 112.39 14.14 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.24 84.64 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.605 2.204 . . . . 0.0 112.127 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 t -171.99 -24.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.027 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -105.92 -161.5 0.81 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -67.48 149.07 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.974 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.645 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -55.33 -50.58 69.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.248 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.6 pttt -171.12 144.8 2.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.629 ' CD1' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -102.03 154.23 19.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.738 179.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.73 147.77 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 111.376 179.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -134.0 109.32 8.91 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.339 176.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.761 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 6.0 mtp180 -122.84 127.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 5.6 p90 -161.08 159.68 29.49 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.354 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -158.95 165.92 17.47 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.343 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 52.2 Cg_exo -54.29 115.88 2.68 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 121.283 1.322 . . . . 0.0 112.619 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.726 ' HB3' HG13 ' A' ' 50' ' ' VAL . 6.3 tptm -34.05 -53.6 0.47 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.79 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -101.67 -44.41 5.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.866 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.42 ' C ' ' HB2' ' A' ' 21' ' ' PRO . 47.0 t -76.61 -177.24 4.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.6 m -128.94 132.18 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.15 34.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.522 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.58 139.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.421 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HD2' ' A' ' 20' ' ' ARG . 62.0 m95 -60.3 167.08 2.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.723 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -132.29 158.91 40.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 30' ' ' GLU . 10.5 pm0 -138.11 127.92 25.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.356 0.598 . . . . 0.0 112.431 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 17' ' ' LEU . . . -143.14 122.47 13.06 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.353 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 m -107.47 120.97 43.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.702 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.63 107.26 34.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.559 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.7 Cg_endo -72.67 110.75 3.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.316 2.011 . . . . 0.0 112.42 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.47 -120.78 23.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.508 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -143.73 68.52 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.326 0.584 . . . . 0.0 110.935 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.74 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -65.64 -33.03 74.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.928 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -174.42 -172.42 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.659 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.9 m -85.2 105.74 16.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -93.5 107.56 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.484 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.92 140.38 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.308 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.423 HD13 ' HZ ' ' A' ' 71' ' ' PHE . 2.3 mp -100.18 130.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.71 75.77 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.113 0.483 . . . . 0.0 111.287 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.725 ' H ' HD12 ' A' ' 45' ' ' LEU . . . -150.4 11.0 0.86 Allowed Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.285 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.78 ' N ' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -124.82 -152.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.233 -0.483 . . . . 0.0 109.755 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.968 ' HA ' ' H ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 160.52 162.0 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 123.728 0.643 . . . . 0.0 110.492 178.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 11.3 Cg_endo -54.31 -6.9 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.544 2.163 . . . . 0.0 112.123 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.63 -46.57 4.25 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.955 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.656 ' O ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -113.78 136.87 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 111.544 179.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 22' ' ' LYS . 3.0 p -103.02 117.57 48.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.065 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.641 ' HB2' HD23 ' A' ' 45' ' ' LEU . 30.4 m-85 -102.05 125.88 48.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.788 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 2.1 tt0 -78.7 126.73 31.13 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.654 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -115.29 159.6 13.69 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.062 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.2 tt0 -133.48 114.46 13.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.0 111.762 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -101.36 106.2 17.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.976 178.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 51.2 mt -116.49 120.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.716 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.52 138.18 35.48 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.902 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.8 mp -117.71 130.6 72.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.46 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -82.99 -176.58 6.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.04 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 61' ' ' TYR . 4.5 pt20 -61.05 -30.59 70.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.913 0.387 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.488 ' N ' ' HG3' ' A' ' 60' ' ' GLN . 2.1 p90 -103.24 -4.64 24.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.99 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.902 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 105.83 156.99 22.17 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.669 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 22.2 m80 65.97 135.97 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 111.362 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.643 ' HB2' ' O ' ' A' ' 57' ' ' SER . 1.9 mm-40 -166.49 -57.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.769 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.7 tp10 -145.51 144.6 30.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.511 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.7 t -134.77 121.69 35.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.72 0.295 . . . . 0.0 111.779 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.26 121.69 17.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.23 121.81 45.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.735 0.303 . . . . 0.0 111.132 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -151.97 131.56 13.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.627 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.788 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.9 p30 -92.95 138.73 31.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.423 ' HZ ' HD13 ' A' ' 42' ' ' ILE . 28.8 p90 -141.31 161.89 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.366 . . . . 0.0 111.872 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.19 134.45 20.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.902 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' C ' ' A' ' 72' ' ' THR . 1.4 t 162.77 78.86 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.968 ' H ' ' HA ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -160.31 -169.57 2.52 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.746 -0.596 . . . . 0.0 111.132 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER 75.95 76.96 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.5 -153.77 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.62 62.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.535 HG22 ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -168.21 150.54 5.17 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.754 0.311 . . . . 0.0 111.493 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HD2' HG22 ' A' ' 78' ' ' THR . 0.2 OUTLIER -28.95 143.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.281 3.321 . . . . 0.0 113.973 179.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.97 102.9 0.23 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.43 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.4 p -162.64 -176.04 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 110.989 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -124.8 -179.39 4.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.17 132.51 9.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -165.75 27.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.702 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 38.1 m80 64.31 159.09 0.09 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.241 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -92.94 75.98 4.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.78 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -133.55 100.58 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.2 2.15 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.067 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.956 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tpp . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.811 0.339 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.9 ttp-105 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.03 -30.45 4.49 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.15 94.67 9.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.803 0.335 . . . . 0.0 110.88 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -82.99 -48.89 10.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.55 74.07 40.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.226 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.05 -26.11 6.79 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.974 2.45 . . . . 0.0 112.241 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -58.94 133.59 87.11 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.063 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.73 93.51 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.418 2.079 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.52 -63.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.41 -167.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.743 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.688 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.3 tp -84.51 153.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.1 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.678 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -56.52 -45.32 81.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.48 144.04 8.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.778 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -104.2 156.61 17.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.505 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -120.78 148.42 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-O 121.355 0.598 . . . . 0.0 111.347 179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.468 ' H ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -133.06 109.85 9.8 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.745 176.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.798 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.9 mtt180 -118.37 127.84 54.07 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 2.2 p90 -161.35 153.65 20.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 117.901 -1.52 . . . . 0.0 114.904 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.83 164.07 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.025 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -56.73 110.63 0.61 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 121.584 1.523 . . . . 0.0 112.588 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 50' ' ' VAL . 9.0 tptt -30.79 -47.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.379 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 -44.06 7.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.807 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -79.51 82.71 5.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.022 0.439 . . . . 0.0 110.842 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.92 145.32 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.76 -88.9 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -134.28 125.01 26.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.953 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.484 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 68.1 m95 -64.12 171.48 2.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.825 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.1 mttt -120.96 162.92 19.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -134.48 123.92 24.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.098 0.475 . . . . 0.0 112.031 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.92 111.78 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.64 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.97 118.16 35.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 111.405 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.033 HG22 HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -132.75 111.51 13.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.463 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.824 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.8 Cg_exo -46.61 160.67 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.64 2.227 . . . . 0.0 113.024 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.24 105.05 0.28 Allowed Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.664 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 44.17 39.08 2.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -72.7 -16.61 61.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.839 0.352 . . . . 0.0 110.546 179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.709 ' HB3' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -172.57 169.62 5.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 m -83.57 106.3 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -117.79 120.04 36.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 m -116.38 146.45 42.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG21 ' HZ ' ' A' ' 71' ' ' PHE . 2.5 mp -94.95 117.66 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.44 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.51 61.77 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.187 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.44 -17.23 4.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.888 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -92.43 137.78 32.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.877 0.37 . . . . 0.0 110.408 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' O ' HG23 ' A' ' 49' ' ' VAL . 15.7 pttt -104.01 161.5 22.74 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.333 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.667 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 38.5 Cg_exo -55.83 96.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.252 1.968 . . . . 0.0 112.832 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.37 -9.49 3.5 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.847 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' HB ' ' HE1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -120.55 138.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.313 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 22' ' ' LYS . 2.4 p -112.62 116.94 53.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.211 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 34.1 m-85 -105.39 124.9 50.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.25 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 1.017 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 10.3 tt0 -79.53 126.6 31.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -112.98 156.63 15.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.583 ' NE2' HD11 ' A' ' 56' ' ' ILE . 60.3 tt0 -132.7 114.58 14.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.91 0.386 . . . . 0.0 111.226 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -100.54 106.18 17.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.862 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 77.0 mt -116.9 121.26 67.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.4 m -82.22 135.98 35.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.501 . . . . 0.0 110.071 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.688 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.7 mt -117.03 132.38 66.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.021 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.723 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -95.2 -175.68 3.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.321 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HG3' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.41 -27.43 67.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.593 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 12.2 p90 -103.31 -5.49 22.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.747 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.688 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 97.87 151.87 27.76 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.921 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 66.2 129.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 111.447 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 7.7 mm-40 -156.53 -51.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.26 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 4.6 tt0 -144.11 145.15 31.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 56' ' ' ILE . 58.0 t -134.62 123.25 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 111.277 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -137.34 120.5 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.939 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -112.9 118.42 34.83 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.68 137.49 13.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.661 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 1.017 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 16.1 p-10 -92.3 135.28 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.987 0.422 . . . . 0.0 110.152 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.494 ' HZ ' HG21 ' A' ' 42' ' ' ILE . 9.1 p90 -140.82 162.97 34.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.063 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 74' ' ' THR . 0.5 OUTLIER -149.85 131.52 14.95 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.02 177.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.638 ' H ' HD23 ' A' ' 45' ' ' LEU . 5.0 t -84.48 12.21 7.3 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.667 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -118.33 -179.9 3.92 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.157 -175.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.77 -164.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.545 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -154.02 95.6 1.87 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 m -166.15 -164.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.591 HG22 ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -169.35 162.47 7.42 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.74 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 78' ' ' THR . 23.9 Cg_endo -89.47 1.8 5.71 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.012 2.475 . . . . 0.0 113.03 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.41 -61.21 0.28 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.788 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.423 ' HB3' ' H ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER 62.58 -89.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.59 0.233 . . . . 0.0 111.079 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' H ' ' HB3' ' A' ' 81' ' ' SER . 0.0 OUTLIER -110.49 160.43 16.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.8 t -127.8 -72.01 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -124.36 -87.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.819 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -27.13 0.86 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -165.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -100.09 105.84 17.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -156.99 -43.16 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.893 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.887 0.375 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 2' ' ' ARG . 4.7 ptp85 -104.1 -40.06 6.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.773 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.31 -166.31 12.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.375 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -165.94 -171.5 2.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -74.38 -80.15 0.08 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.74 66.05 2.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -88.2 14.55 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.123 2.549 . . . . 0.0 112.194 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.38 84.78 0.2 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.876 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.79 159.62 45.02 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.418 2.079 . . . . 0.0 112.386 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.88 -46.9 76.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.437 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 4.5 p-80 -144.25 168.25 20.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.048 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.689 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -96.79 151.36 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.689 ' N ' HG13 ' A' ' 12' ' ' ILE . 20.3 m -49.74 -49.25 48.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -168.47 144.16 3.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.103 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.532 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -106.7 156.97 18.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.715 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.728 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.66 147.61 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -133.34 109.61 9.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.606 177.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.17 127.15 44.07 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.696 ' HB2' ' O ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -162.54 164.6 26.79 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 118.449 -1.3 . . . . 0.0 114.117 -176.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 138.01 10.2 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 113.681 -1.6 . . . . 0.0 108.219 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 13.9 Cg_endo -55.57 109.34 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.172 1.915 . . . . 0.0 111.37 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.721 ' HB3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -49.79 -59.22 4.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.808 -179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -62.77 -43.94 97.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.303 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -103.3 67.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.806 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -47.05 137.8 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.345 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.14 -82.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -154.17 148.77 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.861 0.362 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -67.11 170.68 6.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.3 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.8 tptt -138.0 165.8 25.66 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.3 pt-20 -142.32 126.28 17.24 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.901 0.381 . . . . 0.0 111.808 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.92 129.69 21.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -105.09 119.5 39.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 111.538 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -116.81 106.67 47.53 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.548 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 9.7 Cg_exo -72.0 97.64 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.683 2.255 . . . . 0.0 113.044 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 45.15 44.83 9.89 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.217 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 56.15 79.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.3 -32.9 72.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.776 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 -164.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.638 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.26 105.65 16.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -122.99 107.85 12.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.681 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.35 147.36 45.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.554 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.628 HD12 ' HZ ' ' A' ' 71' ' ' PHE . 14.8 mt -90.77 137.22 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.76 149.59 38.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.254 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 113.55 23.46 5.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.855 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.6 OUTLIER -125.61 171.95 10.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.661 0.267 . . . . 0.0 110.526 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.959 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 4.8 pttt -178.35 165.7 1.12 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.697 ' HD3' ' HA ' ' A' ' 74' ' ' THR . 92.3 Cg_exo -47.61 -22.98 3.3 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.587 2.191 . . . . 0.0 112.218 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.51 -36.2 17.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.405 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -114.2 124.22 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 120.992 0.425 . . . . 0.0 111.782 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.721 HG13 ' HB3' ' A' ' 22' ' ' LYS . 1.8 p -102.04 131.22 50.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.078 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m-85 -112.18 119.21 37.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.518 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -78.98 127.77 32.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -127.71 158.1 21.2 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.898 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.7 tt0 -133.63 121.18 21.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 111.552 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 6.0 mt -110.22 106.84 16.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.024 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.728 ' H ' HG22 ' A' ' 16' ' ' ILE . 32.4 mt -112.55 119.6 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.897 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.663 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.63 135.04 35.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.357 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 ' HA2' ' A' ' 62' ' ' GLY . 1.5 mp -117.33 132.16 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.897 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -86.82 -176.78 5.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.487 179.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -63.61 -30.28 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.578 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -102.6 1.07 34.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 101.46 150.23 23.52 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.028 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 65.83 144.64 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 111.578 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -169.2 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.072 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -144.56 144.08 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.612 -178.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 56' ' ' ILE . 84.7 t -133.91 114.07 19.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -137.1 120.3 16.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.705 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -112.22 133.98 54.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.94 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 4.4 p90 -156.56 154.83 30.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.932 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -100.88 122.0 42.69 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.628 ' HZ ' HD12 ' A' ' 42' ' ' ILE . 2.4 p90 -138.62 163.8 31.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.387 0.613 . . . . 0.0 111.826 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.606 ' O ' HG23 ' A' ' 74' ' ' THR . 0.1 OUTLIER -139.26 134.44 32.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.693 177.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.855 HG22 ' HB2' ' A' ' 45' ' ' LEU . 3.6 t -55.39 -31.4 61.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.953 0.406 . . . . 0.0 110.261 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.959 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 68.6 p 55.75 112.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.345 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 t -77.75 43.8 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.271 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.01 119.3 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.7 m -147.49 12.64 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.175 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -167.95 69.6 0.86 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 111.25 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.28 20.21 1.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.737 2.291 . . . . 0.0 112.545 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.15 37.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m 55.89 88.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.857 0.36 . . . . 0.0 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -68.52 -74.2 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m 55.04 -162.94 0.14 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.115 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -132.35 101.59 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -118.65 162.66 18.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -107.55 -8.23 16.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.047 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -118.35 -61.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.79 100.82 10.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.84 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.969 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptp . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.766 0.317 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER 57.68 -169.92 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.187 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.4 -155.69 19.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.631 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -111.35 135.55 51.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.326 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -121.64 71.26 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.02 125.43 0.02 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.201 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.78 140.68 56.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.32 2.014 . . . . 0.0 112.233 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -116.5 157.9 44.61 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.25 -165.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.761 2.308 . . . . 0.0 112.538 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.441 ' HB2' ' H ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -67.39 -155.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.561 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.441 ' H ' ' HB2' ' A' ' 10' ' ' SER . 11.7 m80 62.28 172.77 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.846 0.355 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.626 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.6 OUTLIER -75.33 145.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' HG13 ' A' ' 12' ' ' ILE . 4.9 t -53.02 -44.96 67.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.88 0.372 . . . . 0.0 110.106 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 6.7 pttt -175.8 146.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.964 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -101.38 154.37 18.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.605 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -114.89 147.96 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.408 0.623 . . . . 0.0 112.037 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -132.14 109.53 10.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.536 176.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -117.93 127.47 53.88 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.668 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -158.66 159.98 35.96 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 118.435 -1.306 . . . . 0.0 113.405 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' HG3' ' CE3' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -157.46 155.84 28.02 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.194 178.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 17.1 Cg_endo -54.08 109.79 0.43 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 122.347 2.032 . . . . 0.0 111.202 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HB3' HG13 ' A' ' 50' ' ' VAL . 1.1 tmtp? -45.83 -55.27 6.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.205 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.55 -43.87 8.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.799 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 8.5 t -71.07 150.89 45.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.988 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.97 135.12 25.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.031 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.39 -159.85 22.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.55 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 14.6 ptp180 -116.75 164.25 14.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.49 ' CE3' ' HG3' ' A' ' 20' ' ' ARG . 60.7 m95 -66.46 167.79 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.718 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.52 160.08 37.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.03 179.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 123.79 24.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 111.969 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.44 112.4 7.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.107 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 m -97.86 130.42 44.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 112.193 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.86 HG22 HD11 ' A' ' 37' ' ' LEU . 1.1 pt -137.2 106.44 8.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.672 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 85.5 Cg_endo -81.92 122.0 3.75 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 35.46 7.48 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.375 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 50.48 78.25 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.986 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.21 -30.62 71.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.495 ' H ' HD12 ' A' ' 37' ' ' LEU . 11.7 t30 -168.26 174.88 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.672 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -77.09 105.12 7.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.219 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -115.57 117.05 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.613 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.36 141.86 47.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.409 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 17' ' ' LEU . 2.8 mp -86.76 134.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.882 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.47 53.45 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.056 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.51 2.63 24.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.281 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -108.41 129.35 55.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.388 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -111.52 163.34 17.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.542 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.64 ' HA ' ' OG1' ' A' ' 74' ' ' THR . 10.3 Cg_endo -49.82 95.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.639 2.226 . . . . 0.0 112.671 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.21 -6.73 5.37 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.778 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -120.77 138.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.737 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.8 p -115.13 133.96 59.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.502 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.805 ' HB2' HD23 ' A' ' 45' ' ' LEU . 17.3 m-85 -116.43 130.03 56.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.583 0.23 . . . . 0.0 111.331 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 37.8 tt0 -88.27 127.8 35.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -117.09 155.24 16.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.704 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ARG . 6.1 tt0 -132.27 114.45 14.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.841 0.353 . . . . 0.0 111.747 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 4.9 mt -103.12 106.77 17.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.111 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLU . 96.7 mt -117.09 122.67 70.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.0 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -81.25 134.73 35.65 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 16' ' ' ILE . 1.7 mp -120.26 130.7 74.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.693 ' HB2' ' CD ' ' A' ' 64' ' ' GLN . 4.7 mm100 -126.12 -174.02 3.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -6.6 27.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.828 0.347 . . . . 0.0 111.011 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -103.05 -4.76 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.707 -178.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.39 161.93 5.87 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.805 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.1 t60 66.69 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.693 ' CD ' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 59.65 -95.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.571 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.563 ' O ' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.65 144.27 51.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.869 -178.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -133.65 126.3 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.623 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.15 124.46 21.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.64 125.6 54.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.241 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.445 ' CE1' HD12 ' A' ' 55' ' ' LEU . 16.3 p90 -156.31 127.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 111.928 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.777 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.56 133.32 39.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.978 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -140.95 163.69 32.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.617 0.722 . . . . 0.0 112.515 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.968 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -148.18 133.18 18.17 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.554 177.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.556 HG22 HD13 ' A' ' 45' ' ' LEU . 4.7 t -83.22 28.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.759 0.79 . . . . 0.0 108.982 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.781 HG23 ' OG1' ' A' ' 72' ' ' THR . 0.5 OUTLIER -140.95 -71.18 0.36 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -177.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.451 ' N ' ' OG1' ' A' ' 74' ' ' THR . 0.2 OUTLIER -57.02 -68.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 72' ' ' THR . 23.3 p 50.13 37.35 14.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 110.912 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.585 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 0.6 OUTLIER 60.03 -160.48 0.29 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.062 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 7.5 t 42.66 41.43 0.58 Allowed Pre-proline 0 N--CA 1.469 0.496 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.665 ' HD3' ' N ' ' A' ' 78' ' ' THR . 34.4 Cg_endo -100.26 47.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.37 2.047 . . . . 0.0 112.429 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.84 142.99 16.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.835 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.59 89.57 1.34 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.736 0.303 . . . . 0.0 110.781 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -106.77 70.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 t -165.74 113.33 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.83 -70.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.044 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -121.14 -68.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.183 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.11 139.65 46.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.81 -26.32 7.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 88.02 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mtm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.801 0.334 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -148.39 -12.62 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.77 -3.33 0.03 OUTLIER Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.482 -0.865 . . . . 0.0 112.851 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p -76.34 79.23 3.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -147.85 155.36 41.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.97 75.45 0.57 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.128 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.94 118.66 5.58 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.532 2.155 . . . . 0.0 112.255 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -89.4 159.27 44.69 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.686 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -42.79 -73.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.729 2.286 . . . . 0.0 112.391 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -168.84 7.94 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.696 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -135.09 132.41 38.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.945 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.928 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.5 OUTLIER -95.07 154.02 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.414 179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.718 ' N ' HG13 ' A' ' 12' ' ' ILE . 1.2 m -46.26 -41.07 12.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 17.1 pttt -174.2 143.5 0.89 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.562 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -101.41 147.36 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -115.04 148.22 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 CA-C-O 121.183 0.516 . . . . 0.0 111.219 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -126.03 109.35 12.32 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.005 176.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.2 mtt-85 -118.2 125.87 51.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.712 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -156.2 157.01 35.14 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 117.878 -1.529 . . . . 0.0 114.133 -176.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.76 151.76 17.05 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.871 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 54.2 Cg_exo -53.61 108.64 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 120.888 1.058 . . . . 0.0 111.242 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' H ' ' H ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -21.9 -51.8 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.294 -1.776 . . . . 0.0 112.896 -179.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -44.15 6.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.226 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.31 67.52 9.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.289 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -53.82 124.17 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.882 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.09 76.23 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.697 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 27' ' ' ARG . 6.5 mtt-85 65.08 125.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 0.0 111.544 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -62.28 166.96 4.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.779 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.779 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.1 mmpp? -127.33 152.83 46.95 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -129.17 124.26 34.18 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -142.94 111.66 6.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.981 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 111.88 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -138.58 106.92 7.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.184 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.715 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 61.3 Cg_endo -72.29 111.87 3.3 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.234 1.956 . . . . 0.0 113.1 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.75 11.45 36.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.173 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.18 84.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -66.0 -18.35 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.765 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' OD1' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -160.48 -178.71 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.726 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.97 105.82 9.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -99.69 105.68 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -122.07 146.03 47.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.225 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.02 134.33 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -108.63 -4.89 16.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.909 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.48 -63.08 5.4 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.394 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.796 HD12 HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -36.87 109.74 0.1 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.748 0.419 . . . . 0.0 111.333 179.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -102.78 157.39 33.82 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.557 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.653 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 1.1 Cg_endo -42.37 104.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.383 2.722 . . . . 0.0 113.351 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.47 -12.02 8.43 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.447 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 46' ' ' LYS . 8.1 p -120.85 139.35 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.827 ' HA ' ' HB ' ' A' ' 72' ' ' THR . 1.5 p -111.26 128.42 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.818 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.871 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 21.3 m-85 -107.55 120.36 41.98 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.003 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.931 ' HA ' ' HA ' ' A' ' 70' ' ' ASP . 14.8 tt0 -80.13 127.08 31.89 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -116.04 152.63 17.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mt-30 -130.9 117.06 18.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.0 111.602 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.2 mt -100.22 106.27 17.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.17 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.9 mp -109.44 113.92 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.742 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.928 ' HB3' HD13 ' A' ' 12' ' ' ILE . 2.1 m -87.58 121.23 29.76 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.192 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.712 ' HA ' ' HB3' ' A' ' 64' ' ' GLN . 1.9 mt -114.6 133.32 61.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.408 0.623 . . . . 0.0 112.577 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.639 ' H ' ' HB2' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -96.6 -174.89 3.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.741 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.64 6.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.41 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.24 4.14 36.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.716 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 58' ' ' ILE . . . 92.53 -133.41 11.72 Favored Glycine 0 N--CA 1.454 -0.128 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.869 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -43.83 102.95 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.887 0.375 . . . . 0.0 110.209 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . 5.5 tp-100 -110.45 -52.56 2.77 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 56' ' ' ILE . 1.8 mm-40 -146.52 144.95 29.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 0.0 111.243 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -135.96 131.78 49.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.67 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.91 126.39 23.43 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.057 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HG2' ' OE1' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -112.69 123.66 50.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.559 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -155.62 126.89 7.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.463 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.931 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -93.33 139.0 31.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.091 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -145.27 159.51 42.91 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.428 0.632 . . . . 0.0 111.979 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.827 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -149.6 132.4 16.01 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.299 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.796 HG22 HD12 ' A' ' 45' ' ' LEU . 2.4 t -93.38 11.58 27.83 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.653 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -107.13 -24.38 11.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 112.426 -2.17 . . . . 0.0 111.317 -177.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 t -98.33 42.02 1.11 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.678 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.2 p -130.67 -51.15 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.464 ' HB2' ' H ' ' A' ' 78' ' ' THR . 2.4 p -98.55 -154.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.669 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 15.3 t -147.09 39.54 0.23 Allowed Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 78' ' ' THR . 48.7 Cg_endo -93.3 177.97 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.137 1.891 . . . . 0.0 112.585 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.21 -111.94 1.15 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.447 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.71 -163.03 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 58.31 16.12 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.7 t -164.71 -96.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.04 22.55 4.52 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.867 0.365 . . . . 0.0 110.991 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.0 178.2 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.655 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.53 86.55 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -136.47 136.45 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.919 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t60 55.8 70.67 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.888 -179.938 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.745 0.307 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 ttt-85 54.74 57.16 5.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.795 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.55 -153.4 24.74 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.4 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.6 m 58.99 89.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.93 40.36 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.962 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 62.9 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.308 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.31 122.67 11.12 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.575 2.183 . . . . 0.0 112.296 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.466 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 6.0 mt-30 -68.3 111.86 9.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.728 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.45 169.58 9.47 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.455 2.104 . . . . 0.0 112.075 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 t -78.16 1.62 20.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -147.78 176.58 10.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.744 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -79.52 148.45 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.909 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' HG13 ' A' ' 12' ' ' ILE . 66.2 m -49.51 -45.73 47.57 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 1.1 pttt -170.77 143.46 2.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.093 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -107.85 147.18 31.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.594 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.571 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -115.72 145.08 21.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.003 0.43 . . . . 0.0 110.692 179.118 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -122.93 111.83 17.1 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.795 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -117.86 128.6 54.99 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.739 ' HB2' ' HA2' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -159.46 162.97 35.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.996 0.903 . . . . 0.0 113.301 -178.233 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.578 HH12 ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -159.6 144.24 11.19 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.761 178.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 10.8 Cg_endo -54.61 112.43 1.01 Allowed 'Trans proline' 0 C--N 1.335 -0.142 0 C-N-CA 122.489 2.126 . . . . 0.0 112.085 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HA ' HH12 ' A' ' 20' ' ' ARG . 6.0 tptt -51.6 -34.28 36.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.223 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -98.29 -44.06 6.71 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.275 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -79.6 127.4 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.398 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.4 p -72.52 115.06 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.932 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.24 -169.32 20.93 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.345 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.35 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.672 0.272 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -64.6 176.36 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.981 0.419 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.795 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -136.79 159.99 40.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.582 179.297 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -141.79 128.52 20.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.44 . . . . 0.0 111.295 -179.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.02 114.44 8.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -93.77 115.58 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 111.823 -179.468 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.67 107.55 33.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.027 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 28.1 Cg_exo -61.07 90.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.312 2.008 . . . . 0.0 112.925 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 43.8 52.9 6.48 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.225 179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 t60 52.63 60.8 3.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -65.86 -22.27 66.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.538 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.617 ' HB3' HD22 ' A' ' 37' ' ' LEU . 3.4 p-10 -170.53 -171.84 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.2 105.46 9.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -97.97 130.19 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -101.37 148.01 25.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.184 0.516 . . . . 0.0 112.259 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 44' ' ' GLY . 18.7 mt -94.28 138.58 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.653 179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.743 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -32.97 -41.67 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.015 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 120.74 114.36 2.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.189 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.872 ' HB3' HG22 ' A' ' 73' ' ' THR . 0.5 OUTLIER -100.63 122.84 43.97 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.704 0.288 . . . . 0.0 110.499 179.683 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.995 ' O ' HG21 ' A' ' 73' ' ' THR . 0.0 OUTLIER -83.76 135.13 43.3 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.95 -178.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 75' ' ' SER . 3.4 Cg_exo -39.15 144.4 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.982 3.121 . . . . 0.0 114.537 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.27 -5.85 68.23 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.055 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.4 138.13 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 2.1 p -97.38 122.44 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.523 ' CE2' HD12 ' A' ' 45' ' ' LEU . 38.2 m-85 -110.75 133.48 53.3 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -97.49 129.12 44.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.018 179.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.739 ' HA2' ' HB2' ' A' ' 19' ' ' TRP . . . -124.12 150.88 17.06 Favored Glycine 0 C--N 1.329 0.158 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.778 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 18' ' ' ARG . 44.4 tt0 -132.62 144.42 50.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.914 0.388 . . . . 0.0 111.482 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD12 ' HG ' ' A' ' 17' ' ' LEU . 1.3 mp -123.06 107.66 12.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.409 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.571 ' HB ' HG22 ' A' ' 16' ' ' ILE . 82.0 mt -114.0 117.71 56.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.228 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.744 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -82.21 138.5 34.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.389 0.614 . . . . 0.0 111.025 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG23 ' HA2' ' A' ' 62' ' ' GLY . 4.2 mt -118.16 132.24 68.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.951 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.699 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -94.69 -176.41 3.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.351 178.657 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -61.41 -29.92 70.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.53 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -103.08 -1.55 28.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 95.22 155.47 31.39 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.49 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 75.3 t60 65.94 126.55 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.699 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 2.9 mm-40 -155.6 -56.96 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.6 tt0 -145.4 143.82 30.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.436 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.88 115.79 19.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.299 178.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m -136.15 121.58 19.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.291 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.17 139.62 43.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.38 135.97 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 4.1 p-10 -95.94 137.47 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 50' ' ' VAL . 29.4 p90 -141.43 165.57 27.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 18.1 p -99.12 166.4 11.26 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.995 HG21 ' O ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -51.54 175.58 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.298 -178.402 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.684 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -98.68 -55.99 2.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.058 -178.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.505 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 5.9 p 54.04 22.37 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.348 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 74' ' ' THR . 3.5 t -157.87 68.23 0.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.097 0.475 . . . . 0.0 110.831 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.58 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 2.8 m -62.26 -178.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.166 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.622 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 12.4 t -91.07 -27.91 0.31 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 78' ' ' THR . 75.4 Cg_endo -80.34 -163.97 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.293 1.995 . . . . 0.0 112.508 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.85 -9.17 7.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.344 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 178.91 6.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 0.0 110.809 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.96 114.93 29.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 24.45 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.826 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 65.28 154.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.138 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 167.1 16.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -63.36 157.48 22.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.728 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.3 148.82 20.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.071 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.91 139.22 30.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.034 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -98.17 87.58 3.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.15 177.73 16.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.487 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -105.14 -81.33 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.632 0.254 . . . . 0.0 110.82 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 56.02 -159.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.74 113.9 8.9 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.08 -18.75 30.16 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.632 2.221 . . . . 0.0 112.411 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -112.09 99.25 45.41 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.93 162.78 34.29 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.528 2.152 . . . . 0.0 112.497 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.99 81.69 7.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.855 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.748 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 6.5 p80 -74.41 165.87 24.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.229 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.736 HG13 ' N ' ' A' ' 13' ' ' SER . 0.6 OUTLIER -88.44 152.47 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.051 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.736 ' N ' HG13 ' A' ' 12' ' ' ILE . 39.0 t -52.32 -45.21 65.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.065 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.798 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 21.4 pttt -174.6 144.53 0.86 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.685 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.16 157.22 17.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.876 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -114.64 147.7 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-O 121.181 0.515 . . . . 0.0 111.181 179.473 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -128.2 110.42 12.4 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.626 176.525 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.776 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 1.5 mtp-105 -122.37 125.63 46.32 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.561 ' CB ' ' HA2' ' A' ' 53' ' ' GLY . 2.0 p90 -162.89 153.3 16.45 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 118.887 -1.125 . . . . 0.0 113.356 -177.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -159.95 162.72 24.0 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.766 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 15.2 Cg_endo -56.75 124.03 15.27 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 C-N-CA 122.656 2.238 . . . . 0.0 112.046 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 54.3 tttt -67.32 -44.03 80.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.883 -178.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -89.75 -36.55 15.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.962 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 3.1 m -85.08 -18.17 35.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.501 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 25' ' ' VAL . 5.7 p 33.62 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.296 0.57 . . . . 0.0 112.102 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . -108.33 -106.8 3.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.901 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 152.87 36.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -74.8 150.94 39.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.252 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.776 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -121.84 140.43 52.39 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -122.23 128.84 51.64 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -141.64 115.39 9.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.674 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.37 118.19 33.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 111.331 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -129.84 112.27 17.44 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 60.2 Cg_exo -52.11 175.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.672 2.248 . . . . 0.0 112.481 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . -43.17 94.86 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 113.18 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 35' ' ' GLY . 1.1 p-80 22.75 72.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.358 0.663 . . . . 0.0 112.613 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.632 HD11 HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -69.23 -30.29 68.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.328 179.353 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 37' ' ' LEU . 3.4 p-10 -174.25 -163.41 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.506 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -90.81 105.82 18.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.019 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -116.73 113.1 22.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -128.69 146.57 50.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.245 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.8 128.52 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.537 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -165.1 1.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 0.0 111.563 -179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.14 25.5 75.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.683 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.953 ' HB3' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -125.2 -178.68 4.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.189 -179.538 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.51 142.04 35.71 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.95 104.37 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.566 2.177 . . . . 0.0 111.977 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.66 -13.95 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.378 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.983 ' HB ' HG23 ' A' ' 74' ' ' THR . 2.2 t -116.52 139.62 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 117.195 0.497 . . . . 0.0 111.441 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' HA ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -76.59 146.29 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.111 0.481 . . . . 0.0 109.964 178.488 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' HE2' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -143.98 101.05 3.67 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.093 -179.949 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 10.4 pt-20 -77.58 126.81 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.463 -0.895 . . . . 0.0 108.962 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 19' ' ' TRP . . . -126.35 152.03 18.17 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.632 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -134.8 141.62 46.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 111.583 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 1.5 mt -121.38 106.21 11.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.663 178.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.667 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.6 mp -116.01 118.34 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.781 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -82.03 133.63 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.573 0.701 . . . . 0.0 111.144 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -119.28 133.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.594 ' HB2' ' CG ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -117.12 -175.45 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.345 . . . . 0.0 110.29 178.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -63.92 -13.63 47.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.473 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -103.15 -4.97 23.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.116 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.47 143.87 0.88 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.511 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 60.48 107.38 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.645 0.26 . . . . 0.0 110.981 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.671 ' HB2' ' O ' ' A' ' 57' ' ' SER . 78.8 mm-40 -129.85 -67.19 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.96 146.67 50.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.99 -178.537 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.424 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.77 126.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.293 179.023 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.15 132.38 41.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.48 117.43 33.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -144.47 126.92 15.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.747 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.8 122.14 42.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.422 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 51' ' ' TYR . 38.2 p90 -122.71 162.86 21.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.309 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 50' ' ' VAL . 7.0 p -128.37 133.45 48.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.9 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.564 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.2 OUTLIER 161.11 97.2 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.593 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.983 HG23 ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -158.84 -163.22 1.2 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.855 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.62 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 0.9 OUTLIER 87.84 93.31 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.774 0.671 . . . . 0.0 111.198 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -171.89 14.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.787 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.433 ' C ' ' HD3' ' A' ' 79' ' ' PRO . 1.5 m -138.47 -114.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.712 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.608 ' N ' ' HD3' ' A' ' 79' ' ' PRO . 8.8 t 35.89 49.59 1.1 Allowed Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 78' ' ' THR . 29.1 Cg_endo -101.57 32.96 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.707 2.271 . . . . 0.0 112.939 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.02 178.48 16.43 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.438 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.5 t -158.58 -69.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.688 0.28 . . . . 0.0 111.243 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -101.9 134.98 44.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.173 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 t 55.67 91.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.197 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -60.34 158.95 10.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.9 170.18 9.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.43 71.37 0.58 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -86.84 24.88 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.07 -12.1 6.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.721 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -87.01 168.18 13.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.97 39.59 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.549 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.39 77.83 0.21 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.849 0.357 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -69.97 -169.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.22 128.36 7.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.22 -89.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.436 2.091 . . . . 0.0 112.244 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 53.22 74.54 0.75 Allowed Pre-proline 0 C--N 1.333 -0.147 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.159 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.4 90.48 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.464 2.109 . . . . 0.0 112.377 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.18 123.22 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.281 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.82 -151.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.602 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.2 tt -67.26 148.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.676 0.274 . . . . 0.0 110.826 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.462 ' N ' HG13 ' A' ' 12' ' ' ILE . 5.7 t -51.24 -48.02 62.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -175.4 149.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.763 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.5 m-85 -102.19 136.64 41.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.37 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.87 122.88 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 111.633 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -108.25 114.73 28.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.879 179.034 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.723 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 2.7 mtt180 -116.93 128.77 55.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.815 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 7.9 p90 -150.35 153.39 35.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.706 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.57 159.03 29.89 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.364 -179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.7 114.05 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.095 1.864 . . . . 0.0 111.745 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -32.13 73.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -38.3 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.39 170.43 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.139 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.88 136.45 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.846 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.98 33.41 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.979 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.66 173.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.051 0.453 . . . . 0.0 111.519 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 67.6 m95 -90.15 -171.47 3.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.723 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -142.35 145.43 33.91 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.474 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -120.4 133.31 55.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.269 0.556 . . . . 0.0 112.139 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.08 112.19 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.98 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 38.8 m -89.35 137.72 32.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.293 0.568 . . . . 0.0 112.474 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -132.81 106.25 12.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.381 178.056 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.95 100.32 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.408 2.072 . . . . 0.0 112.383 -179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.88 -90.17 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.472 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -177.18 79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.744 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' HG ' HD22 ' A' ' 38' ' ' ASN . 0.5 OUTLIER -72.7 -33.22 66.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.597 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -173.4 -165.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.801 179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.05 118.32 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -103.55 113.26 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.576 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 t -121.7 134.0 54.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.296 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 HD11 HD22 ' A' ' 17' ' ' LEU . 6.9 mt -98.02 116.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -121.46 134.09 55.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 25.92 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 51' ' ' TYR . 0.9 OUTLIER -101.35 175.02 5.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 21.8 mtmt -98.23 124.74 46.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 14.5 Cg_exo -69.0 4.69 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.777 2.318 . . . . 0.0 112.365 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 -30.45 6.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.652 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.62 134.23 63.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.22 146.97 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.415 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.406 ' CE1' ' HB3' ' A' ' 45' ' ' LEU . 74.2 m-85 -118.51 107.74 14.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.76 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 18.3 pt-20 -79.7 130.39 35.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.379 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -133.01 153.94 20.94 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.398 -0.906 . . . . 0.0 113.191 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.527 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -133.64 134.01 42.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.639 0.257 . . . . 0.0 110.393 179.675 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.19 106.97 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.89 0.376 . . . . 0.0 110.365 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' HD2' ' A' ' 18' ' ' ARG . 5.2 mp -105.46 115.31 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.815 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.602 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -86.0 119.75 26.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 8.4 mt -109.67 112.29 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.253 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -89.45 -177.24 5.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.572 179.631 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -68.07 -14.86 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.603 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -101.46 0.9 37.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.766 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 112.4 177.34 19.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.284 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -57.92 144.34 39.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.578 0.228 . . . . 0.0 110.596 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.4 2.77 0.23 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.574 -179.59 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.539 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 2.5 tt0 -145.63 129.77 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 111.896 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -134.88 131.28 53.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.012 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -136.15 123.74 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.927 179.762 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG2' HE21 ' A' ' 54' ' ' GLN . 36.8 mtm180 -102.54 135.7 43.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.963 0.411 . . . . 0.0 111.371 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.58 155.06 32.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.23 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -106.73 134.02 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.05 153.54 34.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.141 0.496 . . . . 0.0 112.287 -178.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.97 166.75 26.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.446 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -47.21 29.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.451 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -168.37 48.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.082 0.468 . . . . 0.0 111.2 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.6 t -142.58 -25.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 52.93 -97.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.52 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.554 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -159.15 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.727 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -162.4 -51.91 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.727 ' HD2' ' H ' ' A' ' 78' ' ' THR . 29.8 Cg_endo -63.55 131.97 33.74 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.159 1.906 . . . . 0.0 112.246 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.96 -28.29 31.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.684 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.69 142.74 19.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.989 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.79 54.79 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.686 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.77 65.92 1.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.693 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.65 45.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.041 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 m170 62.56 112.96 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -19.41 62.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.113 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -114.33 141.36 47.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.95 108.63 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.3 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.883 179.969 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.728 0.299 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -137.48 128.36 27.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.31 105.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 t -152.2 135.0 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.732 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.92 169.71 8.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -146.04 124.64 6.46 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 42.5 Cg_exo -57.42 135.4 69.71 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.571 2.18 . . . . 0.0 112.532 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -132.49 101.13 14.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.707 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.71 -47.99 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.558 2.172 . . . . 0.0 112.499 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 m -133.55 175.48 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.774 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -153.4 148.05 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.205 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.715 HG13 ' N ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -70.83 154.08 8.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 179.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.715 ' N ' HG13 ' A' ' 12' ' ' ILE . 58.0 m -52.37 -41.3 62.99 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.2 pttt -172.23 149.04 2.22 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.041 0.448 . . . . 0.0 111.713 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -106.82 134.08 50.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.78 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.633 HG13 HD12 ' A' ' 58' ' ' ILE . 2.8 mm -114.28 120.23 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.154 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -104.24 114.69 29.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.267 179.537 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -116.25 129.55 56.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.542 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -154.37 158.69 40.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 111.493 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -159.54 163.42 23.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.666 -179.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -57.52 114.45 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.982 1.788 . . . . 0.0 111.616 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -50.71 -31.23 15.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.357 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -70.17 -37.36 75.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -176.48 4.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.97 13.11 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.82 -160.24 8.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.647 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 57.81 70.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -84.45 162.57 19.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 25.7 mttp -141.26 133.87 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.876 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 2.2 pt-20 -120.52 132.69 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.11 0.481 . . . . 0.0 111.977 -179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -131.67 111.99 12.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.808 179.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 84.8 m -91.79 132.09 36.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.471 HG13 ' C ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -136.92 104.8 8.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.115 177.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.5 Cg_exo -60.22 105.64 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.447 2.098 . . . . 0.0 112.15 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.36 -94.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.122 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -171.03 109.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.928 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.6 mp -82.74 -34.13 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.692 HD22 ' H ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -178.01 -112.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.053 -179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.692 ' H ' HD22 ' A' ' 38' ' ' ASN . 55.0 m -121.43 105.09 10.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.39 109.01 21.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -120.88 132.11 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.5 mt -98.61 127.72 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.088 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 -166.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.83 29.76 28.16 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.357 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.692 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.7 OUTLIER -93.94 172.04 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.782 -179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -122.93 136.8 27.22 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.81 165.42 18.64 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.645 2.23 . . . . 0.0 112.466 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.4 -33.03 3.49 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.735 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -119.55 116.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.781 0.324 . . . . 0.0 110.905 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 61.9 t -77.77 144.29 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 71' ' ' PHE . 3.2 m-85 -102.36 126.55 49.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.516 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 130.62 52.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.61 158.03 27.97 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.744 HE21 ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -132.46 145.11 50.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.294 179.669 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 107.25 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -106.64 114.83 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.6 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -88.51 125.04 34.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.913 0.387 . . . . 0.0 111.263 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 45.9 mt -102.43 123.35 55.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.536 ' HG3' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -100.23 -175.05 2.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.943 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.83 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.301 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.03 6.9 38.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.76 175.49 18.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.64 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 3.0 p80 -55.99 157.41 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.716 0.293 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.536 HE21 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -161.35 -17.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.409 -179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -114.2 127.75 56.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.178 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 t -134.09 130.68 55.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.415 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.23 121.2 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.744 ' HG2' HE21 ' A' ' 54' ' ' GLN . 2.5 mtt180 -96.87 132.65 42.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.318 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -155.62 156.65 35.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.263 0.554 . . . . 0.0 111.965 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.62 137.81 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 4.3 p90 -150.0 141.69 23.61 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.514 -178.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' HD13 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -149.68 166.77 28.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.336 178.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 45' ' ' LEU . 4.1 t -91.31 127.96 36.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.716 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 73' ' ' THR . 3.9 t 45.41 24.71 0.18 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.951 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t -134.31 -68.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 60.14 178.27 0.09 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.301 -179.904 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.527 ' H ' HG22 ' A' ' 76' ' ' THR . 0.3 OUTLIER -153.31 126.89 8.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.3 p 48.88 88.13 0.12 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.479 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.91 83.24 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.64 2.227 . . . . 0.0 112.221 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.24 -9.26 39.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.421 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t 57.39 57.04 4.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.746 0.308 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 55.07 85.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 t -143.82 140.07 29.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -116.5 -26.9 6.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -90.94 59.91 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -105.13 91.54 3.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -89.1 174.8 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.46 162.36 15.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.939 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HG3' ' H ' ' A' ' 2' ' ' ARG . 2.4 tpt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.546 ' H ' ' HG3' ' A' ' 1' ' ' MET . 17.3 mtp85 -72.93 -156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.51 109.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.456 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.1 p -103.97 -9.63 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.799 0.333 . . . . 0.0 111.094 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -93.59 137.47 32.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.19 87.77 32.84 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.1 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.25 -47.41 6.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.531 2.154 . . . . 0.0 112.402 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 57.13 85.58 0.19 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.173 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.77 101.64 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.541 2.161 . . . . 0.0 112.208 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.33 132.77 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.096 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.7 152.61 43.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.667 HD13 ' HB3' ' A' ' 57' ' ' SER . 4.7 tt -97.31 157.35 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.87 -52.72 22.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.796 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.611 ' HD2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -166.17 144.79 5.75 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.198 0.523 . . . . 0.0 111.754 179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 32' ' ' THR . 4.8 m-85 -102.37 136.87 41.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.873 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.34 129.86 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.853 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -118.11 114.84 23.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.986 179.438 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.58 129.21 50.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.709 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -149.73 162.02 41.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 2.8 ptt180 -158.56 153.43 21.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 18.0 Cg_endo -58.49 109.61 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.967 1.778 . . . . 0.0 111.367 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.518 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 4.1 ttpp -57.36 -35.21 69.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.935 -179.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -70.3 -29.25 65.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -78.22 -161.02 0.23 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.999 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 p -113.35 -7.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.349 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' HH11 ' A' ' 20' ' ' ARG . . . 179.67 -128.58 1.24 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.952 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.435 HH11 ' HB3' ' A' ' 27' ' ' ARG . 0.0 OUTLIER 64.6 75.24 0.38 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.918 0.389 . . . . 0.0 111.06 -179.757 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 93.5 m95 -83.04 175.8 9.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.145 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 13.7 mttm -154.25 136.88 15.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.767 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -120.16 135.77 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.052 0.453 . . . . 0.0 112.131 -178.762 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.23 114.86 8.94 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.13 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 25.7 m -96.62 137.78 35.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.149 0.5 . . . . 0.0 112.222 -179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -135.39 110.75 10.6 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.456 179.311 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.652 ' HB2' HD12 ' A' ' 37' ' ' LEU . 73.7 Cg_exo -50.15 93.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.766 2.31 . . . . 0.0 113.169 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.64 28.09 3.42 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.24 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.5 69.79 0.67 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.988 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -71.89 -7.21 47.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.164 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.3 p-10 -164.02 -174.6 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -80.47 105.53 11.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.359 . . . . 0.0 110.75 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -114.82 107.42 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.778 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -114.59 146.58 40.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.6 mm -91.62 124.38 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -138.56 161.77 36.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.74 21.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.313 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 10.6 mt -74.59 -161.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.505 0.193 . . . . 0.0 110.55 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -143.15 133.81 12.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.643 0.258 . . . . 0.0 111.397 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 75' ' ' SER . 35.8 Cg_exo -57.1 155.45 28.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.448 2.099 . . . . 0.0 111.796 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.18 -21.48 10.06 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.921 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.38 117.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.772 0.32 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 62.5 t -81.26 144.54 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.428 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 53.4 m-85 -124.62 103.9 8.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' A' ' 22' ' ' LYS . 12.9 pt-20 -79.67 130.18 35.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.903 0.383 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.53 161.34 24.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.972 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.4 mt-30 -132.62 139.17 47.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 110.432 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -99.91 107.11 19.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.2 mp -111.03 115.17 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.486 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.667 ' HB3' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -92.2 117.7 30.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.164 179.337 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.611 ' HB ' ' HD2' ' A' ' 14' ' ' LYS . 43.2 mt -101.73 116.13 44.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.812 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.458 HE22 HE21 ' A' ' 60' ' ' GLN . 1.2 mm100 -90.0 -175.07 4.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.32 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.458 HE21 HE22 ' A' ' 59' ' ' GLN . 9.6 pt20 -60.44 -23.05 64.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.06 14.15 32.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.645 0.259 . . . . 0.0 111.48 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.01 -174.56 23.36 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.803 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -52.34 161.99 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.724 0.297 . . . . 0.0 111.238 -179.925 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -169.27 -20.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.587 -179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -123.72 128.42 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.53 -179.278 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.89 133.24 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.814 0.34 . . . . 0.0 111.799 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 3.1 m -137.8 123.86 20.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.71 134.45 40.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.731 0.3 . . . . 0.0 111.636 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.93 159.08 38.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.507 179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -109.51 133.7 52.78 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 51' ' ' TYR . 1.9 p90 -151.82 145.98 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -148.51 148.12 29.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 178.524 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -70.16 144.64 51.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.425 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 m 64.51 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.093 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 47' ' ' PRO . 8.5 t -72.71 -174.16 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.047 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.77 176.53 12.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.053 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.85 -28.3 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.152 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.7 135.56 9.89 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.212 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.4 102.42 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.591 2.194 . . . . 0.0 112.275 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.19 -154.0 6.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.569 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -107.05 10.78 30.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -93.38 23.39 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.802 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.3 m -105.51 -172.65 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -84.68 65.05 8.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -66.6 166.36 12.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.08 79.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.954 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -102.41 61.28 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.29 154.07 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.987 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.818 0.342 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -114.04 98.21 6.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.23 -174.09 14.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 -79.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.673 0.273 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 52.78 74.45 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -101.67 130.81 23.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 72.6 Cg_endo -88.54 -178.06 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.847 2.365 . . . . 0.0 112.402 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -81.04 128.2 71.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.22 -38.11 57.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.495 2.13 . . . . 0.0 112.175 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 -176.16 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.807 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -118.93 142.18 48.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 57' ' ' SER . 1.6 tt -79.72 155.25 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.742 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.48 ' H ' HG13 ' A' ' 12' ' ' ILE . 3.2 m -49.91 -53.36 26.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.764 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.821 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -158.89 144.91 16.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.1 m-85 -104.7 137.72 42.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.202 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -114.25 142.69 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.916 0.389 . . . . 0.0 110.81 179.827 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.48 115.83 17.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.12 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 3.4 mtp180 -118.99 129.77 55.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.646 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -152.6 158.82 43.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.085 0.469 . . . . 0.0 111.991 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -159.36 157.07 26.78 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.291 179.792 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 19.1 Cg_endo -58.78 113.41 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.318 2.012 . . . . 0.0 112.083 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.444 -179.476 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -95.02 -41.2 9.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -87.15 161.82 17.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.22 148.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' C ' ' HG3' ' A' ' 27' ' ' ARG . . . 170.39 -140.6 6.09 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.517 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -139.88 166.77 23.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 110.971 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 74.0 m95 -75.65 174.61 9.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 18.2 mttt -145.31 141.16 28.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.679 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -119.98 134.92 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.18 0.514 . . . . 0.0 111.92 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.59 128.3 21.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.825 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.1 m -112.39 135.67 52.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.57 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -137.21 106.76 8.67 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.153 178.418 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.821 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 31.8 Cg_exo -58.84 111.6 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 112.477 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.83 -104.95 0.51 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.368 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.85 93.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.72 -25.75 32.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.979 179.9 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' H ' HD22 ' A' ' 37' ' ' LEU . 1.2 p-10 178.74 -168.49 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.456 179.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -76.49 105.82 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -108.8 112.84 25.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.725 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -121.57 132.62 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.267 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.8 mt -90.21 126.08 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.57 165.92 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.648 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.44 -16.36 4.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.243 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -69.63 160.16 32.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.716 0.293 . . . . 0.0 110.368 -179.998 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HG2' ' HD2' ' A' ' 47' ' ' PRO . 3.3 ttmt -104.77 133.44 20.16 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.047 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.593 ' HD2' ' HG2' ' A' ' 46' ' ' LYS . 55.2 Cg_exo -52.0 133.03 45.06 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.524 2.149 . . . . 0.0 112.18 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.12 -22.1 40.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.12 120.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.311 . . . . 0.0 110.953 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.64 ' HA ' HG22 ' A' ' 72' ' ' THR . 14.0 t -85.78 140.63 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -123.08 161.51 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 0.3 OUTLIER -129.82 132.2 46.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.926 179.408 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.73 155.42 26.49 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.413 -179.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.91 131.64 41.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 5.9 tp -99.7 106.48 18.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.891 0.376 . . . . 0.0 111.011 -179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 16' ' ' ILE . 3.8 mp -92.07 138.44 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.955 179.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 12' ' ' ILE . 1.4 m -110.4 114.98 28.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.313 0.578 . . . . 0.0 111.011 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 5.6 mt -95.5 114.13 31.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.591 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' NE2' ' HG2' ' A' ' 60' ' ' GLN . 0.9 OUTLIER -97.03 -176.26 3.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.327 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.554 ' HG2' ' NE2' ' A' ' 59' ' ' GLN . 11.4 pt20 -62.12 -21.94 65.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.57 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -102.83 12.08 36.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.725 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 100.8 173.36 29.23 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.434 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 7.0 p80 -53.55 147.93 10.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.483 0.183 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 2.0 pt20 -165.33 -6.64 0.03 OUTLIER 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 3.4 tt0 -132.65 112.99 12.49 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.891 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.2 p -136.98 140.99 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.3 m -132.24 122.12 24.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.715 179.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HE ' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.29 141.49 30.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 111.304 -179.373 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.14 158.31 37.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.49 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.22 129.46 56.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.707 178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -152.06 163.76 38.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 50' ' ' VAL . 11.4 p -141.22 167.09 23.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.751 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -42.87 -60.07 1.74 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.717 0.294 . . . . 0.0 111.292 -179.885 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.587 ' H ' HG23 ' A' ' 73' ' ' THR . 1.0 OUTLIER -177.06 85.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 179.637 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -160.95 -50.23 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 t -126.64 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.394 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.24 153.91 0.08 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.257 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.09 144.37 3.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.3 86.94 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.561 2.174 . . . . 0.0 112.439 -179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.43 -125.85 5.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.474 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -130.48 112.68 13.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.783 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.39 -74.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.32 -8.0 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.36 156.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.43 179.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 103.6 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.982 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -147.37 154.53 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.18 153.48 37.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -126.86 108.31 10.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.928 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' H3 ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -122.26 146.77 46.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.81 140.53 4.35 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.641 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -135.22 26.75 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.897 0.379 . . . . 0.0 110.763 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -75.89 -169.72 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -157.68 102.87 1.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 4.31 3.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.678 2.252 . . . . 0.0 112.598 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -104.46 113.65 64.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.953 -179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' GLN . 3.8 Cg_exo -80.05 -24.94 5.36 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.899 2.399 . . . . 0.0 112.139 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.669 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -148.67 88.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 -179.905 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.5 m80 59.97 -86.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.201 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.483 HD12 ' HG3' ' A' ' 59' ' ' GLN . 1.6 tt -77.81 150.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.984 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -49.21 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.611 179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.5 OUTLIER -166.13 146.07 6.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -102.04 141.99 34.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.38 179.971 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.632 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -115.16 142.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.487 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.49 115.46 19.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.416 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -120.85 137.95 54.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.674 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -156.73 159.51 38.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.43 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.597 ' HB3' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -158.45 157.45 28.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.521 -179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.72 110.86 0.73 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.269 1.979 . . . . 0.0 112.014 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.42 67.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.66 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.8 ' HB2' HG23 ' A' ' 49' ' ' VAL . 19.4 m-20 -100.3 -36.05 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.404 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.16 -167.78 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.001 0.429 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.25 154.39 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.022 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.43 23.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.443 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 60.87 175.17 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.029 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.597 ' HA ' ' HB3' ' A' ' 20' ' ' ARG . 68.0 m95 -85.61 -172.33 4.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.4 mttt -148.3 154.76 40.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.242 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -131.17 138.27 49.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 112.092 -179.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.52 111.82 6.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 92.5 m -98.4 131.19 44.88 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -134.69 106.05 10.77 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.268 178.124 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 52.0 Cg_exo -56.23 98.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.688 2.258 . . . . 0.0 112.895 -179.019 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 10' ' ' SER . . . 51.5 22.88 8.43 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.163 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.481 ' HA ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 57.13 98.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 179.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.705 HD13 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -82.66 -18.37 41.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -169.09 -163.19 0.4 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.762 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.17 105.48 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.608 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.21 106.75 16.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.35 144.05 45.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.084 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mp -102.86 129.33 54.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.213 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 141.77 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.09 56.08 0.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.654 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 73' ' ' THR . 3.0 mt -137.18 78.02 1.67 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.4 ttpt -34.75 130.41 0.47 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.466 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 45.2 Cg_exo -56.89 175.79 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.635 2.223 . . . . 0.0 112.661 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.05 -35.53 3.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.265 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 23' ' ' ASN . 2.8 p -115.04 127.15 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.881 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.67 142.08 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 7.8 m-85 -108.8 136.79 47.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.893 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -112.26 130.1 56.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.119 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.67 156.49 26.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.975 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.6 146.0 51.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 18.8 tp -100.23 107.0 18.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.92 0.391 . . . . 0.0 110.859 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 16' ' ' ILE . 1.7 mp -95.12 122.06 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.491 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.4 OUTLIER -94.83 114.91 26.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.424 0.631 . . . . 0.0 109.926 179.723 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 27.6 mt -106.7 111.16 34.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.953 -179.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.483 ' HG3' HD12 ' A' ' 12' ' ' ILE . 1.7 mt-30 -90.2 -176.17 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.887 178.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.75 -15.94 45.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.747 0.308 . . . . 0.0 110.844 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -103.12 0.62 32.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.32 176.39 19.4 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.26 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 15.9 p80 -55.36 156.31 4.49 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.548 0.174 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.9 1.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 3.7 tt0 -145.53 113.73 6.59 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.2 p -136.75 139.58 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.497 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 m -137.1 124.73 22.3 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.448 179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -85.01 141.01 30.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.88 0.371 . . . . 0.0 111.779 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -155.86 156.63 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.731 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -114.96 131.64 56.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.873 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -152.04 162.55 40.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.284 0.564 . . . . 0.0 112.486 -178.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.24 154.8 41.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.202 179.222 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 45' ' ' LEU . 14.1 t -75.21 -24.77 57.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.715 0.293 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.517 ' OG1' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -161.51 63.6 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 t -160.95 -132.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.023 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 t -64.58 -170.68 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 111.645 -179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.02 156.98 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.341 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.8 138.75 12.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.876 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.93 66.1 8.86 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.457 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -128.92 12.07 6.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.98 -172.86 4.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.699 0.285 . . . . 0.0 110.855 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 55.04 78.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.22 173.95 6.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.805 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -69.53 -34.29 74.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.022 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -162.55 127.15 3.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.08 -160.34 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.101 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -95.99 -7.18 37.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.125 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.79 -5.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.033 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.339 -0.838 . . . . 0.0 111.059 179.871 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.863 0.363 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttm105 -118.44 26.55 9.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.4 -54.85 0.4 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.577 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.0 t -61.26 138.26 58.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 111.144 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -79.77 130.97 35.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.29 68.53 3.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.1 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.11 6.69 4.48 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.542 2.161 . . . . 0.0 112.336 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 64.86 138.66 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.01 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.25 7.47 2.95 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.457 2.105 . . . . 0.0 112.553 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 m -140.24 -79.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -163.01 165.6 24.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.727 HD12 ' HG3' ' A' ' 59' ' ' GLN . 0.2 OUTLIER -72.98 147.48 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.042 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.71 ' N ' HG13 ' A' ' 12' ' ' ILE . 14.8 m -52.13 -45.99 65.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.651 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.83 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -158.78 144.65 16.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.042 0.448 . . . . 0.0 111.416 179.512 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -112.89 142.97 44.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 179.682 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -113.89 138.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.028 0.442 . . . . 0.0 111.221 -179.587 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -122.03 114.86 21.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.283 179.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.35 129.98 51.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.149 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -158.52 158.44 34.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.402 0.62 . . . . 0.0 112.526 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.586 ' NH1' HG23 ' A' ' 25' ' ' VAL . 1.9 ptt180 -159.73 162.27 25.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.665 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 31.3 Cg_exo -58.82 109.62 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.929 1.753 . . . . 0.0 111.621 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -65.78 -22.62 66.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.968 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.0 -17.98 31.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.591 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -158.48 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG23 ' NH1' ' A' ' 20' ' ' ARG . 14.4 p -166.66 139.03 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.75 -60.06 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.574 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ptt-85 -165.5 157.17 14.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.382 . . . . 0.0 111.076 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.53 ' CE2' ' HD3' ' A' ' 20' ' ' ARG . 59.0 m95 -92.36 172.73 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.737 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 14.2 mttp -132.51 128.2 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.83 130.41 54.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.319 0.58 . . . . 0.0 112.303 -178.241 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.08 111.79 8.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.872 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.9 m -93.91 130.87 39.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' CD2' ' A' ' 40' ' ' TYR . 4.4 mp -136.68 107.65 9.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.66 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 87.0 Cg_exo -45.89 91.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.167 2.578 . . . . 0.0 113.249 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 39.39 42.46 1.84 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.227 -0.442 . . . . 0.0 113.506 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 54.34 47.84 22.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.588 HD13 ' H ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -70.95 -24.27 62.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.731 -179.544 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.588 ' H ' HD13 ' A' ' 37' ' ' LEU . 1.7 p-10 -133.77 168.93 17.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -78.94 105.88 10.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.718 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.605 ' CD2' HG21 ' A' ' 33' ' ' ILE . 8.8 p90 -121.34 130.7 53.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.755 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.8 t -102.02 145.02 29.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.241 -179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.57 137.37 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.437 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 123.88 17.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.825 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.29 146.65 28.85 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.63 -179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 71' ' ' PHE . 11.3 mt -103.75 173.02 6.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 12.6 ttpp -94.98 125.28 51.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 34.2 Cg_exo -59.57 111.77 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.638 2.225 . . . . 0.0 112.236 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.84 -5.58 8.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.657 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.87 135.22 58.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 10.8 t -81.24 137.05 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.75 179.581 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.86 97.04 4.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.2 pt-20 -87.38 132.08 34.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.091 0.472 . . . . 0.0 110.519 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.67 154.0 24.94 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.69 134.81 50.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.843 0.354 . . . . 0.0 110.392 179.811 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' CD1' HD12 ' A' ' 17' ' ' LEU . 13.2 tp -99.56 107.67 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.578 ' CG1' ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -102.42 115.36 44.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 0.0 111.547 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -81.41 113.73 19.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.714 HG23 ' H ' ' A' ' 63' ' ' HIS . 30.4 mt -105.64 126.39 60.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.601 -179.386 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.727 ' HG3' HD12 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -112.5 -174.98 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.419 179.8 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.27 -7.48 2.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.332 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' HB2' HE22 ' A' ' 64' ' ' GLN . 55.4 m-85 -97.97 -5.25 34.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.81 106.54 0.04 OUTLIER Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.374 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.714 ' H ' HG23 ' A' ' 58' ' ' ILE . 44.8 m80 61.6 120.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.419 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.603 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -157.5 -20.33 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.874 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -145.94 119.49 9.11 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.865 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.578 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -137.32 132.88 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.008 0.432 . . . . 0.0 112.06 179.157 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.6 m -137.5 128.69 27.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.727 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 2.0 mtm180 -96.3 148.03 23.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.181 0.515 . . . . 0.0 111.136 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -156.43 158.84 38.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.237 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -113.58 127.27 56.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.023 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 45' ' ' LEU . 1.4 p90 -148.29 161.3 41.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.089 0.471 . . . . 0.0 112.121 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -147.21 166.84 25.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.009 178.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 74' ' ' THR . 0.3 OUTLIER -50.96 -54.14 26.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.209 179.926 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.502 ' H ' HG23 ' A' ' 73' ' ' THR . 1.1 t -167.29 75.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.0 -26.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 77' ' ' SER . 0.2 OUTLIER 55.8 -169.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.29 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -141.98 156.73 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.044 -179.992 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.499 ' H ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -111.07 -53.66 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.572 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 78' ' ' THR . 94.6 Cg_endo -85.49 163.26 10.99 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.361 2.041 . . . . 0.0 112.582 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.6 -164.08 33.38 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.614 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.8 p -70.31 -4.74 23.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -60.46 103.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -79.36 -168.81 1.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.798 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.24 77.39 7.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -76.11 145.5 39.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.791 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.46 173.19 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -103.39 3.46 35.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -67.85 175.64 2.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.125 -0.941 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpp . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.767 0.318 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 2' ' ' ARG . 7.0 mmt180 -123.7 -2.23 8.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.27 178.09 47.71 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.4 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -135.77 85.89 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.769 0.319 . . . . 0.0 110.822 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.9 -43.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.04 137.49 87.88 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.178 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.11 178.98 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.554 2.169 . . . . 0.0 112.313 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -112.84 93.09 22.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.71 -20.85 70.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.654 2.236 . . . . 0.0 112.034 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.7 p -147.36 137.72 23.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.604 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -84.15 147.33 27.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.239 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.747 HD11 ' HG2' ' A' ' 59' ' ' GLN . 0.5 OUTLIER -67.62 144.02 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.3 179.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.53 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -49.71 -57.72 6.71 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.025 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 144.33 18.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.897 178.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.7 m-85 -108.93 136.6 48.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG12 HG23 ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.37 129.58 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.245 0.545 . . . . 0.0 111.081 -179.729 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 114.88 28.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.053 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -124.03 129.47 50.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.761 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -151.01 160.61 43.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.468 . . . . 0.0 111.666 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 21' ' ' PRO . 6.2 ptt180 -159.41 161.38 27.41 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.208 179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 20' ' ' ARG . 14.0 Cg_endo -57.95 110.39 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.186 1.924 . . . . 0.0 111.796 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -62.77 -48.06 80.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.724 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.75 -38.91 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.8 -179.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.03 -179.52 7.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.498 . . . . 0.0 111.85 -179.281 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.72 143.4 13.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.772 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -154.83 18.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.146 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 27' ' ' ARG . 9.8 mtt180 -135.74 162.88 31.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.381 . . . . 0.0 111.074 -179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -66.86 157.19 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.772 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.8 mmtt -132.14 136.11 46.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HH21 ' A' ' 18' ' ' ARG . 0.2 OUTLIER -119.87 127.21 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.092 0.473 . . . . 0.0 111.935 -178.754 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.44 111.68 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.142 179.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -91.5 135.21 34.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.098 0.475 . . . . 0.0 111.927 -179.263 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.97 107.79 32.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.307 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.69 88.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.793 2.329 . . . . 0.0 113.061 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 46.74 30.66 4.91 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.118 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 53.54 72.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 0.0 111.19 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.94 -31.89 71.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -146.18 -165.34 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 p -77.69 106.14 9.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.51 102.29 7.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 t -127.95 143.12 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.3 mm -81.68 116.92 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 134.76 37.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.917 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.81 17.39 1.88 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.312 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' HG22 ' A' ' 73' ' ' THR . 11.9 mt -76.05 -143.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.521 0.2 . . . . 0.0 110.75 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -146.94 122.81 5.48 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 120.647 0.26 . . . . 0.0 110.973 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.523 ' HB3' HG22 ' A' ' 74' ' ' THR . 39.2 Cg_endo -66.79 91.16 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.423 2.082 . . . . 0.0 111.851 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.64 -23.79 0.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.398 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -117.72 113.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.103 179.414 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.27 130.42 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 0.0 111.348 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 45' ' ' LEU . 48.8 m-85 -105.57 107.14 17.98 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.428 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 130.33 34.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.88 159.65 28.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.131 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 146.59 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -102.05 106.43 17.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.201 -179.869 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.3 mp -92.48 126.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.148 179.309 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.56 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -90.17 135.53 33.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.225 0.536 . . . . 0.0 110.194 179.648 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.2 mt -115.02 109.11 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.563 -179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.747 ' HG2' HD11 ' A' ' 12' ' ' ILE . 7.1 mm100 -101.12 -175.1 2.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.293 178.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -61.11 -14.5 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.742 0.305 . . . . 0.0 110.794 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.669 ' HB2' HE22 ' A' ' 64' ' ' GLN . 42.7 m-85 -103.21 -5.25 23.34 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.975 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . 113.21 -153.71 17.39 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.854 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.47 ' C ' ' HG2' ' A' ' 64' ' ' GLN . 2.6 m-70 -62.28 141.23 58.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 122.862 -0.199 . . . . 0.0 110.778 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.669 HE22 ' HB2' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -145.22 -59.51 0.35 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 2.5 tt0 -100.49 114.2 27.61 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.8 p -136.12 132.1 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 0.0 112.081 178.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -137.29 125.18 22.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 142.32 30.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -156.1 159.31 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.436 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -109.42 135.46 50.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CE2' HD11 ' A' ' 45' ' ' LEU . 4.8 p90 -151.61 141.25 21.76 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.326 -178.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 76' ' ' THR . 0.2 OUTLIER -151.59 167.12 29.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.072 179.255 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 45' ' ' LEU . 1.5 t -86.33 77.82 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.178 178.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 47' ' ' PRO . 0.4 OUTLIER 69.02 157.98 0.15 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.892 -179.237 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.58 67.12 0.65 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.417 HG21 ' OG1' ' A' ' 72' ' ' THR . 1.2 m -170.69 149.71 3.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.964 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t 59.28 -170.62 0.13 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.24 164.06 43.5 Favored Pre-proline 0 N--CA 1.452 -0.375 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.382 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -28.55 114.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.595 2.863 . . . . 0.0 113.607 179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.41 81.14 0.27 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.646 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -88.78 133.49 34.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 110.755 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -2.12 25.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.27 -175.53 3.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 110.22 16.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.69 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -149.77 29.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -97.73 -17.82 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.902 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.96 23.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.58 -167.57 1.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.023 -179.924 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.905 0.383 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -139.86 49.48 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.822 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.99 178.71 36.11 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.515 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 t -111.51 98.46 7.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.825 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -126.05 -82.88 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.73 92.64 44.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.248 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.05 -165.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.784 2.323 . . . . 0.0 112.459 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 11' ' ' HIS . 14.4 pt20 -114.25 147.0 36.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.19 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 11' ' ' HIS . 90.6 Cg_endo -80.62 62.03 8.41 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.723 2.282 . . . . 0.0 112.58 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 m 65.21 -2.73 0.72 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.306 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 94.7 m-70 -147.03 172.54 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.578 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 57' ' ' SER . 0.8 OUTLIER -101.04 157.37 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -59.47 -44.33 93.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.984 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.05 144.62 0.76 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.801 179.471 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' THR . 12.5 m-85 -105.62 136.82 44.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.835 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.75 127.71 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 178.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.667 ' HG ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -116.44 116.52 27.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -118.82 128.78 54.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.741 -179.732 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.692 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 2.7 p90 -152.2 142.7 22.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.482 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -147.9 153.62 42.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.662 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 67.6 Cg_exo -57.13 126.71 23.0 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.586 2.191 . . . . 0.0 113.05 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.43 -33.43 19.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.784 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 49' ' ' VAL . 51.7 t30 -99.17 -43.92 6.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -83.92 -15.72 46.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.686 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 24' ' ' SER . 0.9 OUTLIER 55.18 170.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.763 179.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 -138.54 7.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.646 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.0 ttm105 -110.9 155.12 23.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.091 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.453 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 79.0 m95 -77.78 175.27 10.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.051 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -139.26 135.65 34.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.401 179.31 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 4.2 pt-20 -120.1 131.62 55.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.987 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.75 128.05 32.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.844 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.4 m -102.1 132.1 48.18 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -139.42 106.7 7.15 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.752 178.965 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' HD21 ' A' ' 37' ' ' LEU . 77.7 Cg_endo -82.31 102.45 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.322 2.015 . . . . 0.0 113.549 -178.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 8.85 87.61 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.51 178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.75 88.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.824 0.345 . . . . 0.0 110.706 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -66.32 -22.06 66.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.41 -172.91 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.762 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.43 106.55 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.724 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -108.32 109.41 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.093 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.27 126.26 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.748 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 mt -81.87 118.52 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.178 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.12 76.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' C ' HD13 ' A' ' 45' ' ' LEU . . . -136.01 22.31 3.45 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.628 179.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.882 ' HB2' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -98.03 -157.5 0.6 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.86 155.87 14.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.796 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HB3' ' OG1' ' A' ' 74' ' ' THR . 12.3 Cg_endo -55.99 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.723 2.282 . . . . 0.0 112.64 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.56 6.66 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.357 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG11 ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER -120.43 137.08 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.559 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.071 HG23 HG22 ' A' ' 72' ' ' THR . 1.5 p -114.48 148.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.747 177.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 21' ' ' PRO . 19.4 m-85 -114.49 143.56 44.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 5.0 tt0 -79.51 128.63 33.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.45 133.65 9.33 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.517 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' HD11 ' A' ' 56' ' ' ILE . 12.0 tt0 -134.15 116.86 15.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.634 0.254 . . . . 0.0 110.811 179.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD22 ' HG ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -99.64 107.75 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 179.282 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.653 HG23 HG22 ' A' ' 66' ' ' VAL . 4.3 mp -111.44 114.59 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.602 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -84.02 138.36 33.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.134 179.144 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.595 ' HB ' ' HG2' ' A' ' 14' ' ' LYS . 2.6 mt -115.19 108.49 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.867 -179.525 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 4.7 tp60 -86.49 -175.86 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.708 179.39 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.52 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 6.6 mm100 -61.27 -20.51 62.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.58 -179.548 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.72 16.01 27.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.515 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.84 -108.56 3.08 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -51.77 111.48 0.61 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.805 ' HB2' ' HB2' ' A' ' 59' ' ' GLN . 4.1 tp-100 -120.97 -67.72 0.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HB3' ' OG ' ' A' ' 57' ' ' SER . 4.2 tt0 -139.51 145.43 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.653 HG22 HG23 ' A' ' 56' ' ' ILE . 96.8 t -135.04 133.96 53.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 m -136.76 134.46 37.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.223 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.0 122.62 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 -179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.92 133.95 11.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.217 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.47 137.65 38.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -152.06 158.71 43.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.071 HG22 HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -143.59 166.82 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.649 177.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.882 HG22 ' HB2' ' A' ' 45' ' ' LEU . 2.7 t -69.22 -42.52 75.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.741 0.305 . . . . 0.0 111.216 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.814 HG23 HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -134.44 -172.06 2.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 66.9 170.33 0.25 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.3 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.34 134.62 48.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -151.01 -28.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.77 103.68 5.82 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.42 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.16 -170.01 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.677 2.251 . . . . 0.0 112.358 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.41 65.97 2.72 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.469 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 m -114.42 -10.7 12.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.785 0.326 . . . . 0.0 111.029 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.15 -166.22 1.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.983 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -114.46 144.41 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.036 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -162.17 -43.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.771 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.51 160.37 36.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.745 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 79.42 8.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 -173.44 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -98.7 -172.1 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.909 179.942 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.654 0.264 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -121.12 -67.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.44 65.76 0.18 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.59 101.28 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.317 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -99.21 -71.57 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.5 91.17 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.959 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.74 148.61 35.84 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.48 2.12 . . . . 0.0 112.317 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 57.21 67.41 2.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.95 -166.16 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.659 2.239 . . . . 0.0 112.257 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -87.59 -45.65 10.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 179.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.57 -153.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.67 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.662 HG21 ' CE1' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -66.86 155.5 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.343 179.524 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.455 ' H ' HG13 ' A' ' 12' ' ' ILE . 2.2 m -56.57 -52.81 63.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.034 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.607 ' HB2' HG23 ' A' ' 32' ' ' THR . 0.1 OUTLIER -176.66 145.76 0.55 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.569 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.758 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 3.3 m-30 -101.66 141.09 35.05 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.102 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 55' ' ' LEU . 21.2 mm -114.75 132.74 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 111.573 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -121.24 114.22 21.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.237 178.564 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 4.6 mtp180 -109.99 129.17 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.682 -179.411 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.65 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 3.1 p90 -142.4 140.18 31.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.25 0.548 . . . . 0.0 111.699 179.673 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HB2' ' HA ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.92 144.84 17.13 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.915 -179.803 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 51.2 Cg_exo -56.94 117.73 4.47 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.252 1.968 . . . . 0.0 112.327 -179.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 8.5 mmmt -58.58 -17.86 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.228 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -86.74 -18.57 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.141 -179.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.31 -166.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.949 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.18 -26.29 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.057 179.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 175.92 -128.57 1.39 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.423 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.0 63.05 1.87 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.03 0.443 . . . . 0.0 110.833 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.561 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . 74.6 m95 -63.71 -177.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.061 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 8.2 mmtp -131.94 152.3 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.425 179.197 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.23 133.77 55.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.15 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.446 178.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 14' ' ' LYS . 51.6 m -106.51 126.45 52.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.309 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -140.16 105.24 6.66 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.811 178.087 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.54 107.45 2.01 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.167 1.911 . . . . 0.0 112.658 -179.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.09 116.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.401 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.26 102.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.084 0.468 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.23 -33.12 33.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.68 -179.773 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -179.32 -159.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.308 179.9 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 m -77.3 105.37 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 0.0 110.383 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -94.6 114.41 26.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -98.71 147.65 24.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.036 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 43' ' ' LYS . 3.6 mt -99.57 115.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB2' ' H ' ' A' ' 44' ' ' GLY . 3.8 mmpt? 18.4 -93.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.089 0.868 . . . . 0.0 112.584 179.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 43' ' ' LYS . . . 178.84 105.5 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.387 -179.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -73.49 -175.55 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.638 0.256 . . . . 0.0 110.886 -179.808 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 160.96 33.69 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.086 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG3' HG21 ' A' ' 74' ' ' THR . 47.6 Cg_exo -56.07 149.92 50.59 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.684 2.256 . . . . 0.0 112.881 -179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.62 -2.18 59.48 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.052 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.08 112.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.701 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.3 t -91.56 148.05 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 179.026 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.445 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 53.3 m-85 -139.68 107.47 5.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.926 178.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 1.4 tp10 -87.92 128.85 35.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -117.22 147.59 18.84 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.545 -178.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.447 ' HB3' HD11 ' A' ' 56' ' ' ILE . 1.1 mt-30 -133.52 115.75 15.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.202 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 17' ' ' LEU . 32.7 tp -99.19 107.36 19.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.76 -179.565 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.3 mp -112.18 115.25 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.582 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 64' ' ' GLN . 7.9 m -82.14 133.4 35.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.626 HG23 ' HA2' ' A' ' 62' ' ' GLY . 2.8 mp -121.67 133.14 69.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.334 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 3.8 tt0 -110.79 -175.14 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.507 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -61.08 -17.7 53.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.1 -5.71 23.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 110.68 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' HG23 ' A' ' 58' ' ' ILE . . . 77.47 153.16 5.68 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.999 178.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.3 t60 58.37 97.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.619 0.247 . . . . 0.0 110.898 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 1.3 mp0 -122.77 -60.72 1.51 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 tt0 -135.54 145.32 46.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.913 -178.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.7 t -134.35 114.48 18.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.614 178.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.9 m -133.37 127.18 32.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -104.06 132.09 50.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -155.58 130.81 9.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.618 -179.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.45 149.81 20.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.82 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -150.8 148.18 28.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.513 0.673 . . . . 0.0 112.671 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 50' ' ' VAL . 1.7 p -149.04 146.17 27.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.516 179.314 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.958 HG23 HG23 ' A' ' 74' ' ' THR . 5.9 t -75.55 -40.66 56.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.446 -179.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.958 HG23 HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -131.88 -24.85 2.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.255 -179.886 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -171.87 1.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.051 -179.824 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.98 130.5 18.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.115 -179.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.6 t -157.37 26.26 0.3 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.59 86.29 18.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.993 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -76.3 5.78 4.39 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.741 2.294 . . . . 0.0 112.648 -179.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.82 -172.96 45.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -65.17 -39.3 92.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.726 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 82' ' ' ARG . 10.4 mtt85 -146.38 165.16 30.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.979 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.97 138.09 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.652 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -141.33 115.3 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -115.1 -52.14 2.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.644 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -153.63 -17.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.624 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.445 ' HB3' ' H ' ' A' ' 88' ' ' HIS . 1.8 t-160 60.34 -87.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.25 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.445 ' H ' ' HB3' ' A' ' 87' ' ' HIS . 0.5 OUTLIER 63.67 169.01 0.16 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.924 0.392 . . . . 0.0 111.04 -179.773 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.963 -179.763 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.721 0.295 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 2' ' ' ARG . 2.8 ttp180 58.46 -164.57 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.032 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 159.36 74.86 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.494 -179.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.5 p -76.09 -179.26 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.1 48.11 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.84 97.33 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.213 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 135.21 28.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.492 2.128 . . . . 0.0 112.305 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.47 131.78 23.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.99 80.74 2.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.474 2.116 . . . . 0.0 112.246 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.509 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -64.47 -25.4 67.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.732 179.881 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 59.34 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG22 ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER -101.59 157.44 4.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.955 0.407 . . . . 0.0 111.306 -179.989 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.6 t -82.16 -31.68 30.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.837 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 4.0 pttt -175.86 143.92 0.6 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.973 179.317 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HB2' HG13 ' A' ' 33' ' ' ILE . 34.1 m-85 -108.04 143.14 37.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.597 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.68 122.81 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.129 0.49 . . . . 0.0 110.736 179.66 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.779 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -109.96 114.61 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.631 179.372 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.02 129.61 51.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.043 -179.252 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.642 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.7 p90 -150.38 149.36 29.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.568 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.568 HH12 ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -153.79 145.41 16.69 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 -179.514 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 49.0 Cg_exo -59.15 110.55 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.706 2.271 . . . . 0.0 112.568 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HE2' HH12 ' A' ' 20' ' ' ARG . 0.5 OUTLIER -64.63 -19.64 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.091 179.978 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.1 -18.24 62.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.528 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 t -117.57 -162.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.608 179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.09 125.59 74.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.386 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.57 -142.49 47.89 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.669 179.651 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 63.14 59.74 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.091 0.472 . . . . 0.0 111.138 -179.975 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -76.53 174.81 9.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.749 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.773 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.8 mttt -142.43 132.31 24.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.857 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -119.68 135.62 54.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.298 0.571 . . . . 0.0 112.396 -178.489 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.14 111.77 6.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 179.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 m -88.31 132.61 34.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.146 0.498 . . . . 0.0 112.294 -178.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -140.4 105.54 6.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.217 179.29 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.837 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 17.6 Cg_endo -58.2 -179.75 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.504 2.136 . . . . 0.0 113.516 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.559 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -65.79 88.9 0.11 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.237 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.596 ' HB3' HD13 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -179.81 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 109.898 -179.508 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.875 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -79.74 -3.48 47.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.762 179.39 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.681 HD22 ' H ' ' A' ' 39' ' ' SER . 6.1 p-10 42.47 -125.17 0.7 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.992 -179.835 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.681 ' H ' HD22 ' A' ' 38' ' ' ASN . 2.1 m -88.28 117.04 26.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.735 0.303 . . . . 0.0 110.974 179.878 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.43 ' CB ' HD13 ' A' ' 33' ' ' ILE . 32.5 t80 -83.52 126.73 33.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.286 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 t -97.98 147.44 24.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.421 -179.637 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.32 131.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.908 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -62.51 -111.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.1 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' C ' HD22 ' A' ' 45' ' ' LEU . . . -81.39 140.13 20.95 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.908 -0.663 . . . . 0.0 114.14 -178.021 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' H ' HG21 ' A' ' 73' ' ' THR . 2.9 mm? -126.67 3.59 6.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.61 179.223 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' N ' HG21 ' A' ' 73' ' ' THR . 3.2 mtmt 62.54 154.65 0.11 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.157 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' CA ' HG23 ' A' ' 74' ' ' THR . 88.4 Cg_endo -78.41 155.56 28.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.797 2.332 . . . . 0.0 112.513 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.76 3.35 59.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.192 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.92 112.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.089 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.0 t -89.44 148.37 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.05 0.452 . . . . 0.0 110.494 178.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' CE1' ' HG3' ' A' ' 21' ' ' PRO . 39.5 m-85 -138.78 104.42 5.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.623 179.428 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 8.4 tt0 -90.26 128.63 36.46 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.532 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 18' ' ' ARG . . . -142.2 147.94 19.55 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.331 -179.084 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' CB ' ' HA ' ' A' ' 68' ' ' ARG . 6.0 pm0 -133.83 138.83 45.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.162 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.779 ' HG ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -100.03 107.89 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.071 0.462 . . . . 0.0 111.647 -178.66 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 5.3 mp -101.69 114.1 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.137 179.157 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 1.3 m -87.31 136.34 32.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 -179.705 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.804 HD13 ' HE3' ' A' ' 14' ' ' LYS . 3.6 mp -118.87 132.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.046 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 30.1 tt0 -92.73 -175.77 4.04 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.427 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.58 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 5.4 mt-30 -60.33 -29.53 68.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.092 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.37 7.98 42.47 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.323 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.474 ' HA2' ' CG2' ' A' ' 58' ' ' ILE . . . 94.0 147.95 23.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.082 179.343 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.575 ' H ' HG23 ' A' ' 58' ' ' ILE . 5.3 m-70 64.37 157.25 0.08 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.5 0.19 . . . . 0.0 111.285 179.746 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.764 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -179.01 -57.47 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 179.281 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 3.5 tt0 -145.09 144.19 30.81 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.114 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.28 114.07 16.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 178.433 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.9 m -137.2 120.74 17.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.814 179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' CB ' ' A' ' 54' ' ' GLN . 6.5 mtp85 -97.94 132.62 43.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.864 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' O ' ' O ' ' A' ' 53' ' ' GLY . 19.8 p90 -149.4 131.31 15.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.191 0.52 . . . . 0.0 112.295 -179.717 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 52' ' ' GLU . 1.7 m-20 -95.2 141.64 28.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.016 179.256 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -152.66 160.75 43.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.475 0.655 . . . . 0.0 112.491 -178.853 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 75' ' ' SER . 1.0 OUTLIER -148.11 167.13 25.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.835 178.952 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.991 HG23 HG22 ' A' ' 74' ' ' THR . 8.8 t -96.69 -47.07 6.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.683 0.278 . . . . 0.0 111.68 -179.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.991 HG22 HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -135.97 -2.93 2.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.025 0.44 . . . . 0.0 110.865 -179.736 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 72' ' ' THR . 0.9 OUTLIER -88.75 166.11 14.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.811 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.15 100.34 13.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.74 105.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.994 179.835 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 118.04 0.68 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.083 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 70' ' ' ASP . 36.9 Cg_endo -64.9 149.35 89.66 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.477 2.118 . . . . 0.0 112.344 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.95 3.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.582 -179.956 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 59.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 0.0 110.803 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.18 156.52 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 161.96 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -66.64 108.74 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -77.43 90.7 3.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -65.77 -76.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.146 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.51 -29.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.088 -179.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -117.43 99.53 7.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.818 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.9 0.381 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -130.01 -20.54 3.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.47 -6.92 65.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.56 -86.71 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.69 0.281 . . . . 0.0 111.206 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -51.46 69.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.961 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.34 119.94 29.23 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.95 -93.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.426 2.084 . . . . 0.0 112.083 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 15.9 pt20 -84.0 148.1 52.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.707 179.77 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 8' ' ' GLN . 6.6 Cg_exo -72.95 -157.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.75 2.3 . . . . 0.0 112.362 -179.722 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.94 69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.755 179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.674 ' HB2' ' HA3' ' A' ' 35' ' ' GLY . 10.2 p-80 -64.11 162.75 13.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.689 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.664 HG13 ' N ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -97.14 152.09 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.87 179.885 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.664 ' N ' HG13 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.51 -46.63 48.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.283 179.485 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 16.5 pttm -162.05 144.26 11.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.134 179.366 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -113.07 140.6 47.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.707 179.211 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.421 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -114.22 125.35 71.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 179.745 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -109.41 114.28 27.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.323 179.789 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -112.21 129.15 56.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.771 179.487 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 15.0 p90 -146.21 147.15 31.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.273 0.559 . . . . 0.0 112.234 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -151.29 145.67 18.23 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.024 179.911 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 47.3 Cg_exo -57.53 109.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.334 2.023 . . . . 0.0 112.549 -179.594 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 1.7 mttm -68.45 -32.68 72.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.52 179.471 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -80.58 -18.85 47.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 21' ' ' PRO . 1.7 m -149.48 72.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.576 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 20' ' ' ARG . 22.7 m -47.02 146.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.947 -179.474 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.86 79.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.7 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' A' ' 28' ' ' TRP . 14.5 ttp180 65.15 147.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 111.54 179.728 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.509 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 37.2 m95 -101.72 -176.63 3.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -139.08 153.26 48.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.353 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 138.32 54.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.2 111.97 7.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.823 179.066 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 1.1 m -93.77 126.23 38.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.721 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 1.8 mt -138.2 107.04 7.97 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 178.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 24.1 Cg_exo -64.13 109.91 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.515 2.143 . . . . 0.0 113.325 -178.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 11' ' ' HIS . . . 49.54 24.73 5.8 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.818 178.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 60.71 115.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.086 0.47 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HD2' ' A' ' 34' ' ' PRO . 5.9 mp -82.44 -33.21 28.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -177.51 -153.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.117 -179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -76.8 104.83 7.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -118.19 122.75 43.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 -179.411 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 141.57 49.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.287 -179.713 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.7 mm -89.96 130.19 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.714 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -112.89 156.96 22.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.856 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.35 20.56 1.96 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.26 -179.785 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.766 ' HB2' ' HB ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -121.61 177.98 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.952 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.659 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -139.45 163.47 45.17 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.702 0.286 . . . . 0.0 111.652 -179.173 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HG3' HG21 ' A' ' 74' ' ' THR . 19.9 Cg_exo -66.1 109.51 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.629 2.219 . . . . 0.0 112.605 -179.692 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.0 -0.21 11.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.104 179.399 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 46' ' ' LYS . 14.7 p -120.23 137.12 55.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.397 . . . . 0.0 111.351 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 71' ' ' PHE . 0.5 OUTLIER -112.7 137.88 43.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.01 179.7 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.689 ' CD1' HD23 ' A' ' 45' ' ' LEU . 7.9 m-85 -111.21 174.14 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.279 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 19' ' ' TRP . 0.2 OUTLIER -116.21 129.49 56.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.736 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.71 132.17 9.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 119.857 -1.163 . . . . 0.0 113.797 -178.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' THR . 1.4 mt-30 -133.56 113.83 12.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.112 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 15' ' ' TYR . 3.9 mt -100.66 107.56 19.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 4.4 mp -101.77 115.68 44.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.504 ' OG ' HD13 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -82.6 119.17 23.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 110.437 179.739 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 63' ' ' HIS . 20.5 mt -110.62 119.17 58.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.51 -179.472 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -175.68 4.11 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.082 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -61.58 -17.44 55.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.658 0.266 . . . . 0.0 111.1 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.422 ' HE1' HE21 ' A' ' 64' ' ' GLN . 1.7 p90 -103.14 -5.17 23.51 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.28 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.92 179.61 16.01 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -49.4 157.67 0.48 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.681 0.277 . . . . 0.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.422 HE21 ' HE1' ' A' ' 61' ' ' TYR . 1.4 pt20 -165.46 -2.58 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.852 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.649 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -145.33 133.69 21.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.606 0.241 . . . . 0.0 111.383 -179.689 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' ILE . 67.3 t -134.94 133.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.975 179.231 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' GLN . 6.2 m -137.51 137.22 38.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.145 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.48 139.65 44.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.52 161.59 40.78 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.306 -179.621 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.8 141.25 29.0 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.245 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 1.1 t80 -120.24 139.1 53.18 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -174.157 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 p -152.09 168.52 25.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.366 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 1.2 t -115.44 -64.85 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.876 179.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.755 ' H ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -107.34 -31.96 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 -179.462 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 t -78.07 89.85 4.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.43 105.37 0.11 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.232 -179.758 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 101.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.31 69.76 21.97 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.32 -166.28 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.993 2.462 . . . . 0.0 112.241 -179.777 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.49 99.28 0.01 OUTLIER Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.478 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m 55.78 -149.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.463 0.173 . . . . 0.0 110.671 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HB3' ' H ' ' A' ' 83' ' ' SER . 0.1 OUTLIER 59.05 -147.12 0.5 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.794 179.906 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.464 ' H ' ' HB3' ' A' ' 82' ' ' ARG . 3.0 m -60.0 173.98 0.55 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.837 0.351 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -104.37 146.42 28.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -157.82 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.664 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 13.74 29.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -100.46 -168.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.011 -179.926 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.23 129.2 21.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.918 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.19 116.86 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.12 -124.91 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -132.91 105.1 6.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.782 0.325 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -21.91 63.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.974 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . . . 58.78 93.62 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 6' ' ' ALA . 14.8 Cg_endo -57.47 131.4 44.37 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.578 2.185 . . . . 0.0 112.465 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.39 67.44 5.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.609 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.82 -72.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.742 2.295 . . . . 0.0 112.05 -179.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -131.98 1.21 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.77 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -68.18 -103.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 57' ' ' SER . 0.4 OUTLIER -105.2 148.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 179.954 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -43.29 52.22 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.154 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -175.61 144.94 0.69 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.274 178.863 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.745 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.4 m-85 -100.79 150.2 23.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.612 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.2 mm -125.02 123.3 65.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.79 179.552 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.695 HD12 HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -110.11 114.09 27.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.517 178.818 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.55 129.68 56.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.4 -179.646 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 4.8 p90 -141.28 149.27 41.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.168 0.508 . . . . 0.0 111.739 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -159.21 147.98 14.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.405 -179.849 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 48.4 Cg_exo -57.81 114.73 2.09 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.543 2.162 . . . . 0.0 112.665 -179.595 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.814 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 27.6 mtpt -75.31 -25.07 57.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.957 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -86.23 -35.87 19.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.204 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.69 -175.53 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 111.111 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.03 132.24 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.067 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.5 -165.49 31.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.8 150.04 21.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.82 177.6 5.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -137.17 154.57 50.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.881 179.415 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.62 133.44 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.19 0.519 . . . . 0.0 111.891 -179.463 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.85 111.43 8.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.469 179.015 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 58.8 m -90.56 136.74 32.86 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.318 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.799 HG22 HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -140.07 103.8 6.76 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.474 177.668 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' O ' ' HB1' ' A' ' 6' ' ' ALA . 4.6 Cg_exo -79.35 127.4 7.41 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.58 2.186 . . . . 0.0 112.699 -179.241 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.19 165.82 36.67 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.991 179.597 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -81.89 67.13 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.064 0.459 . . . . 0.0 110.759 179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.799 HD12 HG22 ' A' ' 33' ' ' ILE . 2.7 mt -78.81 -2.88 41.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.027 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER 105.96 174.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.503 1.127 . . . . 0.0 110.608 -179.675 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -77.18 111.75 13.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 -179.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -97.66 117.48 32.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.449 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -127.4 142.17 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.74 116.66 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -119.49 42.36 2.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.82 10.47 58.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -83.28 166.23 18.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 110.887 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.691 ' O ' HG21 ' A' ' 73' ' ' THR . 0.0 OUTLIER -94.06 134.85 25.31 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.148 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 66.9 Cg_exo -38.96 123.38 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.5 2.8 . . . . 0.0 114.07 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.0 7.2 17.67 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.127 178.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 73' ' ' THR . 2.0 t -121.52 136.67 57.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 117.551 0.676 . . . . 0.0 112.301 -179.876 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.816 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -115.34 133.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.993 178.186 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' PHE . 27.4 m-85 -116.18 -173.12 2.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.814 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 9.8 tm-20 -126.07 129.45 49.15 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.91 118.47 4.25 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.085 -179.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.689 HE21 HD11 ' A' ' 56' ' ' ILE . 37.9 tt0 -132.66 113.89 13.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.043 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.695 HD13 HD12 ' A' ' 17' ' ' LEU . 22.7 tp -103.44 106.74 17.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.507 -179.195 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.689 HD11 HE21 ' A' ' 54' ' ' GLN . 4.9 mp -100.52 138.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.591 178.838 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.822 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 4.7 m -94.85 151.11 19.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.356 0.598 . . . . 0.0 110.975 -179.5 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 25.8 mt -116.41 131.84 67.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.508 -179.417 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.882 ' HG2' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -118.74 -176.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.442 178.461 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -75.22 -20.68 59.12 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.748 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -104.47 -5.68 21.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.445 179.809 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.27 139.21 1.76 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.187 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.28 81.78 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.819 0.343 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.882 ' HB2' ' HG2' ' A' ' 59' ' ' GLN . 1.1 tt0 -101.48 -67.75 0.85 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.608 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.822 ' H ' ' HB2' ' A' ' 57' ' ' SER . 4.0 tp10 -140.54 127.56 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.04 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.628 HG13 HG13 ' A' ' 56' ' ' ILE . 5.4 t -116.27 138.29 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 111.861 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.87 134.12 34.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.413 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -111.67 143.87 41.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.0 0.429 . . . . 0.0 111.706 -179.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.72 161.1 40.78 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.94 148.03 22.51 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.624 ' HB3' ' HB2' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -120.16 142.38 49.01 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.456 -176.339 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.816 HG23 HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -149.92 168.08 24.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.592 179.272 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 46' ' ' LYS . 6.0 p -80.13 -147.35 0.05 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.916 179.558 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.539 ' OG1' ' HG3' ' A' ' 47' ' ' PRO . 1.8 p -65.31 -10.47 32.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.965 0.412 . . . . 0.0 110.621 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.19 163.67 6.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.109 -179.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.91 98.86 11.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.26 34.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.46 86.48 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.44 -158.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.452 2.101 . . . . 0.0 112.296 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.13 -67.26 1.41 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.421 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.19 -91.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.661 0.267 . . . . 0.0 110.852 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.66 -14.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.777 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.0 m -150.52 -1.08 0.4 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.56 59.38 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.872 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.89 -116.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 -179.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.83 -165.7 0.14 Allowed 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.791 0.329 . . . . 0.0 110.986 -179.878 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 55.61 74.69 0.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.025 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.09 -16.0 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.305 -0.855 . . . . 0.0 110.942 179.897 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.817 0.341 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.39 34.81 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.59 -79.9 0.19 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.519 179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m 55.45 33.43 20.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.76 0.314 . . . . 0.0 110.96 -179.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 59.3 179.39 0.08 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.101 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.31 67.44 6.23 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.28 167.37 25.32 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.449 2.099 . . . . 0.0 112.247 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.05 106.1 39.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.71 -178.74 4.82 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.519 2.146 . . . . 0.0 112.572 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 m -82.97 -2.03 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -139.68 -155.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 ' CD1' ' HG3' ' A' ' 64' ' ' GLN . 7.9 tp -70.85 144.95 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.391 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.87 95.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.055 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -167.46 145.41 4.68 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.467 179.513 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.73 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 1.4 m-85 -100.45 145.3 28.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.688 179.349 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.624 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -115.03 121.06 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.003 0.43 . . . . 0.0 109.938 179.217 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.747 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.26 114.07 27.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.476 -179.909 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 8.5 mtp85 -114.75 128.75 56.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.747 179.3 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.669 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 9.2 p90 -144.6 145.72 31.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.3 0.572 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB3' ' CD2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -152.06 145.88 18.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.335 -179.812 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG3' ' HE1' ' A' ' 51' ' ' TYR . 42.3 Cg_exo -58.77 110.24 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.444 2.096 . . . . 0.0 112.335 -179.78 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.77 ' HG2' ' HB2' ' A' ' 52' ' ' GLU . 8.7 mmtm -72.11 -13.97 61.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.384 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 50' ' ' VAL . 15.4 p30 -96.13 -26.92 15.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.549 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.82 -12.93 15.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 t 50.41 70.67 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.6 -154.26 11.94 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.607 -179.811 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -89.49 141.18 28.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 110.649 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.465 ' CD2' ' HB3' ' A' ' 20' ' ' ARG . 42.1 m95 -73.21 178.0 4.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 -179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 1.5 mtpp -139.48 147.87 41.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.05 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -119.81 137.0 54.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.275 0.559 . . . . 0.0 112.304 -178.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.01 122.12 14.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.623 HG22 ' HB2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -97.21 116.76 30.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.221 0.534 . . . . 0.0 112.395 -178.79 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.73 ' O ' ' HB2' ' A' ' 15' ' ' TYR . 0.3 OUTLIER -136.87 106.77 8.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.989 178.945 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 14' ' ' LYS . 37.3 Cg_exo -59.94 -157.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.535 2.157 . . . . 0.0 114.157 -177.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.696 ' O ' HD23 ' A' ' 37' ' ' LEU . . . -63.38 110.25 3.26 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.618 -0.719 . . . . 0.0 114.485 -178.339 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 35' ' ' GLY . 12.9 p80 3.7 69.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.218 1.007 . . . . 0.0 113.504 178.911 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.809 ' HG ' ' HB2' ' A' ' 39' ' ' SER . 0.1 OUTLIER -84.16 0.66 47.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.518 179.472 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 81.79 25.02 0.22 Allowed 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -174.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.809 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . 5.7 t -75.77 176.68 7.53 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 110.809 -2.905 . . . . 0.0 112.776 -178.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.13 108.48 4.67 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.747 -1.569 . . . . 0.0 112.076 -177.309 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -104.28 141.87 35.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.806 178.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.734 HD13 HD22 ' A' ' 17' ' ' LEU . 1.3 mp -82.3 129.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.052 0.453 . . . . 0.0 111.691 -179.314 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -174.29 -170.72 0.54 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.563 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.99 84.79 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.777 179.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.796 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.6 mm? -115.37 167.57 10.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.83 ' O ' HG21 ' A' ' 73' ' ' THR . 0.0 OUTLIER -96.8 126.4 43.03 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.377 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.641 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 13.2 Cg_exo -32.66 137.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.751 3.634 . . . . 0.0 114.963 -179.483 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.52 -4.16 54.09 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.61 177.932 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -122.63 126.84 74.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 117.842 0.821 . . . . 0.0 112.966 -179.238 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.926 HG23 HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.29 146.29 12.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 177.364 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HE1' ' HG3' ' A' ' 21' ' ' PRO . 71.2 m-85 -137.55 130.94 30.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.672 0.272 . . . . 0.0 110.988 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.77 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . 8.9 tp10 -79.85 129.46 34.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.479 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.68 127.17 7.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.089 -178.265 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -134.23 114.05 12.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.747 ' HG ' HD12 ' A' ' 17' ' ' LEU . 2.1 mt -101.97 106.4 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 111.495 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.61 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.6 mp -104.13 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.882 178.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.616 ' HB2' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -82.52 150.14 27.13 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.743 0.782 . . . . 0.0 111.131 -179.039 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -116.65 132.26 66.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.585 -179.137 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.945 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -108.13 -174.21 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.531 ' H ' ' NE2' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -60.05 -31.71 70.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.248 179.533 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -103.97 -4.95 22.71 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.146 179.332 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.85 156.39 30.02 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.858 179.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.7 t60 64.0 134.01 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.322 0.249 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.945 ' HG2' ' HB2' ' A' ' 59' ' ' GLN . 3.6 mm-40 -161.2 -68.86 0.06 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.631 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.616 ' H ' ' HB2' ' A' ' 57' ' ' SER . 1.5 tt0 -137.53 115.34 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.183 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -123.4 129.8 74.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 111.933 178.795 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -129.42 141.27 51.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.366 179.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -104.88 133.46 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.573 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -155.99 136.36 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.991 179.534 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.1 142.73 27.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -148.91 161.32 42.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.171 0.51 . . . . 0.0 111.393 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.926 HG23 HG23 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -137.67 170.32 16.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.738 -179.341 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.83 HG21 ' O ' ' A' ' 46' ' ' LYS . 9.4 p -58.39 -139.39 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.042 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.423 HG23 ' HD3' ' A' ' 47' ' ' PRO . 6.7 p -72.51 11.86 0.56 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 73' ' ' THR . 8.8 t -94.17 -35.08 12.67 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m 68.04 141.86 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.807 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 94.5 p -149.67 19.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.749 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.3 p -108.97 112.58 59.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.11 -7.54 14.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.443 2.096 . . . . 0.0 112.532 -179.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.87 92.4 0.14 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.655 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.7 t 55.67 -98.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 111.13 179.905 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.471 ' HB3' ' H ' ' A' ' 83' ' ' SER . 10.5 ttp-105 -170.37 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.471 ' H ' ' HB3' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -143.35 -156.81 0.72 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.932 -179.973 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -65.95 -174.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 111.301 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -139.36 14.66 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.862 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.0 t60 56.16 81.35 0.13 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -66.55 121.18 14.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -108.95 -49.91 3.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.787 179.931 . . . . . . . . 1 1 . 1 stop_ save_